As filed with the U.S. Securities and Exchange Commission on March 24, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Ategrity Specialty Holdings LLC*
(Exact name of registrant as specified in its charter)
| |
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
|
6331
(Primary Standard Industrial
Classification Code Number)
|
|
|
82-4925734
(I.R.S. Employer
Identification Number)
|
|
9 West 57th Street, 33rd Floor, New York, NY 10019
Telephone: (212) 509-1600
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Justin Cohen
Chief Executive Officer
9 West 57th Street, 33rd Floor, New York, NY 10019
Telephone: (212) 509-1600
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| |
Marc D. Jaffe
Erika L. Weinberg
Gary D. Boss
Latham & Watkins LLP
1271 Avenue of the Americas
New York, NY 10020
(212) 906-1200
|
|
|
Eric Crespolini
Ategrity Specialty Holdings LLC
9 West 57th Street, 33rd Floor,
New York, NY 10019
Telephone: (212) 509-1600
|
|
|
Dwight S. Yoo
Elena M. Coyle
Ryan J. Dzierniejko
Skadden, Arps, Slate, Meagher &
Flom LLP
One Manhattan West
New York, NY 10001
(212) 735-3000
|
|
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement is declared effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| |
Large accelerated filer
☐
|
|
|
Accelerated filer
☐
|
|
| |
Non-accelerated filer
☒
|
|
|
Smaller reporting company
☐
|
|
| |
|
|
|
Emerging growth company
☒
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
* Ategrity Specialty Holdings LLC will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings prior to the consummation of this offering.
The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted
Subject to completion, dated , 2025
Preliminary prospectus
shares
Common stock
This is the initial public offering of shares of common stock of Ategrity Specialty Insurance Company Holdings.
Prior to this offering, there has been no public market for our common stock. The initial public offering price of our common stock is estimated to be between $ and $ per share. We have applied to list our common stock on the New York Stock Exchange (the “NYSE”) under the symbol “ASIC.” The listing will be subject to the approval of our application.
We are an “emerging growth company” as that term is defined in the Jumpstart Our Business Startups Act of 2012, and, as such, have elected to comply with certain reduced public company reporting requirements for this registration statement and may do so in future filings. See “Prospectus summary—Implications of being an emerging growth company.”
Upon completion of this offering, Zimmer Financial Services Group LLC (“ZFSG”) will continue to own more than a majority of the voting power of our shares of common stock eligible to vote in the election of our directors. As a result, we will be a “controlled company” as defined under the corporate governance rules of NYSE and will be exempt from certain corporate governance requirements of such rules. See “Management—Director independence and controlled company exemption.”
Investing in our common stock involves risks. See “Risk factors” beginning on page 16 to read about factors you should consider before purchasing shares of our common stock.
Neither the Securities and Exchange Commission (“SEC”) nor any state securities commission or regulatory authority has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| |
|
|
|
Per share
|
|
|
Total
|
|
| |
Initial public offering price
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
| |
Underwriting discounts and commissions(1)
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
| |
Proceeds to us, before expenses
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
(1) See “Underwriting” for a description of compensation to be paid to the underwriters.
At our request, the underwriters have reserved for sale, at the initial public offering price, up to % of the shares offered by this prospectus, excluding the additional shares that the underwriters have an option to purchase, for sale to certain of our employees, certain of our directors and certain other parties. See “Underwriting—Directed Share Program.”
We have granted the underwriters an option for a period of 30 days from the date of this prospectus to purchase up to an additional shares of our common stock from us at the initial public offering price less the underwriting discounts and commissions to cover over-allotments.
The underwriters expect to deliver the shares of common stock through the book-entry facilities of the Depository Trust Company on or about , 2025.
| |
J.P. Morgan
|
|
|
Barclays
|
|
, 2025
Table of contents
| |
|
|
Page
|
|
|
|
|
|
|
|
i |
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
55 |
|
|
|
|
|
|
|
|
57 |
|
|
|
|
|
|
|
|
58 |
|
|
|
|
|
|
|
|
59 |
|
|
|
|
|
|
|
|
60 |
|
|
|
|
|
|
|
|
62 |
|
|
|
|
|
|
|
|
82 |
|
|
|
|
|
|
|
|
97 |
|
|
|
|
|
|
|
|
108 |
|
|
|
|
|
|
|
|
113 |
|
|
|
|
|
|
|
|
122 |
|
|
|
|
|
|
|
|
133 |
|
|
|
|
|
|
|
|
135 |
|
|
|
|
|
|
|
|
142 |
|
|
|
|
|
|
|
|
145 |
|
|
|
|
|
|
|
|
149 |
|
|
|
|
|
|
|
|
159 |
|
|
|
|
|
|
|
|
160 |
|
|
|
|
|
|
|
|
F-1
|
|
|
About this prospectus
Market and industry data
In this prospectus, we present certain market and industry data. This information is based on third-party sources which we believe to be reliable. We have not independently verified any third-party information. Forecasts and projections are based on historical market data, other publicly available information, our knowledge of our industry, and assumptions based on such information and knowledge. These forecasts and projections have not been verified by any independent source. In addition, assumptions and estimates of our and our industry’s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk factors.” These and other factors could cause future performance to differ materially from our assumptions and estimates. See “Forward-looking statements.”
Trademarks and service marks
Trade names, trademarks, and service marks of other companies appearing in this prospectus are the property of their respective holders. Solely for convenience, the trademarks, service marks, and trade names are referred to in this prospectus without the SM and ® symbols, but such references are not intended to indicate, in any way, that the owner thereof will not assert, to the fullest extent under applicable law, such owner’s rights to their trademarks, service marks, and trade names.
Non-GAAP financial measures
This prospectus contains certain financial measures that are not presented in accordance with generally accepted accounting principles in the United States (“GAAP”). Under U.S. securities laws, these measures are called “non-GAAP financial measures.” We believe that certain non-GAAP financial measures provide investors in our common stock with additional useful information in evaluating our performance. Management believes that excluding certain items that are not indicative of core performance assists in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.
These non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are limitations related to the use of these non-GAAP financial measures as compared to the most directly comparable GAAP financial measures.
We use the following non-GAAP financial measures throughout this prospectus as defined below:
•
Underwriting income is defined as income before income taxes excluding the impact of net investment income, net realized and unrealized gains (losses) on investments, other income, interest expense, and other expenses (which include expenses related to corporate activities and expenses recorded by us in anticipation of this offering).
•
Adjusted net income attributable to members is defined as net income attributable to members excluding certain non-operating expenses, which include expenses recorded by us in anticipation of this offering.
•
Adjusted return on members’ equity is defined as adjusted net income attributable to members expressed as a percentage of average beginning and ending members’ equity during the period.
For a reconciliation of such measures to their most directly comparable GAAP financial measures, see “Management’s discussion and analysis of financial condition and results of operations—Reconciliation of non-GAAP financial measures.”
Glossary
The following are abbreviations and definitions of certain insurance, reinsurance, financial, and other terms used in this prospectus.
Absolute Return MidCap Fund—ZP Master MidCap Fund, Ltd., a Cayman Islands exempted company.
Absolute Return Utility & Infrastructure Fund—ZP Master Utility Fund, Ltd., a Cayman Islands exempted company.
Admitted insurer—An insurer that has received a license or certificate of authority from a state regulatory authority to sell insurance in that state. Admitted insurers are subject to various state laws that govern organization, capitalization, policy forms, premium rate approvals, and claims handling.
A.M. Best—A.M. Best Company, Inc., a rating agency and publisher for the insurance industry.
Ategrity Ltd—Our Bermuda-regulated reinsurance subsidiary, Ategrity Specialty Insurance Limited, a Bermuda exempted company (formerly known as Sequentis Reinsurance Company Limited) and wholly-owned indirect subsidiary of the Company.
Ategrity Specialty—Our Delaware-regulated insurance subsidiary, Ategrity Specialty Insurance Company, a Delaware corporation and wholly-owned direct subsidiary of the Company. Ategrity Specialty is licensed in the State of Delaware to transact certain lines of property and casualty insurance and is eligible or approved to write surplus lines in 48 states and the District of Columbia.
BMA—Bermuda Monetary Authority.
Combined ratio—The sum of the loss ratio and the expense ratio. A combined ratio under 100% indicates an underwriting profit. A combined ratio over 100% indicates an underwriting loss.
Commission—The fee paid to an agent or a broker for placing insurance or reinsurance, generally determined as a percentage of the written premium.
Distribution partners—Intermediaries with whom we have strategic partnerships, such as agents, brokers, or digital platforms, that help us reach and serve consumers more effectively. We count our distribution partners as our individual commercial relationships based on the unique producer code assigned to such distribution partner.
ES Requirements—The Economic Substance Act 2018 and the Economic Substance Regulations 2018.
Excess and surplus lines (“E&S”)—Lines of insurance which are generally unavailable from admitted insurers due to perceived risk related to the insured’s business and which, consequently, are placed by surplus lines agents or brokers with insurers that are not admitted in the subject jurisdiction. E&S insurance policies generally are not subject to regulations governing premium rates or policy language.
Excess of loss—A type of reinsurance that indemnifies the reinsured against all, or a specified portion of, losses on underlying insurance policies in excess of a specified amount, which is called an “attachment level” or “retention.” Excess of loss reinsurance may be written in multiple layers, in which, on any given layer, a reinsurer or group of reinsurers accepts a band of coverage up to a specified amount. Any liability exceeding the outer limit of the program reverts to the ceding company, which also bears credit risk to the reinsurers.
Expense ratio—The ratio, expressed as a percentage, of underwriting, acquisition, and insurance expenses less fee income to net premiums earned.
Facultative reinsurance—Facultative reinsurance is a specific reinsurance policy for which terms can be negotiated by the insurer and reinsurer on a risk-by-risk basis, rather than as to a group or class of business.
Feeder Fund—ZP Utility Fund, LP, a Delaware limited partnership. The Feeder Fund operates as a feeder fund in a “master-feeder” structure, in which the Feeder Fund invests substantially all of its assets in the Absolute Return Utility & Infrastructure Fund.
Financial strength rating—The opinion of rating agencies regarding the financial ability of an insurance or reinsurance company to meet its financial obligations under its policies.
GAAP—Generally accepted accounting principles in the United States.
General Partners—The MidCap General Partner and the Utility General Partner.
Gross written premiums—Total premiums recorded on the books of an insurer at the time an insurance policy is issued, before deductions for premiums on ceded reinsurance.
Hard market—An insurance market generally driven by a shortage of underwriting capacity whereby coverage is harder to place, resulting in elevated rates and premiums.
Incurred but not yet reported (“IBNR”) reserves—Loss reserves for estimated losses which have been incurred but not yet reported to the insurer.
Incurred losses—The total losses sustained by an insurance company under a policy or policies, whether paid or unpaid. Incurred losses include a provision for claims that have occurred but have not yet been reported to the insurer.
Investment Manager—Zimmer Partners, LP, a Delaware limited partnership and the investment manager of the Absolute Return Utility & Infrastructure Fund, the Absolute Return MidCap Fund, and our fixed income portfolios. The Investment Manager is registered with the SEC as a registered investment advisor under the Investment Advisors Act of 1940. The Investment Manager is an entity affiliated with and controlled by ZFSG.
IRIS—NAIC Insurance Regulatory Information System, which is a collection of analytical tools designed to provide state insurance regulators with an integrated approach to screening and analyzing the financial condition of insurance companies operating in their respective states.
Limited Partnership Agreements—The MidCap Limited Partnership Agreement and the Utility Limited Partnership Agreement.
Limited Partnerships—The MidCap Limited Partnership and the Utility Limited Partnership.
Long-tail—Losses that usually have a longer delay between the occurrence of a loss and the time the loss is reported. Casualty losses are generally longer tailed.
Loss ratio—The ratio, expressed as a percentage, of losses and loss adjustment expenses to net premiums earned.
Loss adjustment expenses—The expenses of settling claims, including legal and other fees, and the portion of general expenses allocated to claim resolution.
Losses and loss adjustment expenses—Liabilities established by insurers to reflect the estimated cost of claims payments that the insurer will ultimately be required to pay with respect to insurance it has written. Reserves are established for losses and for loss adjustment expenses and consist of case reserves and IBNR reserves.
MidCap General Partner—ZP MidCap GP, LLC, a Delaware limited liability company and the general partner of the MidCap Limited Partnership. The MidCap General Partner is an entity affiliated with and controlled by ZFSG.
MidCap Limited Partnership—ZP MidCap Fund, L.P., a Delaware limited partnership. The MidCap Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the MidCap Limited Partnership invests substantially all of its assets in the Absolute Return MidCap Fund. As of January 1, 2025, the Company and its subsidiaries own 17.1% of the limited partnership interest in the MidCap Limited Partnership.
MidCap Limited Partnership Agreement—The Amended and Restated Limited Partnership Agreement dated July 1, 2020, among the MidCap General Partner, as general partner, and the other limited partners thereof, to which we and Ategrity Ltd acceded by way of a subscription agreement on January 1, 2025.
National Association of Insurance Commissioners (“NAIC”)—A voluntary organization of state insurance officials that promulgates model laws regulating the insurance industry, values securities owned by insurers, develops and modifies insurer financial reporting statements and insurer performance criteria, and performs other services with respect to the insurance industry.
Net premiums earned—The portion of net written premiums that is recognized for accounting purposes as income during a period.
Net written premiums—Gross written premiums for a given period less premiums ceded to reinsurers during such period.
Non-admitted market—The insurance market of companies not licensed to transact the business of insurance in a particular U.S. jurisdiction. A non-admitted company is permitted to issue insurance policies only in accordance with an exemption from the jurisdiction’s insurance licensing laws, for example, through an E&S lines broker licensed in that jurisdiction, or to issue policies “self-procured” by the insured or its broker from the insurer outside the jurisdiction of the insured.
Probable maximum loss (“PML”)—The maximum amount of loss that we would expect to incur on a policy or collection of policies under ordinary circumstances, based on computer modeling and actuarial techniques.
Productionized Underwriting—Our term for the technology-driven method of standardizing, simplifying, and automating our transaction process.
Reinsurance—The practice whereby one party, called the reinsurer, in consideration of a premium paid to it, agrees to indemnify another party, called the reinsured, for part or all of the liability assumed by the reinsured under a policy or policies of insurance which it has issued. The reinsured may be referred to as the original or primary insurer, the direct writing company or the ceding company.
Reinsurer—An insurer that agrees to indemnify another insurer against all or part of a loss which the latter may incur under a policy or policies it has issued.
Retention—The amount or portion of risk which an insurer or reinsurer retains or assumes for its own account. Losses, or a portion thereof, in excess of the retention level are paid by the reinsurer or a retrocessionaire. In proportional treaties, the retention may be a percentage of the original policy’s limit. In excess of loss business, the retention is a dollar amount of loss, a loss ratio, or a percentage.
SAP—Those statutory accounting principles and practices which provide the framework for the preparation of insurance company financial statements and the recording of transactions, in accordance with the rules and procedures adopted by regulatory authorities, generally emphasizing solvency considerations rather than a going-concern concept of accounting.
Short-tail—Losses that are usually known and reported within a relatively short period of time after the underlying loss event has occurred. Property losses are generally short tailed.
Soft market—Insurance markets characterized by a stable or excessive supply of underwriting capacity, resulting in flat or declining rates or premiums.
Specialty P&C market—Although no standard definition for the specialty market exists, Standard & Poor’s Ratings Services indicates that the following lines of business or exposure profiles exemplify the space: high-hazard or nonstandard insurance, niche market segments, tailored underwriting, and both admitted and E&S lines. Many specialty insurers offer both admitted and E&S products, depending on the market conditions and regulatory requirements. Admitted product rates and policy forms are highly regulated and coverage tends to be standardized, while E&S products and policies have freedom of rate and form and can be highly customized.
Statutory surplus—Total admitted assets less total liabilities, as determined in accordance with SAP.
Submission—An application for insurance coverage received by a direct insurer from a prospective policyholder or its broker acting for consideration in connection with possible issuance of an insurance policy by that insurer.
Underwriting—The insurer’s process of reviewing applications submitted for the insurance coverage, deciding whether to accept all or part of the coverage requested and determining the applicable premiums.
Underwriting expenses—The aggregate of policy acquisition costs, including commissions, and the portion of administrative, general, and other expenses attributable to underwriting operations.
Unearned premiums—The portion of a premium representing the unexpired portion of the contract term as of a certain date.
Utility & Infrastructure Investments—Our managed investments in yield-oriented securities in lower-volatility sectors such as utilities, pipelines, infrastructure, and real estate. These investments currently consist of an allocation to each of the Absolute Return Utility & Infrastructure Fund and the Absolute Return MidCap Fund.
Utility General Partner—ZP Utility Insurance GP, LLC, a Delaware limited liability company and the general partner of the Utility Limited Partnership. The Utility General Partner is an entity affiliated with and controlled by ZFSG.
Utility Limited Partnership—ZP Utility Insurance Fund, L.P., a Delaware limited partnership. The Utility Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the Utility Limited Partnership invests substantially all of its assets in the Absolute Return Utility & Infrastructure Fund. The Company and its subsidiaries owned 100% of the limited partnership interest in the Utility Limited Partnership.
Utility Limited Partnership Agreement—The Amended and Restated Limited Partnership Agreement dated April 1, 2018, among us, Ategrity Specialty and Ategrity Ltd, as limited partners, and the Utility General Partner.
Wholesale agent—An intermediary who negotiates contracts of insurance between retail agents and insurance companies, receiving a commission for placement and other services rendered.
Wholesale broker—An intermediary who negotiate contracts of insurance between retail agents and brokers and insurance companies, receiving a commission for placement and other services rendered.
ZFSG—Zimmer Financial Services Group LLC, a Delaware limited liability company.
ZIS—Zimmer Insurance Services LLC, a Delaware limited liability company.
ZTG—Zimmer Technology Group LLC, a Delaware limited liability company.
Other considerations
You should rely only on the information contained in this prospectus. We and the underwriters have not authorized anyone to provide you with information different from that contained in this prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are offering to sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our shares of common stock. Our business, financial condition, results of operations, and prospects may have changed since that date. Information contained on our website is not part of this prospectus.
No action is being taken in any jurisdiction outside the United States to permit a public offering of shares of common stock or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction.
Prospectus summary
This summary highlights information contained elsewhere in this prospectus and does not contain all the information you should consider before making an investment decision. You should read this entire prospectus carefully, including the sections entitled “Risk factors,” “Forward-looking statements,” “Management’s discussion and analysis of financial condition and results of operations,” and our consolidated financial statements and the accompanying notes included elsewhere in this prospectus. References in this prospectus to the “Company,” “Ategrity,” “we,” “us,” and “our” are to Ategrity Specialty Holdings LLC (which will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings prior to the consummation of this offering) and its subsidiaries, unless the context otherwise requires.
Our company
Who we are
We are a profitable and growing specialty insurance company dedicated to providing excess and surplus (“E&S”) products to small to medium-sized businesses (“SMBs”) across the United States. We have built a proprietary underwriting platform that combines sophisticated data analytics with automated and streamlined processes to efficiently serve our clients and deliver long-term value to our stockholders. The SMB market is characterized by large volumes of small-sized policies, and we believe our competitive edge lies in our ability to offer consistent, high-speed, and low-touch interactions that our distribution partners value. This advantage stems from our technology-driven method of standardizing, simplifying, and automating our transaction process, which we call productionized underwriting.
We target industry verticals where we have deep expertise and develop data-driven insights to gain a competitive advantage. We leverage our expertise and our efficient underwriting platform to deliver tailored insurance products and customized services that meet the needs of our distribution partners. We believe the universe of distributors in the SMB segment of the E&S market is rapidly shifting toward agents and brokers who were raised in the digital age. These digital-native and tech-savvy distribution partners expect real-time, frictionless insurance transactions that mirror the seamless experiences they encounter in their daily lives. In an industry where insurance applications are often submitted via email with slow response times, we have designed a technology-driven underwriting process that addresses our distribution partners’ demands for rapid, high-quality interactions. Our strong value proposition has contributed to a growing network of 460 distribution partners as of December 31, 2024, which provides us with increased transaction opportunities and diversified sources of business. Our fully integrated claims management function is designed to enable us to resolve claims efficiently and effectively. We take an active approach to risk management through real-time performance analytics, rigorous risk aggregation monitoring, and robust reinsurance protection aimed at minimizing volatility and generating consistent underwriting results.
We have grown our business substantially while generating attractive underwriting results. For the year ended December 31, 2024, we wrote $437.0 million in gross written premiums, representing a compound annual growth rate of 28.4% over the last two years. Our combined ratio for the year ended December 31, 2024, was 93.9%, a decrease of 3.6% from the year ended December 31, 2023. Our members’ equity at December 31, 2024, was $398.3 million, an increase of $76.6 million (23.8%) from December 31, 2023. We believe that our productionized underwriting capabilities will continue to drive enhanced profitability as we continue to scale our business.
Productionized underwriting
Our company’s mission is to transform the E&S marketplace for SMBs through the power of productionized underwriting with precision, simplicity, and efficiency. When we entered the E&S industry, we found what we believe to be an under-served and inefficient marketplace that was hindered by inconsistent and antiquated processes of legacy insurance carriers. We also believe that many distribution partners and their end-clients were
struggling with slow response times, unpredictable underwriting capacity, and subpar pricing, which we believe make the market ripe for technology and efficiency-driven disruption.
To address these challenges, we developed a technology-enabled underwriting process that we believe sets us apart in the E&S market. Our productionized underwriting approach combines rigorous technical underwriting with a highly efficient and centralized operating platform powered by advanced technology. This process begins with a deep understanding of our end-clients, the insurance policyholders. We intensely study the industry and geographical micro-segments in which our end-clients operate using sophisticated data analytics. We leverage these analytics to build quantitative risk models that shape our risk appetite and client targeting.
Furthermore, we aim to eliminate unnecessary complexity by standardizing our processes and automating key underwriting tasks, such as submission intake, risk classification, pricing, and documentation. This allows our underwriters to focus on high-value underwriting tasks and make timely and accurate decisions in a uniform manner. For each individual transaction opportunity, our underwriting models efficiently determine which components of the process can be automated. For simpler products with clearly identified risk characteristics, we can execute the entire underwriting process without human intervention. We believe our productionized underwriting approach generates consistent, efficient, and scalable processes that allow us to deliver differentiated value to our distribution partners without compromising accuracy and profitability.
How We Achieve Productionized Underwriting
Our business
We offer property and casualty insurance solutions tailored to meet the needs of SMBs. Currently, the verticals that we focus on are Real Estate, Hospitality, Construction, and Retail. By leveraging deep fundamental research and advanced data analytics, we meticulously analyze the universe of potential insureds, stratify their risk characteristics by micro-segments, and quantify the perils they face. Once we have acquired a deep understanding of a specific market, we define target business profiles that match our risk appetite and design products that meet our end-clients’ needs.
For example, in our Hospitality vertical, one area of focus is the hotel and motel industry. We segment this industry into three primary subgroups: luxury hotels, mid-tier hotels, and budget motels. We then identify micro-segments such as boutique hotels, beachfront resorts, economy roadside motels, and extended-stay hotels. Each of these micro-segments presents a distinct risk profile, such as higher exposure to natural disasters for beachfront resorts or increased liability concerns for extended-stay hotels with more prolonged guest interactions. Another example of micro-segmentation in our Hospitality vertical is restaurants, where we classify businesses into casual dining, family restaurants, fine dining, diners, and buffet restaurants, among others. In our Real Estate, Construction and Retail verticals, we also categorize micro-segments based on applicable risk characteristics. We price and design products that are specifically tailored to cover the unique risks associated with each micro-segment. We believe our enhanced micro-segmentation of traditional industry classifications allows us to accurately identify and address homogeneous groups of risk, which provides us with a competitive underwriting advantage.
We offer commercial property, low-limit general liability, and management & professional liability products on both a primary basis and an excess basis. By targeting SMBs, we have built a portfolio of small premium size policies. Furthermore, we deliberately focus on underwriting risks with shorter loss-reporting tails and limited catastrophe risk. This reduces the volatility of our results and strengthens our ability to actively manage business risks. The following charts reflect the percentage of our gross written premiums by duration of risk, products, policy size, and vertical for the year ended December 31, 2024(1).
| |
Premium by Risk Duration
|
|
|
Premium by Product
|
|
| |
|
|
|
|
|
| |
Premium by Policy Size
|
|
|
Premium by Vertical
|
|
| |
|
|
|
|
|
(1) Based on policies written in the year ended December 31, 2024 derived from our internal systems.
We operate on a surplus lines basis in 48 states and the District of Columbia. As of December 31, 2024, there were four states in which 5.0% or more of our gross written premiums were concentrated: California (21.0%), Florida (16.2%), Texas (12.8%), and New York (6.4%).
Our diversified and expansive distribution strategy centers around the principle of giving our distribution partners an efficient, consistent, and simplified way of doing business with us. The key to this is our single appointment contract, which gives our distribution partners access to all our channels, resulting in a greater flow of business per partner. We categorize our products as either Brokerage or Small Business. Brokerage is comprised of medium-sized accounts with limited-to-moderate complexity; Small Business is comprised of more standardized risks with smaller premium amounts and lower policy limits than Brokerage. Although wholesale brokers tend to focus on our Brokerage channel and wholesale agents on our Small Business channel, through our unified contract we can provide distribution partners with access to both, which increases our revenue opportunities. Another pillar of our distribution strategy is our rapid response times, enabled in part by our digital platform. For instance, in our Brokerage channel we use automation and risk-scoring models to accelerate the intake process and route transactions to the most efficient and optimal underwriting method. For our Small Business channel, our distribution partners use our cloud-based underwriting engine that automatically defines and manages data requirements, forms, pricing, and risk appetite.
We partner with technology-forward and innovative distribution partners who are leaders in their respective markets and choose us as their partner in this process. We have significantly invested in gaining access to a broader distribution network, increasing the number of agents and brokerage teams with whom we work from 180 distribution partners as of December 31, 2021 to 460 distribution partners as of December 31, 2024. Our in-house distribution team, which is focused on developing and maintaining our distributor relationships, diligently expands our network by onboarding new distribution partners who have books of business that match our risk appetite. We believe our distribution relationships are highly diversified and less concentrated than our E&S competitors, with the three largest wholesale distribution corporations in the United States representing 48% of our gross written premiums written for the year ended December 31, 2024. The following charts reflect the growth of our distribution partners as of December 31 over the last three years, as well as our premiums by distribution channel for the year ended December 31, 2024:
| |
Number of Distribution Partners
|
|
|
Premium by Channel(2)
|
|
| |
|
|
|
|
|
We have a fully integrated internal claims management system that employs proactive strategies to manage claims thoughtfully and efficiently. Our internal claims team consists of specialized and experienced claims professionals, including lawyers, managers, and adjusters. Our claims team leverages our effective technology to process, analyze, and research incoming claims to rapidly determine each claim’s value and resolution path. We seek to settle valid claims expeditiously, but if we believe a claim may be frivolous, we thoroughly investigate it and, if needed, we challenge or litigate it. We use claims roundtables, a curated panel of third-party law firms, expense benchmarking systems, auditing procedures, and precise life-of-claim tracking to optimize outcomes for
(2) Based on policies written in the year ended December 31, 2024 derived from our internal systems.
our insureds and stakeholders. We believe that our holistic and proactive approach, grounded in analytical conviction, allows us to act decisively and protect against inflationary pressures on losses.
We believe having a strong balance sheet is critical for our long-term success and enhancing our partners’ confidence in our business. As such, we have deliberately maintained a conservatively capitalized balance sheet with zero financial leverage, which supports the “A-” (Excellent) financial strength rating from A.M. Best assigned to both Ategrity Specialty and to Ategrity Ltd. Our well-capitalized balance sheet is complemented by rigorous reserve practices. For example, we have minimal exposure to pre-2020 reserves and frequently and proactively review the adequacy of our reserves using various methodologies: daily tracking of claims volumes relative to underlying reserving assumptions, monthly claim-by-claim reserving evaluations, quarterly and year-end studies, quarterly designated committee reviews of actual versus expected losses, and quarterly frequency and severity loss analyses. We also use independent actuaries to assess the strength of our reserves. Given our focus on shorter-tail lines, we believe we have more visibility into claims patterns and the strength of our underlying reserves compared to other specialty peers that have longer tails and less visibility into losses and future claims.
Our business commenced operations in 2018 and we have a limited operating history as a result. See “Risk factors—Risks related to our growth—Our limited operating history makes it difficult to evaluate our current business performance, implementation of our business model and our future prospects.”
Our competitive strengths
Exclusive focus on E&S market, targeting smaller accounts. We operate exclusively in the E&S market, a specialty segment of insurance that has outpaced the growth in the admitted lines market over the last ten years. The E&S market involves lines of insurance which are generally unavailable from admitted insurers due to perceived risk related to the insured’s business and which, consequently, are placed by surplus lines agents or brokers with insurers that are not admitted in the subject jurisdiction. This non-admitted market comprises companies not licensed to transact the business of insurance in a particular U.S. jurisdiction but that are permitted to issue insurance policies only in accordance with an exemption from insurance licensing laws, for example, through an E&S lines broker licensed in that jurisdiction. In contrast to the admitted market, the E&S market provides insurers regulatory flexibility with regard to underwriting standards, forms, and pricing, which we use to design optimized product offerings and underwriting strategies. While E&S insurers are often subject to special licensing, surplus lines tax, and/or due diligence requirements by the home state of the insured, they may rely on third-party surplus lines brokers to facilitate compliance with such laws and regulations.
Within the E&S market, we specialize in solving the needs of SMBs in targeted segments or verticals. We believe the SMB segment tends to attract less competition than other segments due to the operational complexities required to efficiently serve this low-premium and high-volume market niche. Brokers and agents operating in this segment demand ease of use, rapid execution, and consistent underwriting capacity from insurers, and we believe we are poised to deliver these on a consistent basis.
Productionized underwriting supported by efficient operating platform. We purposefully built our platform with the holistic goal of productionizing underwriting to efficiently address the unique needs of smaller accounts within the E&S market. We combine deep technical underwriting with a highly efficient operating platform, supported by technology, to make timely, consistent, and precision-oriented underwriting decisions. We achieve this through sophisticated and data-driven risk segmentation and by utilizing meticulously crafted pricing models, thoughtfully designed products, and uniform underwriting guidelines. We aim to accurately and efficiently price risks that are within our risk appetite, rather than customize coverage for risks outside of our segmentation or other risk criteria. We designed and built our operating platform to be highly efficient and scalable. We automate repeatable underwriting tasks, such as submission processing, risk grading, and document generation, so our underwriters can focus on rapidly analyzing individual risks and delivering accurate and timely quotes. For example, our service delivery platform is capable of parsing unstandardized policy submissions by assembling data and applicant information into digital files which are analyzed by our underwriters. We believe our productionized approach to underwriting provides us with a strong competitive advantage to efficiently serve smaller E&S accounts.
Growing and diversified distribution relationships driven by speed, consistency, and ease-of-use. We currently maintain relationships with 460 distribution partners as of December 31, 2024. We believe our distribution relationships are highly diverse and less concentrated than our E&S competitors, with the three largest wholesale distribution corporations in the United States representing 48% of our gross written premiums written for the year ended December 31, 2024. We have significantly grown the number of our distribution relationships from 180 distribution partners as of December 31, 2021 to 460 distribution partners as of December 31, 2024. We can intake a high volume of submissions from our expansive distribution network, evaluate them quickly, and generate bindable quotes on the basis of our consistently defined risk appetite. We believe that our technology-driven approach to distribution is especially attractive to the next generation of innovative and digital-native brokers and agents, who we believe will have a growing presence in the SMB segment of the E&S market.
Fully integrated claims management. We believe that disciplined and efficient claims management is key in maintaining lower loss and loss adjustment ratios. We have built an in-house team of specialized and experienced claims professionals including lawyers, managers, and adjusters. We have built effective processes to identify optimal outcomes as efficiently as possible. Our in-house claims management team enables us to maintain full control over the claims adjustment process from the initial notice of claim to its resolution, allowing us to promptly evaluate incoming claims and swiftly determine the appropriate resolution path. If the claim is valid, we seek to settle it expeditiously. However, if we believe a claim may be frivolous, we thoroughly investigate and, if needed, will challenge or litigate.
Active risk management approach. We believe that active risk management is key to our long-term profitability and success given our focus on underwriting diversified specialized risks. We continuously monitor our aggregate exposures using sophisticated data analytics tools to ensure we are building an appropriately balanced and diversified book of business that is within our risk appetite. Our risk auditing capabilities ensure that we rapidly incorporate any deviations from our loss expectations in our prospective underwriting. We have limited net catastrophe exposure as we actively seek reinsurance protection from highly rated counterparties to manage our aggregated risk exposures and to protect our earnings and balance sheet from potential volatility.
Well-capitalized balance sheet with minimal pre-2020 reserves. We have a conservatively capitalized balance sheet and zero financial leverage which supports the “A-” (Excellent) financial strength rating from A.M. Best assigned to both Ategrity Specialty and to Ategrity Ltd. In addition, we have minimal exposure to pre-2020 reserves and have benefited from the current favorable pricing environment. Furthermore, our underwriting strategy focuses on shorter-tail and frequency-driven exposures where claims are reported quickly and are subject to conservative policy limits. Our reserving process is rigorous and has regular reviews of our actuarial estimates in consultation with independent experts. We believe our focus on smaller-account and shorter-tail products helps give us high visibility into, and confidence in, our reserves.
Our strategy
Develop distinguished expertise in our core focus areas. Our strategy begins with developing strong expertise in our targeted classes and geographies within the E&S market. We thoroughly assess and evaluate the unique characteristics and prospective loss costs of each vertical we serve, which enables us to clearly define our risk appetite. We believe our ability to micro-segment our targeted lines of business through data-driven risk modeling allows us to achieve higher-precision underwriting and find attractive opportunities that fit our return expectations and appetite. By gaining deep and data-driven insights, we are able to design tailored insurance solutions that we believe position us as the preferred insurer among our distribution partners in our core focus areas.
Deliver a consistent value proposition to our clients. We attract and retain distribution partners by providing them with a compelling and consistent value proposition. We have designed an intelligent underwriting framework built around a pre-defined client profile and standardized products. By having clearly specified rules and criteria for pre-qualifying risks as well as defined information requirements, we can move swiftly without burdening our clients with excessive information requirements. In addition, our service delivery platform simplifies, streamlines, and automates easily executable underwriting tasks, which contributes to providing a seamless experience for our
distribution partners. Moreover, our multi-faceted distribution strategy, which is enabled by a single appointment contract, provides our distribution partners with potential access to all our distribution channels. Our focus on providing broad access with a consistent and high-quality level of service is a key driver of long-lasting relationships with our clients.
Pursue targeted growth initiatives with product, industry, and distribution expansion. We believe we are well-positioned to continue our profitable growth and expand our share of the E&S market through methodical expansion into new products and industry verticals. When we approach a new industry vertical, we typically begin with selective underwriting in the small business market, where we aim to collect a robust dataset that provides us with unique insights on products, pricing, and risk attributes. We follow this by expanding more broadly and repeating the process in the mid-sized business market. In addition to introducing new products and industry verticals, we seek to establish new distribution partnerships with firms that are aligned with our innovative vision and recognize the value of our data-driven and productionized underwriting approach. This will further broaden our market reach and diversify our business sources without compromising profitability.
Continued investment in enhancing our technology to drive innovation and efficiency. We are continuously investing in technology to enhance our underwriting capabilities and interactions with our distribution partners. Innovations in automation, data analytics, and products are directly linked to our mission of delivering high-quality and scalable underwriting and offering unparalleled ease of use. Ategrity Select is our proprietary solution through which we pre-underwrite specific classes of business, enabling our distribution partners to bind quotes in as little as a few minutes. We plan to leverage Ategrity Select to grow into new verticals. Another example is our administration system, AtegrityOne, which is designed to swiftly adapt to change, such as the introduction of new products and pricing, thereby enabling us to provide cost-effective support for new targeted classes with agility and scalability.
Achieve strong returns on capital for our stockholders. Our principal goal is to achieve strong risk-adjusted returns for our stockholders by delivering attractive underwriting results through the cycle. By targeting smaller-account business and leveraging our productionized underwriting approach, we believe we can generate superior underwriting results through market cycles. We use deep data insights to form our own view of risks and execute promptly when opportunities arise. We only pursue opportunities that align with our risk appetite and where we expect underwriting profitability to meet or exceed our internal return thresholds.
Investments
We seek to maintain a balanced investment portfolio that produces stable and attractive risk-adjusted returns. We generally aim to match the duration of our fixed income investment portfolio to the duration of our insurance liabilities, with a large portion of the portfolio allocated to maintaining sufficient readily available funds to pay claims and expenses.
Our portfolio is primarily composed of cash and cash equivalents and investment-grade fixed income securities, supplemented by our Utility & Infrastructure Investments. These investments currently consist of an allocation to the Absolute Return Utility & Infrastructure Fund, which is managed by our affiliate, the Investment Manager, and which employs a long/short strategy that seeks to deliver uncorrelated, absolute returns in all market conditions, primarily through investments in yield-oriented securities in lower-volatility sectors such as utilities, pipelines, infrastructure, and real estate. We believe that by allocating a portion of our assets to Utility & Infrastructure Investments, we can achieve more consistent total returns in our aggregate portfolio, particularly in a market environment characterized by increasing volatility in interest rates and security prices, as seen in recent years. For example, as a result of its focus on lower-volatility sectors and disciplined risk management, the Absolute Return Utility & Infrastructure Fund has not experienced an annual loss in over 25 years. Nonetheless, the Utility & Infrastructure Investments are speculative, entail substantial risks, and are subject to various conflicts of interest. For example, the Utility & Infrastructure Investments are made through various commingled investment vehicles that are managed on behalf of multiple clients of the Investment Manager, and while we think the strategy is well matched for our investment objectives, it was not specifically designed for our financial objectives or anticipated insurance and reinsurance liabilities. See “Risk Factors—Risks related to our investment strategy”.
On March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd redeemed an aggregate of $94 million from the Absolute Return Utility & Infrastructure Fund and on March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd, as lenders, executed a Loan Agreement (the “ZIS Loan”) with Zimmer Insurance Services (“ZIS”), an employee benefits company that is wholly owned by ZFSG, as the borrower. The ZIS Loan is guaranteed by ZFSG and secured by the shares ZFSG holds in ZIS and shares of our common stock held by ZFSG. See “Certain relationships and related party transactions—Related Party Loan.” The ZIS Loan provides for a fixed interest rate of 5.5%, payable annually in cash. After giving effect to the ZIS Loan and the AtegrityOne Transaction, and assuming the proceeds from this offering are invested in fixed-income securities (using an assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus), approximately % of our portfolio assets will be allocated to the Utility & Infrastructure Investments and the remainder will be invested in fixed-rate investments, including the ZIS Loan. The purpose of our entry into the ZIS Loan is to replace the variable income from the Absolute Return Utility & Infrastructure Investments Fund with fixed income in the form of the ZIS Loan. For a description of the risks associated with the ZIS Loan, see “Risk Factors—Risks related to our investment strategy—The ZIS Loan is a Related Party Transaction and is subject to the credit risk of an investment in ZIS and ZFSG.”
Summary of risk factors
Investing in our common stock involves substantial risk. The risks described under the heading “Risk factors” immediately following this summary may cause us to not realize the benefits of our strengths or may cause us to be unable to successfully execute all or part of our strategy. Some of the more significant risks include:
•
If we are unable to underwrite risks accurately and charge competitive yet profitable rates to our policyholders, our business, financial condition, and results of operations will be adversely affected.
•
Competition for business in our industry is intense.
•
We may be unable to obtain reinsurance coverage at reasonable prices or on terms that adequately protect us.
•
We are subject to reinsurance counterparty credit risk.
•
Our loss reserves may be inadequate to cover our actual losses, which could have an adverse effect on our financial condition, results of operations, and cash flows.
•
Given the inherent uncertainty of models, the usefulness of such models as a tool to evaluate risk is subject to a high degree of uncertainty that could result in actual losses that are materially different than our estimates. A deviation from our loss estimates may adversely impact, perhaps significantly, our financial results.
•
A decline in the financial strength rating or financial size category assigned to Ategrity Specialty or to Ategrity Ltd may adversely affect the amount of business we write and thus our business, financial condition, and results of operation.
•
We rely on a select group of brokers, and such relationships may not continue.
•
Because our business depends on wholesale agents and brokers, we are exposed to certain risks arising out of our reliance on these distribution channels that could adversely affect our results.
•
Unexpected changes in the interpretation of our coverage or provisions, including loss limitations and exclusions, in our policies could have an adverse effect on our business, financial condition, and results of operations.
•
Our failure to accurately pay claims in a timely manner and to monitor and detect fraud could adversely affect our business, financial condition, results of operations, and prospects.
•
Adverse economic factors, including recession, inflation, periods of high unemployment, or lower economic activity could result in the sale of fewer policies than expected or an increase in frequency or severity of claims and premium defaults, and even the falsification of claims, or a combination of these effects, which, in turn, could affect our growth and profitability.
•
The insurance business is historically cyclical in nature, and we believe we are currently experiencing a relatively hard market cycle, which may affect our financial performance and cause our results of operation to vary from quarter to quarter and may not be indicative of future performance.
•
We are subject to extensive regulation, which may adversely affect our ability to achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our financial condition and results of operations.
•
Our business, prospects, financial condition, or results of operations may be adversely affected by the performance of our investment portfolio or reductions in the aggregate value of our investment portfolio.
•
Our investment portfolios and their performance substantially depend on the ability the Investment Manager to select and manage appropriate investments.
Our structure
We are the 100% owner of Ategrity Specialty, which is a Delaware-domiciled insurance company that writes excess and surplus lines insurance in the United States. We are also the 100% owner of our direct subsidiary, Ategrity Specialty Holdings Limited, which is the 100% owner of Ategrity Ltd, a provider of specialty property and casualty reinsurance products to Ategrity Specialty.
The chart below displays our simplified corporate structure, after giving effect to this offering:
Corporate information
Our address is 9 West 57th Street, 33rd Floor, New York NY 10019 and our telephone number is (212) 509-1600. Our website is https://ategrity.com. The information on our website is not part of this prospectus.
Implications of being an emerging growth company
As a company with less than $1.235 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”), enacted in April 2012.
An emerging growth company may take advantage of reduced reporting requirements that are otherwise applicable to public companies. These provisions include, but are not limited to:
•
being permitted to present only two years of audited financial statements and only two years of related disclosure in our “Management’s discussion and analysis of financial condition and results of operations” in our periodic reports and registration statements, including this prospectus;
•
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”);
•
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements, and registration statements, including this prospectus; and
•
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
We may take advantage of these provisions until the last day of our fiscal year following the fifth anniversary of the date of the first sale of our common equity securities pursuant to an effective registration statement under the Securities Act. Such fifth anniversary will occur in . However, if certain events occur prior to the end of such five-year period, including if we become a “large accelerated filer,” our gross revenues for any fiscal year equal or exceed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period.
We have elected to take advantage of certain of the reduced disclosure obligations in this prospectus and may elect to take advantage of other reduced reporting requirements in our future filings with the SEC. As a result, the information that we provide to our stockholders may be different than what you might receive from other public reporting companies in which you hold equity interests.
We have elected to avail ourselves of the provision of the JOBS Act that permits emerging growth companies to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies.
For additional information, see “Risk factors—Risks related to this offering and ownership of our common stock—We qualify as an emerging growth company, and any decision on our part to comply with reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.”
The offering
Common stock offered by us in this offering
shares (or shares if the underwriters exercise their option to purchase additional shares in full).
Common stock to be outstanding immediately after this offering
shares (or shares if the underwriters exercise their option to purchase additional shares in full).
Underwriters’ option to purchase additional shares
The underwriters have an option for a period of 30 days from the date of this prospectus to purchase up to an additional shares of our common stock to cover over-allotments.
We estimate that the net proceeds to us from this offering will be approximately $ million (or approximately $ million if the underwriters exercise their option to purchase additional shares in full), after deducting underwriting discounts and commissions and estimated offering expenses payable by us, based on an assumed initial public offering price of $ per share, which is the midpoint of the price range set forth on the cover page of this prospectus.
The principal purposes of this offering are to increase our capitalization and financial flexibility and to create a public market for our common stock. We intend to use the net proceeds from this offering as capital to grow our business and for other general corporate purposes. We initially intend to invest such net proceeds in fixed income securities. See “Use of proceeds.”
Upon completion of this offering, ZFSG will continue to own more than a majority of the voting power of our shares of common stock entitled to vote in the election of our directors. As a result, we will be a “controlled company” as defined under the corporate governance rules of the NYSE and will be exempt from certain corporate governance requirements of such rules. ZFSG and its affiliates will also be able to exert significant influence over the vote in any election of directors and any amendment of our charter. See “Risk factors—Risks related to this offering and ownership of our common stock—We will be a “controlled company” within the meaning of the rules of the NYSE and, as a result, will qualify for, and rely on, exemptions from certain corporate governance requirements. You will not have the same protections afforded to stockholders of companies that are subject to such requirements”, “Risk factors—Risks related to this offering and ownership of our common stock—ZFSG and its affiliates will be able to exert significant influence over us and our corporate decisions”, and “Management—Director independence and controlled company exemption.”
We do not anticipate paying any dividends in the foreseeable future. Any determination to pay dividends or other
distributions in the future will be at the discretion of our board of directors, subject to applicable laws. The ability of our insurance or reinsurance subsidiaries to pay dividends to us is subject to limits under insurance laws of the state or foreign jurisdiction in which Ategrity Specialty or Ategrity Ltd is domiciled. See “Dividend policy.”
We have applied to list our common stock on the NYSE, under the symbol “ASIC.”
You should read the “Risk factors” section beginning on page 16 of this prospectus for a discussion of factors to carefully consider before deciding to invest in shares of our common stock.
At our request, the underwriters have reserved for sale, at the initial public offering price, up to % of the shares offered by this prospectus, excluding the additional shares that the underwriters have an option to purchase, for sale to certain of our employees, certain of our directors and certain other parties. Shares purchased in such directed share program will be subject to the 180-day lock-up restriction described in the section of this prospectus titled “Underwriting.” The number of shares of common stock available for sale to the general public will be reduced to the extent these individuals purchase such reserved shares. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same basis as the other shares offered by this prospectus. J.P. Morgan Securities LLC will administer our directed share program. See “Underwriting—Directed Share Program.”
Unless otherwise indicated and except for our historical consolidated financial information and our historical consolidated financial statements and related notes included elsewhere in this prospectus, the information in this prospectus:
•
reflects a -for-1 conversion of each of the outstanding units of Ategrity Specialty Holdings LLC in connection with the Corporate Conversion (as defined herein);
•
assumes the filing of our articles of conversion containing our articles of incorporation with the Nevada Secretary of State and the adoption of our bylaws in connection with the consummation of the offering;
•
assumes that the initial public offering price of the common stock will be $ per share, which is the midpoint of the range we show on the cover of this prospectus; and
•
assumes no exercise by the underwriters of their option to purchase up to an additional shares.
In addition, except as otherwise indicated, all information contained in this prospectus relating to the number of shares of common stock to be outstanding reflects shares outstanding immediately after this offering, after giving effect to the sale of shares in this offering, and excludes:
•
an aggregate of shares of common stock issuable upon the exercise of Tranche 1 warrants held by ZFSG with an exercise price of $ per share;
•
An aggregate of shares of common stock issuable upon the exercise of Tranche 2 warrants held by ZFSG with an exercise price of $ per share;
•
an aggregate of shares of common stock issuable upon the exercise of options outstanding under our Equity Incentive Plan, effective as of February 5, 2019 and amended as of January 1, 2024 (the “2019 Plan”) with a weighted average exercise price of $ per share, as of , 2025;
•
an aggregate of shares of common stock reserved for issuance under the 2025 Incentive Plan (the “2025 Plan”), that will become effective in connection with this offering; and
•
the 2025 Plan also provides for automatic annual increases in the number of shares reserved thereunder.
See “Executive and director compensation—Equity incentive plans” for more information.
Summary consolidated financial and other data
The following tables present our summary consolidated financial and other data, at the dates and for the periods indicated. The summary consolidated financial and other data set forth below as of and for the years ended December 31, 2024 and 2023 have been derived from our consolidated financial statements, included elsewhere in this prospectus.
These historical results are not necessarily indicative of the results that may be expected for any future period. The following information is only a summary and should be read in conjunction with the section entitled “Management’s discussion and analysis of financial condition and results of operations” and our consolidated financial statements and the accompanying notes included elsewhere in this prospectus.
| |
|
|
Year ended
December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
2023
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross written premiums
|
|
|
|
$ |
437,036 |
|
|
|
|
$ |
352,591 |
|
|
|
Ceded written premiums
|
|
|
|
|
(137,830) |
|
|
|
|
|
(84,375) |
|
|
|
Net written premiums
|
|
|
|
|
299,206 |
|
|
|
|
|
268,216 |
|
|
|
Net premiums earned
|
|
|
|
|
290,635 |
|
|
|
|
|
231,464 |
|
|
|
Fee income
|
|
|
|
|
918 |
|
|
|
|
|
660 |
|
|
|
Net investment income
|
|
|
|
|
24,046 |
|
|
|
|
|
11,366 |
|
|
|
Net realized and unrealized gains (losses) on investments
|
|
|
|
|
28,140 |
|
|
|
|
|
(2,269) |
|
|
|
Other income
|
|
|
|
|
95 |
|
|
|
|
|
95 |
|
|
|
Total revenues
|
|
|
|
|
343,834 |
|
|
|
|
|
241,316 |
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses and loss adjustment expenses
|
|
|
|
$ |
175,234 |
|
|
|
|
$ |
154,107 |
|
|
|
Underwriting, acquisition and insurance expenses
|
|
|
|
|
98,567 |
|
|
|
|
|
72,155 |
|
|
|
Interest expense(1)
|
|
|
|
|
2,042 |
|
|
|
|
|
2,237 |
|
|
|
Other expenses
|
|
|
|
|
1,727 |
|
|
|
|
|
196 |
|
|
|
Total expenses
|
|
|
|
|
277,570 |
|
|
|
|
|
228,695 |
|
|
|
Income before income taxes
|
|
|
|
|
66,264 |
|
|
|
|
|
12,621 |
|
|
|
Income tax expense (benefit)
|
|
|
|
|
12,316 |
|
|
|
|
|
2,518 |
|
|
|
Net income
|
|
|
|
|
53,948 |
|
|
|
|
|
10,103 |
|
|
|
Less: Net income attributable to non-controlling interest–General Partner
|
|
|
|
|
6,858 |
|
|
|
|
|
55 |
|
|
|
Net income attributable to members
|
|
|
|
$ |
47,090 |
|
|
|
|
$ |
10,048 |
|
|
|
Selected balance sheet data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, cash and cash equivalents
|
|
|
|
$ |
788,459 |
|
|
|
|
$ |
617,585 |
|
|
|
Premium receivable, net
|
|
|
|
|
53,500 |
|
|
|
|
|
49,103 |
|
|
|
Deferred policy acquisition costs, net
|
|
|
|
|
21,552 |
|
|
|
|
|
23,245 |
|
|
|
Reinsurance recoverables, net
|
|
|
|
|
133,616 |
|
|
|
|
|
125,671 |
|
|
|
Ceded unearned premiums
|
|
|
|
|
68,205 |
|
|
|
|
|
37,852 |
|
|
|
Total assets
|
|
|
|
|
1,123,438 |
|
|
|
|
$ |
882,042 |
|
|
| |
|
|
Year ended
December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
2023
|
|
|
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
$ |
403,576 |
|
|
|
|
$ |
320,936 |
|
|
|
Unearned premiums
|
|
|
|
|
212,828 |
|
|
|
|
|
173,905 |
|
|
|
Payable to reinsurers
|
|
|
|
|
27,160 |
|
|
|
|
|
15,669 |
|
|
|
Total liabilities
|
|
|
|
$ |
724,631 |
|
|
|
|
$ |
559,845 |
|
|
|
Total members’ equity
|
|
|
|
$ |
398,307 |
|
|
|
|
$ |
321,697 |
|
|
|
Key Operating and Financial Metrics:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio(2)
|
|
|
60.3%
|
|
|
66.6%
|
|
|
Expense ratio(3)
|
|
|
33.6%
|
|
|
30.9%
|
|
|
Combined ratio(4)
|
|
|
93.9%
|
|
|
97.5%
|
|
|
Return on members’ equity
|
|
|
13.1%
|
|
|
3.4%
|
|
|
Other Data/Non-GAAP Metrics:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting income(5)
|
|
|
|
$ |
17,752 |
|
|
|
|
$ |
5,862 |
|
|
|
Adjusted net income attributable to members(6)
|
|
|
|
$ |
48,266 |
|
|
|
|
$ |
10,048 |
|
|
|
Adjusted return on members’ equity(7)
|
|
|
13.4%
|
|
|
3.4%
|
|
(1) Consists of fees on our letter of credit agreements. See “Management’s discussion and analysis of financial condition and results of operations—Liquidity and capital resources.”
(2) The loss ratio is the ratio, expressed as a percentage, of losses and loss adjustment expenses to net premiums earned.
(3) The expense ratio is the ratio, expressed as a percentage, of underwriting, acquisition, and insurance expenses less fee income to net premiums earned.
(4) The combined ratio is the sum of the loss ratio and the expense ratio.
(5) Underwriting income is a non-GAAP financial measure. See “Management’s discussion and analysis of financial condition and results of operations—Reconciliation of non-GAAP financial measures” for a reconciliation of underwriting income to income before income taxes.
(6) Adjusted net income attributable to members is a non-GAAP financial measure. See “Management’s discussion and analysis of financial condition and results of operations—Reconciliation of non-GAAP financial measures” for a reconciliation of adjusted net income attributable to members to net income attributable to members.
(7) Adjusted return on members’ equity is a non-GAAP financial measure. See “Management’s discussion and analysis of financial condition and results of operations—Reconciliation of non-GAAP financial measures” for a reconciliation of adjusted return on members’ equity to return on members’ equity.
Risk factors
Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this prospectus, before deciding to invest in our common stock. The risks and uncertainties described below are not the only ones facing us. There may be additional risks and uncertainties of which we currently are unaware or currently believe to be immaterial. The occurrence of any of these risks could materially and adversely affect our business, financial condition, liquidity, results of operations, or prospects. In that event, the market price of our common stock could decline, and you could lose all or part of your investment.
Risks related to our business and industry
If we are unable to underwrite risks accurately and charge competitive yet profitable rates to our policyholders, our business, financial condition, and results of operations will be adversely affected.
In general, the premiums for our insurance policies are established at the time a policy is issued and, therefore, before all of our underlying costs are known. Like other insurance companies, we rely on estimates and assumptions in setting our premium rates. Establishing adequate premium rates is necessary, together with investment income, to generate sufficient revenue to offset losses, loss adjustment expenses, and other underwriting costs and to earn a profit. If we do not accurately assess the risks that we assume, we may not charge adequate premiums to cover our losses and expenses, which would adversely affect our results of operations and our profitability. Alternatively, we could set our premiums too high, which could reduce our competitiveness and lead to lower revenues.
Pricing involves the acquisition and analysis of historical loss data and the projection of future trends, loss costs and expenses, and inflation trends, among other factors, for each of our products in multiple risk tiers and many different markets. In order to accurately price our policies, we must:
•
collect and properly analyze a substantial volume of data from our insureds;
•
develop, test, and apply appropriate actuarial projections and ratings formulas;
•
closely monitor and timely recognize changes in trends; and
•
project both frequency and severity of our insureds’ losses with reasonable accuracy.
We seek to implement our pricing accurately in accordance with our assumptions. Our ability to undertake these efforts successfully and, as a result, accurately price our policies, is subject to a number of risks and uncertainties, including:
•
insufficient or unreliable data;
•
incorrect or incomplete analysis of available data;
•
uncertainties generally inherent in estimates and assumptions;
•
our failure to implement appropriate actuarial projections and ratings formulas or other pricing methodologies;
•
regulatory constraints on rate increases;
•
our failure to accurately estimate investment yields and the duration of our liability for loss and loss adjustment expenses; and
•
unanticipated court decisions, legislation, or regulatory action.
Competition for business in our industry is intense.
We face competition from other specialty insurance companies, standard insurance companies, and underwriting agencies, as well as from diversified financial services companies that are larger than we are and that have greater financial, marketing, and other resources than we do. Some of these competitors also have longer experience and more market recognition than we do in certain lines of business. In addition, it may be difficult or
prohibitively expensive for us to implement technology systems and processes that are competitive with the systems and processes of these larger companies.
In particular, competition in the insurance industry is based on many factors, including price of coverage, the general reputation and perceived financial strength of the company, relationships with brokers, terms and conditions of products offered, ratings assigned by independent rating agencies, including any downgrades, withdrawal of ratings, or negative watch/outlooks, speed of claims payment and reputation, and the experience and reputation of the members of our underwriting team in the particular lines of insurance and reinsurance we seek to underwrite. See “Business—Competition.” In recent years, the insurance industry has undergone increasing consolidation, which may further increase competition. In particular, private equity sponsors have invested significantly into the insurance sector, and such investments may provide additional capital to our competitors. New competitors, whether newly formed insurers or competitors resulting from alliances or mergers among existing competitors, could emerge and gain significant market share, and some of our competitors may have or may develop a lower cost structure, adopt more aggressive pricing policies or provide services that gain greater market acceptance than the services that we offer or develop. Competitors may be able to respond to the need for technological changes and innovate faster, or price their services more aggressively. They may also compete for skilled professionals, finance acquisitions, fund internal growth, and compete for market share more effectively than we do.
A number of new, proposed, or potential legislative or industry developments could further increase competition in our industry. For example, there has been an increase in capital-raising by companies with whom we compete, which could result in new entrants to our markets and an excess of capital in the industry. Additionally, the possibility of federal regulatory reform of the insurance industry could increase competition from standard carriers.
We may not be able to continue to compete successfully in the insurance markets. Increased competition in these markets could result in a change in the supply and demand for insurance, affect our ability to price our products at risk-adequate rates, and retain existing business, or underwrite new business on favorable terms. If this increased competition so limits our ability to transact business, our business, financial condition, and our results of operation could be adversely affected.
We may be unable to obtain reinsurance coverage at reasonable prices or on terms that adequately protect us.
We use reinsurance to help manage our exposure to insurance risks. Reinsurance is a practice whereby one insurer, called the reinsurer, agrees to indemnify another insurer, called the ceding insurer, for all or part of the potential liability arising from one or more insurance policies issued by the ceding insurer. The availability and cost of reinsurance are subject to prevailing market conditions, both in terms of price and available capacity, which can affect our business volume and profitability. In addition, reinsurance programs are generally subject to renewal on an annual basis. We may not be able to obtain reinsurance on acceptable terms or from entities with satisfactory creditworthiness. In addition to using external reinsurers, we primarily use Ategrity Ltd, to reinsure our products. As of December 31, 2024, 80% of Ategrity Specialty’s net written premium was ceded via a quota share arrangement to Ategrity Ltd. If we are unable to obtain new reinsurance facilities or to renew expiring facilities, our net exposures would increase. In such event, if we are unwilling to bear an increase in our net exposure, we would have to reduce the level of our underwriting commitments, which would reduce our revenues.
Many reinsurance companies have begun to exclude certain coverages from, or alter terms in, the reinsurance contracts we enter into with them. Some exclusions are with respect to risks that we cannot exclude in policies we write due to business or regulatory constraints. In addition, reinsurers are imposing terms, such as lower per occurrence and aggregate limits, on direct insurers that do not wholly cover the risks written by these direct insurers. As a result, we, like other direct insurance companies, write insurance policies which to some extent do not have the benefit of reinsurance protection. These gaps in reinsurance protection expose us to greater risk and greater potential losses. We may also write risks that do not fall within the coverage provided by our reinsurance contracts, or we may purchase types of reinsurance that inadequately cover our risks, and in such an event, we may be exposed to greater risk and greater potential losses. See also “Business—Reinsurance.”
We are subject to reinsurance counterparty credit risk.
The reinsurance contracts that we enter into to help manage our risks require us to pay premiums to the reinsurance carriers who will in turn reimburse us for a portion of covered policy claims. In many cases, a reinsurer will be called upon to reimburse us for policy claims many years after we paid insurance premiums to the insurer. Although reinsurance makes the reinsurer liable to us to the extent the risk is transferred or ceded to the reinsurer, it does not relieve us (the ceding insurer) of our primary liability to our policyholders. Our current reinsurance program is designed to limit our financial risk. Our reinsurers may not pay claims made by us on a timely basis, or they may not pay some or all of these claims. For example, reinsurers may default in their financial obligations to us as the result of insolvency, lack of liquidity, operational failure, fraud, asserted defenses based on agreement wordings or the principle of utmost good faith, asserted deficiencies in the documentation of agreements, or other reasons. Any disputes with reinsurers regarding coverage under reinsurance contracts could be time-consuming, costly, and uncertain of success. We evaluate each reinsurance claim based on the facts of the case, historical experience with the reinsurer on similar claims and existing case law and include any amounts deemed uncollectible from the reinsurer in our reserve for uncollectible reinsurance. As of December 31, 2024, we had $133.6 million of reinsurance recoverable, net of allowance for credit losses of $0. These risks could cause us to incur increased net losses, and, therefore, adversely affect our business and financial condition.
Our loss reserves may be inadequate to cover our actual losses, which could have an adverse effect on our financial condition, results of operations, and cash flows.
Our success depends on our ability to accurately assess the risks related to the businesses and people that we insure. We establish reserves for losses and loss adjustment expenses for the best estimate of the ultimate payment of all claims that have been incurred, or could be incurred in the future, and the related costs of adjusting those claims, as of the date of our consolidated financial statements. Reserves do not represent an exact calculation of liability. Rather, reserves represent an estimate of what we expect the ultimate settlement and administration of claims will cost us, and our ultimate liability may be greater or less than our estimate.
As part of the reserving process, we review historical data and consider the impact of such factors as:
•
claims inflation, which is the sustained increase in cost of raw materials, labor, medical services, and other components of claims cost;
•
claims development patterns by line of business and by “claims made” versus “occurrence” policies;
•
pricing for our products;
•
legislative activity;
•
social and economic patterns; and
•
litigation, judicial, and regulatory trends.
These variables are affected by both internal and external events that could increase our exposure to losses, and we continually monitor our reserves using new information on reported claims and a variety of statistical techniques and modeling simulations. This process assumes that past experience, adjusted for the effects of current developments and anticipated trends, is an appropriate basis for predicting future events. There is, however, no precise method for evaluating the impact of any specific factor on the adequacy of reserves, and actual results may deviate, perhaps substantially, from our reserve estimates. Furthermore, our business has been and will continue to be subject to change as we grow and introduce new product lines. If our overall product mix changes significantly from what it has been in the past, the historical information and data we rely on for purposes of making decisions with respect to our reserve practices may not represent our current product mix or claims environment, and such information may cause our reserves to be inadequate as a result.
The following uncertainties may also have an impact on the adequacy of our resources:
•
When we write “occurrence” policies, we are obligated to pay covered claims, up to the contractually agreed amount, for any covered loss that occurs while the policy is in force even if such claims are only brought after
the policy has lapsed. Accordingly, claims may arise many years after a policy has lapsed. Nearly all of our net casualty loss reserves were associated with “occurrence” policies as of December 31, 2024.
•
When a claim is received (irrespective of whether the policy is a “claims made” or “occurrence” basis form), it may take considerable time to fully appreciate the extent of the covered loss suffered by the insured and, consequently, estimates of loss associated with specific claims can increase over time.
•
New theories of liability are enforced retroactively from time to time by courts.
•
Volatility in the financial markets, economic events, and other external factors may result in an increase in the number of claims and severity of the claims reported. In addition, elevated inflationary conditions would, among other things, cause loss costs to increase. See also “—Adverse economic factors, including recession, inflation, periods of high unemployment, or lower economic activity could result in the sale of fewer policies than expected or an increase in frequency or severity of claims and premium defaults, and even the falsification of claims, or a combination of these effects, which, in turn, could affect our growth and profitability.”
•
If claims were to become more frequent, even if we had no liability for those claims, the cost of evaluating such potential claims could escalate beyond the amount of the reserves we have established. As we enter new lines of business, or as a result of new theories of claims, we may encounter an increase in claims frequency and greater claims handling costs than we had anticipated.
In addition, there may be significant reporting lags between the occurrence of the insured event and the time it is actually reported to us and additional lags between the time of reporting and final settlement of any claims. Consequently, estimates of loss associated with specified claims can increase as new information emerges, which could cause the reserves for the claim to become inadequate.
If any of our reserves should prove to be inadequate, we will be required to increase our reserves resulting in a reduction in our net income and stockholders’ equity in the period in which the deficiency is identified. Future loss experience substantially in excess of established reserves could also have an adverse effect on our future earnings and liquidity and our financial rating. See “Management’s discussion and analysis of financial condition and results of operations—Critical accounting policies and estimates—Reserves for unpaid losses and loss adjustment expenses.”
Given the inherent uncertainty of models, the usefulness of such models as a tool to evaluate risk is subject to a high degree of uncertainty that could result in actual losses that are materially different than our estimates. A deviation from our loss estimates may adversely impact, perhaps significantly, our financial results.
Our approach to risk management relies on subjective variables that entail significant uncertainties. In addition, we and the Investment Manager rely on historical data and scenarios in managing credit and interest rate risks in our investment portfolio. Estimates, models, data, and scenarios that are utilized may not produce accurate predictions and consequently, we could incur losses both in the risks we underwrite and to the value of our investment portfolio.
We use analytics and models to provide us with objective risk assessment relating to our portfolio of insurance risks, some of which relies on third-party vendor’s capabilities. We use these models to help us measure and control risk accumulation, to inform management and other stakeholders of capital requirements, to improve the risk/return profile of our insurance portfolio, and to design our reinsurance structure and assess the optimal amount of reinsurance to purchase. Given the inherent uncertainty of modeling techniques and the application of such techniques, however, these models and databases may not accurately address a variety of matters which might impact certain of our coverages.
Small changes in assumptions, which depend heavily on our judgment and foresight, can have a significant impact on the modeled outputs. These assumptions address a number of factors that impact loss potential and these factors vary considerably across lines of business. Examples include, but are not limited to business class, industry classifications, or areas of practice or operations; company financial condition; stock price volatility; insured investment strategies; company policies and procedures; distribution and volatility of expected claim
amounts; future trends in claim severity and frequency; expected development of historical paid and reported claims; and regulatory and judicial environment associated with insured location or venue. Furthermore, there are risks which are either poorly represented or not represented at all by our models. Each modeling assumption or un-modeled risk introduces uncertainty into our estimates that management must consider. These uncertainties can include, but are not limited to, the following:
•
the models do not address all the possible hazard characteristics;
•
the models may not accurately represent loss potential to insurance or reinsurance contract coverage limits, terms, and conditions; and
•
the models may not accurately reflect the impact on the economy of the area affected or the financial, judicial, political or regulatory impact on insurance claim payments.
The outputs from the models and other tools we use, together with other qualitative and quantitative assessments, are used in our underwriting process to evaluate risk. Our methodology for estimating losses may differ from methods used by other companies and external parties given the various assumptions and judgments required.
As a result of these factors and contingencies, our reliance on assumptions, tools, and data we use is subject to a high degree of uncertainty that could result in actual losses that are materially different from our estimates and our financial results could be adversely affected.
A decline in the financial strength rating or financial size category assigned to Ategrity Specialty or to Ategrity Ltd may adversely affect the amount of business we write and thus our business, financial condition, and results of operation.
Participants in the insurance industry use ratings from independent ratings agencies, such as A.M. Best, as an important means of assessing the financial strength and quality of insurers. In setting its ratings, A.M. Best uses a quantitative and qualitative analysis of a company’s balance sheet strength, operating performance and business profile. This analysis includes comparisons to peers and industry standards as well as assessments of operating plans, philosophy, and management. A.M. Best financial strength ratings range from “A++” (Superior) to “F” for insurance companies that have been publicly placed in liquidation. As of December 31, 2024, A.M. Best has assigned a financial strength rating of “A-” (Excellent) to both Ategrity Specialty and to Ategrity Ltd. A.M. Best assigns ratings that are intended to provide an independent opinion of an insurance company’s ability to meet its obligations to policyholders and such ratings are not evaluations directed to investors and are not a recommendation to buy, sell, or hold our common stock or any other securities we may issue. A.M. Best periodically reviews the financial strength ratings assigned to Ategrity Specialty and to Ategrity Ltd and may revise downward or revoke such ratings at its sole discretion based primarily on its analysis of our balance sheet strength (including capital adequacy and loss adjustment expense reserve adequacy), operating performance, and business profile. Factors that could affect such analysis include, but are not limited to:
•
if we change our business practices from our organizational business plan in a manner that no longer supports A.M. Best’s rating;
•
if unfavorable financial, regulatory, or market trends affect us, including excess market capacity;
•
if our losses exceed our loss reserves;
•
if we experience worse-than-expected underwriting results or increased volatility in those results;
•
if we have unresolved issues with government regulators;
•
if we are unable to retain our senior management or other key personnel;
•
if our investment portfolio incurs significant losses or our liquidity is limited; or
•
if A.M. Best alters its capital adequacy assessment methodology in a manner that would adversely affect our rating.
These and other factors could result in a downgrade of the financial strength rating assigned to Ategrity Specialty or to Ategrity Ltd or may result in A.M. Best placing such financial strength rating outlook on a negative watch. A downgrade or withdrawal of the ratings assigned to Ategrity Specialty or to Ategrity Ltd could result in any of the following consequences, among others:
•
causing our current and future brokers and insureds to choose other, more highly-rated competitors;
•
increasing the cost or reducing the availability of reinsurance to us;
•
severely limiting or preventing us from writing new and renewal insurance contracts; or
•
making it more difficult for us to incur indebtedness if we are required to do so.
In 2021, A.M. Best issued a negative outlook to Ategrity Specialty and Ategrity Ltd which reflected A.M. Best’s concern over then-recent underwriting volatility, which resulted in pressure on our results of operations and enterprise risk management fundamentals. Although the outlook was subsequently changed to stable in 2023 after a change in management team and improvements in results of operations and enterprise risk management, the financial strength rating assigned to Ategrity Specialty and to Ategrity Ltd may be impacted in the future by volatility and other factors. In addition, in light of the earnings and capital pressures recently experienced by many financial institutions, including insurance companies, it is possible that rating organizations will heighten the level of scrutiny that they apply to such institutions, increase the frequency and scope of their credit reviews, request additional information from the companies that they rate, or increase the capital and other requirements employed in the rating organizations’ models for maintenance of certain ratings levels. We can offer no assurance that our rating will remain at its current level. It is possible that such reviews of us may result in adverse ratings consequences, which could have an adverse effect on our business, financial condition, and results of operations.
We rely on a select group of brokers, and such relationships may not continue.
We distribute the majority of our products through a select group of brokers. For the year ended December 31, 2024, 48%, or $206.4 million, of our gross written premiums were distributed through three of our approximately 460 brokers.
Our relationship with any of these brokers may be discontinued at any time. Even if the relationships do continue, they may not be on terms that are profitable for us. The termination of a relationship with one or more significant brokers could result in lower gross written premiums and could have an adverse effect on our business, financial condition, results of operations, and prospects.
Because our business depends on wholesale agents and brokers, we are exposed to certain risks arising out of our reliance on these distribution channels that could adversely affect our results.
Substantially all of our products are ultimately distributed through wholesale agents and brokers who have the principal relationships with retail agents and brokers who themselves have the relationships with our end-client policyholders. Wholesale agents and brokers generally own the “renewal rights,” and thus our business model is dependent on our relationships with, and the success of, the wholesale agents and brokers with whom we do business. Further, we are also dependent on the relationships our wholesale agents and brokers maintain with the retail agents and brokers from whom they source their business.
Our relationship with our wholesale agents and brokers may be discontinued at any time. Even if the relationships do continue, they may not be on terms that are profitable for us. For example, as insurance distribution firms continue to consolidate, their ability to influence commission rates may increase as may the concentration of business we have with a particular broker. Further, certain premiums from policyholders, where the business is produced by brokers, are collected directly by the brokers and remitted to us. In certain jurisdictions, when the insured pays its policy premium to its broker for payment on behalf of Ategrity Specialty, the premium might be considered to have been paid under applicable insurance laws and regulations. Accordingly, the insured would no longer be liable to us for those amounts, whether or not we have actually received the premium from that broker. Consequently, we assume a degree of credit risk associated with the agents and brokers with which we work. Although the failure by any of our brokers to remit premiums to us has not been material to date, there may be instances where our brokers collect premiums but do not remit them to us and we may be required under
applicable law to provide the coverage set forth in the policy despite no related premiums being paid to us. Similarly, if we are limited in our ability to cancel policies for non-payment, our underwriting profits may decline and our business, financial condition, and results of operations could be adversely affected.
We review the financial condition of potential new brokers before we agree to transact business with them, and we periodically review the agencies and brokers with whom we do business to identify those that are not aligned with our business objectives. Following these periodic reviews, we may restrict such distributors’ access to certain types of products or terminate our relationship with them, subject to applicable contractual and regulatory requirements that limit our ability to terminate agents or require us to renew policies. Even through the utilization of these measures, we may not achieve the desired results. We also periodically conduct audits of our policyholders to ensure that their revenues and other exposure metrics are in-line with our underwriting decision at the time of binding the policy. If we find that exposure metrics are higher than originally estimated, we bill the policyholder for additional premiums. Because audits are often performed after the expiration of a policy, we are exposed to uncollectability of those premiums if a policyholder has failed or refuses to pay its additional premiums.
Because we rely on these distributors as our sales channel, any deterioration in the relationships with our distributors or failure to provide competitive compensation could lead our distributors to place more premium with other carriers and less premium with us. In addition, we could be adversely affected if the distributors with whom we do business exceed their granted authority, fail to transfer collected premium to us or breach the obligations that they owe to us. Although we routinely monitor our distribution relationships, such actions could expose us to liability.
Also, if insurance distribution firm consolidation continues at its current pace or increases in the future, our sales channels could be affected in a number of ways, including loss of market access or market share in certain geographic areas. Specifically, we could be negatively affected due to loss of talent as the people or individual brokers most knowledgeable about our products and with whom we have developed strong working relationships, or that represent a larger portion of our business, exit the business following an acquisition, or increases in our commission costs as larger distributors acquire more negotiating leverage over their fees. Any such disruption that materially affects our sales channel could have a negative impact on our business, financial condition, and results of operations.
As the speed of digitization accelerates, we are subject to risks associated with both our distributors and their ability to keep pace. In an increasingly digital world, distributors who cannot provide a digital or technology-driven experience risk losing customers who demand such an experience, and such customers may choose to utilize more technology-driven distributors.
Unexpected changes in the interpretation of our coverage or provisions, including loss limitations and exclusions in our policies, could have an adverse effect on our business, financial condition, and results of operations.
It is possible that loss limitations or exclusions in our policies will not be enforceable in the manner we intend. As industry practices and legal, judicial, social, and other conditions change, unexpected and unintended issues related to claims and coverage may emerge. For example, some of our policies may limit the period during which a policyholder may bring a claim, which may be shorter than the statutory period under which such claims can be brought against our policyholders. While these limitations and exclusions help us assess and mitigate our loss exposure, it is possible that a court or regulatory authority could nullify or void a limitation or exclusion or legislation could be enacted modifying or barring the use of such limitations or exclusions. These types of governmental actions could result in higher than anticipated losses and loss adjustment expenses, which could have an adverse effect on our business, financial condition, and results of operations. In addition, court decisions could read policy exclusions narrowly so as to expand coverage, thereby requiring insurers to create and write new exclusions.
These issues may adversely affect our business by either broadening coverage beyond our underwriting intent or by increasing the frequency or severity of claims. In some instances, these changes may not become apparent
until sometime after we have issued insurance contracts that are affected by the changes. As a result, the full extent of liability under our insurance contracts may not be known for many years after a contract is issued. We may also become subject to disputes relating to bad faith allegations which could result in us incurring losses in excess of policy limits.
Our failure to accurately pay claims in a timely manner and to monitor and detect fraud could adversely affect our business, financial condition, results of operations, and prospects.
We must accurately and promptly evaluate and pay claims that are made under our policies. Many factors affect our ability to accurately pay claims in a timely manner, including the training and experience of our claims representatives, the effectiveness of our claims representatives and management, our ability to develop or select and implement appropriate procedures and systems to support our claims functions, and other factors. Our failure to accurately pay claims in a timely manner could lead to regulatory and administrative actions or material litigation, including bad faith claims, undermine our reputation in the marketplace, and adversely affect our business, financial condition, results of operations, and prospects.
We may be unable to prevent, monitor, or detect fraudulent activity, including policy acquisitions or payments of claims that are fraudulent in nature.
If we fail to maintain adequate systems and processes to prevent, monitor, and detect fraud, including fraudulent policy acquisitions or claims activity, or if inadvertent errors occur with such prevention, monitoring, and detection systems due to human or computer error, our business could be adversely impacted. While we believe past incidents of fraudulent activity have been relatively isolated, we cannot be certain that our systems and processes will always be adequate in the face of increasingly sophisticated and ever-changing fraud schemes. We use a variety of tools to protect against fraud, but these tools may not always be successful at preventing such fraud.
Instances of fraud may result in increased costs, including possible settlement and litigation expenses, and could have an adverse effect on our business and reputation. In addition, failure to monitor and detect fraud can result in regulatory fines or penalties.
Severe weather conditions and other catastrophes may result in an increase in the number and amount of claims filed against us.
Our business is exposed to the risk of severe weather conditions, earthquakes, and man-made catastrophes. In particular, the risks of these events may be heightened in certain geographies where we provide insurance coverage, including the risk of hurricanes in Florida, Texas, the Gulf Coast states and certain East Coast states, the risk of fires, floods, and earthquakes in California, and the risk of severe convective storms in certain Midwest states. Catastrophes can be caused by various events, including natural events such as severe winter weather, tornadoes, windstorms, earthquakes, hailstorms, severe thunderstorms, and fires, or man-made events such as explosions, war, terrorist attacks, and riots. Over the past several years, changing weather patterns and climatic conditions, such as global warming, have added to the unpredictability and frequency of natural disasters in certain parts of the world, including the markets in which we operate. Climate change may increase the frequency and severity of extreme weather events. This effect has led to conditions in the ocean and atmosphere, including warmer-than-average sea-surface temperatures and low wind shear that increase hurricane activity. The occurrence of a natural disaster or other catastrophe loss could adversely affect our business, financial condition, and results of operations. Additionally, any increased frequency and severity of such weather events, including hurricanes, could have an adverse effect on our ability to predict, quantify, reinsure, and manage catastrophe risk and may materially increase our losses resulting from such catastrophe events.
The extent of losses from catastrophes is a function of both the frequency and severity of the insured events and the total amount of insured exposure in the areas affected. The incidence and severity of catastrophes and severe weather conditions are inherently unpredictable. We manage our exposure to losses by analyzing the probability and severity of the occurrence of loss events and the impact of such events on our overall underwriting and investment portfolio. In addition, our inability to obtain reinsurance coverage at reasonable rates and in
amounts adequate to mitigate the risks associated with severe weather conditions and other catastrophes could have an adverse effect on business, financial condition, and results of operations.
Our business is also exposed to the risk of pandemics, outbreaks, public health crises, and geopolitical and social events, and their related effects. If pandemics, outbreaks, and other events occur or re-occur, our business, financial condition, results of operations, and cash flows may be adversely affected.
Because we provide our agents with the ability to bind smaller-sized policies directly in our cloud-based underwriting system, failures to comply with our underwriting guidelines may occur, which could adversely impact our business, financial condition, and results of operations.
We market and distribute our smaller-sized insurance products through agents that have limited quoting and binding authority through our cloud-based underwriting system. These agents can bind certain risks. If any of these agents fail to comply with our underwriting guidelines and the terms of their appointments, such as misclassifying certain risks, we could be bound on a particular risk or number of risks that were not anticipated when we developed the insurance products or estimated losses and loss adjustment expenses. Such actions could adversely affect our business, financial condition, and results of operations. We actively audit the business bound through our systems by agents, including digital monitoring, but we cannot ensure that all compliance failures are detected and resolved.
If actual renewals of our existing contracts do not meet expectations, our written premiums in future years and our future results of operations and prospects could be adversely affected.
Many of our contracts are written for a one-year term. In our financial forecasting process, we make assumptions about the rates of renewal of our prior year’s contracts. The insurance and reinsurance industries have historically been cyclical businesses with intense price competition due to excessive underwriting capacity, as well as periods when shortages of capacity permitted an increase in pricing and, thus, more favorable underwriting profits. An increase in premium levels is often offset over time by an increasing supply of insurance capacity in the form of capital provided by new entrants and existing insurers, which may cause prices to decrease. Additionally, during periods of intense competition, the E&S market may shrink as standard insurance carriers expand risk appetite and extend coverage to the E&S market. Any of these factors could lead to a significant reduction in premium rates, less favorable policy terms, and fewer opportunities to underwrite insurance risk. If we are unable to modify our pricing in response to such fluctuations to stay competitive and retain our customers, our business, financial condition, results of operations, and cash flows may be adversely affected. In addition, if actual renewals do not meet expectations or if we choose not to write a renewal because of pricing conditions, our written premiums in future years and our future operations and prospects would be adversely affected.
We may act based on inaccurate or incomplete information regarding the accounts we underwrite.
We rely on information provided by insureds or their representatives when underwriting insurance policies. While we may make inquiries to validate or supplement the information provided, we may make underwriting decisions based on incorrect or incomplete information. It is possible that we will misunderstand the nature or extent of the activities or facilities and the corresponding extent of the risks that we insure because of our reliance on inadequate or inaccurate information.
Our employees could take excessive risks, which could negatively affect our financial condition and business.
As an insurance enterprise, we are in the business of binding certain risks. The employees who conduct our business, including executive officers and other members of management, underwriters, product managers, and other employees, do so in part by making decisions and choices that involve exposing us to risk. These include decisions such as setting underwriting guidelines and standards, product design and pricing, determining which business opportunities to pursue, and other decisions. We endeavor, in the design and implementation of our compensation programs and practices, to avoid giving our employees incentives to take excessive risks. Employees may, however, take such risks regardless of the structure of our compensation programs and practices. Similarly, although we employ controls and procedures designed to monitor employees’ business decisions and
prevent them from taking excessive risks, these controls and procedures may not be effective. If our employees take excessive risks, the impact of those risks could have an adverse effect on our financial condition and business operations.
Changes in accounting practices and future pronouncements may materially affect our reported financial results.
Developments in accounting practices may require us to incur considerable additional expenses to comply, particularly if we are required to prepare information relating to prior periods for comparative purposes or to apply the new requirements retroactively. The impact of changes in current accounting practices and future pronouncements cannot be predicted but may affect the calculation of net income, stockholders’ equity, and other relevant financial statement line items.
Ategrity Specialty is required to comply with SAP. SAP is subject to constant review by the NAIC and its task forces and committees, as well as state insurance departments, in an effort to address emerging issues and otherwise improve financial reporting. Various proposals are pending before committees and task forces of the NAIC, some of which, if enacted, could have negative effects on insurance industry participants. The NAIC continuously examines existing laws and regulations. We cannot predict whether or in what form such reforms will be enacted and, if so, whether the enacted reforms will positively or negatively affect us.
Public attention to environmental, social, and governance initiatives may expose us to negative public perception, cause reputational harm, impose additional costs on our business, or impact our stock price.
In the past, attention has been directed towards publicly traded companies regarding environmental, social, and governance (“ESG”) matters. A failure, or perceived failure, to respond to investor or customer expectations related to ESG concerns could cause harm to our business and reputation. More recently, public statements with respect to ESG matters, such as emissions reduction goals, other environmental targets, or other commitments addressing certain social issues, are becoming increasingly subject to heightened scrutiny from public and governmental authorities related to the risk of potential “greenwashing,” (i.e., misleading information or false claims overstating potential ESG benefits). Our insureds include a wide variety of industries, including potentially controversial industries. Damage to our reputation as a result of our provision of policies to certain insureds could result in decreased demand for our insurance products and could have an adverse effect on our business, operational results, and financial results, as well as require additional resources to rebuild our reputation, competitive position, and brand strength.
In addition, this emphasis on ESG matters has resulted and may result in the adoption of new laws and regulations, including new reporting requirements, including with respect to climate change. ESG and sustainability-related regulation and legislation, to the extent implemented, will require us to incur significant additional costs to comply, including the implementation of significant additional internal controls, processes, and procedures regarding matters that have not been subject to such controls in the past, and impose increased oversight obligations on our management and board of directors as well as impose additional disclosure obligations on us. Additionally, our customers or other business partners may require us to provide additional climate-related information if they are also subject to additional climate-related disclosure laws or regulations in other jurisdictions. If we fail to comply with new laws, regulations, or reporting requirements, or we fail to provide complete and accurate information to our customers or other business partners, our reputation and business could be adversely impacted.
Risks related to the market and economic conditions
Adverse economic factors, including recession, inflation, periods of high unemployment, or lower economic activity could result in the sale of fewer policies than expected or an increase in frequency or severity of claims and premium defaults, and even the falsification of claims, or a combination of these effects, which, in turn, could affect our growth and profitability.
Factors, such as business revenue, economic conditions, the volatility and strength of the capital markets and inflation can affect the business and economic environment. These same factors affect our ability to generate
revenue and profits. In an economic downturn that is characterized by higher unemployment, declining spending and reduced corporate revenues, the demand for insurance products is generally adversely affected, which directly affects our premium levels and profitability. Negative economic factors may also affect our ability to receive the appropriate rate for the risk we insure with our policyholders and may adversely affect the number of policies we can write, including with respect to our opportunities to underwrite profitable business. In an economic downturn, our customers may have less need for insurance coverage, cancel existing insurance policies, modify their coverage, or not renew the policies they hold with us. Existing policyholders may exaggerate or even falsify claims to obtain higher claims payments. In addition, if certain segments of the economy, such as real estate, hospitality, construction, and retail (which would affect several of our underwriting divisions at one time), were to significantly change, it could adversely affect our results. These outcomes would reduce our underwriting profit to the extent these factors are not reflected in the rates we charge.
As of December 31, 2024, there were four states in which 5.0% or more of our gross written premiums were concentrated: California (21.0%), Florida (16.2%), Texas (12.8%), and New York (6.4%). Any economic downturn in any such states could have an adverse effect on our business, financial condition, and results of operations.
The insurance business is historically cyclical in nature and we believe we are currently experiencing a relatively hard market cycle, which may affect our financial performance and cause our results of operations to vary from quarter to quarter and may not be indicative of future performance.
Historically, insurance carriers have experienced significant fluctuations in results of operations due to competition in our industry, frequency and severity of catastrophic events, fluctuating interest rates, claims exceeding loss reserves, levels of capacity, deviations from expected renewal rates of existing policies and contracts, adverse investment performance, cost of reinsurance coverage, adverse litigation trends, regulatory constraints, general economic conditions, and other factors. The supply of insurance is related to prevailing prices, the level of insured losses, and the level of capital available to the industry that, in turn, may fluctuate in response to changes in rates of return on investments being earned in the insurance industry. As a result, the insurance business historically has been a cyclical industry characterized by periods of intense price competition due to excessive underwriting capacity (soft market cycle) as well as periods when shortages of capacity increased premium levels (hard market cycle). Demand for insurance depends on numerous factors, including the frequency and severity of catastrophic events, levels of capacity, the introduction of new capital providers, and general economic conditions. All of these factors fluctuate and may contribute to price declines generally in the insurance industry.
Although an individual insurance company’s financial performance depends on its own specific business characteristics, the profitability of most P&C insurance companies tends to follow this cyclical market with higher gross written premium growth and improved profitability during hard market cycles. Further, this cyclical market pattern can be more pronounced in the E&S market than in the standard insurance market. When the standard insurance market hardens, the E&S market typically hardens, and growth in the E&S market can be significantly more rapid than growth in the standard insurance market. Similarly, when conditions begin to soften, many customers that were previously driven into the E&S market may return to the admitted market, exacerbating the effects of rate decreases on our financial results. At present, we believe we are experiencing a relatively hard market cycle. However, we cannot predict the timing or duration of changes in the market cycle because the cyclicality is due in large part to the actions of our competitors and general economic factors. As a result, our results of operations are subject to fluctuation and have historically varied from quarter to quarter. We expect our quarterly results will continue to fluctuate in the future due to a number of factors, including the general economic conditions in the markets where we operate, the frequency of occurrence or severity of catastrophe or other insured events, fluctuating interest rates, claims exceeding our loss reserves, competition in our industry, deviations from expected premium retention rates of our existing policies and contracts, adverse investment performance, and the cost of reinsurance coverage.
Global climate change may have an adverse effect on our financial results.
Although uncertainty remains as to the nature and effect of future efforts to curb greenhouse gas emissions and thereby mitigate their potential long-term effects on the climate, a broad spectrum of scientific evidence
suggests that manmade production of greenhouse gas has had an adverse effect on the global climate. Our insurance policies are generally written for one year and repriced annually to reflect changing exposures. However, assessing the risk of loss and damage associated with the adverse effects of climate change and the range of approaches to address loss and damage associated with the adverse effects of climate change, including impacts related to extreme weather events and slow onset events, remains a challenge and might adversely impact our business, financial condition, and results of operations.
Risks related to the regulatory environment
We are subject to extensive regulation, which may adversely affect our ability to achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our financial condition and results of operations.
Ategrity Specialty is subject to extensive regulation in Delaware, its state of domicile, and to a lesser degree, the other states in which it operates. Ategrity Ltd is subject to extensive regulation in Bermuda. Most insurance regulations are designed to protect the interests of insurance policyholders, as opposed to the interests of investors or stockholders. These regulations generally are administered by a department of insurance in each state and relate to, among other things, authorizations to write E&S lines of business, capital and surplus requirements, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and a variety of other financial and non-financial aspects of our business. Significant changes in these laws and regulations could further limit our discretion or make it more expensive to conduct our business. State insurance regulators and the BMA also conduct periodic examinations of the affairs of insurance companies and require the filing of annual and other reports relating to financial condition, holding company issues and other matters. In addition, state surplus lines laws, or laws pertaining to non-admitted insurance business, require that surplus lines brokers comply with diligent search/exempt commercial purchaser laws and affidavit/document filing requirements, as well as requiring the collection and paying of any taxes, stamping fees, assessment fees, and other applicable charges on such business. Excess and surplus lines businesses, such as Ategrity Specialty’s businesses, are often subject to special licensing, surplus lines tax, and/or due diligence requirements by the home state of the insured. We rely on third-party surplus lines brokers to comply with such laws and regulations. Fines for failing to comply with these surplus lines requirements, specifically for failing to comply with the surplus lines licensing or due diligence requirements, vary by state but can range to several million dollars. These regulatory requirements may impose timing and expense constraints that could adversely affect our ability to achieve some or all of our business objectives.
In addition, state insurance regulators have broad discretion to deny or revoke licenses for various reasons, including violation of regulations. In some instances, where there is uncertainty as to applicability, we follow practices based on our interpretations of regulations or practices that we believe generally to be followed by the industry. These practices may turn out to be different from the interpretations of regulatory authorities. If we do not have the requisite licenses and approvals or do not comply with applicable regulatory requirements, state insurance regulators could preclude or temporarily suspend us from carrying on some or all of our activities or could otherwise penalize us. This could adversely affect our ability to operate our business. Further, changes in the level of regulation of the insurance industry or changes in laws or regulations themselves or interpretations by regulatory authorities could interfere with our operations and require us to bear additional costs of compliance, which could adversely affect our ability to operate our business.
Failure to maintain our risk-based capital at the required levels could adversely affect our ability to maintain regulatory authority to conduct our business.
Ategrity Specialty is required to have sufficient capital and surplus in order to comply with insurance regulatory requirements, support its business operations and minimize its risk of insolvency. The NAIC has developed a system to test the adequacy of statutory capital and surplus of U.S.-based insurers, known as risk-based capital, that all states have adopted. This system establishes the minimum amount of capital and surplus necessary for an insurance company to support its overall business operations in consideration of its size and risk profile. It identifies insurers that may be inadequately capitalized by looking at certain risk factors, including asset risk, credit risk,
and underwriting risk with respect to the insurer’s business in order to determine an insurer’s authorized control level risk-based capital. An insurer’s risk-based capital ratio measures the relationship between its total adjusted capital and its authorized control level risk-based capital.
Insurers with a ratio falling below certain calculated thresholds may be subject to varying degrees of regulatory action, including heightened supervision, examination, rehabilitation, or liquidation. An insurance company with total adjusted capital that is less than 200% of its authorized control level risk-based capital is at a company action level, which would require the insurance company to file a risk-based capital plan that, among other things, contains proposals of corrective actions the company intends to take that are reasonably expected to result in the elimination of the company action level event. Additional action level events occur when the insurer’s total adjusted capital falls below 150%, 100%, and 70% of its authorized control level risk-based capital. Lower percentages trigger increasingly severe regulatory responses. In the event of a mandatory control level event (triggered when an insurer’s total adjusted capital falls below 70% of its authorized control level risk-based capital), an insurer’s primary regulator is required to take steps to place the insurer into receivership.
In addition, the IRIS is a collection of analytical tools designed to provide state insurance regulators with an integrated approach to screening and analyzing the financial condition of insurance companies operating in their respective states. If our ratios fall outside of the usual range for one or more ratios set forth by the IRIS for any number of reasons, it could subject us to heightened regulatory scrutiny or measures or create investor uncertainty around the stability of our financial condition, which could harm our business.
Further, the NAIC has promulgated a Model Regulation to Define Standards and Commissioner’s Authority for Companies Deemed to be in Hazardous Financial Condition (the “Hazardous Financial Condition Standards”), which has been adopted by many states in whole or part. If our financial condition is deemed by state insurance regulators to meet the Hazardous Financial Conditions Standards, it could subject us to heightened regulatory scrutiny or measures or create uncertainty around the stability of our financial condition, which could harm our business.
As a relatively new entrant to the insurance industry, we may face additional capital and surplus requirements as compared to those of our larger and more established competitors. Failure to maintain adequate risk-based capital at the levels required by law and/or the Delaware Department of Insurance as described above could result in increasingly onerous reporting and examination requirements and could adversely affect our ability to maintain regulatory authority to conduct our business.
State insurance regulators impose additional reporting requirements regarding enterprise risk on insurance holding company systems, with which we must comply as an insurance holding company.
In the past decade, various state insurance regulators have increased their focus on risks within an insurer’s holding company system that may pose enterprise risk to the insurer. In 2012, the NAIC adopted significant amendments to the Insurance Holding Company Act and related regulations (the “NAIC Amendments”). The NAIC Amendments are designed to respond to perceived gaps in the regulation of insurance holding company systems in the United States. One of the major changes is a requirement that an insurance holding company system’s ultimate controlling person submit annually to its lead state insurance regulator an “enterprise risk report” that identifies activities, circumstances, or events involving one or more affiliates of an insurer that, if not remedied properly, are likely to have an adverse effect upon the financial condition or liquidity of the insurer or its insurance holding company system as a whole. Currently, as Mr. Zimmer, a revocable trust for Mr. Zimmer’s benefit, and an irrevocable trust for his immediate family are the ultimate controlling persons in our insurance holding company system, he and the trusts are required to file an annual enterprise risk report in Delaware. Other changes include the requirement that a controlling person submit prior notice to its domiciliary insurance regulator of a divestiture of control, having detailed minimum requirements for cost sharing and management agreements between an insurer and its affiliates and expanding of the agreements between an insurer and its affiliates to be filed with its domiciliary insurance regulator, including states in which the insurer is commercially domiciled. The NAIC Amendments must be adopted by the individual state legislatures and insurance regulators in order to be effective, and many states, including Delaware, have already done so.
The NAIC and international insurance regulators, including the International Association of Insurance Supervisors, are also working to develop group capital standards. In December 2020, the NAIC adopted a group capital calculation (“GCC”) tool using an RBC aggregation methodology for all entities within the insurance holding company system, including non-U.S. entities. The goal is to provide U.S. regulators with a method to aggregate the available capital and the minimum capital of each entity in a group in a way that applies to all groups regardless of their structure. The NAIC has stated that the calculation is a regulatory tool and does not constitute a capital requirement or standard, but there can be no guarantee that will remain the case. It is unclear how the GCC will interact with existing capital requirements for insurance companies in the United States and with international capital standards. It is possible that we may be required to hold additional capital as a result of future developments.
We may become subject to additional government or market regulations which may have an adverse impact on our business.
Our business could be adversely affected by changes in state laws, including those relating to asset and reserve valuation requirements, surplus requirements, limitations on investments and dividends, enterprise risk and risk-based capital requirements, and, at the federal level, by laws and regulations that may affect certain aspects of the insurance industry, including proposals for preemptive federal regulation. The U.S. federal government generally has not directly regulated the insurance industry except for certain areas of the market, such as insurance for flood, nuclear, and terrorism risks. However, the federal government has undertaken initiatives or considered legislation in several areas that may affect the insurance industry, including tort reform, corporate governance, and the taxation of reinsurance companies.
The Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) also established the Federal Insurance Office (the “FIO”) and vested the FIO with the authority to monitor all aspects of the insurance sector and the ability to recommend to the Financial Stability Oversight Council the designation of an insurer as “systemically significant” and therefore subject to regulation by the Federal Reserve as a bank holding company. Legislation has been introduced from time to time in Congress that, if enacted, could result in the federal government assuming a more direct role in the regulation of the insurance industry, including federal licensing in addition to or in lieu of state licensing and requiring reinsurance for natural catastrophes. In addition, the Bermuda reinsurance regulatory framework has become subject to increased scrutiny in many jurisdictions. As a result, the BMA has implemented and imposed additional requirements on the companies it regulates, which requirements could adversely impact the operations of Ategrity Ltd. We are unable to predict whether any legislation will be enacted or any regulations will be adopted, or the effect any such developments could have on our business, financial condition, or results of operations.
Additionally, we currently derive revenues from customers in the cannabis industry. As such, any risks related to the cannabis industry, including but not limited to cannabis being deemed a controlled substance under federal laws, may adversely impact our clients and potential clients, which may in turn, impact our services. The legality of cannabis could be reversed in one or more states, which might force businesses, including our customers, to cease operations in one or more states entirely. A change in the legal status of, or the enforcement of federal laws related to, the cannabis industry could negatively impact us and lead to a decrease in our revenue through the loss of current and potential customers.
Increased regulation or scrutiny of alternative investment advisors and certain trading methods such as short selling could affect the Investment Manager’s ability to manage our investment portfolios or affect our business reputation.
A substantial portion of our portfolio assets are allocated to the Utility & Infrastructure Investments, which is comprised of investments in private investment funds managed by the Investment Manager. The legal, tax, and regulatory environment worldwide for private investment funds and their managers is evolving. New laws and regulations or actions taken by regulators that restrict the ability of the Investment Manager to pursue its investment program or employ brokers and other counterparties could have a material adverse effect on the Utility & Infrastructure Investments.
The Investment Manager is regularly involved in trading activities that involve a number of U.S. and foreign securities law regimes. Violations of any such law (or allegations of such violations) could directly or indirectly result in severe restrictions on the Investment Manager’s activities and, indirectly, do damage to our investment portfolio or the reputation of the Investment Manager and to us. In addition, the securities and futures markets are subject to comprehensive statutes, regulations, and margin requirements. The SEC, other regulators, and self-regulatory organizations and exchanges are authorized to take extraordinary actions in the event of market emergencies. The regulation of derivatives transactions and funds that engage in such transactions is an evolving area of law and is subject to modification by government and judicial action. Any future regulatory change could have a significant negative impact on our investment portfolio and, accordingly, our financial condition and results of operations.
For example, the Investment Manager routinely engages in short selling for the account of the funds underlying the Utility & Infrastructure Investments. Short sale transactions have been subject to increased regulatory scrutiny, including the imposition of restrictions on short selling certain securities and reporting requirements. The Investment Manager’s ability to execute a short selling strategy in managing the Utility & Infrastructure Investments may be adversely impacted by temporary or new permanent rules, interpretations, prohibitions, and restrictions adopted in response to these adverse market events. Temporary restrictions or prohibitions on short selling activity may be imposed by regulatory authorities with little or no advance notice and may impact prior and future trading activities of the Investment Manager. Additionally, the SEC, its non-U.S. counterparts, other governmental authorities, or self-regulatory organizations may at any time promulgate permanent rules or interpretations consistent with such temporary restrictions or that impose additional or different permanent or temporary limitations or prohibitions. The SEC might impose different limitations or prohibitions on short selling from those imposed by various non-U.S. regulatory authorities. These different regulations, rules, or interpretations might have different effective periods.
Regulatory authorities could, from time to time, impose restrictions that adversely affect the Investment Manager’s ability to borrow certain securities in connection with short sale transactions for the Utility & Infrastructure Investments. In addition, traditional lenders of securities are often less likely to lend securities under certain market conditions. As a result, the Investment Manager may not be able to effectively pursue a short selling strategy due to a limited supply of securities available for borrowing. We may also incur additional costs in connection with short sale transactions effected for the Utility & Infrastructure Investments, including in the event that the Investment Manager is required to enter into a borrowing arrangement with respect to the Utility & Infrastructure Investments in advance of any short sales. Moreover, the ability to continue to borrow a security is not guaranteed and our account will be subject to strict delivery requirements. The inability to deliver securities within the required time frame may subject us to mandatory close out by the executing broker-dealer. A mandatory close out may subject us to unintended costs and losses. Certain action or inaction by third parties, such as executing broker-dealers or clearing broker-dealers, may materially impact the Investment Manager’s ability to effect short sale transactions for the Utility & Infrastructure Investments.
Additionally, the NAIC may institute changes to the risk-based capital charges and capital requirements for invested assets held by insurers, including additional requirements that may apply in relation to alternative investments such as the Utility & Infrastructure Investments, requiring Ategrity Specialty to hold additional capital in order to support its investments and meet relevant state risk based capital requirements.
Risks related to our operations
We could be adversely affected by the loss of one or more key personnel or by an inability to attract and retain qualified personnel.
We depend on our ability to attract and retain experienced and seasoned personnel who are knowledgeable about our business. Our senior management team, including our Chief Executive Officer, Justin Cohen, and our President and Chief Underwriting Officer, Chris Schenk, plays an important role in our strategic direction, broker partnership, corporate culture, and our continued success as an organization. The loss of Mr. Cohen, Mr. Schenk, or other members of our senior management team could adversely impact our business.
We could be adversely affected if we fail to adequately plan for the succession of our senior leaders and key executives. Our current succession plans and employment arrangements with certain key executives do not guarantee their services will continue to be available to us.
The pool of talent from which we actively recruit is limited and may fluctuate based on market dynamics specific to our industry and independent of overall economic conditions. As such, higher demand for employees having the desired skills and expertise could lead to increased compensation expectations for existing and prospective personnel, making it difficult for us to retain and recruit key personnel and maintain labor costs at desired levels. Certain of our employees are subject to non-compete and non-solicitation provisions that generally apply during, and extend for six to twelve months following the termination of, their employment. Not all jurisdictions permit such non-compete agreements, and regardless of the jurisdiction, our key personnel could still pursue employment opportunities with other parties, including with any of our competitors and there are no assurances that our non-compete agreements with any such key personnel would be enforceable in a cost-effective manner, if at all. Should any of our key personnel terminate his or her employment with us, or if we are unable to retain and attract talented personnel, we may be unable to maintain our current competitive position in the specialized markets in which we operate, which could adversely affect our results of operations.
We could suffer security breaches, loss of data, cyberattacks, and other information technology failures, and are subject to laws and regulations concerning data privacy and security that are continually evolving. Actual or suspected information technology failures or failures to comply with applicable law could disrupt our operations, damage our reputation, and adversely affect our business, financial condition, or results of operations.
Our business is highly dependent on our information technology and telecommunications systems, including our underwriting systems. We rely on these systems to interact with brokers, agents, and insureds, to underwrite business, to prepare policies and process premiums, to perform actuarial and other modeling functions, to process claims and make claims payments, and to prepare internal and external financial statements. We also rely on our information and telecommunications systems for employees to interact with each other within the company, as most employees work on a remote basis a majority of their time as opposed to in physical offices. Some of these systems may include or rely on third-party systems provided by third-party service providers and/or not located on our premises or under our control.
We and our service providers face numerous and evolving cybersecurity risks that threaten the confidentiality, integrity, and availability of systems and confidential information, including vulnerabilities in commercial software that is integrated into our (or our suppliers’ or service providers’) IT systems, products, or services. The risk of a data security breach or a disruption has generally increased in frequency, intensity, and sophistication. Techniques used to compromise or sabotage systems change frequently, may originate from less regulated and remote areas of the world and be difficult to detect and generally are not recognized until launched against a target. Events such as natural catastrophes, terrorist attacks, industrial accidents, computer viruses, ransomware, a security breach by an unauthorized person, employee error, malfeasance, faulty password management, or other irregularity, and other cyber-attacks may cause our systems to fail or be inaccessible for extended periods of time. We have implemented security measures designed to protect against breaches of security, such as business contingency plans and other reasonable plans to protect our systems, whether housed internally or through third-party cloud services. In addition, while we generally monitor vendor risk, including the security and stability of our critical vendors, we may fail to properly assess and understand the risks and costs involved in the third-party relationships. We cannot guarantee that these measures will be effective and sustained or repeated system failures or service denials could severely limit our ability to write and process new and renewal business, provide customer service, pay claims in a timely manner, or otherwise operate in the ordinary course of business. We may be unable to adequately investigate or remediate any vulnerabilities to our systems, even if identified, due to attackers using tools and techniques that are designed to circumvent controls, avoid detection, and remove or obfuscate forensic evidence.
Any such event may result in operational disruptions as well as unauthorized access to, the disclosure of, or loss of, our proprietary information or our customers’ data and information, which in turn may result in legal claims,
regulatory scrutiny and liability, reputational damage, the incurrence of costs to eliminate or mitigate further exposure, the loss of customers or affiliated advisors, or other damage to our business. In addition, the trend toward general public notification of such incidents could exacerbate the harm to our business, financial condition, and results of operations. Even if we successfully protect our technology infrastructure and the confidentiality of sensitive data, we could suffer harm to our business and reputation if attempted security breaches are publicized. We cannot be certain that advances in criminal capabilities, discovery of new vulnerabilities, attempts to exploit vulnerabilities in our systems, data thefts, physical system or network break-ins, inappropriate access, or other developments will not compromise or breach the technology or other security measures protecting the networks and systems used in connection with our business.
In addition, as part of our normal business activities, we handle information related to individuals including, but not limited to, employees, claimants, individual third-party brokers or agents, and individual vendors. As such, we are subject to various federal, state, and local laws, regulations, and industry standards. The regulatory environment surrounding information security and privacy is increasingly demanding, with frequent imposition of new and changing requirements that are subject to differing interpretations. In the United States, there are numerous federal and state data privacy and security laws, rules, and regulations governing the collection, use, storage, sharing, transmission, and other processing of personal information, including federal and state data privacy laws, data breach notification laws, and consumer protection laws.
Any failure or perceived failure by us to comply with laws, regulations, policies, or regulatory guidance relating to privacy or data security may result in governmental investigations and enforcement actions, litigation, fines and penalties, or adverse publicity and could cause our customers and consumers to lose trust in us, which could have an adverse effect on our reputation and business.
The effects of litigation on our business are uncertain and could have an adverse effect on our business.
As is typical in our industry, we continually face risks associated with litigation of various types, including disputes relating to insurance claims under our policies as well as other general commercial and corporate litigation. Although we are not currently involved in any material litigation with our customers, other members of the insurance industry are the target of class action lawsuits and other types of litigation, some of which involve claims for substantial or indeterminate amounts, and the outcomes of which are unpredictable. This litigation is based on a variety of issues, including insurance and claim settlement practices. We cannot predict with any certainty whether we will be involved in such litigation in the future or what impact such litigation would have on our business.
Any failure to protect our intellectual property rights could impair our ability to protect our proprietary technology platform and brand, or we may be sued by third parties for alleged infringement of their proprietary rights.
Our success and ability to compete depend in part on our intellectual property, which includes our rights in our proprietary technology platform and our brand. We primarily rely on copyright, trade secret and trademark laws, and confidentiality or license agreements with our employees, customers, service providers, partners, and others to protect our intellectual property rights. The steps we take to protect our intellectual property, however, may be inadequate. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming, and distracting to management and could result in the impairment or loss of portions of our intellectual property. Additionally, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability and scope of our intellectual property rights. Our failure to secure, protect, and enforce our intellectual property rights could adversely affect our brand and adversely impact our business.
Our success depends also in part on our not infringing on the intellectual property rights of others. Our competitors, as well as a number of other entities and individuals, may own or claim to own intellectual property relating to our industry or to our brand. In the future, third parties may claim that we are infringing on their intellectual property rights, and we may be found to be infringing on such rights. Any claims or litigation could
cause us to incur significant expenses and, if successfully asserted against us, could require that we pay substantial damages or ongoing royalty payments, prevent us from offering our services or require that we comply with other unfavorable terms. Even if we were to prevail in such a dispute, any litigation could be costly and time-consuming and divert the attention of our management and key personnel from our business operations.
We employ third-party and open-source licensed software for use in our business, and the inability to maintain these licenses, errors in the software we license or the terms of open- source licenses could result in increased costs or reduced service levels, which would adversely affect our business.
Our business relies on certain third-party software obtained under licenses from other companies. We anticipate that we will continue to rely on such third-party software in the future. Although we believe that there are commercially reasonable alternatives to the third-party software we currently license, this may not always be the case, or it may be difficult or costly to replace. In addition, integration of new third-party software may require significant work and require substantial investment of our time and resources. Our use of additional or alternative third-party software would require us to enter into license agreements with third parties, which may not be available on commercially reasonable terms or at all. Many of the risks associated with the use of third-party software cannot be eliminated, and these risks could negatively affect our business.
Additionally, the software powering our technology systems incorporates software covered by open-source licenses. The terms of many open-source licenses have not been interpreted by U.S. courts and there is a risk that the licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to operate our systems. If portions of our proprietary software are determined to be subject to an open-source license, we could be required to publicly release the affected portions of our source code or re-engineer all or a portion of our technology systems, each of which could reduce or eliminate the value of our technology systems. Such risk could be difficult or impossible to eliminate and could adversely affect our business, financial condition, and results of operations.
We may not be able to effectively implement or adapt to changes in technology, particularly with respect to artificial intelligence, which may result in interruptions to our business or even in a competitive disadvantage.
Developments in technology are affecting the insurance business. For example, insurance companies are beginning to use artificial intelligence in a number of applications, including risk assessment, claims processing, customer service, fraud detection, and predictive analytics and modeling. We believe that the development and implementation of new technologies will require additional investment of our capital resources in the future, and it is possible that we may not be able to effectively implement or adapt to new technologies. We have not determined the amount of resources and the time that this development and implementation may require, which may result in short-term, unexpected interruptions to our business, or may result in a competitive disadvantage in price and/or efficiency, as we endeavor to develop or implement new technologies. In addition, changes in technology typically outpace corresponding regulations, which may lead to periods of uncertainty in the permissible uses of certain technology and to differences or even inconsistencies in the regulatory approaches across jurisdictions. The absence of regulations or conflicts in regulations may further limit our ability to implement new technology in an effective and timely manner.
We are subject to stringent and changing privacy and data security laws, regulations, and standards related to data privacy and security. Our actual or perceived failure to comply with such obligations could harm our reputation, subject us to significant fines and liability, or adversely affect our business.
We are subject to the privacy provisions of the federal Gramm-Leach-Bliley Act and the NAIC Insurance Information and Privacy Protection Model Act, to the extent adopted and implemented by various state legislatures and insurance regulators in states in which we conduct our business. The regulations implementing these laws require insurance companies to disclose their privacy practices to consumers, allow them to opt-in or opt-out, depending on the state, of the sharing of certain personal information with unaffiliated third parties, and maintain certain security controls to protect their information. Violators of these laws face regulatory enforcement action, substantial civil penalties, injunctions, and in some states, private lawsuits for damages.
Privacy and data security regulation in the United States is rapidly evolving. For example, California enacted the California Consumer Privacy Act (the “CCPA”), which became effective January 1, 2020. The CCPA and related regulations give California residents expanded rights to access and request deletion of their personal information, opt out of certain personal information sharing and receive detailed information about how their personal information is used and shared. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches, which is expected to increase the volume and success of class action data breach litigation. In addition to increasing our compliance costs and potential liability, the CCPA’s restrictions on “sales” of personal information may restrict our use of cookies and similar technologies for advertising purposes. The CCPA excludes information covered by Gramm-Leach-Bliley Act, the Driver’s Privacy Protection Act, the Fair Credit Reporting Act from the CCPA’s scope, but the CCPA’s definition of “personal information” is broad and may encompass other information that we maintain. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the U.S., and multiple states have enacted or proposed similar laws. There is also discussion in Congress of new comprehensive federal data protection and privacy law to which we likely would be subject if it is enacted.
In addition, California voters approved the November 2020 ballot measure which enacted the California Privacy Rights Act (the “CPRA”), substantially expanding the requirements of the CCPA. As of January 1, 2023, the CPRA gave consumers the ability to limit use of precise geolocation information and other categories of information classified as “sensitive”; add e-mail addresses and passwords to the list of personal information that, if lost or breached, would give the affected consumers the right to bring private lawsuits; increase the maximum penalties threefold for violations concerning consumers under age 16; and establish the California Privacy Protection Agency to implement and enforce the new law, as well as impose administrative fines. The effects of the CCPA, CPRA and other similar state or federal laws are potentially significant and may require us to modify our data processing practices and policies, incur substantial compliance costs, and subject us to increased potential liability.
Additionally, we are subject to the terms of our privacy policies, privacy-related disclosures and contractual and other privacy-related obligations to our customers and other third parties. Any failure or perceived failure by us or third parties we work with to comply with these policies, disclosures, and obligations to customers or other third parties, or privacy or data security laws may result in governmental or regulatory investigations, enforcement actions, regulatory fines, criminal compliance orders, litigation, or public statements against us by consumer advocacy groups or others, and could cause customers to lose trust in us, all of which could be costly and have an adverse effect on our business.
Any future acquisitions, strategic investments, or new platforms could expose us to further risks or turn out to be unsuccessful.
From time to time, we may pursue growth through acquisitions and strategic investments in businesses or new underwriting or marketing platforms. The negotiation of potential acquisitions or strategic investments as well as the integration of an acquired business, personnel, or underwriting or marketing platforms could result in a substantial diversion of management resources and the emergence of other risks, such as potential losses from unanticipated litigation, a higher level of claims than is reflected in reserves, loss of key personnel in acquired businesses, or an inability to generate sufficient revenue to offset acquisition costs.
Our ability to manage our growth through acquisitions, strategic investments, or new or alternative platforms will depend, in part, on our success in addressing such risks. While we are not currently contemplating any such acquisitions or strategic investments, our nimble approach to capital management based on opportunities presented and sought out means that we may opportunistically from time to time pursue such acquisitions, new platforms, or strategic investment strategies. Any failure by us to implement our acquisitions, new platforms, or strategic investment strategies effectively could have an adverse effect on our business, financial condition, results of operations, and prospects.
Risks related to our growth
Our limited operating history makes it difficult to evaluate our current business performance, implementation of our business model and our future prospects.
Our business commenced operations in 2018. Our limited operating history may make it difficult to evaluate our current business and our future prospects. While our revenue has grown in recent periods, this growth rate may not be sustainable and should not be considered indicative of future performance, and we may not realize sufficient revenue to maintain profitability in the future. As we grow our business, we expect our revenue growth rates may slow in future periods due to several reasons, which may include slowing demand for our products, increasing competition, a decrease in the growth of our overall market, and our failure to capitalize on growth opportunities or the maturation of our business. In addition, we have encountered and will continue to encounter risks and difficulties frequently experienced by growing companies in rapidly changing industries, including increasing and unforeseen expenses as we continue to grow our business. If we do not manage these risks successfully, our business may be harmed.
We may not be able to manage our growth effectively.
Our gross written premiums grew from $352.6 million for the year ended December 31, 2023, to $437.0 million for the year ended December 31, 2024. As of December 31, 2024, we had 169 total employees, up from 111 as of December 31, 2023. In addition, since our business commenced operations in 2018, we have expanded our geographic footprint, now offering insurance in 48 states. Our rapid growth has placed and may continue to place significant demands on our management and our operational and financial resources. We have hired and expect to continue hiring additional personnel to support our rapid growth. Our organizational structure is becoming more complex as we add staff, and we will need to enhance our operational, financial, and management controls as well as our reporting systems and procedures. In addition, our growth plan will require us to make significant investments in technology. Such investments will also require us to roll out and integrate new technology platforms and to migrate our products from our existing platforms. Such technology may not perform up to our specifications and we may be required to make additional expenditures to remediate any deficiencies. We may not achieve our desired returns on such investments in technology as a result. Additionally, we have experienced and may continue to experience periods of increased levels of demand that place strains on our existing resources. Our human resources, systems, and technology may not be adequate to sustain the level of customer service and quality control we strive to provide in such situations. Such demand may exceed the capacity of the infrastructure and systems we have in place to meet such demand. Any failure under such circumstances to address our clients’ needs on a timely and efficient basis could result in loss of business and damage to our reputation. Any of the foregoing could have an adverse effect on our customer satisfaction, reputation, competitive position, and our brand. Additionally, we intend to further grow our business in the future, which could require additional capital, systems development, and skilled personnel. However, we must be able to meet our capital needs, expand our systems and our internal controls effectively, allocate our human resources optimally, identify and hire qualified employees, or effectively incorporate the components of any businesses we may acquire in our effort to achieve growth. The failure to manage our growth effectively could have an adverse effect on our business, financial condition, and results of operations.
Risks related to our liquidity and access to capital
Because we are a holding company and substantially all of our operations are conducted by our insurance subsidiaries, our ability to pay dividends and service our debt obligations depends on our ability to obtain cash dividends or other permitted payments from our insurance subsidiaries.
The continued operation and growth of our business will require substantial capital. Accordingly, after the completion of this offering, we do not intend to declare and pay cash dividends or make other distributions on shares of our common stock in the foreseeable future. See “Dividend policy.” Because we are a holding company with no business operations of our own, our ability to pay dividends and other distributions to stockholders largely depends on dividends and other distributions from our primary insurance subsidiaries, Ategrity Specialty
and Ategrity Ltd. State and foreign insurance laws, including the laws of Delaware and Bermuda, restrict the ability of Ategrity Specialty and Ategrity Ltd, respectively, to determine how we declare stockholder dividends and make other distributions. State and foreign insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. See “Management’s discussion and analysis of financial condition and results of operation—Liquidity and capital resources” and “Regulation—Restrictions on paying dividends.”
The payment of any extraordinary dividend by Ategrity Specialty requires the prior approval (or no disapproval after thirty days’ notice) of the Commissioner of the Delaware Department of Insurance. “Extraordinary dividend” is defined under the Delaware Insurance Code as any dividend or distribution of cash or other property, whose fair market value together with that of other dividends or distributions made within the preceding twelve months, exceeds the greater of (a) ten percent of Ategrity Specialty’s surplus as of December 31 of the preceding year, or (b) Ategrity Specialty’s net income for the twelve-month period ending December 31 of the preceding year, but does not include pro rata distributions of any class of the insurance company’s own securities. In addition, Ategrity Specialty’s may not declare or pay a dividend or other distribution from any source other than earned surplus without the Delaware Commissioner’s prior approval.
In addition, insurance regulators have broad powers to prevent a reduction of statutory surplus to inadequate levels, and there is no assurance that dividends of the maximum amount calculated under any applicable formula would be permitted. Delaware may in the future adopt statutory provisions more restrictive than those currently in effect.
Ategrity Ltd is highly regulated and is required to comply with various conditions before it can pay dividends or make distributions to us. Bermuda law, including the Insurance Act 1978, as amended, and related rules and regulations (the “Insurance Act”), and the Companies Act 1981, as amended (the “Companies Act”) impose restrictions on Ategrity Ltd’s ability to pay dividends to us based on solvency margins and surplus and capital requirements. These restrictions, and any other future restrictions adopted by the BMA, could have the effect, under certain circumstances, of significantly reducing dividends or other amounts payable to us by Ategrity Ltd without affirmative approval of the BMA.
Any determination to pay dividends or other distributions in the future will be at the discretion of our Board of Directors and will depend upon results of operations, financial condition, contractual restrictions pursuant to our debt agreements, our indebtedness, restrictions imposed by applicable law, and other factors our Board of Directors deems relevant. Consequently, investors may need to sell all or part of their holdings of our common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking immediate cash dividends should not purchase our common stock.
The maximum amount of dividends that our subsidiaries can pay us during 2025 without regulatory approval is $37.4 million.
Our ability to incur a substantial level of indebtedness may reduce our financial flexibility, affect our ability to operate our business and divert cash flow from operations for debt service.
As of December 31, 2024, we had no outstanding indebtedness, and no amounts drawn on our letter of credit agreements. See “Management’s discussion and analysis of financial condition and results of operation—Liquidity and capital resources.”
We may incur substantial indebtedness in the future, and, if we do so, the risks related to our level of indebtedness could increase.
If we were to incur indebtedness in the future, it could affect our operations in several ways, including but not limited to the following:
•
increase our vulnerability to changes in general economic, industry, and competitive conditions;
•
require us to dedicate a portion of our cash flow to make payments on our indebtedness, thereby reducing the availability of our cash flow to fund other corporate purposes;
•
place us at a competitive disadvantage compared to our competitors that are less leveraged and therefore potentially more able to take advantage of opportunities that our level of indebtedness would prevent us from pursuing; and
•
impair our ability to obtain additional financing in the future.
We may require additional capital in the future, which may not be available or may only be available on unfavorable terms.
Our future capital requirements depend on many factors, including our ability to write new business successfully and to establish premium rates and reserves at levels sufficient to cover losses. To the extent that the funds generated by this offering are insufficient to fund future operating requirements and cover claim losses, we may need to raise additional funds through financings or curtail our growth. Many factors will affect the amount and timing of our capital needs, including our growth rate and profitability, our claims experience, the availability of reinsurance, market disruptions, and other unforeseeable developments. If we need to raise additional capital, equity or debt financing may not be available at all or may be available only on terms that are not favorable to us. In the case of equity financings, dilution to our stockholders could result. In the case of debt financings, we may be subject to covenants that restrict our ability to freely operate our business. In any case, such securities or other debt may have rights, preferences, and privileges that are senior to those of the shares of common stock offered hereby. If we cannot obtain adequate capital on favorable terms or at all, we may not have sufficient funds to implement our operating plans and our business, financial condition, or results of operations could be adversely affected.
Risks related to our investment strategy
Our business, prospects, financial condition, or results of operations may be adversely affected by the performance of our investment portfolios or reductions in the aggregate value of our investment portfolios.
Our results of operations depend in part on the performance of our investment portfolio, including our Utility & Infrastructure Investments and our fixed income portfolios which are managed by us or the Investment Manager. We derive a significant portion of our income or loss from our investment in the Absolute Return Utility & Infrastructure Fund. As of December 31, 2024, consolidated investments in the Absolute Return Utility & Infrastructure Fund through the Utility Limited Partnership, reflected on a net asset basis, totaled $270.4 million, representing approximately 99.8% of the net assets of the Utility Limited Partnership. As of December 31, 2024, the Utility Limited Partnership had gross assets of $287.3 million and gross liabilities of $16.9 million. As a result, we have significant exposure to the investments in the Absolute Return Utility & Infrastructure Fund, as well as to our other investment assets. Our investments held through the Utility Limited Partnership are carried on the balance sheet of the Absolute Return Utility & Infrastructure Fund at fair market value and are subject to potential losses and declines in market value. In turn, we value our investment in the Utility Limited Partnership at fair value, which is estimated based on our share of the net asset value (“NAV”) of the Absolute Return Utility & Infrastructure Fund as provided by the Investment Manager. Our invested assets in the Absolute Return Utility & Infrastructure Fund totaled $270.4 million as of December 31, 2024. For more information about the risks of this investment, see “—Risks associated with the Investment Manager’s strategy in managing the Utility & Infrastructure Investments could be greater than the investment risks faced by some of the other insurers with whom we compete.”
Our investment portfolio that is not invested in the Utility & Infrastructure Investments consists almost entirely of cash, cash equivalents, treasuries, and predominantly investment-grade fixed-income securities, which are held in accounts managed internally or by the Investment Manager. Our fixed-income security invested assets totaled $438.8 million as of December 31, 2024. This fixed investment portfolio is subject to risks associated with potential declines in credit quality related to specific issuers or specific industries and a general weakening of the economy, which are typically reflected through credit spreads. Credit spread is the additional yield on fixed income securities and loans above the risk-free rate, typically referenced as the yield on U.S. treasury securities, that market participants require to compensate them for assuming credit, liquidity, and/or prepayment risks. Credit
spreads vary in response to the market’s perception of risk and liquidity in a specific issuer or specific sector. Additionally, credit spreads are influenced by the credit ratings, and the reliability of those ratings, published by external rating agencies. Although we have the ability to use derivative financial instruments to manage these risks, the effectiveness of such instruments varies with liquidity and other conditions that may impact derivative and bond markets.
The U.S. inflation rate began increasing in 2021, peaked in the middle of 2022 and began to gradually decline in the second half of 2022. Sustained levels of high inflation generally cause the U.S. Federal Reserve (the “Fed”) and other central banks to increase interest rates. The Fed raised its benchmark interest rate 11 times between March 2022 and July 2023 to curb inflation. The Fed wants inflation to return to its 2% goal over time and it is still high in absolute terms. The Fed has lowered its benchmark interest rate three times since September 2024 by an aggregate 100 basis points to a new range of 4.25-4.50% from its 23-year high of 5.25% to 5.50%. Should interest rates continue to decline, including as a result of steps taken by the federal government to slow inflation, such as the passage of the Inflation Reduction Act of 2022, a low interest rate environment would place pressure on our net investment income, particularly as it relates to these securities and short-term investments, which, in turn, may adversely affect our results of operations. Conversely, future increases in interest rates could cause the values of our fixed income securities portfolios to decline, with the magnitude of the decline depending on the duration of securities included in our portfolio and the amount by which interest rates increase. Some fixed income securities have call or prepayment options, which create possible reinvestment risk in declining rate environments. Other fixed income securities, such as mortgage-backed and asset-backed securities, carry prepayment risk or, in a rising interest rate environment, may not prepay as quickly as expected.
Alternatively, a decline in market interest rates could have an adverse effect on investment income as we invest cash in new investments that may earn less than our portfolio’s average yield. In a low interest rate environment, borrowers may prepay or redeem securities more quickly than expected as they seek to refinance at lower rates. Sustained low interest rates could also lead to purchases of longer-term or riskier assets in order to obtain adequate investment yields, which could also result in a duration gap when compared to the duration of liabilities. Although we attempt to take measures to manage the risks of investing in changing interest rate environments, we may not be able to mitigate interest rate or credit spread sensitivity effectively.
Our investments are subject to general economic conditions and market risks as well as risks inherent to particular securities. The success of our investments will be affected by, among other things, interest rates, availability of credit, inflation rates, economic uncertainty, changes in laws (including laws relating to taxation of our investments), market structure, trade barriers, currency exchange controls, national and international political circumstances (including wars, terrorist acts, or security operations), and the occurrence of various events (including hurricanes, earthquakes, and other natural disasters). For example, the increasing use of tariffs, economic sanctions and export controls may impact the success of our investments. The current U.S. presidential administration has discussed imposing broad-based tariffs on imported goods, which, if implemented, could increase the cost of production and impact the success of our investments. This may also provoke responses from foreign governments that negatively impact supply chains and increase the costs for affected imported goods, which could also affect the success of our investments. As a result, U.S. markets have recently experienced significant volatility in reaction to the threat of new tariffs and potential trade wars. See “Management’s discussion and analysis of financial condition and results of operation—Quantitative and qualitative disclosures about market risk.” In addition, the Utility & Infrastructure Investments portfolio is broadly concentrated in utility and infrastructure-related industries, thus exposing our investments to energy and commodity price fluctuations.
Adverse economic conditions or other factors could cause declines in the quality and valuation of our investment portfolios that would result in realized and unrealized losses. The concentration of our investment portfolios in any particular issuer, industry, collateral type, group of related industries, geographic sector, or risk type could have an adverse effect on our investment portfolios and consequently on our results of operations and financial condition. Prolonged and severe disruptions in the public debt and equity markets, including, among other things, volatility of interest rates, widening of credit spreads, bankruptcies, defaults, significant ratings downgrades, geopolitical instability, and a decline in equity or commodity markets, may cause significant losses in our
investment portfolio. Market volatility can make it difficult to value certain securities if their trading becomes infrequent. Depending on market conditions, we could incur substantial additional realized and unrealized investment losses in future periods. This could have a material effect on certain of our investments. Further, extreme market volatility may leave us unable to react to market events in a prudent manner consistent with our historical practices in dealing with more orderly markets.
Separately, the occurrence of large claims may force us to liquidate securities at an inopportune time, which may cause us to realize capital losses. Large investment losses could decrease our asset base and thereby affect our ability to underwrite new business. Additionally, such losses could have an adverse impact on our stockholders’ equity, business and financial strength, and debt ratings.
The aggregate performance of our investment portfolio also depends to a significant extent on the ability of us and the Investment Manager, in the management of our portfolios, to select and manage appropriate investments. As a result, we are also exposed to operational risks which may include, but are not limited to, a failure of the Investment Manager to perform its services in a manner consistent with product mandates or our investment guidelines.
The market and credit risks described above could reduce our net investment income and result in realized or unrealized investment losses. Our investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid. The valuation of investments is more subjective when markets are illiquid, thereby increasing the risk that the estimated fair value (i.e., the carrying amount) of the securities we hold in our portfolio do not reflect prices at which actual transactions would occur. In addition, although we seek to employ investment strategies that are not correlated with our insurance and reinsurance exposures, losses in our investment portfolio may occur at the same time as underwriting losses and, therefore, exacerbate the adverse effect of the losses on us.
We could be forced to sell investments to meet our liquidity requirements.
We invest the premiums we receive from our insureds until they are needed to pay policyholder claims. Consequently, we seek to manage the duration of our investment portfolio based on the duration of our loss and loss adjustment expense reserves to ensure sufficient liquidity and avoid having to liquidate investments to fund claims. Risks such as inadequate loss and loss adjustment reserves, unexpected sudden large losses, such as catastrophes, or unfavorable trends in litigation could potentially result in the need to sell investments to fund these liabilities. We may not be able to sell our investments at favorable prices or at all. Sales could result in significant realized losses depending on the conditions of the general market, interest rates, and credit issues with individual securities. See “—Risks related to our investment strategy—We have a limited ability to withdraw our capital from the Utility & Infrastructure Investments.”
We face risks associated with our reliance on the Investment Manager and its employees.
The performance of our investments is dependent on the ability of the Investment Manager, and more specifically, the portfolio managers of the Investment Manager, to develop and implement investment strategies that achieve the investment objectives of the accounts that they manage. If Stuart J. Zimmer ceases to be involved in the management of the Investment Manager or our other portfolios managed by the Investment Manager, the Utility Limited Partnership could be adversely affected. Mr. Zimmer is not prohibited from resigning. In addition, Mr. Zimmer has material responsibilities within the Investment Manager that are completely separate from his duties to our accounts and the Utility & Infrastructure Investments. There is no prohibition on an expansion or change to such other responsibilities. We have no special withdrawal rights if Mr. Zimmer were to cease to be involved in the management of the Investment Manager, or materially reduce his duties with respect to the Utility & Infrastructure Investments or our other portfolios managed by the Investment Manager; rather we would have the right to withdraw only in accordance with the withdrawal provisions detailed in the Utility Limited Partnership Agreement. See “Certain relationships and related party transactions—Investment management.”
The Utility & Infrastructure Investments and our other portfolio investments managed by the Investment Manager face operational risks from the Investment Manager’s’ management of the Utility & Infrastructure Investments and our other portfolio investments, including from misconduct by employees or service providers of the Investment Manager, which could result in material losses to our investment portfolio and, by extension, to us.
Our investment portfolio is exposed to operational risks from the Investment Manager and its employees and service providers, including from potential non-compliance with policies and regulations, employee misconduct, negligence, and fraud, each of which could result in material losses to the investment portfolio. In recent years, a number of investment managers and other financial institutions have suffered material losses due to, for example, the actions of traders executing unauthorized trades or other employee misconduct.
It is not always possible to deter or fully prevent employee misconduct and the precautions the Investment Advisers take to prevent and detect this activity may not always be effective. Any impact from the incident described above or other similar operational risks may result in material losses to our investment portfolio and, by extension, the Company.
Our investment portfolios and their performance substantially depend upon the ability of the Investment Manager to select and manage appropriate investments.
Pursuant to the investment management agreements for the fixed income accounts and the Utility & Infrastructure Investments, the Investment Manager has discretion and authority to make all investment decisions on behalf of our accounts, including the power to purchase, acquire, hold, invest, reinvest, sell, or otherwise dispose of the underlying assets or securities.
The trading strategies that the Investment Manager utilizes with respect to the Utility & Infrastructure Investments at any time may encompass a variety of techniques, both directly and derivatively, all of which may be based on any combination of systematic and discretionary analysis as determined by the Investment Manager in its sole discretion. The Utility & Infrastructure Investments are subject to all of the risks associated with the purchase and sale of complex leveraged instruments, including without limitation, the difficulty of accurately predicting price movements in particular investment positions and the difficulty of assessing the impact that an unpredictable multitude of economic and other events may have on prices or the value of investments. The Investment Manager utilizes a variety of speculative trading strategies which, if unsuccessful, could result in a complete loss of our investments. The trading and investment activities employed by the Investment Manager with respect to the Utility & Infrastructure Investments are not limited to these strategies and techniques and the Investment Manager is permitted to pursue any investment strategy and/or technique that the Investment Manager determines in its sole discretion to be appropriate for the Utility & Infrastructure Investments from time to time. We cannot assure stockholders as to how assets will be allocated to different investment opportunities, including long and short positions and derivatives trading, which could increase the level of risk associated with the Utility & Infrastructure Investments. The performance of the Utility & Infrastructure Investments depends fundamentally on the ability of the Investment Manager to select and manage appropriate investments for the Utility & Infrastructure Investments.
The Utility & Infrastructure Investments are speculative, entail substantial risks, and are subject to various conflicts of interest. There is no guarantee, assurance, or representation that the investment objectives of the Utility & Infrastructure Investments will be achieved or that the Utility & Infrastructure Investments will not result in significant losses, which consequently could significantly and negatively affect our business, results of operations, and financial condition.
In addition, under each of the Limited Partnership Agreements, each General Partner has the authority to dismiss from employment any and all agents, managers, consultants, advisors, and other persons, and has general management discretion and authority regarding the applicable Limited Partnership. Because each General Partner is an affiliate of the Investment Manager, it may have conflicts of interest with respect to decisions relating to such matters.
Each Limited Partnership is required to indemnify and hold harmless such Limited Partnership’s General Partner and under certain circumstances, the Investment Manager pursuant to the applicable Limited Partnership Agreement. As a result, in general, we do not expect to have recourse to the Investment Manager for our losses in the event that the Investment Manager (or its affiliates) incur losses, all of which could have an adverse impact on our financial conditions and results of operations.
We have a limited ability to withdraw our capital from the Utility & Infrastructure Investments.
Because the Utility Limited Partnership Agreement limits our ability to withdraw our capital from the Utility Limited Partnership to certain specified uses without the Utility General Partner’s consent, including without limitation, to pay insurance claims, operating expenses, in each case at the end of the quarter upon 45 days written notice, and because there is no secondary market for interests in the Utility Limited Partnership, an investment in the Utility Limited Partnership has limited liquidity.
Under the MidCap Limited Partnership Agreement, we are permitted to redeem 25% of our capital in the MidCap Limited Partnership at the end of a quarter upon 75 days’ notice. After such redemption, we may withdraw the remainder of our capital in equal installments for successive calendar quarters upon at least 75 days’ notice. A withdrawal made prior to the last business day of the third full calendar quarter occurring on or after the day immediately preceding the date on which our capital contribution was made will be subject to a withdrawal reduction of 3.75% of the gross withdrawal proceeds attributable to such capital. There is no secondary market for interests in the MidCap Limited Partnership. In light of the above restrictions, an investment in the MidCap Limited Partnership has limited liquidity.
Should the Limited Partnerships be terminated by the General Partners (as applicable), all assets will be liquidated in accordance with the terms set out in the applicable Limited Partnership Agreements and we will no longer receive returns in connection with this investment. If any of the Limited Partnerships is terminated, there can be no assurance that we will be able to replace the Investment Manager as our investment manager or achieve investment results comparable or better than those achieved by such Limited Partnership.
The General Partners, the Investment Manager, and their respective affiliates have potential conflicts of interest that could adversely affect us.
The structure and operations of the Investment Manager and its affiliates (and, by extension, how the Utility & Infrastructure Investments and the fixed income accounts managed by the Investment Manager are constructed, managed, and advised) give rise to a number of actual and potential conflicts of interest which may adversely affect us.
The Investment Manager and the General Partners are both controlled by ZFSG, which is also our controlling stockholder. The Investment Manager and its affiliates currently manage, and expect to continue to manage, third-party client and proprietary accounts, some of which have objectives that overlap with the investment objectives of the Utility & Infrastructure Investments and our fixed income portfolios managed by the Investment Manager. The Investment Manager’s interests will at times conflict with our interests, which may potentially adversely affect our and the Limited Partnerships’ investment opportunities and returns. Additionally, we pay management fees to the Investment Manager pursuant to the agreements we have entered into with the Investment Manager which may be different from the fees paid by other accounts managed by the Investment Manager. See “Certain relationships and related party transactions” for more details relating to such fee arrangements.
ZFSG and its affiliates, including the Investment Manager, engage in other business ventures and investment opportunities that will not be allocated equitably among us and such other business ventures.
ZFSG and its affiliates, including the Investment Manager, participate in various financial activities and have created multiple products that employ overlapping or substantially similar strategies and/or compete for limited trading and investment opportunities but are designed to achieve materially different expected risk-reward profiles. ZFSG and its affiliates, including the Investment Manager, engage in a wide-range of investment and other financial activities, many of which are not offered to us or to our accounts that are managed by the Investment Manager.
The Investment Manager also serves as investment manager of other investment vehicles. The Investment Manager, its principal, and its affiliates conduct investment activities for their own accounts and may serve as investment adviser, investment manager, or in a similar capacity to various other entities, co-investors, and managed accounts in the future. Situations may occur where our accounts that are managed by the Investment Manager could be disadvantaged because of the investment activities conducted by the Investment Manager for other clients due to, among other things, the limited availability of an opportunity or the market impact of orders for multiple accounts.
Additionally, decisions made by the Investment Manager on behalf of our accounts have the potential to vary materially from the decisions made by the Investment Manager and its affiliates on behalf of other clients (including its principal and its affiliates), including during times of market stress and during liquidation events. Because the Investment Manager employs the same or substantially similar strategies on behalf of many of its clients (including ZFSG and its affiliates) and because such clients often trade the same or similar instruments, the decisions made by the Investment Manager, on behalf of any individual client are likely to have a material impact on other clients. This impact is likely to be exacerbated during times of market stress and/or during liquidation events. For example, to the extent that the Investment Manager decides to liquidate or “de-lever” all or any portion of another client’s portfolio for any reason, the market’s reaction to such liquidation or deleveraging is likely to adversely affect the Utility & Infrastructure Investments or the Investment Manager’s ability to liquidate or de-lever the same or similar positions, whether or not the Investment Manager has made the independent decision to liquidate or de-lever the Utility & Infrastructure Investments.
The historical performance of the Investment Manager (including the performance of the Utility & Infrastructure Investments) should not be considered as indicative of our or the Utility & Infrastructure Investments’ future results.
The historical returns of the funds managed by the Investment Manager (including the performance of the Utility & Infrastructure Investments) are not necessarily indicative of future results. Results for the Utility & Infrastructure Investments could differ materially from the results of other funds managed by the Investment Manager. In addition, even if the Utility & Infrastructure Investments generate investment income in a given period, our overall performance could be adversely affected by losses generated by our insurance and reinsurance operations or other market dynamics. Poor performance of the Utility & Infrastructure Investments would cause a decline in our revenue and would therefore have a negative effect on our financial performance.
The ZIS Loan is a Related Party Transaction and is subject to the credit risk of an investment in ZIS and ZFSG, our parent company.
The ZIS Loan is a related party transaction. See “Certain relationships and related party transactions—Related Party Loan.” ZIS, which is a wholly-owned subsidiary of ZFSG, is the borrower under the ZIS Loan. Pursuant to the ZIS Loan, Ategrity Specialty Holdings LLC and Ategrity Ltd have provided a loan with a principal amount of $94 million to ZIS. The ZIS Loan is guaranteed by ZFSG. ZFSG is also a guarantor under the Investment Manager’s credit facility. The ZIS Loan is secured by the shares ZFSG holds in ZIS and certain of our shares of common stock that are held by ZFSG.
ZIS is an employee benefits business with a very limited operating history. ZIS was formed in 2023 for the purpose of providing certain business services to affiliates of ZFSG, including Ategrity. ZIS also sponsors self-insurance healthcare plans on behalf of employers, with equity capital provided by ZFSG. On October 1, 2024, ZIS commenced providing insurance and other ancillary benefits to our employees and employees of other ZFSG affiliates pursuant to such plans. In connection with its self-insurance business, ZIS collects premiums and is responsible for the payment of claims pursuant to such plans. There are certain risks associated with the self-insurance model, including the risk that claims are reported in excess of ZIS’s available reserves. ZIS’s current customers are ZFSG affiliates, including Ategrity; however, ZIS intends to expand its offerings to other employers. Our investment in the ZIS Loan is dependent on cash from operating activities of ZIS in order to service the interest and principal payments on the ZIS Loan. If ZIS were not able to service its indebtedness on the ZIS Loan, or if there were a default on such loan, the value of the collateral underlying the ZIS Loan may not be sufficient
to cover the amount we have invested in the ZIS Loan. In the event of bankruptcy proceedings relating to ZFSG, if a bankruptcy court were to substantively consolidate ZIS obligations with such proceedings, the recovery of our security interest could be subject to court approval and the timing of such recovery may be impeded as a result. In the event we were not able to recover the full value of our investment in the ZIS Loan, it could have a material adverse effect on our financial condition or results of operations.
Risks associated with the ZIS Loan and the Investment Manager’s strategy in managing the Utility & Infrastructure Investments could be greater than the investment risks faced by some of the other insurers with whom we compete.
We have a significant amount of financial exposure to the Utility & Infrastructure Investments and the ZIS Loan. As a result, our results of operations depend materially on the performance of the Utility & Infrastructure Investments and the ZIS Loan. The ZIS Loan is concentrated exposure to the credit of ZFSG and ZIS. The ZIS Loan is secured only by the shares of ZIS held by ZFSG as well as certain of our shares owned by ZFSG. This investment may present more concentrated risk exposure than the fixed income investments of other insurers with which we compete.
The Utility & Infrastructure Investments are inherently speculative and involve certain risks. The Utility & Infrastructure Investments are made through various commingled investment vehicles that are managed on behalf of multiple clients of the Investment Manager, and not structured in relation to our specific financial objectives or anticipated insurance and reinsurance liabilities. To the extent we are required to fund these or other liabilities in meaningful amounts and/or unexpectedly, we could be forced to liquidate investments at a significant loss or at prices that are not optimal, which could significantly and adversely affect our financial results.
The risks associated with the ZIS Loan and the Investment Manager’s investment strategy could be greater than the risks associated with traditional investment strategies employed by some of the insurers with whom we compete. For example, the Absolute Return Utility & Infrastructure Fund currently employs a utility and infrastructure-focused, long/ short strategy, investing primarily in equities. Because the Absolute Return Utility & Infrastructure Fund’s investment portfolio is concentrated in utilities and infrastructure, our investment therein may be subject to more rapid change in value, including as a result of energy and commodity price fluctuations, than would be the case if the Absolute Return Utility & Infrastructure Fund were to maintain a wide diversification among securities or industry sectors. Furthermore, even within utilities and infrastructure, the investment portfolio may be relatively concentrated. This lack of diversification may subject the investments of the Absolute Return Utility & Infrastructure Fund to more rapid change in value than would be the case if the assets of the Absolute Return Utility & Infrastructure Fund were more widely diversified.
Fees to the Investment Manager are paid not only in the form of a management fee based on the amount invested in the Utility & Infrastructure Investments, but also are paid as a 20% annual incentive fee on the profits of the relevant fund at the end of each performance period. In the case of the Absolute Return MidCap Fund, such incentive fee increases to 30% above a 15% annualized return hurdle. The Investment Manager generally will not be penalized for losses or decreases in the value of the Utility & Infrastructure Investments. Therefore, the Investment Manager could be incentivized to pursue strategies that are speculative or expose us to more risk in order to focus on near-term gains rather than long-term growth, which may have an adverse impact on our financial condition, results of operations, and cash flows. Additionally, such fees may reduce the returns to our portfolio versus other possible strategies that have different fee structures or no fees at all.
The Investment Manager employs hedging for Utility & Infrastructure Investments by taking long and short positions in related instruments. Hedging against a decline in the value of a portfolio position does not eliminate fluctuations in the values of such portfolio positions or prevent losses if the values of such positions decline, but establishes other positions designed to gain from those same developments, thus seeking to moderate the decline in the value of such portfolio position. Such hedging transactions also limit the opportunity for gain if the value of the portfolio position should increase. In the event of an imperfect correlation between a position in a hedging instrument and the portfolio position that it is intended to protect, the desired protection may not be obtained, and the Utility & Infrastructure Investments may be exposed to risk of loss. In addition, it is not possible
to hedge fully or perfectly against any risk, and hedging entails its own costs. Positions which would typically serve as hedges could actually move in the same direction as the instruments they were initially attempting to hedge, adding further risk (and losses). The Investment Manager may determine not to hedge against certain risks, and certain risks exist that cannot be hedged.
Moreover, there are likely to be an increasing number of market participants who rely on strategies and techniques that are similar to those used by the Investment Manager, which may result in a substantial number of market participants taking the same action with respect to an investment and some of these market participants may be substantially larger than our positions in the Utility & Infrastructure Investments.
In managing the Utility & Infrastructure Investments, the Investment Manager will trade on margin and use other forms of financial leverage, which could potentially adversely affect our results.
The Investment Manager employs substantial leverage with respect to the Utility & Infrastructure Investments. Such leverage is achieved by borrowing funds from U.S. and non-U.S. brokers, banks, dealers, and other lenders, purchasing or selling instruments on margin or with collateral and using options, futures, forward contracts, swaps and various other forms of derivatives, and other instruments which have substantial embedded leverage.
If any fund underlying the Utility & Infrastructure Investments can no longer utilize margin or post collateral under such lending arrangements, it could be required to liquidate a significant portion of its portfolio, and trading would be constrained, adversely affecting such fund’s performance.
Trading on leverage may result in greater risks, exposures, interest charges, and costs, which may be explicit (e.g., in the case of loans) or implicit (e.g., in the case of many derivative instruments) and such charges or costs could be substantial. The use of leverage, both through direct borrowing and through the investment in various types of instruments across a wide variety of asset classes, can substantially increase the market exposure (and market risk) to which the Utility & Infrastructure Investments are subject. Specifically, if the value of the portfolio of any fund underlying the Utility & Infrastructure Investments fell below the margin or collateral level required by a prime broker or dealer, the prime broker or dealer would require additional margin deposits or collateral amounts. If such fund were unable to satisfy such a margin or collateral call by a prime broker or dealer, the prime broker or dealer could liquidate the fund’s positions in its account with the prime broker or for which the dealer is the counterparty and cause such fund to incur significant losses. The failure to satisfy a margin or collateral call, or the occurrence of other material defaults under margin, collateral, or other financing agreements, could trigger cross-defaults under such fund’s agreements with other brokers, dealers, lenders, clearing firms, or other counterparties, multiplying the adverse impact to the fund. In addition, because the use of leverage will allow such fund control of or exposure to positions worth significantly more than the margin or collateral posted for such positions, the amount that such fund may lose in the event of adverse price movements will be high in relation to the amount of this margin or collateral amount and could exceed the value of the assets of such fund. Trading of futures, forward contracts, equity swaps, and other derivatives, for example, generally involves little or no margin deposit or collateral requirement and therefore provides substantial implicit leverage. Accordingly, relatively small price movements in these instruments (and others) can result in immediate and substantial losses.
In the event of a sudden decrease in the value of any fund underlying the Utility & Infrastructure Investments, such fund might not be able to liquidate assets quickly enough to satisfy its margin or collateral requirements. In that event, such fund would become subject to claims of financial intermediaries that extended “margin” loans or counterparty credit. Such claims could exceed the value of the assets of the fund. Trading of futures generally involves little or no margin deposit requirement and therefore provides substantial leverage. Accordingly, relatively small price movements in these instruments (and others) can result in immediate and substantial losses.
The banks, dealers, and counterparties (including prime brokers, futures commission merchants, and central clearing houses) that provide financing to the funds underlying the Utility & Infrastructure Investments can apply essentially discretionary margin, haircut, financing, and collateral valuation policies. Changes by banks, dealers, and counterparties in any of the foregoing may result in large margin calls, loss of financing, and forced liquidations
of positions at disadvantageous times or prices. There can be no assurance that the Utility & Infrastructure Investments will be able to secure or maintain adequate financing.
We and the Investment Manager engage in short selling, which could expose us to the potential for large losses.
The investment program for the Utility & Infrastructure Investments includes a significant amount of short selling. We also engage in certain short selling of treasury securities at the holding company level. Short selling transactions expose us and the Utility & Infrastructure Investments to the risk of loss in an amount greater than the initial investment, and such losses can increase rapidly and without effective limit. Short sales can, in certain circumstances, substantially increase the impact of adverse price movements in the Utility & Infrastructure Investments. A short sale of an instrument involves the risk of a theoretically unlimited loss from a theoretically unlimited increase in the market price of the instrument, which could result in an inability to cover the short position. In addition, there can be no assurance that securities or other instruments necessary to cover a short position will be available for purchase. There is the risk that the instruments borrowed in connection with a short sale would need to be returned to the lender on short notice. If such request for return of instruments occurs at a time when other short sellers of the subject instrument are receiving similar requests, a “short squeeze” can occur, wherein the holder of the short position might be compelled, at the most disadvantageous time, to replace the borrowed instruments previously sold short with purchases on the open market, possibly at prices significantly in excess of the proceeds received earlier in originally selling the instruments short. Purchasing instruments to close out the short position can itself cause the price of the instruments to rise further, thereby exacerbating any loss. There can be no assurance that securities necessary to cover a short position will be available for purchase.
Risks related to this offering and ownership of our common stock
There is no public market for our common stock and a market may never develop.
Before this offering, there has not been a public trading market for our common stock. We have applied to list our common stock on the NYSE under the symbol “ASIC.” However, an active and liquid trading market for our common stock may not develop or be sustained after this offering. If an active and liquid trading market does not develop, you may have difficulty selling your shares of common stock at an attractive price, or at all. The initial public offering price for our common stock sold in this offering has been determined by negotiations among us and the representatives of the underwriters. This price may not be indicative of the price at which our common stock will trade after this offering. The market price of our common stock may decline below the initial public offering price, and you may not be able to sell your common stock at or above the price you paid in this offering, or at all.
Our stock price may be volatile, or may decline regardless of our operating performance, and you could lose all or part of your investment.
Our quarterly results of operations are likely to fluctuate in the future as a publicly-traded company. In addition, securities markets worldwide have experienced, and are likely to continue to experience, significant price and volume fluctuations. This market volatility, as well as general economic, market, or political conditions, could subject the market price of our shares to wide price fluctuations regardless of our operating performance. You should consider an investment in our common stock to be risky, and you should invest in our common stock only if you can withstand a significant loss and wide fluctuation in the market value of your investment. The market price of our common stock could be subject to significant fluctuations after this offering in response to the factors described in this “Risk factors” section and other factors, many of which are beyond our control. Among the factors that could affect our stock price are:
•
market conditions in the broader stock market;
•
actual or anticipated variations in our quarterly and annual results of operations or those of other companies in our industry;
•
changes in market valuations of companies perceived to be similar to us;
•
introduction of new products or services by us or our competitors;
•
publication of research reports or news stories about us, our competitors, or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts;
•
results of operations or balance sheet items, such as reserves, that vary from expectations of securities analysts and investors;
•
guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance;
•
the public’s response to our or our competitors’ filings with the SEC, press releases, or other announcements regarding acquisitions, restructurings, litigation, regulation, or other strategic actions and significant matters;
•
changes in our Board of Directors, senior management, or other key personnel;
•
sales of our common stock, including by our directors, executive officers, and principal stockholders;
•
short sales, hedging, and other derivative transactions in our common stock;
•
any indebtedness we may incur or securities we may issue in the future;
•
actions by stockholders;
•
changes in accounting principles;
•
the occurrence of severe weather conditions and other catastrophes that affect or are perceived by investors as affecting us or our industry;
•
exposure to capital and credit market risks that adversely affect our investment portfolio or our capital resources;
•
investment performance;
•
changes in our credit ratings; and
•
the actual or anticipated passage of legislation or other regulatory developments affecting us or our industry.
The securities markets have from time to time experienced extreme price and volume fluctuations that often have been unrelated or disproportionate to the operating performance of particular companies. These broad market fluctuations, as well as general market, economic, and political conditions, such as recessions, loss of investor confidence, or interest rate changes, may negatively affect the market price of our common stock.
In addition, the stock markets, including the NYSE, have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. If any of the foregoing occurs, it could cause our stock price to fall and may expose us to securities class action litigation that, even if unsuccessful, could be costly to defend, divert management’s attention and resources or harm our business.
If securities analysts do not publish research or reports about our business or our industry or if they issue unfavorable commentary or issue negative recommendations with respect to our common stock, the price of our common stock could decline.
The trading market for our common stock will be influenced by the research and reports that equity research and other securities analysts publish about us, our business, and our industry. We do not have control over these analysts and we may be unable or slow to attract research coverage. One or more analysts could issue negative recommendations with respect to our common stock or publish other unfavorable commentary or cease publishing reports about us, our business, or our industry. If one or more of these analysts cease coverage of us, we could lose visibility in the market. As a result of one or more of these factors, the market price of our common stock price could decline rapidly and our common stock trading volume could be adversely affected.
Our articles of incorporation and bylaws will provide that the Eighth Judicial District Court of the State of Nevada (or if such court does not have jurisdiction, another state or the federal courts (as appropriate) located within the State of Nevada) will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees, or stockholders or make the litigation of such disputes more costly for stockholders.
Our articles of incorporation and bylaws will provide that, unless we consent to the selection of an alternative forum, the Eighth Judicial District Court of the State of Nevada, sitting in Clark County (or if such court does not have jurisdiction, another state or the federal courts (as appropriate) located within the State of Nevada) shall, to the fullest extent permitted by law, be the sole and exclusive forum for any actions, suits, or proceedings, whether civil, administrative, or investigative (i) brought in our name or right or on our behalf, (ii) asserting a claim for breach of any fiduciary duty owed by any of our current or former directors, officers, employees, or agents to us or our stockholders, (iii) that is an internal action (as defined in Nevada Revised Statutes (“NRS”) 78.046), including any action or claim arising under or pursuant to NRS Chapters 78 or 92A or any provision of our articles of incorporation or our bylaws, or as to which the NRS confers jurisdiction on the District Court of the State of Nevada, (iv) to interpret, apply, enforce, or determine the validity of our articles of incorporation and bylaws or any agreement entered into pursuant to NRS 78.365 to which we are a party or a stated beneficiary or (v) asserting a claim governed by the internal affairs doctrine. Section 27 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision in our articles of incorporation and bylaws will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Our articles of incorporation and bylaws will further provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. However, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce a duty or liability created by the Securities Act or the rules and regulations thereunder and, accordingly, we cannot be certain that a court would enforce such provision. See “Description of capital stock—Exclusive forum.”
Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and consented to the forum provisions in our articles of incorporation, except our stockholders will not be deemed to have waived (and cannot waive) compliance with the federal securities laws and the rules and regulations thereunder. This choice of forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our current or former directors, officers, other employees, or stockholders which may discourage lawsuits with respect to such claims or make such lawsuits more costly for stockholders. Alternatively, if a court were to find the choice of forum provision contained in our articles of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, financial condition, and results of operations.
Provisions in our articles of incorporation and bylaws and Nevada law could discourage, delay, or prevent a change in control of our company and may adversely affect the trading price of our common stock.
Provisions of our articles of incorporation and bylaws and Nevada law may discourage, delay, or prevent a merger, acquisition, or other change in control that stockholders may consider advantageous, including transactions in which you would otherwise receive a premium for your shares of our common stock. These provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management. These provisions will provide for, among other things:
•
there is no cumulative voting in the election of our directors, which prevents the minority stockholders from electing director candidates;
•
from and after such time as ZFSG and its affiliates no longer beneficially own more than 50% of the voting power of our capital stock, our board of directors will have an the exclusive right to elect a director to fill a
vacancy created by the expansion of the board of directors or the resignation, death, or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;
•
from and after such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, actions to be taken by our stockholders may only be effected at an annual or special meeting of our stockholders and not by written consent;
•
special meetings of our stockholders can be called only by the Chair of the board of directors, by our corporate secretary at the direction of our board of directors, or, until such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, the majority of the holders of our common stock;
•
advance notice procedures that stockholders, other than ZFSG for so long as it and its affiliates beneficially own more than 50% of the voting power of our capital stock, must comply with in order to nominate candidates to our board of directors and propose matters to be brought before an annual meeting of our stockholders may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company;
•
pursuant to Nevada law, a 662∕3% stockholder vote is required for removal of a director (with or without cause);
•
from and after such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, a 662∕3% stockholder vote is required for the amendment, repeal, or modification of certain provisions of our articles of incorporation and any provisions of our bylaws; and
•
our board of directors may, without stockholder approval, issue series of preferred stock, or rights to acquire preferred stock, that could dilute the interest of, or impair the voting power of, holders of our common stock or could also be used as a method of discouraging, delaying, or preventing a change of control.
The existence of the foregoing provisions and anti-takeover measures could limit the price that investors might be willing to pay in the future for shares of our common stock. They could also deter potential acquirers of our company, thereby reducing the likelihood that you could receive a premium for your common stock in an acquisition.
Certain anti-takeover provisions under Nevada law also apply to our company. We may be subject to Nevada’s statutes governing “combinations with interested stockholders” (NRS 78.411-78.444), which could prohibit us from entering into a “combination” with an “interested stockholder” for up to four years after the person first became an interested stockholder, unless certain conditions are met (for example in some circumstances, approval by our board of directors before such person became an interested stockholder, or approval by both our board of directors and a supermajority of the disinterested stockholders). Under these statutes, an interested stockholder is a person who beneficially owns (or is one of our affiliates or associates and, within the immediately prior two years, beneficially owned) stock with 10% or more of the corporation’s voting power. The inability of an interested stockholder to pursue the types of combinations restricted by these statutes could discourage, delay or prevent a merger, acquisition, or other change in control of our company. Our articles of incorporation will not opt out of NRS 78.411 through 78.444.
Further, if Nevada’s “acquisition of controlling interest” statutes (NRS 78.378-78.3793) are applicable to us, a person acquiring a significant proportion of our voting stock could be precluded from voting all or a portion of such shares under these statutes, which prohibit an acquirer of stock, under certain circumstances, from voting its “control shares” (meaning shares of outstanding voting stock that put the acquirer above certain specified ownership thresholds) acquired within 90 days immediately prior to crossing those ownership threshold percentages, unless the acquirer obtains approval of the disinterested stockholders or unless the articles of incorporation or bylaws of the issuing corporation in effect on the tenth day following the acquisition of the controlling interest provide that these statutes do not apply. If the voting rights are not approved, these statutes would allow us to call all of such control shares for redemption at the average price paid for such shares. In our articles of incorporation and bylaws, we intend not to opt out of these statutes. We intend to opt out of these statutes in our bylaws with respect to acquisitions of shares by ZFSG and its affiliates.
These anti-takeover provisions could make it more difficult for a third party to acquire us even if many of our stockholders are in favor of the third party’s offer. These provisions also may have the effect of preventing changes in our board of directors and may make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests. As a result, our stockholders may be limited in their ability to obtain a premium for their shares or control our management or board.
Applicable insurance laws may make it difficult to effect a change of control.
Under applicable Delaware insurance laws and regulations, no person may acquire control of a domestic insurer until written approval is obtained from the state insurance commissioner following a public hearing on the proposed acquisition. Such approval would be contingent upon the state insurance commissioner’s consideration of a number of factors including, among others, the financial strength of the proposed acquiror, the acquiror’s plans for the future operations of the domestic insurer, and any anti-competitive results that may arise from the consummation of the acquisition of control. Delaware insurance laws and regulations pertaining to changes of control apply to both the direct and indirect acquisition of ten percent or more of the voting stock of a Delaware-domiciled insurer. Accordingly, the acquisition of ten percent or more of our common stock would be considered an indirect change of control of Ategrity Specialty and would trigger the applicable change of control filing requirements under Delaware insurance laws and regulations, absent a disclaimer of control filing and its acceptance by the Delaware Insurance Department. These requirements may discourage potential acquisition proposals and may delay, deter, or prevent a change of control of Ategrity, including through transactions that some or all of the stockholders of Ategrity might consider to be desirable. See also “Regulation—Changes of control.”
Future sales, or the perception of future sales, of our common stock may depress the market price of our common stock.
Upon completion of this offering, we will have outstanding an aggregate of shares of our common stock. Of these shares, shares to be sold in this offering (or shares if the underwriters exercise their option to purchase additional shares in full) will be freely tradable without restriction or further registration under the Securities Act, unless such shares are held by our directors, executive officers, or any of our affiliates, as that term is defined in Rule 144 under the Securities Act (“Rule 144”). All remaining shares of common stock outstanding following this offering will be “restricted securities” within the meaning of Rule 144. Restricted securities may not be sold in the public market unless the sale is registered under the Securities Act or an exemption from registration is available. The Stockholders’ Agreement (as defined below) we enter into with ZFSG will grant certain registration rights to ZFSG with respect to shares of our common stock. Any shares registered pursuant to such registration rights described in “Certain relationships and related party transactions” will be freely tradable in the public market following a 180-day lock-up period as described below. Sales of our common stock in the public market after this offering, or the perception that these sales could occur, could cause the market price of our common stock to decline and may make it more difficult for us to sell equity or equity-linked securities in the future at a time and at a price that we deem necessary or appropriate.
In connection with this offering, our directors, executive officers, and holders of substantially all of our outstanding capital stock have each agreed to enter into “lock-up” agreements with the underwriters and thereby be subject to a lock-up period, meaning that they and their permitted transferees will not be permitted to sell any shares of our common stock for 180 days after the date of this prospectus, subject to certain exceptions without the prior consent of the representatives of the underwriters. Although we have been advised that there is no present intention to do so, the representatives may, in their sole discretion, release all or any portion of the shares from the restrictions in any of the lock-up agreements described above. See “Underwriting.” Possible sales of these shares in the market following the waiver or expiration of such agreements could exert significant downward pressure on our stock price.
We expect that upon the consummation of this offering, our Board of Directors and our stockholders will have approved the 2025 Incentive Plan which will permit us to issue, among other things, stock options, restricted stock units, and restricted stock to eligible employees (including our named executive officers), directors, and advisors, as determined by the compensation committee of the Board of Directors. We intend to file a registration
statement under the Securities Act, as soon as practicable after the consummation of this offering, to cover the issuance of shares upon the exercise of awards granted, and of shares granted, under the 2025 Incentive Plan. As a result, any shares issued under the 2025 Incentive Plan after the consummation of this offering also will be freely tradable in the public market. If equity securities are granted under the 2025 Incentive Plan and it is perceived that they will be sold in the public market, then the price of our common stock could decline.
Also, in the future, we may issue our securities in connection with investments or acquisitions. The amount of shares of our common stock issued in connection with an investment or acquisition could constitute a material portion of our then outstanding shares of our common stock.
ZFSG and its affiliates’ interests may conflict with our interests and the interests of our other stockholders. Conflicts of interest between ZFSG and its affiliates and us could be resolved in a manner unfavorable to us and our other stockholders.
Various conflicts of interest could arise between ZFSG and its affiliates and us. Ownership interests of directors or officers of ZFSG and its affiliates in our common stock and ownership interests of our directors and officers in the units of ZFSG and its affiliates, or a person’s service either as an employee, consultant, board observer, director, or officer of both companies, could create or appear to create potential conflicts of interest when those directors and officers are faced with decisions relating to us. These conflicts of interest could relate to:
•
corporate opportunities;
•
the impact that operating decisions for our business may have on ZFSG and its affiliates’ consolidated financial statements;
•
differences in tax positions between ZFSG and its affiliates and us and allocations of tax benefits under a Tax Allocation Agreement between us, Ategrity Specialty, Ategrity Ltd, and ZFSG, dated April 1, 2018 (the “Tax Agreement”);
•
future, potential commercial arrangements between ZFSG and its affiliates and us or between ZFSG and its affiliates and third parties;
•
the fact that some of our management and other employees are also employed by, are consultants to, or serve as a board observer or director of ZFSG or its affiliates and may have conflicts of interest as a result of such dual roles;
•
business combinations involving us;
•
our dividend policy;
•
certain board nomination and consent rights granted to ZFSG and its affiliates under the Stockholders’ Agreement;
•
management stock ownership; and
•
the intercompany agreements between ZFSG and its affiliates and us.
Furthermore, disputes may arise between ZFSG and its affiliates and us relating to our past and ongoing relationship and these potential conflicts of interest may make it more difficult for us to favorably resolve such disputes, including those related to:
•
tax, employee benefits, indemnification, and other matters;
•
the nature, quality, and pricing of services ZFSG and its affiliates agree to provide to us;
•
sales or other disposals by ZFSG and its affiliates of all or a portion of its ownership interest in us; and
•
business combinations involving us.
We may not be able to resolve any potential conflicts, and even if we do, the resolution may be less favorable to us than if we were dealing with an unaffiliated party.
We have various contracts and other arrangements in place with ZFSG and its affiliates. Certain related party transactions with ZFSG and its affiliates will also be pre-approved by our audit committee in accordance with our
policy concerning related party transactions to be entered into in connection with this offering. You should read “Certain relationships and related party transactions” carefully for more detail on the nature and terms of the arrangements between us and ZFSG and its affiliates. While we are controlled by ZFSG and its affiliates, we may not have the leverage to negotiate amendments to our agreements with ZFSG and its affiliates, if required, on terms as favorable to us as those we would negotiate with an unaffiliated third party.
We will be a “controlled company” within the meaning of the rules of the NYSE and, as a result, will qualify for, and rely on, exemptions from certain corporate governance requirements. You will not have the same protections afforded to stockholders of companies that are subject to such requirements.
Following the completion of this offering, ZFSG and its affiliates will continue to hold more than 50.0% of the voting power of our shares eligible to vote. As a result, we will be a “controlled company” under the rules of the NYSE. Under these rules, a company of which more than 50.0% of the voting power in the election of directors is held by an individual, group, or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements, including the requirements that (i) a majority of the board of directors consist of independent directors and (ii) the board of directors have compensation and nominating and corporate governance committees composed entirely of independent directors.
Following the completion of this offering, we intend to utilize these exemptions. As a result, following the completion of this offering, we do not intend to have a majority of independent directors on our board of directors and do not intend to have a compensation, nominating, and corporate governance committee composed entirely of independent directors. Accordingly, although we may transition to a board with a majority of independent directors prior to the time we cease to be a “controlled company,” for such period of time you will not have the same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements set by the NYSE. In the event that we cease to be a “controlled company” and our shares continue to be listed on the NYSE, we will be required to comply with these provisions within the applicable transition periods. These exemptions do not modify the independence requirements for our audit committee, and we intend to comply with the applicable requirements of the SEC and the NYSE with respect to our audit committee.
ZFSG and its affiliates will be able to exert significant influence over us and our corporate decisions.
Immediately following the completion of this offering, ZFSG and its affiliates are expected to own, in the aggregate, approximately % of our outstanding common stock (or approximately % if the underwriters exercise their option to purchase additional shares in full). So long as ZFSG and its affiliates owns a significant amount of our outstanding common stock, ZFSG will be able to exert significant voting influence over us and our corporate decisions, including any matter requiring stockholder approval regardless of whether others believe that the matter is in our best interests. For example, ZFSG and its affiliates will be able to exert significant influence over the vote in any election of directors and any amendment of our charter. ZFSG and its affiliates may act in a manner that advances their best interests and not necessarily those of other stockholders, including investors in this offering, by, among other things:
•
delaying, preventing, or deterring a change in control of us;
•
delaying, preventing, or deterring a change in the composition of our management or our Board of Directors;
•
approval of the termination of the agreements described in “Certain relationships and related party transactions”; or
•
attempting to influence us to enter into transactions or agreements, including with related parties, that may not be in the best interests of all stockholders.
Substantially all of our net invested assets are managed by ZFSG through the Investment Manager. Accordingly, ZFSG and its affiliates may have a conflict of interest in managing our investments, which could increase amounts payable by us for asset management services or cause us to receive a lower return on our investments than if
our investment portfolio was managed by another party. The investment strategies employed by the Investment Manager may expose us to more volatility and risk than more traditional insurance industry investment strategies might.
In connection with this offering, we will enter into a Stockholders’ Agreement that will grant ZFSG the right to nominate individuals to our Board of Directors (including the Chair of the Board of Directors) and its committees, provided certain ownership requirements are met. See “Certain relationships and related party transactions—Stockholders’ Agreement.”
The concentration of our ownership could deprive stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company, reduce liquidity in our common stock to the extent it reduces our public float, and may ultimately affect the market price of our common stock. Additionally, ZFSG currently consolidates the Company in the preparation of its financial statements and in order to continue to consolidate, ZFSG may be incentivized to maintain an ownership percentage in us above 80% for an indefinite period of time.
Our articles of incorporation will provide that ZFSG has no obligation to offer us corporate opportunities.
ZFSG and the members of our board of directors who are affiliated with ZFSG, by the terms of our articles of incorporation to be in effect upon consummation of this offering, will not be required to offer us any corporate opportunity of which they become aware and could take any such opportunity for themselves or offer it to other companies in which they have an investment, unless such opportunity is expressly offered to them solely in their capacity as our directors. We, by the terms of our articles of incorporation, expressly renounce any interest in any such corporate opportunity to the extent permitted under applicable law, even if the opportunity is one that we would reasonably be deemed to have pursued if given the opportunity to do so. Our articles of incorporation cannot be amended to eliminate our renunciation of any such corporate opportunity arising prior to the date of any such amendment. ZFSG is in the business of making investments in portfolio companies and may from time to time acquire and hold interests in businesses that compete with us, and ZFSG has no obligation to refrain from acquiring competing businesses. Any competition could intensify if an affiliate or subsidiary of ZFSG were to enter into or acquire a business similar to ours. These potential conflicts of interest could have an adverse effect on our business, financial condition, results of operations, or prospects if attractive corporate opportunities are allocated by ZFSG to itself, its portfolio companies, or its other affiliates instead of to us.
We will incur significant increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.
As a public company, we will incur significant legal, accounting, and other expenses that we did not incur as a private company. After completion of this offering, we will be subject to the reporting requirements of the Exchange Act, which will require, among other things, that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition and therefore we will need to have the ability to prepare financial statements that comply with all SEC reporting requirements on a timely basis. In addition, we will be subject to other reporting and corporate governance requirements, including certain requirements of and certain provisions of the Sarbanes-Oxley Act and the regulations promulgated thereunder, which will impose significant compliance obligations upon us.
The Sarbanes-Oxley Act and the Dodd-Frank Act, as well as new rules subsequently implemented by the SEC and the NYSE, have increased regulation of, and imposed enhanced disclosure and corporate governance requirements on, public companies. Our efforts to comply with these evolving laws, regulations, and standards will increase our operating costs and divert management’s time and attention from revenue-generating activities.
These changes will also place significant additional demands on our finance and accounting staff and on our financial accounting and information systems. We may in the future hire additional accounting and financial staff with appropriate public company reporting experience and technical accounting knowledge. Other expenses associated with being a public company include increases in auditing, accounting, and legal fees and expenses, investor relations expenses, increased directors’ fees, and director and officer liability insurance costs, registrar and transfer agent fees, and listing fees, as well as other expenses. As a public company, we will be required, among other things, to:
•
prepare and file periodic reports and distribute other stockholder communications, in compliance with the federal securities laws and requirements of the NYSE;
•
define and expand the roles and the duties of our Board of Directors and its committees;
•
institute more comprehensive compliance and investor relations functions; and
•
evaluate and maintain our system of internal control over financial reporting, and report on management’s assessment thereof, in compliance with rules and regulations of the SEC and the Public Company Accounting Oversight Board.
We may not be successful in implementing these requirements and implementing them could adversely affect our business. The increased costs will decrease our net income and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our Board of Directors, our board committees, or as executive officers.
In addition, if we fail to implement the required controls with respect to our internal accounting and audit functions, our ability to report our results of operations on a timely and accurate basis could be impaired. If we do not implement the required controls in a timely manner or with adequate compliance, we may be subject to sanctions or investigation by regulatory authorities, such as the SEC or the NYSE. Any such action could harm our reputation and the confidence of investors in, and clients of, our company and could negatively affect our business and cause the price of our shares of common stock to decline.
You will incur immediate dilution as a result of this offering.
The initial public offering price is substantially higher than the net stockholders’ tangible equity per share of our common stock based on the total value of our tangible assets less our total liabilities divided by our shares of common stock outstanding immediately following this offering. Therefore, if you purchase common stock in this offering, you will experience immediate and substantial dilution in net tangible stockholders’ equity per share value after consummation of this offering. You may experience additional dilution upon future equity issuances. See “Dilution.”
If we were to identify a material weakness in our internal controls, our business, financial condition, and results of operations could be harmed, which could have a negative effect on the trading price of our common stock.
As a public company with SEC reporting obligations, we will be required to document and test our internal control procedures to satisfy the requirements of Section 404(a) of the Sarbanes-Oxley Act, which will require annual assessments by management of the effectiveness of our internal control over financial reporting. We are an emerging growth company, and thus we are exempt from the auditor attestation requirement of Section 404(b) of Sarbanes-Oxley until such time as we no longer qualify as an emerging growth company. See also “—We qualify as an emerging growth company, and any decision on our part to comply with reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.” Regardless of whether we qualify as an emerging growth company, we will still need to implement substantial internal control systems and procedures in order to satisfy the reporting requirements under the Exchange Act and applicable requirements. The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation. As a result, to comply with the requirements of being a reporting company under the Exchange Act, we may need to upgrade our information technology systems; implement additional financial and management controls, reporting systems, and procedures; and hire additional accounting and finance staff. If we or, if required, our auditors are unable to conclude that our internal control over
financial reporting is effective, investors may lose confidence in our financial reporting and the trading price of our common stock may decline.
During the course of our assessment, we may identify deficiencies that we are unable to remediate in a timely manner. Testing and maintaining our internal control over financial reporting may also divert management’s attention from other matters that are important to the operation of our business. We may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404(a) of the Sarbanes-Oxley Act. If we conclude that our internal control over financial reporting is not effective, we cannot be certain as to the timing of completion of our evaluation, testing, and remediation actions or their effect on our operations. Moreover, any material weaknesses or other deficiencies in our internal control over financial reporting may impede our ability to file timely and accurate reports with the SEC. Any of the above could cause investors to lose confidence in our reported financial information or our common stock listing on the NYSE to be suspended or terminated, which could have a negative effect on the trading price of our common stock.
We qualify as an emerging growth company, and any decision on our part to comply with reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.
We are an “emerging growth company,” and, for as long as we continue to be an emerging growth company, we currently intend to take advantage of exemptions from various reporting requirements applicable to other public companies but not to “emerging growth companies,” including, but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our registration statements, periodic reports, and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We will cease to be an emerging growth company upon the earliest of: (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (ii) the last day of our fiscal year following the fifth anniversary of the date of the completion of this offering; (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; and (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC.
We cannot predict whether investors will find our common stock less attractive if we choose to rely on these exemptions while we are an emerging growth company. If some investors find our common stock less attractive as a result of any choices to reduce future disclosure, there may be a less active trading market for our common stock and the price of our common stock may be more volatile.
Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.
We have broad discretion in the use of the net proceeds from the sale of shares by us in this offering and may not use them effectively.
Our management will have broad discretion in the application of the net proceeds from the sale of shares by us in this offering, including for any of the purposes described in the section entitled “Use of proceeds,” and you will not have the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately. Because of the number and variability of factors that will determine our use of the net proceeds from the sale of shares by us in this offering, their ultimate use may vary substantially from their currently intended use. Our management may not apply our net proceeds in ways that ultimately increase the value of your investment. The failure by our management to apply these funds effectively could harm our business. If we do not invest or apply the net proceeds from the sale of shares by us in this offering in ways that enhance stockholder value, we may fail to achieve expected financial results, which could cause our stock price to decline.
Forward-looking statements
This prospectus contains forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. You can identify forward-looking statements in this prospectus by the use of words such as “anticipates,” “estimates,” “expects,” “intends,” “plans,” and “believes,” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could.” These forward-looking statements include, among others, statements relating to our future financial performance, our business prospects and strategy, anticipated financial position, liquidity and capital needs, and other similar matters. These forward-looking statements are based on management’s current expectations and assumptions about future events, which are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict.
Our actual results may differ materially from those expressed in, or implied by, the forward-looking statements included in this prospectus as a result of various factors, including, among others:
•
the intense competition for business in our industry;
•
the inability to obtain reinsurance coverage at reasonable prices and on terms that adequately protect us;
•
the possibility that our loss reserves may be inadequate to cover our actual losses, which could have an adverse effect on our financial condition, results of operations, and cash flows;
•
the inherent uncertainty of models resulting in actual losses that are materially different than our estimates;
•
a decline in the financial strength rating assigned to Ategrity Specialty or to Ategrity Ltd adversely affecting the amount of business we write;
•
our reliance on a select group of brokers;
•
unexpected changes in the interpretation of our coverage or provisions;
•
adverse economic factors, including recession, inflation, periods of high unemployment. or lower economic activity resulting in the sale of fewer policies than expected, or an increase in frequency or severity of claims and premium defaults, or both, affecting our growth and profitability;
•
the performance of our investment portfolio adversely affecting our financial results;
•
the potential loss of one or more key executives or an inability to attract and retain qualified personnel adversely affecting our results of operations;
•
the failure of any of the loss limitations or exclusions we employ, or change in other claims or coverage issues, having a material adverse effect on our financial condition or results of operations;
•
extensive regulation adversely affecting our ability to achieve our business objectives or the failure to comply with these regulations adversely affecting our financial condition and results of operations;
•
the effects of litigation having an adverse effect on our business;
•
the inability to manage our growth effectively;
•
the ability to pay dividends and other distributions and service our debt obligations being dependent on our ability to obtain cash dividends or other permitted payments from Ategrity Specialty;
•
being forced to sell investments to meet our liquidity requirements;
•
our underwriters and other associates taking excessive risks;
•
the possibility that severe weather conditions and other catastrophes may result in an increase in the number and amount of claims filed against us;
•
the ability of ZFSG and its affiliates to exert significant influence over us and our corporate decisions;
•
the failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act; and
•
other risks and uncertainties discussed in “Risk factors” and elsewhere in this prospectus.
Accordingly, you should read this prospectus completely and with the understanding that our actual future results may be materially different from what we expect.
Forward-looking statements speak only as of the date of this prospectus. Except as expressly required under federal securities laws and the rules and regulations of the SEC, we do not have any obligation, and do not undertake, to update any forward-looking statements to reflect events or circumstances arising after the date of this prospectus, whether as a result of new information, future events, or otherwise. You should not place undue reliance on the forward-looking statements included in this prospectus or that may be made elsewhere from time to time by us, or on our behalf. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.
Use of proceeds
We estimate the net proceeds from the sale of shares by us in this offering will be approximately $ million, based on an assumed initial public offering price of $ per share of common stock, which is the midpoint of the range we show on the cover of this prospectus, and after deducting the underwriting discounts and commissions and our estimated offering expenses of $ million.
A $1.00 increase (decrease) in the assumed initial public offering price of $ per share would increase (decrease) the net proceeds to us from this offering by approximately $ million, assuming the number of shares offered by us, which we show on the cover of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions. Similarly, a 1.0 million increase (decrease) in the number of shares of our common stock sold in this offering by us, which we show on the cover of this prospectus, would increase (decrease) the net proceeds to us from this offering by approximately $ million, assuming an initial public offering price of $ per share, the midpoint of the price range which we show on the cover of this prospectus, remains the same, and after deducting underwriting discounts and estimated offering expenses payable by us. The information discussed above is illustrative only and will adjust based on the actual initial public offering price and other terms of this offering determined at pricing.
The principal purposes of this offering are to increase our capitalization and financial flexibility and to create a public market for our common stock. We intend to use the net proceeds from this offering as capital to grow our business and for other general corporate purposes. We initially intend to invest such net proceeds in fixed income securities. We periodically evaluate strategic opportunities; however, we have no current commitments for any material acquisitions or investments at this time.
This expected use of net proceeds from this offering represents our intentions based on our current plans and business conditions, which could change in the future as our plans and business conditions evolve. As a result, our management will retain broad discretion over the use of the net proceeds from the sale of shares by us in this offering and our existing cash and cash equivalents.
Dividend policy
We do not currently intend to pay cash dividends on our shares of common stock in the foreseeable future. However, in the future, subject to the factors described below and our future liquidity and capitalization, we may change this policy and choose to pay dividends or other distributions. Any determination to pay dividends or other distributions in the future will be at the discretion of our Board of Directors and will depend upon our results of operations, cash requirements, financial condition, contractual restrictions, restrictions imposed by applicable laws, and other factors that our Board of Directors may deem relevant.
Our status as a holding company and a legal entity separate and distinct from our subsidiaries affects our ability to pay dividends and make other payments. As a holding company without significant operations of our own, the principal sources of our funds are dividends and other payments from our subsidiaries. The ability of our insurance or reinsurance subsidiaries to pay dividends to us is subject to limits under insurance laws of the state or foreign jurisdiction in which Ategrity Specialty or Ategrity Ltd is domiciled. See “Risk factors—Risks related to our business and industry—Because we are a holding company and substantially all of our operations are conducted by our insurance subsidiaries, our ability to pay dividends and make other distributions and service our debt obligations depends on our ability to obtain cash dividends or other permitted payments from our insurance subsidiaries” and “Management’s discussion and analysis of financial condition and results of operations—Liquidity and capital resources” and “Regulation.”
Our future ability to pay cash dividends and other distributions may also be limited by the terms of any future debt or preferred securities or future credit facility.
Capitalization
The following table summarizes our consolidated capitalization as of December 31, 2024:
•
on an actual basis; and
•
on an as adjusted basis to give effect to our sale of shares of common stock in this offering at an assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus, after the deduction of the estimated underwriting discounts and commissions and estimated offering expenses payable by us.
You should read this table in conjunction with the section of this prospectus entitled “Management’s discussion and analysis of financial condition and results of operations” and our financial statements and accompanying notes included elsewhere in this prospectus.
|
(Dollars in millions)
|
|
|
Actual
|
|
|
As adjusted(1)
|
|
|
Cash and cash equivalents
|
|
|
|
$ |
26,573 |
|
|
|
|
$ |
|
|
|
|
Members’ Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LLC units ( authorized units; issued units, actual)
|
|
|
|
|
398,307 |
|
|
|
|
|
|
|
|
|
Stockholders’ Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock–par value $ per share ( authorized shares;
issued shares, actual) ( authorized shares; issued shares, as
adjusted)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock–par value $ per share ( authorized shares;
zero issued shares, actual) ( authorized shares; zero issued shares, as adjusted)
|
|
|
|
|
Retained earnings
|
|
|
|
|
34,569 |
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income
|
|
|
|
|
2,997 |
|
|
|
|
|
|
|
|
|
Total members’/stockholders’ equity
|
|
|
|
|
398,307 |
|
|
|
|
|
|
|
|
|
Non-controlling interest
|
|
|
|
$ |
500 |
|
|
|
|
$ |
|
|
|
|
Total capitalization
|
|
|
|
$ |
398,807 |
|
|
|
|
$ |
|
|
|
(1) Each $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the as adjusted amount of each of cash and cash equivalents, total equity, and total capitalization by approximately $ million, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of million shares in the number of shares of common stock offered by us at the assumed initial public offering price of $ per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the as adjusted amount of each of cash and cash equivalents, total equity, and total capitalization by approximately $ million, assuming the shares of our common stock offered by this prospectus are sold at the assumed initial public offering price of $ per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.
The number of shares of common stock in the table above excludes:
•
an aggregate of shares of common stock issuable upon the exercise of Tranche 1 warrants held by ZFSG with an exercise price of $ per share;
•
an aggregate of shares of common stock issuable upon the exercise of Tranche 2 warrants held by ZFSG with an exercise price of $ per share;
•
an aggregate of shares of common stock issuable upon the exercise of options outstanding under the 2019 Plan as of , 2025, with a weighted average exercise price of $ per share; and
•
an aggregate of shares of common stock reserved for issuance under the 2025 Plan, that will become effective in connection with this offering.
Dilution
If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per share and the pro forma as adjusted net tangible book value (deficit) per share of our common stock immediately after this offering.
Pro forma net tangible book value (deficit) per share has been determined by dividing net tangible book value (deficit) (total tangible assets less total liabilities) by the pro forma number of shares of common stock that will be outstanding immediately prior to the closing of this offering. Pro forma net tangible book value (deficit) as of was $ million, or $ per share of common stock.
Pro forma as adjusted net tangible book value (deficit) is our pro forma net tangible book value, plus the effect of the sale by us of shares of our common stock in this offering at an assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Our pro forma as adjusted net tangible book value (deficit) as of was $ million, or $ per share of common stock. This amount represents an immediate increase in pro forma as adjusted net tangible book value (deficit) of $ per share to our existing stockholders, and an immediate dilution of $ per share to new investors participating in this offering. We determine dilution per share to new investors by subtracting pro forma as adjusted net tangible book value (deficit) per share after this offering from the initial public offering price per share paid by new investors.
The following table illustrates the per share dilution that a purchaser of our common stock in this offering will incur given the assumptions above:
| |
Assumed initial public offering price per share
|
|
|
|
|
|
|
$ |
|
|
|
| |
Pro forma net tangible book value (deficit) per share as of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Increase in pro forma net tangible book value (deficit) per share attributable to new investors in this offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Pro forma as adjusted net tangible book value (deficit) per share immediately after this offering
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
| |
Dilution in pro forma net tangible book value (deficit) per share to new investors
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
| |
A $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus, would increase (decrease) the pro forma as adjusted net tangible book value (deficit) per share immediately after this offering by approximately $ , and dilution in pro forma net tangible book value (deficit) per share to new investors by approximately $ , assuming that the number of shares offered by us, which we show on the cover of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.
If the underwriters exercise their option to purchase additional shares of our common stock from us to cover over-allotments, the pro forma as adjusted net tangible book value (deficit) per share of our common stock would be $ , and the dilution in pro forma as adjusted net tangible book value (deficit) per share of our common stock to new investors participating in this offering would be $ .
The following table summarizes, as of , on a pro forma as adjusted basis as described above, the differences between the number of shares of common stock purchased from us, the total consideration paid to us, and the average price per share paid by existing stockholders and by investors purchasing shares of common stock in this offering. The calculation below is based on an assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus, before deducting underwriting discounts and commissions and estimated offering expenses payable by us.
| |
|
|
|
Shares Purchased
|
|
|
Total Consideration
|
|
|
Average
Price Per
Share
|
|
| |
|
|
|
Number
|
|
|
Percent
|
|
|
Dollars
(in millions)
|
|
|
Percent
|
|
| |
|
|
|
|
|
|
|
|
%
|
|
|
|
|
$ |
|
|
|
|
|
|
%
|
|
|
|
|
$ |
|
|
|
| |
Existing stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
New investors
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
| |
Total
|
|
|
|
|
|
|
|
100.0% |
|
|
|
|
$ |
|
|
|
|
|
|
100.0% |
|
|
|
|
$ |
|
|
|
If the underwriters exercise their option to purchase additional shares in full, the number of shares held by new investors will increase to , or % of the total number of shares of common stock outstanding after this offering and the number of shares held by existing stockholders will decrease to , or % of the total number of shares of common stock outstanding after this offering.
To the extent that any options or other equity incentive grants are issued in the future with an exercise price or purchase price below the initial public offering price, new investors will experience further dilution.
Management’s discussion and analysis of financial condition and results of operations
The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. See “Risk factors” and “Forward-looking statements” herein. Our actual results could differ materially from the forward-looking statements included herein. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section entitled “Risk factors” and elsewhere in this prospectus.
Overview
We are a profitable and growing specialty insurance company dedicated to providing excess and surplus (“E&S”) products to small to medium-sized businesses (“SMBs”) across the United States. We have built a proprietary underwriting platform that combines sophisticated data analytics with automated and streamlined processes to efficiently serve our clients and deliver long-term value to our stockholders. The SMB market is characterized by large volumes of small-sized policies, and we believe our competitive edge lies in our ability to offer consistent, high-speed, and low-touch interactions that our distribution partners value. This advantage stems from our technology-driven method of standardizing, simplifying, and automating our transaction process, which we call productionized underwriting.
We target industry verticals where we have deep expertise and develop data-driven insights to gain a competitive advantage. We leverage our expertise and our efficient underwriting platform to deliver tailored insurance products and customized services that meet the needs of our distribution partners. We believe the universe of distributors in the SMB segment of the E&S market is rapidly shifting toward agents and brokers who were raised in the digital age. These digital-native and tech-savvy distribution partners expect real-time, frictionless insurance transactions that mirror the seamless experiences they encounter in their daily lives. In an industry where insurance applications are often submitted via email with slow response times, we have designed a technology-driven underwriting process that addresses our distribution partners’ demands for rapid, high-quality interactions. Our strong value proposition has contributed to a growing network of 460 distribution partners as of December 31, 2024, which provides us with increased transaction opportunities and diversified sources of business. Our fully integrated claims management function is designed to enable us to resolve claims efficiently and effectively. We take an active approach to risk management through real-time performance analytics, rigorous risk aggregation monitoring, and robust reinsurance protection aimed at minimizing volatility and generating consistent underwriting results.
We have grown our business substantially while generating attractive underwriting results. For the year ended December 31, 2024, we wrote $437.0 million in gross written premiums, representing a compound annual growth rate of 28.4% over the last two years. Our combined ratio for the year ended December 31, 2024, was 93.9%, a decrease of 3.6% from the year ended December 31, 2023. Our members’ equity at December 31, 2024, was $398.3 million, an increase of $76.6 million (23.8%) from December 31, 2023. We believe that our productionized underwriting capabilities will continue to drive enhanced profitability as we continue to scale our business.
We operate on a surplus lines basis in 48 states and the District of Columbia. As of December 31, 2024, there were four states in which 5.0% or more of our gross written premiums were concentrated: California (21.0%), Florida (16.2%), Texas (12.8%), and New York (6.4%).
We operate our business in a single segment and as one reporting unit for purposes of assessing performance, making operating decisions and allocating decisions.
Components of results of operations
Gross written premiums
Gross written premiums are the amount received or to be received for insurance policies written or assumed by us during a specific period of time without reduction for policy acquisition costs, reinsurance costs, or other deductions. The volume of our gross written premiums in any given period is generally influenced by:
•
New business submissions;
•
Binding of new business submissions into policies;
•
Renewals of existing policies; and
•
Average size and premium rate of new and existing policies.
Ceded written premiums
Certain premiums and losses are ceded to other insurance and reinsurance companies under various excess of loss and quota-share reinsurance contracts. Ceded written premiums are the amount of gross written premiums ceded to reinsurers. We enter into reinsurance contracts to limit our exposure to potential large losses as well as to provide additional capacity for growth. Ceded written premiums are earned over the reinsurance contract period in proportion to the period of risk covered. The volume of our ceded written premiums is impacted by the level of our gross written premiums and any decision we make to increase or decrease retention levels.
Net premiums earned
Net premiums earned represent the earned portion of our net written premiums. Written premiums are earned on a pro rata basis over the terms of the policies, which are generally 12 months. The portion of premiums written applicable to the terms of the policies that have already elapsed is recorded as earned premiums.
Fee income
Fee income includes policy fees charged to insureds and is recognized in earnings when the related premiums are written. Policy fees are a flat charge and are primarily impacted by the volume of our written policies.
Losses and loss adjustment expenses
Losses and loss adjustment expenses are a function of the amount and type of insurance contracts we write and the loss experience associated with the underlying coverage. In general, our losses and loss adjustment expenses are affected by:
•
frequency of claims associated with the particular types of insurance contracts that we write;
•
trends in the average size of losses incurred on a particular type of business;
•
mix of business written by us;
•
reinsurance agreements we have in place at the time of loss;
•
changes in the legal or regulatory environment related to the business we write;
•
trends in legal defense costs;
•
wage inflation; and
•
inflation in medical costs.
Losses and loss adjustment expenses are based on actual paid losses and an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Losses and loss adjustment expenses may be paid out over a period of years.
Underwriting, acquisition, and insurance expenses
Underwriting, acquisition, and insurance expenses include policy acquisition costs and other underwriting expenses. Policy acquisition costs are principally comprised of the commissions we pay our brokers, net of ceding commissions we receive on business ceded under certain reinsurance contracts. Policy acquisition costs also include deferred underwriting expenses that are directly related to the successful acquisition of those policies. Other underwriting expenses represent general and administrative expenses related to our insurance business, including employee compensation, software and technology costs, travel, marketing, and professional fees.
Net investment income
We earn investment income on our portfolio of cash and invested assets. Our cash and invested assets are primarily comprised of fixed maturity securities, the Utility & Infrastructure Investments, and cash and cash
equivalents. We also earn investment income on our short-term investments, equity securities, note receivable from affiliate, and securities sold not-yet purchased. Net investment income related to the Utility & Infrastructure Investments includes our proportionate share of the rebate, dividend, interest and other income, net of investment expenses, and investment management fees for the funds underlying the Utility & Infrastructure Investments. The principal factors that influence net investment income are the size of our investment portfolio and the yield on that portfolio as measured by amortized cost (which excludes changes in fair market value, such as from changes in interest rates) and investment management expenses. The size of our investment portfolio is mainly a function of our invested equity capital along with premiums we receive from our insureds less payments on policyholder claims. For the years ended December 31, 2024 and 2023 the Utility & Infrastructure Investments consisted of our investment in the Absolute Return Utility & Infrastructure Fund via the Utility Limited Partnership. To optimize our Utility & Infrastructure Investments, we re-allocated a $10 million portion of our portfolio to the Absolute Return MidCap Fund on January 1, 2025. On March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd redeemed an aggregate of $94 million from the Absolute Return Utility & Infrastructure Fund and on March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd, as lenders, executed the ZIS Loan. See “Certain relationships and related party transactions—Related Party Loan.”
Net realized and unrealized gains (losses) on investments
Net realized and unrealized gains (losses) on investments include realized gains and losses which are a function of the difference between the amount received by us on the sale of a security and the security’s amortized cost, as well as the change in unrealized gains (losses) on equity securities and unrealized appreciation (depreciation) on securities sold not yet purchased. Net realized and unrealized gains (losses) on investments also includes appreciation on securities, derivative contracts, and foreign currency transactions allocated from the funds underlying the Utility & Infrastructure Investments. Such allocation represents our proportionate share of the Utility & Infrastructure Investments’ net realized gains (losses) of the funds underlying the Utility & Infrastructure Investments which are a function of the difference between the amount received on the sale of a security and the security’s amortized cost as well as change in unrealized appreciation (depreciation) on securities, derivative contracts, and foreign currency transactions. For the years ended December 31, 2023 and 2024, the Utility & Infrastructure Investments consisted of our investment in the Absolute Return Utility & Infrastructure Fund via the Utility Limited Partnership. To optimize our Utility & Infrastructure Investments, we re-allocated a $10 million portion of our portfolio to the Absolute Return MidCap Fund on January 1, 2025. On March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd redeemed an aggregate of $94 million from the Absolute Return Utility & Infrastructure Fund and on March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd, as lenders, executed the ZIS Loan. See “Certain relationships and related party transactions—Related Party Loan.”
Interest expense
Interest expense primarily consists of fees incurred during the period related to our letters of credit issued for the benefit of Ategrity Specialty on behalf of Ategrity Ltd. As of December 31, 2024 and 2023, there was no amount drawn on our letters of credit.
Other income
Other income includes income related to corporate activities that are not allocated to our insurance operations.
Other expenses
Other expenses includes expenses related to corporate activities that are not allocated to our insurance operations, including expenses related to our initial public offering (which includes expenses related to corporate activities and expenses recorded by us in anticipation of this offering). Other expenses includes compensation and share-based compensation expenses associated with share-based awards granted in anticipation of our initial public offering.
Income tax expense (benefit)
Currently our income tax expense (benefit) consists mainly of federal income taxes imposed on our operations. Our effective tax rates are dependent upon the components of pretax earnings and the related tax effects. The amount of income tax expense (benefit) recorded in future periods will depend on the jurisdictions in which we operate and the tax laws and regulations in effect.
Key metrics
We discuss certain key metrics, described below, which provide useful information about our business and the operational factors underlying our financial performance.
Underwriting income is a non-GAAP financial measure. We define underwriting income as income before income taxes excluding the impact of net investment income, net realized and unrealized gains (losses) on investments, other income, interest expense, and other expenses (which include expenses relating to corporate activities and expenses recorded by us in anticipation of this offering). For a reconciliation of underwriting income to the most directly comparable GAAP financial measure, information about why we consider underwriting income useful and a discussion of the material risks and limitations of underwriting income, see “—Reconciliation of non- GAAP financial measures”.
Adjusted net income attributable to members is a non-GAAP financial measure. We define adjusted net income attributable to members as net income attributable to members, excluding certain non-operating expenses, which include expenses recorded by us in anticipation of this offering. For a reconciliation of adjusted net income attributable to members to the most directly comparable GAAP financial measure, information about why we consider adjusted net income attributable to members useful and a discussion of the material risks and limitations of adjusted net income, see “—Reconciliation of non-GAAP financial measures”.
Loss ratio, expressed as a percentage, is the ratio of losses and loss adjustment expenses to net premiums earned.
Expense ratio, expressed as a percentage, is the ratio of underwriting, acquisition, and insurance expenses less fee income to net premiums earned.
Combined ratio is the sum of loss ratio and expense ratio. A combined ratio under 100% indicates an underwriting profit. A combined ratio over 100% indicates an underwriting loss.
Return on members’ equity is net income attributable to members expressed as a percentage of average beginning and ending members’ equity during the period.
Adjusted return on members’ equity is a non-GAAP financial measure. We define adjusted return on members’ equity as adjusted net income attributable to members, expressed as a percentage of average beginning and ending members’ equity during the period. For a reconciliation of adjusted return on members’ equity to the most directly comparable GAAP financial measure, information about why we consider adjusted return on members’ equity useful and a discussion of the material risks and limitations of adjusted net income, see “—Reconciliation of non-GAAP financial measures”.
Corporate conversion
In connection with our initial public offering, Ategrity Specialty Holdings LLC will be converted from a Delaware limited liability company to a Nevada corporation and each of the units representing a limited liability interest in Ategrity Specialty Holdings LLC will be converted into shares of common stock of the resulting corporation (the “Corporate Conversion”). Thereafter, references to “members’ equity” herein will become references to “stockholders’ equity”.
Results of operations
Year ended December 31, 2024, compared to year ended December 31, 2023
The following table sets forth a summary of our consolidated results of operations for the periods indicated. This information should be read together with our consolidated financial statements and related notes included
elsewhere in this prospectus. The operating results in any period are not necessarily indicative of the results that may be expected for any future period.
| |
|
|
Year ended December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
2023
|
|
|
$ Change
|
|
|
% Change
|
|
|
Gross written premiums
|
|
|
|
$ |
437,036 |
|
|
|
|
$ |
352,591 |
|
|
|
|
$ |
84,445 |
|
|
|
23.9%
|
|
|
Ceded written premiums
|
|
|
|
|
(137,830) |
|
|
|
|
|
(84,375) |
|
|
|
|
|
(53,455) |
|
|
|
(63.4)%
|
|
|
Net written premiums
|
|
|
|
|
299,206 |
|
|
|
|
|
268,216 |
|
|
|
|
|
30,990 |
|
|
|
11.6%
|
|
|
Net premiums earned
|
|
|
|
|
290,635 |
|
|
|
|
|
231,464 |
|
|
|
|
|
59,171 |
|
|
|
25.6%
|
|
|
Fee income
|
|
|
|
|
918 |
|
|
|
|
|
660 |
|
|
|
|
|
258 |
|
|
|
39.1%
|
|
|
Losses and loss adjustment expenses
|
|
|
|
|
175,234 |
|
|
|
|
|
154,107 |
|
|
|
|
|
21,127 |
|
|
|
13.7%
|
|
|
Underwriting, acquisition and insurance expenses
|
|
|
|
|
98,567 |
|
|
|
|
|
72,155 |
|
|
|
|
|
26,412 |
|
|
|
36.6%
|
|
|
Underwriting income(1)
|
|
|
|
|
17,752 |
|
|
|
|
|
5,862 |
|
|
|
|
|
11,890 |
|
|
|
202.8%
|
|
|
Net investment income
|
|
|
|
|
24,046 |
|
|
|
|
|
11,366 |
|
|
|
|
|
12,680 |
|
|
|
111.6%
|
|
|
Net realized and unrealized gains (losses) on investments
|
|
|
|
|
28,140 |
|
|
|
|
|
(2,269) |
|
|
|
|
|
30,409 |
|
|
|
|
|
NM |
|
|
|
Interest expense
|
|
|
|
|
2,042 |
|
|
|
|
|
2,237 |
|
|
|
|
|
(195) |
|
|
|
(8.7)%
|
|
|
Other income
|
|
|
|
|
95 |
|
|
|
|
|
95 |
|
|
|
|
|
— |
|
|
|
0.0%
|
|
|
Other expenses
|
|
|
|
|
1,727 |
|
|
|
|
|
196 |
|
|
|
|
|
1,531 |
|
|
|
781.1%
|
|
|
Income before income taxes
|
|
|
|
|
66,264 |
|
|
|
|
|
12,621 |
|
|
|
|
|
53,643 |
|
|
|
425.0%
|
|
|
Income tax expense
|
|
|
|
|
12,316 |
|
|
|
|
|
2,518 |
|
|
|
|
|
9,798 |
|
|
|
389.1%
|
|
|
Net income
|
|
|
|
$ |
53,948 |
|
|
|
|
$ |
10,103 |
|
|
|
|
$ |
43,845 |
|
|
|
434.0%
|
|
|
Less: Net income attributable to non-controlling interest-General Partner
|
|
|
|
|
6,858 |
|
|
|
|
|
55 |
|
|
|
|
|
6,803 |
|
|
|
|
|
NM |
|
|
|
Net income attributable to members
|
|
|
|
$ |
47,090 |
|
|
|
|
$ |
10,048 |
|
|
|
|
$ |
37,042 |
|
|
|
368.7%
|
|
|
Key Metrics
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income attributable to members(1)
|
|
|
|
$ |
48,266 |
|
|
|
|
$ |
10,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio
|
|
|
60.3%
|
|
|
66.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense ratio
|
|
|
33.6%
|
|
|
30.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined ratio
|
|
|
93.9%
|
|
|
97.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on members’ equity
|
|
|
13.1%
|
|
|
3.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted return on members’ equity(1)
|
|
|
13.4%
|
|
|
3.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NM = Percentage change is not meaningful.
(1) Each of these metrics is a non-GAAP financial measure. See “—Reconciliation of non-GAAP financial measures” for a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP measure.
Premiums
The following table presents gross written premiums by product for the years ended December 31, 2024 and 2023:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
% of total
|
|
|
2023
|
|
|
% of total
|
|
|
Casualty
|
|
|
|
$ |
263,328 |
|
|
|
|
|
60.3% |
|
|
|
|
$ |
203,916 |
|
|
|
57.8%
|
|
|
Property
|
|
|
|
|
173,708 |
|
|
|
|
|
39.7% |
|
|
|
|
|
148,675 |
|
|
|
42.2%
|
|
|
Gross written premiums
|
|
|
|
$
|
437,036
|
|
|
|
|
|
100.0%
|
|
|
|
|
$
|
352,591
|
|
|
|
100.0%
|
|
| |
Our gross written premiums were $437.0 million for the year ended December 31, 2024 compared to $352.6 million for the year ended December 31, 2023, an increase of approximately $84.4 million, or 23.9%. The increase was a result of continued growth in business across our casualty and property lines.
Net written premiums were $299.2 million for the year ended December 31, 2024, compared to $268.2 million for the year ended December 31, 2023, an increase of approximately $31.0 million, or 11.6%. The increase was primarily driven by the growth in our gross written premiums partially offset by the increase in ceded written premiums primarily due to the volume of written premiums subject to ceded quota share reinsurance treaties within our casualty business.
Net premiums earned were $290.6 million for the year ended December 31, 2024, compared to $231.5 million for the year ended December 31, 2023, an increase of approximately $59.2 million, or 25.6%. The increase was primarily due to the increased gross written premiums offset by the increase of ceded written premiums under our ceded quota share reinsurance treaties.
Fee income
Fee income was $0.9 million for the year ended December 31, 2024 compared to $0.7 million for the year ended December 31, 2023, an increase of approximately $0.3 million, or 39.1%. The increase was primarily driven by growth in our gross written premiums and policy count subject to fees.
Loss ratio
Our loss ratio was 60.3% for the year ended December 31, 2024 compared to 66.6% for the year ended December 31, 2023. The decrease was driven by improved results on our property lines.
Expense ratio
The following table summarizes the components of the expense ratio for the years ended December 31, 2024 and 2023:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
% of net
earned
premiums
|
|
|
2023
|
|
|
% of net
earned
premiums
|
|
|
Policy acquisition costs . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
|
|
|
$ |
60,692 |
|
|
|
|
|
20.9% |
|
|
|
|
|
46,201 |
|
|
|
20.0%
|
|
|
Other operating and general expenses, net of fee income(1)
|
|
|
|
|
36,957 |
|
|
|
|
|
12.7% |
|
|
|
|
|
25,294 |
|
|
|
10.9%
|
|
|
Underwriting, acquisition and insurance expenses, net of fee income . . . . . . . .
|
|
|
|
$
|
97,649
|
|
|
|
|
|
33.6%
|
|
|
|
|
$
|
71,495
|
|
|
|
30.9%
|
|
| |
(1) Net of fee income of $918 and $660 for the years ended December 31, 2024 and 2023, respectively.
Our expense ratio was 33.6% for the year ended December 31, 2024 compared to 30.9% for the year ended December 31, 2023. The increase was driven by 0.9% higher net policy acquisition ratio and 1.8% higher
operating and general expense ratio as a result of strategic investments across our operations to support our growth and position the company for its initial public offering.
Investing results
| |
|
|
Year ended December 31,
|
|
|
($ in thousands, except percentages)
|
|
|
2024
|
|
|
2023
|
|
|
$ Change
|
|
|
% Change
|
|
|
Investment income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
|
$ |
14,296 |
|
|
|
|
$ |
1,974 |
|
|
|
|
$ |
12,322 |
|
|
|
624.2%
|
|
|
Short-term investments
|
|
|
|
|
2,703 |
|
|
|
|
|
— |
|
|
|
|
|
2,703 |
|
|
|
|
|
NM |
|
|
|
Cash equivalents
|
|
|
|
|
5,122 |
|
|
|
|
|
6,368 |
|
|
|
|
|
(1,246) |
|
|
|
(19.6)%
|
|
|
Equity securities
|
|
|
|
|
44 |
|
|
|
|
|
— |
|
|
|
|
|
44 |
|
|
|
|
|
NM |
|
|
|
Note receivable from affiliate
|
|
|
|
|
1,002 |
|
|
|
|
|
1,002 |
|
|
|
|
|
— |
|
|
|
0.0%
|
|
|
Securities sold, not yet purchased
|
|
|
|
|
(569) |
|
|
|
|
|
(795) |
|
|
|
|
|
226 |
|
|
|
28.4%
|
|
|
Total fixed income
|
|
|
|
|
22,598 |
|
|
|
|
|
8,549 |
|
|
|
|
|
14,049 |
|
|
|
164.3%
|
|
|
Utility & Infrastructure Investments
|
|
|
|
|
1,669 |
|
|
|
|
|
3,030 |
|
|
|
|
|
(1,361) |
|
|
|
(44.9)%
|
|
|
Other expenses
|
|
|
|
|
(221) |
|
|
|
|
|
(213) |
|
|
|
|
|
(8) |
|
|
|
(3.8)%
|
|
|
Net investment income
|
|
|
|
$ |
24,046 |
|
|
|
|
$ |
11,366 |
|
|
|
|
$ |
12,680 |
|
|
|
111.6%
|
|
|
Net realized and unrealized gains (losses) on investments
|
|
|
|
$ |
28,140 |
|
|
|
|
$ |
(2,269) |
|
|
|
|
$ |
30,409 |
|
|
|
|
|
NM |
|
|
| |
NM = Percentage change is not meaningful.
Net investment income was $24.0 million for the year ended December 31, 2024, compared to $11.4 million for the year ended December 31, 2023, an increase of $12.7 million, or 111.6%. This increase was driven by the growth in our investment portfolio primarily generated from strong operating cash flows and deployment of cash equivalents that were held at the beginning of the year at higher interest rates relative to the prior year period. Included in net investment income were $1.7 million and $3.0 million attributable to Utility & Infrastructure Investments, net of investment management fees for the years ended December 31, 2024 and 2023, respectively.
Net realized and unrealized gains on investments was $28.1 million for the year ended December 31, 2024, compared to a loss of $2.3 million for the year ended December 31, 2023, an increase of $30.4 million. This increase was primarily driven by the strong performance of our Utility & Infrastructure Investments. The income related to Utility & Infrastructure Investments was $32.4 million and $(2.6) million for the years ended December 31, 2024 and 2023, respectively.
The Utility & Infrastructure Investments produced returns, net of investment management fees, of 13.0% and 0.16% for the years ended December 31, 2024 and 2023, respectively.
For additional information on investment management fees related to the Utility & Infrastructure Investments see “Certain relationships and related party transactions—Investment Management—Utility & Infrastructure Investments.”
Interest expense
Interest expense was $2.0 million for the year ended December 31, 2024 compared to $2.2 million for the year ended December 31, 2023, a decrease of approximately $0.2 million, or 8.7% related to the cost of our letters of credit.
Other income
Other income was $0.1 million for the year ended December 31, 2024 compared to $0.1 million for the year ended December 31, 2023, with no change year over year.
Other expenses
Other expenses was $1.7 million for the year ended December 31, 2024 compared to $0.2 million for the year ended December 31, 2023, an increase of approximately $1.5 million primarily due to additional stock-based compensation expenses related to the anticipated initial public offering.
Income tax expense (benefit)
Income tax expense was $12.3 million for the year ended December 31, 2024 compared to $2.5 million for the year ended December 31, 2023, an increase of approximately $9.8 million. Our effective tax rate was 18.6% for the year ended December 31, 2024 compared to 20.0% for the year ended December 31, 2023. The decrease in our effective tax rate was driven by permanent differences related to the non-controlling interest.
Reconciliation of non-GAAP financial measures
We report our financial results in accordance with GAAP. However, we believe that certain non-GAAP financial measures provide investors in our common stock with additional useful information in evaluating our performance. Management believes that excluding certain items that are not indicative of core performance assists in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.
These non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are limitations related to the use of these non-GAAP financial measures as compared to the most directly comparable GAAP financial measures.
Underwriting income
We define underwriting income as income before income taxes excluding the impact of net investment income, net realized and unrealized gains (losses) on investments, other income, interest expense, and other expenses (which include expenses related to corporate activities and expenses recorded by us in anticipation of this offering). Underwriting income is a measure of the pre-tax profitability of our underwriting operations and allows us to evaluate our underwriting performance without regard to net investment income among other things. We use this metric as we believe it gives our management and other users of our financial information useful insight into our underlying business performance. Underwriting income should not be viewed as a substitute for income before income taxes calculated in accordance with GAAP and other companies may define underwriting income differently.
Underwriting income for the years ended December 31, 2024 and 2023 reconciles to income before income taxes as follows:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Income before income taxes
|
|
|
|
$ |
66,264 |
|
|
|
|
$ |
12,621 |
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
|
|
(24,046) |
|
|
|
|
|
(11,366) |
|
|
|
Net realized and unrealized (gains) losses on investments
|
|
|
|
|
(28,140) |
|
|
|
|
|
2,269 |
|
|
|
Other income
|
|
|
|
|
(95) |
|
|
|
|
|
(95) |
|
|
|
Add:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
|
|
2,042 |
|
|
|
|
|
2,237 |
|
|
|
Other expenses
|
|
|
|
|
1,727 |
|
|
|
|
|
196 |
|
|
|
Underwriting income
|
|
|
|
$ |
17,752 |
|
|
|
|
$ |
5,862 |
|
|
| |
Adjusted net income attributable to members
We define adjusted net income attributable to members as net income attributable to members excluding certain other non-operating expenses, which include expenses recorded by us in anticipation of this offering. Adjusted net income attributable to members excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We use adjusted net income attributable to members as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted net income attributable to members should not be viewed as a substitute for net income attributable to members calculated in accordance with GAAP, and other companies may define adjusted net income differently.
Adjusted net income attributable to members for the years ended December 31, 2024 and 2023 reconciles to net income attributable to members as follows:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Net income attributable to members
|
|
|
|
$ |
47,090 |
|
|
|
|
$ |
10,048 |
|
|
|
Adjustments:
Other non-operating expenses(1)
|
|
|
|
|
1,489 |
|
|
|
|
|
— |
|
|
|
Tax impact
|
|
|
|
|
(313) |
|
|
|
|
|
— |
|
|
|
Adjusted net income attributable to members
|
|
|
|
$ |
48,266 |
|
|
|
|
$ |
10,048 |
|
|
| |
(1) In the year ended December 31, 2024, other non-operating expenses includes share-based compensation expenses recorded by us related to our anticipated initial public offering.
Adjusted return on members’ equity
We define adjusted return on members’ equity as adjusted net income attributable to members, expressed as a percentage of average beginning and ending members’ equity during the period. Adjusted net income attributable to members excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We use adjusted return on members’ equity as an internal performance measure in the management of our operations because we believe it gives our management and other users of our financial information useful insight into our results of operations and our underlying business performance. Adjusted return on members’ equity should not be viewed as a substitute for return on members’ equity calculated in accordance with GAAP, and other companies may define adjusted return on members’ equity and adjusted net income attributable to members differently.
Adjusted return on members’ equity for the years ended December 31, 2024 and 2023 reconciles to return on members’ equity as follows:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Numerator: Adjusted net income attributable to members
|
|
|
|
$ |
48,266 |
|
|
|
|
$ |
10,048 |
|
|
|
Denominator: Average members’ equity
|
|
|
|
$ |
360,002 |
|
|
|
|
$ |
297,415 |
|
|
|
Adjusted return on members’ equity
|
|
|
|
|
13.4% |
|
|
|
|
|
3.4% |
|
|
| |
Liquidity and capital resources
We are organized as a holding company with our operations primarily conducted by Ategrity Specialty, which is domiciled in Delaware. We may receive cash through (1) loans from banks, (2) issuance of equity and debt securities, (3) corporate service fees from Ategrity Specialty, (4) payments from our subsidiaries pursuant to the Tax Agreement (as defined herein) and other transactions, and (5) dividends from Ategrity Specialty and
Ategrity Ltd. We have historically financed our operations primarily through cash from operations and contributions of capital from ZFSG. We may use the proceeds from these sources to contribute funds to Ategrity Specialty in order to support premium growth, reduce our reliance on reinsurance, to pay dividends and/or taxes, and for other business purposes. Our primary uses of cash are payments of losses and loss adjustment expenses and operating expenses.
We have two letter of credit agreements, each in the amount of $35.0 million. These letters of credit were issued to the benefit of Ategrity Specialty on behalf of Ategrity Ltd as collateral for its liabilities under the quota- share reinsurance agreement. As of December 31, 2024, no amounts were drawn on the letters of credit.
We believe that our sources of liquidity and capital, including proceeds from this offering, will be sufficient to finance our growth strategy and resulting operations, planned capital expenditures, and the additional expenses we expect to incur as a public company for at least the next twelve months. However, we cannot assure you that cash provided by operating activities or cash and cash equivalents will be sufficient to meet our future needs. If we are unable to generate sufficient cash flows from operations in the future, we may have to obtain additional financing. We may also seek additional financing to pursue acquisitions or other strategic initiatives, or in light of favorable market conditions. If we obtain additional capital by issuing equity, the interests of our existing stockholders will be diluted. If we incur additional indebtedness, that indebtedness may contain significant financial and other covenants that may significantly restrict our operations. We cannot assure you that we could obtain additional financing on favorable terms or at all. See “Risk factors—Risks related to our liquidity and access to capital—We may require additional capital in the future, which may not be available or may only be available on unfavorable terms.”
As of December 31, 2024, we held $26.6 million in cash and cash equivalents compared to $264.6 million as of December 31, 2023. As of December 31, 2024, we held $788.5 million in cash and investments compared to $617.6 million as of December 31, 2023. The maximum amount of dividends that our subsidiaries can pay us during 2025 without regulatory approval is $37.4 million. We believe the dividend distribution capacity of our subsidiaries without regulatory approval, which was estimated at $37.4 million at December 31, 2024, will provide us with sufficient liquidity for the foreseeable future.
State insurance laws restrict the ability of Ategrity Specialty to declare stockholder dividends without prior regulatory approval or non-disapproval. State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. The maximum dividend distribution Ategrity Specialty may make absent the approval or non-disapproval of the insurance regulatory authority in Delaware is limited by Delaware law to the greater of (1) 10% of policyholder surplus as of December 31 of the previous year, or (2) net income, not including realized capital gains or pro rata distributions of any class of Ategrity Specialty’s own securities, for the previous calendar year. The Delaware statute also requires that dividends and other distributions be paid out of positive unassigned surplus without prior approval. Insurance regulators have broad powers to ensure that statutory surplus remains at adequate levels, and there is no assurance that dividends of the maximum amount calculated under any applicable formula would be permitted. In the future, state insurance regulatory authorities that have jurisdiction over the payment of dividends by Ategrity Specialty may adopt statutory provisions more restrictive than those currently in effect.
Under the Insurance Act and related regulations, Ategrity Ltd is required to maintain certain solvency and liquidity levels, which it maintained as of December 31, 2024. Bermuda regulations limit the amount of dividends and return of capital paid by a regulated entity. Furthermore, the Insurance Act limits the ability of Ategrity Ltd to pay dividends or make capital distributions by stipulating certain margin and solvency requirements and by requiring approval from the BMA prior to a reduction of 15% or more of a Class 3A insurer’s total statutory capital as reported on its prior year statutory balance sheet. Further, under the Companies Act, as amended (the “Companies Act”), Ategrity Ltd may only declare or pay a dividend, or make a distribution out of contributed surplus, if it has no reasonable grounds for believing that: (1) it is, or would after the payment be, unable to pay its liabilities as they become due, or (2) the realizable value of its assets would be less than its liabilities.
See “Regulation” contained elsewhere herein for additional details on such restrictions.
Cash flows
Our most significant source of cash is from premiums received from our insureds, which, for most policies, we receive at the beginning of the coverage period. Our most significant cash outflow is for claims that arise when a policyholder incurs an insured loss. Because the payment of claims occurs after the receipt of the premium, often years later, we invest the cash in various investment securities that earn interest and dividends. We also use cash to pay commissions to brokers, as well as to pay for ongoing operating expenses such as salaries, rent, taxes, and interest expense. We use reinsurance to manage the risk that we take on our policies. We cede, or pay out, part of the premiums we receive to our reinsurers and collect cash back when losses subject to our reinsurance coverage are paid.
The timing of our cash flows from operating activities can vary among periods due to the timing by which payments are made or received. Some of our payments and receipts, including loss settlements and subsequent reinsurance receipts, can be significant, so their timing can influence cash flows from operating activities in any given period. Management believes that cash receipts from premiums, proceeds from investment sales and redemptions, and investment income are sufficient to cover cash outflows in the foreseeable future.
The following table set forth a summary of our cash flows for the periods indicated:
| |
|
|
Year ended December 31,
|
|
|
($ in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Net cash provided by operating activities
|
|
|
|
$ |
125,611 |
|
|
|
|
$ |
85,707 |
|
|
|
Net cash (used in) provided by investing activities
|
|
|
|
|
(363,270) |
|
|
|
|
|
14,512 |
|
|
|
Net cash (used in) provided by financing activities
|
|
|
|
|
(414) |
|
|
|
|
|
32,275 |
|
|
|
Net increase in cash, cash equivalents, and restricted cash
|
|
|
|
$ |
(238,073) |
|
|
|
|
|
132,494 |
|
|
| |
Operating activities
Our net cash provided by operating activities was approximately $125.6 million for the year ended December 31, 2024, compared to $85.7 million for the year ended December 31, 2023. The increase was primarily due to growth in our gross premiums written.
Investing activities
Net cash used in investing activities was approximately $363.3 million for the year ended December 31, 2024, compared to net cash provided by investing activities of approximately $14.5 million for the year ended December 31, 2023. The increase in cash used by investing activities was primarily driven by increased cash flows from operations which were used to purchase fixed maturity securities and short-term investments as well as deployment of the cash equivalents that were held at the beginning of the year, offset by proceeds from sales, maturities and redemptions of fixed maturity securities.
Financing activities
Net cash used in financing activities was approximately $0.4 million for the year ended December 31, 2024, compared to $32.3 million for the year ended December 31, 2023, which consisted primarily of a capital contribution from ZFSG.
Reinsurance
We enter into reinsurance contracts to limit our exposure to potential large losses and to provide additional capacity for growth. Our reinsurance is primarily contracted under quota-share reinsurance treaties and excess of loss treaties. In quota-share reinsurance, the reinsurer agrees to assume a specified percentage of the ceding company’s losses arising out of a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission. In excess of loss reinsurance, the reinsurer agrees to assume all or a
portion of the ceding company’s losses, in excess of a specified amount. In excess of loss reinsurance, the premium payable to the reinsurer is negotiated by the parties based on their assessment of the amount of risk being ceded to the reinsurer because the reinsurer does not share proportionately in the ceding company’s losses.
For the year ended December 31, 2024, property insurance represented 39.7% of our gross written premiums. When we write property insurance, we buy reinsurance to significantly mitigate our risk to large losses. We use sophisticated computer models to analyze the risk of severe losses from weather-related events and earthquakes. We measure exposure to these catastrophe losses in terms of PML, which is an estimate of what level of loss we would expect to experience in a windstorm or earthquake event occurring once in every 100 or 250 years. We manage this PML by purchasing catastrophe reinsurance coverage. Effective July 1, 2024, we purchased catastrophe reinsurance coverage of $48 million per event in excess of our $12 million per event retention. Our property catastrophe reinsurance includes a reinstatement provision which requires us to pay reinstatement premiums after a loss has occurred in order to preserve coverage. Including the reinstatement provision, the maximum aggregate loss recovery limit is $96 million and is in addition to the coverage provided by our other property reinsurance.
Reinsurance contracts do not relieve us from our obligations to policyholders. Failure of the reinsurer to honor its obligation could result in losses to us, and therefore, we established an allowance for credit risk based on historical analysis of credit losses for highly rated companies in the insurance industry. The Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from its exposure to individual reinsurers. As of December 31, 2024, Ategrity Specialty has only contracted with reinsurers with A.M. Best financial strength ratings of “A-” (Excellent) or better. At December 31, 2024, the net reinsurance receivable, defined as the sum of paid and unpaid reinsurance recoverables, ceded unearned premiums less reinsurance payables, from five reinsurers represented 58.4% of the total balance. At December 31, 2024, we recorded an allowance for credit losses of $0 million related to our reinsurance balances.
Ratings
Ategrity Specialty and Ategrity Ltd both have a financial strength rating of “A-” (Excellent) from A.M. Best. A.M. Best assigns 16 ratings to insurance companies, which currently range from “A++” (Superior) to “F” (In Liquidation). “A-” (Excellent) is the fourth highest rating issued by A.M. Best. The “A-” (Excellent) rating is assigned to insurers that have, in A.M. Best’s opinion, an excellent ability to meet their ongoing obligations to policyholders. This rating is intended to provide an independent opinion of an insurer’s ability to meet its obligation to policyholders and is not an evaluation directed at investors. See also “Risk factors—Risks related to our business and industry—A decline in the financial strength rating or financial size category assigned to Ategrity Specialty or to Ategrity Ltd may adversely affect the amount of business we write and thus our business, financial condition, and results of operation.”
The financial strength ratings assigned by A.M. Best have an impact on the ability of the insurance companies to attract and retain agents and brokers and on the risk profiles of the submissions for insurance that the insurance companies receive. The “A-” (Excellent) rating obtained by Ategrity Specialty is consistent with our business plan and allows us to actively pursue relationships with the agents and brokers identified in our marketing plan.
Contractual obligations and commitments
Our gross reserves for losses and loss adjustment expenses at December 31, 2024 were $403.6 million, of which $147.4 million of payments are expected to be paid in less than one year and $256.2 million of payments are expected to be paid in one year or more. Reserves for losses and loss adjustment expenses represent our best estimate of the ultimate cost of settling reported and unreported claims and related expenses. The estimation of loss and loss expense reserves requires a high degree of judgment and is subject to a number of variables. Ultimate settlement of losses and related loss adjustment expenses may vary significantly from the estimates reflected in our consolidated financial statements. See Note 10 of the notes to the consolidated financial statements and “—Critical accounting policies and estimates” for a discussion of estimates and assumptions related to the reserves for unpaid losses and loss adjustment expenses.
Our leases consist of one operating lease on our office space that expires in 2028 and is subject to a renewal option at market rates prevailing at the time of renewal. We became a sublessor of the same office space when it entered into a sublease agreement effective July 1, 2022 with ZFSG. Our obligations under such lease will require us to pay approximately $0.8 million per year for the life of the lease. We do not have any other contractual obligations and commitments.
Financial condition
Members’ equity
As of December 31, 2024, total members’ equity was $398.3 million compared to $321.7 million total members’ equity as of December 31, 2023. The $76.6 million increase in total members’ equity over the prior year end balance was primarily driven by net profits generated during the period and a $20.1 million contribution by ZFSG.
Declaration of Dividends or Other Distributions
We did not declare any dividends or other distributions during the years ended December 31, 2024 and 2023. We do not anticipate paying any dividends or other distributions in the foreseeable future. Any determination to pay dividends or other distributions in the future will be at the discretion of our board of directors, subject to applicable laws. See “Dividend Policy” contained elsewhere herein.
Investment portfolio
Our cash and invested assets consist of fixed maturity securities, cash and cash equivalents, short-term investments, equity securities, and investments in the Absolute Return Utility & Infrastructure Fund.
|
($ in thousands, except percentages)
|
|
|
Fair value
|
|
|
% of total
|
|
|
Cash and cash equivalents
|
|
|
|
$ |
26,573 |
|
|
|
3.4%
|
|
|
Fixed maturity securities
|
|
|
|
|
438,752 |
|
|
|
55.6%
|
|
|
Short-term investments
|
|
|
|
|
52,612 |
|
|
|
6.7%
|
|
|
Utility & Infrastructure Investments
|
|
|
|
|
270,242 |
|
|
|
34.3%
|
|
|
Other Invested assets
|
|
|
|
|
280 |
|
|
|
NM
|
|
|
Total cash and invested assets
|
|
|
|
$ |
788,459 |
|
|
|
100.0%
|
|
| |
NM = Percentage not meaningful.
At December 31, 2024, $26.6 million represented the cash and cash equivalents portion of our total cash and invested assets of $788.5 million.
At December 31, 2024, $438.8 million, was comprised of fixed maturity securities that are classified as available- for-sale and carried at fair value with unrealized gains and losses on these securities, net of any deferred taxes, reported as a separate component of accumulated other comprehensive income. Also included in our investment portfolio were $52.6 million of short-term investments. Our fixed maturity and short-term securities had a weighted average duration of 3.8 years and an average rating of “A-” at December 31, 2024. Our fixed maturity and short-term securities portfolio had a book yield of 5.7% at December 31, 2024, compared to 2.9% at December 31, 2023.
At December 31, 2024, the amortized cost and fair value of our fixed maturity securities and short-term investments were as follows:
| |
|
|
December 31, 2024
|
|
|
($ in thousands, except percentages)
|
|
|
Amortized
cost
|
|
|
Estimated fair
value
|
|
|
% of total
fair value
|
|
|
Fixed maturity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities and obligations guaranteed by the U.S. government
|
|
|
|
$ |
84,456 |
|
|
|
|
$ |
84,195 |
|
|
|
|
|
17.1% |
|
|
|
Corporate
|
|
|
|
|
349,693 |
|
|
|
|
|
353,805 |
|
|
|
|
|
72.0% |
|
|
|
Commercial mortgage and asset-backed securities
|
|
|
|
|
816 |
|
|
|
|
|
752 |
|
|
|
|
|
0.2% |
|
|
|
Total fixed maturity securities
|
|
|
|
$ |
434,965 |
|
|
|
|
$ |
438,752 |
|
|
|
|
|
89.3% |
|
|
|
Short-term investments
|
|
|
|
|
52,612 |
|
|
|
|
|
52,612 |
|
|
|
|
|
10.7% |
|
|
|
Total
|
|
|
|
$ |
487,577 |
|
|
|
|
$ |
491,364 |
|
|
|
|
|
100.0% |
|
|
| |
The amortized cost and fair value of our available-for-sale investments in fixed maturity securities summarized by contractual maturity as of December 31, 2024, were as follows:
| |
|
|
December 31, 2024
|
|
|
($ in thousands, except percentages)
|
|
|
Amortized
cost
|
|
|
Estimated fair
value
|
|
|
% of
Fair value
|
|
|
One year or less
|
|
|
|
$ |
0 |
|
|
|
|
$ |
0 |
|
|
|
|
|
0% |
|
|
|
After one year through five years
|
|
|
|
|
256,299 |
|
|
|
|
|
258,631 |
|
|
|
|
|
58.9% |
|
|
|
After five years through ten years
|
|
|
|
|
158,930 |
|
|
|
|
|
160,262 |
|
|
|
|
|
36.5% |
|
|
|
After ten years
|
|
|
|
|
18,920 |
|
|
|
|
|
19,107 |
|
|
|
|
|
4.4% |
|
|
|
Commercial and residential mortgage-backed and other asset-backed
|
|
|
|
|
816 |
|
|
|
|
|
752 |
|
|
|
|
|
0.2% |
|
|
|
Total fixed maturity securities
|
|
|
|
$ |
434,965 |
|
|
|
|
$ |
438,752 |
|
|
|
|
|
100.0% |
|
|
| |
Actual maturities may differ from contractual maturities because some borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
At December 31, 2024, $270.4 million represented the investments in the Absolute Return Utility & Infrastructure Fund with fair values measured using our interest in the unadjusted net asset value (“NAV”) as reported by the Investment Manager in the audited financial statements of the Absolute Return Utility & Infrastructure Fund. The Utility Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the Utility Limited Partnership invests substantially all of its assets in the Absolute Return Utility & Infrastructure Fund. As of December 31, 2024 and 2023, we invested 35% and 72%, respectively, of our total invested assets in the Absolute Return Utility & Infrastructure Fund through the Utility Limited Partnership.
The Absolute Return Utility & Infrastructure Fund investment objective is to employ an energy and infrastructure- focused long/short strategy which seeks to deliver absolute returns in all market conditions with minimal correlation to energy sector indices and broader market indices. The Absolute Return Utility & Infrastructure Fund invests primarily in the equities of electric and gas utilities, integrated utilities, water utilities, telecommunication companies, independent power producers and pipelines, exploration and production companies, oilfield service companies, and more broadly in energy and infrastructure-related industries (such as chemicals, materials, transportation infrastructure, and real estate equities). We value our investment in the Absolute Return Utility & Infrastructure Fund at fair value, which is estimated based on our share of the NAV of the Absolute Return Utility & Infrastructure Fund, as provided by the Investment Manager. See Note 2 to our consolidated financial statements appearing elsewhere in this prospectus.
The Absolute Return Utility & Infrastructure Fund invests in equity securities and related instruments and derivatives, and fixed income, comprising 94.4% and 5.6% of gross investments, respectively, as of December 31,
2024. As of December 31, 2024 and December 31, 2023, the following table summarizes the sectors of the Absolute Return Utility & Infrastructure Fund’s gross assets:
| |
|
|
Year ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
|
($ in thousands, except percentages)
|
|
|
% of total(1)
|
|
|
% of total(1)
|
|
|
Utilities
|
|
|
|
|
60.6% |
|
|
|
|
|
65.3% |
|
|
|
Pipelines
|
|
|
|
|
20.0% |
|
|
|
|
|
17.6% |
|
|
|
Real Estate
|
|
|
|
|
10.1% |
|
|
|
|
|
8.9% |
|
|
|
Other Sectors
|
|
|
|
|
9.3% |
|
|
|
|
|
8.2% |
|
|
|
Total
|
|
|
|
|
100.0%
|
|
|
|
|
|
100.0% |
|
|
| |
(1) Amounts presented are subject to rounding adjustments and, as a result, the totals may not sum.
Off-balance sheet arrangements
We invest in certain financial instruments with off-balance sheet risk. These financial instruments include securities sold, not yet purchased. Generally, these financial instruments represent future commitments to purchase other financial instruments at specific terms at specified future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market values of the securities underlying the financial instruments or index values may exceed the amounts recognized in the balance sheet.
From time to time we enter into short sales as a hedge against certain risks within our investment strategy. A short sale is a transaction in which we sell securities we do not own in anticipation of a decline in the market price of the securities and our clearing broker executes a borrow transaction to deliver the securities resulting from our short sale. We are obligated to replace the securities borrowed in connection with a short sale.
Securities sold, not yet purchased represent our obligations to make future delivery of specific securities and, to the extent that we do not already have the securities in its possession, correspondingly create an obligation to purchase the securities at prevailing market prices. Accordingly, these transactions result in off-balance sheet risk as our satisfaction of the obligations may exceed the amount recognized in the balance sheet. As of December 31, 2024, our obligations relating to short sales were $0.9 million. Cash related to short sales is restricted until the securities are purchased. The ultimate gain or loss depends upon the prices at which the securities are purchased to settle our obligations.
See Note 6 of our consolidated financial statements included elsewhere in this prospectus for additional details. As of December 31, 2024, we did not have any other off-balance sheet arrangements.
Critical accounting policies and estimates
We believe that the following accounting policies and estimates involve a high degree of judgment and complexity. Accordingly, these are the policies and estimates we believe are the most critical to aid in fully understanding and evaluating our financial condition and results of our operations. We use significant judgment concerning future results and developments in applying these critical accounting policies and estimates and in preparing our consolidated financial statements. These judgments and estimates affect our reported amounts of assets, liabilities, revenues and expenses, and the disclosure of our material contingent assets and liabilities. See Note 2 to our consolidated financial statements appearing elsewhere in this prospectus for a description of our other significant accounting policies. The preparation of our consolidated financial statements in conformity with GAAP requires us to make estimates and judgments that affect the amounts reported in those financial statements and accompanying notes. Although we believe that the estimates we use are reasonable, due to the inherent uncertainty involved in making those estimates, actual results reported in future periods could differ from those estimates. We evaluate our estimates regularly using information that we believe to be relevant.
Reserves for unpaid losses and loss adjustment expenses
The reserves for unpaid losses and loss adjustment expenses represent our best estimate of the ultimate cost of settling reported and unreported claims and related expenses. See Note 10 to our consolidated financial statements appearing elsewhere in this prospectus for a discussion of estimates and assumptions related to the reserves for unpaid losses and loss adjustment expenses.
As a relatively new company, our historical loss experience is limited. We estimate the reserves using individual case-basis valuations of reported claims and statistical analyses. Those estimates are based on our historical information, industry information, and our estimates of future trends in variable factors such as loss severity, loss frequency, and other factors such as inflation. We regularly review our estimates and adjust them as necessary as experience develops or as new information becomes known to us. Such adjustments are included in current operations. Additionally, during the loss settlement period, it often becomes necessary to refine and adjust the estimates of liability on a claim either upward or downward. Even after such adjustments, ultimate liability may exceed or be less than the revised estimates. Accordingly, the ultimate settlement of losses and the related loss adjustment expenses may vary significantly from the estimate included in our financial statements.
We categorize our reserves for unpaid losses and loss adjustment expenses into two types: case reserves and reserves for incurred but not yet reported losses (“IBNR”). Our gross reserves for losses and loss adjustment expenses at December 31, 2024 were $403.6 million. Of this amount, 70% related to IBNR. Our net reserves for losses and loss adjustment expenses at December 31, 2024 were $284.0 million. Of this amount, 68% related to IBNR. A 5% change in net IBNR reserves at December 31, 2024 would equate to a $9.7 million change in the net reserve for losses and loss adjustment expenses at such date, as well as a $7.7 million change in net income, a 1.9% change in members’ equity, at or for the year ended December 31, 2024.
The following table summarizes our gross and net reserves for unpaid losses and loss adjustment expenses at December 31, 2024:
| |
|
|
December 31, 2024
|
|
|
($ in thousands, except percentages)
|
|
|
Gross
|
|
|
% of total
|
|
|
Net
|
|
|
% of total
|
|
|
Case reserves
|
|
|
|
$ |
120,317 |
|
|
|
|
|
29.8% |
|
|
|
|
$ |
90,036 |
|
|
|
|
|
31.7% |
|
|
|
IBNR
|
|
|
|
|
283,259 |
|
|
|
|
|
70.2% |
|
|
|
|
|
193,944 |
|
|
|
|
|
68.3% |
|
|
|
Total
|
|
|
|
$ |
403,576 |
|
|
|
|
|
100.0% |
|
|
|
|
|
283,980 |
|
|
|
|
|
100.0% |
|
|
| |
Case reserves are established for individual claims that have been reported to us. We are notified of losses by our insureds or their brokers. Based on the information provided, we establish case reserves by estimating the ultimate losses from the claim, including defense costs associated with the ultimate settlement of the claim. Our claims department personnel use their knowledge of the specific claim along with advice from internal and external experts, including underwriters and legal counsel, to estimate the expected ultimate losses.
In addition, we conduct a full spectrum study of reserves annually to analyze reserving adequacy. Reserve analyses are conducted using a multi-method process which includes a full suite of traditional methodologies (such as Chain-Ladder, Bornhuetter-Ferguson, Cape Cod, and Frequency and Severity methods), individual open claim analyses, as well as a sensitivity analysis to provide a range of reasonable estimates.
Our Reserve Committee consists of our Head of Reserving and other select members of senior management. The Reserve Committee meets quarterly to review the actuarial recommendations made by the Head of Reserving. In establishing the quarterly actuarial recommendation for the reserves for losses and loss adjustment expenses, our actuary estimates an initial expected ultimate loss ratio for each of our lines of business by accident year. Input from our underwriting and claims departments, including premium pricing assumptions and historical experience, is considered by our actuary in estimating the initial expected loss ratios. Our reserving methodology uses a loss reserving model that calculates a point estimate for our ultimate losses. Although we believe that our assumptions and methodology are reasonable, our ultimate payments may vary, potentially materially, from the estimates we have made.
In addition, we retain an independent external actuary to assist in determining if the reserve levels are reasonable. The independent actuary is not involved in the establishment and recording of our loss reserve. The actuarial consulting firm prepares its own estimate of our reserves for loss and loss adjustment expenses, and we compare their estimate to the reserves for losses and loss adjustment expenses reviewed and approved by the Reserve Committee in order to incorporate important changes and gain additional comfort on the adequacy of those reserves.
The table below quantifies the impact of potential reserve deviations from our carried reserve at December 31, 2024. We applied a sensitivity factor to net reserves for unpaid losses and loss adjustment expenses for our two lines of business. We believe that potential changes such as these would not have a material impact on our liquidity.
| |
|
|
Potential impact on 2024
|
|
Line of business
($ in thousands)
|
|
|
Net reserves
for unpaid
losses
and loss
adjustment
expenses
|
|
|
7.5% higher
|
|
|
Pre-tax
income
|
|
|
Members’
equity
|
|
|
7.5% lower
|
|
|
Pre-tax
income
|
|
|
Members’
equity
|
|
|
Casualty
|
|
|
|
$ |
236,966 |
|
|
|
|
$ |
254,738 |
|
|
|
|
$ |
(17,772) |
|
|
|
|
$ |
(14,040) |
|
|
|
|
$ |
219,194 |
|
|
|
|
$ |
17,772 |
|
|
|
|
$ |
14,040 |
|
|
|
Property
|
|
|
|
$ |
47,014 |
|
|
|
|
$ |
50,540 |
|
|
|
|
$ |
(3,526) |
|
|
|
|
$ |
(2,786) |
|
|
|
|
$ |
43,488 |
|
|
|
|
$ |
3,526 |
|
|
|
|
$ |
2,786 |
|
|
The amount by which estimated losses differ from those originally reported for a period is known as “development.” Development is unfavorable when the losses ultimately settle for more than the amount reserved or subsequent estimates indicate a basis for reserve increases on unresolved claims. Development is favorable when losses ultimately settle for less than the amount reserved, or subsequent estimates indicate a basis for reducing loss reserves on unresolved claims. We reflect favorable or unfavorable development of loss reserves in the results of operations in the period the estimates are changed.
During the year ended December 31, 2024, our net incurred losses for prior accident years increased by $5.4 million primarily due to enhancements to our claims reserving approach with respect to loss adjustment expenses in our casualty lines.
During the year ended December 31, 2023, our net incurred losses for prior accident years increased by $17.2 million primarily due to higher-than-expected emergence in property lines driven by catastrophes in the 2022 accident year. Specifically, Winter Storm Elliott was a freeze-event in the southeast United States on December 26, 2022 that resulted in higher severity losses from widespread water damage than originally booked at year-end, and Hurricane Ian was a catastrophic event in Florida on September 28, 2022 that resulted in higher losses than originally booked due to re-opened and litigated claims. In 2023, we undertook a variety of risk management actions to limit the late emergence of claims from these types of events going forward. Additionally, this prior year development included decreases in ceded reserves on prior year’s casualty lines.
Investment valuation and fair value
Like other accounting estimates, fair value measurements may be based on subjective information and generally involve uncertainty and judgment. Fair value is defined as the exchange price that would be received for an
asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. Three levels of inputs are used to measure fair value of financial instruments: (1) Level 1: quoted price (unadjusted) in active markets for identical assets, (2) Level 2: inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument, and (3) Level 3: inputs to the valuation methodology are unobservable for the asset or liability.
To measure fair value, we obtain quoted market prices for its investment securities from its outside investment managers. If a quoted market price is not available, we use prices of similar securities. Values for U.S. Treasury and
publicly traded equity securities are generally based on Level 1 inputs which use the market approach valuation technique. The values of our investments in all other fixed maturity securities generally incorporate significant Level 2 inputs, and in some cases, Level 3 inputs, using the market approach and income approach valuation techniques.
We value our investment in the Absolute Return Utility & Infrastructure Fund at fair value, which is estimated based on our share of the NAV of the Absolute Return Utility & Infrastructure Fund, as provided by the Investment Manager.
We review fair value prices provided by its outside investment managers for reasonableness by comparing the fair values provided by the managers to those provided by our investment custodian. We also review and monitor changes in unrealized gains and losses. We have not historically adjusted security prices. We obtain an understanding of the methods, models, and inputs used by the investment managers and independent pricing services and controls are in place to validate that prices provided represent fair values. Our control process includes, but is not limited to, initial and ongoing evaluation of the methodologies used, a review of specific securities and an assessment for proper classification within the fair value hierarchy, and obtaining and reviewing internal control reports for our investment manager that obtains fair values from independent pricing services.
We periodically review our available-for-sale fixed maturities securities to determine whether any unrealized losses exist that are due to credit-related factors. An allowance for credit losses is established for any credit- related impairments, limited to the amount by which fair value is below amortized cost. Changes in the allowance for credit losses are recognized in earnings and included in net investment income. Unrealized losses that are not credit are recognized in other comprehensive income.
We consider the extent to which fair value is below amortized cost in determining whether a credit-related loss exists. We also consider the credit quality rating of the security, with a special emphasis on securities downgraded below investment grade. A comparison is made between the present value of expected future cash flows for a security and its amortized cost. If the present value of future expected cash flows is less than its amortized cost, a credit loss is presumed to exist and an allowance for credit losses is established. Management may conclude that a qualitative analysis is sufficient to support its conclusion that the present value of the expected cash flows equals or exceeds a security’s amortized cost. We also consider whether we intend to sell the security or if it is more likely than not that it will be required to sell the security before recovery of its amortized cost.
When assessing whether we intend to sell a fixed maturity security or if it is likely to be required to sell a fixed- maturity security before recovery of its amortized cost, we evaluate facts and circumstances including, but not limited to, decisions to reposition the investment portfolio, potential sales of investments to meet cash flow needs and potential sales of investments to capitalize on favorable pricing.
Reinsurance recoverable
We enter into reinsurance contracts to limit our exposure to potential large losses and to provide additional capacity for growth. Reinsurance refers to an arrangement in which a company called a reinsurer agrees in a contract (often referred to as a treaty) to assume specified risks written by an insurance company (known as a ceding company) by paying the insurance company all or a portion of the insurance company’s losses arising under specified classes of insurance policies in return for a share in premiums.
Reinsurance recoverables recorded on insurance losses ceded under reinsurance contracts are subject to judgments and uncertainties similar to those involved in estimating gross loss reserves. In addition to these uncertainties, our reinsurance recoverables may prove uncollectible if the reinsurers are unable or unwilling to perform under the reinsurance contracts. In establishing our reinsurance allowance for amounts deemed uncollectible, we evaluate the financial condition of our reinsurers and monitor concentration of credit risk arising from our exposure to individual reinsurers. To determine if an allowance is necessary, we consider, among other factors, published financial information, reports from rating agencies, payment history, collateral held, and our legal right to offset balances recoverable against balances we may owe. The allowance for uncollectible
reinsurance recoverables is subject to uncertainty and volatility due to the time lag involved in collecting amounts recoverable from reinsurers. Over the period of time that losses occur, reinsurers are billed and amounts are ultimately collected, economic conditions, as well as the operational and financial performance of particular reinsurers may change and these changes may affect the reinsurers’ willingness and ability to meet their contractual obligations to us. It is difficult to fully evaluate the impact of major catastrophic events on the financial stability of reinsurers, as well as the access to capital that reinsurers may have when such events occur. The ceding of insurance does not legally discharge us from our primary liability for the full amount of the policies, and we will be required to pay the loss and bear the collection risk if any reinsurer fails to meet its obligations under the reinsurance contracts. We target reinsurers with A.M. Best financial strength ratings of “A-” (Excellent) or better. Based on our evaluation of the factors discussed above, we believe all of our recoverables are collectible and, therefore, no allowance for uncollectible reinsurance was provided for at December 31, 2024.
Accounting pronouncements
Refer to Note 2, “Significant Accounting Policies,” in our consolidated financial statements in this prospectus for further discussion regarding our recent accounting pronouncements.
Quantitative and qualitative disclosures about market risk
We are exposed to market risks in the ordinary course of our business. Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices. The primary components of market risk affecting us are credit risk, interest rate risk, and equity rate risk.
Credit risk
Credit risk is the potential loss resulting from adverse changes in an issuer’s ability to repay its debt obligations. We have exposure to credit risk as a holder of fixed maturity investments. Our risk management strategy and investment policy is to primarily invest in debt instruments of high credit quality issuers and to limit the amount of credit exposure with respect to particular ratings categories and any one issuer. At December 31, 2024, our fixed maturity and short-term securities portfolio had an average rating of “A-,” with approximately 33% of securities in that portfolio rated “A” or better by at least one nationally recognized rating organization. Our policy is to invest predominantly in investment grade securities, while making strategic, risk-adjusted allocations to targeted investment opportunities across the credit spectrum. We monitor the financial condition of all of the issuers of fixed maturity securities in our portfolio. The credit profile of our fixed-maturity and short-term securities portfolio was comprised of 27.9% AAA, 4.9% A, 52.3% BBB, 11.8% BB and 3.1% below BB or unrated securities.
We are exposed to credit losses from reinsurers being unable to meet their obligations. We evaluate the financial condition of potential reinsurers and reinsure our business with highly rated reinsurers with a rating of “A-” (Excellent) or better from A.M. Best. We have not experienced any credit losses from reinsurance recoverables and did not record an allowance for uncollectible reinsurance recoverables as of December 31, 2024. See Note 2 of our consolidated financial statements included elsewhere in this prospectus for additional details.
Interest rate risk
The market risk inherent in our financial instruments and in our financial position represents the potential loss arising from adverse changes in interest rates or exchange rates. As of December 31, 2024, we had cash, cash equivalents and short-term investments of $79.2 million, consisting of interest-bearing money market accounts and investments in government agency securities, for which the fair market value would be affected by changes in the general level of United States interest rates. However, due to the short-term maturities and the low-risk profile of our investments, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our cash and investments.
Equity risk
Our Utility & Infrastructure Investments have equity risk due to the equity strategy, and therefore, we have indirect equity risk through our Utility & Infrastructure Investments. Equity risk represents the potential economic losses due to adverse changes in equity security prices. As of December 31, 2024, we had no direct holdings of equity securities.
Emerging growth company status
In April 2012, the JOBS Act was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” may take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Therefore, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period under the JOBS Act until the earlier of the date we (1) are no longer an emerging growth company, or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Business
Who we are
We are a profitable and growing specialty insurance company dedicated to providing excess and surplus (“E&S”) products to small to medium-sized businesses (“SMBs”) across the United States. We have built a proprietary underwriting platform that combines sophisticated data analytics with automated and streamlined processes to efficiently serve our clients and deliver long-term value to our stockholders. The SMB market is characterized by large volumes of small-sized policies, and we believe our competitive edge lies in our ability to offer consistent, high-speed and low-touch interactions that our distribution partners value. This advantage stems from our technology-driven method of standardizing, simplifying, and automating our transaction process, which we call productionized underwriting.
We target industry verticals where we have deep expertise and develop data-driven insights to gain a competitive advantage. We leverage our expertise and our efficient underwriting platform to deliver tailored insurance products and customized services that meet the needs of our distribution partners. We believe the universe of distributors in the SMB segment of the E&S market is rapidly shifting toward agents and brokers who were raised in the digital age. These digital-native and tech-savvy distribution partners expect real-time, frictionless insurance transactions that mirror the seamless experiences they encounter in their daily lives. In an industry where insurance applications are often submitted via email with slow response times, we have designed a technology-driven underwriting process that addresses our distribution partners’ demands for rapid, high-quality interactions. Our strong value proposition has contributed to a growing network of 460 distribution partners as of December 31, 2024, which provides us with increased transaction opportunities and diversified sources of business. Our fully integrated claims management function is designed to enable us to resolve claims efficiently and effectively. We take an active approach to risk management through real-time performance analytics, rigorous risk aggregation monitoring, and robust reinsurance protection aimed at minimizing volatility and generating consistent underwriting results.
We have grown our business substantially while generating attractive underwriting results. For the year ended December 31, 2024, we wrote $437.0 million in gross written premiums, representing a compound annual growth rate of 28.4% over the last two years. Our combined ratio for the year ended December 31, 2024, was 93.9%, a decrease of 3.6% from the year ended December 31, 2023. Our members’ equity at December 31, 2024, was $398.3 million, an increase of $76.6 million(23.8%) from December 31, 2023. We believe that our productionized underwriting capabilities will continue to drive enhanced profitability as we continue to scale our business.
Productionized underwriting
Our company’s mission is to transform the E&S marketplace for SMBs through the power of productionized underwriting with precision, simplicity, and efficiency. When we entered the E&S industry, we found what we believe to be an under-served and inefficient marketplace that was hindered by inconsistent and antiquated processes of legacy insurance carriers. We also believe that many distribution partners and their end-clients were struggling with slow response times, unpredictable underwriting capacity, and subpar pricing, which we believe make the market ripe for technology and efficiency-driven disruption.
To address these challenges, we developed a technology-enabled underwriting process that we believe sets us apart in the E&S market. Our productionized underwriting approach combines rigorous technical underwriting with a highly efficient and centralized operating platform powered by advanced technology. This process begins with a deep understanding of our end-clients, the insurance policyholders. We intensely study the industry and geographical micro-segments in which our end-clients operate using sophisticated data analytics. We leverage these analytics to build quantitative risk models that shape our risk appetite and client targeting.
Furthermore, we aim to eliminate unnecessary complexity by standardizing our processes and automating key underwriting tasks, such as submission intake, risk classification, pricing, and documentation. This allows our
underwriters to focus on high-value underwriting tasks and make timely and accurate decisions in a uniform manner. For each individual transaction opportunity, our underwriting models efficiently determine which components of the process can be automated. For simpler products with clearly identified risk characteristics, we can execute the entire underwriting process without human intervention. We believe our productionized underwriting approach generates consistent, efficient, and scalable processes that allow us to deliver differentiated value to our distribution partners without compromising accuracy and profitability.
How We Achieve Productionized Underwriting
Our business
We offer property and casualty insurance solutions tailored to meet the needs of SMBs. Currently, the verticals that we focus on are Real Estate, Hospitality, Construction, and Retail. By leveraging deep fundamental research and advanced data analytics, we meticulously analyze the universe of potential insureds, stratify their risk characteristics by micro-segments, and quantify the perils they face. Once we have acquired a deep understanding of a specific market, we define target business profiles that match our risk appetite and design products that meet our end-clients’ needs.
For example, in our Hospitality vertical, one area of focus is the hotel and motel industry. We segment this industry into three primary subgroups: luxury hotels, mid-tier hotels, and budget motels. We then identify micro-segments such as boutique hotels, beachfront resorts, economy roadside motels, and extended-stay hotels. Each of these micro-segments presents a distinct risk profile, such as higher exposure to natural disasters for beachfront resorts or increased liability concerns for extended-stay hotels with more prolonged guest interactions. Another example of micro-segmentation in our Hospitality vertical is restaurants, where we classify businesses into casual dining, family restaurants, fine dining, diners, and buffet restaurants, among others. In our Real Estate, Construction and Retail verticals, we also categorize micro-segments based on applicable risk characteristics. We price and design products that are specifically tailored to cover the unique risks associated with each micro-segment. We believe our enhanced micro-segmentation of traditional industry classifications allows us to accurately identify and address homogeneous groups of risk, which provides us with a competitive underwriting advantage.
We offer commercial property, low-limit general liability, and management & professional liability products on both a primary basis and an excess basis. By targeting SMBs, we have built a portfolio of small premium size policies. Furthermore, we deliberately focus on underwriting risks with shorter loss-reporting tails and limited catastrophe risk. This reduces the volatility of our results and strengthens our ability to actively manage business risks. The following charts reflect the percentage of our gross written premiums by duration of risk, products, policy size, and vertical for the year ended December 31, 2024(3).
| |
Premium by Risk Duration
|
|
|
Premium by Product
|
|
| |
|
|
|
|
|
| |
Premium by Policy Size
|
|
|
Premium by Vertical
|
|
| |
|
|
|
|
|
We operate on a surplus lines basis in 48 states and the District of Columbia. As of December 31, 2024, there were four states in which 5.0% or more of our gross written premiums were concentrated: California (21.0%), Florida (16.2%), Texas (12.8%), and New York (6.4%).
Our diversified and expansive distribution strategy centers around the principle of giving our distribution partners an efficient, consistent, and simplified way of doing business with us. The key to this is our single appointment contract, which gives our distribution partners access to all our channels, resulting in a greater flow of business per partner. We categorize our products as either Brokerage or Small Business. Brokerage is comprised of medium-sized accounts with limited-to-moderate complexity; Small Business is comprised of more standardized risks with smaller premium amounts and lower policy limits than Brokerage. Although wholesale
(3) Based on policies written in the year ended December 31, 2024 derived from our internal systems.
brokers tend to focus on our Brokerage channel and wholesale agents on our Small Business channel, through our unified contract we can provide distribution partners with access to both, which increases our revenue opportunities. Another pillar of our distribution strategy is our rapid response times, enabled in part by our digital platform. For instance, in our Brokerage channel we use automation and risk-scoring models to accelerate the intake process and route transactions to the most efficient and optimal underwriting method. For our Small Business channel, our distribution partners use our cloud-based underwriting engine that automatically defines and manages data requirements, forms, pricing, and risk appetite.
We partner with technology-forward and innovative distribution partners who are leaders in their respective markets and choose us as their partner in this process. We have significantly invested in gaining access to a broader distribution network, increasing the number of agents and brokerage teams with whom we work from 180 distribution partners as of December 31, 2021 to 460 distribution partners as of December 31, 2024. Our in-house distribution team, which is focused on developing and maintaining our distributor relationships, diligently expands our network by onboarding new distribution partners who have books of business that match our risk appetite. We believe our distribution relationships are highly diversified and less concentrated than our E&S competitors, with the three largest wholesale distribution corporations in the United States representing 48% of our gross written premiums written for the year ended December 31, 2024. The following charts reflect the growth of our distribution partners as of December 31 over the last three years, as well as our premiums by distribution channel for the year ended December 31, 2024:
| |
Number of Distribution Partners
|
|
|
Premium by Channel(4)
|
|
| |
|
|
|
|
|
We have a fully integrated internal claims management system that employs proactive strategies to manage claims thoughtfully and efficiently. Our internal claims team consists of specialized and experienced claims professionals, including lawyers, managers, and adjusters. Our claims team leverages our effective technology to process, analyze, and research incoming claims to rapidly determine each claim’s value and resolution path. We seek to settle valid claims expeditiously, but if we believe a claim may be frivolous, we thoroughly investigate it and, if needed, we challenge or litigate it. We use claims roundtables, a curated panel of third-party law firms, expense benchmarking systems, auditing procedures, and precise life-of-claim tracking to optimize outcomes for our insureds and stakeholders. We believe that our holistic and proactive approach, grounded in analytical conviction, allows us to act decisively and protect against inflationary pressures on losses.
We believe having a strong balance sheet is critical for our long-term success and enhancing our partners’ confidence in our business. As such, we have deliberately maintained a conservatively capitalized balance sheet with zero financial leverage, which supports the “A-” (Excellent) financial strength rating from A.M. Best assigned to both Ategrity Specialty and to Ategrity Ltd. Our well-capitalized balance sheet is complemented by rigorous reserve practices. For example, we have minimal exposure to pre-2020 reserves and frequently and proactively review the adequacy of our reserves using various methodologies: daily tracking of claims volumes relative to underlying reserving assumptions, monthly claim-by-claim reserving evaluations, quarterly and year-end studies, quarterly designated committee reviews of actual versus expected losses, and quarterly frequency and
(4) Based on policies written in the year ended December 31, 2024 derived from our internal systems.
severity loss analyses. We also use independent actuaries to assess the strength of our reserves. Given our focus on shorter-tail lines, we believe we have more visibility into claims patterns and the strength of our underlying reserves compared to other specialty peers that have longer tails and less visibility into losses and future claims.
Our business commenced operations in 2018 and we have a limited operating history as a result. See “Risk factors—Risks related to our growth—Our limited operating history makes it difficult to evaluate our current business performance, implementation of our business model and our future prospects.”
Our competitive strengths
Exclusive focus on E&S market, targeting smaller accounts. We operate exclusively in the E&S market, a specialty segment of insurance that has outpaced the growth in the admitted lines market over the last ten years. The E&S market involves lines of insurance which are generally unavailable from admitted insurers due to perceived risk related to the insured’s business and which, consequently, are placed by surplus lines agents or brokers with insurers that are not admitted in the subject jurisdiction. This non-admitted market comprises companies not licensed to transact the business of insurance in a particular U.S. jurisdiction but that are permitted to issue insurance policies only in accordance with an exemption from insurance licensing laws, for example, through an E&S lines broker licensed in that jurisdiction. In contrast to the admitted market, the E&S market provides insurers regulatory flexibility with regard to underwriting standards, forms, and pricing, which we use to design optimized product offerings and underwriting strategies. While E&S insurers are often subject to special licensing, surplus lines tax, and/or due diligence requirements by the home state of the insured, they may rely on third-party surplus lines brokers to facilitate compliance with such laws and regulations.
Within the E&S market, we specialize in solving the needs of SMBs in targeted segments or verticals. We believe the SMB segment tends to attract less competition than other segments due to the operational complexities required to efficiently serve this low-premium and high-volume market niche. Brokers and agents operating in this segment demand ease of use, rapid execution, and consistent underwriting capacity from insurers and we believe we are poised to deliver these on a consistent basis.
Productionized underwriting supported by efficient operating platform. We purposefully built our platform with the holistic goal of productionizing underwriting to efficiently address the unique needs of smaller accounts within the E&S market. We combine deep technical underwriting with a highly efficient operating platform, supported by technology, to make timely, consistent, and precision-oriented underwriting decisions. We achieve this through sophisticated and data-driven risk segmentation and by utilizing meticulously crafted pricing models, thoughtfully designed products, and uniform underwriting guidelines. We aim to accurately and efficiently price risks that are within our risk appetite, rather than customize coverage for risks outside of our segmentation or other risk criteria. We designed and built our operating platform to be highly efficient and scalable. We automate repeatable underwriting tasks, such as submission processing, risk grading, and document generation, so our underwriters can focus on rapidly analyzing individual risks and delivering accurate and timely quotes. For example, our service delivery platform is capable of parsing unstandardized policy submissions by assembling data and applicant information into digital files which are analyzed by our underwriters. We believe our productionized approach to underwriting provides us with a strong competitive advantage to efficiently serve smaller E&S accounts.
Growing and diversified distribution relationships driven by speed, consistency, and ease-of-use. We currently maintain relationships with 460 distribution partners as of December 31, 2024. We believe our distribution relationships are highly diverse and less concentrated than our E&S competitors, with the three largest wholesale distribution corporations in the United States representing 48% of our gross written premiums written for the year ended December 31, 2024. We have significantly grown the number of our distribution relationships from 180 distribution partners as of December 31, 2021 to 460 distribution partners as of December 31, 2024. We can intake a high volume of submissions from our expansive distribution network, evaluate them quickly, and generate bindable quotes on the basis of our consistently defined risk appetite. We believe that our technology-driven approach to distribution is especially attractive to the next generation of innovative and digital-native brokers and agents, who we believe will have a growing presence in the SMB segment of the E&S market.
Fully integrated claims management. We believe that disciplined and efficient claims management is key in maintaining lower loss and loss adjustment ratios. We have built an in-house team of specialized and experienced claims professionals including lawyers, managers, and adjusters. We have built effective processes to identify optimal outcomes as efficiently as possible. Our in-house claims management team enables us to maintain full control over the claims adjustment process from the initial notice of claim to its resolution, allowing us to promptly evaluate incoming claims and swiftly determine the appropriate resolution path. If the claim is valid, we seek to settle it expeditiously. However, if we believe a claim may be frivolous, we thoroughly investigate and, if needed, will challenge or litigate.
Active risk management approach. We believe that active risk management is key to our long-term profitability and success given our focus on underwriting diversified specialized risks. We continuously monitor our aggregate exposures using sophisticated data analytics tools to ensure we are building an appropriately balanced and diversified book of business that is within our risk appetite. Our risk auditing capabilities ensure that we rapidly incorporate any deviations from our loss expectations in our prospective underwriting. We have limited net catastrophe exposure as we actively seek reinsurance protection from highly rated counterparties to manage our aggregated risk exposures and to protect our earnings and balance sheet from potential volatility.
Well-capitalized balance sheet with minimal pre-2020 reserves. We have a conservatively capitalized balance sheet and zero financial leverage which supports the “A-” (Excellent) financial strength rating from A.M. Best assigned to both Ategrity Specialty and to Ategrity Ltd. In addition, we have minimal exposure to pre-2020 reserves and have benefited from the current favorable pricing environment. Furthermore, our underwriting strategy focuses on shorter-tail and frequency-driven exposures where claims are reported quickly and are subject to conservative policy limits. Our reserving process is rigorous and has regular reviews of our actuarial estimates in consultation with independent experts. We believe our focus on smaller-account and shorter-tail products helps give us high visibility into, and confidence in, our reserves.
Our strategy
Develop distinguished expertise in our core focus areas. Our strategy begins with developing strong expertise in our targeted classes and geographies within the E&S market. We thoroughly assess and evaluate the unique characteristics and prospective loss costs of each vertical we serve, which enables us to clearly define our risk appetite. We believe our ability to micro-segment our targeted lines of business through data-driven risk modeling allows us to achieve higher-precision underwriting and find attractive opportunities that fit our return expectations and appetite. By gaining deep and data-driven insights, we are able to design tailored insurance solutions that we believe position us as the preferred insurer among our distribution partners in our core focus areas.
Deliver a consistent value proposition to our clients. We attract and retain distribution partners by providing them with a compelling and consistent value proposition. We have designed an intelligent underwriting framework built around a pre-defined client profile and standardized products. By having clearly specified rules and criteria for pre-qualifying risks as well as defined information requirements, we can move swiftly without burdening our clients with excessive information requirements. In addition, our service delivery platform simplifies, streamlines, and automates easily executable underwriting tasks, which contributes to providing a seamless experience for our distribution partners. Moreover, our multi-faceted distribution strategy, which is enabled by a single appointment contract, provides our distribution partners with potential access to all our distribution channels. Our focus on providing broad access with a consistent and high-quality level of service is a key driver of long-lasting relationships with our clients.
Pursue targeted growth initiatives with product, industry, and distribution expansion. We believe we are well-positioned to continue our profitable growth and expand our share of the E&S market through methodical expansion into new products and industry verticals. When we approach a new industry vertical, we typically begin with selective underwriting in the small business market, where we aim to collect a robust dataset that provides us with unique insights on products, pricing, and risk attributes. We follow this by expanding more broadly and repeating the process in the mid-sized business market. In addition to introducing new products and
industry verticals, we seek to establish new distribution partnerships with firms that are aligned with our innovative vision and recognize the value of our data-driven and productionized underwriting approach. This will further broaden our market reach and diversify our business sources without compromising profitability.
Continued investment in enhancing our technology to drive innovation and efficiency. We are continuously investing in technology to enhance our underwriting capabilities and interactions with our distribution partners. Innovations in automation, data analytics, and products are directly linked to our mission of delivering high-quality and scalable underwriting and offering unparalleled ease of use. Ategrity Select is our proprietary solution through which we pre-underwrite specific classes of business, enabling our distribution partners to bind quotes in as little as a few minutes. We plan to leverage Ategrity Select to grow into new verticals. Another example is our administration system, AtegrityOne, which is designed to swiftly adapt to change, such as the introduction of new products and pricing, thereby enabling us to provide cost-effective support for new targeted classes with agility and scalability.
Achieve strong returns on capital for our stockholders. Our principal goal is to achieve strong risk-adjusted returns for our stockholders by delivering attractive underwriting results through the cycle. By targeting smaller-account business and leveraging our productionized underwriting approach, we believe we can generate superior underwriting results through market cycles. We use deep data insights to form our own view of risks and execute promptly when opportunities arise. We only pursue opportunities that align with our risk appetite and where we expect underwriting profitability to meet or exceed our internal return thresholds.
Industry
P&C insurance companies provide insurance coverage under a policy in exchange for premiums paid by the customer. An insurance policy is a contract between the insurance company and the insured under which the insurance company agrees to pay for losses suffered by the insured, or a third-party claimant, that are covered under the policy. Generally speaking, property insurance provides protection against direct physical damage to property (such as from fire, theft, and weather), while casualty insurance provides coverage for reimbursement of expenses borne by the insured, or for third party loss such as bodily injury, financial loss, or in instances when an obligation is not fulfilled.
The type of coverage and source of premiums are often classified based on how long an insurer may have exposure to the risks covered by the policy. Losses that are generally short-tailed, are usually known, reported and paid within a relatively short period of time after the underlying loss event has occurred. Losses that are long-tailed, typically have a significant delay between the occurrence of a loss and the time the claim is settled. Property losses are generally short tailed, while casualty losses are generally longer tailed.
In addition to the property and casualty distinction, P&C insurance can broadly be classified into personal lines, or insurance provided to individuals, or commercial lines, insurance provided to businesses. According to S&P Global, the U.S. P&C insurance industry generated approximately $966.7 billion in premiums in 2023, with approximately $481.3 billion, 49.8% of total premiums, in commercial lines.
Within commercial lines, we operate in the specialty P&C market. Although no standard definition for the specialty market exists, S&P Global indicates that the following lines of business or exposure profiles exemplify the space: high-hazard or nonstandard insurance, niche market segments, tailored underwriting and both admitted and E&S lines. Many specialty insurers offer both admitted and E&S products, depending on the market conditions and regulatory requirements. Admitted product rates and policy forms are highly regulated and coverage tends to be standardized, while E&S products and policies have freedom of rate and form and can be highly customized. For the year ended December 31, 2024, all of our gross written premiums were attributable to E&S products.
E&S coverage is generally placed only when determined to be unavailable in other markets. Because E&S markets typically require specialized knowledge, E&S policies tend to be priced higher and coverage more narrowly defined compared to standard policies in the admitted market. In addition to price, competition between insurance carriers in the E&S market also focuses on other value-based considerations, such as availability, service and expertise. According to S&P Global, the U.S. P&C industry generated approximately $84.0 billion in commercial E&S direct premiums, representing approximately 17% of the overall U.S. commercial P&C market. According to S&P Global, from 2018 to 2023, direct premiums written for the U.S. commercial E&S market generated a CAGR of 20% compared to a CAGR of 8% for the overall U.S. commercial P&C market over the same period.
P&C companies are exposed to pricing cycles that alternate between periods of “soft” and “hard” market conditions. A soft market is characterized by a stable or excessive supply of underwriting capacity, resulting in flat or declining rates or premiums. Meanwhile, a hard market is generally driven by a shortage of underwriting capacity whereby coverage is harder to place, resulting in elevated rates and premiums. We believe that over the last several years elevated attritional loss activity, increasing frequent natural catastrophic events and social inflation have driven pricing increases, resulting in an increased flow of P&C business into E&S markets.
Within the E&S market, we are focused on SMBs that we believe are often inefficiently served by larger competitors. Since the vast majority of E&S premium volume is comprised of larger-sized premium accounts, many of our competitors have not spent the resources to build the infrastructure required to manage the high-volume, low-touch SMB business. Furthermore, we believe the antiquated business processes of legacy E&S insurers have created transactional inefficiencies for their distribution partners with burdensome demands, slow response times, volatile capital, and inaccurate pricing.
Underwriting
Our underwriting strategy is centered on building an intellectual edge in key industry verticals, while applying consistent, efficient processes across our operations. This method, which we call productionized underwriting, allows us to generate underwriting profits while reducing friction for our distribution partners across the transaction process.
Underwriting an E&S account can be a complex and unstructured endeavor, involving numerous data points and risk factors related to a potential policyholder. At Ategrity, we simplify this process by focusing on the key risk factors that are demonstrably predictive of losses. Through comprehensive market research and data analysis, we identify risk factors that we believe have the most statistically significant impact on underwriting results. We break down our target verticals into micro-segments, studying loss exposures, risk characteristics, and coverage requirements to develop differentiated underwriting views. This in-depth understanding of our target markets, enables us to selectively underwrite micro-segments based on factors like volatility, predictability, and size of opportunity. With this focused strategy, we maintain conviction in our risk appetite, allowing us to offer sustainable underwriting capacity to our distribution partners.
With a deep understanding of our micro-segments and their most critical risk factors, we design tailored products that meet the specific needs of targeted end-clients, reduce the burden of information requests for our distribution partners and offer pricing that is sensible, transparent, and profitable. We further streamline processes to enhance speed, efficiency, and service for our distribution partners. This includes our Service Delivery Center that utilizes automation and cost-effective human resources to manage high-volume, low-value tasks.
Our organizational structure is designed for consistent, scalable, and efficient underwriting. Our centralized leadership team of Product Leaders, Technical Specialists, and Distribution/Marketing Professionals report to our Chief Underwriting Officer and collaborate to develop our underwriting framework and implement our productionized underwriting process.
Product Leaders across our different lines of business ensure our products are technically sound and commercially viable. Our Technical Specialists include the Head of Pricing and Underwriting Analytics (pricing), Head of Product Innovation (forms), Head of Exposure Management (risk), and Head of Underwriting Excellence (governance). Together, these specialists develop and manage our underwriting framework using data analytics and applied insights. Our Distribution/Marketing Professionals aim to ensure that our products align with market demands, all while upholding rigorous underwriting standards.
Our leadership team oversees transactions executed by either our trained Production Underwriters or our automated underwriting technology. Our Production Underwriters use our platform to assess and bind risk, ensuring compliance with our firmwide underwriting framework. Our automated underwriting technology includes our cloud-based underwriting engine in our Small Business channel where the submission-to-bind process is fully automated, as well as other applications dedicated to specific product offerings. To maintain high standards and risk controls, the Head of Underwriting Excellence oversees quality assurance and conducts audits across all areas of underwriting.
Our expertise and operating structure allow us to set annual growth targets for each vertical based on both emerging insights and performance. These targets help us maintain a balanced, long-term portfolio of risks, supported by detailed underwriting plans that align products, distribution channels, resources, and technology. We track progress towards these targets and refine our broader strategy through comprehensive, data-driven quarterly business reviews.
Methodical risk management is a critical component of our underwriting strategy. Our centralized leadership team actively manages our risk portfolio, adjusting our pricing, product design, marketing, and capital allocation to our changing view of the risk and competitive landscape. In addition, we enforce strong governance over case underwriting, ensuring that underwriters follow established guidelines on an account-by-account basis. This disciplined approach optimizes the quality of the underwriting decisions and leads to consistency in our product
for our distribution partners. We believe this approach allows us to implement and execute on clear underwriting guidelines with the goal of consistently superior underwriting results through market cycles.
Marketing and distribution
Our approach to distribution is rooted in the principle of giving our distribution partners a rapid, consistent, and simplified way of doing business with us. A key driver of this approach is our single appointment contract, which gives our distribution partners access to all our channels and products. This combined with our use of advanced digital tools, automated underwriting processes and short response times make us partner of choice for distribution partners resulting in a greater flow of business.
We market and distribute our products through two main channels, Brokerage and Small Business.
Brokerage channel: comprised of mostly medium-sized accounts with limited-to-moderate complexity. In the Brokerage channel, our underwriters utilize our platform to directly assess and quote each application efficiently. We have streamlined processes to speed up decision-making, enhance accuracy, and consistency in underwriting.
Small Business channel: comprised of standardized risks with small-ticket policies. For our Small Business channel, our distribution partners benefit from our cloud-based underwriting engine that automatically defines and manages data requirements, forms, and pricing. This system simplifies the underwriting process, making it easier for our partners to submit applications and receive quotes quickly.
Although wholesale brokers tend to focus on our Brokerage channel and wholesale agents on our Small Business channel, our unified contract provides distribution partners with potential access to both, enhancing their ability to meet diverse needs of their clients. This integrated approach ensures that our distribution partners can leverage our full suite of products and services, thereby maximizing their business opportunities.
Our in-house distribution division plays a crucial role in expanding our network by diligently onboarding new distribution partners whose books of business align with our risk appetite. We strategically partner with tech-forward, innovative distribution partners who are leaders in their respective markets. We have established a highly diversified network of distribution partners with the three largest wholesale distribution corporations in the United States representing 48% of our gross written premiums for the twelve months ended December 31, 2024. We seek to establish new distribution partnerships with firms that are aligned with our innovative vision and recognize the value of our data-driven, productionized underwriting approach.
We believe our distribution strategy is beginning to show indicators of success. We continue to grow our market presence by expanding our network, providing access to distribution partners across multiple channels, and presenting a strong value proposition. For example, for the year ended December 31, 2024, we received approximately 180,000 submissions from our distribution partners. Additionally, our distribution partners are increasingly adopting our unified contract, with approximately 26.5% binding policies with us across multiple channels in 2024.
Claims
Our claims management team is deeply integrated across underwriting, actuarial, and legal departments, ensuring consistent and streamlined approach to all claims matters.
We manage our claims in-house to maintain full control of all aspects of the claims workflow and resolve claims fairly and effectively while delivering exceptional service to our clients in their time of need. We leverage the expertise of third-party partners including attorneys and field adjusters, if needed. These experienced partners are thoroughly vetted and approved by the claims leadership team. This helps us achieve optimal outcomes on each claims file, manage our losses and loss adjustment expenses, and preemptively identify possible legal issues.
When a claim arises, our approach is to quickly and promptly investigate the claim with our highly experienced and specialized claims adjusters, with the aim to minimize potential losses. Our average closed claim amount from
January 1, 2022 through December 31, 2024 was approximately $48,000, which we believe reflects the smaller nature of our accounts and the lesser potential impact of any individual claim.
As part of our productionized underwriting model, our claims system provides real-time feedback that can drive underwriting adjustments in each vertical. Claims examiners work closely with members of the underwriting staff to keep them apprised of claims trends, identify emerging areas of loss experience and address key issues. This company-wide collaboration helps drive underwriting success across our verticals. In addition, real-time sharing of information on open claims and regular reporting of detailed claims metrics are utilized by senior leadership to drive effective enterprise decision-making.
Technology
Our technology is at the core of our productionized underwriting model. Our centralized, cloud-based platform supports critical functions such as information intake, risk selection, pricing, policy administration, and claims management. It enhances automation, enables data-driven decision-making, and improves efficiency and scalability across our operations.
AtegrityOne is the next iteration of our core policy administration system that performs those functions, purpose-built for our specific needs. It was developed to efficiently handle product and pricing changes and support the launch of new targeted verticals. Its modular and largely no-code design allows us to continue to implement it across our business easily and cost-effectively as we continue to scale our business. We are actively migrating our products onto this system.
Our technology platform facilitates data collection and analysis across the organization, building a robust data repository that informs underwriting, reserving, and claims management. This cloud-based infrastructure helps us better understand risk patterns and align our underwriting approach with our risk appetite, enabling more precise and informed decision-making. As a result, we believe it provides us with agility in adapting to evolving market trends.
Innovation is a cornerstone of our strategy. We have built proprietary solutions using emerging technologies to accelerate our underwriting process, provide seamless interactions with our distribution partners and optimize our expense efficiency. For example, we built Ategrity Select, which pre-underwrites specific classes of business, enabling distribution partners to bind quotes within minutes. We also utilize artificial intelligence-enabled optical character recognition to automatically extract underwriting data from policy submissions that we receive in various forms and feed them into our risk scoring and pre-qualification algorithms. Additionally, we have implemented bots to provide automated responses to digital-savvy agents, streamlining their interactions with us. The use of these programs and processes streamlines the underwriting process and better empowers our distribution partners to serve their clients quicker, thereby, further strengthening our brand and relationships.
We remain committed to investing in technology, with an extensive development pipeline focused on driving automation, strengthening our underwriting capabilities and delivering value to the market.
Reinsurance
We proactively manage our loss exposure and protect our capital by strategically purchasing reinsurance from third parties. Our reinsurance program allows us to reduce volatility in our underwriting performance and protect our balance sheet from large losses by transferring a portion of our loss exposure to reinsurers that in turn receive a portion of our gross premiums (less a ceding commission paid to us).
We utilize a mix of quota share, excess of loss reinsurance and facultative reinsurance coverages. A quota share reinsurance program is an agreement in which the reinsurer(s) agrees to take on a fixed percentage of all policies written by us in exchange for an agreed-upon percentage of premium. An excess of loss reinsurance treaty is an agreement in which the reinsurer(s) covers losses that exceed a specified amount, known as the attachment point, up to a predetermined limit in return for a negotiated premium. For instance, we purchase catastrophe excess of loss reinsurance, which entails reinsurer(s) assuming all or a portion of our losses relating to a group of policies
occurring in relation to specified events, subject to customary exclusions, in excess of a specified amount. Facultative coverage is a reinsurance agreement provided on a risk-by-risk basis, rather than a group or class of business. We purchase facultative reinsurance for our property and vertical-specific products. The mix of reinsurance purchased takes into consideration efficiency, cost, our risk appetite, and specific factors of the underlying risks we underwrite.
The following is a summary of our key excess of loss reinsurance programs:
•
Catastrophe excess of loss treaty up to $48 million in losses in excess of $12 million
•
Property per risk excess of loss treaty of 47.5% of $4 million in excess of $1 million in losses
Our focus on small-to-medium sized enterprises results in a large volume of policies that may be exposed to small losses due to catastrophe events. We actively manage and monitor our limited property catastrophe exposure through constant monitoring of exposure concentration, in-house catastrophe loss modeling, and aggregate limit caps for individual geographic zones. To further protect our balance sheet and limit earnings impact from severe events such as hurricanes, convective storms, and earthquakes, we strategically buy catastrophe reinsurance coverage. To inform our purchase of catastrophe reinsurance, we use third-party stochastic and our deterministic models to analyze the risk of aggregation of losses from such events. These models provide a quantitative view of PML events, which is an estimate of the amount of loss we would expect to meet or exceed once in a given number of years. Based on our modeling, effective December 31, 2024, our estimated net probable maximum loss, excluding reinstatement premiums, was $12.0 million for a 1-in-250 year event which represents 3% of our members’ equity as of December 31, 2024.
Our reinsurance treaties typically have a 12-month term, and during each renewal cycle, we may change our coverage terms or the composition of our reinsurance panel. Although precise cession percentages and limits as well as exact terms may vary at each renewal cycle, we aim to renew on similar terms so as to maintain a consistent and balanced level of net risk.
We seek to purchase reinsurance from high-quality carriers rated “A-” (Excellent) or better by A.M. Best. As of December 31, 2024, 100% of our reinsurance recoverables were derived from reinsurers rated “A-” or better by A.M. Best, or managed on a funds withheld basis.
Reserves
We maintain loss and loss adjustment expense reserves to cover estimated liabilities for all claims reported and for IBNR claims. The reserves are estimated in accordance with industry practice and based on generally accepted actuarial reserving techniques that take into account actuarial projections and the expected ultimate cost to settle and administer each claim. Our reserves estimates are based upon past loss experience modified for current trends as well as prevailing economic, legal, and social conditions and facts and circumstances known at each point in time. We continually monitor and analyze reserves using new information on reported claims and a variety of statistical analyses and adjust the reserves if necessary. Anticipated inflation is reflected implicitly in the reserving process through analysis of cost trends and the review of historical development. We estimate our reserves on both a gross and net of reinsurance basis but present them net of reinsurance recoverables.
When a claim is reported, we establish a case reserve for the estimated amount of the ultimate payment after an appropriate assessment of coverage, damages, and other investigation has been made. The estimate is based on our reserving practices and on the claims adjuster’s knowledge of the nature and value of the specific type of claim. Claim volumes are tracked, monitored, and evaluated weekly relative to the underlying reserve assumptions. Each quarter, we analyze the actual versus expected losses for all prior accident years and utilize on-level trended loss ratios and a Frequency and Severity method to calculate the current accident year loss ratio. For older accident years and catastrophe claims, we select our best estimate using our expertise and team’s experience. For reinsurance netting analysis, estimates are tailored to each line of business and type of reinsurance. Results of this quarterly analysis are presented to the Quarterly Reserve Committee at the end of each fiscal quarter, which monitors the approach and claim developments compared to expected reserves.
In addition, we conduct a full spectrum study of reserves annually to analyze reserving adequacy. Reserve analyses are conducted using a multi-method process which includes a full suite of traditional methodologies (such as Chain-Ladder, Bornhuetter Ferguson, Cape Cod, and Frequency and Severity methods) individual open claim analyses, as well as a sensitivity analysis to provide a range of reasonable estimates. Every year, we prepare a reserve study for each product to evaluate the current reserve levels compared with claims and developments over the last year. We also conduct an external actuarial assessment and release annual statement reports and a Statement of Actuarial Opinion.
Given our focus on smaller accounts and shorter-tail products, minimal exposure to pre-2020 reserves and our rigorous reserving practices, we believe we have high visibility and confidence in the strength and reliability of our reserves.
Investments
We seek to maintain a balanced investment portfolio that produces stable and attractive risk-adjusted returns. We generally aim to match the duration of our fixed income investment portfolio to the duration of our insurance liabilities, with a large portion of the portfolio allocated to maintaining sufficient readily available funds to pay claims and expenses.
Our portfolio is primarily composed of cash and cash equivalents and investment-grade fixed income securities, supplemented by our Utility & Infrastructure Investments. These investments currently consist of an allocation to the Absolute Return Utility & Infrastructure Fund, which is managed by our affiliate, the Investment Manager, and which employs a long/short strategy that seeks to deliver uncorrelated, absolute returns in all market conditions, primarily through investments in yield-oriented securities in lower-volatility sectors such as utilities, pipelines, infrastructure, and real estate. We believe that by allocating a portion of our assets to Utility & Infrastructure Investments, we can achieve more consistent total returns in our aggregate portfolio, particularly in a market environment characterized by increasing volatility in interest rates and security prices, as seen in recent years. For example, as a result of its focus on lower-volatility sectors and disciplined risk management, the Absolute Return Utility & Infrastructure Fund has not experienced an annual loss in over 25 years. Nonetheless, the Utility & Infrastructure Investments are speculative, entail substantial risks, and are subject to various conflicts of interest. For example, the Utility & Infrastructure Investments are made through various commingled investment vehicles that are managed on behalf of multiple clients of the Investment Manager, and while we think the strategy is well matched for our investment objectives, it was not specifically designed for our financial objectives or anticipated insurance and reinsurance liabilities. See “Risk Factors—Risks related to our investment strategy”.
On March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd redeemed an aggregate of $94 million from the Absolute Return Utility & Infrastructure Fund and on March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd, as lenders, executed the ZIS Loan with ZIS, an employee benefits company that is wholly owned by ZFSG, as the borrower. The ZIS Loan is guaranteed by ZFSG and secured by the shares ZFSG holds in ZIS and shares of our common stock held by ZFSG. See “Certain relationships and related party transactions—Related Party Loan.” The ZIS Loan provides for a fixed interest rate of 5.5%, payable annually in cash. After giving effect to the ZIS Loan and the AtegrityOne Transaction, and assuming the proceeds from this offering are invested in fixed-income securities (using an assumed initial public offering price of $ per share, which is the midpoint of the range we show on the cover of this prospectus), approximately % of our portfolio assets will be allocated to the Utility & Infrastructure Investments and the remainder will be invested in fixed-rate investments, including the ZIS Loan. The purpose of our entry into the ZIS Loan is to replace the variable income from the Absolute Return Utility & Infrastructure Investments Fund with fixed income in the form of the ZIS Loan. For a description of the risks associated with the ZIS Loan, see “Risk Factors—Risks related to our investment strategy—The ZIS Loan is a Related Party Transaction and is subject to the credit risk of an investment in ZIS and ZFSG.”
Our portfolio is managed both internally and by the Investment Manager. We currently self-manage our investments in cash, cash equivalents, and treasuries. Outside of self-managed holdings, we also leverage the expertise of the Investment Manager for our fixed incomes portfolios.
We actively manage and monitor our investment risk to balance the goals of capital preservation and income generation with our need to comply with the insurance regulatory frameworks. The Investment Committee of our Board of Directors reviews and approves our investment policy and guidelines. The Investment Committee meets on a quarterly basis to review and monitor our investment results and performance against our investment objectives, guidelines, and risk appetite.
A summary of our investment portfolio at December 31, 2024 is as follows:
| |
|
|
December 31, 2024
|
|
|
($ in thousands, except percentages)
|
|
|
Fair Value
|
|
|
% of total
|
|
|
Cash and cash equivalents
|
|
|
|
$ |
26,573 |
|
|
|
3.4 %
|
|
|
Fixed maturity securities
|
|
|
|
|
438,752 |
|
|
|
55.6
|
|
|
Short-term investments
|
|
|
|
|
52,612 |
|
|
|
6.7%
|
|
|
Utility & Infrastructure Investments
|
|
|
|
|
270,242 |
|
|
|
34.3%
|
|
|
Other Invested assets
|
|
|
|
|
280 |
|
|
|
NM
|
|
|
Total cash and invested assets
|
|
|
|
$ |
788,459 |
|
|
|
100.0%
|
|
| |
NM = Percentage not meaningful.
As of December 31, 2024, our fixed income and short-term portfolio had a weighted average effective duration of 3.8 years and an average “A-” credit rating. It is currently split between corporate (72.1%) and government (27.7%) assets, and commercial mortgage and asset-backed (0.2%) assets, with an average yield of 5.7%.
Ratings
Ategrity Specialty and Ategrity Ltd both currently hold an “A-” (Excellent) (Outlook Stable) financial strength rating from A.M. Best, which rates insurance companies based on factors of concern to policyholders. A.M. Best currently assigns 16 ratings to insurance companies, which range from “A++” (Superior) to “S” (Rating Suspended). “A-“ (Excellent) is the fourth highest rating. When assessing a company’s financial and operational performance, A.M. Best examines several key factors, including profitability, leverage, and liquidity. Additionally, they review the company’s book of business, the adequacy and reliability of its reinsurance, the quality and estimated market value of its assets, the adequacy of its loss and loss expense reserves, the adequacy of its surplus, its capital structure, the experience and competence of its management, and its market presence. A.M. Best’s ratings represent its opinion on an insurance company’s financial strength, operational performance, and ability to fulfill its obligations to policyholders. These evaluations are not directed to purchasers of an insurance company’s securities.
Competition
The specialty property and casualty industry is highly competitive. We compete with domestic and international insurers, managing general agents and program administrators. We may also compete with new market entrants in the future. Additionally, we may begin to compete against new competitors as we explore new verticals and business lines. Competition is based on many factors, including the perceived financial strength of the insurer, pricing, other terms and conditions, services provided, the speed of claims payments, the reputation and experience of the insurer, reputation and experience of the members of the underwriting and claims teams, and the ratings assigned by independent rating organizations such as A.M. Best, among others. Given the focus on targeted areas and specialized underwriting, certain competitors may be specific to only one or two of our areas of focus.
Today our primary competition in the E&S sector includes Kinsale Capital Group, Inc., RLI Corp., Markel Corporation, and W.R. Berkley Corporation. In identifying the listed companies as some of our competitors, we considered factors such as the amount of premiums written by such companies, the business mix of such companies and such companies’ reputation within the E&S space.
Human capital management
As of December 31, 2024, we had 169 employees across a number of different functions including underwriting, claims, technology, finance, actuarial, and legal. Our success is deeply rooted in the experience, dedication, and innovation of our employees. We prioritize recruiting and retaining top talent through comprehensive benefits packages, attractive compensation, and a supportive work environment that fosters professional growth and development. We recognize that a diverse workplace enhances creativity and decision-making and embrace our employees’ differences in knowledge and life experience. We believe that our top-tier talent plays a significant role in our unique culture, reputation, and achievements. By investing in our people, we ensure that our teams remain agile and responsive to the evolving needs of our clients, thereby driving sustainable growth and long-term value for our stockholders.
We provide and maintain a comprehensive benefits package focused on preserving the well-being of our talent, which includes medical, dental, and vision insurance; a 401(k) plan; paid time off; family leave; and various other ancillary benefits. We have a performance review framework for our employees, allowing us to offer competitive compensation relative to performance.
Our compensation structure is designed to align our teams with the long-term success and goals of our organization. We are deeply committed to fostering long-term career paths to grow and develop our talent.
Facilities
We have office space located in New York, New York and Scottsdale, Arizona. We do not own any real estate property. We believe our existing facilities are sufficient for our current needs.
Legal proceedings
We are subject to routine legal proceedings in the normal course of operating our insurance business. We are not currently involved in any legal proceedings which reasonably could be expected to have a material adverse effect on our business, results of operations, or financial condition.
Regulation
Insurance regulation
Our insurance business is subject to regulation and supervision in each of the U.S. jurisdictions in which it conducts business as well as in Bermuda. U.S. state insurance laws and regulations generally are designed to protect the interests of policyholders, consumers, and claimants rather than stockholders or other investors. The nature and extent of state regulation varies by jurisdiction, and state insurance regulators generally have broad administrative power relating to, among other matters, setting capital and surplus requirements, licensing of insurers, insurance producers and adjusters, review and approval of product forms and rates, establishing standards for reserve adequacy, prescribing statutory accounting methods and the form and content of statutory financial reports, regulating certain transactions with affiliates, and prescribing types and amounts of investments.
Restrictions on cancellation, non-renewal, or withdrawal
Many U.S. states have laws and regulations that limit the ability of an insurance company licensed by that state to exit a market. Some states prohibit an insurer from withdrawing from one or more lines of business in the state except pursuant to a plan approved by the state insurance regulator, which may disapprove a plan that may lead to market disruption. Some state statutes may explicitly or by interpretation apply these restrictions to insurers operating on a surplus lines basis.
Licensing of our employees and adjustors
Licensing
Ategrity Specialty is organized and domiciled in the state of Delaware and is authorized (licensed) in the State of Delaware to transact certain lines of property and casualty insurance. This license is in good standing and, pursuant to applicable Delaware laws and regulations, will continue in force unless otherwise suspended, revoked, or otherwise terminated, subject to certain conditions, including the filing of an annual registration statement with the Delaware Department of Insurance (“Delaware DOI”).
Ategrity Specialty currently operates on a surplus lines basis in 48 states and the District of Columbia. While Ategrity Specialty is not required to apply for and maintain a license in those states (with the exception of Delaware, its domiciliary state), it is subject to maintaining suitability standards or approval under each particular state’s surplus lines laws to be included as an approved surplus lines carrier. In states in which it operates on a surplus lines basis, Ategrity Specialty has freedom of rate and form on the majority of its business. This means that Ategrity Specialty can implement a change in policy form, underwriting guidelines, or rates for a product on an immediate basis without regulatory approval.
All insurance is written through licensed agents and brokers. In states in which we operate on a non-admitted basis, general agents and their retail insurance brokers may be required to certify that a certain number of licensed admitted insurers had been offered and declined to write a particular risk prior to placing that risk with us.
Insurance holding company regulation
We are subject to the insurance holding company laws of Delaware, which require Ategrity Specialty to register with the Delaware DOI and furnish information concerning the operations of companies within the holding company system that may materially affect the operations, management, or financial condition of Ategrity Specialty. These statutes also provide that all transactions among members of a holding company system must be fair and reasonable and, if material or of specified types, such transactions require prior notice and approval or non-disapproval by the Delaware DOI.
Changes of control
Before a person can acquire control of a U.S. domestic insurer, prior written approval must be obtained from the insurance commissioner of the state where the insurer is domiciled, or the acquiror must request an exemption
from the Form A filing and approval requirements or a determination of non-control (each, an “Exemption Request”) or file a Disclaimer with the insurance department of such state and obtain approval thereon. Since Ategrity Specialty is domiciled in the state of Delaware, the insurance laws and regulations of Delaware would be applicable to any proposed acquisition of control of Ategrity Specialty. Under applicable Delaware insurance laws and regulations, no person may acquire control of a domestic insurer until written approval is obtained from the state insurance commissioner following a public hearing on the proposed acquisition. Such approval would be contingent upon the state insurance commissioner’s consideration of a number of factors, including, among others, the financial strength of the proposed acquiror, the integrity and management of the acquiror’s board of directors and executive officers, the acquiror’s plans for the future operations of the domestic insurer, and any anti-competitive results that may arise from the consummation of the acquisition of control.
Delaware law provides that control over a Delaware domestic insurer is presumed to exist if any person, directly or indirectly, owns, controls, holds with the power to vote, or holds proxies representing, ten percent or more of the voting securities of the domestic insurer. This statutory presumption of control may be rebutted by a showing that control does not exist in fact. The Delaware DOI, however, may find that “control” exists in circumstances in which a person owns or controls less than ten percent of the voting securities of the domestic insurer.
Delaware insurance laws and regulations pertaining to changes of control would apply to both the direct and indirect acquisition of ten percent or more of the voting stock of a Delaware-domiciled insurer (or potentially of less than ten percent of the voting stock if there is other indicia of control). Accordingly, the acquisition of ten percent or more of our common stock would be considered an indirect change of control of Ategrity Specialty and would trigger the applicable change of control filing requirements under Delaware insurance laws and regulations, absent the filing of an Exemption Request or Disclaimer and its acceptance by the Delaware DOI. These requirements may discourage potential acquisition proposals and may delay, deter, or prevent a change of control of us, including through transactions that some or all of our stockholders might consider to be desirable.
Restrictions on paying dividends
Substantially all of our operations are conducted through our wholly-owned insurance and service company subsidiaries. Consequently, our ability to pay dividends to stockholders and meet our debt payment obligations is largely dependent on dividends and other distributions from Ategrity Specialty and our other operating companies. Ategrity Specialty’s ability to pay dividends is restricted under the insurance laws and regulations of its domiciliary state and dividends from sources other than earned surplus may not be declared or paid from any source without the Delaware DOI’s prior approval. Earned surplus refers to an amount equal to the unassigned funds of Ategrity Specialty as set forth in its most recent annual statement submitted to the Delaware DOI, including all or part of the surplus arising from unrealized capital gains or revaluation of assets. Under the insurance laws of Delaware, an insurer may make an ordinary dividend if its surplus as regards policyholders is reasonable in relation to the insurer’s outstanding liabilities and is adequate to its financial needs. Dividends in larger amounts, or extraordinary dividends, are subject to approval by the Delaware DOI. An extraordinary dividend or distribution is defined as a dividend or distribution that, in the aggregate in any 12-month period, exceeds the greater of (i) 10% of surplus as regards policyholders as of the preceding December 31, or (ii) the insurer’s net income for such 12-month period, not including realized capital gains. See “Management’s discussion and analysis of financial condition and results of operations—Liquidity and capital resources”.
Insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that dividends of the maximum amounts calculated under any applicable formula would be permitted. State insurance regulatory authorities that have jurisdiction over the payment of dividends by our insurance company subsidiary may in the future adopt statutory provisions, or impose additional constraints more restrictive than those currently in effect.
Investment regulation
Ategrity Specialty is subject to Delaware laws that require diversification of our investment portfolios and prescribe limits on the kind, quality, and concentration of investments. Surpassing the investment limitations set
forth under Delaware law, Ategrity Specialty has received consent from the Delaware DOI to invest up to 15% of the assets of Ategrity Specialty in the Utility Limited Partnership. Failure to comply with these laws and regulations would cause nonconforming investments to be treated as non-admitted assets for purposes of measuring statutory surplus and, in some instances, would require us to sell those investments.
State legislative and regulatory activity
From time to time, increased scrutiny has been placed upon the insurance regulatory framework, including licensing of employees, and a number of state legislatures have considered or enacted legislative measures that alter, and in many cases increase, state authority to regulate insurance companies. In addition to legislative initiatives of this type, insurance regulators, and the NAIC, a standard-setting association of state insurance regulators, are continuously involved in a process of reexamining existing laws and regulations and their application to insurance companies. The NAIC also establishes statutory accounting and reporting standards and drafts model insurance laws and regulations for adoption by the states.
As part of its solvency modernization efforts, the NAIC adopted the Risk Management and Own Risk and Solvency Assessment Model Act (the “ORSA Model Act”), which has been enacted in Delaware. The ORSA Model Act requires insurance companies to assess the adequacy of their and their group’s risk management and current and future solvency position. Under the ORSA Model Act, an insurer must undertake an internal risk management review no less often than annually (but also at any time when there are significant changes to the risk profile of the insurer or its insurance group), in accordance with the NAIC’s ORSA Guidance Manual, and prepare a confidential summary report (“ORSA Report”) assessing the adequacy of the insurer’s risk management and capital in light of its current and future business plans. The ORSA Report is filed with a company’s lead state regulator and is available to other domiciliary regulators within the holding company system.
Also, in furtherance of its solvency modernization efforts, the NAIC adopted the Corporate Governance Annual Disclosure Model Act and Model Regulation, which has been enacted in Delaware and requires an insurer to provide an annual disclosure regarding its corporate governance practices to its lead state and/or domestic regulator.
In addition, in December 2020, the NAIC adopted a group capital calculation tool (“GCC”) to provide U.S. regulators with a method to aggregate the available capital and the minimum capital of each entity in a group in a way that applies to all groups regardless of their structure. In connection with the GCC, the NAIC also adopted changes to the Insurance Holding Company System Regulatory Model Act and Regulation, which have been enacted in Delaware, to require, subject to certain exemptions, the ultimate controlling person of every insurer subject to the holding company registration requirement to file an annual GCC with its lead state. The GCC uses an RBC aggregation methodology for all entities within an insurance holding company system group, including non-U.S. entities.
Additionally, in response to the growing threat of cyber-attacks in the insurance industry, certain jurisdictions have begun to consider new cybersecurity measures, including the adoption of cybersecurity regulations which, among other things, would require insurance companies to establish and maintain a cybersecurity program and implement and maintain cybersecurity policies and procedures. On October 24, 2017, the NAIC adopted its Insurance Data Security Model Law, which has been enacted in Delaware, intended to serve as model legislation for states to enact in order to govern cybersecurity and data protection practices of insurers, insurance agents and other licensed entities registered under state insurance laws.
Federal regulation
Although the federal government generally has not directly regulated the business of insurance except for certain areas of the market, such as insurance for flood, nuclear, and terrorism risks, federal initiatives often affect the insurance industry in a variety of ways. The U.S. federal government’s oversight of the insurance industry was expanded under the Dodd-Frank Act, which, among other things, established the Federal Insurance Office (the “FIO”). The FIO performs various functions with respect to insurance, including the submission of reports to
Congress that could ultimately lead to changes in the regulation of insurers and reinsurers in the U.S., although the FIO has no express regulatory authority over insurance companies or other insurance industry participants.
The Dodd-Frank Act also incorporated the Nonadmitted and Reinsurance Reform Act of 2010 (“NRRA”), which became effective on July 21, 2011, and establishes national uniform standards on how states may regulate and tax surplus lines insurance. In particular, the NRRA gives regulators in the home state of an insured exclusive authority to regulate and tax surplus lines insurance transactions. In August 2023, the NAIC adopted revisions to its Nonadmitted Insurance Model Act intended to implement the changes to the regulation of surplus lines insurance resulting from the NRRA.
In addition, a number of federal laws affect and apply to the insurance industry, including various privacy laws and the economic and trade sanctions implemented by the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury. OFAC maintains and enforces economic sanctions against certain foreign countries and groups and prohibits U.S. persons from engaging in certain transactions with certain persons or entities. OFAC has imposed civil penalties on persons, including insurance and reinsurance companies, arising from violations of its economic sanctions program.
Credit for reinsurance
State insurance laws permit U.S. insurance companies, as ceding insurers, to take financial statement credit for reinsurance that is ceded, so long as the assuming reinsurer satisfies the state’s credit for reinsurance laws. In general, credit for reinsurance is allowed if the assuming reinsurer is licensed or “accredited” in the state in which the ceding insurer is domiciled or maintains certain types of qualifying collateral.
The FIO and the Office of the U.S. Trade Representative exercised their authority under the Dodd-Frank Act and entered into a “covered agreement” with the European Union, as well as a similar “covered agreement” with the United Kingdom, which established standards on collateral requirements for reinsurance, insurance group supervision and confidentiality. In 2019, the NAIC adopted amendments to its Credit for Reinsurance Model Law to implement the reinsurance collateral provisions of the covered agreements, eliminating reinsurance collateral requirements for qualifying reinsurers domiciled in jurisdictions subject to an in-force covered agreement. The amended Credit for Reinsurance Model Law, which has been adopted in all U.S. states, including Delaware, also extends the zero reinsurance collateral provisions in the covered agreements to qualified reinsurers that have been approved as a “certified reinsurer” or “reciprocal jurisdiction reinsurer” and to qualified reinsurers that are domiciled in a U.S. jurisdiction that is accredited by the NAIC or in a non-U.S. jurisdiction that has not entered into a covered agreement with the U.S. but which is designated as a “reciprocal jurisdiction” by the NAIC. The NAIC list of reciprocal jurisdictions includes Bermuda, Japan, and Switzerland. Our Bermuda Subsidiary intends to submit an application with the Delaware Department to be approved as a “reciprocal jurisdiction reinsurer” in Delaware.
Periodic financial and market conduct examinations
The Delaware DOI, Ategrity Specialty’s domiciliary state insurance regulator, is authorized to conduct on-site visits and examinations of the affairs of Ategrity Specialty, including its financial condition, its relationships and transactions with affiliates and its dealings with policyholders, every three to five years, and may conduct special or targeted examinations to address particular concerns or issues at any time. Insurance regulators of other states in which we do business in the future also may conduct examinations. The results of these examinations can give rise to regulatory orders requiring remedial, injunctive, or other corrective action. Insurance regulatory authorities have broad administrative powers to restrict or revoke licenses to transact business and to levy fines and monetary penalties against insurers and insurance agents and brokers found to be in violation of applicable laws and regulations.
Trade practices
The manner in which insurance companies and insurance agents and brokers conduct the business of insurance is regulated by state statutes in an effort to prohibit practices that constitute unfair methods of competition or
unfair or deceptive acts or practices. Prohibited practices include, but are not limited to, disseminating false information or advertising, unfair discrimination, rebating, and false statements. We set business conduct policies and provide training to make our employee-producers aware of these prohibitions, and we require them to conduct their activities in compliance with these statutes.
Unfair claims practices
Generally, insurance companies, adjusting companies, and individual claims adjusters are prohibited by state statutes from engaging in unfair claims practices on a flagrant basis or with such frequency to indicate a general business practice. Unfair claims practices include, but are not limited to, misrepresenting pertinent facts or insurance policy provisions; failing to acknowledge and act reasonably promptly upon communications with respect to claims arising under insurance policies; and attempting to settle a claim for less than the amount to which a reasonable person would have believed such person was entitled. We set business conduct policies and provide training to make our employee-producers aware of these prohibitions, and we require them to conduct their activities in compliance with these statutes.
Quarterly and annual financial reporting
Our insurance company subsidiary is required to file quarterly and annual financial reports with state insurance regulators using SAP rather than GAAP. In keeping with the intent to assure policyholder protection, SAP emphasizes solvency considerations. For a summary of the significant differences for our insurance company subsidiary between SAP and GAAP, see Note 19, “Statutory Matters,” to our consolidated financial statements included in this prospectus.
Risk-based capital
Risk-based capital (“RBC”) laws are designed to assess the minimum amount of capital that an insurance company needs to support its overall business operations and to ensure that it has an acceptably low expectation of becoming financially impaired. State insurance regulators use RBC to set capital requirements, considering the size and degree of risk taken by the insurer and taking into account various risk factors including asset risk, credit risk, underwriting risk and interest rate risk. As the ratio of an insurer’s total adjusted capital and surplus decreases relative to its risk-based capital, the RBC laws provide for increasing levels of regulatory intervention culminating with mandatory control of the operations of the insurer by the domiciliary insurance department at the so-called mandatory control level.
Delaware has largely adopted the model legislation promulgated by the NAIC pertaining to RBC and requires annual reporting by Delaware-domiciled insurers to confirm that the minimum amount of RBC necessary for an insurer to support its overall business operations has been met. Delaware-domiciled insurers falling below a calculated threshold may be subject to varying degrees of regulatory action, including supervision, rehabilitation, or liquidation by the Delaware DOI. Failure to maintain our risk-based capital at the required levels could adversely affect the ability of Ategrity Specialty to maintain the regulatory authority necessary to conduct our business. See “Risk factors—Risks related to the regulatory environment—We are subject to extensive regulation, which may adversely affect our ability to achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our financial condition and results of operations.”
IRIS ratios
The NAIC IRIS is part of a collection of analytical tools designed to provide state insurance regulators with an integrated approach to screening and analyzing the financial condition of insurance companies operating in their respective states. IRIS is intended to assist state insurance regulators in targeting resources to those insurers in greatest need of regulatory attention. IRIS consists of two phases: statistical and analytical. In the statistical phase, the NAIC database generates key financial ratio results based on financial information obtained from insurers’ annual statutory statements. The analytical phase is a review of the annual statements, financial ratios,
and other automated solvency tools. The primary goal of the analytical phase is to identify companies that appear to require immediate regulatory attention. A ratio result falling outside the usual range of IRIS ratios is not considered a failing result; rather, unusual values are viewed as part of the regulatory early monitoring system. Furthermore, in some years, it may not be unusual for financially sound companies to have several ratios with results outside the usual ranges. An insurance company may fall out of the usual range for one or more ratios because of specific transactions that are in themselves immaterial.
Bermuda insurance regulation
Insurance regulation generally
The Insurance Act 1978, as amended, and related rules and regulations (the “Insurance Act”), provides that no person shall carry on insurance business in or from within Bermuda unless registered as an insurer under the Insurance Act by the Bermuda Monetary Authority (the “BMA”). The BMA, in deciding whether to grant registration, has broad discretion to act as it thinks fit in the public interest. The BMA is required by the Insurance Act to determine whether the applicant is a fit and proper body to be engaged in the insurance business and, in particular, whether it has, or has available to it, adequate knowledge and expertise.
The continued registration of an applicant as an insurer is subject to its complying with the terms of its registration and such other conditions as the BMA may impose at any time. The Insurance Act also grants to the BMA powers to supervise, investigate, and intervene in the affairs of insurance companies.
The Insurance Act does not distinguish between insurers and reinsurers: companies are registered (licensed) under the Insurance Act as “insurers” (although in certain circumstances a condition to registration may be imposed to the effect that the company may carry on only reinsurance business). The Insurance Act uses the defined term “insurance business” to include reinsurance business. References herein to insurance companies include reinsurance companies.
Ategrity Ltd is registered as a Class 3A general business insurer.
The Insurance Act imposes on Bermuda insurance companies’ solvency and liquidity standards, as well as auditing and reporting requirements.
Certain significant aspects of the Bermuda insurance regulatory framework are set forth below.
Classifications as a Class 3A insurer
A body corporate is registrable as a Class 3A insurer where (i) 50% or more of its net premiums written, or (ii) 50% or more of its net loss and loss expense provisions, represent unrelated business and its total net premiums written from unrelated business are less than $50,000,000.
Minimum paid-up share capital
As a Class 3A insurer, Ategrity Ltd is required to maintain fully paid-up share capital of at least $120,000.
Principal representative and principal office
As a Class 3A insurer, Ategrity Ltd is required to maintain a principal office and to appoint and maintain a principal representative in Bermuda. For the purposes of the Insurance Act, the principal office of Ategrity Ltd is located at Point House 6 Front Street Hamilton HM 11 Bermuda and Aon Insurance Managers (Bermuda) Ltd. serves as its principal representative.
It is the duty of the principal representative to forthwith notify the BMA where the principal representative reaches the view that there is a likelihood of the insurer (for which the principal representative acts) becoming insolvent, or on it coming to the knowledge of the principal representative, or the principal representative having reason to believing that a reportable “event” has occurred. Examples of a reportable “event” include a failure
by the insurer to comply substantially with a condition imposed upon it by the BMA relating to a solvency margin or a liquidity or other ratio, a significant loss reasonably likely to cause the insurer to fail to comply with its enhanced capital requirement (discussed below) and the occurrence of a “material change” (as such term is defined under the Insurance Act) in its business operations. Within 14 days of such notification to the BMA, the principal representative must furnish the BMA with a written report setting out all the particulars of the case that are available to the principal representative.
Head office
A Class 3A insurer shall maintain its head office in Bermuda. In determining whether the insurer satisfies this requirement, the BMA shall consider, inter alia, the following factors: (i) where the underwriting, risk management, and operational decision-making of the insurer occurs; (ii) whether the presence of senior executives who are responsible for, and involved in, the decision-making related to the insurance business of the insurer are located in Bermuda; and (iii) where meetings of the board of directors of the insurer occur. In making its determination, the BMA may also have regard to (a) the location where management of the insurer meets to effect policy decisions of the insurer; (b) the residence of the officers, insurance managers, or employees of the insurer; and (c) the residence of one or more directors of the insurer in Bermuda.
Loss reserve specialist
As a Class 3A insurer, Ategrity Ltd is required to appoint an individual approved by the BMA to be its loss reserve specialist. In order to qualify as an approved loss reserve specialist, the applicant must be an individual qualified to provide an opinion in accordance with the requirements of the Insurance Act and the BMA must be satisfied that the individual is fit and proper to hold such an appointment.
As a Class 3A insurer, Ategrity Ltd is required to submit annually an opinion of its approved loss reserve specialist with its capital and solvency return with respect to its total general business insurance technical provisions (i.e. the aggregate of its net premium provisions, net loss and loss expense provisions, and risk margin, as each is reported in the insurer’s statutory economic balance sheet). The loss reserve specialist’s opinion must state, among other things, whether or not the aggregate amount of technical provisions shown in the statutory economic balance sheet as at the end of the relevant financial year (i) meets the requirements of the Insurance Act, and (ii) makes reasonable provision for the total technical provisions of the insurer under the terms of its insurance contracts and agreements.
Annual financial statements and returns
Ategrity Ltd must prepare and submit, on an annual basis, audited GAAP financial statements and audited statutory financial statements.
As a Class 3A insurer, Ategrity Ltd is also required to file with the BMA a statutory financial return no later than four months after its financial year end (unless specifically extended with the approval of the BMA). The statutory financial return of a Class 3A insurer shall consist of (i) an insurer information sheet, (ii) an auditor’s report, (iii) the statutory financial statements, and (iv) notes to the statutory financial statements.
In addition, each year the insurer is required to file with the BMA a capital and solvency return along with its annual statutory financial return. The prescribed form of capital and solvency return comprises the insurer’s Bermuda Solvency Capital Requirement (“BSCR”) model or an approved internal capital model in lieu thereof, together with schedules as prescribed by the Insurance (Prudential Standards) (Class 3A Solvency Requirement) Rules 2011, as amended from time to time.
Neither the statutory financial return nor the capital and solvency return is available for public inspection.
Declaration of compliance
At the time of filing its statutory financial statements, a Class 3A insurer is also required to deliver to the BMA a declaration of compliance, in such form and with such content as may be prescribed by the BMA, declaring whether
or not the Class 3A insurer has, with respect to the preceding financial year (i) complied with all requirements of the minimum criteria applicable to it; (ii) complied with the minimum margin of solvency as at its financial year end; (iii) complied with the applicable enhanced capital requirements as at its financial year end; and (iv) complied with applicable conditions, directions, and restrictions imposed on, or approvals granted to, the Class 3A insurer; and (v) complied with the minimum liquidity ratio for general business as at its financial year end.
Public disclosures
Pursuant to the Insurance Act, all commercial insurers and insurance groups are required to prepare and file with the BMA and also publish on their website, a financial condition report. The BMA has the discretion to approve modifications and exemptions to the public disclosure rules, on application by the insurer if, among other things, the BMA is satisfied that the disclosure of certain information will result in a competitive disadvantage or compromise confidentiality obligations of the insurer.
Independent approved auditor
Ategrity Ltd has appointed Ernst & Young Ltd.—Bermuda as its independent auditor. The independent auditor will audit and report on Ategrity Ltd’s GAAP financial statements and statutory financial statements, each of which are required to be filed annually with the BMA.
Non-insurance business
No Class 3A insurer may engage in non-insurance business unless that non-insurance business is ancillary to its core business. Non-insurance business means any business other than insurance business and includes carrying on investment business, managing an investment fund as an operator, carrying on business as a fund administrator, carrying on banking business, underwriting debt or securities, or otherwise engaging in investment banking, engaging in commercial or industrial activities, and carrying on the business of management, sales, or leasing of real property.
Minimum liquidity and solvency ratios
Ategrity Ltd is required to maintain the value of its relevant assets at not less than 75% of the amount of its relevant liabilities. Relevant assets include cash and time deposits, quoted investments, unquoted bonds and debentures, first liens on real estate, investment income due and accrued, accounts and premiums receivable, reinsurance balances receivable, funds held by ceding reinsurers, and any other assets which the BMA, on application in any particular case made to it with reasons, accepts in that case. There are certain categories of assets which, unless specifically permitted by the BMA, do not automatically qualify as relevant assets, such as unquoted equity securities, investments in and advances to affiliates and real estate, and collateral loans. The relevant liabilities are total general business insurance reserves and total other liabilities less deferred income taxes and letters of credit, guarantees, and other instruments.
In addition, Ategrity Ltd is also required to ensure that the value of its statutory assets exceed the value of its statutory liabilities by an amount greater than its prescribed minimum solvency margin (“MSM”) and to maintain available statutory economic capital and surplus at a level equal to or in excess of its enhanced capital requirement (“ECR”) which is established by reference to either the prescribed Bermuda model or an approved internal capital model.
Failure to meet any of these minimum requirements are reportable events.
Codes of conduct
The Insurance Code of Conduct (the “Code”) prescribes the duties, standards, procedures, and sound business principles with which all insurers registered under the Insurance Act must comply. The BMA will assess an insurer’s compliance with the Code in a proportional manner relative to the nature, scale, and complexity of its business. Failure to comply with the requirements of the Code will be taken into account by the BMA in determining whether
an insurer is conducting its business in a sound and prudent manner as prescribed by the Insurance Act, may result in the BMA exercising its powers of intervention and investigation (see below) and will be a factor in calculating the operational risk charge under the insurer’s applicable capital model.
In addition to ensuring adherence to the Code, the BMA has recognized that cyber incidents can cause significant financial losses and/or reputational impacts across the insurance industry and has implemented the Insurance Sector Operational Cyber Risk Management Code of Conduct (the “Cyber Risk Code”) to ensure that those operating in the Bermuda insurance sector can mitigate such risks. All Bermuda insurers are now required to develop a cyber risk policy which is to be delivered pursuant to an operational cyber risk management programme and appoint an appropriately qualified member of staff or outsourced resource to the role of Chief Information Security Officer.
Restrictions on dividends and distributions
Ategrity Ltd is prohibited from declaring or paying a dividend if it is in breach of its MSM, ECR, or minimum liquidity ratio or if the declaration or payment of such dividend would cause such a breach. Where an insurer fails to meet its MSM or minimum liquidity ratio on the last day of any financial year, it will be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.
In addition, a Ategrity Ltd is prohibited from declaring or paying in any financial year dividends of more than 25% of its total statutory capital and surplus (as shown on its previous financial year’s statutory balance sheet) unless it files (at least seven days before payment of such dividends) with the BMA an affidavit signed by at least two directors (one of whom must be a Bermuda resident director if any of the insurer’s directors are resident in Bermuda) and the principal representative stating that it will continue to meet its solvency margin and minimum liquidity ratio. Where such an affidavit is filed, it shall be available for public inspection at the offices of the BMA.
Reduction of capital
Ategrity Ltd may not reduce its total statutory capital by 15% or more, as set out in its previous year’s financial statements, unless it has received the prior approval of the BMA. Total statutory capital consists of the insurer’s paid-in share capital, its contributed surplus (sometimes called additional paid-in capital) and any other fixed capital designated by the BMA as statutory capital (such as letters of credit).
A Class 3A insurer seeking to reduce its statutory capital by 15% or more, as set out in its previous year’s financial statements, is also required to submit an affidavit signed by at least two directors (one of whom must be a Bermuda resident director if any of the insurer’s directors are resident in Bermuda) and the principal representative stating that the proposed reduction will not cause the insurer to fail its relevant margins and such other information as the BMA may require. Where such an affidavit is filed, it shall be available for public inspection at the offices of the BMA.
Policyholder priority
In the event of a liquidation or winding up of an insurer, policyholders’ liabilities receive prior payment ahead of general unsecured creditors. Subject to the prior payment of preferential debts under the Employment Act 2000 and the Companies Act, the insurance debts of an insurer must be paid in priority to all other unsecured debts of the insurer. “Insurance debt” is defined as a debt to which an insurer is or may become liable pursuant to an insurance contract, excluding debts owed to an insurer under an insurance contract where the insurer is the person insured. “Insurance contract” is defined as any contract of insurance, capital redemption contract, or a contract that has been recorded as insurance business in the financial statements of the insurer pursuant to the Insurance Accounts 1980 or the Insurance Account Rules 2016, as applicable.
Fit and proper controllers
The BMA maintains supervision over the controllers of all registered insurers in Bermuda.
A controller includes (i) the managing director of the registered insurer or its parent company; (ii) the chief executive of the registered insurer or of its parent company; (iii) a shareholder controller; and (iv) any person in accordance with whose directions or instructions the directors of the registered insurer or of its parent company are accustomed to act.
The definition of shareholder controller is set out in the Insurance Act but generally refers to (i) a person who holds 10% or more of the shares carrying rights to vote at a shareholders’ meeting of the registered insurer or its parent company, or (ii) a person who is entitled to exercise 10% or more of the voting power at any shareholders’ meeting of such registered insurer or its parent company, or (iii) a person who is able to exercise significant influence over the management of the registered insurer or its parent company by virtue of its shareholding or its entitlement to exercise, or control the exercise of, the voting power at any shareholders’ meeting.
All shareholder controllers are required to provide notice of becoming or ceasing to be such a controller to the BMA. Any person who contravenes the Insurance Act by failing to give notice or knowingly becoming a controller of any description before the required time period has elapsed is guilty of an offence and liable to a fine of $25,000 on summary conviction.
The BMA may file a notice of objection to any person who has become a controller of any description where it appears that such person is not, or is no longer, a fit and proper person to be a controller of the registered insurer. Before issuing a notice of objection, the BMA is required to serve upon the person concerned a preliminary written notice stating the BMA’s intention to issue a formal notice of objection. Upon receipt of the preliminary written notice, the person served may, within 28 days, file written representations with the BMA which shall be taken into account by the BMA in making its final determination. Any person who continues to be a controller of any description after having received a notice of objection shall be guilty of an offence and shall be liable on summary conviction to a fine of $25,000 (and a continuing fine of $500 per day for each day that the offence is continuing) or, if convicted on indictment, to a fine of $100,000 and/or 2 years in prison.
Notification by registered person of change of controllers and officers
All registered insurers are required to give written notice to the BMA of the fact that a person has become, or ceased to be, a controller or officer of the registered insurer within 45 days of becoming aware of such fact. An officer in relation to a registered insurer means a director, chief executive, or senior executive performing duties of underwriting, actuarial, risk management, compliance, internal audit, finance, or investment matters.
Certain other Bermuda law considerations
All Bermuda “exempted companies” are exempt from certain Bermuda laws restricting the percentage of share capital that may be held by non-Bermudians. However, exempted companies may not participate in certain business transactions, including (1) the acquisition or holding of land in Bermuda except that required for their business and held by way of lease or tenancy for a term not exceeding more than 50 years or, with the consent of the Minister granted in his discretion, land to provide accommodation or recreational facilities for officers and employees of the company for a term not exceeding 21 years, (2) the taking of mortgages on land in Bermuda to secure an amount in excess of $50,000 without the consent of the Minister, (3) the acquisition of any bonds or debentures secured by any land in Bermuda, other than certain types of Bermuda government securities or securities issued by Bermuda public authorities, or (4) the carrying on of business of any kind in Bermuda, except in furtherance of business carried on outside Bermuda or under license granted by the Minister. Generally, it is not permitted without a special license granted by the Minister to insure Bermuda domestic risks or risks of persons of, in or based in Bermuda.
All Bermuda companies must comply with the provisions of the Companies Act regulating the payment of dividends and the making of distributions from contributed surplus. A company may not declare or pay a dividend, or make a distribution out of contributed surplus, if there are reasonable grounds for believing that: (a) the company is, or would after the payment be, unable to pay its liabilities as they become due; or (b) the realizable value of the company’s assets would thereby be less than its liabilities.
Under the ES Requirements, each entity resident in Bermuda that carries on a “relevant activity” is required to comply with the economic substance requirements under the ES Requirements unless resident for tax purposes in a jurisdiction outside Bermuda that is not on the EU list of non-cooperative jurisdictions for tax purposes. Engaging in insurance business in accordance with the Insurance Act constitutes a “relevant activity”.
In relation to carrying on the relevant activity of insurance, compliance with the ES Requirements also requires compliance with requirements in the Companies Act relating to corporate governance and requirements of the Insurance Act and other instruments (including the Code) made thereunder. The Registrar of Companies will have regard to an insurer’s compliance with the Insurance Act and the Companies Act in his assessment of compliance with economic substance requirements and on the basis that an insurer complies with such requirements, the insurer will generally be considered to operate in Bermuda with adequate substance. An insurer will be required to complete and file a declaration form, and the Registrar of Companies will also have regard to the information provided in the declaration form in making his assessment of compliance with economic substance requirements.
Ategrity Ltd may also be subject to change in tax laws resulting from the Organisation of Economic Co-operation and Development (“OECD”) and/or European Union tax initiatives to the extent that such or similar tax legislation is enacted or otherwise adopted by Bermuda. For example, the OECD, together with the G20 countries, has committed to reduce perceived abusive global tax avoidance, referred to as base erosion and profit shifting (“BEPS”). As part of this commitment, in December 2021, the OECD issued model rules aimed at implementing a global minimum corporate tax rate of 15%. Bermuda has signed on to the BEPS inclusive framework. In response to the framework, Bermuda adopted the Corporate Income Tax Act 2023 (the “CIT Act”) on December 27, 2023.
Entities subject to tax under the CIT Act will be Bermuda constituent entities of multi-national groups with respect to fiscal years beginning on or after January 1, 2025, notwithstanding any assurances that may have been provided pursuant to the Exempted Undertakings Tax Protection Act 1966. A multi-national group is defined under the CIT Act as a group with entities in more than one jurisdiction with consolidated revenues of at least EUR 750 million for two of the four previous fiscal years. If Bermuda constituent entities of a multi-national group are subject to tax under the CIT Act, such tax is charged at a rate of 15% of the net income of such constituent entities (as determined in accordance with the CIT Act, including after adjusting for any relevant foreign tax credits applicable to the Bermuda constituent entities).
Ategrity is still evaluating whether the CIT Act will be applicable to Ategrity Ltd and, if applicable, the extent to which the impact of any Bermuda corporate income tax could be offset by any tax credits available under Part 4 of the CIT Act. The CIT Act could, if applicable to Ategrity Ltd or any subsidiary of Ategrity that is incorporated or has a permanent establishment in Bermuda, increase taxes payable by Ategrity and adversely affect Ategrity’s financial condition.
Additionally, in response to other European Union and OECD initiatives, the Economic Substance Act 2018 and the Economic Substance Regulations 2018 were adopted in Bermuda. As an insurance company, Ategrity Ltd conducts a relevant activity and will be subject to the ES Requirements. As a result, Ategrity Ltd may be required to change or increase our business operations in Bermuda in order to meet the new requirements, which may adversely affect Ategrity’s operations or financial condition.
Ategrity Ltd may also be subject to the Personal Information Protection Act 2016 (“PIPA”), which is the principal Bermuda legislation regulating the right to personal informational privacy, to the extent that it uses personal information in Bermuda. In December 2016, PIPA sections relating generally to the establishment, staffing, funding, and general powers of the Privacy Commissioner came into force and in January 2020, a Privacy Commissioner was appointed. On January 1, 2025, PIPA was fully implemented. PIPA applies to every organization (which includes any individual, entity or public authority) that uses personal information in Bermuda where that personal information is used by automated or other means which form, or are intended to form, part of a structured filing system. For the purposes of PIPA, “personal information” means any information about an identified or identifiable individual (meaning a natural person), and “use” or “using” are very broadly defined and effectively include possessing or carrying out any operation on personal information.
Management
Directors, director nominees, and executive officers
Set forth below are the names, ages, and positions of our directors, director nominees, and executive officers as of the date of this prospectus. The director nominees are expected to become members of our Board of Directors upon consummation of this offering.
|
Name
|
|
|
Age
|
|
|
Position
|
|
|
Justin Cohen
|
|
|
|
|
50 |
|
|
|
Chief Executive Officer, Director
|
|
|
Chris Schenk
|
|
|
|
|
43 |
|
|
|
President, Chief Underwriting Officer
|
|
|
Neelam Patel
|
|
|
|
|
47 |
|
|
|
Chief Financial Officer
|
|
|
Stuart J. Zimmer
|
|
|
|
|
56 |
|
|
|
Director, Chair
|
|
|
Tom Hulst
|
|
|
|
|
59 |
|
|
|
Director
|
|
|
William Mercer
|
|
|
|
|
55 |
|
|
|
Director Nominee
|
|
|
Robert C. Merton, Ph.D.
|
|
|
|
|
80 |
|
|
|
Director Nominee
|
|
|
Mitchell Pressman
|
|
|
|
|
60 |
|
|
|
Director Nominee
|
|
|
John (Jack) L. Sennott, Jr.
|
|
|
|
|
59 |
|
|
|
Director Nominee
|
|
Justin Cohen has served as our Chief Executive Officer since January 2023, and as one of our directors since December 2021, bringing over 25 years of experience in the insurance and financial services sectors. Before that, Mr. Cohen served as our Deputy Chief Executive Office since December 2021. He began his career at Donaldson, Lufkin & Jenrette as an investment banker focused on the insurance industry, specializing in mergers & acquisitions, public offerings, merchant banking, and insurance-linked securities. He later joined Capital Z Partners, where he worked on the demutualization and operational turnaround of British Marine Insurance, as well as other holdings in the insurance, banking, and financial technology sectors. Mr. Cohen subsequently joined Eton Park Capital Management, L.P., where he founded and operated Epoch Re, a reinsurer established after Hurricane Katrina, and where he was responsible for investments in insurance and financial services. He then founded Roundfield Financial, an investment management firm dedicated to the insurance and financial services sectors, where he served as Chief Executive Officer with backing from Steinhardt Management. Mr. Cohen has also served as a member of the Board of Managers of various operating subsidiaries of ZFSG. He was previously on the Board of Managers of Carrick Specialty Holdings LLC, for which he led the sale of the company in December 2023. Additionally, he has served as Head of Financials at the Investment Manager since 2020, during which time he has led the firm’s investments in the insurance and financial services sectors. He graduated summa cum laude from the University of Pennsylvania’s Management & Technology program in 1996, earning dual degrees in Insurance & Risk Management and Finance from The Wharton School and in Computer Science & Engineering. At the University of Pennsylvania, Mr. Cohen received an industry-sponsored scholarship award for innovation in insurance for developing web-based automated underwriting software as part of his engineering thesis.
We believe Mr. Cohen’s qualifications to serve on our Board of Directors include his over 25 years of experience in the insurance and financial services sectors.
Chris Schenk has served as our President since September 2024 and our Chief Underwriting Officer since December 2021, bringing 20 years of experience spanning public policy and insurance. Over the last 12 years, Mr. Schenk has held roles in underwriting management, data, and analytics and strategy. Prior to joining Ategrity in 2021, Mr. Schenk worked at Munich Re Specialty Insurance, where he was Head of Data and Analytics and led a team to deliver critical strategic and go-to-market capabilities for the launch of the new E&S insurance division of Munich Reinsurance. Before that, Chris held the position of Head of Pricing, Strategy, and Underwriting Analytics at Hiscox Insurance, where he led initiatives to modernize pricing capabilities, remediate underperforming lines and develop data-augmented underwriting models. Chris transitioned from an eight-year career in politics and public policy to pursue a Master’s in Finance and Economics at New York University in 2010 and changed sectors upon graduating.
Neelam Patel has served as our Chief Financial Officer since September 2024, bringing over 20 years of experience in financial leadership within the insurance industry. She joined Ategrity from W.R. Berkley, where she was Chief Financial Officer of Berkley One, contributing to significant growth and operational success over five years. Prior to that, Ms. Patel spent 18 years at Chubb Ltd., where she held various finance leadership positions across multiple divisions. Her expertise includes budgeting, forecasting, and financial reporting, with a strong focus on aligning strategic objectives with financial outcomes. Ms. Patel holds a Bachelor of Commerce in Accounting from Gujarat University and is a Certified Public Accountant in the state of Delaware.
Stuart J. Zimmer serves as Chair of our Board of Directors and has served as one of our directors since our founding in 2018. Mr. Zimmer has over 30 years of experience in the asset management industry. He is the Chief Executive Officer of ZFSG, an insurance and asset management firm. Mr. Zimmer is also the Portfolio Manager and Chief Executive Officer of the Investment Manager, ZFSG’s asset management subsidiary, which advises private funds and fixed income accounts. In the insurance space, in addition to Ategrity, ZFSG’s interests previously included Carrick Specialty Holdings LLC, a provider of reinsurance and run-off management solutions, which it sold in 2023. Mr. Zimmer started his career at Steinhardt Partners, known as one of the pioneer firms of the investment fund industry. At Steinhardt, Mr. Zimmer was a research analyst with a focus on energy investments, including electric and gas utilities. His experience at Steinhardt also included trading of equities, fixed income, currencies, and derivatives. In 1997, Mr. Zimmer launched the Absolute Return Utility & Infrastructure Fund and served as the Portfolio Manager to its predecessor investment manager. In 2013, Mr. Zimmer launched the Investment Manager, which continues to manage the Absolute Return Utility & Infrastructure Fund, and has over the years expanded its product offerings to include infrastructure, mid-cap, and real estate private funds as well as fixed income investment management services. Mr. Zimmer graduated Phi Beta Kappa from Harvard College with Honors in Mathematics in 1991, where he wrote his thesis under Robert C. Merton, the 1997 Nobel Laureate in Economics.
We believe Mr. Zimmer’s qualifications to serve on our Board of Directors include his over 30 years of experience in the asset management industry.
Tom Hulst has served as one of our directors since 2018. Mr. Hulst is the Chairman and CEO of the Ivy group of companies, a co-investment vehicle for Global Atlantic Financial Group which is focused on closed block life and pension risk transfer reinsurance. He is also the President and Founder of ReThink, a Bermuda based consulting firm, a non-executive director for several insurers, and a Vice Chairman of ABIC, the Association of Bermuda International Companies. From 2005 to 2015, Mr. Hulst was part of the founding management team of Ariel Reinsurance Company, serving as CEO from 2008−2015, through the sale of the business to Goldman Sachs in 2012 and subsequent spin-out of the Global Atlantic Financial Group. Prior to serving with Ariel Re, Mr. Hulst held progressively senior roles within the General Re Group from 1990−2005. Mr. Hulst graduated cum laude from the University of Michigan and received his M.B.A from the J.L Kellogg School of Management at Northwestern.
We believe Mr. Hulst’s qualifications to serve on our Board of Directors include his over 30 years of experience in the insurance and financial services sectors.
William Mercer is currently a director nominee and will become a member of our Board of Directors upon the completion of this offering. Mr. Mercer recently joined Stout Risius Ross, LLC (“Stout”), a global advisory firm, following the successful sale of DebtX Analytics, Inc. (“DebtX Analytics”) to Stout in November 2024. Prior to the sale, Mr. Mercer served as the Chief Executive Officer of DebtX Analytics, a financial advisory firm, from December 2022 to November 2024. From May 2007 to December 2022, Mr. Mercer served in a number of different capacities at The Debt Exchange, Inc., a technology-enabled loan sales and trading business, including initially as the Managing Director, Trading and then as Executive Vice President, Valuation and Analytics, where he was responsible for the strategic and operational oversight of the Loan Valuations and Analytics department. From December 2003 to April 2007, Mr. Mercer held positions of increasing responsibility at Sun Life Assurance Company of Canada (“Sun Life”), an insurance company in Canada. Mr. Mercer started his career at PaineWebber & Co. (now UBS) before transitioning into the insurance industry in April 1999 at Sun Life where he worked until February 2002. Prior to his return to Sun Life in December 2003, Mr. Mercer worked at John Hancock Life
Insurance Company (U.S.A.), an insurance company based in Boston, as an Investment Officer. Mr. Mercer graduated from Harvard University in 1991 and is a CFA Charterholder.
We believe Mr. Mercer’s qualifications to serve on our Board of Directors include his over 20 years of experience in the financial services industry.
Robert C. Merton, Ph.D. is currently a director nominee and will become a member of our Board of Directors upon the completion of this offering. Dr. Merton currently serves as the School of Management Distinguished Professor of Finance at MIT Sloan School of Management, a position he has held since 2010. He also currently serves as the John and Natty McArthur University Professor Emeritus at Harvard University, a position he has held since 2010. Dr. Merton is also currently a resident scientist at Dimensional Holdings, Inc., a position he has held since 2010, where he created Target Retirement Solution, a global integrated retirement-funding solution system. From 1998 to 2010, Dr. Merton was a Professor at Harvard Business School. Dr. Merton also served as the J.C. Penney Professor of Management at MIT’s Sloan School of Management from 1970 to 1988. Throughout his career, Dr. Merton has received numerous accolades, including the Alfred Nobel Memorial Prize in Economic Sciences in 1997 for a new method to determine the value of derivatives, the inaugural Financial Engineer of the Year Award from the International Association for Quantitative Finance, and the Nicholas Molodovsky Award from the CFA Institute. Dr. Merton received Risk Magazine’s Lifetime Achievement Award for contributions to the field of risk management and the 2014 Lifetime Achievement Award from the Financial Intermediation Research Society. Dr. Merton received a Bachelor of Science in engineering mathematics from Columbia University, a Master of Science in applied mathematics from California Institute of Technology, a Ph.D. in economics from MIT, and honorary degrees from 18 universities.
We believe Dr. Merton’s qualifications to serve on our Board of Directors include his extensive leadership experience in finance and academia.
Mitchell Pressman is currently a director nominee and will become a member of our Board of Directors upon the completion of this offering. Mr. Pressman currently serves as Chief Financial Officer of the Investment Manager, a position he has held since January 2013. From February 2006 to December 2012, he was the Chief Financial Officer, a position that he also held from 2001 to 2003, and a Partner at Ivory Investment Management, L.P. (“Ivory Investment”), a long-short equity firm. In 2003, he joined Triage Management, LP (“Triage”), a distressed and special situation hedge fund, where he served as the Chief Financial Officer until he re-joined Ivory Investment in February 2006. Prior to Triage, Mr. Pressman worked at GPU Inc. from 1996 to 2000, where he served in financial roles, including as a divisional Finance Director. From 1993 to 1996, he served as a financial consultant for Arthur Andersen LLP, an accounting firm. Mr. Pressman started his career as an auditor and consultant with PricewaterhouseCoopers. Mr. Pressman graduated magna cum laude from the University of Miami with a B.B.A in accounting and finance in 1988 and received a Master’s degree in accounting from the University of Texas at Austin in 1989.
We believe Mr. Pressman’s qualifications to serve on our Board of Directors include his over 30 years experience in the investment and financial services industry.
John (Jack) L. Sennott, Jr. is currently a director nominee and will become a member of our Board of Directors upon the completion of this offering. Mr. Sennott currently serves on the board of directors of ALPS Corporation, a lawyer’s professional liability insurance company, a position he has held since May 2013. From July 2019 to September 2022, Mr. Sennott served as the Chairman, Chief Executive Officer, and President of CapSpecialty, Inc. (“CapSpecialty”), a specialty insurance provider, and contributed to significant growth and operational success at CapSpecialty. Before joining CapSpecialty, from April 2013 to June 2019, Mr. Sennott was the Senior Vice President and Chief Financial Officer at Alleghany Corporation (“Alleghany”), the parent company of CapSpecialty and a Fortune 500 investment holding company with interests in insurance, reinsurance, and industrial businesses. From October 2008 to April 2012, Mr. Sennott served as the Executive Vice President and Chief Corporate Strategy Officer at Allied World Assurance Company Holdings, Ltd., a global specialty insurance and reinsurance firm. Mr. Sennott also currently serves on the boards of directors of Hartford Stage and the Simsbury
Meadows Performing Arts Center, Connecticut-based nonprofit organizations that focus on the performing arts in Connecticut. Mr. Sennott graduated from the University of Massachusetts, Amherst with a B.B.A. in Accounting in 1987.
We believe Mr. Sennott’s qualifications to serve on our Board of Directors include his extensive business and leadership experience in the insurance industry.
Our executive officers are elected by, and serve at the discretion of, our Board of Directors. There are no family relationships between any of our executive officers or directors.
Board of directors
The Board of Directors is responsible for the oversight of management of the Company. Upon the consummation of this offering, our Board of Directors will consist of seven members.
Director independence and controlled company exemption
Following the completion of this offering, ZFSG will continue to beneficially own more than 50% of the voting power of our common stock. As a result, we will be considered a “controlled company” under the NYSE listing rules, which means that more than 50% of the power to vote our securities is held by an individual, a group, or another company. On this basis, we will be eligible to avail ourselves of the “controlled company” exemption under the corporate governance rules of the NYSE and therefore, we are not required to have a majority of “independent directors” on our board of directors or to have a compensation committee and a nominating and corporate governance committee composed entirely of independent directors. The “controlled company” exemption does not modify the independence requirements for the audit committee, and we intend to comply with the requirements of the Sarbanes-Oxley Act and the NYSE, which require that our audit committee be composed of at least three members, at least one of whom will be independent upon the listing of our common stock, a majority of whom will be independent within 90 days of listing, and each of whom will be independent within one year of listing. Our Board of Directors has determined that Tom Hulst, Robert C. Merton, John (Jack) L. Sennott, Jr., and William Mercer are independent within the meaning of the NYSE listing rules.
Committees of the board of directors
Upon the consummation of this offering, we will have one standing committee of the Board of Directors: the Audit Committee.
Audit committee
Our Audit Committee will consist of Tom Hulst, who will serve as the Chair of the Audit Committee, Robert C. Merton, John (Jack) L. Sennott, Jr., and William Mercer. Our Board of Directors has determined that each of Tom Hulst, Robert C. Merton, John (Jack) L. Sennott, Jr., and William Mercer qualifies as an independent director under the NYSE listing rules and Rule 10A-3 under the Exchange Act. Our Board of Directors has determined that qualifies as an “audit committee financial expert” as such term is defined in Item 407(d)(5) of Regulation S-K, and possesses financial sophistication as defined under the NYSE listing rules. The Audit Committee assists our Board of Directors in fulfilling its oversight responsibilities relating to, among other responsibilities:
•
the quality and integrity of our financial statements and our financial reporting process;
•
internal and external auditing and the independent registered public accounting firm’s qualifications and independence;
•
the performance of our internal audit function after it has been established and independent registered public accounting firm;
•
the integrity of our systems of internal accounting and financial controls; and
•
establishing procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters.
In so doing, the Audit Committee is responsible for maintaining free and open communication between the committee, our independent registered public accounting firm and our management. In this role, the Audit Committee is empowered to investigate any matter brought to its attention with full access to all books, records, facilities, and personnel of our Company and has the power to retain outside counsel or other experts for this purpose.
The Audit Committee has direct responsibility for the appointment, compensation, retention and oversight of our independent registered public accounting firm. The Audit Committee meets in executive session with the independent registered public accounting firm at least quarterly.
Code of business conduct and ethics
Upon completion of this offering, we will have a Code of Business Conduct and Ethics (the “Code of Conduct”) applicable to our directors, officers, and employees that complies with the requirements of applicable rules and regulations of the SEC and the NYSE. This code is designed to deter wrongdoing and to promote, among other matters:
•
honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
•
full, fair, accurate, timely and understandable disclosure in reports and documents that we file with, or submit to, the SEC and in other public communications made by us;
•
compliance with applicable governmental laws, rules, and regulations; and
•
prompt internal reporting to an appropriate person or persons identified in the Code of Conduct of violations of the Code of Conduct and accountability for adherence to the Code of Conduct.
Upon completion of this offering, our Code of Conduct will be available on the investor relations portion of our website.
We intend to post on our website all disclosures that are required by law or the NYSE rules concerning any amendments to, or waivers from, any provision of the Code of Conduct.
Executive and director compensation
This section discusses the material components of the executive compensation program for our executive officers who are named in the “2024 Summary Compensation Table” below. As an emerging growth company, we comply with the executive compensation disclosure rules applicable to “smaller reporting companies,” as such term is defined in the rules promulgated under the Securities Act, which require compensation disclosure for our principal executive officer, our two most highly compensated executive officers other than our principal executive officer. These officers are referred to as our “named executive officers.”
In 2024, our named executive officers and their positions were as follows:
•
Justin Cohen, Chief Executive Officer;
•
Chris Schenk, President and Chief Underwriting Officer; and
•
Neelam Patel, Chief Financial Officer.
This discussion may contain forward-looking statements that are based on our current plans, considerations, expectations, and determinations regarding future compensation programs. Actual compensation programs that we adopt following the completion of this offering may differ materially from the currently planned programs summarized in this discussion.
2024 Summary compensation table
The following table sets forth information concerning the compensation of our named executive officers for the year ended December 31, 2024.
|
Name and principal position
|
|
|
Year
|
|
|
Salary
($)
|
|
|
Bonus(1)
($)
|
|
|
Option
awards(2)
($)
|
|
|
All other
compensation(3)
($)
|
|
|
Total
($)
|
|
|
Justin Cohen Chief Executive Officer
|
|
|
|
|
2024 |
|
|
|
|
|
64,904 |
|
|
|
|
|
— |
|
|
|
|
|
3,400,408 |
|
|
|
|
|
— |
|
|
|
|
|
3,465,312 |
|
|
|
Chris Schenk President and Chief Underwriting Officer
|
|
|
|
|
2024 |
|
|
|
|
|
470,000 |
|
|
|
|
|
282,000 |
|
|
|
|
|
266,250 |
|
|
|
|
|
17,250 |
|
|
|
|
|
1,035,500 |
|
|
|
Neelam Patel(4) Chief Financial Officer
|
|
|
|
|
2024 |
|
|
|
|
|
107,805 |
|
|
|
|
|
575,000 |
|
|
|
|
|
200,000 |
|
|
|
|
|
9,135 |
|
|
|
|
|
891,940 |
|
|
(1) Amounts shown represent each named executive officer’s annual bonus earned with respect to fiscal year 2024. Refer to “—2024 Annual Bonuses” below for additional information regarding the Company’s annual bonuses. In addition, for Ms. Patel, amount includes a signing bonus in the amount of $75,000 which was subject to repayment by Ms. Patel in the event of her voluntary departure during the first 180 days following her start date.
(2) Amounts reflect the full grant date fair value of option awards granted during 2024 computed in accordance with ASC Topic 718, Compensation—Stock Compensation, or ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of option awards in Note 16 to the audited financial statements included in this prospectus.
(3) Amounts shown represent matching contributions under the Company’s 401(k) retirement plan.
(4) Ms. Patel’s employment with our company as Chief Financial Officer commenced on September 16, 2024.
Narrative to summary compensation table
2024 Annual base salaries
The named executive officers receive a base salary to compensate them for services rendered to our company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation and, except with respect to Mr. Cohen, was set at a level reflecting the executive’s skillset, experience, role, and responsibilities. The 2024 annual base salaries for our named executive officers were as follows:
|
Name
|
|
|
2024 Annual base salary
($)
|
|
|
Justin Cohen
|
|
|
|
$ |
65,000 |
|
|
|
Chris Schenk
|
|
|
|
$ |
470,000 |
|
|
|
Neelam Patel
|
|
|
|
$ |
400,000 |
|
|
Mr. Cohen’s base salary for 2024 was set at a nominal level with the intent that his 2024 compensation would be primarily delivered in the form of equity incentive compensation (as discussed below).
2024 Annual bonuses
For the fiscal year ended December 31, 2024, Mr. Schenk and Ms. Patel were eligible for an annual cash bonus, as determined by the Board. Mr. Schenk’s target bonus opportunity was equal to 60% of his annual base salary and Ms. Patel’s target bonus opportunity was equal to $500,000. Mr. Cohen was not eligible for an annual cash bonus for the fiscal year ended 2024.
Equity compensation
Our equity-based incentive awards are designed to align our interests and those of our equityholders with those of our employees, including our executive officers. The board of directors or an authorized committee thereof is responsible for approving equity grants.
Prior to this offering, we have granted options and restricted stock units to our employees pursuant to our Equity Incentive Plan, effective as of February 5, 2019 and most recently amended and restated effective as of December 8, 2024 (the “2019 Plan”). Following this offering, we expect to grant equity awards under the terms of our 2025 Incentive Award Plan (the “2025 Plan”). The terms of our equity plans are described under the subsection titled “—Equity Incentive Plans” below.
The following table sets forth the options granted to our named executive officers during 2024 under our 2019 Plan. These options have exercise prices that are not less than the per unit fair market value of our units on the date of grant, as determined by the board of directors. These options vest as described in the Outstanding Equity Awards at 2024 Fiscal Year-End table.
|
Name
|
|
|
2024 Options granted
(#)
|
|
|
Justin Cohen
|
|
|
|
|
27,097,710 |
|
|
|
Chris Schenk
|
|
|
|
|
10,125,000 |
|
|
|
Neelam Patel
|
|
|
|
|
1,000,000 |
|
|
The 2024 option award to Mr. Cohen represented approximately 6.62% of the company’s outstanding common units as of the date of grant and was granted to him as a one-time extraordinary award in respect of the services he has provided to our company since his commencement of employment. The 2024 option award formalizes and replaces ZFSG’s agreement to issue to Mr. Cohen stock-based awards in the form of 16,277,800 options to purchase Members’ units of the Company held by ZFSG subject to certain vesting conditions (as described below in the section entitled “—Certain relationships and related party transactions—CEO options”). The 2024 option award to Mr. Cohen contains certain restrictions on exercisability: no portion of the options may be exercised prior to the completion of this offering, and until the second anniversary of the completion of this offering, no portion of the options may be exercised unless the Board of Directors, in consultation with ZFSG, determines that such exercise would not cause ZFSG to cease to own at least 80% of the aggregate number of issued and outstanding units of our company as of the proposed exercise date. Options granted under the 2019 plan generally have a 10-year term, subject to customary post-termination exercise provisions under which the option will expire three to twelve months after termination of employment (depending on the circumstances of such termination). However, Mr. Cohen’s 2024 option award does not include such provisions for early expiration following termination of his employment, and, to the extent the option is vested as of the date of his termination (or vesting is
accelerated upon certain qualifying terminations of employment, pursuant to the terms of the award agreement), it will remain exercisable until the expiration of the 10-year term.
Outstanding equity awards at 2024 fiscal year-end
The following table summarizes the number of outstanding option awards for each named executive officer as of December 31, 2024. None of our named executive officers held restricted stock units as of December 31, 2024.
| |
|
|
|
|
|
|
|
|
Option awards(1)
|
|
|
Name
|
|
|
Grant date
|
|
|
Number of
securities
underlying
unexercised
options (#)
exercisable
|
|
|
Number of
securities
underlying
unexercised
options (#)
unexercisable
|
|
|
Equity
incentive
plan awards:
number of securities underlying unexercised unearned options (#)
|
|
|
Option
exercise
price
($)
|
|
|
Option
expiration
date
|
|
|
Justin Cohen
|
|
|
|
|
12/8/2024 |
|
|
|
|
|
16,258,626(2) |
|
|
|
|
|
10,839,084(2) |
|
|
|
|
|
|
|
|
|
|
$ |
0.88 |
|
|
|
|
|
12/8/2034 |
|
|
|
Chris Schenk
|
|
|
|
|
1/1/2022 |
|
|
|
|
|
62,500(3) |
|
|
|
|
|
93,750(3) |
|
|
|
|
|
|
|
|
|
|
$ |
1.00 |
|
|
|
|
|
1/1/2032 |
|
|
| |
|
|
|
|
1/1/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
468,750(4) |
|
|
|
|
$ |
1.00 |
|
|
|
|
|
1/1/2032 |
|
|
| |
|
|
|
|
1/1/2024 |
|
|
|
|
|
|
|
|
|
|
|
4,125,000(5) |
|
|
|
|
|
|
|
|
|
|
$ |
1.00 |
|
|
|
|
|
1/1/2034 |
|
|
| |
|
|
|
|
1/1/2024 |
|
|
|
|
|
|
|
|
|
|
|
3,000,000(6) |
|
|
|
|
|
|
|
|
|
|
$ |
2.00 |
|
|
|
|
|
1/1/2034 |
|
|
| |
|
|
|
|
1/1/2024 |
|
|
|
|
|
|
|
|
|
|
|
3,000,000(7) |
|
|
|
|
|
|
|
|
|
|
$ |
3.00 |
|
|
|
|
|
1/1/2034 |
|
|
|
Neelam Patel
|
|
|
|
|
12/8/2024 |
|
|
|
|
|
|
|
|
|
|
|
1,000,000(8) |
|
|
|
|
|
|
|
|
|
|
$ |
1.00 |
|
|
|
|
|
12/8/2034 |
|
|
(1) All awards were granted under our 2019 Plan.
(2) Represents an option to purchase 27,097,710 units of our company. The option was vested as to 60% of the underlying units upon grant. An additional 20% of the underlying units will vest on the first anniversary of the completion of this offering (or, in the event this offering does not occur on or prior to December 31, 2025, on the second anniversary of the grant date), and the remaining 20% of the underlying units will vest on the second anniversary of the completion of this offering (or, in the event this offering does not occur on or prior to December 31, 2025, on the third anniversary of the grant date), in each case, subject to Mr. Cohen’s continuous service through the applicable vesting date, provided that, any unvested portion of the option award shall accelerate if Mr. Cohen is terminated by the Company without “cause” or due to death or “disability” (each as defined in the option award agreement).
(3) Represents an option to purchase 156,250 units of our company. The option vests in five equal annual installments beginning on January 1, 2023, subject to Mr. Schenk’s continuous service through the applicable vesting date.
(4) Represents an option to purchase 468,750 units of our company. The option will become eligible to vest as to 50% of the underlying units on January 1, 2026 based on the satisfaction of performance criteria, as determined by the board of directors. The remaining 50% of the underlying units will become eligible to vest on January 1, 2027 based on the satisfaction of performance criteria, as determined by the board of directors. Vesting of the option is further subject to Mr. Schenk’s continuous service through the applicable vesting date.
(5) Represents an option to purchase 4,125,000 units of our company. The option vests in five equal annual installments beginning on January 1, 2025, subject to Mr. Schenk’s continuous service through the applicable vesting date.
(6) Represents an option to purchase 3,000,000 units of our company. The option vests in five equal annual installments beginning on January 1, 2025, subject to Mr. Schenk’s continuous service through the applicable vesting date.
(7) Represents an option to purchase 3,000,000 units of our company. The option vests in five equal annual installments beginning on January 1, 2025, subject to Mr. Schenk’s continuous service through the applicable vesting date.
(8) Represents an option to purchase 1,000,000 units of our company. The option vests in five equal annual installments beginning on December 8, 2025, subject to Ms. Patel’s continuous service through the applicable vesting date.
Executive compensation arrangements
The Company has entered into employment arrangements with each of Mr. Schenk and Ms. Patel, the material terms and conditions of which are described below. The Company is not currently a party to an employment agreement with Mr. Cohen. However, the Company intends to enter into an employment agreement with Mr. Cohen prior to the completion of this offering, the material terms of which will be summarized in subsequent submissions of this registration statement, and the employment agreement will be filed as an exhibit to the registration statement of which this prospectus forms a part, once such terms are finalized.
Chris Schenk
We have entered into a second amended and restated employment agreement (as amended and restated, the “Schenk Employment Agreement”) with Mr. Schenk pursuant to which he serves as our President and Chief Underwriting Officer. The Schenk Employment Agreement provides that, effective as of April 1, 2025, Mr. Schenk is entitled to an annual base salary of $550,000 and an annual target bonus opportunity of 100% of his annual base salary.
If Mr. Schenk is terminated by us without “cause” (as defined in the Schenk Employment Agreement), then, subject to his continued compliance with restrictive covenants to which he is subject and his timely execution and non-revocation of a release of claims in our favor, he is entitled to receive severance payments and benefits consisting of (i) 12 months of base salary continuation; (ii) any earned but unpaid bonus with respect to the calendar year prior to the year of termination; and (iii) a pro rata portion of his target bonus for the year of termination.
The Schenk Employment Agreement also contains a non-competition restriction that lasts for 12 months post-termination; provided, that the Company may reduce the length of such non-competition restriction in connection with a corresponding reduction to the base salary continuation provided as severance (but may not reduce it below 3 months), a non-solicitation restriction that lasts for 18 months post-termination, and standard confidentiality restrictions and provisions related to intellectual property protection.
Neelam Patel
We have entered into an employment agreement (the “Patel Employment Agreement”) with Ms. Patel pursuant to which she serves as our Chief Financial Officer. In addition to providing for an annual target bonus opportunity of $500,000, the Patel Employment Agreement provides for an option award with respect to 1,000,000 units in the Company (which was granted to her in 2024) and a one-time signing bonus of $75,000, which was subject to repayment by Ms. Patel in the event of her voluntary departure during the first 180 days following her start date.
If Ms. Patel is terminated by us without “cause” (as defined in the Patel Employment Agreement), then, subject to her continued compliance with restrictive covenants to which she is subject and her timely execution and non-revocation of a release of claims in our favor, Ms. Patel is entitled to receive severance payments and benefits consisting of (i) 6 months of base salary continuation; (ii) any earned but unpaid bonus with respect to the calendar year prior to the year of termination; (iii) a pro rata portion of her target bonus for the year of termination; and (iv) 6 months of subsidized COBRA coverage. In the event of Ms. Patel’s death prior to the end of her employment term (which is automatically extended for successive one year periods following completion of the initial two-year term unless 60 days’ notice is given), Ms. Patel’s estate will receive the payments set forth in (ii) and (iii) above, subject to the estate’s execution and non-revocation of a release of claims in our favor.
The Patel Employment Agreement also contains a non-competition restriction that lasts for 6 months post-termination; provided, that the Company may reduce the length of such non-competition restriction in connection with a corresponding reduction to the base salary continuation provided as severance (but may not reduce it below 3 months), a non-solicitation restriction that lasts for 24 months post-termination, and standard confidentiality restrictions and provisions related to intellectual property protection.
Other elements of compensation
Retirement plans
We currently maintain a 401(k) retirement savings plan for our employees, including our named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time employees. The Internal Revenue Code allows eligible employees to defer a portion of their compensation, within prescribed limits, on a pre-tax basis through contributions to the 401(k) plan. Currently, we match 100% of contributions made by participants in the 401(k)
plan up to 5% of eligible compensation. We believe that providing a vehicle for tax-deferred retirement savings though our 401(k) plan, and making matching contributions, adds to the overall desirability of our executive compensation package and further incentivizes our employees, including our named executive officers, in accordance with our compensation policies.
Employee benefits
During their employment, our named executive officers are eligible to participate in our employee benefit plans and programs, including medical and dental benefits, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans.
Clawback policy
We will adopt a compensation recovery policy to be effective upon the closing of this offering that is compliant with the New York Stock Exchange, as required by the Dodd-Frank Act and applicable regulations thereunder.
Equity incentive plans
2025 Incentive award plan
In connection with this offering, we intend to adopt the 2025 Plan, subject to approval by our stockholders, under which we may grant cash and equity incentive awards to eligible service providers in order to attract, motivate, and retain the talent for which we compete. The material terms of the 2025 Plan, as it is currently contemplated, are summarized below. Our board of directors is still in the process of developing, approving, and implementing the 2025 Plan and, accordingly, this summary is subject to change.
Eligibility and administration. Our employees, consultants, and directors, and employees and consultants of our subsidiaries will be eligible to receive awards under the 2025 Plan. The 2025 Plan will be administered by our board of directors with respect to awards to non-employee directors and by our compensation committee with respect to other participants, each of which may delegate its duties and responsibilities to committees of our directors and/or officers (referred to collectively as the plan administrator below), subject to certain limitations that may be imposed under Section 16 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, stock exchange rules, and/or other applicable laws. The plan administrator will have the authority to make all determinations and interpretations under, prescribe all forms for use with, and adopt rules for the administration of, the 2025 Plan, subject to its express terms and conditions. The plan administrator will also set the terms and conditions of all awards under the 2025 Plan, including any vesting and vesting acceleration conditions.
Limitation on awards and shares available. An aggregate of shares of our common stock will initially be available for issuance under the 2025 Plan. No more than shares of common stock may be issued upon the exercise of incentive stock options. Shares issued under the 2025 Plan may be authorized but unissued shares, or shares purchased in the open market.
If an award under the 2025 Plan is forfeited, expires, lapses, or is terminated, exchanged, surrendered, repurchased, cancelled without having been fully exercised, or settled for cash, any shares subject to such award may, to the extent of such forfeiture, expiration, or cash settlement, be used again for new grants under the 2025 Plan. Awards granted under the 2025 Plan upon the assumption of, or in substitution for, awards authorized or outstanding under a qualifying equity plan maintained by an entity with which we enter into a merger or similar corporate transaction will not reduce the shares available for grant under the 2025 Plan, but may count against the maximum number of shares that may be issued upon the exercise of incentive stock options, or ISOs.
Awards. The 2025 Plan provides for the grant of stock options, including ISOs and nonqualified stock options, or NSOs, stock appreciation rights, or SARs, restricted stock, dividend equivalents, restricted stock units, or RSUs, and other stock or cash based awards. Certain awards under the 2025 Plan may constitute or provide for payment of “nonqualified deferred compensation” under Section 409A of the Code. All awards under the 2025 Plan will
be set forth in award agreements, which will detail the terms and conditions of awards, including any applicable vesting and payment terms and post-termination exercise limitations. A brief description of each award type follows.
•
Stock options and SARs. Stock options provide for the purchase of shares of our common stock in the future. ISOs, by contrast to NSOs, may provide tax deferral beyond exercise and favorable capital gains tax treatment to their holders if certain holding period and other requirements of the Code are satisfied. SARs entitle their holder, upon exercise, to receive from us an amount equal to the appreciation of the shares subject to the award between the grant date and the exercise date. The plan administrator will determine the number of shares covered by each option and SAR, the exercise price of each option and SAR and the conditions and limitations applicable to the exercise of each option and SAR. The exercise price of a stock option or SAR will not be less than 100% of the fair market value of the underlying share on the grant date, unless otherwise determined by the plan administrator and except with respect to certain substitute awards granted in connection with a corporate transaction. Unless otherwise determined by the plan administrator, the term of a stock option or SAR may not be longer than ten years. Notwithstanding the foregoing, ISOs granted to certain significant stockholders will have an exercise price no less than 110% of the fair market value of the underlying share on the grant date and a term no longer than five years.
•
Restricted stock and RSUs. Restricted stock is an award of nontransferable shares of our common stock that remain forfeitable unless and until specified conditions are met and which may be subject to a purchase price. RSUs are contractual promises to deliver shares of our common stock in the future, which may also remain forfeitable unless and until specified conditions are met and may be accompanied by the right to receive the equivalent value of dividends paid on shares of our common stock prior to the delivery of the underlying shares. The plan administrator may provide that the delivery of the shares underlying RSUs will be deferred on a mandatory basis or at the election of the participant. The terms and conditions applicable to restricted stock and RSUs will be determined by the plan administrator, subject to the conditions and limitations contained in the 2025 Plan.
•
Other stock or cash based awards. Other stock or cash based awards are awards of cash, fully vested shares of our common stock and other awards valued wholly or partially by referring to, or otherwise based on, shares of our common stock or other property. Other stock or cash based awards may be granted to participants and may also be available as a payment form in the settlement of other awards, as standalone payments and as payment in lieu of compensation to which a participant is otherwise entitled. The plan administrator will determine the terms and conditions of other stock or cash based awards, which may include any purchase price, performance goal, transfer restrictions, and vesting conditions.
Performance criteria. The plan administrator may select performance criteria for an award to establish performance goals for a performance period. Performance criteria under the 2025 Plan may include, but are not limited to, the following: net earnings or losses (either before or after one or more of interest, taxes, depreciation, amortization, and non-cash equity-based compensation expense); gross or net sales or revenue or sales or revenue growth; net income (either before or after taxes) or adjusted net income; profits (including but not limited to gross profits, net profits, profit growth, net operation profit, or economic profit), profit return ratios or operating margin; budget or operating earnings (either before or after taxes or before or after allocation of corporate overhead and bonus); cash flow (including operating cash flow and free cash flow or cash flow return on capital); return on assets; return on capital or invested capital; cost of capital; return on stockholders’ equity; total stockholder return; return on sales; costs, reductions in costs, and cost control measures; expenses; working capital; earnings or loss per share; adjusted earnings or loss per share; price per share or dividends per share (or appreciation in, or maintenance of, such price or dividends); regulatory achievements or compliance; implementation, completion, or attainment of objectives relating to research, development, regulatory, commercial, or strategic milestones or developments; market share; economic value or economic value added models; division, group, or corporate financial goals; customer satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation and other legal matters; strategic partnerships and transactions; financial ratios (including those measuring liquidity, activity, profitability, or leverage); debt levels or reductions; sales-related goals; financing and other capital raising transactions; cash on hand; acquisition activity; investment sourcing activity; and marketing
initiatives, any of which may be measured in absolute terms or as compared to any incremental increase or decrease. Such performance goals also may be based solely by reference to the company’s performance or the performance of a subsidiary, division, business segment, or business unit of the company or a subsidiary, or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. When determining performance goals, the plan administrator may provide for exclusion of the impact of an event or occurrence which the plan administrator determines should appropriately be excluded, including, without limitation, non-recurring charges or events, acquisitions or divestitures, changes in the corporate or capital structure, events unrelated to the business or outside of the control of management, foreign exchange considerations, and legal, regulatory, tax, or accounting changes.
Certain transactions. In connection with certain corporate transactions and events affecting our common stock, including a change in control, or change in any applicable laws or accounting principles, the plan administrator has broad discretion to take action under the 2025 Plan to prevent the dilution or enlargement of intended benefits, facilitate the transaction or event or give effect to the change in applicable laws or accounting principles. This includes canceling awards for cash or property, accelerating the vesting of awards, providing for the assumption or substitution of awards by a successor entity, adjusting the number and type of shares subject to outstanding awards and/or with respect to which awards may be granted under the 2025 Plan, and replacing or terminating awards under the 2025 Plan. In addition, in the event of certain non-reciprocal transactions with our stockholders, the plan administrator will make equitable adjustments to awards outstanding under the 2025 Plan as it deems appropriate to reflect the transaction. In the event of a change in control (as defined in the 2025 Plan), to the extent that the surviving entity declines to continue, convert, assume, or replace outstanding awards, then all such awards may become fully vested and exercisable in connection with the transaction. Individual award agreements may provide for additional accelerated vesting and payment provisions.
Provisions of the 2025 Plan relating to director compensation. The 2025 Plan provides that the plan administrator may establish compensation for non-employee directors from time to time subject to the 2025 Plan’s limitations. In connection with this offering, we intend to approve and implement a compensation program for our non-employee directors. Our board of directors or its authorized committee may modify the non-employee director compensation program from time to time in the exercise of its business judgment, taking into account such factors, circumstances and considerations as it shall deem relevant from time to time, provided that the sum of any cash compensation or other compensation and the grant date fair value of any equity awards granted under the 2025 Plan as compensation for services as a non-employee director during any fiscal year may not exceed $ in the fiscal year of the non-employee director’s initial service and $ in any other fiscal year. The plan administrator may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the plan administrator may determine in its discretion, subject to the limitations in the 2025 Plan.
Foreign participants, claw-back provisions, transferability, and participant payments. The plan administrator may modify awards granted to participants who are foreign nationals or employed outside the United States or establish subplans or procedures to address differences in laws, rules, regulations, or customs of such foreign jurisdictions. All awards will be subject to any company claw-back policy as set forth in such claw-back policy or the applicable award agreement. Except as the plan administrator may determine or provide in an award agreement, awards under the 2025 Plan are generally non-transferrable, except by will or the laws of descent and distribution, or, subject to the plan administrator’s consent, pursuant to a domestic relations order, and are generally exercisable only by the participant. With regard to tax withholding obligations arising in connection with awards under the 2025 Plan and exercise price obligations arising in connection with the exercise of stock options under the 2025 Plan, the plan administrator may, in its discretion, accept cash, wire transfer, or check, shares of our common stock that meet specified conditions, a promissory note, a “market sell order,” such other consideration as the plan administrator deems suitable or any combination of the foregoing.
Plan amendment and termination. Our board of directors may amend or terminate the 2025 Plan at any time; however, no amendment, other than an amendment that increases the number of shares available under the 2025
Plan, may materially and adversely affect an award outstanding under the 2025 Plan without the consent of the affected participant and stockholder approval will be obtained for any amendment to the extent necessary to comply with applicable laws. Further, the plan administrator may, without the approval of our stockholders, amend any outstanding stock option or SAR to reduce its price per share. The 2025 Plan will remain in effect until the tenth anniversary of its effective date, unless earlier terminated by our board of directors. No awards may be granted under the 2025 Plan after its termination.
2019 Plan
Our board of managers has approved our 2019 Plan, under which we may grant options, restricted units, and other unit-based awards to employees, directors, and consultants of our company or its subsidiaries. We have reserved a total of 50,000,000 units for issuance under the 2019 Plan.
Following the effectiveness of the 2025 Plan, we will not make any further grants under the 2019 Plan. However, the 2019 Plan will continue to govern the terms and conditions of the outstanding awards granted under it. Units subject to awards granted under the 2019 Plan that are forfeited, lapse unexercised, or are settled in cash and which following the effective date of the 2025 Plan are not issued under the 2019 Plan will be available for issuance under the 2025 Plan. As of December 31, 2024, a total of 46,785,154 units were subject to outstanding options granted under the 2019 Plan and a total of 33,400 restricted units were outstanding under the 2019 Plan.
Eligibility and administration. Our employees, officers, and directors, along with consultants to the Company, are eligible to receive awards under the 2019 Plan. Our board of managers or a committee thereof is authorized to administer the 2019 Plan. Subject to the express terms and conditions of the 2019 Plan, the plan administrator has the authority to make all determinations and interpretations under the plan, prescribe all forms for use with the plan, and adopt, amend, and repeal rules, guidance, and practices for the administration of the 2019 Plan. Our board may delegate to one or more designated individuals or committees of our board. The plan administrator also sets the terms and conditions of all awards under the plan, including any vesting and vesting acceleration conditions.
Awards. The 2019 Plan provides for the grant of options, restricted units and other unit-based awards. Options granted under the 2019 Plan may only be exercised using a “net exercise” arrangement that reduces the number of units issued to the optionee by the largest whole number of units with fair market value equal to the aggregate exercise price and, unless otherwise determined by the plan administrator, the required tax withholding that arises on exercise.
Certain transactions. The plan administrator has broad discretion to adjust the provisions of the 2019 Plan and the terms and conditions of existing and future awards, including with respect to the aggregate number and kind of units or other equity securities subject to the 2019 Plan and awards granted pursuant to the 2019 Plan and the purchase or exercise price of awards granted pursuant to the 2019 Plan, in order to prevent substantial dilution or enlargement of the rights of participants under the 2019 Plan in the event of certain transactions and events affecting our equity securities, such as a reorganization, merger, consolidation, combination, repurchase, recapitalization, liquidation, dissolution, or sale, transfer, exchange, or other disposition of assets of the Company, or sale or exchange of the Company’s units or other securities of the Company, issuance of warrants, or other rights to purchase units of the Company or other securities of the Company. The plan administrator may also provide for the assumption, substitution, acceleration, replacement, or cash-out of awards in the event of the transactions mentioned above.
Amendment and termination. Our board of managers may suspend or terminate the 2019 Plan at any time and from time to time. Furthermore, we must generally obtain member approval to the extent required by applicable law, rule, or regulation.
2024 Director compensation table
Mr. Zimmer did not receive any compensation from us for 2024 for his service as a director.
Mr. Hulst receives annual cash compensation in the amount of $65,000 (plus reimbursement of expenses) for his service on our Board of Directors.
The table below shows all compensation to our non-employee directors for the year ended December 31, 2024.
|
Name
|
|
|
Fees earned
or paid in cash
($)
|
|
|
Option
awards
($)(1)
|
|
|
All other
compensation
($)(2)
|
|
|
Total
($)
|
|
|
Tom Hulst
|
|
|
|
|
65,000 |
|
|
|
|
|
30,000 |
|
|
|
|
|
5,362 |
|
|
|
|
|
100,362 |
|
|
(1) Amounts reflect the full grant date fair value of an option award granted during 2024 computed in accordance with ASC Topic 718, Compensation—Stock Compensation, or ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of option awards in Note 16 to the audited financial statements included in this prospectus. As of December 31, 2024, Mr. Hulst held an option to purchase 150,000 units of our company, which option vests in three equal annual installments beginning on December 8, 2025, subject to Mr. Hulst’s continuous service through the applicable vesting date. As of December 31, 2024, Mr. Hulst did not hold any stock awards.
(2) Consists of travel expenses paid by the Company.
Post-IPO director compensation program
In connection with this offering, we intend to adopt and ask our members to approve a compensation program for our non-employee directors that consists of annual retainer fees and long-term equity awards. The material terms of this program will be described in this prospectus once they are finalized.
Certain relationships and related party transactions
In addition to the director and executive officer compensation arrangements discussed above under “Management” and “Executive and director compensation” the following is a description of transactions since January 1, 2022, to which we have been a party in which the amount involved exceeded or will exceed $120,000 and in which any of our directors, executive officers, beneficial owners of more than 5% of our common stock, or their immediate family members or entities affiliated with them, had or will have a direct or indirect material interest.
Relationship with ZFSG
As described in more detail below, we have a strategic relationship with ZFSG, which has control over our units of members’ equity and whose affiliate, the Investment Manager, acts as the investment manager for a number of our investment portfolios. In particular, Stuart J. Zimmer, the Chair of our Board of Directors, is the Chief Executive Officer and founder of ZFSG and the Investment Manager, and Mitchell Pressman, a member of our Board of Directors, is the Chief Financial Officer of ZFSG and the Investment Manager. In addition, Justin Cohen, our Chief Executive Officer and a member of our board of directors, is an employee of the Investment Manager and serves as a member of or observer on the boards of managers of certain ZFSG affiliates, including the board of directors of ZIS, and will receive customary compensation in connection therewith. Mr. Cohen previously served as a director of Carrick Specialty Holdings LLC, prior to its sale by ZFSG on December 27, 2023, as described further below.
Historical shared overhead
Employee services
From time to time, employees of ZFSG subsidiaries have provided services to us in connection with the development of our business and we have not historically had formal arrangements relating to such services outside of the Management & Cost Sharing Agreement, effective September 30, 2023, with ZIS, a wholly owned subsidiary of ZFSG (the “MCSA”). We intend to enter into a Shared Services Agreement with ZFSG prior to this offering relating to certain services and other matters as described below under “—Shared Services Agreement.”
Use of New York City office space
The Investment Manager has provided us and our employees with ad-hoc access to and use of its office spaces in New York City at no cost. Following this offering, use of such facilities will be subject to the terms of the Shared Services Agreement described below under “—Shared Services Agreement.”
Management & Cost Sharing Agreement
Pursuant to the MCSA, ZIS makes available to us certain personnel and services of ZIS. We agree in the MCSA to contribute to the operating costs and expenses of ZIS in proportion and to the extent to which we and our respective subsidiaries make use of the services therein, as invoiced to us by ZIS. We also agree that assets may be transferred between us and ZIS upon the payment of the fair market value for such assets, as determined by us. The MCSA can be terminated for any reason upon ninety days’ notice or, in the event of a breach of the MCSA, at the end of a written 30-day notice and cure period if the breach has not been cured. The MCSA can also be terminated immediately in the event of a regulatory requirement by the Delaware Insurance Commissioner. In the MCSA, ZIS provides certain indemnities to us and our employees and affiliates. In the year ended December 31, 2024, $0.8 million was paid to ZIS pursuant to the MCSA. During 2024, certain corporate and shared service functions were provided by ZIS and the Investment Manager. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated on a pro rata basis based on measures considered to be a reasonable reflection of the historical utilization levels of these services. For each of the years ended December 31, 2024 and 2023, we recorded $0.8 million and $0.5 million, respectively, of such allocated expense recognized in compensation and benefits expenses in the consolidated statements of operations.
Shared Services Agreement
Prior to this offering, we intend to enter into a Shared Services Agreement with ZFSG (the “Shared Services Agreement”) pursuant to which ZFSG will provide us with certain services, including but not limited to, human resources, tax, legal and corporate secretary, transaction advisory, information technology, internal audit, investment accounting, investor relations and actuarial services. The Shared Services Agreement will provide that ZFSG will be reimbursed on a quarterly basis for such services on a “cost plus” basis, including pursuant to allocation methodologies to be specified therein. We will also reimburse ZFSG for its allocable share of any reasonable, documented out-of-pocket expenses that are actually incurred by ZFSG in the course of performing the services under the Shared Services Agreement. The Shared Services Agreement will also permit us to make use from time to time of its office space and facilities at 9 West 57th Street, New York, New York. The term of this Services Agreement shall be for a period of five years, and will automatically renew for two-year periods thereafter unless either party provides the other party with 90 days’ written notice before expiration of its intention not to renew. If either party is in material breach of the Shared Services Agreement, the other party may terminate at the end of a written 30-day period if such breach has not been cured. Notwithstanding the foregoing, the Shared Services Agreement shall be automatically terminated if ZFSG ceases to be our affiliate unless ZFSG provides prior written notice waiving such automatic termination.
Employee matters
Dual employment arrangements
Certain of our employees are or were also employees of ZFSG affiliates. Although these individuals dedicate substantially all of their time to our business and activities, they are or were dual employees of both ZFSG affiliates and of ours, and as a result, may continue to engage in employment activities for ZFSG affiliates. Each of Justin Cohen, our Chief Executive Officer, and David Rosenzweig, our former Chief Financial Officer are or were also employees of the Investment Manager. Mr. Cohen entered into an employment agreement with the Investment Manager on February 4, 2020, which is expected to be terminated on or prior to this offering. Justin Cohen will receive a termination payment from the Investment Manager of $ in connection with such termination. Justin Cohen has received compensation from the Investment Manager in his role as an employee of the Investment Manager. Such compensation was determined not to be allocable to services Mr. Cohen provided to Ategrity for the year ended December 31, 2024.
Consulting agreements
On December 28, 2022, ZFSG entered into a consulting agreement with our President, Chris Schenk, pursuant to which Mr. Schenk agreed to provide certain consulting services to ZFSG for matters unrelated to the Company. In the year ended December 31, 2023, ZFSG paid Mr. Schenk $519,000 in full and complete payment for such services.
On March 3, 2022, ZFSG entered into a consulting agreement with an entity owned by our former Chief Executive Officer, Michael Miller, pursuant to which such entity agreed to provide certain consulting services to ZFSG for matters unrelated to the Company. In the year ended December 31, 2022, ZFSG paid such entity $1,092,000 in full and complete payment for such services.
ZFSG is expected to enter into a consulting agreement with our Chief Executive Officer, Justin Cohen, related to services Mr. Cohen has provided to a subsidiary of ZFSG unrelated to the Company. Pursuant to the consulting agreement, Mr. Cohen will receive consulting fees in connection with such services. No payments have been received for such consulting services prior to the date hereof.
CEO Options
As part of Mr. Cohen’s compensation as Chief Executive Officer, and solely for the services provided by him in such capacity, ZFSG agreed to issue to Mr. Cohen stock-based awards in the form of 16,277,800 options to purchase Members’ units of the Company held by ZFSG subject to certain vesting conditions. The terms of the CEO
Options were agreed in February 2022, which terms included a contractual term of 10 years and a four-year vesting period. On December 8, 2024, this agreement was replaced by the 2024 option awards described in the section entitled “ — Executive and director Compensation — Equity compensation.”
Health insurance
Starting on October 1, 2024, our employees participate in a self-insured healthcare plan sponsored by ZIS. ZIS provides insurance to our employees pursuant to such plan and other ancillary benefits. Ategrity Specialty made contributions of $1.6 million toward the employer portion of insurance premiums for the benefit of its employees in the year ended December 31, 2024.
Scottsdale, Arizona office sublease
We lease approximately 23,490 square feet of office space in Scottsdale, Arizona from an unrelated third party pursuant to a lease that expires in 2028. On July 1, 2022, we entered into a Sublease Agreement with ZFSG whereby ZFSG subleases such office space from us. Per the terms of the Sublease Agreement, we continue to utilize a portion of the leased premises. The base rent under the sublease is equal to the rent we pay under the headlease, and the sublease terminates on the same date as the headlease. We received and recorded sublease fees from ZFSG of $0.7 million, $0.7 million, and $0.3 million in each of the years ended December 31, 2024, 2023, and 2022, respectively.
Capital structure
LLC Agreement
Our unitholders entered into the Amended and Restated Limited Liability Company Agreement, dated April 1, 2018 (the “LLC Agreement”), which governs our operations. The LLC Agreement will be terminated in connection with the Corporate Conversion. Only certain limited indemnification, exculpation, and confidentiality provisions of the LLC Agreement will survive such termination thereof. The LLC Agreement provides that our Board of Managers have the power and discretion to manage and control our business and affairs and contains certain customary indemnification provisions.
Capital contributions and withdrawals
In September 2022, ZFSG made a non-cash contribution to us of $75.0 million in the form of an in-kind contribution of an interest in the Utility Limited Partnership and received 95,724,314 of our units for such contribution.
In October 2023, ZFSG made a cash contribution of $35.0 million to us and received 44,164,038 of our units for such contribution.
In October 2024, ZFSG made an in-kind contribution of $22.2 million in principal amount of U.S. Treasury Notes with a fair market value of $20.1 million to us and received (i) 23,022,550 of our units, (ii) 11,511,275 warrants to purchase our units with an exercise price of $3.00 per unit (“Tranche 1 Warrants”), and (iii) 4,000,000 warrants to purchase our units with an exercise price of $2.00 per unit (“Tranche 2 Warrants” and, together with the Tranche 1 Warrants, the “Warrants”) for such contribution. Such underlying units and exercise prices of the Warrants are subject to customary anti-dilution adjustments set forth in each warrant certificate relating thereto. ZFSG is entitled to exercise the Warrants for a term of ten years starting from October 2024 by paying the exercise price in cash or on a cashless basis.
In January 2025, ZFSG made an in-kind contribution of $20.0 million in principal amount of U.S. Treasury Notes with a fair market value of $20.0 million to us and received 21,436,227 of our units.
The Utility General Partner withdrew $6.9 million, $3.1 million, and $3.9 million from its capital account at the Utility Limited Partnership in each of the years ended December 31, 2024, 2023, and 2022, respectively. Such withdrawals were made out of the Utility General Partner’s earnings from the Utility Limited Partnership.
Tax Allocation Agreement
We have historically been included in the consolidated federal income tax return of ZFSG. On April 1, 2018, we, Ategrity Specialty and Ategrity Ltd entered into a Tax Allocation Agreement with ZFSG (the “Tax Agreement”) which governs the allocation of consolidated tax liability among the parties to the agreement, the reimbursement of ZFSG for payments of such liabilities, the compensation of affiliated companies of ZFSG for the use of its tax attributes and the allocation of refunds or subsequent adjustments to tax liabilities. We and our subsidiaries received a net amount of $0.9 million, $3.7 million, and $0.5 million in tax sharing payments in cash to ZFSG pursuant to the Tax Agreement, in the years ended December 31, 2024, 2023, and 2022, respectively. Amounts receivable from (payable to) ZFSG pursuant to the Tax Agreement were $(26.5) million, ($8.9 million), and $4.3 million in the years ended December 31, 2024, 2023, and 2022, respectively.
Investment management
Utility & Infrastructure Investments
Utility Limited Partnership Agreement
On April 1, 2018, we entered into the Amended and Restated Limited Partnership Agreement (the “Utility Limited Partnership Agreement”) of the Utility Limited Partnership. The Utility Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the Utility Limited Partnership invests substantially all of its assets in the Absolute Return Utility & Infrastructure Fund. The Utility General Partner is responsible for the investment decisions of the Utility Limited Partnership. The Investment Manager, an affiliate of ZFSG, is the investment manager of the Absolute Return Utility & Infrastructure Fund and the Utility Limited Partnership.
Utility General Partner, an affiliate of ZFSG, is the general partner of the Utility Limited Partnership and is responsible for the investment decisions of the Utility Limited Partnership, including the appointment of the investment manager of the Utility Limited Partnership. The Utility General Partner owned less than 0.2% of the Utility Limited Partnership as of December 31, 2024.
Under the terms of the Utility Limited Partnership Agreement, the Utility General Partner is entitled to an incentive fee allocation equal to 20% of the Utility Limited Partnership’s net profits (the “Incentive Fee”). Such Incentive Fee is subject to a cap in any given year of the excess of 20% of the Utility Limited Partnership’s net profits less the sum of all of the Utility Limited Partnership’s prior year net losses that were not subsequently offset by prior net year profits, as adjusted for withdrawals. The Incentive Fee for the Utility Limited Partnership was $6.8 million, $0.1 million, and $2.8 million for the years ended December 31, 2024, 2023, and 2022, respectively.
Under the terms of the Utility Limited Partnership Agreement, the Utility Limited Partnership is responsible for paying certain fund expenses.
Pursuant to the Utility Limited Partnership Agreement, the Utility Limited Partnership has a quarterly liquidity option at the end of the quarter upon 45 days written notice:
•
to the extent required to pay insurance claims, but only to the extent other funds are not available for such purpose;
•
to the extent required to pay for reasonable operating expenses as may be determined by the board of directors but only to the extent other funds are not available for such purpose;
•
in the event we receive a notification from A.M. Best that such withdrawal is required to maintain our financial strength rating of at least A-, or
in the event we are required to diversify assets pursuant to a law, order, or regulation. The Utility General Partner may withdraw all or a portion of its capital account at any time.
Utility Limited Partnership IMA
The Utility Limited Partnership entered into an Investment Management Agreement, dated April 1, 2018 (the “Utility Limited Partnership IMA”) with the Investment Manager, pursuant to which the Utility General Partner
appointed the Investment Manager to manage its assets and granted the Investment Manager the full and exclusive authority and discretion to effect investment transactions through the portfolio, subject to the Investment Guidelines set forth therein. The Investment Manager is paid a quarterly fixed fee of 50 basis points (i.e., 0.5%) per quarter of the balance of each limited partner’s capital account (the “Fixed Fee”). The Fixed Fee for the Utility Limited Partnership was $5.2 million, $4.9 million, and $4.2 million for the years ended December 31, 2024, 2023, and 2022, respectively.
The Utility Limited Partnership IMA will remain in effect until April 1, 2026, subject to automatic renewal for additional successive three-year periods and may be terminated by any party thereto upon sixty (60) days’ prior written notice to the end of the initial term or the end of any automatic renewal date.
Pursuant to the Utility Limited Partnership IMA, the Utility Limited Partnership will exculpate, indemnify, and hold harmless the Investment Manager and certain of its affiliates, except to the extent arising from losses caused by such indemnified party’s gross negligence or willful malfeasance.
MidCap Limited Partnership Agreement
On January 1, 2025, we entered into the Amended and Restated Limited Partnership Agreement (the “MidCap Limited Partnership Agreement”) of the MidCap Limited Partnership. The MidCap Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the MidCap Limited Partnership invests substantially all of its assets in the Absolute Return MidCap Fund.
MidCap General Partner, an affiliate of ZFSG, is the general partner of the MidCap Limited Partnership and is responsible for the investment decisions of the MidCap Limited Partnership, including the appointment of the investment manager of the MidCap Limited Partnership. The Investment Manager, an affiliate of ZFSG, is the investment manager of the Absolute Return MidCap Fund and the MidCap Limited Partnership.
Under the terms of the MidCap Limited Partnership Agreement, the MidCap General Partner is entitled to an incentive fee allocation equal to 20% of the MidCap Limited Partnership’s net profits (the “Incentive Fee”). Such Incentive Fee is subject to a cap in any given year of the excess of 20% of the MidCap Limited Partnership’s net profits less the sum of all of the MidCap Limited Partnership’s prior year net losses that were not subsequently offset by prior net year profits, as adjusted for withdrawals. Such Incentive Fee increases to 30% of the MidCap Limited Partnership’s net profits above a 15% annualized return hurdle.
Under the terms of the MidCap Limited Partnership Agreement, the MidCap Limited Partnership is responsible for paying certain fund expenses.
Pursuant to the MidCap Limited Partnership Agreement, we are permitted to redeem 25% of our capital in the MidCap Limited Partnership at the end of a quarter upon 75 days’ notice. After such redemption, we may withdraw the remainder of our capital in equal installments for successive calendar quarters upon at least 75 days’ notice. A withdrawal made prior to the last business day of the third full calendar quarter occurring on or after the day immediately preceding the date on which our capital contribution was made will be subject to a withdrawal reduction of 3.75% of the gross withdrawal proceeds attributable to such capital.
The MidCap General Partner may withdraw all or a portion of its capital account at any time.
MidCap Limited Partnership IMA
The MidCap Limited Partnership entered into an Investment Management Agreement, dated April 1, 2020 (the “MidCap Limited Partnership IMA”) with the Investment Manager, pursuant to which the MidCap General Partner appointed the Investment Manager to manage its assets and granted the Investment Manager the full and exclusive authority and discretion to effect investment transactions through the portfolio, subject to the Investment Guidelines set forth therein. The Investment Manager is paid a quarterly fixed fee computed at an annual rate of 2.0% (i.e., 0.5% per quarter) of the balance of the capital account of each feeder fund (the “Fixed Fee”).
The MidCap Limited Partnership IMA has a one-year term ending on December 31 of each calendar year, is subject to automatic renewal for additional successive one-year periods and may be terminated by any party thereto upon sixty (60) days’ prior written notice to the end of any automatic renewal date.
Pursuant to the MidCap Limited Partnership IMA, the MidCap Limited Partnership will exculpate, indemnify, and hold harmless the Investment Manager and certain of its affiliates, except to the extent arising from losses caused by such indemnified party’s gross negligence or willful malfeasance.
Fixed income investment management agreements
Ategrity Ltd IMA
Ategrity Ltd entered into an Amended & Restated Investment Management Agreement, dated October 1, 2024 (as amended, the “Ategrity Ltd IMA”) with the Investment Manager, pursuant to which Ategrity Ltd appointed the Investment Manager to manage a portfolio of assets and granted the Investment Manager the full and exclusive authority and discretion to effect investment transactions through the portfolio, subject to the Investment Guidelines set forth therein. Ategrity Ltd IMA will remain in effect until December 31, 2027, subject to automatic renewal for additional successive three year periods, and may be terminated by any party thereto upon 60 days’ written notice prior to the end of the applicable term. Ategrity Ltd may change the Investment Guidelines at any time or withdraw any or all of the assets in the portfolio upon five business days’ prior written notice for certain specified uses.
The Ategrity Ltd IMA provides that the Investment Manager will be paid, on a quarterly basis, a fee equal to 5 basis points (0.05%) per quarter of the adjusted net asset value. For the initial term of the Ategrity Ltd IMA, this fee is reduced to 1.25 basis points (0.0125%) per quarter. Ategrity Ltd is responsible for payment of certain of the Investment Manager’s expenses, costs, and external fees as outlined in Ategrity Ltd IMA. The fee incurred pursuant to the Ategrity Ltd IMA was $0.1 million for the year ended December 31, 2024, and Ategrity Ltd reimbursed expenses of the Investment Manager of $0, for the year ended December 31, 2024.
Pursuant to the Ategrity Ltd IMA, Ategrity Ltd will exculpate, indemnify, and hold harmless the Investment Manager and certain of its affiliates, except to the extent arising from losses caused by such indemnified party’s gross negligence or willful malfeasance. The Investment Manager agrees to indemnify and hold harmless Ategrity Ltd and certain of its affiliates as a direct result of the Investment Manager’s gross negligence, willful malfeasance, or reckless disregard of its obligations and duties.
HoldCo IMA
We have entered into an Amended & Restated Investment Management Agreement, dated October 1, 2024 (as amended, the “HoldCo IMA”) with the Investment Manager, pursuant to which we appointed the Investment Manager to manage a portfolio of assets and granted the Investment Manager the full and exclusive authority and discretion to effect investment transactions through the portfolio, subject to the Investment Guidelines set forth therein. The HoldCo IMA will remain in effect until December 31, 2027, subject to automatic renewal for additional successive three year periods, and may be terminated by any party thereto upon 60 days’ written notice prior to the end of the applicable term. We may change the Investment Guidelines at any time or withdraw any or all of the assets in the portfolio upon five (5) business days’ prior written notice for certain specified uses.
The HoldCo IMA provides that the Investment Manager will be paid, on a quarterly basis, a fee equal to 5 basis points (0.05%) per quarter of the adjusted net asset value. For the initial term of the Ategrity Ltd IMA, this fee is reduced to 1.25 basis points (0.0125%) per quarter. We are responsible for payment of certain of the Investment Manager’s expenses, costs, and external fees as outlined in the HoldCo IMA. The fee incurred pursuant to the HoldCo IMA was $26,000, $0, and $0 for the years ended December 31, 2024, 2023, and 2022, respectively, and we reimbursed expenses of the Investment Manager of $0, $0, and $0 for the years ended December 31, 2024, 2023, and 2022, respectively.
Pursuant to the HoldCo IMA, we will exculpate, indemnify, and hold harmless the Investment Manager and certain of its affiliates, except to the extent arising from losses caused by such indemnified party’s gross negligence or willful malfeasance.
Related Party Loan
On March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd redeemed $94 million in the aggregate from our investments in the Utility Limited Partnership (which had previously invested such funds in the Absolute Return Utility & Infrastructure Fund managed by the Investment Manager) and on March , 2025, Ategrity Specialty Holdings LLC and Ategrity Ltd, as lenders, executed the ZIS Loan with ZIS, an employee medical benefits company that is wholly owned by ZFSG, as the borrower, with an effective date of April 1, 2025. The ZIS Loan is secured by the shares ZFSG holds in ZIS. ZIS used the proceeds from the loan to purchase $94 million of Feeder Fund interests (calculated based on the March 31, 2025 net asset value of the Absolute Return Utility & Infrastructure Fund). The ZIS Loan is also secured by our shares of common stock that are held by ZFSG. The ZIS Loan accrues interest at a rate of 5.5%, payable annually in cash. The ZIS Loan matures on April 30, 2032. ZIS has the option to prepay the ZIS Loan at any time, in whole or in part, without penalty or premium. The ZIS Loan is guaranteed by ZFSG and is secured by the shares of ZIS held by ZFSG. The ZIS Loan is subject to customary negative and affirmative covenants, including without limitation, a negative pledge on the collateral for the ZIS Loan. On March , 2025, ZFSG and ZIS paid us and Ategrity Ltd a nonrefundable structuring fee equal to $940,000 in the aggregate in connection with the issuance of the ZIS Loan. The ZIS Loan agreement will be filed as an exhibit to the registration statement of which this prospectus forms a part.
Technology Transactions
We entered into certain technology transactions (the “Technology Transactions”) effective January 1, 2023, with ZFSG and ZTG.
Technology Transactions agreement
As part of the Technology Transactions, we obtained a license to continue using certain software and technologies as part of our operations for one year at a cost of $750,000 per annum, with a right to renew the license for additional one-year periods. We agreed to provide services relating to the assets to ZTG for an initial one-year term with the actual internal and external costs incurred by us in performing the services to be paid by ZTG.
We entered into a Technology Transactions Agreement effective January 1, 2023, and the related schedules, whereby (i) we agreed to sell, assign, grant, convey, and transfer certain software to ZTG for a fee of $13,501,290, (ii) ZTG granted to us a worldwide right and license under all applicable intellectual property rights to use such software for a fee of $750,000 payable in equal quarterly installments of $187,500, with a right to renew the license for additional one-year periods, and (iii) we agreed to work with third-party vendors to develop proposals to provide supporting infrastructure, support services, ongoing maintenance, and continued development of such software for the benefit of ZTG. In the event that ZTG chooses to approve any proposals developed at our request, ZTG agreed to bear all third-party costs for such development. Where ZTG has not paid such costs directly to the applicable third-party vendor(s), ZTG shall pay such costs as fees to us. We made payments to ZTG pursuant to the foregoing arrangements of $0.8 million and $0.6 million in the years ended December 31, 2024 and 2023, respectively, and ZTG made payments to us pursuant to the foregoing arrangements of $4.0 million and $2.3 million in the years ended December 31, 2024 and 2023, respectively.
AtegrityOne Transaction
We entered into a transaction with ZTG, effective April 1, 2025, to acquire certain technology assets developed by or on behalf of ZTG for Ategrity Specialty after the date of the Technology Transactions, including the rights to the AtegrityOne software, for the purchase price of $3.2 million, which was paid following a redemption on March , 2025, of our interests in the Absolute Return Utility & Infrastructure Fund in such amount (the
“AtegrityOne Transaction”). The AtegrityOne Transaction confirms our ownership of, and enables us to further develop, the AtegrityOne software, which is a core technology linked to our underwriting plan and strategy.
Promissory note
As part of Technology Transactions, in consideration for the assets acquired by ZTG, ZFSG issued a promissory note to Ategrity Specialty bearing interest at 7.42% per annum with a maturity date of December 31, 2029 (the “ZFSG Promissory Note”).
As of December 31, 2024, the balance of the ZFSG Promissory Note was $13.5 million. ZFSG paid interest on the promissory note of $1.0 million and $0.75 million in the years ended December 31, 2024 and 2023, respectively.
Carrick Re
We have entered into certain reinsurance transactions with Carrick Re Limited (“Carrick Re”), a subsidiary of Carrick Specialty Holdings LLC, which prior to its sale on December 27, 2023, was a majority owned subsidiary of ZFSG. For additional information with respect to these transactions, see Note 11 to our consolidated financial statements included elsewhere herein. The terms of such arrangements are described in more detail below.
Loss portfolio transfer agreement
On December 30, 2021, each of Ategrity Specialty and Ategrity Ltd entered into a Brokerage Property Loss Portfolio Transfer Contract (the “Ategrity Specialty LPT” and the “Ategrity Ltd LPT”, respectively, and together, the “LPTs”) with Carrick Re, pursuant to which Carrick Re accepts from Ategrity Specialty and Ategrity Ltd, respectively, certain net losses relating to certain policies properly classified as Brokerage Property business with claims or losses occurring on or prior to September 30, 2021.
In consideration of the acceptance by Carrick Re of Ategrity Specialty LPT and the Ategrity Ltd LPT, we paid to Carrick Re a total premium of $1.4 million after withholding a portion of the premium equal to $46.7 million. We made combined net payments to Carrick Re of $33,000, $(2.5) million and $9.4 million pursuant to Ategrity Specialty LPT and the Ategrity Ltd LPT in the years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2023 and 2022, the reinsurance recoverable for ceded loss and loss adjustment expense reserves under Ategrity Specialty LPT was $0.9 million and $2.4 million, respectively.
Professional Services Agreement
On December 30, 2021, Ategrity Specialty and Ategrity Ltd entered into an agreement with Carrick Limited (the “Professional Services Agreement”), pursuant to which Carrick Limited provides certain ceded reinsurance administration services for certain facultative reinsurance certificates covering business also reinsured under the LPTs (the “Certificates”).
Carrick Limited may terminate the Professional Services Agreement on sixty (60) days prior written notice following termination or expiration of the LPTs. In addition, the Professional Services Agreement may be terminated at any time by the mutual agreement of the parties. In addition, any party may terminate the Professional Services Agreement upon written notice in the event of a material breach related to the Professional Services Agreement that has not been cured by the non-terminating party within thirty (30) days from receiving such notice. Additionally, the Services Agreement will automatically terminate upon the termination of the LPTs triggered by a specified reinsurer credit event.
In consideration of Carrick Limited’s performance of services pursuant to the Professional Services Agreement, Ategrity Specialty and Ategrity Ltd collectively pay Carrick Limited 50% of all collections from the Certificates collected during the term of the Services Agreement. Ategrity Specialty and Ategrity Ltd have collectively paid Carrick Limited $0.1 million, $0.4 million, and $0.3 million pursuant to the Professional Services Agreement in the years ended December 31, 2024, 2023, and 2022, respectively.
Stockholders’ agreement
In connection with the consummation of the offering, we intend to enter into a stockholders’ agreement with ZFSG (the “Stockholders’ Agreement”). Pursuant to such Stockholders’ Agreement, ZFSG will have the right to designate a specified number of directors to be nominated for election to our Board of Directors, based on ZFSG and its affiliates’ ownership percentages below, calculated using the total shares of our common stock outstanding at such time:
|
Percentage
|
|
|
Director
Nominees
|
|
|
40% or greater
|
|
|
|
|
5 |
|
|
|
<40% but ≥ 30%
|
|
|
|
|
4 |
|
|
|
<30% but ≥ 20%
|
|
|
|
|
3 |
|
|
|
<20% but ≥ 10%
|
|
|
|
|
2 |
|
|
|
Less than 10%
|
|
|
|
|
0 |
|
|
ZFSG will have the exclusive right to fill vacancies for its designees whether as a result of the resignation, death, or removal of such director. Upon any increase in the number of directors on the board, ZFSG will have the right to designate a proportional number of persons for nomination and election to our Board of Directors (rounded up to the nearest whole, even number) as prior to such increase. Pursuant to the terms of the Stockholders’ Agreement and the bylaws, ZFSG will also have the right, for so long as ZFSG and its affiliates own at least 25% of the shares outstanding, to appoint the Chair of the Board of Directors from the directors elected. ZFSG will have the right to appoint one director from the directors elected on each committee of the Board of Directors to the extent not prohibited by applicable law or stock exchange regulations.
The Stockholders’ Agreement will also contain provisions that will require us to register, subsequent to the IPO, under the federal securities laws the offer and sale of shares of our common stock held by ZFSG, including shares underlying warrants held by ZFSG, upon demand thereof. The agreement will also grant ZFSG the opportunity to include its shares, including shares underlying warrants held by ZFSG, in any registration statement filed by us in connection with a subsequent public offering of our equity securities (customarily known as “piggyback rights”). These registration rights will be subject to certain conditions and limitations. We will generally be obligated to pay all registration expenses in connection with these registration obligations, regardless of whether a registration statement is filed or becomes effective. The Stockholders’ Agreement will also contain customary indemnification and contribution provisions with respect to the registration rights contained therein.
Indemnification agreements
In connection with the consummation of the offering, we intend to enter into separate indemnification agreements with each of our directors and executive officers. Each indemnification agreement is expected to provide, among other things, for indemnification to the fullest extent permitted by law and our articles of incorporation and bylaws against (i) any and all expenses and liabilities, including judgments, fines, penalties, interest, and amounts paid in settlement of any claim with our approval and counsel fees and disbursements, (ii) any liability pursuant to a loan guarantee, or otherwise, for any of our indebtedness, and (iii) any liabilities incurred as a result of acting on behalf of us (as a fiduciary or otherwise) in connection with an employee benefit plan. The indemnification agreements will provide for the advancement or payment of expenses to the indemnitee and for reimbursement to us if it is found that such indemnitee is not entitled to such indemnification under applicable law and our articles of incorporation and bylaws. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, or persons controlling us pursuant to the foregoing provisions, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
We believe that these indemnification agreements, as well as our maintaining directors’ and officers’ liability insurance, help us to attract and retain qualified persons as directors and officers.
Directed Share Program
At our request, the underwriters have reserved for sale, at the initial public offering price, up to % of the shares offered by this prospectus, excluding the additional shares that the underwriters have an option to purchase, for sale to certain of our employees, certain of our directors and certain other parties. J.P. Morgan Securities LLC will administer our directed share program as described in under “Underwriting—Directed Share Program”. Shares purchased in such directed share program will be subject to the 180-day lock-up restriction described under “Underwriting.” We agreed to indemnify J.P. Morgan Securities LLC in connection with the directed share program, including for the failure of any participant to pay for its shares. Other than the underwriting discount described on the front cover of this prospectus, the underwriters will not be entitled to any commission with respect to shares of stock sold pursuant to the directed share program.
Policy concerning related party transactions
Prior to the consummation of this offering, our Board of Directors will adopt a written policy for the review of any transaction, arrangement, or relationship in which we are a participant, the amount involved exceeds $120,000 and one of our executive officers, directors, or beneficial owners (including, and in the aggregate with, their immediate family members) of more than 5% of our common stock is implicated, each of whom we refer to as a “related person,” has a direct or indirect material interest.
If a related person proposes to enter into such a transaction, arrangement, or relationship, which we refer to as a “related person transaction,” the related person must report the proposed related person transaction to our Chief Financial Officer (or his or her designee). The policy calls for the proposed related person transaction to be reviewed and, if deemed appropriate, approved by the audit committee. In approving or rejecting such proposed transactions, the audit committee is expected to take into consideration the relevant facts and circumstances available and deemed relevant to the audit committee, including the material terms of the transaction, risks, benefits, costs, availability of other comparable services or products, and, if applicable, the impact on director’s independence.
Whenever practicable, the reporting, review, and approval will occur prior to entering into the transaction. If advance review and approval is not practicable, the audit committee will review and may, in its discretion, ratify the related person transaction retroactively. All of the transactions described in this section occurred prior to the adoption of this policy.
Certain types of transactions are deemed pre-approved pursuant to our written policies concerning related party transactions. In particular, for operational and administrative ease, certain transactions with ZFSG and its affiliates that fit within the defined parameters below for transactions that are consistent with our investment strategies and investment management relationships will be pre-approved by the Audit Committee pursuant to such policies and will not require additional approval by the Audit Committee as a result. As described below, these exceptions include specific arrangements under which we may engage ZFSG or its affiliates in an investment management or advisory capacity without prior Audit Committee review or approval. The following transactions, among others, are expressly included as pre-approved transactions and do not require the consent or review of the Audit Committee:
•
Any investment or upsize of an existing investment by us in any investment fund or other investment vehicle whose investment activities are managed or advised, directly or indirectly, by an entity whose general partner or managing member is owned, directly or indirectly, by ZFSG or by one or more of ZFSG’s subsidiaries (each, as “Zimmer Vehicle”); provided, that such investment is an existing investment or is a new investment that provides us with a most favored nations clause or the same or better terms, taken as a whole with respect to such Zimmer Vehicle, as those applicable to other investors in the same Zimmer Vehicle who invested an amount in such fund equal to or less than that invested by us (without consideration of any terms (“Designated Terms”) that are offered to employees of ZFSG and their relatives (“Designated Investors”)); and provided further that such investment or investments by us represent no more than
80% of the outstanding or expected equity interests of such Zimmer Vehicle which percentage, with respect to any Zimmer Vehicle with a master-feeder structure, shall be calculated at the master fund level;
•
Any upsizing of an existing investment by us or Ategrity Ltd in the ZIS Loan, so long as the percent increase in size does not exceed the growth rate of our total invested assets in any period;
•
Entering into any investment management agreement (“IMA”) with ZFSG so long as (i) such agreement is on terms in the aggregate (including expense reimbursement and indemnities) materially consistent with IMAs existing on the date hereof or otherwise no less favorable to us than customary market terms (excluding the fees charged under the IMA); and (ii) either (a) for fixed income IMAs, the rates on assets under management (“AUM”) under such agreement do not exceed 75 basis points per annum; or (b) for all other products, (1) management fees earned by ZFSG shall not exceed 2% of assets or commitment, as applicable, and (2) carried interest or performance fees earned by ZFSG for any such investment shall not exceed 20% of the profits; provided that the carried interest or performance fee may step up to 30% if performance exceeds a specified performance hurdle;
•
Amending an IMA currently in effect or entering into a new IMA, in each case, for the purpose of adding new investment guidelines or terms as directed by our Chief Executive Officer on terms not more economically favorable in the aggregate to ZFSG than those in the IMA which is currently in effect, unless, such IMA or amendment imposes any new fee or increases the rate at which fees are charged (except as otherwise permitted under the bullet below);
•
Any increase in the fee rates on AUM charged to us with respect to any Zimmer Vehicle or IMA as long as such increase would not cause the fee rate on AUM charged to us with respect to such Zimmer Vehicle or IMA to increase over any one-year period by more than the greater of (x) 5% and (y) the then-current Consumer Price Index for All Urban Consumers;
•
Any transfer of our equity securities among ZFSG and its affiliates;
•
The performance in accordance with its terms of any agreement validly entered into with the ZFSG and in existence as of the date of this offering;
•
The performance by employees of ZFSG of any services for us that are designated as “dual hatted” services pursuant to any arrangements then in place for the purpose of governing such arrangements; and
•
Any autorenewal of the term of any investment in a Zimmer Vehicle or IMA.
Principal stockholders
The following table sets forth certain information with respect to the beneficial ownership of our common stock as of , and as adjusted to reflect the sale of the shares of common stock we will issue and sell in this offering for:
•
each of our named executive officers for the year ended December 31, 2024;
•
each of our directors and director nominees;
•
all of our directors and executive officers as a group; and
•
each person, or group of persons, known by us to be the beneficial owner of more than 5% of the outstanding shares of our common stock.
We have determined beneficial ownership in accordance with the rules of the SEC. Except as otherwise noted below, we believe, based on the information furnished to us, that the persons and entities named in the table below have sole voting and investment power with respect to all shares of our common stock that they beneficially own, subject to applicable community property laws.
The information with respect to beneficial ownership after giving effect to the reclassification and the offering assumes that we complete the reclassification, and that:
•
the initial public offering price will be $ per share, which is the midpoint of the range we show on the cover of this prospectus;
•
we will issue and sell in the offering shares of our common stock; and
•
shares of our common stock will be outstanding immediately prior to the offering and shares of our common stock will be outstanding following the offering.
Percentage of beneficial ownership in the following table is based on shares of our common stock outstanding immediately prior to the completion of this offering and shares of our common stock outstanding upon completion of this offering, assuming no exercise of the underwriters’ option to purchase additional shares of our common stock from us to cover over-allotments, or shares of our common stock, assuming the underwriters exercise in full their option to purchase additional shares of our common stock from us to cover over-allotments. In addition, the following table does not reflect any shares of our common stock that may be purchased in this offering pursuant to our Directed Share Program as described under “Underwriting—Directed Share Program.”
In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, we deemed outstanding all shares of common stock subject to options, warrants, or other convertible securities held by that person that are currently exercisable or exercisable within 60 days of . We, however, did not deem these shares of common stock outstanding for the purpose of computing the percentage ownership of any other person.
Except as otherwise noted below, the address of each beneficial owner listed in the table is c/o Ategrity Specialty Holdings LLC, 9 West 57th Street, 33rd Floor, New York NY 10019.
| |
|
|
Shares of
common stock
beneficially
owned before
this offering
|
|
|
Shares of
common stock
beneficially
owned after
this offering
|
|
|
Shares of
common stock
beneficially
owned after
this offering
assuming full
exercise of
overallotment
option
|
|
|
Name of beneficial owner
|
|
|
Number
|
|
|
%
|
|
|
Number
|
|
|
%
|
|
|
Number
|
|
|
%
|
|
|
Greater than 5% Stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ZFSG(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officers, Directors, and Director Nominees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stuart J. Zimmer(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tom Hulst
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Justin Cohen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neelam Patel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chris Schenk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William Mercer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert C. Merton
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mitchell Pressman
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John (Jack) L. Sennott, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Executive Officers, Directors, and Director Nominees as a group ( persons)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Less than 1%.
(1) Consists of held of record by , over which holds voting and dispositive power.
Description of capital stock
The following is a description of the material terms of our articles of incorporation and our bylaws that will be in effect upon the consummation of this offering. The following description is intended as a summary only and is qualified in its entirety by reference to our articles of incorporation and our bylaws, the forms of which will be filed with the SEC as exhibits to the registration statement of which this prospectus is a part, and the applicable provisions of Nevada Revised Statutes (the “NRS”).
General
Upon the consummation of this offering, our authorized capital stock will consist of:
•
shares of common stock, par value $ per share; and
•
shares of preferred stock, par value $ per share.
Immediately following the consummation of this offering, there will be:
•
shares of common stock issued and outstanding; and
•
no shares of preferred stock outstanding.
Common stock
We will have one class of common stock. All holders of our common stock will be entitled to the same rights and privileges, as described below:
Voting rights
Each holder of our common stock will be entitled to one vote for each share on all matters submitted to a vote of the holders of our common stock, including the election of directors. Holders of our common stock will not have cumulative voting rights in the election of directors.
Directors standing for election at an annual meeting of stockholders will be elected by a plurality of the votes cast in the election of directors at the annual meeting, which voting power is present either in person or represented by properly authorized proxy.
Rights to dividends or other distributions
Subject to the prior rights of holders of any then outstanding shares of our preferred stock, holders of our common stock will be entitled to receive ratably any dividends or other distributions that may be declared from time to time by our Board of Directors out of funds legally available therefor.
Liquidation rights
Subject to the prior rights of our creditors and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of our preferred stock, in the event of our liquidation, dissolution, or winding up, holders of our common stock will be entitled to share ratably in all assets legally available for distribution to stockholders.
Preemptive rights
Holders of our common stock will not be entitled to preemptive or other similar subscription rights.
Preferred stock
Our Board of Directors will have the authority to issue from time to time, without action by our stockholders, preferred stock in one or more series and to fix the rights, preferences, privileges, and restrictions thereof, including voting, dividend, conversion, exchange, redemption, and liquidation rights. The rights with respect to a series of preferred stock may be greater than the rights attached to our common stock.
It is not possible to state the actual effect of the issuance of any shares of our preferred stock on the rights of holders of our common stock until our Board of Directors determines the specific rights attached to that preferred stock. The effect of issuing preferred stock could include, among other things, one or more of the following:
•
restricting dividends or other distributions on our common stock;
•
diluting the voting power of our common stock or providing that holders of preferred stock have the right to vote on matters as a separate class;
•
impairing the liquidation rights of our common stock; or
•
delaying, discouraging, or preventing a change of control of us.
Warrants
Immediately following the consummation of this offering, there will be outstanding (i) warrants to purchase shares of our common stock at an exercise price of $ per share (“Tranche 1 Warrants”), and (ii) warrants to purchase shares of our common stock at an exercise price of $ per share (“Tranche 2 Warrants” and, together with the Tranche 1 Warrants, the “Warrants”). Warrants can be exercised for a term of ten years starting from October 2024 by paying the exercise price in cash or on a cashless basis.
Anti-takeover effects of certain provisions of Nevada law, our articles of incorporation, and bylaws
Our articles of incorporation and our bylaws will contain provisions that are intended to enhance the likelihood of continuity and stability in the composition of our Board of Directors and that could make it more difficult to acquire control of our company by means of a tender offer, open market purchases, a proxy contest, or otherwise. These provisions may discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our Board of Directors, which we believe may result in an improvement of the terms of any such acquisition in favor of our stockholders. However, they also give our Board of Directors the power to discourage acquisitions that some stockholders may favor or may consider in their best interests. A summary of these provisions is set forth below. We also intend to enter into the Stockholders’ Agreement with ZFSG as the initial stockholder in connection with the consummation of this offering, the material terms of which are described under “Certain relationships and related party transactions—Stockholders’ Agreement.” The Stockholders’ Agreement will provide ZFSG with certain board, committee and chair nomination rights.
Classified board of directors
Our articles of incorporation will provide that once ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, our board of directors will be divided into three classes, with the classes as nearly equal in number as possible and each class serving three-year staggered terms.
Quorum
Our bylaws will provide that a majority of the members of the Board of Directors shall constitute a quorum; provided that, for so long as ZFSG and its affiliates beneficially own more than 50% of the voting power of our capital stock, the Chair of the Board of Directors or a ZFSG designee pursuant to the Stockholders’ Agreement must be present to constitute a quorum (unless all such individuals have recused themselves from such board action).
Our bylaws will provide that stockholders representing a majority of the voting power of our capital stock, represented in person or by proxy (regardless of whether the proxy has authority to vote on any matter), are necessary to constitute a quorum for the transaction of business at any meeting.
Number of directors fixed by board only
Our articles of incorporation and bylaws will provide that, for so long as ZFSG and its affiliates beneficially own more than 50% of the voting power of our capital stock, the number of directors on our board may be fixed by resolution adopted by our Board of Directors or by holders of at least a majority of our outstanding common stock; thereafter, the number of directors on our board will be fixed exclusively pursuant to resolution adopted by our Board of Directors; provided our bylaws will require the designees of ZFSG to approve any change to the size of the board of directors.
Vacancies filled by board
Our articles of incorporation and bylaws will provide that, any vacancy in our Board of Directors, whether from an increase in the size of the board or otherwise, may be filled by a majority of the directors then in office, even if less than a quorum, or by a sole remaining director; provided, for so long as ZFSG and its affiliates beneficially own more than 50% of the voting power of our capital stock, any vacancy in our Board of Directors whether from an increase in the size of the board or otherwise may be filled by holders of at least a majority of our outstanding common stock.
Chief Executive Officer
Our bylaws will provide that for so long as ZFSG and its affiliates own at least 25% of the shares of our common stock then outstanding, the approval of ZFSG’s designees to our Board of Directors will be required in connection with hiring or terminating our Chief Executive Officer.
No action by stockholders without a meeting
The NRS permits stockholder action by written consent unless the corporation’s articles of incorporation or bylaws provide otherwise. Our articles of incorporation and bylaws will provide that stockholder action can be taken only at an annual or special meeting of stockholders and cannot be taken by written consent in lieu of a meeting once ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock.
Calling of special meetings of stockholders
Our articles of incorporation and bylaws will provide that special meetings of our stockholders for any purpose or purposes may be called at any time only (1) by the Chair of our Board of Directors, (2) pursuant to a resolution adopted by a majority of our Board of Directors, or (3) until the date that ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, at the request of holders of at least a majority of our outstanding common stock. Except as described above, stockholders will not have the authority to call a special meeting of stockholders.
Advance notice of stockholder nominations and proposals
Our bylaws will establish advance notice procedures for stockholder proposals (other than proposals brought by ZFSG) to be brought before an annual meeting of stockholders, including proposed nominations of candidates for election to our Board of Directors. Stockholders at an annual meeting will only be able to consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our Board of Directors, or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary of the stockholder’s intention to bring such business before the meeting. These provisions could have the effect of delaying stockholder actions until the next stockholder meeting (i.e., by precluding the conduct of certain business at the current annual meeting if the proper procedures are not followed) that are favored by the holders of a majority of our outstanding voting securities or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us.
Exclusive forum
Our articles of incorporation and bylaws will provide that, unless we consent to the selection of an alternative forum, the Eighth Judicial District Court of the State of Nevada, sitting in Clark County (or if such court does not have jurisdiction, another state or the federal courts (as appropriate) located within the State of Nevada) shall, to the fullest extent permitted by law, be the sole and exclusive forum for any actions, suits or proceedings, whether civil, administrative or investigative (i) brought in our name or right or on our behalf, (ii) asserting a claim for breach of any fiduciary duty owed by any of our current or former directors, officers, employees or agents to us or our stockholders, (iii) that is an internal action (as defined in Nevada Revised Statutes (“NRS”) 78.046), including any action or claim arising under or pursuant to NRS Chapters 78 or 92A or any provision of our articles of incorporation or our bylaws, or as to which the NRS confers jurisdiction on the District Court of the State of Nevada, (iv) to interpret, apply, enforce or determine the validity of our articles of incorporation and bylaws or any agreement entered into pursuant to NRS 78.365 to which we are a party or a stated beneficiary or (v) asserting a claim governed by the internal affairs doctrine. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision in our articles of incorporation and bylaws will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Our articles of incorporation and bylaws will also provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause or causes of action against us or any defendant arising under the Securities Act. Although we believe this provision benefits us by providing increased consistency in the application of Nevada law in the types of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers or make such lawsuits more costly for stockholders; however, our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. Furthermore, if a court were to find the choice of forum provisions in our articles of incorporation or bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, results of operations and financial condition. For example, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce such a forum selection provision as written in connection with claims arising under the Securities Act.
“Blank check” preferred stock
We believe that the availability of authorized shares of preferred stock under our articles of incorporation will provide us with flexibility in addressing corporate issues that may arise. Having these authorized shares available for issuance will allow us to issue shares of preferred stock without the expense and delay of a special stockholders’ meeting. The authorized shares of preferred stock will be available for issuance without action by our stockholders unless action is required by applicable law or the rules of any stock exchange on which our securities may be listed.
Our Board of Directors will have the power, subject to applicable law, to authorize the issuance of shares of preferred stock that could, depending on the terms of the series, impede the completion of a merger, tender offer, or other takeover attempt. For instance, subject to applicable law, a series of preferred stock may impede a business combination by including class voting rights which would enable the holder or holders of such series to block a proposed transaction. Our Board of Directors will make any determination to issue shares of preferred stock based on its judgment as to our company’s and our stockholders’ interests. Our Board of Directors, in so acting, could issue preferred stock having terms which could discourage an acquisition attempt or other transaction that some, or a majority, of the stockholders may believe to be in their interests or in which stockholders would have received a premium for their stock over the then prevailing market price of the stock.
Supermajority provisions
The NRS generally provides that the affirmative vote of a majority of the voting power of the outstanding shares entitled to vote is required to amend a corporation’s articles of incorporation, unless the corporation’s articles of incorporation require a greater percentage. Our articles of incorporation will not require a greater percentage until such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock. From and after such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, a 662∕3% stockholder vote is required for the amendment, repeal, or modification of certain provisions of our articles of incorporation relating to the anti-takeover provisions described herein. Pursuant to the terms of our articles of incorporation and bylaws, and subject to the terms of the Stockholders’ Agreement, from and after such time as ZFSG and its affiliates cease to beneficially own more than 50% of the voting power of our capital stock, a 662∕3% stockholder vote is also required for the amendment, repeal, or modification of any provisions of our bylaws (provided our bylaws may be amended at any time by action of our Board of Directors).
Constituency Considerations
NRS 78.139 provides that directors may resist a change or potential change in control of the corporation if the board of directors determines that the change or potential change is opposed to or not in the best interest of the corporation upon consideration of any relevant facts, circumstances, contingencies or constituencies pursuant to NRS 78.138(4).
Combinations with Interested Stockholders
Nevada’s “combinations with interested stockholders” statutes (NRS 78.411 through 78.444) provide that specified types of business “combinations” between certain Nevada corporations and any person deemed to be an “interested stockholder” of the corporation are prohibited for two years after such person first becomes an “interested stockholder” unless the corporation’s board of directors approves the combination (or the transaction by which such person becomes an “interested stockholder”) in advance, or unless the combination is approved by the board of directors and 60% of the corporation’s voting power not beneficially owned by the interested stockholder, its affiliates and associates. Furthermore, in the absence of prior approval certain restrictions may apply even after such two-year period. For purposes of these statutes, an “interested stockholder” is any person who is (1) the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the corporation, or (2) an affiliate or associate of the corporation and at any time within the two previous years was the beneficial owner, directly or indirectly, of 10% or more of the voting power of the then-outstanding shares of the corporation. The definition of the term “combination” is sufficiently broad to cover most significant transactions between a corporation and an “interested stockholder”.
These statutes generally apply to Nevada corporations with 200 or more stockholders of record (a “resident domestic corporation”) and the statutes will not apply to any person that first became a holder of 10% or more of the voting power of the then-outstanding shares of the corporation at the time the corporation became a resident domestic corporation solely as a result of it becoming a resident domestic corporation. However, a Nevada corporation may elect in its articles of incorporation not to be governed by these particular laws, but if such election is not made in the corporation’s original articles of incorporation, the amendment (1) must be approved by the affirmative vote of the holders of stock representing a majority of the outstanding voting power of the corporation not beneficially owned by interested stockholders or their affiliates and associates, and (2) is not effective until 18 months after the vote approving the amendment and does not apply to any combination with a person who first became an interested stockholder on or before the effective date of the amendment.
Our articles of incorporation will not opt out of NRS 78.411 through 78.444.
Acquisitions of Controlling Interests
Nevada law also protects the corporation and its stockholders from persons acquiring a “controlling interest” in a corporation. These provisions are found in NRS 78.378 through 78.3793. Pursuant to NRS 78.379, any person
who acquires a controlling interest in a corporation may not exercise voting rights with respect to any “control shares” unless such voting rights are conferred by a majority vote of the disinterested stockholders of the issuing corporation at a special meeting of such stockholders held at the request and at the expense of the acquiring person. NRS 78.3785 provides that a “controlling interest” means the ownership of outstanding voting shares of an issuing corporation sufficient to enable the acquiring person, individually or in association with others, directly or indirectly, to exercise (i) one fifth or more but less than one third, (ii) one third or more but less than a majority or (iii) a majority or more of the voting power of the issuing corporation in the election of directors, and once an acquirer crosses one of these thresholds, shares which it acquired in the transaction taking it over the threshold and within the 90 days immediately preceding the date when the acquiring person acquired or offered to acquire a controlling interest become “control shares” to which the voting restrictions described above apply. In the event that the control shares are accorded full voting rights, and the acquiring person acquires control shares with a majority or more of all the voting power, any stockholder, other than the acquiring person, who does not vote in favor of authorizing voting rights for the control shares is entitled to dissenter’s rights under NRS Chapter 92A.
NRS 78.3788 provides that these statutes apply as of a particular date only to a corporation that has 200 or more stockholders of record, at least 100 of whom have addresses in Nevada appearing on the corporation’s stock ledger at all times during the 90 days immediately preceding that date, and which does business in Nevada directly or indirectly or through an affiliated corporation. NRS 78.378(2) provides that the corporation, by virtue of its articles of incorporation, bylaws or resolutions adopted by directors, may impose stricter requirements if it so desires. A corporation is entitled to opt out of these acquisition of controlling interest statutes by making an election in its articles of incorporation or bylaws, provided that the opt-out is in effect on the 10th day following the acquisition of a controlling interest by the acquiring person.
We intend to opt out of these statutes in our bylaws with respect to acquisitions of shares by ZFSG and its affiliates.
Corporate opportunities; conflicts of interest
Our articles of incorporation will provide that we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any business opportunity of ZFSG and its affiliates and certain related persons or any director who is not our employee. We do not renounce any interest in any corporate opportunity offered to any such director or officer if such opportunity is expressly offered to such person solely in his or her capacity as our director or officer.
Our articles of incorporation will provide that ZFSG and its affiliates and certain related persons will have no duty to refrain from (i) engaging in a corporate opportunity in the same or similar lines of business in which we or our affiliates now engage or propose to engage, or (ii) otherwise competing with us or our affiliates. In the event that ZFSG and its affiliates or such related person acquires knowledge of a potential transaction or other business opportunity that may be a corporate opportunity, such person will have no duty to communicate or offer such transaction or business opportunity to us or our affiliates and they may take any such opportunity for themselves or offer it to another person or entity unless such knowledge was acquired solely in such person’s capacity as our director or officer.
Limitations on liability and indemnification of directors and officers
To the fullest extent permitted by NRS Chapter 78, our directors and officers are not liable to us or any of our stockholders or creditors for monetary damages for breaches of fiduciary duties as a director or officer. Under Nevada law, unless otherwise provided in the articles of incorporation or pursuant to certain statutory exceptions, a director or officer is not individually liable for damages as a result of an act or failure to act in his or her capacity as a director or officer unless a statutory presumption established under NRS 78.138(3) (that such person, in deciding upon matters of business, acted in good faith, on an informed basis and with a view to the interests of the corporation) has been rebutted, and it is proven both that the act or failure to act constituted a
breach of a fiduciary duty as a director or officer and that such breach involved intentional misconduct, fraud or a knowing violation of law.
Our articles of incorporation will include a provision that eliminates the individual liability of our directors and officers to the fullest extent permitted under Nevada law.
In addition, our articles of incorporation and bylaws will provide that we will indemnify our directors and officers to the fullest extent permitted by law. We will also be expressly required to advance certain expenses to our directors and officers and carry directors’ and officers’ insurance providing indemnification for our directors and officers for certain liabilities, provided that such advancement is made upon receipt of an undertaking by the director or officer to repay the amounts advanced if it should be ultimately determined that the director or officer is not entitled to indemnification.
Prior to consummation of this offering, we intend to enter into separate indemnification agreements with each of our directors and executive officers. See “Certain relationships and related party transactions—Indemnification agreements.”
We believe that these provisions of our articles of incorporation and Nevada law, indemnification agreements, as well as our maintaining directors’ and officers’ liability insurance, help to attract and retain qualified persons as directors and officers.
Listing
We have applied to list our common stock on the NYSE under the symbol “ASIC.”
Transfer agent and registrar
The transfer agent and registrar for the common stock is Equiniti Trust Company, LLC. The transfer agent and registrar’s address is 55 Challenger Road, Ridgefield Park, New Jersey 07660.
Shares eligible for future sale
Sales or the availability for sale of substantial amounts of our common stock in the public market may adversely affect the market price of our common stock. Prior to this offering, there has been no public market for our common stock, and we cannot assure you that a significant public market for our common stock will develop or be sustained after this offering. Future sales of significant amounts of our common stock in the public market after this offering could adversely affect the prevailing market price of our common stock and could impair our future ability to raise capital through the sale of our equity securities.
Resale of restricted shares and lock-up agreements
Upon completion of this offering, we will have shares of common stock outstanding. Of these shares, all of the shares of our common stock sold in this offering will be freely tradable without restriction under the Securities Act, except shares purchased by our affiliates (as that term is defined in Rule 144 under the Securities Act).
The remaining shares of our common stock held by existing stockholders will be “restricted securities” within the meaning of Rule 144 and may not be sold in the absence of registration under the Securities Act unless an exemption from registration is available, including the exemptions contained in Rule 144. As a result of the contractual restrictions described below and subject to the provisions of Rule 144, the shares of our common stock that are “restricted securities” will be available for sale in the public market as follows:
•
shares of common stock will be eligible for sale upon completion of the offering; and
•
shares of common stock will be eligible for sale upon expiration of the lock-up agreements, described below, beginning 180 days after the date of this prospectus.
S-8 registration statement
We intend to file a registration statement or statements on Form S-8 under the Securities Act covering shares of common stock reserved for issuance under our new omnibus incentive plan and pursuant to all outstanding option grants made prior to this offering. These registration statements are expected to be filed as soon as practicable after the closing date of this offering. Shares issued upon the exercise of stock options after the effective date of the applicable Form S-8 registration statement will be eligible for resale in the public market without restriction, subject to Rule 144 limitations applicable to affiliates and the lock-up agreements described above.
Lock-up agreements
We, our directors and executive officers, and holders of substantially all of our outstanding capital stock have signed lock-up agreements under which they have agreed not to offer, sell, contract to sell, pledge, or otherwise dispose of, or to enter into any hedging transactions with respect to, any shares of our common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock for a period of 180 days commencing on the date of this prospectus, subject to certain exceptions. See “Underwriting.”
Rule 144
Sales by non-affiliates. In general, under Rule 144, a holder of shares of restricted common stock who is not and has not been one of our affiliates at any time during the three months preceding the proposed sale can resell the shares as follows:
If we have been a reporting company under the Exchange Act for at least 90 days immediately before the sale, then:
•
beginning six months after the shares were acquired from us or any of our affiliates, the holder can resell the shares, subject to the condition that current public information about us must be available (as described below), but without any other restrictions; and
•
beginning one year after the shares were acquired from us or any of our affiliates, the holder can resell the shares without any restrictions.
•
If we have not been a public reporting company under the Exchange Act for at least 90 days immediately before the sale, then the holder may not resell the shares until at least one year has elapsed since the shares were acquired from us or any of our affiliates, and may resell the shares without restrictions after that time.
Sales by affiliates. In general, under Rule 144, a holder of shares of restricted common stock who is one of our affiliates at the time of the sale or any time during the three months preceding the sale can resell shares, subject to the restrictions described below.
•
If we have been a public reporting company under the Exchange Act for at least 90 days immediately before the sale, then at least six months must have elapsed since the shares were acquired from us or one of our affiliates; in all other cases, at least one year must have elapsed since the shares were acquired from us or one of our affiliates.
•
The number of shares sold by such person within any three-month period cannot exceed the greater of:
•
1% of the total number of shares of our common stock then outstanding (approximately shares immediately after this offering); or
•
the average weekly trading volume of our common stock during the four calendar weeks preceding the date on which notice on Form 144 with respect to the sale is filed with the SEC (or, if Form 144 is not required to be filed, the four calendar weeks preceding the date the selling broker receives the sell order).
•
Conditions relating to the manner of sale, notice requirements (filing of Form 144 with the SEC) and the availability of public information about us must also be satisfied.
Current public information. For sales by affiliates and non-affiliates, the satisfaction of the current public information requirement depends on whether we are a public reporting company under the Exchange Act.
•
If we have been a public reporting company for at least 90 days immediately before the sale, then the current public information requirement is satisfied if we have filed all periodic reports (other than Form 8-K) required to be filed under the Exchange Act during the 12 months immediately before the sale (or such shorter period as we have been required to file those reports).
•
If we have not been a public reporting company for at least 90 days immediately before the sale, then the requirement is satisfied if specified types of basic information about us (including our business, management, and our financial condition and results of operations) are publicly available.
No assurance can be given as to (1) the likelihood of an active market for our common stock developing, (2) the liquidity of any such market, (3) the ability of stockholders to sell the shares, or (4) the prices that stockholders may obtain for any of the shares. No prediction can be made as to the effect, if any, that future sales of shares or the availability of shares for future sale will have on the market price prevailing from time to time. Sales of substantial amounts of our common stock, or the perception that such sales could occur, may adversely affect prevailing market prices of our common stock. See “Risk factors.”
Rule 701
Any of our employees, officers, or directors who acquired shares of our common stock under a written compensatory plan or contract may be entitled to sell them in reliance on Rule 701. Rule 701 permits affiliates to sell their Rule 701 shares of common stock under Rule 144 without complying with the holding period requirements of Rule 144. Rule 701 further provides that non-affiliates may sell these shares of common stock in reliance on Rule 144 without complying with the holding period, public information, volume limitation or notice provisions of Rule 144. All holders of Rule 701 shares of our common stock are required to wait until 90 days after the date of this prospectus before selling such shares of common stock. However, the shares of our common stock issued under Rule 701 that are subject to lock-up agreements will only become eligible for sale when the 180-day lock-up agreements expire.
Registration rights
ZFSG is entitled to certain rights with respect to the registration of the shares of our common stock they hold under the Securities Act. For a description of these registration rights, see “Certain relationships and related party transactions—Stockholders’ Agreement.” If these shares of our common stock are registered, they will be freely tradable without restriction under the Securities Act unless acquired or owned by us or one of our affiliates.
Material U.S. federal income tax considerations to non-U.S. holders
The following discussion is a summary of material U.S. federal income tax considerations to Non-U.S. Holders (as defined below) of the purchase, ownership, and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the “IRC”), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the “IRS”), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership, and disposition of our common stock.
This discussion is limited to Non-U.S. Holders that hold our common stock as a “capital asset” within the meaning of Section 1221 of the IRC (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Non-U.S. Holder’s particular circumstances, including the impact of the Medicare contribution tax on net investment income and any alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders subject to special rules, including, without limitation:
•
U.S. expatriates and former citizens or long-term residents of the United States;
•
persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as part of a conversion transaction or other integrated investment;
•
banks, insurance companies, and other financial institutions;
•
brokers, dealers, or traders in securities;
•
“controlled foreign corporations,” “passive foreign investment companies,” and corporations that accumulate earnings to avoid U.S. federal income tax;
•
partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein);
•
tax-exempt organizations or governmental organizations;
•
persons deemed to sell our common stock under the constructive sale provisions of the IRC;
•
persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation;
•
tax-qualified retirement plans;
•
“qualified foreign pension funds” as defined in Section 897(l)(2) of the IRC and entities all of the interests of which are held by qualified foreign pension funds; and
•
persons subject to special tax accounting rules as a result of any item of gross income with respect to the stock being taken into account in an applicable financial statement.
If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them.
THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS
TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.
Definition of a Non-U.S. Holder
For purposes of this discussion, a “Non-U.S. Holder” is any beneficial owner of our common stock that is neither a “U.S. person” nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following:
•
an individual who is a citizen or resident of the United States;
•
a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, created or organized under the laws of the United States, any state thereof, or the District of Columbia;
•
an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
•
a trust that (1) is subject to the primary supervision of a U.S. court and the control of one or more “United States persons” (within the meaning of Section 7701(a)(30) of the IRC), or (2) has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes.
Distributions
As described in the section entitled “Dividend policy,” we do not anticipate declaring or paying dividends or otherwise making distributions to holders of our common stock in the foreseeable future. However, if we do make distributions of cash or property on our common stock (other than certain distributions of our stock), such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a Non-U.S. Holder’s adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under “—Sale or Other Taxable Disposition.”
Subject to the discussion below on effectively connected income, dividends paid to a Non-U.S. Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty.
If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States.
Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules.
Sale or other taxable disposition
Subject to the discussions below under “—Information reporting and backup withholding” and “—Additional withholding tax on payments made to foreign accounts,” a Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless:
•
the gain is effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable);
•
the Non-U.S. Holder is an individual present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or
•
our common stock constitutes a U.S. real property interest (“USRPI”) by reason of our status as a U.S. real property holding corporation (“USRPHC”) for U.S. federal income tax purposes.
Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.
A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses.
With respect to the third bullet point above, we believe we currently are not, and do not anticipate becoming, a USRPHC. Because the determination of whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests and our other business assets, there can be no assurance we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal income tax if our common stock is “regularly traded,” as defined by applicable Treasury Regulations, on an established securities market and such Non-U.S. Holder owned, actually and constructively, 5% or less of our common stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition or the Non-U.S. Holder’s holding period; however, no assurance can be provided that our common stock will be “regularly traded” on an established securities market at all times relevant for purposes of this rule.
Non-U.S. Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.
Information reporting and backup withholding
Payments of dividends on our common stock will not be subject to backup withholding, provided the applicable withholding agent does not have actual knowledge or reason to know the holder is a United States person and the holder either certifies its non-U.S. status, such as by furnishing a valid IRS Form W-8BEN, W-8BEN-E, or W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above and does not have actual knowledge or reason to know that such holder is a United States person or the holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a non-U.S. office of a non-U.S. broker generally will not be subject to backup withholding or information reporting.
Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides or is established.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder’s U.S. federal income tax liability, provided the required information is timely furnished to the IRS.
Additional withholding tax on payments made to foreign accounts
Withholding taxes may be imposed under Sections 1471 to 1474 of the IRC (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or “FATCA”) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a “foreign financial institution” or a “non-financial foreign entity” (each as defined in the IRC), unless (1) the foreign financial institution undertakes certain diligence and reporting obligations, (2) the non-financial foreign entity either certifies it does not have any “substantial United States owners” (as defined in the IRC) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain “specified United States persons” or “United States owned foreign entities” (each as defined in the IRC), annually report certain information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.
Under the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of stock on or after January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued.
Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock.
Underwriting
We are offering the shares of common stock described in this prospectus through a number of underwriters. J.P. Morgan Securities LLC and Barclays Capital Inc. are acting as joint book-running managers of the offering and as representatives of the underwriters. We have entered into an underwriting agreement with the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the initial public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following table:
|
Name
|
|
|
Number of shares
|
|
|
J.P. Morgan Securities LLC
|
|
|
|
|
|
Barclays Capital Inc.
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
Total
|
|
|
|
|
| |
The underwriters are committed to purchase all the common shares offered by us if they purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated.
The underwriters propose to offer the common shares directly to the public at the initial public offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of $ per share. Any such dealers may resell shares to certain other brokers or dealers at a discount of up to $ per share from the initial public offering price. After the initial offering of the shares to the public, if all of the common shares are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. Sales of any shares made outside of the United States may be made by affiliates of the underwriters.
The underwriters have an option to buy up to additional shares of common stock from us to cover sales of shares by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase additional shares. If any shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered.
The underwriting fee is equal to the initial public offering price per share of common stock less the amount paid by the underwriters to us per share of common stock. The underwriting fee is $ per share. The following table shows the per share and total underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters’ option to purchase additional shares.
| |
|
|
|
No exercise of
option to
purchase
additional
shares
|
|
|
Full exercise of
option to
purchase
additional
shares
|
|
| |
Per Share
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
| |
Total
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees, and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be
approximately $ million. We have agreed to reimburse the underwriters for certain of their out-of-pocket expenses in an amount not to exceed $ .
A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in this offering, or by their affiliates. In those cases, prospective investors may view offering terms online and, depending upon the particular underwriter or selling group member, prospective investors may be allowed to place orders online. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to online brokerage account holders. Any such allocation for online distributions will be allocated by the representatives to underwriters and selling group members that may make online distributions on the same basis as other allocations.
We have agreed that we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any shares of our common stock or securities convertible into or exercisable or exchangeable for any shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, loan, disposition, or filing, or (ii) enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without the prior written consent of J.P. Morgan Securities LLC and Barclays Capital Inc. for a period of 180 days after the date of this prospectus (such period, the “restricted period”).
The restrictions on our actions, as described above, do not apply to certain transactions, including (i) the shares of our common stock to be issued and sold in this offering, (ii) the issuance of shares of common stock or securities convertible into or exercisable for shares of our common stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of restricted stock units (“RSUs”) (including net settlement), in each case outstanding on the date of the underwriting agreement and described in this prospectus; (iii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable for shares of our common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the closing of this offering and described in this prospectus, provided that such recipients enter into a lock-up agreement with the underwriters; (iv) the issuance of up to 5% of the outstanding shares of our common stock, or securities convertible into, exercisable for, or which are otherwise exchangeable for, shares of our common stock, immediately following the completion of this offering, in connection with acquisitions, joint ventures, commercial or other strategic transactions, provided that such recipients enter into a lock-up agreement with the underwriters or (v) our filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of the underwriting agreement and described in this prospectus or any assumed benefit plan pursuant to an acquisition or other strategic transaction; or (vi) the facilitation of the establishment of a trading plan on behalf of a stockholder, officer or director pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of our common stock; provided that (a) such plans do not provide for the transfer of shares of our common stock during the restricted period and (b) no filing by any party under the Exchange Act or other public announcement shall be required or made voluntarily in connection with such trading plan (other than any required disclosure on Form 10-Q or Form 10-K, as applicable, of the entrance into any trading plan during the relevant fiscal quarter, provided that such disclosure includes a statement to the effect that no transfers may be made pursuant to such trading plan during the restricted period).
Our directors and executive officers and holders of substantially all of our outstanding capital stock (such persons, the “lock-up parties”) have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for restricted period, may not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of
J.P. Morgan Securities LLC and Barclays Capital Inc., (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by such lock-up parties in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant (collectively with the common stock, the “lock-up securities”)), (ii) enter into any hedging, swap, or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the lock-up securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of lock-up securities, in cash or otherwise, (iii) make any demand for, or exercise any right with respect to, the registration of any lock-up securities, or (iv) publicly disclose the intention to do any of the foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap, or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (by any person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or otherwise.
The restrictions described in the immediately preceding paragraph and contained in the lock-up agreements between the underwriters and the lock-up parties do not apply, subject in certain cases to various conditions, to certain transactions, including (a) transfers of lock-up securities: (i) as bona fide gifts, or for bona fide estate planning purposes, including without limitation to charitable organizations or educational institutions, (ii) by will other testamentary document or intestacy, (iii) to any member of the lock-up party’s immediate family or to any trust or other legal entity for the direct or indirect benefit of the lock-up party or the immediate family of the lock-up party, or if the lock-up party is a trust, to a trustor, trustee or beneficiary of the trust or to the estate of a beneficiary of such trust, (iv) to a corporation, partnership, limited liability company or other entity of which the lock-up party and the immediate family of the lock-up party are the legal and beneficial owner of all of the outstanding equity securities or similar interests, (v) if the lock-up party is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act) of the lock-up party, or to any investment fund or other entity controlling, controlled by, managing, managed by or under common control with (or managed or advised by the same management company or investment advisor (or an affiliate of such management company or investment advisor)) as the lock-up party or affiliates of the lock-up party (including, for the avoidance of doubt, where the lock-up party is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as part of a distribution or transfer to members, shareholders, partners or other equity holders of the lock-up party (including, without limitation, to any entity or entities that directly or indirectly controls the lock-up party); (vi) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (v) above; (vii) by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or pursuant to a final order of a court or regulatory agency; (viii) to us from an employee upon death, disability or termination of employment, in each case, of such employee; (ix) as part of a sale or transfer of the lock-up securities acquired in open market transactions after the completion of this offering; (x) to us in connection with the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of our common stock (including, in each case, by way of “net” or “cashless” exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants or rights, provided that any such shares of our common stock received upon such exercise, vesting or settlement shall remain subject to the restrictions in the immediately preceding paragraph, and provided further that any such restricted stock units, options, warrants or rights are held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is described in this
prospectus; or (xi) pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by our Board Of Directors and made to all holders of our capital stock involving a change of control, in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding our voting securities (or the surviving entity)); provided that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, all such lock-up securities would remain subject to the restrictions in the immediately preceding paragraph; (b) exercise of the options, settlement of RSUs or other equity awards, or the exercise of warrants granted pursuant to plans or other equity compensation arrangements described in this prospectus, provided that any lock-up securities received upon such exercise, vesting, or settlement would be subject to restrictions similar to those in the immediately preceding paragraph; (c) the conversion of outstanding preferred stock, warrants to acquire preferred stock or convertible securities into shares of our common stock or warrants to acquire shares of our common stock, provided that any common stock or warrant received upon such conversion would be subject to restrictions similar to those in the immediately preceding paragraph; and (d) the establishment by lock-up parties of trading plans under Rule 10b5-1 under the Exchange Act, provided that such plan does not provide for the transfer of lock-up securities during the restricted period. provided that such plan does not provide for the transfer of lock-up securities during the restricted period and to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the lock-up or us regarding the establishment of such plan during the restricted period, such announcement or filing shall include a statement to the effect that no transfer of lock-up securities may be made under such plan during the restricted period.
J.P. Morgan Securities LLC and Barclays Capital Inc. may release the securities subject to any of the lock-up agreements with the underwriters described above, in whole or in part at any time.
We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act.
We have applied to have our common stock approved for listing on the NYSE under the symbol “ASIC “.
In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing, and selling shares of common stock in the open market for the purpose of preventing or retarding a decline in the market price of the common stock while this offering is in progress. These stabilizing transactions may include making short sales of common stock, which involves the sale by the underwriters of a greater number of shares of common stock than they are required to purchase in this offering, and purchasing shares of common stock on the open market to cover positions created by short sales. Short sales may be “covered” shorts, which are short positions in an amount not greater than the underwriters’ option to purchase additional shares referred to above, or may be “naked” shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may purchase shares through the option to purchase additional shares. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase shares in the open market to cover the position.
The underwriters have advised us that, pursuant to Regulation M under the Securities Act, they may also engage in other activities that stabilize, maintain, or otherwise affect the price of the common stock, including the imposition of penalty bids. This means that if the representatives of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short sales, the representatives can require the underwriters that sold those shares as part of this offering to repay the underwriting discount received by them.
These activities may have the effect of raising or maintaining the market price of the common stock or preventing or retarding a decline in the market price of the common stock, and, as a result, the price of the common stock
may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may carry out these transactions on the , in the over-the-counter market or otherwise.
Prior to this offering, there has been no public market for our common stock. The initial public offering price will be determined by negotiations between us and the representatives of the underwriters. In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including:
•
the information set forth in this prospectus and otherwise available to the representatives;
•
our prospects and the history and prospects for the industry in which we compete;
•
an assessment of our management;
•
our prospects for future earnings;
•
the general condition of the securities markets at the time of this offering;
•
the recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and
•
other factors deemed relevant by the underwriters and us.
Neither we nor the underwriters can assure investors that an active trading market will develop for our common shares, or that the shares will trade in the public market at or above the initial public offering price.
Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.
Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they have received and may continue to receive customary fees and commissions. In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or equity securities or loans, and may do so in the future.
Directed Share Program
At our request, the underwriters have reserved for sale, at the initial public offering price, up to % of the shares offered by this prospectus, excluding the additional shares that the underwriters have an option to purchase, for sale to certain of our employees, certain of our directors and certain other parties. Shares purchased in such directed share program will be subject to the 180-day lock-up restriction described above. The number of shares of common stock available for sale to the general public will be reduced to the extent these individuals purchase such reserved shares. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same basis as the other shares offered by this prospectus. J.P. Morgan Securities LLC will administer our directed share program. We agreed to indemnify J.P. Morgan Securities LLC in connection with the directed share program, including for the failure of any participant to pay for its shares. Other than the underwriting discount described on the front cover of this prospectus, the underwriters will not be entitled to any commission with respect to shares of stock sold pursuant to the directed share program.
Selling restrictions
Notice to prospective investors in the European Economic Area (“EEA”)
In relation to each Member State of the EEA (each a “Member State”), no shares of common stock have been offered or will be offered pursuant to the offering to the public in that Member State prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the competent authority in that Member State or, where appropriate, approved in another Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation (as defined below), except that shares of common stock may be offered to the public in that Member State at any time:
(a) to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation;
(b) to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or
(c) in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
provided that no such offer of shares of common stock shall require us or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation and each person who initially acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and the Company that it is a “qualified investor” within the meaning of Article 2(e) of the Prospectus Regulation. In the case of any shares of common stock being offered to a financial intermediary as that term is used in the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged, and agreed that the shares of common stock acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any shares of common stock to the public other than their offer or resale in a Member State to qualified investors as so defined or in circumstances in which the prior consent of the underwriters have been obtained to each such proposed offer or resale.
For the purposes of this provision, the expression an “offer to the public” in relation to any shares of common stock in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the expression “Prospectus Regulation” means Regulation (EU) 2017/1129 (as amended).
Notice to prospective investors in the United Kingdom
No shares of common stock have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the shares of common stock which has been (i) approved by the Financial Conduct Authority or (ii) is to be treated as if it had been approved by the Financial Conduct Authority in accordance with the transitional provisions in Article 74 (transitional provisions) of the Prospectus Amendment etc. (EU Exit) Regulations 2019/1234, except that the shares of common stock may be offered to the public in the United Kingdom at any time:
(a) to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation (as defined below);
(b) to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or
(c) in any other circumstances falling within Section 86 of the Financial Services and Markets Act 2000, as amended (the “FSMA”),
provided that no such offer of shares of common stock shall require us and/or any underwriters or any of their affiliates to publish a prospectus pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation.
For the purposes of this provision, the expression “offer to the public” in relation to shares of common stock in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock and the expression “UK Prospectus Regulation” means Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018.
In addition, in the United Kingdom, this prospectus is for distribution only to, and is directed only at, and any offer subsequently made may only be directed at persons who are “qualified investors” (as defined in the UK Prospectus Regulation) (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), (ii) who are high net worth entities or other persons falling within Article 49(2)(a) to (d) of the Order, or (iii) who are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any shares of common stock may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This prospectus is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons.
Notice to prospective investors in Canada
The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions, and Ongoing Registrant Obligations. Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights or consult with a legal advisor.
Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
Notice to prospective investors in Australia
This prospectus:
•
does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth) (the “Corporations Act”);
•
has not been, and will not be, lodged with the Australian Securities and Investments Commission, as a disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document for the purposes of the Corporations Act; and
•
may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, available under section 708 of the Corporations Act (“Exempt Investors”).
The shares of common stock may not be directly or indirectly offered for subscription or purchased or sold, and no invitations to subscribe for or to buy the shares of common stock may be issued, and no draft or definitive offering memorandum, advertisement, or other offering material relating to any shares of common stock may be distributed in Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the shares of common stock, you represent and warrant to us that you are an Exempt Investor.
As any offer of shares of common stock under this document will be made without disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the shares of common stock you undertake to us that you will not, for a period of 12 months from the date of issue of the shares of common stock, offer, transfer, assign, or otherwise alienate those shares of common stock to investors in Australia except in circumstances where disclosure to investors is not required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with the Australian Securities and Investments Commission.
Notice to prospective investors in Korea
The shares of common stock have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees and regulations thereunder (the “FSCMA”), and the shares of common stock have been and will be offered in Korea as a private placement under the FSCMA. None of the shares of common stock may be offered, sold, or delivered directly or indirectly, or offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the FSCMA and the Foreign Exchange Transaction Law of Korea and the decrees and regulations thereunder (the “FETL”). The shares of common stock have not been listed on any of securities exchanges in the world including, without limitation, the Korea Exchange in Korea. Furthermore, the purchasers of the shares of common stock shall comply with all applicable regulatory requirements (including but not limited to requirements under the FETL) in connection with the purchase of the shares of common stock. By the purchase of the shares of common stock, the relevant holders thereof will be deemed to represent and warrant that if they are in Korea or are a resident of Korea, they purchased the shares of common stock pursuant to the applicable laws and regulations of Korea.
Notice to prospective investors in Brazil
The offer and sale of the shares of common stock have not been and will not be registered with the Brazilian Securities Commission (Comissão de Valores Mobiliários, or “CVM”) and, therefore, will not be carried out by any means that would constitute a public offering in Brazil under CVM Resolution No. 160, dated 13 July 2022, as amended, or unauthorized distribution under Brazilian laws and regulations. The shares of common stock will be authorized for trading on organized non-Brazilian securities markets and may only be offered to Brazilian Professional Investors (as defined by applicable CVM regulation), who may only acquire the shares of common stock through a non-Brazilian account, with settlement outside Brazil in non-Brazilian currency. The trading of these shares of common stock on regulated securities markets in Brazil is prohibited.
Notice to prospective investors in the United Arab Emirates
The shares of common stock have not been, and are not being, publicly offered, sold, promoted, or advertised in the United Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority, Financial Services Regulatory Authority, or the Dubai Financial Services Authority.
Notice to prospective investors in Hong Kong
The shares of common stock have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a) to “professional investors” as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (the “SFO”) of Hong Kong and any rules made thereunder; or (b) in other circumstances which do not result in the document being a “prospectus” as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong (the “CO”) or which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation, or document relating to the common stock has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares of common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” as defined in the SFO and any rules made thereunder.
Notice to prospective investors in Japan
The shares of common stock have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Act. Accordingly, none of the common stock nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any “resident” of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations, and ministerial guidelines of Japan in effect at the relevant time.
Notice to prospective investors in Singapore
This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of common stock may not be circulated or distributed, nor may the common stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (the “SFA”)) pursuant to Section 274 of the SFA; (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
Where the shares of common stock are subscribed or purchased under Section 275 of the SFA by a relevant person which is:
•
a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or
•
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,
securities or securities-based derivatives contract (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the common stock pursuant to an offer made under Section 275 of the SFA except:
•
to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA;
•
where no consideration is or will be given for the transfer;
•
where the transfer is by operation of law;
•
as specified in Section 276(7) of the SFA; or
•
as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities based Derivatives Contracts) Regulations 2018.
Singapore SFA Product Classification—Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of the SFA, the company has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the shares of common stock are “prescribed capital markets products” (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).
Notice to prospective investors in Switzerland
This prospectus does not constitute an offer to the public or a solicitation to purchase or invest in any shares of common stock. No shares of common stock have been offered or will be offered to the public in Switzerland, except that offers of shares of common stock may be made to the public in Switzerland at any time under the following exemptions under the Swiss Financial Services Act (“FinSA”):
(a) to any person which is a professional client as defined under the FinSA;
(b) to fewer than 500 persons (other than professional clients as defined under the FinSA), subject to obtaining the prior consent of the joint book-running managers for any such offer; or
(c) in any other circumstances falling within Article 36 FinSA in connection with Article 44 of the Swiss Financial Services Ordinance,
provided that no such offer of shares of common stock shall require the Company or any bank to publish a prospectus pursuant to Article 35 FinSA.
The shares of common stock have not been and will not be listed or admitted to trading on a trading venue in Switzerland.
Neither this document nor any other offering or marketing material relating to the shares of common stock constitutes a prospectus as such term is understood pursuant to the FinSA and neither this document nor any other offering or marketing material relating to the shares of common stock may be publicly distributed or otherwise made publicly available in Switzerland.
Legal matters
Certain legal matters relating to this offering will be passed upon for us by Latham & Watkins LLP, New York, NY, and the validity of the shares of common stock offered hereby will be passed upon for us by Brownstein Hyatt Farber Schreck, LLP, Las Vegas, NV. Certain matters will be passed upon for the underwriters by Skadden, Arps, Slate, Meagher & Flom LLP, New York, NY.
Experts
The consolidated financial statements and schedules of Ategrity Specialty Holdings LLC and subsidiaries at December 31, 2024 and 2023, and for each of the two years in the period ended December 31, 2024, appearing in this Prospectus and Registration Statement have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
Where you can find more information
We have filed with the SEC, a registration statement on Form S-1 under the Securities Act with respect to the common stock offered in this prospectus. This prospectus, filed as part of the registration statement, does not contain all of the information set forth in the registration statement and its exhibits and schedules, portions of which have been omitted as permitted by the rules and regulations of the SEC. You can find further information about us in the registration statement and its exhibits and schedules. Statements in this prospectus about the contents of any contract, agreement, or other document are not necessarily complete and, in each instance, we refer you to the copy of such contract, agreement, or document filed as an exhibit to the registration statement, with each such statement being qualified in all respects by reference to the document to which it refers. Anyone may inspect the registration statement and its exhibits and schedules without charge at the Public Reference Room of the SEC located at 100 F Street, N.E., Washington, DC 20549. You may obtain copies of all or any part of these materials from the SEC upon the payment of certain fees prescribed by the SEC. You may obtain further information about the operation of the SEC’s Public Reference Room by calling the SEC at 1-800-SEC-0330. You may also inspect these reports and other information without charge at the SEC’s website (http://www.sec.gov).
Upon the closing of this offering, we will become subject to the informational requirements of the Exchange Act, as amended, and will be required to file periodic current reports, proxy statements, and other information with the SEC. You will be able to inspect and copy these reports, proxy statements, and other information at the SEC’s public reference facilities at the address noted above. You also will be able to inspect this material without charge at the SEC’s website. We intend to furnish our stockholders with annual reports containing financial statements audited by an independent accounting firm.
In addition, following the closing of this offering, we will make the information filed with or furnished to the SEC available free of charge through our website (http://www.ategrity.com) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information contained on our website is not a part of this prospectus.
Ategrity Specialty Holdings LLC and Subsidiaries
Index to Financial Statements
| |
|
|
Page
|
|
|
Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-2 |
|
|
|
|
|
|
|
|
F-3 |
|
|
|
|
|
|
|
|
F-4 |
|
|
|
|
|
|
|
|
F-5 |
|
|
|
|
|
|
|
|
F-6 |
|
|
|
|
|
|
|
|
F-7 |
|
|
|
Financial Statement Schedules
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-45 |
|
|
|
|
|
|
|
|
F-46 |
|
|
|
|
|
|
|
|
F-49 |
|
|
|
|
|
|
|
|
F-50
|
|
|
Schedules other than those listed are omitted for the reason that they are not required, are not applicable or that equivalent information has been included in the financial statements or notes thereto or elsewhere herein.
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Ategrity Specialty Holdings LLC and subsidiaries
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Ategrity Specialty Holdings LLC and subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive income, changes in members’ equity and non-controlling interest and cash flows for each of the two years in the period ended December 31, 2024, and the related notes and financial statement schedules (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2018.
Tysons, Virginia
March 04, 2025
Ategrity Specialty Holdings LLC and Subsidiaries
Consolidated Balance Sheets
| |
|
|
As of December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at fair value (amortized cost of $434,965 in 2024 and $103,789 in 2023)
|
|
|
|
$ |
438,752 |
|
|
|
|
$ |
98,200 |
|
|
|
Equity securities, at fair value (cost of $0 in 2024 and $1,000 in 2023)
|
|
|
|
|
— |
|
|
|
|
|
1,000 |
|
|
|
Utility & infrastructure investments, at fair value (cost of $216,075 in 2024 and $221,175 in 2023)
|
|
|
|
|
270,242 |
|
|
|
|
|
253,045 |
|
|
|
Short-term investments
|
|
|
|
|
52,612 |
|
|
|
|
|
— |
|
|
|
Other invested assets
|
|
|
|
|
280 |
|
|
|
|
|
694 |
|
|
|
Total invested assets
|
|
|
|
|
761,886 |
|
|
|
|
|
352,939 |
|
|
|
Cash and cash equivalents
|
|
|
|
|
26,573 |
|
|
|
|
|
264,646 |
|
|
|
Investment income due and accrued
|
|
|
|
|
5,642 |
|
|
|
|
|
1,098 |
|
|
|
Premiums receivable, net of allowance for credit losses of $5,907 in 2024 and $2,953 in 2023
|
|
|
|
|
53,500 |
|
|
|
|
|
49,103 |
|
|
|
Deferred policy acquisition costs, net of ceding commissions
|
|
|
|
|
21,552 |
|
|
|
|
|
23,245 |
|
|
|
Note receivable from affiliate
|
|
|
|
|
13,501 |
|
|
|
|
|
13,501 |
|
|
|
Prepaid reinsurance premiums
|
|
|
|
|
3,905 |
|
|
|
|
|
396 |
|
|
|
Deferred income tax asset, net
|
|
|
|
|
9,670 |
|
|
|
|
|
7,221 |
|
|
|
Reinsurance recoverable, net of allowance for credit losses of $0 in 2024 and $0 in
2023
|
|
|
|
|
133,616 |
|
|
|
|
|
125,671 |
|
|
|
Ceded unearned premiums
|
|
|
|
|
68,205 |
|
|
|
|
|
37,852 |
|
|
|
Other assets
|
|
|
|
|
25,388 |
|
|
|
|
|
6,370 |
|
|
|
Total assets
|
|
|
|
$ |
1,123,438 |
|
|
|
|
$ |
882,042 |
|
|
|
Liabilities, members’ equity and non-controlling interest:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
|
403,576 |
|
|
|
|
|
320,936 |
|
|
|
Unearned premiums
|
|
|
|
|
212,828 |
|
|
|
|
|
173,905 |
|
|
|
Securities sold, not yet purchased, at fair value (cost of $932 in 2024 and $12,379
in 2023)
|
|
|
|
|
930 |
|
|
|
|
|
12,130 |
|
|
|
Payable to reinsurers
|
|
|
|
|
27,160 |
|
|
|
|
|
15,669 |
|
|
|
Due to broker
|
|
|
|
|
9,189 |
|
|
|
|
|
— |
|
|
|
Accounts payable and accrued expenses
|
|
|
|
|
38,061 |
|
|
|
|
|
17,899 |
|
|
|
Funds held under reinsurance treaties
|
|
|
|
|
2,092 |
|
|
|
|
|
4,589 |
|
|
|
Income tax payable
|
|
|
|
|
26,488 |
|
|
|
|
|
8,852 |
|
|
|
Other liabilities
|
|
|
|
|
4,307 |
|
|
|
|
|
5,865 |
|
|
|
Total liabilities
|
|
|
|
|
724,631 |
|
|
|
|
|
559,845 |
|
|
|
Members’ equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Members’ equity
|
|
|
|
|
360,741 |
|
|
|
|
|
338,634 |
|
|
|
Retained earnings (deficit)
|
|
|
|
|
34,569 |
|
|
|
|
|
(12,521) |
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
|
2,997 |
|
|
|
|
|
(4,416) |
|
|
|
Total members’ equity
|
|
|
|
|
398,307 |
|
|
|
|
|
321,697 |
|
|
|
Non-controlling interest−General Partner
|
|
|
|
|
500 |
|
|
|
|
|
500 |
|
|
|
Total members’ equity and non-controlling interest
|
|
|
|
|
398,807 |
|
|
|
|
|
322,197 |
|
|
|
Total liabilities, members’ equity and non-controlling interest
|
|
|
|
$ |
1,123,438 |
|
|
|
|
$ |
882,042 |
|
|
| |
See accompanying Notes to Consolidated Financial Statements.
Ategrity Specialty Holdings LLC and Subsidiaries
Consolidated Statements of Operations and Comprehensive Income
| |
|
|
For the Years Ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross written premiums
|
|
|
|
$ |
437,036 |
|
|
|
|
$ |
352,591 |
|
|
|
Ceded written premiums
|
|
|
|
|
(137,830) |
|
|
|
|
|
(84,375) |
|
|
|
Net written premiums
|
|
|
|
|
299,206 |
|
|
|
|
|
268,216 |
|
|
|
Change in unearned premiums
|
|
|
|
|
(8,571) |
|
|
|
|
|
(36,752) |
|
|
|
Net premiums earned
|
|
|
|
|
290,635 |
|
|
|
|
|
231,464 |
|
|
|
Fee income
|
|
|
|
|
918 |
|
|
|
|
|
660 |
|
|
|
Net investment income
|
|
|
|
|
24,046 |
|
|
|
|
|
11,366 |
|
|
|
Net realized and unrealized gains (losses) on investments
|
|
|
|
|
28,140 |
|
|
|
|
|
(2,269) |
|
|
|
Other income
|
|
|
|
|
95 |
|
|
|
|
|
95 |
|
|
|
Total revenues
|
|
|
|
|
343,834 |
|
|
|
|
|
241,316 |
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses and loss adjustment expenses
|
|
|
|
|
175,234 |
|
|
|
|
|
154,107 |
|
|
|
Underwriting, acquisition and insurance expenses
|
|
|
|
|
98,567 |
|
|
|
|
|
72,155 |
|
|
|
Interest expense
|
|
|
|
|
2,042 |
|
|
|
|
|
2,237 |
|
|
|
Other expenses
|
|
|
|
|
1,727 |
|
|
|
|
|
196 |
|
|
|
Total expenses
|
|
|
|
|
277,570 |
|
|
|
|
|
228,695 |
|
|
|
Income before income taxes
|
|
|
|
|
66,264 |
|
|
|
|
|
12,621 |
|
|
|
Income tax expense
|
|
|
|
|
12,316 |
|
|
|
|
|
2,518 |
|
|
|
Net income
|
|
|
|
|
53,948 |
|
|
|
|
|
10,103 |
|
|
|
Less: Net income attributable to non-controlling interest−General
Partner
|
|
|
|
|
6,858 |
|
|
|
|
|
55 |
|
|
|
Net income attributable to members
|
|
|
|
|
47,090 |
|
|
|
|
|
10,048 |
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains, net of taxes
|
|
|
|
|
7,413 |
|
|
|
|
|
3,246 |
|
|
|
Less: Unrealized gains, net of taxes attributable to non-controlling interest
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
Total comprehensive income attributable to members
|
|
|
|
$ |
54,503 |
|
|
|
|
$ |
13,294 |
|
|
|
Earnings per member’s unit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
$ |
0.12 |
|
|
|
|
$ |
0.03 |
|
|
|
Diluted
|
|
|
|
$ |
0.12 |
|
|
|
|
$ |
0.03 |
|
|
|
Weighted-average units outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
390,738,224 |
|
|
|
|
|
349,938,678 |
|
|
|
Diluted
|
|
|
|
|
390,756,416 |
|
|
|
|
|
349,948,799 |
|
|
See accompanying Notes to Consolidated Financial Statements.
Ategrity Specialty Holdings LLC and Subsidiaries
Consolidated Statements of Changes in Members’ Equity and
Non-Controlling Interest
| |
|
|
Members’
Equity
|
|
|
Retained
Earnings
(Deficit)
|
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
|
Total
Members’
Equity
|
|
|
Non-
Controlling
Interest
|
|
|
Total Members’
Equity and
Non-Controlling
Interest
|
|
| |
|
|
(in thousands)
|
|
|
Balance at January 1, 2023
|
|
|
|
$ |
303,364 |
|
|
|
|
$ |
(22,569) |
|
|
|
|
$ |
(7,662) |
|
|
|
|
$ |
273,133 |
|
|
|
|
$ |
3,584 |
|
|
|
|
$ |
276,717 |
|
|
|
Member units issued
|
|
|
|
|
35,243 |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
35,243 |
|
|
|
|
|
— |
|
|
|
|
|
35,243 |
|
|
|
Share-based compensation
|
|
|
|
|
27 |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
27 |
|
|
|
|
|
— |
|
|
|
|
|
27 |
|
|
|
Distributions
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
(3,139) |
|
|
|
|
|
(3,139) |
|
|
|
Net income
|
|
|
|
|
— |
|
|
|
|
|
10,048 |
|
|
|
|
|
— |
|
|
|
|
|
10,048 |
|
|
|
|
|
55 |
|
|
|
|
|
10,103 |
|
|
|
Other comprehensive income,
net of taxes
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
3,246 |
|
|
|
|
|
3,246 |
|
|
|
|
|
— |
|
|
|
|
|
3,246 |
|
|
|
Balance at December 31, 2023
|
|
|
|
$ |
338,634 |
|
|
|
|
$ |
(12,521) |
|
|
|
|
$ |
(4,416) |
|
|
|
|
$ |
321,697 |
|
|
|
|
$ |
500 |
|
|
|
|
$ |
322,197 |
|
|
|
Member units issued
|
|
|
|
|
20,100 |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
20,100 |
|
|
|
|
|
— |
|
|
|
|
|
20,100 |
|
|
|
Share-based compensation
|
|
|
|
|
2,007 |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
2,007 |
|
|
|
|
|
— |
|
|
|
|
|
2,007 |
|
|
|
Distributions
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
(6,858) |
|
|
|
|
|
(6,858) |
|
|
|
Net income
|
|
|
|
|
— |
|
|
|
|
|
47,090 |
|
|
|
|
|
— |
|
|
|
|
|
47,090 |
|
|
|
|
|
6,858 |
|
|
|
|
|
53,948 |
|
|
|
Other comprehensive income,
net of taxes
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
7,413 |
|
|
|
|
|
7,413 |
|
|
|
|
|
— |
|
|
|
|
|
7,413 |
|
|
|
Balance at December 31,
2024
|
|
|
|
$ |
360,741 |
|
|
|
|
$ |
34,569 |
|
|
|
|
$ |
2,997 |
|
|
|
|
$ |
398,307 |
|
|
|
|
$ |
500 |
|
|
|
|
$ |
398,807 |
|
|
| |
See accompanying Notes to Consolidated Financial Statements.
Ategrity Specialty Holdings LLC and Subsidiaries
Consolidated Statements of Cash Flows
| |
|
|
For the Years Ended
December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$ |
53,948 |
|
|
|
|
$ |
10,103 |
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of premium/discount on fixed maturity securities, available-for-sale
|
|
|
|
|
(3,807) |
|
|
|
|
|
326 |
|
|
|
Net realized and unrealized gains (losses) on investments
|
|
|
|
|
(27,921) |
|
|
|
|
|
2,412 |
|
|
|
Net investment income
|
|
|
|
|
(3,102) |
|
|
|
|
|
(2,979) |
|
|
|
Depreciation and amortization
|
|
|
|
|
699 |
|
|
|
|
|
227 |
|
|
|
Share-based compensation
|
|
|
|
|
2,007 |
|
|
|
|
|
27 |
|
|
|
Expenses allocated from affiliate
|
|
|
|
|
— |
|
|
|
|
|
244 |
|
|
|
Change in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
|
|
(4,412) |
|
|
|
|
|
(6,970) |
|
|
|
Investment income due and accrued
|
|
|
|
|
(4,544) |
|
|
|
|
|
(575) |
|
|
|
Premiums receivable, net
|
|
|
|
|
(4,398) |
|
|
|
|
|
(6,166) |
|
|
|
Deferred policy acquisition costs, net of ceding commissions
|
|
|
|
|
1,693 |
|
|
|
|
|
(3,597) |
|
|
|
Note receivable from affiliate
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
Prepaid reinsurance premiums
|
|
|
|
|
(3,509) |
|
|
|
|
|
(143) |
|
|
|
Income tax receivable
|
|
|
|
|
— |
|
|
|
|
|
4,344 |
|
|
|
Reinsurance recoverable
|
|
|
|
|
(7,945) |
|
|
|
|
|
1,656 |
|
|
|
Ceded unearned premiums
|
|
|
|
|
(30,353) |
|
|
|
|
|
(1,674) |
|
|
|
Other assets
|
|
|
|
|
(19,488) |
|
|
|
|
|
(857) |
|
|
|
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
|
82,640 |
|
|
|
|
|
44,498 |
|
|
|
Unearned premiums
|
|
|
|
|
38,924 |
|
|
|
|
|
38,427 |
|
|
|
Payable to reinsurers
|
|
|
|
|
11,491 |
|
|
|
|
|
143 |
|
|
|
Accounts payable and accrued expenses
|
|
|
|
|
30,163 |
|
|
|
|
|
5,551 |
|
|
|
Funds held under reinsurance treaties
|
|
|
|
|
(2,497) |
|
|
|
|
|
(6,817) |
|
|
|
Income tax payable
|
|
|
|
|
17,636 |
|
|
|
|
|
8,852 |
|
|
|
Other liabilities
|
|
|
|
|
(1,614) |
|
|
|
|
|
(1,325) |
|
|
|
Net cash provided by operating activities
|
|
|
|
|
125,611 |
|
|
|
|
|
85,707 |
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of fixed maturity securities, available-for-sale
|
|
|
|
|
(389,306) |
|
|
|
|
|
(136,964) |
|
|
|
Proceeds from sale of fixed maturity securities, available-for-sale
|
|
|
|
|
99,377 |
|
|
|
|
|
124,323 |
|
|
|
Maturities and redemptions of fixed maturity securities, available-for-sale
|
|
|
|
|
17,665 |
|
|
|
|
|
15,173 |
|
|
|
Purchase of equity securities
|
|
|
|
|
— |
|
|
|
|
|
(1,000) |
|
|
|
Redemptions of Utility & Infrastructure investments
|
|
|
|
|
414 |
|
|
|
|
|
2,725 |
|
|
|
Purchase of other assets
|
|
|
|
|
(164) |
|
|
|
|
|
(66) |
|
|
|
Change in Treasury bills, net
|
|
|
|
|
(39,199) |
|
|
|
|
|
— |
|
|
|
Change in short-term investments, net
|
|
|
|
|
(53,381) |
|
|
|
|
|
— |
|
|
|
Purchases to cover securities sold, not yet purchased
|
|
|
|
|
1,257 |
|
|
|
|
|
(56,974) |
|
|
|
Proceeds from sale of securities sold, not yet purchased
|
|
|
|
|
(348) |
|
|
|
|
|
67,703 |
|
|
|
Proceeds from sale of other invested assets
|
|
|
|
|
415 |
|
|
|
|
|
— |
|
|
|
Purchase of other invested assets
|
|
|
|
|
— |
|
|
|
|
|
(408) |
|
|
|
Net cash (used in) provided by investing activities
|
|
|
|
|
(363,270) |
|
|
|
|
|
14,512 |
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Members’ units
|
|
|
|
|
— |
|
|
|
|
|
35,000 |
|
|
|
Capital distribution
|
|
|
|
|
(414) |
|
|
|
|
|
(2,725) |
|
|
|
Net cash (used in) provided by financing activities
|
|
|
|
|
(414) |
|
|
|
|
|
32,275 |
|
|
|
Net change in cash and cash equivalents
|
|
|
|
|
(238,073) |
|
|
|
|
|
132,494 |
|
|
|
Cash and cash equivalents, at beginning of period
|
|
|
|
|
264,646 |
|
|
|
|
|
132,152 |
|
|
|
Cash and cash equivalents, at end of period
|
|
|
|
$ |
26,573 |
|
|
|
|
$ |
264,646 |
|
|
|
Supplementary cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
|
|
$ |
2,124 |
|
|
|
|
$ |
2,192 |
|
|
|
Cash paid for taxes
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
Supplementary non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Members’ units issued in exchange for U.S. Treasury bills
|
|
|
|
$ |
20,100 |
|
|
|
|
$ |
— |
|
|
|
Note receivable from affiliate received from the sale of property and equipment, net
|
|
|
|
$ |
— |
|
|
|
|
$ |
13,501 |
|
|
See accompanying Notes to Consolidated Financial Statements.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
1. Organization
Ategrity Specialty Holdings LLC (“ASHL”) is an insurance holding company formed in 2017 and commenced operations in 2018. ASHL is registered in Delaware and conducts its operations principally through its wholly owned subsidiaries providing excess and surplus lines insurance and reinsurance products. The Company is majority owned by Zimmer Financial Services Group LLC (“ZFSG”), a financial services holding company with operations in the insurance and asset management industries. The following are ASHL’s operating subsidiaries:
•
Ategrity Specialty Insurance Company (“ASIC”), which is registered in Delaware and organized for the purpose of writing excess and surplus lines insurance on a non-admitted basis in the United States.
•
Ategrity Specialty Insurance Limited (“ASIL”) was incorporated under the laws of Bermuda (owned through Ategrity Specialty Holdings Limited, an intermediate holding company domiciled in Bermuda) for the sole purpose of providing quota-share insurance to ASIC.
ASHL and its subsidiaries own approximately 99.8% of ZP Utility Insurance Fund, L.P. (the “Utility Limited Partnership”). The Utility Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the Utility Limited Partnership invests substantially all of its assets in ZP Master Utility Fund, Ltd. (the “Absolute Return Utility & Infrastructure Fund”), an exempted company incorporated in the Cayman Islands.
2. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of ASHL and its consolidated subsidiaries, as well as the Utility Limited Partnership, a variable interest entity (“VIE”) that meets the requirements for consolidation (see Note 3 for further details) (collectively referred to as the “Company”). All intercompany accounts and transactions have been eliminated in consolidation.
Estimates and Assumptions
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. Management makes estimates and assumptions that include, but are not limited to, reserves for unpaid losses and loss adjustment expenses, fair value of financial assets and liabilities, allowance for credit losses, and income taxes.
Those estimates are inherently subject to change, and actual results may ultimately differ from those estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash includes $26.1 million and $10.0 million of cash, primarily held at two major financial institutions, as of December 31, 2024 and 2023, respectively. The cash amount on deposit may exceed the insured limit of the institution and exposes the Company to credit risk. As of December 31, 2024 and 2023, the Company held $0.5 million and $254.7 million, respectively, in cash equivalents which includes money market funds and highly liquid short-term deposits and securities with maturities of 90 days or less at the date of purchase.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Short-term Investments
Short-term investments are carried at amortized cost, which approximates fair value. Short-term investments have maturities greater than three months but less than one year at the date of purchase.
Investments
Available-for-Sale
Fixed maturity securities classified as “available-for-sale” are carried at fair value with unrealized gains and losses on such securities, net of any deferred taxes, reported as a separate component of accumulated other comprehensive income.
The Company does not have any securities classified as “held-to-maturity.”
Interest on fixed-maturity securities is credited to earnings as it accrues. Premiums and discounts are amortized or accreted using the constant yield method over the lives of the related fixed maturities, or to the earliest call date for securities purchased at a premium. This method includes an adjustment for estimated principal prepayments, if any, on asset- and mortgage-backed securities. To the extent that the estimated lives of such securities change as a result of changes in estimated prepayment rates, the adjustments are included in net investment income using the retrospective method.
Realized investment gains or losses are determined on a specific identification basis. Interest income is recognized as earned and dividend income is recognized on the ex-dividend date.
Allowance for Credit Losses
The Company performs a periodic assessment of its available-for-sale portfolio to determine if there is a decline in the fair value below the amortized cost basis and if it is due to credit-related factors or noncredit-related factors (i.e., changes in market-based interest rates). An allowance for credit losses is recorded for any credit-related impairments, limited to the amount by which fair value is below amortized cost. Changes in the allowance for credit losses are recognized in earnings and included in net investment income. Unrealized losses that are not credit-related are recognized in other comprehensive income. See Note 4 for further discussion of credit losses. The Company also considers whether it intends to sell the security or if it is more likely than not that it will be required to sell the security before recovery of its amortized cost. When assessing whether it intends to sell a fixed-maturity security or if it is likely to be required to sell a fixed-maturity security before recovery of its amortized cost, the Company evaluates facts and circumstances including, but not limited to, decisions to reposition the investment portfolio, potential sales of investments to meet cash flow needs, and potential sales of investments to capitalize on favorable pricing.
The Company reports accrued interest receivable as a component of accrued investment income on its consolidated balance sheets which is presented separately from available-for-sale securities. The Company does not measure an allowance for credit losses on accrued interest receivable and instead would write off accrued interest receivable at the time an issuer defaults or is expected to default on payments.
Equity Securities
Equity securities are reported at fair value. Changes in unrealized gains and losses in fair value of these investments are recognized in net income.
Utility & Infrastructure Investments
Utility & Infrastructure Investments consisted of our investment in the Absolute Return Utility & Infrastructure Fund via the Utility Limited Partnership. In consolidating the Utility Limited Partnership, the Company retained the
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
specialized industry accounting (as described below) and presents its investment in the Absolute Return Utility & Infrastructure Fund as a single net asset, equal to the Company’s proportionate share of the underlying net asset value (“NAV”) of the Absolute Return Utility & Infrastructure Fund. The performance of the Company is directly affected by the performance of the Absolute Return Utility & Infrastructure Fund.
The Company accounts for its investment in the Absolute Return Utility & Infrastructure Fund under the variable interest model at NAV as a practical expedient for fair value. Increases or decreases in such fair values are recorded within net realized gains and unrealized gains (losses) on investments in the consolidated statement of operations. Realized gains or losses upon any withdrawals of investments in the Absolute Return Utility & Infrastructure Fund are calculated using the weighted average method. Net investment income from the Absolute Return Utility & Infrastructure Fund, net of related expenses, is recorded with net investment income in the consolidated statement of operations. Generally, all investment income received is reinvested into the Absolute Return Utility & Infrastructure Fund. The assets and liabilities of the Absolute Return Utility & Infrastructure Fund are recorded at fair value, or at amounts approximating fair value. The Company records contributions and withdrawals related to its investments in the Absolute Return Utility & Infrastructure Fund on the transaction date.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities that qualify as financial instruments under fair value accounting guidance approximates the carrying amounts presented in the consolidated financial statements.
Fair value estimates are made at a specific point in time based on market conditions and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates (see Note 5 for further details).
Non-controlling Interest
General Partner in the consolidated balance sheets represents ZP Utility Insurance GP, LLC’s (the “Utility General Partner”) interest in the Utility Limited Partnership. See Note 3 for further discussion and related disclosures regarding VIEs.
Written Premiums
Written premiums are earned on a pro rata basis over the terms of the policies, which are generally 12 months. The portion of premiums written applicable to the unexpired terms of the policies in force is recorded as unearned premiums. Advanced premiums, if received prior to the policy effective date, are included within other liabilities in the accompanying consolidated balance sheets. Policies are accounted for on an individual basis, with no aggregation by counterparty.
Premiums Receivable, Net
Premiums receivable are carried at face value, net of any allowance for credit losses. The allowance for credit losses represents an estimate of amounts considered uncollectible based on the Company’s assessment of the collectability of receivables. The estimate considers historical collection data, current economic conditions and expectations of future conditions that could affect ultimate collections. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following table presents the rollforward of the allowance for credit losses for premiums receivable for the years ended December 31, 2024 and 2023.
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Beginning balance
|
|
|
|
$ |
2,953 |
|
|
|
|
$ |
— |
|
|
| |
Current period change for estimated uncollectible premiums
|
|
|
|
|
2,954 |
|
|
|
|
|
2,953 |
|
|
| |
Write-offs of uncollectible premiums receivable
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Ending balance
|
|
|
|
$ |
5,907 |
|
|
|
|
$ |
2,953 |
|
|
| |
Deferred Policy Acquisition Costs
Costs which are incrementally or directly related to the successful acquisition of new or renewal insurance business are deferred. These deferred costs are primarily commissions to distribution partners and the portion of underwriting compensation and payroll-related fringe benefits directly related to an insurance contract that has been acquired, net of ceding commissions related to reinsurance ceded. Amortization of such policy acquisition costs is charged to expense in proportion to premium earned over the estimated policy life. To the extent that unearned premiums on existing policies are not adequate to cover projected related costs and expenses, deferred policy acquisition costs are charged to earnings. The Company considers anticipated investment income when determining whether premium deficiency exists. No premium deficiency reserves were recorded as of December 31, 2024 and 2023, respectively.
Reinsurance Recoverable and Prepaid Reinsurance Premiums
Certain premiums and losses are ceded to other insurance companies under various excess of loss and quota-share reinsurance contracts. The Company enters into ceded reinsurance contracts to limit its exposure to large losses, to limit exposure on new lines of insurance written by the Company and to provide additional capacity for growth.
Premiums, commissions and losses and loss adjustment expenses on reinsured business are accounted for on a basis consistent with that used in accounting for the original policies issued and the terms of the reinsurance contracts. Reinsurance recoverable and prepaid reinsurance premiums are reported as assets. The Company is exposed to credit losses from reinsurers being unable to meet their obligations. The Company uses a provision matrix to calculate the allowance for credit losses on reinsurance recoverables by applying impairment rates based on historical loss data to similarly rated reinsurance companies based on the expected duration of the receivables. The Company also considers the expected impact of current and future expected economic conditions and adjusts estimates if needed based on an evaluation of these factors. The Company also evaluates the financial condition of potential reinsurers and reinsures its business with highly rated reinsurers with a rating of “A-” (Excellent) or better from A.M. Best. The Company has not experienced any credit losses from reinsurance recoverables and did not record an allowance for uncollectible reinsurance recoverables as of December 31, 2024 or 2023.
The Company may purchase reinsurance on certain lines of business in the form of loss portfolio transfers (“LPT”). These contracts provide indemnification of losses related to past loss events where the reinsurer shares losses, either a proportion of or in its entirety, depending on certain dollar thresholds. Income generated from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period and losses are charged to net income immediately. Subsequent changes in the measurement of the retroactive reinsurance contract are accounted for under a full retrospective method.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The Company receives ceding commissions in connection with certain ceded reinsurance. The ceding commissions do not exceed amounts paid on direct business and are recorded as a reduction of underwriting, acquisition and insurance expenses.
Payable to Reinsurers and Funds Held Under Reinsurance Treaties
Payable to reinsurers includes ceded premiums due to reinsurers. Funds held under reinsurance treaties includes ceded premiums retained by the Company under contracts to fund ceded losses as they become due.
Fee Income
Fee income includes policy fees charged to insureds and is recognized in earnings when the related premium is written.
Income Taxes
The Company is included in ZFSG’s consolidated Federal income tax return and in various combined State income tax returns. The income tax expense in the Company’s consolidated financial statements was determined on a stand-alone return basis which requires the recognition of income taxes using the liability method. Under this method, the Company calculates its tax provision on a stand-alone basis, separately from ZFSG, reporting taxable income or loss and paying applicable tax based on a separate taxable income and associated tax attributes in each tax jurisdiction.
The income tax expense, deferred income tax assets and deferred income tax liabilities reflect management’s best assessment of estimated future taxes to be paid. Significant judgments and estimates are required in determining our consolidated income tax expense.
Deferred income tax assets and deferred income tax liabilities are provided for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of assets and liabilities and their respective U.S. tax bases. Deferred income tax assets and liabilities are measured using enacted U.S. corporate tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets are reduced by a valuation allowance only when management believes it is more likely than not that some, or all, of the deferred tax assets will not be realized. The Company evaluates deferred tax assets for recoverability using a consistent approach which considers the relative impact of negative and positive evidence, including historical financial performance, projections of future taxable income, future reversals of existing taxable temporary differences, any available carryback capacity and tax planning strategies.
Leases
At the inception date, the Company assesses whether or not a contract is or contains a lease and any lease’s classification as a finance or operating lease. All of the Company’s leases existing as of December 31, 2024 qualify as operating leases. For operating leases with a term longer than 12 months, the Company recognizes a lease liability and right-of-use asset within other liabilities and other assets respectively, in the accompanying consolidated balance sheets, at the present value of the lease payments. Payments made under operating leases are recognized in the consolidated statements of operations and comprehensive income on a straight-line basis over the term of the lease. Lease terms include all contractual periods covered by options that are reasonably certain to be exercised. As lease contracts generally do not provide an implicit discount rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date to determine the present value of the lease payments. The weighted-average discount rate used in calculating the lease liabilities and right-of-use assets in 2024 was 5.25%.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Reserves for Unpaid Losses and Loss Adjustment Expenses
The reserves for unpaid losses and loss adjustment expenses represent the estimated ultimate cost of all reported and unreported losses and loss adjustment expenses incurred and unpaid at the balance sheet date. The Company does not discount this reserve. The process of estimating the reserves for unpaid losses and loss adjustment expenses requires a high degree of judgment and is subject to a number of variables. The estimates are based on actuarial methods that use a combination of management’s initial expected loss ratios and reporting patterns for those losses based on industry data and the Company’s actual reported losses and loss adjustment expenses. If actual loss emergence is better than initial expected ratio assumptions, the Company will experience favorable development; if it is worse than initial expected ratio assumptions, the Company will experience adverse development.
Catastrophes of significant magnitude, including hurricanes and earthquakes, involve complex coverage issues. In estimating the reserves for unpaid losses and loss adjustment expenses for these catastrophes, management uses case reserve estimates based on information obtained from site inspections by the Company’s adjustors and the terms of coverage provided in the policies. Management estimates reserves for incurred but not reported claims (“IBNR”) for these catastrophes using judgment based on an assessment of the Company’s property insurance exposures where the catastrophes occur and the Company’s progress in settling claims.
Although management believes that the reserves for unpaid losses and loss adjustment expenses are reasonable, it is possible that the Company’s actual incurred losses and loss adjustment expenses will not develop in a manner consistent with the assumptions inherent in the determination of these reserves. Specifically, the Company’s actual ultimate loss ratio could differ from management’s initial expected loss ratio and/or the Company’s actual reporting patterns for losses could differ from the expected reporting patterns. Accordingly, the ultimate settlement of losses and the related loss adjustment expenses may vary significantly from the estimates included in the Company’s financial statements. These estimates are reviewed regularly by management and are adjusted as necessary as experience develops or new information becomes known; such adjustments are included in current operations.
Variable Interest Entities (“VIEs”)
Entities that do not have sufficient equity at risk to allow the entity to finance its activities without additional financial support or in which the equity investors, as a group, do not have the characteristic of a controlling financial interest are referred to as VIEs. A VIE is consolidated by the variable interest holder that is determined to have the controlling financial interest (primary beneficiary) as a result of having both the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. The Company determines whether it is the primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE’s capital structure, contractual terms, nature of the VIE’s operations and purpose and the Company’s relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE. The Company reassesses its VIE determination with respect to an entity on an ongoing basis. See Note 3 for further discussion and related disclosures regarding VIEs.
Share-Based Compensation
Compensation cost for awards of equity instruments to employees is measured based on the grant-date fair value of those awards and compensation expense is recognized over the service period that the awards vest. Forfeitures of share-based compensation awards are recognized as they occur. See Note 16 for further discussion and related disclosures regarding share-based compensation.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Allocation of Expenses
The Company accounts for costs incurred by ZFSG and affiliated entities for services provided to the Company by applying the direct usage method when identifiable, with the remainder using proportional cost allocation methodology based on a reasonable allocation basis, i.e., time spent for compensation.
Securities Sold, Not Yet Purchased
Securities sold, not yet purchased, represent obligations to deliver specified securities. The Company is obligated to acquire the securities sold, not yet purchased at prevailing market prices in the future to satisfy these obligations. Securities sold, not yet purchased, are stated at fair value in the consolidated balance sheets.
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own Members’ units, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period end date while the warrants are outstanding. All of the Company’s warrants have met the criteria for equity treatment and are accounted for at fair value on the issuance date and are not required to be remeasured at each reporting date until the warrants are settled.
Recent Accounting Pronouncements
The Company currently qualifies as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Accordingly, the Company is provided the option to adopt new or revised accounting guidance either (i) within the same periods as those otherwise applicable to non-emerging growth companies or (ii) within the same time periods as private companies.
Accounting Standard Updates Adopted in 2023
The Company adopted Accounting Standards Update (ASU), No. 2016-13, Financial instruments — Credit losses (Topic 326): Measurement of credit losses on financial instruments on January 1, 2023 using the modified retrospective method for all financial assets in scope. The new accounting standard introduced the current expected credit losses methodology (“CECL”) for estimating allowance for credit losses. In accordance with the new guidance, the Company is required to estimate expected credit losses on financial assets in scope based on historical experience, current conditions, and reasonable forecasts. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements and disclosures.
Accounting Standard Updates Adopted in 2024
The Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements by requiring disclosures of significant reportable segment expenses that are regularly provided to the Chief Operating Decision Maker (“CODM”) and included within each reported measure of a segment’s profit or loss. The ASU also requires disclosure of the title and position of the individual identified as the CODM and an explanation of how the CODM uses the reported measures of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. Additionally, ASU 2023-07 requires all segment profit or loss and assets disclosures to be provided on an
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
annual and interim basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024. See Note 17 for the Company’s segment reporting disclosures.
Accounting Standard Updates Not Yet Adopted
In December 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). ASU 2023-09 requires public companies, on an annual basis, to provide enhanced rate reconciliation disclosures, including disclosures of specific categories and additional information that meet a quantitative threshold. This update also requires public companies to, among other things, disaggregate income taxes paid by federal, state and foreign taxes. The guidance is effective for fiscal years beginning after December 15, 2024. The Company is evaluating the effect of the amendments on its consolidated financial statements and disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods thereafter, with early adoption permitted. The Company is evaluating the effect of the amendments on its consolidated financial statements and disclosures.
3. Variable Interest Entities
The Company has entered into the Amended and Restated Limited Partnership Agreement of the ZP Utility Insurance Fund, L.P. The Utility Limited Partnership was formed on March 19, 2018 under the laws of the State of Delaware and commenced operations on April 1, 2018. The Utility Limited Partnership operates as a feeder fund in a “master-feeder” structure, in which the Utility Limited Partnership invests substantially all of its assets in the Absolute Return Utility & Infrastructure Fund, an exempted company incorporated in the Cayman Islands. The Utility General Partner is responsible for the investment decisions of the Utility Limited Partnership.
Zimmer Partners, LP (the “Investment Manager”), a Delaware limited partnership and a related party, is the investment manager of the Absolute Return Utility & Infrastructure Fund and the Utility Limited Partnership. The Investment Manager is registered with the United States Securities and Exchange Commission as a registered investment advisor under the Investment Advisors Act of 1940.
ZP Utility Insurance GP, LLC a Delaware limited liability company and a related party, is the general partner of the Utility Limited Partnership and is responsible for the investment decisions of the Utility Limited Partnership. The Utility General Partner owned less than 1% of the Utility Limited Partnership as of December 31, 2024 and 2023.
The Company performed an assessment of all relevant facts and circumstances and determined that the Utility Limited Partnership is a VIE as the equity holders as a group lack the characteristics of a controlling financials interest and that substantially all of the activities of the VIE are conducted on behalf of the Company. As a result, the Company concluded that it is the primary beneficiary of the Utility Limited Partnership.
The Company consolidates the Utility Limited Partnership as its primary beneficiary, meeting both the “power” and “benefits” criteria associated with VIE accounting guidance. Non-controlling interests in the consolidated statement of operations and comprehensive income for the years ended December 31, 2024 and 2023 represent the ownership interests in the consolidated VIE held by entities or persons other than the Company. The assets of the consolidated VIE may only be used to settle obligations of the same VIE. In addition, there is no recourse to the Company for the consolidated VIEs’ liabilities.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The carrying amounts of the assets and liabilities of the Utility Limited Partnership consolidated VIE included in the Company’s consolidated balance sheets are as follows:
| |
|
|
|
As of December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Cash
|
|
|
|
$ |
5 |
|
|
|
|
$ |
27 |
|
|
| |
Investments in the Absolute Return Utility & Infrastructure Fund, at fair value
|
|
|
|
|
270,242 |
|
|
|
|
|
253,045 |
|
|
| |
Investment in affiliated fund, at fair value (cost $191)
|
|
|
|
|
280 |
|
|
|
|
|
281 |
|
|
| |
Due from the Absolute Return Utility & Infrastructure Fund
|
|
|
|
|
16,857 |
|
|
|
|
|
413 |
|
|
| |
Total assets
|
|
|
|
$ |
287,384 |
|
|
|
|
$ |
253,766 |
|
|
| |
Liabilities and partners’ capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Withdrawals payable
|
|
|
|
$ |
16,858 |
|
|
|
|
$ |
414 |
|
|
| |
Accrued expenses and other liabilities
|
|
|
|
|
88 |
|
|
|
|
|
34 |
|
|
| |
Total liabilities
|
|
|
|
|
16,946 |
|
|
|
|
|
448 |
|
|
| |
Partners’ capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Limited partners
|
|
|
|
$ |
269,938 |
|
|
|
|
$ |
252,818 |
|
|
| |
General partner
|
|
|
|
|
500 |
|
|
|
|
|
500 |
|
|
| |
Total partners’ capital:
|
|
|
|
|
270,438 |
|
|
|
|
|
253,318 |
|
|
| |
Total liabilities and partners’ capital:
|
|
|
|
$ |
287,384 |
|
|
|
|
$ |
253,766 |
|
|
| |
4. Investments
Fixed Maturity Securities, Available-for-Sale
The Company considers all fixed maturity securities to be available-for-sale and reports them at fair value with the net unrealized gains or losses reported (after-tax) as a component of other comprehensive income. The proceeds from sales of securities were $99.4 million and $124.3 million for the years ended December 31, 2024 and 2023, respectively. Gross gains of $4.3 million and $0.2 million, and gross losses of $9.3 million and $19 thousand were realized on sales of available-for-sale securities during the years ended December 31, 2024 and 2023, respectively. Gains and losses on securities are determined on a specific-identification basis.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The Company’s fixed maturity securities, available-for-sale as of December 31, 2024 and 2023, are summarized as follows:
| |
|
|
|
Cost or
Amortized
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available-for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities and obligations guaranteed by the U.S. government
|
|
|
|
$ |
84,456 |
|
|
|
|
$ |
21 |
|
|
|
|
$ |
(282) |
|
|
|
|
$ |
84,195 |
|
|
| |
Corporate
|
|
|
|
|
349,693 |
|
|
|
|
|
6,257 |
|
|
|
|
|
(2,145) |
|
|
|
|
|
353,805 |
|
|
| |
Commercial and residential mortgage and other asset-backed
|
|
|
|
|
816 |
|
|
|
|
|
— |
|
|
|
|
|
(64) |
|
|
|
|
|
752 |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
$ |
434,965 |
|
|
|
|
$ |
6,278 |
|
|
|
|
$ |
(2,491) |
|
|
|
|
$ |
438,752 |
|
|
| |
| |
|
|
|
Cost or
Amortized
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available-for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Corporate
|
|
|
|
$ |
68,583 |
|
|
|
|
$ |
752 |
|
|
|
|
$ |
(2,350) |
|
|
|
|
$ |
66,985 |
|
|
| |
Municipal taxable
|
|
|
|
|
12,331 |
|
|
|
|
|
— |
|
|
|
|
|
(1,037) |
|
|
|
|
|
11,294 |
|
|
| |
Commercial and residential mortgage and other asset-backed
|
|
|
|
|
22,875 |
|
|
|
|
|
— |
|
|
|
|
|
(2,955) |
|
|
|
|
|
19,921 |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
$ |
103,789 |
|
|
|
|
$ |
752 |
|
|
|
|
$ |
(6,342) |
|
|
|
|
$ |
98,200 |
|
|
| |
Contractual Maturities of Available-for-Sale Fixed-Maturity Securities
The amortized cost and fair value of fixed maturity securities, available-for-sale as of December 31, 2024, categorized by contractual maturity, are summarized as follows:
| |
|
|
|
Amortized Cost
|
|
|
Fair Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Due in one year or less
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
| |
Due after one year through five years
|
|
|
|
|
256,299 |
|
|
|
|
|
258,631 |
|
|
| |
Due after five years through ten years
|
|
|
|
|
158,930 |
|
|
|
|
|
160,262 |
|
|
| |
Due after ten years
|
|
|
|
|
18,920 |
|
|
|
|
|
19,107 |
|
|
| |
Commercial and residential mortgage and other asset-backed
|
|
|
|
|
816 |
|
|
|
|
|
752 |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
$ |
434,965 |
|
|
|
|
$ |
438,752 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Actual maturities may differ from contractual maturities because borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Commercial and residential mortgage and other asset-backed commercial securities are shown separately in the table above as they do not have a single maturity date.
Fixed Maturity Securities, Available-for Sale, in a Loss Position
The following table shows the Company’s gross unrealized losses and fair value for available-for-sale securities aggregated by investment category and the length of time that individual securities have been in a continuous unrealized loss position:
| |
|
|
|
Less Than 12 Months
|
|
|
12 Months or More
|
|
|
Total
|
|
| |
|
|
|
(in thousands)
|
|
| |
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
| |
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities and obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
guaranteed by the U.S. government
|
|
|
|
$ |
84,195 |
|
|
|
|
$ |
(282) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
84,195 |
|
|
|
|
$ |
(282) |
|
|
| |
Corporate
|
|
|
|
|
353,805 |
|
|
|
|
|
(2,145) |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
$ |
353,805 |
|
|
|
|
|
(2,145) |
|
|
| |
Commercial and residential mortgage and other asset-backed
|
|
|
|
|
752 |
|
|
|
|
|
(64) |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
$ |
752 |
|
|
|
|
|
(64) |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
$ |
438,752 |
|
|
|
|
$ |
(2,491) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
438,752 |
|
|
|
|
$ |
(2,491) |
|
|
| |
| |
|
|
|
Less Than 12 Months
|
|
|
12 Months or More
|
|
|
Total
|
|
| |
|
|
|
(in thousands)
|
|
| |
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
|
Gross
Unrealized
(Losses)
|
|
| |
December 31, 2023
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Municipal taxable
|
|
|
|
$ |
345 |
|
|
|
|
$ |
(10) |
|
|
|
|
$ |
10,799 |
|
|
|
|
$ |
(1,027) |
|
|
|
|
$ |
11,144 |
|
|
|
|
$ |
(1,037) |
|
|
| |
Corporate
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
44,798 |
|
|
|
|
|
(2,350) |
|
|
|
|
|
44,798 |
|
|
|
|
|
(2,350) |
|
|
| |
Commercial and residential mortgage and other asset-backed
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
19,921 |
|
|
|
|
|
(2,955) |
|
|
|
|
|
19,921 |
|
|
|
|
|
(2,955) |
|
|
| |
Total fixed maturity securities, available-for- sale
|
|
|
|
$ |
345 |
|
|
|
|
$ |
(10) |
|
|
|
|
$ |
75,518 |
|
|
|
|
$ |
(6,332) |
|
|
|
|
$ |
75,863 |
|
|
|
|
$ |
(6,342) |
|
|
| |
As of December 31, 2024 and 2023, the Company held securities of 28 issuers and 127 issuers, respectively, that were in an unrealized loss position with a total fair value of $146.8 million and $75.9 million, and gross unrealized losses of $1.9 million and $6.3 million, respectively. None of the fixed maturity securities with unrealized losses has ever missed, or been delinquent on, a scheduled principal or interest payment date.
The Company performs a periodic assessment of its available for sale portfolio to determine if there is a decline in the fair value below the amortized cost basis and if the decline is due to credit-related factors or noncredit-related factors (i.e., changes in market-based interest rates). The Company considers several factors in
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
completing its review of potential credit losses, including the extent to which a security’s fair value has been below cost and the financial condition of the issuer. In addition to specific issuer information, the Company also evaluates the current market and interest rate environment. Generally, a change in a security’s value caused by a change in the market or interest rate environment does not constitute a credit loss. There were no credit-related impairments of fixed maturity securities as of December 31, 2024 or 2023.
Management does not intend to sell available-for-sale securities in an unrealized loss position, and it is not “more likely than not” that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs.
The major categories of the Company’s net investment income for the years ended December 31, 2024 and 2023, are summarized as follows:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Investment income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed-maturity securities
|
|
|
|
$ |
14,736 |
|
|
|
|
$ |
2,279 |
|
|
| |
Utility & Infrastructure investments
|
|
|
|
|
6,830 |
|
|
|
|
|
7,933 |
|
|
| |
Short-term investments
|
|
|
|
|
2,703 |
|
|
|
|
|
— |
|
|
| |
Cash equivalents
|
|
|
|
|
5,122 |
|
|
|
|
|
6,368 |
|
|
| |
Note receivable from affiliate
|
|
|
|
|
1,002 |
|
|
|
|
|
1,002 |
|
|
| |
Equity securities
|
|
|
|
|
44 |
|
|
|
|
|
— |
|
|
| |
Securities sold, not yet purchased
|
|
|
|
|
(569) |
|
|
|
|
|
(795) |
|
|
| |
Gross investment income
|
|
|
|
|
29,868 |
|
|
|
|
|
16,787 |
|
|
| |
Management fees(1)
|
|
|
|
|
(5,601) |
|
|
|
|
|
(5,208) |
|
|
| |
Other expenses(1)
|
|
|
|
|
(221) |
|
|
|
|
|
(213) |
|
|
| |
Net investment income
|
|
|
|
$ |
24,046 |
|
|
|
|
$ |
11,366 |
|
|
| |
(1) Amounts related to investment activity.
The following table summarizes Company’s change in net unrealized gains on available-for-sale fixed maturity securities for the years ended December 31, 2024 and 2023:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Fixed maturity securities, available-for-sale
|
|
|
|
| |
Change in net unrealized gains
|
|
|
|
$ |
9,377 |
|
|
|
|
$ |
4,110 |
|
|
| |
Total
|
|
|
|
$ |
9,377 |
|
|
|
|
$ |
4,110 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following table presents realized and unrealized (losses) on investments:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Gross realized gains:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available for sale
|
|
|
|
$ |
4,295 |
|
|
|
|
$ |
161 |
|
|
| |
Short-term investments
|
|
|
|
|
18 |
|
|
|
|
|
— |
|
|
| |
Equity securities
|
|
|
|
|
38 |
|
|
|
|
|
— |
|
|
| |
Cash equivalents
|
|
|
|
|
4 |
|
|
|
|
|
— |
|
|
| |
Securities sold, not yet purchased
|
|
|
|
|
1,130 |
|
|
|
|
|
219 |
|
|
| |
Utility & Infrastructure investments
|
|
|
|
|
43,831 |
|
|
|
|
|
30,503 |
|
|
| |
Total
|
|
|
|
|
49,316 |
|
|
|
|
|
30,883 |
|
|
| |
Gross realized (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available for sale
|
|
|
|
|
(9,285) |
|
|
|
|
|
(19) |
|
|
| |
Short-term investments
|
|
|
|
|
(16) |
|
|
|
|
|
— |
|
|
| |
Cash equivalents
|
|
|
|
|
(2) |
|
|
|
|
|
— |
|
|
| |
Securities sold, not yet purchased
|
|
|
|
|
(479) |
|
|
|
|
|
— |
|
|
| |
Utility & Infrastructure investments
|
|
|
|
|
(22,017) |
|
|
|
|
|
(4,273) |
|
|
| |
Total
|
|
|
|
|
(31,799) |
|
|
|
|
|
(4,292) |
|
|
| |
Net unrealized gains (losses) on investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Securities sold, not yet purchased
|
|
|
|
|
15 |
|
|
|
|
|
(64) |
|
|
| |
Utility & Infrastructure investments
|
|
|
|
|
10,608 |
|
|
|
|
|
(28,796) |
|
|
| |
Total
|
|
|
|
|
10,623 |
|
|
|
|
|
(28,860) |
|
|
| |
Net realized and unrealized gains (losses)
|
|
|
|
$ |
28,140 |
|
|
|
|
$ |
(2,269) |
|
|
| |
Utility & Infrastructure investments
The assets recognized in the Company’s consolidated balance sheets related to the Company’s variable interests in this non-consolidated VIE as of December 31, 2024 and 2023, are summarized as follows:
| |
|
|
|
As of December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
Cost
|
|
|
Net
Unrealized
Gains
(Losses)
|
|
|
Fair
Value
|
|
|
Cost
|
|
|
Net
Unrealized
Gains
(Losses)
|
|
|
Fair Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
Absolute Return Utility & Infrastructure Fund
|
|
|
|
$ |
216,075 |
|
|
|
|
$ |
54,167 |
|
|
|
|
$ |
270,242 |
|
|
|
|
$ |
221,175 |
|
|
|
|
$ |
31,870 |
|
|
|
|
$ |
253,045 |
|
|
| |
The Company accounts for its investment in the Absolute Return Utility & Infrastructure Fund under the variable interest model at NAV as a practical expedient for fair value. This amount represents the Company’s maximum exposure to loss related to the unconsolidated VIE. The Absolute Return Utility & Infrastructure Fund is the
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
master within a “master-feeder” fund structure whereby its current shareholders, Utility Limited Partnership and three other feeder funds (collectively, the “Feeder Funds”), invest substantially all their capital in the Absolute Return Utility & Infrastructure Fund.
The Absolute Return Utility & Infrastructure Fund’s investment objective is to employ an energy and infrastructure-focused long/short strategy which seeks to deliver absolute returns in all market conditions with minimal correlation to energy sector indices and broader market indices. The Absolute Return Utility & Infrastructure Fund invests primarily in the equities of electric and gas utilities, integrated utilities, water utilities, telecommunication companies, independent power producers and pipelines, exploration and production companies, oilfield service companies and more broadly in energy and infrastructure-related industries (such as chemicals, materials, transportation infrastructure and real estate equities). The Absolute Return Utility & Infrastructure Fund’s portfolio is generally managed to be balanced.
The Absolute Return Utility & Infrastructure Fund measures its investments, which consist primarily of equities, and its derivative activities, which relate to swap contracts, foreign currency forward contracts and option contracts, at fair value, being the amount for which an asset could be exchanged between knowledgeable willing parties in an arms-length transaction. As the majority of the Absolute Return Utility & Infrastructure Fund’s investments are exchange-traded securities, such securities are reported at fair value.
The following table summarizes certain investments of the Absolute Return Utility & Infrastructure Fund where the Utility Limited Partnership’s proportionate share of the fair value of the classes of investment represents more than 10% of the Company’s members’ equity as of December 31, 2024 and 2023:
|
Investment in securities
|
|
|
Cost(1)
|
|
|
Fair Value(1)
|
|
|
Percentage of
Members’ Equity
|
|
| |
|
|
(in thousands)
|
|
|
December 31, 2024
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total common stock
|
|
|
|
$ |
452,622 |
|
|
|
|
$ |
484,614 |
|
|
|
|
|
121.67% |
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total common stock
|
|
|
|
$ |
(253,151) |
|
|
|
|
$ |
(259,941) |
|
|
|
|
|
-65.26% |
|
|
(1) Values represent the Company’s proportionate share of the Absolute Return Utility & Infrastructure Fund’s total holdings.
|
Investment in securities
|
|
|
Cost(1)
|
|
|
Fair Value(1)
|
|
|
Percentage of
Members’ Equity
|
|
| |
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
December 31, 2023
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total common stock
|
|
|
|
$ |
207,556 |
|
|
|
|
$ |
228,237 |
|
|
|
|
|
70.95% |
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total common stock
|
|
|
|
$ |
(245,047) |
|
|
|
|
$ |
(252,246) |
|
|
|
|
|
-78.41% |
|
|
(1) Values represent the Company’s proportionate share of the Absolute Return Utility & Infrastructure Fund’s total holdings.
The following table summarizes certain investments of the Absolute Return Utility & Infrastructure Fund where the Utility Limited Partnership’s proportionate share of the fair value of certain investment represents more than 5% of the Company’s members’ equity as of December 31, 2024 and 2023:
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
|
Investment in securities
|
|
|
Quantity(1)
|
|
|
Fair Value(1)
|
|
|
Percentage of
Members’ Equity
|
|
| |
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
December 31, 2024
|
|
|
|
|
|
Targa Resources Corp
|
|
|
|
|
1,331,300 |
|
|
|
|
$ |
23,024 |
|
|
|
|
|
5.78% |
|
|
|
Arthur J. Gallagher & Co
|
|
|
|
|
750,000 |
|
|
|
|
$ |
20,626 |
|
|
|
|
|
5.18% |
|
|
|
Ryan Specialty Group Holdings Inc
|
|
|
|
|
3,700,000 |
|
|
|
|
$ |
23,000 |
|
|
|
|
|
5.77% |
|
|
|
The Boeing Company
|
|
|
|
|
2,224,500 |
|
|
|
|
$ |
38,148 |
|
|
|
|
|
9.58% |
|
|
|
Real Estate–Welltower Inc.
|
|
|
|
|
2,775,294 |
|
|
|
|
$ |
33,888 |
|
|
|
|
|
8.51% |
|
|
|
The Boeing Company
|
|
|
|
|
(2,257,000) |
|
|
|
|
$ |
(38,706) |
|
|
|
|
|
-9.72% |
|
|
(1) Values represent the Company’s proportionate share of the Absolute Return Utility & Infrastructure Fund’s total holdings.
|
Investment in securities
|
|
|
Quantity(1)
|
|
|
Fair Value(1)
|
|
|
Percentage of
Members’ Equity
|
|
| |
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
December 31, 2023
|
|
|
|
|
|
Targa Resources Corp
|
|
|
|
|
201,847 |
|
|
|
|
$ |
17,534 |
|
|
|
|
|
5.45% |
|
|
|
Ryan Specialty Group Holdings Inc
|
|
|
|
|
447,763 |
|
|
|
|
$ |
19,263 |
|
|
|
|
|
5.99% |
|
|
|
Agree Realty Corporation
|
|
|
|
|
278,160 |
|
|
|
|
$ |
17,510 |
|
|
|
|
|
5.44% |
|
|
|
Utilities Select Sector SPDR Fund
|
|
|
|
|
(443,061) |
|
|
|
|
$ |
(28,059) |
|
|
|
|
|
-8.72% |
|
|
|
U.S. Treasury Securities, 1.500% to 4.375%, due 01/31/2027 to 11/15/2052
|
|
|
|
|
(22,582,646) |
|
|
|
|
$ |
(20,907) |
|
|
|
|
|
-6.50% |
|
|
(1) Values represent the Company’s proportionate share of the Absolute Return Utility & Infrastructure Fund’s total holdings.
Effective April 1, 2018, under the Investment Management Agreement, the Investment Manager is paid a quarterly fixed fee computed at an annual rate of 2.0% (i.e., 0.5% per quarter) of the balance of each Limited Partner’s Capital Account (the “Fixed Fee”). The Fixed Fee for the Utility Limited Partnership for the years ended December 31, 2024 and 2023 was $5.2 million and $4.9 million, respectively.
Under the terms of the revised Utility Limited Partnership Agreement of ZP Utility Insurance Fund, L.P., the Utility General Partner is entitled to an incentive allocation equal to 20% of the Utility Limited Partnership’s net profits, subject to high watermark provisions, and adjusted for withdrawals. The Incentive Allocation is credited as of the end of the fiscal year to the Capital Account of the Utility General Partner. The incentive allocation for the years ended December 31, 2024 and 2023, was $6.8 million and $0.1 million, respectively.
The Utility Limited Partnership has a quarterly liquidity option, subject to specific conditions, which are as follows:
•
to the extent it is required to pay insurance claims
•
to the extent it is required to pay for reasonable operating expenses
•
in the event the Company receives a notification from A.M. Best, or
•
to the extent the Company is required to diversify its assets pursuant to a lay, order or regulation.
The Utility General Partner may withdraw all or a portion of its capital account at any time.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Insurance — Statutory Deposits
The Company had invested assets with a carrying value of $0.1 million on deposit with state regulatory authorities as of both December 31, 2024 and 2023, which are included in cash and cash equivalents in the consolidated balance sheets.
5. Fair Value Measurements
Three levels of inputs are used to measure fair value of financial instruments: (1) Level 1: quoted price (unadjusted) in active markets for identical assets, (2) Level 2: inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument and (3) Level 3: inputs to the valuation methodology are unobservable for the asset or liability.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date.
To measure fair value, the Company obtains quoted market prices for its investment securities from its outside investment managers. If a quoted market price is not available, the Company uses prices of similar securities. Values for U.S. Treasury and publicly traded equity securities are generally based on Level 1 inputs which use the market approach valuation technique. The values for all fixed maturity securities (including state and municipal securities and obligations of U.S. government corporations and agencies) generally incorporate significant Level 2 inputs, and in some cases, Level 3 inputs, using the market approach and income approach valuation techniques. There have been no changes in the Company’s use of valuation techniques since commencement of operations.
The Company reviews fair value prices provided by its outside investment managers for reasonableness by comparing the fair values provided by the managers to those provided by the Company’s investment custodian. The Company also reviews and monitors changes in unrealized gains and losses. The Company has not historically adjusted security prices. The Company obtains an understanding of the methods, models and inputs used by the investment managers and independent pricing services, and controls are in place to validate that prices provided represent fair values. The Company’s control process includes, but is not limited to, initial and ongoing evaluation of the methodologies used, a review of specific securities and an assessment for proper classification within the fair value hierarchy and obtaining and reviewing internal control reports for the Company’s investment manager that obtains fair values from independent pricing services.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Financial instruments measured at fair value on a recurring basis as of December 31, 2024 and 2023, are summarized below:
| |
|
|
|
December 31, 2024
Fair Value Measurements Using
|
|
| |
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
| |
|
|
|
(in thousands)
|
|
| |
Assets
|
|
|
|
|
|
| |
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities and obligations guaranteed by the U.S. Government
|
|
|
|
$ |
— |
|
|
|
|
$ |
84,195 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
84,195 |
|
|
| |
Corporate
|
|
|
|
|
— |
|
|
|
|
|
353,805 |
|
|
|
|
|
— |
|
|
|
|
|
353,805 |
|
|
| |
Commercial and residential mortgage and other
asset-backed
|
|
|
|
|
— |
|
|
|
|
|
752 |
|
|
|
|
|
— |
|
|
|
|
|
752 |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
|
— |
|
|
|
|
|
438,752 |
|
|
|
|
|
— |
|
|
|
|
|
438,752 |
|
|
| |
Total assets
|
|
|
|
$ |
— |
|
|
|
|
$ |
438,752 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
438,752 |
|
|
| |
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Securities sold, not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
| |
Total liabilities
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
| |
| |
|
|
|
December 31, 2023
Fair Value Measurements Using
|
|
| |
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
| |
|
|
|
(in thousands)
|
|
| |
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Municipal taxable
|
|
|
|
$ |
— |
|
|
|
|
$ |
11,294 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
11,294 |
|
|
| |
Commercial and residential mortgage and other
asset-backed
|
|
|
|
|
— |
|
|
|
|
|
19,921 |
|
|
|
|
|
— |
|
|
|
|
|
19,921 |
|
|
| |
Corporate
|
|
|
|
|
— |
|
|
|
|
|
66,985 |
|
|
|
|
|
— |
|
|
|
|
|
66,985 |
|
|
| |
Total fixed maturity securities, available-for-sale
|
|
|
|
|
— |
|
|
|
|
|
98,200 |
|
|
|
|
|
— |
|
|
|
|
|
98,200 |
|
|
| |
Equity securities
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
1,000 |
|
|
|
|
|
1,000 |
|
|
| |
Total assets
|
|
|
|
$ |
— |
|
|
|
|
$ |
98,200 |
|
|
|
|
$ |
1,000 |
|
|
|
|
$ |
99,200 |
|
|
| |
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Securities sold, not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities
|
|
|
|
$ |
— |
|
|
|
|
$ |
(12,130) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(12,130) |
|
|
| |
Total liabilities
|
|
|
|
$ |
— |
|
|
|
|
$ |
(12,130) |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(12,130) |
|
|
| |
There were no transfers between Level 1 and Level 2 during 2024 and 2023. The Company recognizes transfers between levels at the beginning of the reporting period.
The fair values of fixed maturity securities owned, and securities sold, not yet purchased have been determined using quoted market prices for securities traded in the public market or prices using bid or closing prices for
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
securities not traded in the public marketplace. The fair values of cash and cash equivalents and short-term investments approximate their carrying values due to their short-term maturity. See Note 4 regarding the fair value of the Absolute Return Utility & Infrastructure Fund.
A reconciliation of the beginning and ending balances of equity securities, measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is shown below:
| |
|
|
|
Years Ended December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Beginning balance
|
|
|
|
$ |
1,000 |
|
|
|
|
$ |
— |
|
|
| |
Transfers in to Level 3
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Transfers out of Level 3
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Purchases
|
|
|
|
|
— |
|
|
|
|
|
1,000 |
|
|
| |
Sales
|
|
|
|
|
(1,038) |
|
|
|
|
|
— |
|
|
| |
Maturities, calls and paydowns
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Amortization of discount
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Total gains or losses (realized/unrealized):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Included in earnings
|
|
|
|
|
38 |
|
|
|
|
|
— |
|
|
| |
Included in other comprehensive income
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Ending balance
|
|
|
|
$ |
(0) |
|
|
|
|
$ |
1,000 |
|
|
| |
The Company held one equity security as of December 31, 2023 for which the fair value was determined using significant unobservable inputs (Level 3). The fair value of $1.0 million as of December 31, 2023 for the equity security was obtained from the asset manager and was derived from an internal model.
Transfers out of Level 3 occur when the Company is able to obtain reliable prices from pricing vendors for which the Company was previously unable to obtain reliable prices. Transfers into Level 3 occur when the Company is unable to obtain reliable prices for securities from pricing vendors and instead must use broker price quotes. There were no transfers into or out of Level 3 during 2024 and 2023.
There were no realized gains or losses included in earnings for the years ended December 31, 2024 and 2023 attributable to the change in unrealized gains or losses relating to Level 3 assets valued at fair value on a recurring basis.
Investments for which external sources are not available or are determined by the Investment Manager not to be representative of fair value are recorded at fair value as determined by the Company, with input from its investment managers and valuation specialists as considered necessary. In determining the fair value of such investments, the Company considers one or more of the following factors: type of security held, convertibility or exchangeability of the security, redeemability of the security (including the timing of redemptions), application of industry accepted valuation models, recent trading activity, liquidity, estimates of liquidation value, purchase cost and prices received for securities with similar terms of the same issuer or similar issuers.
The carrying value approximates the estimated fair value for the note receivable from affiliate as the note accrues interest at a fixed rate. The Company determines fair value using the discounted cash flow approach utilizing inputs that are observable.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
6. Securities Sold, Not Yet Purchased
The Company invests in certain financial instruments with off-balance sheet risk. These financial instruments include securities sold, not yet purchased which represent obligations of the Company to make future delivery of specific securities and, to the extent that the Company does not already have the securities in its possession, correspondingly create an obligation to purchase the securities at prevailing market prices. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market values of the securities underlying the financial instruments or index values may exceed the amounts recognized in the balance sheet.
As a hedge against certain risks within the Company’s investment strategy, the Company sells certain securities that it does not own in anticipation of a decline in the market price of the securities (a “short sale”), and the Company’s clearing broker executes a borrow transaction to deliver the securities resulting from the Company’s short sale. The Company is obligated to replace the securities borrowed in connection with a short sale. Cash related to short sales is restricted until the securities are purchased and is included within “other assets” in the consolidated balance sheets. The ultimate gain or loss depends upon the prices at which the securities are purchased to settle the Company’s obligations.
The Company’s securities sold, not yet purchased, as of December 31, 2024 and 2023, are summarized as follows:
| |
|
|
|
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities
|
|
|
|
$ |
(932) |
|
|
|
|
$ |
2 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
| |
Total securities sold, not yet purchased
|
|
|
|
$ |
(932) |
|
|
|
|
$ |
2 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
(930) |
|
|
| |
| |
|
|
|
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
(Losses)
|
|
|
Fair
Value
|
|
| |
|
|
|
(in thousands)
|
|
| |
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
U.S. Treasury securities
|
|
|
|
$ |
(12,379) |
|
|
|
|
$ |
315 |
|
|
|
|
$ |
(66) |
|
|
|
|
$ |
(12,130) |
|
|
| |
Total securities sold, not yet purchased
|
|
|
|
$ |
(12,379) |
|
|
|
|
$ |
315 |
|
|
|
|
$ |
(66) |
|
|
|
|
$ |
(12,130) |
|
|
| |
Realized gains on purchases to cover securities sold, not yet purchased were $0.7 million and $0.2 million for the years ended December 31, 2024 and 2023, respectively. Unrealized appreciation (depreciation) on securities sold, not yet purchased, was $22 thousand and $(64) thousand for the years ended December 31, 2024 and 2023.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
7. Deferred Policy Acquisition Costs
An analysis of deferred policy acquisition costs as of December 31, 2024 and 2023, is as follows:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Balance at beginning of year
|
|
|
|
$ |
23,245 |
|
|
|
|
$ |
19,648 |
|
|
| |
Policy acquisition costs deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Direct commissions
|
|
|
|
|
75,248 |
|
|
|
|
|
60,217 |
|
|
| |
Ceded commissions
|
|
|
|
|
(29,273) |
|
|
|
|
|
(13,385) |
|
|
| |
Underwriting and other insurance expenses
|
|
|
|
|
2,078 |
|
|
|
|
|
830 |
|
|
| |
Sub-total
|
|
|
|
|
48,053 |
|
|
|
|
|
47,662 |
|
|
| |
Amortization of policy acquisition costs
|
|
|
|
|
(49,746) |
|
|
|
|
|
(44,065) |
|
|
| |
Net change
|
|
|
|
|
(1,693) |
|
|
|
|
|
3,597 |
|
|
| |
Balance at end of year
|
|
|
|
$ |
21,552 |
|
|
|
|
$ |
23,245 |
|
|
| |
8. Underwriting, Acquisition and Insurance Expenses
Underwriting, acquisition and insurance expenses for the years ended December 31, 2024 and 2023, include the following:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Policy acquisition costs
|
|
|
|
$ |
60,692 |
|
|
|
|
$ |
46,201 |
|
|
| |
Other operating and general expenses
|
|
|
|
|
37,875 |
|
|
|
|
|
25,954 |
|
|
| |
Total underwriting, acquisition and insurance expenses
|
|
|
|
$ |
98,567 |
|
|
|
|
$ |
72,155 |
|
|
| |
9. Leases
The Company’s leases consist of one operating lease on its office space in Scottsdale Arizona, that expires in 2028 and is subject to a renewal option at market rates prevailing at the time of renewal. The Company became a sublessor of the same office space when it entered into a sublease agreement effective July 1, 2022 with ZFSG. The base rent under the sublease is equal to that which the Company pays under the headlease and the sublease and the headlease are coterminous. The Company applies the portion of the straight-line sublease income that is equal to its headlease expense as a contra expense to headlease expense in underwriting, acquisition and insurance expenses and records the remainder in other income.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following tables summarize details and balances associated with the Company’s operating lease and sublease:
| |
|
|
|
As of December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Lease Balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Operating lease right-of-use assets
|
|
|
|
$ |
2,278 |
|
|
|
|
$ |
2,776 |
|
|
| |
Operating lease liabilities
|
|
|
|
$ |
(2,738) |
|
|
|
|
$ |
(3,311) |
|
|
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Lease Cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Operating lease cost
|
|
|
|
$ |
655 |
|
|
|
|
$ |
655 |
|
|
| |
Sublease income
|
|
|
|
|
(750) |
|
|
|
|
|
(750) |
|
|
| |
Net lease (income)
|
|
|
|
$ |
(95) |
|
|
|
|
$ |
(95) |
|
|
| |
| |
|
|
|
As of December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
Weighted-average remaining lease term–operating leases
|
|
|
3.92 years
|
|
|
4.92 years
|
|
| |
Weighted-average discount rate–operating leases
|
|
|
|
|
5.25% |
|
|
|
|
|
5.25% |
|
|
Operating cash flows from the operating lease was $0.7 million for both years ended December 31, 2024 and 2023, respectively. The remaining lease term of the operating lease was 3.92 years and 4.92 years as of December 31, 2024 and 2023, respectively. Future minimum lease payments under the operating lease as of December 31, 2024 and 2023, are expected to be as follows:
| |
|
|
|
As of December 31,
2024
|
|
| |
|
|
|
(in thousands)
|
|
| |
Future Minimum Lease Payments
|
|
|
| |
2025
|
|
|
|
$ |
747 |
|
|
| |
2026
|
|
|
|
|
765 |
|
|
| |
2027
|
|
|
|
|
783 |
|
|
| |
2028
|
|
|
|
|
731 |
|
|
| |
Thereafter
|
|
|
|
|
— |
|
|
| |
Total lease payments
|
|
|
|
|
3,026 |
|
|
| |
Less: imputed interest
|
|
|
|
|
(288) |
|
|
| |
Present value of lease liabilities
|
|
|
|
$ |
2,738 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
10. Reserves for Unpaid Losses and Loss Adjustment Expenses
The following table reconciles the beginning and ending reserve balances for unpaid losses and loss adjustment expenses, net of reinsurance, to the gross amounts reported in the consolidated balance sheets for the years ended December 31, 2024 and 2023:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Balance at Beginning of Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
$ |
320,936 |
|
|
|
|
$ |
276,438 |
|
|
| |
Reinsurance recoverable
|
|
|
|
|
(102,723) |
|
|
|
|
|
(107,559) |
|
|
| |
Reserves for unpaid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
|
218,213 |
|
|
|
|
|
168,879 |
|
|
| |
Current Activity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Incurred losses and loss adjustment expenses, net of reinsurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Current year
|
|
|
|
|
169,816 |
|
|
|
|
|
136,869 |
|
|
| |
Prior year
|
|
|
|
|
5,418 |
|
|
|
|
|
17,238 |
|
|
| |
Total net losses and loss and adjustment expenses incurred
|
|
|
|
|
175,234 |
|
|
|
|
|
154,107 |
|
|
| |
Payments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Current year
|
|
|
|
|
(46,258) |
|
|
|
|
|
(36,753) |
|
|
| |
Prior year
|
|
|
|
|
(63,209) |
|
|
|
|
|
(68,020) |
|
|
| |
Total payments
|
|
|
|
|
(109,467) |
|
|
|
|
|
(104,773) |
|
|
| |
Balance at End of Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Reserves for unpaid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
|
283,980 |
|
|
|
|
|
218,213 |
|
|
| |
Reinsurance recoverable
|
|
|
|
|
119,596 |
|
|
|
|
|
102,723 |
|
|
| |
Reserves for unpaid losses and loss adjustment expenses, gross of reinsurance
|
|
|
|
$ |
403,576 |
|
|
|
|
$ |
320,936 |
|
|
| |
During the year end December 31, 2024, the Company incurred net losses from prior accident years of $5.4 million. This amount was primarily due to enhancements to the Company’s claims reserving approach with respect to loss adjustment expenses in its casualty lines.
During the year ended December 31, 2023, the Company’s net incurred losses for prior accident years developed unfavorably by $17.2 million primarily due to higher-than-expected emergence in property lines driven by catastrophes in the 2022 accident year and due to a decrease to ceded reserves on prior year’s casualty lines.
The following table presents incurred and paid losses and allocated loss adjustment expenses, net of reinsurance, as of December 31, 2024 for the property and casualty lines of business. The loss information has been disaggregated so that losses that are expected to develop in a similar manner are grouped together. The information provided regarding incurred and paid accident year claims development for the period ended December 31, 2023, and prior is presented as unaudited supplementary information.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
| |
|
|
Incurred Losses and Allocated Loss Adjustment Expenses,
Net of Reinsurance
|
|
|
As of December 31, 2024
|
|
|
|
| |
|
|
Year Ended December 31,
|
|
|
Total of IBNR
Liabilities plus
Expected
Development on
Reported Claims
|
|
|
Cumulative
# of
Reported
Claims(1)
|
|
|
|
|
Accident Year
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
|
|
| |
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
$ |
12,259 |
|
|
|
|
$ |
12,285 |
|
|
|
|
|
12,569 |
|
|
|
|
$ |
14,111 |
|
|
|
|
$ |
13,928 |
|
|
|
|
$ |
13,859 |
|
|
|
|
$ |
— |
|
|
|
|
|
449 |
|
|
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
|
48,551 |
|
|
|
|
|
50,816 |
|
|
|
|
|
53,852 |
|
|
|
|
|
54,762 |
|
|
|
|
|
55,570 |
|
|
|
|
|
523 |
|
|
|
|
|
1,023 |
|
|
|
|
|
2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,484 |
|
|
|
|
|
57,259 |
|
|
|
|
|
57,225 |
|
|
|
|
|
58,175 |
|
|
|
|
|
579 |
|
|
|
|
|
951 |
|
|
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,070 |
|
|
|
|
|
68,363 |
|
|
|
|
|
68,835 |
|
|
|
|
|
1,560 |
|
|
|
|
|
1,302 |
|
|
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,049 |
|
|
|
|
|
50,209 |
|
|
|
|
|
3,124 |
|
|
|
|
|
1,040 |
|
|
|
|
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,365 |
|
|
|
|
|
16,070 |
|
|
|
|
|
1,169 |
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
317,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
(1) Claim count information is reported per claim and includes claims that did not result with a liability.
| |
|
|
Cumulative Paid Losses and Allocated Loss Adjustment Expenses,
Net of Reinsurance
|
|
| |
|
|
Year Ended December 31,
|
|
|
Accident Year
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
| |
|
|
(in thousands)
|
|
|
|
|
|
|
|
| |
|
|
Unaudited
|
|
|
|
Property
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
$ |
3,897 |
|
|
|
|
$ |
11,368 |
|
|
|
|
|
13,152 |
|
|
|
|
$ |
13,417 |
|
|
|
|
$ |
13,855 |
|
|
|
|
$ |
13,846 |
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
|
21,385 |
|
|
|
|
|
40,799 |
|
|
|
|
|
48,611 |
|
|
|
|
|
52,374 |
|
|
|
|
|
54,363 |
|
|
|
2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,544 |
|
|
|
|
|
50,814 |
|
|
|
|
|
54,691 |
|
|
|
|
|
56,979 |
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,062 |
|
|
|
|
|
58,294 |
|
|
|
|
|
64,533 |
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,592 |
|
|
|
|
|
45,000 |
|
|
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,025 |
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
274,746 |
|
|
|
Liabilities for unpaid losses and allocated loss adjustment expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
42,267 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
| |
|
|
Incurred Losses and Allocated Loss Adjustment Expenses,
Net of Reinsurance
|
|
|
As of December 31, 2024
|
|
| |
|
|
Year Ended December 31,
|
|
|
Total of IBNR
Liabilities plus
Expected
Development on
Reported Claims
|
|
|
Cumulative
# of
Reported
Claims(1)
|
|
Accident
Year
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
| |
|
|
(in thousands)
|
|
| |
|
|
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Casualty
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
$ |
7,951 |
|
|
|
|
$ |
7,954 |
|
|
|
|
|
8,417 |
|
|
|
|
$ |
9,522 |
|
|
|
|
$ |
10,383 |
|
|
|
|
$ |
11,872 |
|
|
|
|
$ |
1,433 |
|
|
|
|
|
160 |
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
|
28,600 |
|
|
|
|
|
30,186 |
|
|
|
|
|
30,920 |
|
|
|
|
|
29,779 |
|
|
|
|
|
31,693 |
|
|
|
|
|
3,373 |
|
|
|
|
|
609 |
|
|
|
2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,226 |
|
|
|
|
|
53,775 |
|
|
|
|
|
53,865 |
|
|
|
|
|
54,152 |
|
|
|
|
|
7,968 |
|
|
|
|
|
1,392 |
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64,915 |
|
|
|
|
|
69,921 |
|
|
|
|
|
71,333 |
|
|
|
|
|
17,235 |
|
|
|
|
|
1,835 |
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78,413 |
|
|
|
|
|
78,850 |
|
|
|
|
|
50,533 |
|
|
|
|
|
1,568 |
|
|
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90,145 |
|
|
|
|
|
76,328 |
|
|
|
|
|
1,278 |
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
338,045 |
|
|
|
|
|
|
|
|
|
| |
(1) Claim count information is reported per claim and includes claims that did not result with a liability.
| |
|
|
Cumulative Paid Losses and Allocated Loss Adjustment Expenses,
Net of Reinsurance
|
|
| |
|
|
Year Ended December 31,
|
|
|
Accident Year
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
2022
|
|
|
2023
|
|
|
2024
|
|
| |
|
|
(in thousands)
|
|
|
|
|
|
|
|
| |
|
|
Unaudited
|
|
|
|
|
|
|
|
|
Casualty
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
$ |
10 |
|
|
|
|
$ |
170 |
|
|
|
|
|
1,445 |
|
|
|
|
$ |
3,518 |
|
|
|
|
$ |
5,881 |
|
|
|
|
$ |
8,203 |
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
|
315 |
|
|
|
|
|
5,276 |
|
|
|
|
|
11,410 |
|
|
|
|
|
19,576 |
|
|
|
|
|
23,713 |
|
|
|
2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,199 |
|
|
|
|
|
9,007 |
|
|
|
|
|
20,687 |
|
|
|
|
|
31,178 |
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,515 |
|
|
|
|
|
17,261 |
|
|
|
|
|
32,703 |
|
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,039 |
|
|
|
|
|
11,717 |
|
|
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,941 |
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110,455 |
|
|
|
Liabilities for unpaid losses and allocated loss adjustment expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
227,590 |
|
|
| |
The following is supplementary unaudited information about average historical claims duration as of December 31, 2024:
| |
|
|
|
Average Annual Percentage(1) Payout of Incurred Claims by Age
|
|
| |
|
|
|
Year 1
|
|
|
Year 2
|
|
|
Year 3
|
|
|
Year 4
|
|
|
Year 5
|
|
|
Year 6
|
|
| |
Property
|
|
|
|
|
50.3% |
|
|
|
|
|
35.2% |
|
|
|
|
|
10.0% |
|
|
|
|
|
4.9% |
|
|
|
|
|
3.5% |
|
|
|
|
|
-0.1% |
|
|
| |
Casualty
|
|
|
|
|
3.3% |
|
|
|
|
|
14.3% |
|
|
|
|
|
20.4% |
|
|
|
|
|
21.2% |
|
|
|
|
|
14.9% |
|
|
|
|
|
19.6% |
|
|
(1) Calculated using weighted average.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following table is a reconciliation of the net incurred and paid claims development tables to the liability for claims and claim adjustment expenses in the consolidated balance sheets:
| |
|
|
|
As of December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Net outstanding liabilities for unpaid losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Property
|
|
|
|
$ |
42,267 |
|
|
|
|
$ |
33,522 |
|
|
| |
Casualty
|
|
|
|
|
227,590 |
|
|
|
|
|
176,918 |
|
|
| |
Liabilities for unpaid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
|
269,857 |
|
|
|
|
|
210,440 |
|
|
| |
Reinsurance recoverable on unpaid losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Property
|
|
|
|
|
30,635 |
|
|
|
|
|
40,379 |
|
|
| |
Casualty
|
|
|
|
|
88,961 |
|
|
|
|
|
62,344 |
|
|
| |
Total reinsurance recoverable on unpaid losses and loss adjustment expenses
|
|
|
|
|
119,596 |
|
|
|
|
|
102,723 |
|
|
| |
Impact of Loss Portfolio Transfer
|
|
|
|
|
(2,051) |
|
|
|
|
|
(4,499) |
|
|
| |
Net unallocated loss adjustment expenses
|
|
|
|
|
16,174 |
|
|
|
|
|
12,272 |
|
|
| |
Gross liability for unpaid losses and loss adjustment expenses
|
|
|
|
$ |
403,576 |
|
|
|
|
$ |
320,936 |
|
|
| |
The Company has not provided insurance coverage that could reasonably be expected to produce material levels of asbestos claims activity. In addition, management does not believe that the Company is exposed to environmental liability claims other than those which it has specifically underwritten and priced as an environmental exposure. This exposure is de minimis and the Company did not record specific reserves for it.
11. Reinsurance
The Company remains liable to policyholders if its reinsurers are unable to meet their contractual obligations under applicable reinsurance agreements. To minimize exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk. The Company’s reinsurance contracts generally require reinsurers that are not authorized as reinsurers under U.S. state insurance regulations or that experience rating downgrades from rating agencies below specified levels to fund their share of the Company’s ceded outstanding losses and loss adjustment expense reserves, typically through the use of irrevocable and unconditional letters of credit or trust accounts.
On December 30, 2021, ASIC and ASIL entered into an LPT with Carrick Re Limited (“Carrick”), an affiliated company at the time, with an effective date of September 30, 2021. As part of the LPT Carrick assumed all reserves related to brokerage property claims with accident dates prior to and including September 30, 2021. No gain on the LPT was recorded upon inception. As of December 31, 2024 and 2023, the reinsurance recoverable for ceded loss and loss adjustment expense reserves under the agreements was $2.1 million and $4.5 million, respectively. Related to the LPT, on December 30, 2021, ASIC and ASIL entered into a service agreement with Carrick Limited, an affiliated company, pursuant to which Carrick Limited provided certain ceded reinsurance administration services. ASIC and ASIL have paid $0.4 million collectively for the year ended December 31, 2023, to Carrick Limited. Effective December 27, 2023, Carrick Re Limited and Carrick Limited were no longer affiliated companies.
As of December 31, 2024 and 2023, the Company had reinsurance recoverables on unpaid losses of $119.6 million and $102.8 million, respectively, and reinsurance recoverables on paid losses of $14.0 million and $22.9 million, respectively. All reinsurance recoverables are from companies with A.M. Best ratings of “A-” (Excellent) or better or are collateralized with letters of credit or funds held.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
As of December 31, 2024, reinsurance recoverables on unpaid losses from the Company’s three largest reinsurers were $20.5 million, $14.9 million and $13.2 million, representing 40.6% of the total balance. As of December 31, 2023, reinsurance recoverables on unpaid losses from the Company’s three largest reinsurers were $17.0 million, $17.0 million and $9.0 million, representing 41% of the total balance.
As of December 31, 2024 and 2023, prepaid reinsurance premiums totaled $3.9 million and $0.4 million, respectively. Premiums written, premiums earned and losses and loss adjustment expenses incurred for the years ended December 31, 2024 and 2023, are summarized as follows:
| |
|
|
|
For the Years Ended
December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Written premiums:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Direct
|
|
|
|
$ |
437,036 |
|
|
|
|
$ |
352,591 |
|
|
| |
Ceded
|
|
|
|
|
(137,830) |
|
|
|
|
|
(84,375) |
|
|
| |
Net written
|
|
|
|
|
299,206 |
|
|
|
|
|
268,216 |
|
|
| |
Earned premiums:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Direct
|
|
|
|
$ |
398,112 |
|
|
|
|
$ |
314,164 |
|
|
| |
Ceded
|
|
|
|
|
(107,477) |
|
|
|
|
|
(82,700) |
|
|
| |
Net earned
|
|
|
|
|
290,635 |
|
|
|
|
|
231,464 |
|
|
| |
Losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Direct
|
|
|
|
|
230,474 |
|
|
|
|
|
205,192 |
|
|
| |
Ceded
|
|
|
|
|
(55,240) |
|
|
|
|
|
(51,085) |
|
|
| |
Net losses and loss adjustment expenses
|
|
|
|
$ |
175,234 |
|
|
|
|
$ |
154,107 |
|
|
| |
12. Commitments and Contingent Liabilities
Contingencies arise in the normal conduct of the Company’s operations and are not expected to have a material effect on the Company’s financial condition or results of operations. However, adverse outcomes are possible and could negatively affect the Company’s financial condition and results of operations. As of December 31, 2024 and 2023, the Company was not subject to any known litigation.
13. Letters of Credit
On December 21, 2020, JPMorgan Chase Bank issued a letter of credit agreement in the amount of $35.0 million for the benefit of ASIC on behalf of ASIL. On December 25, 2020, and as subsequently amended, Barclays Bank issued a letter of credit agreement in the amount of $35.0 million for the benefit of ASIC on behalf of ASIL. As of December 31, 2024 and 2023, there were no amounts drawn on these agreements. Fees paid on the agreements were $2.1 million for both of the years ended December 31, 2024 and 2023 and included in interest expense in the consolidated statement of operations and comprehensive income.
14. Employee Benefits
The Company is party to multi-employer savings plans (the “Savings Plans”) which qualify under Section 401(k) of the U.S. Internal Revenue Code. Participants may contribute certain percentages of their pre -tax salary to the Savings Plans subject to statutory limitations. On January 1, 2020, the Company increased its matching of
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
employees’ contributions to the Saving Plan to one hundred percent, up to a maximum contribution of 5% of the participant’s earnings, subject to certain statutory limitations. For the years ended December 31, 2024 and 2023, the expense associated with the Savings Plans totaled $0.6 million and $0.4 million, respectively.
15. Members’ Equity
As of December 31, 2024 and 2023, Members’ equity consisted of 409,294,742 and 386,238,892 Members’ units, respectively.
On October 21, 2024 (the “Issue Date”), ZFSG made an in-kind contribution of $22.2 million in principal amount of U.S. Treasury Notes with a fair value of $20.1 million to the Company and received (i) 23,022,550 of Members’ units, (ii) 11,511,275 warrants to purchase Members’ units with an exercise price of $3.00 per unit (Tranche 1), and (iii) 4,000,000 warrants to purchase Members’ units with an exercise price of $2.00 per unit (Tranche 2) for such contribution. Such underlying units and exercise prices of the Tranche 1 and Tranche 2 warrants (collectively, the “Warrants”) are subject to customary anti-dilution adjustments set forth in each warrant certificate. ZFSG is entitled to exercise the Warrants for a term of ten years starting from the Issue Date by paying the exercise price in cash or on a cashless basis.
The Company evaluated the Warrants for liability or equity classification in accordance with the provisions of ASC 480, Distinguishing Liabilities from Equity, and determined that equity treatment was appropriate because the Warrants do not meet the definition of liability instruments.
The Warrants are classified as a component of permanent equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the Members’ units with which they were issued, are immediately exercisable, do not embody an obligation for the Company to repurchase its Members’ units, and permit the holders to receive a fixed number of Members’ units upon exercise. In addition, the Warrants do not provide any guarantee of value or return. The Company valued the issuance of the additional Members’ units and the Warrants at issuance using the Black-Scholes option pricing model and determined the fair values of the additional Members’ units and Tranche 1 and 2 warrants to be $19.1 million, $0.6 million and $0.4 million, respectively on the Issue Date. The key inputs to the valuation model for the Warrants included aggregate equity volatility of 35% and an expected term of 10 years.
The U.S. Treasury Notes received in exchange for the Members’ units and Warrants issued are included in fixed maturity securities, available for sale, at fair value, in the consolidated balance sheet.
As of December 31, 2024, all of the Warrants issued are outstanding and remain unexercised.
In October 2023, the Company issued 35,000,000, additional Members’ units to ZFSG, in exchange for cash of $35.0 million.
16. Share-Based Compensation
On January 1, 2019, the Company established the Ategrity Specialty Holdings LLC, and Subsidiaries Equity Incentive Plan (the “Equity Plan”), which provides for restricted units, non-qualified incentive options and other unit-based awards for directors, officers and other employees. The maximum number of the Company’s units that may be issued under the Equity Plan was 6,250,000. On December 8, 2024, the Company amended the Equity Plan to increase the number of Members’ units that may be issued under the Equity Plan to 50,000,000.
The Company recognized total share-based compensation expense of $2.0 million and $27 thousand for the years ended December 31, 2024 and 2023, respectively. The tax benefit recognized was $390 thousand and $6 thousand for the years ended December 31, 2024 and 2023, respectively.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
To estimate the fair value of the restricted units, non-qualified incentive options, it was first required to estimate the Company’s equity value. The Company elected to apply the practical expedient for determining the current stock price input and used GPCM as a reasonable valuation approach. The GPCM involves identifying and selecting publicly traded companies with financial and operating characteristics similar to the company being valued.
The option pricing method (OPM) was used to allocate the Company’s equity value to its Members’ equity, RUs and NQIOs. The OPM involves estimating the fair value of the call options using the Black-Scholes option pricing model at a series of exercise prices that coincide with the liquidation preferences and conversion features of units of Members’ equity.
Non-Qualified Incentive Options (“NQIOs”)
Primarily all outstanding NQIOs were granted with a life of either five or ten years, with either a three or five-year graded vesting period for service conditions. Some NQIOs also have performance conditions in addition to service conditions. For NQIOs which are exercisable only upon the occurrence of a qualifying event, which is generally defined as a change in control event or a public listing, the Company has not recognized any compensation expense because no qualifying events have occurred. For NQIOs that are subject only to a service condition, the Company uses a straight -line attribution method, whereas for NQIOs that are subject to a service condition and a performance condition, the Company uses a graded vesting attribution method.
The following assumptions were used in the model during 2024:
| |
|
|
2024
|
|
|
Fair value of underlying Member units
|
|
|
$0.55–$0.77
|
|
|
Risk-free rate(1)
|
|
|
4.2%–4.3%
|
|
|
Dividend yield(2)
|
|
|
0%– 0%
|
|
|
Volatility(3) |
|
|
35%–33%
|
|
|
Expected life(4)
|
|
|
2 years–0.6 years
|
|
(1) The risk-free rate is the U.S. Treasury yield curve rate with term equal to expected term as of the valuation date.
(2) A dividend yield of 0% was used as the Company does not anticipate paying dividends for the foreseeable future.
(3) Volatility was based on historical volatility of guideline companies over the expected period as of the valuation date.
(4) Expected life represents the period from the valuation date to the expected exit or liquidity event.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following table summarizes NQIO activity:
| |
|
|
Number
of Options
|
|
|
Weighted-
Average
Exercise
Price
|
|
|
Weighted-
Average
Fair Value of
Underlying
Member Unit
|
|
|
Weighted
Average Fair
Value per
Option at
Grant Date
|
|
|
Weighted-
Average
Remaining
Contractual
Term (in years)
|
|
|
Outstanding as of January 1, 2023
|
|
|
|
|
578,750 |
|
|
|
|
$ |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
|
|
(315,000) |
|
|
|
|
|
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2023
|
|
|
|
|
263,750 |
|
|
|
|
$ |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.0 |
|
|
|
Granted
|
|
|
|
|
46,009,382 |
|
|
|
|
|
1.13 |
|
|
|
|
$ |
0.65 |
|
|
|
|
$ |
0.10 |
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2024
|
|
|
|
|
46,273,132 |
|
|
|
|
$ |
1.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.61 |
|
|
|
Vested & Exercisable
|
|
|
|
|
148,500 |
|
|
|
|
$ |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.84 |
|
|
| |
The Company did not grant any awards during the year ended December 31, 2023.
For the years ended December 31, 2024 and 2023, the Company recorded $2.0 million and $0.3 million of compensation expense related to the NQIOs. As of December 31, 2024, the Company had $1.5 million of unrecognized compensation expense expected to be charged to earnings over a period of 4 years.
The intrinsic value of each incentive option is determined based on the difference between the fair value of the underlying share and the exercise price of the underlying incentive option. The aggregate intrinsic value of NQIOs outstanding and exercisable was $0 as of both December 31, 2024 and 2023.
CEO Options
In 2022, as part of the compensation of the Company’s CEO and solely for the services provided by him as a CEO of the Company, ZFSG agreed to issue the CEO share-based awards in the form of 16,277,800 options to purchase Members’ units of the Company held by ZFSG subject to certain vesting conditions (“the CEO Options”). This agreement met the criteria to be deemed a grant. The CEO Options were granted in February 2022 with a contractual term of ten years and a four-year graded vesting period.
To estimate the fair value of the CEO Options, the Company used the same valuation methodology and assumptions as for the Restricted Units and the Non-Qualified Incentive Options as described above. The exercise price and the grant-date fair value of the CEO Options were $0.84 and $0.06, respectively.
For the year ended December 31, 2023, the Company recorded $0.2 million of associated compensation expense, which is reflected in these consolidated financial statements within underwriting, acquisition and insurance expenses, with a corresponding amount recorded as contribution by the parent, ZFSG. As of December 31, 2023, the Company had $0.5 million of unrecognized compensation expense expected to be charged to earnings over a period of 2.1 years.
In December 2024, ZFSG cancelled the original CEO Options and contemporaneously, the Company replaced them with new CEO Options (“the new CEO Options”). The Company issued the new CEO Options in the form of
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
27,097,710 options to purchase Members’ units of the Company subject to certain vesting conditions. This agreement met the criteria to be deemed a Type 1 modification of the original grant pursuant to ASC Topic 718, Compensation — Stock Compensation. The new CEO Options were granted on December 8, 2024 (the “Modification Date”) with a contractual term of ten years and a three-year graded vesting period if the Company completes an IPO on or prior to December 31, 2025, or a four-year graded vesting period if the Company doesn’t complete an IPO on or prior to December 31, 2025. The exercise price and the grant-date fair value of the new CEO Options were $0.88 and $0.221, respectively. On the Modification Date, the Company recognized approximately $1.5 million of compensation expense, which is included in other expenses in the consolidated statements of operations, for the year ended December 31, 2024, with respect to this modification.
As of December 31, 2024, the Company had $1.2 million of unrecognized compensation expense expected to be charged to earnings over a period of 3 years. As of December 31, 2024, 27,097,710 of the new CEO Options were outstanding. None of the new CEO Options were exercised during the years ended December 31, 2024 and 2023. As of December 31, 2024, 18,337,192 of the new CEO Options were vested and none were exercisable.
As of December 31, 2024, the aggregate intrinsic value of the new CEO Options outstanding and the new CEO Options exercisable was $0. As of December 31, 2024, the remaining contractual term of the new CEO Options was ten years.
Restricted Units (“RUs”)
All outstanding RUs were granted with a five-year, graded vesting period. The Company recognized total compensation expense related to the RUs of $20 thousand during each of the years ended December 31, 2024 and 2023, respectively using a straight-line vesting attribution method. As of December 31, 2024 and 2023, the Company had unrecognized compensation expense related to the RUs of $0 and $20 thousand, respectively. The total fair value of RUs vested in 2024 and 2023 was $26 thousand and $17 thousand, respectively.
The following table summarizes RU activity for the year ended December 31, 2024 and 2023:
| |
|
|
For the Years Ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
Units
|
|
|
Weighted-Average
Grant-Date Fair
Value
|
|
|
Units
|
|
|
Weighted-Average
Grant-Date Fair
Value
|
|
|
Non-vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance
|
|
|
|
|
66,700 |
|
|
|
|
$ |
0.99 |
|
|
|
|
|
100,000 |
|
|
|
|
$ |
0.99 |
|
|
|
Granted
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
Vested
|
|
|
|
|
(33,300) |
|
|
|
|
$ |
0.99 |
|
|
|
|
|
(33,300) |
|
|
|
|
$ |
0.99 |
|
|
|
Forfeited
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
Closing Balance
|
|
|
|
|
33,400 |
|
|
|
|
$ |
0.99 |
|
|
|
|
|
66,700 |
|
|
|
|
$ |
0.99 |
|
|
| |
17. Segment Reporting
The Company operates as one operating segment with excess and surplus lines insurance business at its core. The Company’s chief operating decision maker (“CODM”) is the Chief Executive Officer (“CEO”), who uses consolidated net income to make decisions about allocating resources and assessing performance for the entire Company. The measure of segment assets is reported in the consolidated balance sheets as total assets. The accounting policies used to prepare the segment reporting data are the same as those described in Note 2.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The following table presents the Company’s operating results as evaluated by the CODM.
| |
|
|
|
For the Years Ended December 31,
|
|
| |
|
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
(in thousands)
|
|
| |
Revenues
|
|
|
|
| |
Net premiums earned
|
|
|
|
$ |
290,635 |
|
|
|
|
$ |
231,464 |
|
|
| |
Fee income
|
|
|
|
|
918 |
|
|
|
|
|
660 |
|
|
| |
Net investment income
|
|
|
|
|
24,046 |
|
|
|
|
|
11,366 |
|
|
| |
Net realized and unrealized gains (losses) on investments
|
|
|
|
|
28,140 |
|
|
|
|
|
(2,269) |
|
|
| |
Other income
|
|
|
|
|
95 |
|
|
|
|
|
95 |
|
|
| |
Total revenues
|
|
|
|
|
343,834 |
|
|
|
|
|
241,316 |
|
|
| |
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Losses and loss adjustment expenses
|
|
|
|
|
175,234 |
|
|
|
|
|
154,107 |
|
|
| |
Policy acquisition costs
|
|
|
|
|
60,692 |
|
|
|
|
|
46,201 |
|
|
| |
Other operating and general expenses
|
|
|
|
|
37,875 |
|
|
|
|
|
25,955 |
|
|
| |
Interest expense
|
|
|
|
|
2,042 |
|
|
|
|
|
2,237 |
|
|
| |
Other expenses
|
|
|
|
|
1,727 |
|
|
|
|
|
196 |
|
|
| |
Total expenses
|
|
|
|
|
277,570 |
|
|
|
|
|
228,695 |
|
|
| |
Income before income taxes
|
|
|
|
|
66,264 |
|
|
|
|
|
12,621 |
|
|
| |
Income tax expense
|
|
|
|
|
12,317 |
|
|
|
|
|
2,518 |
|
|
| |
Net income
|
|
|
|
|
53,947 |
|
|
|
|
|
10,103 |
|
|
| |
Less: Net income attributable to non-controlling interest-General Partner
|
|
|
|
|
6,858 |
|
|
|
|
|
55 |
|
|
| |
Segment net income
|
|
|
|
$ |
47,089 |
|
|
|
|
$ |
10,048 |
|
|
| |
Reconciliation of profit or loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Adjustments and reconciling items
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
| |
Consolidated net income attributable to members
|
|
|
|
$ |
47,089 |
|
|
|
|
$ |
10,048 |
|
|
| |
The table below presents gross premium written (“GPW”) by product group for the years ended December 31, 2024 and 2023:
| |
|
|
For the Years Ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Product Group
|
|
|
Amount
|
|
|
% of GWP
|
|
|
Amount
|
|
|
% of GWP
|
|
|
Casualty
|
|
|
|
$ |
263,328 |
|
|
|
|
|
60% |
|
|
|
|
$ |
203,916 |
|
|
|
|
|
58% |
|
|
|
Property
|
|
|
|
|
173,708 |
|
|
|
|
|
40% |
|
|
|
|
|
148,675 |
|
|
|
|
|
42% |
|
|
|
Total Gross Written Premium
|
|
|
|
$ |
437,036 |
|
|
|
|
|
100% |
|
|
|
|
$ |
352,591 |
|
|
|
|
|
100% |
|
|
| |
All long-term assets of the Company are based in the United States and similarly, all revenue is derived from customers based in the United States. For the year ended December 31, 2024, the Company had one distribution partner that generated $105.3 million of direct written premiums, representing 24.1% of total direct written premiums. For the year ended December 31, 2023, the Company had two distribution partners that generated
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
$100.7 million and $42.1 million of direct written premiums, representing 28.6% and 11.9% of total direct written premiums, respectively. No other broker generated ten percent or more of the direct written premiums for the years ended December 31, 2024 and 2023.
18. Earnings Per Unit
The following table presents the calculation of basic and diluted earnings per unit for the years ended December 31, 2024 and 2023:
| |
|
|
For the Years Ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands, except for
units and per unit data)
|
|
|
Numerator:
|
|
|
|
|
Net income to Members
|
|
|
|
$ |
47,090 |
|
|
|
|
$ |
10,048 |
|
|
|
Income allocable to participating securities
|
|
|
|
|
360 |
|
|
|
|
|
— |
|
|
|
Net income attributable to Members’ units
|
|
|
|
$ |
46,730 |
|
|
|
|
$ |
10,048 |
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average units outstanding-basic
|
|
|
|
|
393,747,242 |
|
|
|
|
|
349,938,678 |
|
|
|
Weighted-average participating securities
|
|
|
|
|
(3,009,018) |
|
|
|
|
|
— |
|
|
|
Weighted-average units outstanding-basic
|
|
|
|
|
390,738,224 |
|
|
|
|
|
349,938,678 |
|
|
|
Dilutive effect of share-based compensation
|
|
|
|
|
18,192 |
|
|
|
|
|
10,121 |
|
|
|
Weighted-average units outstanding-Diluted
|
|
|
|
|
390,756,416 |
|
|
|
|
|
349,948,799 |
|
|
|
Earnings per unit-basic
|
|
|
|
$ |
0.12 |
|
|
|
|
$ |
0.03 |
|
|
|
Earnings per unit-diluted
|
|
|
|
$ |
0.12 |
|
|
|
|
$ |
0.03 |
|
|
| |
Basic net income per unit is computed by dividing net income attributable to Members by the weighted-average number of Members’ units outstanding during the period. The Company applies the two-class method because the outstanding Warrants are considered participating securities, as they provide the Warrant holder with a nonforfeitable right to receive dividends on the same terms as the Members’ units, regardless of whether the Warrants are exercised. As a result, a portion of net income is allocated to the Warrants before determining net income attributable to Members for the purpose of calculating earnings per unit.
As the Company has not declared any dividends during the years ended December 31, 2024 and 2023, the Company allocated net income between the outstanding Members’ units and the Warrants based on their relative rights to undistributed earnings. As a result, a portion of net income was attributed to the outstanding Warrants, thereby reducing net income available to Members.
For the computation of diluted net income per unit, basic net income per unit attributable to Members is adjusted by the effect of dilutive securities, including awards under the Company’s Equity Plan as described in Note 16. Diluted net income per unit attributable to Members is computed by dividing the resulting net income attributable to Members by the weighted-average number of outstanding Members’ units and any potentially dilutive securities. For the years ended December 31, 2024 and 2023, all of the Company’s NQIOs were excluded from the calculation of the diluted earnings per unit because their effect would have been anti-dilutive.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
19. Dividend Restrictions
The insurance statutes of the U.S.-based insurance subsidiaries’ states of domicile limit the amount of dividends that they may pay annually without first obtaining regulatory approval. Generally, the limitations are based on the greater of statutory net income, excluding realized capital gains, for the preceding year or 10.0% of statutory surplus at the end of the preceding year but limited to earned surplus. However, U.S. insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels and could refuse to permit the payment of dividends. The maximum amount of dividends available to the Company from its U.S. insurance subsidiary during 2024 and 2023 without regulatory approval is zero.
20. Statutory Matters
U.S. state insurance laws and regulations prescribe accounting practices for determining statutory net income and capital and surplus for insurance companies. In addition, state regulators may permit statutory accounting practices (“SAP”) that differ from prescribed practices. SAP prescribed or permitted by regulatory authorities for the Company’s insurance subsidiaries differ from GAAP. The principal differences between SAP and GAAP as they relate to the financial statements of the Company’s insurance subsidiaries are (a) policy acquisition costs are expensed as incurred under SAP, whereas they are deferred and amortized under GAAP, (b) certain assets are not admitted for purposes of determining surplus under SAP, (c) the classification and carrying amounts of investments in certain securities are different under SAP and GAAP and (d) the criteria for providing asset valuation allowances and the methodologies used to determine the amount thereof are different under SAP and GAAP. Combined net income, statutory capital and surplus and minimum required statutory capital and surplus, as determined in accordance with statutory accounting practices, for the U.S. insurance subsidiary as of December 31, 2024 and 2023, and for the years ended December 31, 2024 and 2023, are summarized as follows:
| |
|
|
As of and for the years
ended December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Statutory net income (loss)
|
|
|
|
$ |
6,011 |
|
|
|
|
$ |
10,033 |
|
|
|
Statutory capital and surplus
|
|
|
|
$ |
76,537 |
|
|
|
|
$ |
66,682 |
|
|
|
Minimum required statutory capital and surplus
|
|
|
|
$ |
48,000 |
|
|
|
|
$ |
48,000 |
|
|
Risk-Based Capital (“RBC”) requirements promulgated by the National Association of Insurance Commissioners require property/casualty insurers to maintain minimum capitalization levels determined based on formulas incorporating various business risks of the insurance subsidiaries. As of December 31, 2024 and 2023, ASIC’s adjusted capital and surplus exceeded its authorized control level RBC.
On January 11, 2019, the Delaware Insurance Department approved ASIC’s request to invest up to 15% of its admitted assets in the Utility Limited Partnership.
As a registered insurance company under the Insurance Act 1978, amendments thereto and Related Regulations of Bermuda (the “Act”), ASIL is required to prepare Statutory Financial Statements and to file a Statutory Financial Return annually (or as otherwise agreed, in certain circumstances). The Act also requires ASIL to meet certain defined measures of solvency and liquidity. The statutory capital and surplus amounted to $268.8 million and $156.4 million as of December 31, 2024 and 2023, respectively. ASIL met the minimum statutory capital and surplus requirements as of December 31, 2024 and 2023. The principal difference between ASIL’s statutory capital and surplus and shareholder’s equity as reported in conformity with GAAP relate to prepaid expenses which are non-admitted assets under the Act.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
ASIL is prohibited from declaring or paying a dividend if its Class 3A statutory capital and surplus is less than its Enhanced Capital Requirement, if it is in breach of its solvency margin or minimum liquidity ratio or if the declaration or payment of such dividend would cause such breach. Further, ASIL must obtain the prior approval of the Bermuda Monetary Authority for a reduction by 15% or more of the total statutory capital or 25% of the total statutory capital and surplus, as set forth in its previous year’s financial statements.
21. Other Comprehensive Income
The following table summarizes the components of other comprehensive income for the years ended December 31, 2024 and 2023:
| |
|
|
For the Years Ended
December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Unrealized gains arising during the period, pre-tax
|
|
|
|
$ |
9,377 |
|
|
|
|
$ |
4,110 |
|
|
|
Income tax (expense)
|
|
|
|
|
(1,964) |
|
|
|
|
|
(864) |
|
|
|
Unrealized gains arising during the period, net of taxes
|
|
|
|
|
7,413 |
|
|
|
|
|
3,246 |
|
|
|
Other comprehensive income
|
|
|
|
$ |
7,413 |
|
|
|
|
$ |
3,246 |
|
|
| |
22. Income Taxes
The provision for federal income taxes is different from what would be obtained by applying the statutory federal income tax rate to income before income taxes. Total income tax consists of the following for the years ended December 31, 2024 and 2023:
| |
|
|
For the Years Ended
December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Federal income tax expense at applicable statutory rates (current)
|
|
|
|
$ |
16,728 |
|
|
|
|
$ |
9,489 |
|
|
|
Federal income tax (benefit) at applicable statutory rates (deferred)
|
|
|
|
|
(4,412) |
|
|
|
|
|
(6,971) |
|
|
|
Total income tax expense
|
|
|
|
$ |
12,316 |
|
|
|
|
$ |
2,518 |
|
|
| |
The prevailing federal income tax rate was 21% for both the years ended December 31, 2024 and 2023, respectively. The Company’s effective tax rate on income before income taxes differs from the prevailing federal income tax rate and is summarized as follows:
| |
|
|
For the Years Ended, December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
Amount
|
|
|
Percentage
|
|
|
Amount
|
|
|
Percentage
|
|
| |
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
Income tax expense at federal income tax rate
|
|
|
|
$ |
13,915 |
|
|
|
|
|
21.0% |
|
|
|
|
$ |
2,650 |
|
|
|
|
|
21.0% |
|
|
|
Other
|
|
|
|
|
(1,599) |
|
|
|
|
|
-2.4% |
|
|
|
|
|
(132) |
|
|
|
|
|
-1.0% |
|
|
|
Income tax expense
|
|
|
|
$ |
12,316 |
|
|
|
|
|
18.6% |
|
|
|
|
$ |
2,518 |
|
|
|
|
|
20.0% |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
The significant components of the net deferred tax assets at the corporate income tax rate of 21% are as follows:
| |
|
|
For the Years Ended
December 31,
|
|
| |
|
|
2024
|
|
|
2023
|
|
| |
|
|
(in thousands)
|
|
|
Deferred tax assets:
|
|
|
|
|
Unearned premiums
|
|
|
|
$ |
6,074 |
|
|
|
|
$ |
5,817 |
|
|
|
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
|
4,709 |
|
|
|
|
|
3,732 |
|
|
|
Unrealized losses on fixed-maturity securities, available-for-sale
|
|
|
|
|
— |
|
|
|
|
|
1,311 |
|
|
|
Accrued expenses
|
|
|
|
|
747 |
|
|
|
|
|
442 |
|
|
|
Contingent commissions
|
|
|
|
|
3,305 |
|
|
|
|
|
1,581 |
|
|
|
Allowance for credit losses
|
|
|
|
|
1,240 |
|
|
|
|
|
620 |
|
|
|
Other
|
|
|
|
|
822 |
|
|
|
|
|
521 |
|
|
|
Total deferred tax assets
|
|
|
|
|
16,897 |
|
|
|
|
|
14,024 |
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred policy acquisition costs, net of ceding commissions
|
|
|
|
|
(4,526) |
|
|
|
|
|
(4,882) |
|
|
|
Unrealized gains fixed maturity securities
|
|
|
|
|
(582) |
|
|
|
|
|
— |
|
|
|
Property and equipment
|
|
|
|
|
(137) |
|
|
|
|
|
(170) |
|
|
|
Deferred intercompany gain
|
|
|
|
|
(208) |
|
|
|
|
|
— |
|
|
|
Pass through entities
|
|
|
|
|
(1,553) |
|
|
|
|
|
(1,544) |
|
|
|
Accrued market discount
|
|
|
|
|
(221) |
|
|
|
|
|
(207) |
|
|
|
Total deferred tax liabilities
|
|
|
|
|
(7,227) |
|
|
|
|
|
(6,803) |
|
|
|
Net deferred tax assets
|
|
|
|
$ |
9,670 |
|
|
|
|
$ |
7,221 |
|
|
| |
The Company is subject to federal, state and local corporate income taxes and other taxes applicable to U.S. corporations.
The Company assessed the realizability of its deferred tax assets on a stand-alone basis. As of December 31, 2024, the Company had no federal and state net operating loss (“NOLs”) being carried forward. As of December 31, 2024, the Company’s stand-alone net deferred tax assets amounted to $9.7 million, The Company believes that it is more likely than not that the deferred tax assets will be realized given the reversal of existing temporary differences and future taxable income.
The Company had no reserve for future tax contingencies or liabilities (unrecognized tax benefits). The Company classifies all interest and penalties related to uncertain tax positions as income tax expense. The Company did not incur any interest or penalties related to uncertain tax positions for the years ended December 31, 2024 and 2023.
Tax years 2021 and subsequent are open and subject to examination by the IRS.
23. Related Party Transactions
Technology Transactions
The Company entered into a series of related technology transactions, (the “Technology Transactions”) effective January 1, 2023, with ZFSG and Zimmer Technology Group, LLC (“ZTG”), a wholly owned subsidiary of ZFSG,
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
governing the sale, licensing and services related to certain technology assets developed and owned by the Company. As part of the Technology Transactions, ZTG acquired the assets for a purchase price of $13.5 million paid in the form of a promissory note (“the Promissory Note”) issued by ZFSG bearing interest at 7.42% per annum with a maturity date of December 31, 2029.
Also as part of the Technology Transactions, the Company obtained a license to continue using the assets as part of the Company’s operations at a cost of $0.8 million per annum, with the ability to non-renew the license at the end of each one-year period. The Company also agreed to provide services relating to the assets to ZTG with the actual internal and external costs incurred by the Company in performing the services to be paid by ZTG. The following amounts were recorded in the year ended December 31, 2023 related to the Technology Transactions: (a) $0 gain on the sale of the assets; (b) $1.0 million interest income on the Promissory Note (included in net investment income); (c) $0.8 million licensing fee expense (included in underwriting, acquisition and insurance expenses); and (d) $3.6 million service charges billed to ZTG (included in underwriting, acquisition and insurance expenses as an offset).The following amounts were recorded in the year ended December 31, 2024 related to the Technology Transactions: (a) $1.0 million interest income on the Promissory Note (included in net investment income); (b) $0.8 million licensing fee expense (included in underwriting, acquisition and insurance expenses); and (c) $3.7 million service charges billed to ZTG (included in underwriting, acquisition and insurance expenses as an offset).
As of both December 31, 2024 and 2023, the balance of the Promissory Note was $13.5 million, included as a note receivable from affiliate in the consolidated balance sheets. Accrued interest on the Promissory Note was $0.3 million as of both December 31, 2024 and 2023, included in investment income due and accrued in the consolidated balance sheets.
As of December 31, 2024 and 2023, the receivable from ZTG was $1.0 million and $1.3 million, respectively, and the payable to ZTG was $0.2 million as of both December 31, 2024 and 2023, included in other assets and accounts payable and accrued expenses, respectively, in the consolidated balance sheets.
Management & Cost Sharing
The Company entered into a Management & Cost Sharing Agreement effective September 30, 2023 with Zimmer Insurance Services, LLC (“ZIS”), a wholly owned subsidiary of ZFSG, pursuant to which, amongst other things, ZIS may provide certain Services (as defined therein) to the Company and its affiliates. During 2024, certain corporate and shared service functions were provided by ZIS and Zimmer Partners, LP, an affiliate. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated on a pro rata basis based on measures considered to be a reasonable reflection of the historical utilization levels of these services. For the years ended December 31, 2024 and 2023, the Company recorded $0.8 million and $0.5 million, respectively, of such allocated expense recognized in underwriting, acquisition and insurance expenses in the consolidated statements of operations.
Commencing October 1, 2024, ZIS began providing employee benefit administration services to the Company that were previously provided to the Company by a third-party vendor. As of December 31, 2024, $0.8 million was due to ZIS under this agreement, included in accounts payable and accrued expenses in the consolidated balance sheets. The Company’s expense related to such services provided by ZIS was $0.4 million for the year ended December 31, 2024, included in underwriting, acquisition and insurance expenses in the consolidated statements of operations.
As described in Note 9, the Company subleases office space to ZFSG under a sublease agreement effective July 1, 2022 with ZFSG. The base rent under the sublease is equal to that which the Company pays under the headlease, and the sublease and the headlease are coterminous.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
Payable to ZFSG
As of December 31, 2024, $0.3 million was due to ZFSG for reimbursement of professional services paid by ZFSG and is included in accounts payable and accrued expenses in the consolidated balance sheets.
CEO Compensation
As described in Note 16, as part of the compensation of the Company’s CEO and solely for the services provided by him as a CEO of the Company, ZFSG granted him share-based awards in the form of options to purchase Members’ units of the Company held by ZFSG, subject to certain vesting conditions. For the year ended December 31, 2023, the Company recorded $0.2 million of compensation expense in underwriting, acquisition and insurance expenses in the consolidated statements of operations, with a corresponding amount recorded in the consolidated statements of changes in Members’ equity and non-controlling interest for the capital contribution by ZFSG. In December 2024, this share-based award issued by ZFSG was cancelled and replaced with new CEO Options issued by the Company as described in Note 16.
Investment Management Agreement
ASIL entered into an investment management agreement effective January 1, 2024 with Zimmer Partners, LP pursuant to which ASIL appointed the Investment Manager to manage a portfolio of assets and granted the Investment Manager the full and exclusive authority and discretion to effect investment transactions through the portfolio, subject to the investment guidelines set forth in the investment management agreement. As of December 31, 2024, $0.1 million was due to Zimmer Partners, LP under this agreement, included in accounts payable and accrued expenses in the consolidated balance sheets. The Company’s expense related to services provided by Zimmer Partners LP was $0.1 million for the year ended December 31, 2024, included in other expenses in the consolidated statements of operations.
Withdrawal from the Absolute Return Utility & Infrastructure Fund
On December 31, 2024, the Company submitted a withdrawal request of $16.9 million from the Absolute Return Utility & Infrastructure Fund. This receivable is included in other assets in the consolidated balance sheets. $6.9 million of the withdrawal was made by the Utility General Partner and the payable to the Utility General Partner for this amount as of December 31, 2024 is included in accounts payable and accrued expenses in the consolidated balance sheets.
Consulting Agreements
In January 2023, ZFSG entered into a consulting agreement with the Company’s Chief Underwriting Officer (“CUO”), under which the CUO agreed to provide consulting services to ZFSG for matters unrelated to the Company. The agreement commenced on January 1, 2023, and remained in effect through December 31, 2023. ZFSG paid the CUO $0.5 million as compensation. The terms of the consulting agreement did not affect the CUO’s compensation as the Company’s CUO and any fees paid for consulting services were separate from his standard compensation.
Capital Transactions
Capital transactions with ZFSG during the years ended December 31, 2024 and 2023 are described in Note 15.
During the years ended December 31, 2024 and 2023, the Utility General Partner withdrew $6.9 million and $3.1 million, respectively, from its capital account in the Utility Limited Partnership, which is presented as a distribution for the non-controlling interest in the consolidated statements of changes in members’ equity and non-controlling interest.
Ategrity Specialty Holdings LLC and Subsidiaries
Notes to Consolidated Financial Statements
24. Subsequent Events
In January 2025, the Company issued 21,436,227 additional units of Members’ equity to ZFSG, in exchange for U.S. Treasury bills of $20.0 million.
The Company has evaluated subsequent events through March 4, 2025, the date the consolidated financial statements were available to be issued. Other than the events described above, no subsequent events are known.
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule I—Summary of Investments—Other than Investment in
Related Parties
|
(in thousands)
|
|
|
Cost
|
|
|
Fair Value
(if applicable)
|
|
|
Amount on
Balance Sheet
|
|
|
December 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities and obligations guaranteed by the U.S. Government
|
|
|
|
$ |
84,456 |
|
|
|
|
$ |
84,195 |
|
|
|
|
$ |
84,195 |
|
|
|
Corporate
|
|
|
|
|
349,693 |
|
|
|
|
|
353,805 |
|
|
|
|
|
353,805 |
|
|
|
Commercial and residential mortgage-back and other asset-backed
|
|
|
|
|
816 |
|
|
|
|
|
752 |
|
|
|
|
|
752 |
|
|
|
Total fixed maturity securities, available-for-sale
|
|
|
|
|
434,965 |
|
|
|
|
|
438,752 |
|
|
|
|
|
438,752 |
|
|
| |
|
(in thousands)
|
|
|
Cost
|
|
|
Fair Value
(if applicable)
|
|
|
Amount on
Balance Sheet
|
|
|
December 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
$ |
68,583 |
|
|
|
|
$ |
66,985 |
|
|
|
|
$ |
66,985 |
|
|
|
Municipal taxable
|
|
|
|
|
12,331 |
|
|
|
|
|
11,294 |
|
|
|
|
|
11,294 |
|
|
|
Commercial mortgage and asset-backed
|
|
|
|
|
22,875 |
|
|
|
|
|
19,921 |
|
|
|
|
|
19,921 |
|
|
|
Total fixed maturity securities, available-for-sale
|
|
|
|
|
103,789 |
|
|
|
|
|
98,200 |
|
|
|
|
|
98,200 |
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stocks
|
|
|
|
|
1,000 |
|
|
|
|
|
1,000 |
|
|
|
|
|
1,000 |
|
|
|
Total equity securities
|
|
|
|
|
1,000 |
|
|
|
|
|
1,000 |
|
|
|
|
|
1,000 |
|
|
|
Total investments
|
|
|
|
$ |
104,789 |
|
|
|
|
$ |
99,200 |
|
|
|
|
$ |
99,200 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule II—Condensed Financial Information of Registrant
Balance Sheet (Parent Company)
| |
|
|
For the Years Ended
December 31,
|
|
|
(in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at fair value (amortized cost:
2024–$24,350, 2023–$23,182)
|
|
|
|
$ |
25,052 |
|
|
|
|
$ |
23,835 |
|
|
|
Equity securities, at fair value (cost: 2024–$0, 2023–$1,000)
|
|
|
|
|
— |
|
|
|
|
|
1,000 |
|
|
|
Investment in Utility Limited Partnership, at fair value (cost: 2024–21,168, 2023–$48,045)
|
|
|
|
|
21,168 |
|
|
|
|
|
48,045 |
|
|
|
Investment in subsidiaries
|
|
|
|
|
351,613 |
|
|
|
|
|
228,296 |
|
|
|
Total investment
|
|
|
|
|
397,833 |
|
|
|
|
|
301,176 |
|
|
|
Cash and cash equivalents
|
|
|
|
|
1,041 |
|
|
|
|
|
32,213 |
|
|
|
Investment income due and accrued
|
|
|
|
|
372 |
|
|
|
|
|
19 |
|
|
|
Receivable from affiliates
|
|
|
|
|
2,087 |
|
|
|
|
|
1,740 |
|
|
|
Other assets
|
|
|
|
|
3,504 |
|
|
|
|
|
371 |
|
|
|
Total assets
|
|
|
|
$ |
404,837 |
|
|
|
|
$ |
335,519 |
|
|
|
Liabilities and members’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities sold, not yet purchased, at fair value (cost: 2024–$0, 2023–$12,379)
|
|
|
|
|
— |
|
|
|
|
|
12,130 |
|
|
|
Due to broker
|
|
|
|
|
946 |
|
|
|
|
|
— |
|
|
|
Accounts payable and accrued expenses
|
|
|
|
|
2,847 |
|
|
|
|
|
503 |
|
|
|
Income tax payable
|
|
|
|
|
2,441 |
|
|
|
|
|
1,137 |
|
|
|
Deferred income tax liability, net
|
|
|
|
|
406 |
|
|
|
|
|
272 |
|
|
|
Total liabilities
|
|
|
|
|
6,640 |
|
|
|
|
|
14,042 |
|
|
|
Members’ equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Members’ equity
|
|
|
|
|
360,741 |
|
|
|
|
|
338,635 |
|
|
|
Retained earnings
|
|
|
|
|
12,971 |
|
|
|
|
|
6,080 |
|
|
|
Accumulated other comprehensive loss
|
|
|
|
|
24,485 |
|
|
|
|
|
(23,238) |
|
|
|
Total members’ equity
|
|
|
|
|
398,197 |
|
|
|
|
|
321,477 |
|
|
|
Total liabilities and members’ equity
|
|
|
|
$ |
404,837 |
|
|
|
|
$ |
335,519 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule II—Condensed Financial Information of Registrant
Statement of Operations and Comprehensive Income (Parent
Company)
| |
|
|
For the Years Ended December 31,
|
|
|
(in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Investment Income
|
|
|
|
$ |
3,213 |
|
|
|
|
$ |
908 |
|
|
|
Net realized and unrealized (losses) on investments
|
|
|
|
|
6,403 |
|
|
|
|
|
(100) |
|
|
|
Total Revenues
|
|
|
|
|
9,616 |
|
|
|
|
|
808 |
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation and benefits
|
|
|
|
|
935 |
|
|
|
|
|
747 |
|
|
|
Interest expense
|
|
|
|
|
(40) |
|
|
|
|
|
|
|
|
|
Other expenses
|
|
|
|
|
50 |
|
|
|
|
|
— |
|
|
|
Total expenses
|
|
|
|
|
945 |
|
|
|
|
|
747 |
|
|
|
Income before income taxes
|
|
|
|
|
8,671 |
|
|
|
|
|
61 |
|
|
|
Income tax expense
|
|
|
|
|
1,780 |
|
|
|
|
|
(29) |
|
|
|
Net income
|
|
|
|
|
6,891 |
|
|
|
|
|
90 |
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized (losses) gains on securities available for sale
|
|
|
|
|
(1,019) |
|
|
|
|
|
895 |
|
|
|
Equity in other comprehensive income (loss) of subsidiaries
|
|
|
|
|
8,869 |
|
|
|
|
|
12,089 |
|
|
|
Total comprehensive income
|
|
|
|
$ |
14,741 |
|
|
|
|
$ |
13,074 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule II—Condensed Financial Information of Registrant
Statement of Cash Flows (Parent Company)
| |
|
|
For the Years Ended December 31,
|
|
|
(in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
$ |
6,891 |
|
|
|
|
$ |
90 |
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain/ loss on investments in subsidiaries
|
|
|
|
|
(949) |
|
|
|
|
|
— |
|
|
|
Amortization of premium on fixed maturity securities, available-for-sale
|
|
|
|
|
(38) |
|
|
|
|
|
— |
|
|
|
Net unrealized gains on investment in Utility Limited Partnership
|
|
|
|
|
(6,200) |
|
|
|
|
|
469 |
|
|
|
Net realized gain and unrealized appreciation on securities sold, not yet purchased
|
|
|
|
|
(379) |
|
|
|
|
|
(155) |
|
|
|
Depreciation and amortization
|
|
|
|
|
(2) |
|
|
|
|
|
— |
|
|
|
Share-based compensation
|
|
|
|
|
— |
|
|
|
|
|
244 |
|
|
|
Change in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
|
|
123 |
|
|
|
|
|
(412) |
|
|
|
Investment income due and accrued
|
|
|
|
|
(304) |
|
|
|
|
|
121 |
|
|
|
Other assets
|
|
|
|
|
(3,503) |
|
|
|
|
|
— |
|
|
|
Receivables from affiliates
|
|
|
|
|
(347) |
|
|
|
|
|
260 |
|
|
|
Accounts payable and accrued expenses
|
|
|
|
|
2,345 |
|
|
|
|
|
503 |
|
|
|
Income tax payable
|
|
|
|
|
1,304 |
|
|
|
|
|
123 |
|
|
|
Net cash provided by operating activities
|
|
|
|
|
(1,059) |
|
|
|
|
|
1,243 |
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of fixed maturity securities, available-for-sale
|
|
|
|
|
(230) |
|
|
|
|
|
(136,964) |
|
|
|
Proceeds from sale of fixed maturity securities, available-for-sale
|
|
|
|
|
12,071 |
|
|
|
|
|
122,769 |
|
|
|
Sale of equity securities
|
|
|
|
|
— |
|
|
|
|
|
(1,000) |
|
|
|
Change in Treasury bills, net
|
|
|
|
|
(39,199) |
|
|
|
|
|
— |
|
|
|
Change in short-term investments, net
|
|
|
|
|
(3,467) |
|
|
|
|
|
— |
|
|
|
Purchases to cover securities sold, not yet purchased
|
|
|
|
|
1,210 |
|
|
|
|
|
(56,974) |
|
|
|
Proceeds from sale of securities sold, not yet purchased
|
|
|
|
|
(348) |
|
|
|
|
|
67,703 |
|
|
|
Purchase of investment in subsidiaries
|
|
|
|
|
(31,928) |
|
|
|
|
|
(15,000) |
|
|
|
Redemptions of investment in the Utility Limited Partnership
|
|
|
|
|
31,778 |
|
|
|
|
|
15,000 |
|
|
|
Net cash provided by investing activities
|
|
|
|
|
(30,113) |
|
|
|
|
|
(4,466) |
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of member units
|
|
|
|
|
— |
|
|
|
|
|
35,000 |
|
|
|
Net cash provided by financing activities
|
|
|
|
|
— |
|
|
|
|
|
35,000 |
|
|
|
Net change in cash and cash equivalents
|
|
|
|
|
(31,172) |
|
|
|
|
|
31,777 |
|
|
|
Cash and cash equivalents, at beginning of period
|
|
|
|
|
32,213 |
|
|
|
|
|
436 |
|
|
|
Cash and cash equivalents, at end of period
|
|
|
|
$ |
1,041 |
|
|
|
|
$ |
32,213 |
|
|
|
Supplementary cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
Cash paid for taxes
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
Supplementary non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Member units issued
|
|
|
|
$ |
20,100 |
|
|
|
|
$ |
— |
|
|
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule V—Valuation and Qualifying Accounts
|
(in thousands)
|
|
|
Valuation
Allowance
for Deferred
Tax Assets
|
|
|
Allowance for
Uncollectible
Reinsurance
Recoverable
|
|
|
Allowance for
Uncollectible
Premium
Receivable
|
|
|
Balance at January 1, 2023
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
Charged to costs and expenses
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
2,953 |
|
|
|
Balance at December 31, 2023
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
2,953 |
|
|
|
Charged to costs and expenses
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
2,954 |
|
|
|
Balance at December 31, 2024
|
|
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
5,907 |
|
|
| |
Ategrity Specialty Holdings LLC and Subsidiaries
Supplemental schedules
Schedule VI—Insurance Operations
| |
|
|
As of and For the Years Ended
December 31,
|
|
|
(in thousands)
|
|
|
2024
|
|
|
2023
|
|
|
Deferred policy acquisition costs, net of ceding commissions(1)
|
|
|
|
|
21,552 |
|
|
|
|
|
23,245 |
|
|
|
Reserves for unpaid losses and loss adjustment expenses
|
|
|
|
|
403,576 |
|
|
|
|
|
320,936 |
|
|
|
Unearned premiums
|
|
|
|
|
212,828 |
|
|
|
|
|
173,905 |
|
|
|
Net earned premium(1)
|
|
|
|
|
290,635 |
|
|
|
|
|
231,464 |
|
|
|
Net investment income
|
|
|
|
|
24,046 |
|
|
|
|
|
11,366 |
|
|
|
Loss and loss adjustment expenses(1)
|
|
|
|
|
175,234 |
|
|
|
|
|
154,107 |
|
|
|
Loss and loss adjustment expenses prior year(1)
|
|
|
|
|
5,418 |
|
|
|
|
|
17,238 |
|
|
|
Amortization of policy acquisition costs(1)
|
|
|
|
|
49,746 |
|
|
|
|
|
44,065 |
|
|
|
Paid claims and claim adjustment expenses(1)
|
|
|
|
|
113,356 |
|
|
|
|
|
111,972 |
|
|
|
Net premiums written(1)
|
|
|
|
|
299,206 |
|
|
|
|
|
268,216 |
|
|
|
Ceded unearned premium
|
|
|
|
|
68,205 |
|
|
|
|
|
37,852 |
|
|
|
Deferred ceding commission
|
|
|
|
|
15,258 |
|
|
|
|
|
6,030 |
|
|
(1) Amount is presented net of reinsurance
shares
Common stock
Preliminary prospectus
| |
J.P. Morgan
|
|
|
|
|
|
Barclays
|
|
Until, , 2025 (25 days after the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealer’s obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
Part II
Information not required in prospectus
Item 13. Other expenses of issuance and distribution
The following table sets forth expenses to be paid by us, other than underwriting discounts and commissions, in connection with this offering. All amounts shown are estimates except for the SEC registration fee, the FINRA filing fee, and the stock exchange listing fee.
| |
Securities and Exchange Commission registration fee
|
|
|
|
$ |
15,310 |
|
|
| |
Financial Industry Regulatory Authority, Inc. (FINRA) filing fee
|
|
|
|
|
15,500 |
|
|
| |
Stock exchange listing fee
|
|
|
|
|
* |
|
|
| |
Printing and engraving expenses
|
|
|
|
|
* |
|
|
| |
Legal fees and expenses
|
|
|
|
|
* |
|
|
| |
Accounting fees and expenses
|
|
|
|
|
* |
|
|
| |
Miscellaneous expenses
|
|
|
|
|
* |
|
|
| |
Total
|
|
|
|
$ |
* |
|
|
| |
* To be completed by amendment.
Item 14. Indemnification of directors and officers
Nevada Revised Statutes (“NRS”) 78.138(7) provides that, subject to limited statutory exceptions and unless the articles of incorporation or an amendment thereto (in each case filed on or after October 1, 2003) provide for greater individual liability, a director or officer is not individually liable to a corporation or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer unless the presumption of Nevada’s “business judgment rule” (as codified in NRS 78.138(3)) has been rebutted and it is proven that: (i) the director’s or officer’s act or failure to act constituted a breach of his or her fiduciary duties as a director or officer and (ii) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law. Our articles of incorporation will provide for the exculpation of our directors and officer to the fullest extent under the NRS.
NRS 78.7502 permits a corporation to indemnify, pursuant to that statutory provision, a present or former director, officer, employee or agent of the corporation, or of another entity or enterprise (including as a manager of a limited liability company), for which such person is or was serving in such capacity at the request of the corporation, who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, except an action by or in the right of the corporation, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection therewith, arising by reason of such person’s service in such capacity if such person (i) is not liable pursuant to NRS 78.138, or (ii) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to a criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. In the case of actions brought by or in the right of the corporation, however, no indemnification pursuant to NRS 78.7502 may be made for any claim, issue or matter as to which such person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper. Any discretionary indemnification pursuant to the statutory mechanism provided under NRS 78.7502, unless ordered by a court or advanced to a director or officer by the corporation in accordance with the NRS, may be made by a corporation only as authorized in each specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the
circumstances. Such determination must be made (1) by the stockholders, (2) by the board of directors by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding, (3) if a majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding so orders, by independent legal counsel in a written opinion, or (4) if a quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion.
NRS 78.751 further provides that indemnification pursuant to the statutory mechanism provided under NRS 78.7502 does not exclude any other rights to which a person seeking indemnification or advancement of expenses may be entitled under our articles of incorporation, or any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, for either an action in the person’s official capacity or an action in another capacity while holding office, except that indemnification, unless ordered by a court pursuant to NRS 78.7502 or for the advancement of expenses, may not be made to or on behalf of any director or officer finally adjudged by a court of competent jurisdiction, after exhaustion of any appeals, to be liable for intentional misconduct, fraud or a knowing violation of law, and such misconduct, fraud, or violation was material to the cause of action. Pursuant to NRS 78.751(5), a right to indemnification or to advancement of expenses arising under a provision of the articles of incorporation or any bylaw is not eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after such act or omission has occurred.
Our bylaws will provide that we must indemnify our directors and officers in their respective capacities as such and in any and all other capacities in which any of them serves at our request to the fullest extent permitted by law. We will also be expressly authorized to advance certain expenses (including attorneys’ fees) to our directors and officers and carry directors’ and officers’ insurance providing for indemnification of its directors and officers for some liabilities.
We have in effect a directors and officers liability insurance policy indemnifying our directors and officers for certain liabilities incurred by them, including liabilities under the Securities Act, and the Exchange Act. We pay the entire premium of this policy.
We intend to enter into indemnification agreements with each of our directors and officers that provide the maximum indemnity allowed to directors and officers by the NRS (including NRS 78.751(3)) and which allow for certain additional procedural protections.
These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.
Item 15. Recent sales of unregistered securities
The following sets forth information regarding all unregistered securities sold by us since January 1, 2022:
Unit issuances
In September 2022, ZFSG made a non-cash contribution to us of $75.0 million in the form of an in-kind contribution of an interest in the Utility Limited Partnership and received 95,724,314 of our units for such contribution.
In October 2023, ZFSG made a cash contribution of $35.0 million to us and received 44,164,038 of our units for such contribution.
In October 2024, ZFSG made an in-kind contribution of $22.2 million in principal amount of U.S. Treasury Notes with a fair market value of $20.1 million to us and received (i) 23,022,550 of our units, (ii) 11,511,275 warrants to purchase our units with an exercise price of $3.00, and (iii) 4,000,000 warrants to purchase our units with an exercise price of $2.00 for such contribution.
In January 2025, ZFSG made an in-kind contribution of $20.0 million in principal amount of U.S. Treasury Notes with a fair market value of $20.0 million to us and received 21,436,227 of our units.
Equity plan-related issuances
From January 1, 2022 through the date of this registration statement, we granted to our employees, officers, directors, and consultants options to purchase an aggregate of 75,083,342 units at per unit exercise prices of $0.88, $1.00, $2.00, and $3.00. From January 1, 2022 through the date of this registration statement, we issued no units pursuant to the exercise of options by our employees, officers, directors, and consultants.
The issuances of the securities in the transactions described above were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act and/or Rule 506, Rule 701, or Regulation S promulgated thereunder. The securities were issued directly by us and did not involve a public offering or general solicitation. The recipients of such securities represented their intentions to acquire the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof.
None of the transactions set forth in Item 15 involved any underwriters, underwriting discounts or commissions, or any public offering. All recipients had adequate access, through their relationships with us, to information about us.
Item 16. Exhibits and financial statement schedules
Exhibits
See the Exhibits index immediately following the signature page hereto, which is incorporated by reference as if fully set forth herein.
Financial statement schedules
See the financial statement schedules listed in the Index to the Consolidated Financial Statements, which are incorporated by reference as if fully set forth herein.
Item 17. Undertakings
The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.
(1) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers, and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.
(2) The undersigned registrant hereby undertakes that:
(A) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and
contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
(B) For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Exhibit index
| |
Exhibit
number
|
|
|
Description
|
|
| |
1.1*
|
|
|
Form of Underwriting Agreement.
|
|
| |
3.1*
|
|
|
Form of Articles of Incorporation of Ategrity Specialty Insurance Company Holdings, to be effective upon the consummation of this offering.
|
|
| |
3.2*
|
|
|
Form of Bylaws of Ategrity Specialty Insurance Company Holdings, to be effective upon the consummation of this offering.
|
|
| |
4.1*
|
|
|
Specimen Common Stock Certificate.
|
|
| |
5.1*
|
|
|
Opinion of Brownstein Hyatt Farber Schreck, LLP
|
|
| |
10.1*
|
|
|
Form of Stockholders’ Agreement, to be effective upon the consummation of this offering.
|
|
| |
10.2*
|
|
|
Form of Warrant Certificate.
|
|
| |
10.3#
|
|
|
|
|
| |
10.4*#
|
|
|
Ategrity Specialty Insurance Company Holdings 2025 Incentive Award Plan and forms of award agreements thereunder.
|
|
| |
10.5*#
|
|
|
Non-Employee Director Compensation Policy of the Company, to be effective upon the consummation of this offering.
|
|
| |
10.6*
|
|
|
Form of Indemnification Agreement between Ategrity Specialty Insurance Company Holdings and each of its directors and executive officers
|
|
| |
10.7*+
|
|
|
Form of Shared Services Agreement, by and between Ategrity Specialty Holdings LLC and Zimmer Financial Services Group LLC, to be effective prior to this offering.
|
|
| |
10.8
|
|
|
|
|
| |
10.9+
|
|
|
|
|
| |
10.10
|
|
|
Tax Allocation Agreement, dated as of April 1, 2018, by and among Ategrity Specialty Holdings LLC, Ategrity Specialty Insurance Company, Ategrity Specialty Insurance Limited and Zimmer Financial Services Group LLC.
|
|
| |
10.11
|
|
|
|
|
| |
10.12
|
|
|
|
|
| |
10.13+
|
|
|
Amended and Restated Investment Management Agreement, dated as of October 1, 2024, by and between Ategrity Specialty Insurance Limited and Zimmer Partners, LP.
|
|
| |
10.14+
|
|
|
Amended and Restated Investment Management Agreement, dated as of October 1, 2024, by and between Ategrity Specialty Holdings LLC and Zimmer Partners, LP.
|
|
| |
10.15+
|
|
|
|
|
| |
10.16§
|
|
|
|
|
| |
10.17§
|
|
|
Second Amended and Restated Employment Agreement, dated as of March 21, 2025, by and between Ategrity Specialty Holdings LLC and Chris Schenk.
|
|
| |
10.18§
|
|
|
|
|
| |
10.19*
|
|
|
Form of Employment Agreement, by and between Ategrity Specialty Holdings LLC and Justin Cohen, to be effective upon consummation of this offering.
|
|
* To be filed by amendment
# Compensatory plan or arrangement
+
Certain of the schedules and attachments to this exhibit have been omitted pursuant to Regulation S-K, Item 601(a)(5). The registrant hereby undertakes to provide further information regarding such omitted materials to the SEC upon request.
§
Certain portions of this exhibit (indicated by “[***]”) have been redacted pursuant to Regulation S-K, Item 601(a)(6).
Signatures
Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in New York, New York, this 24th day of March, 2025.
ATEGRITY SPECIALTY HOLDINGS LLC
By:
/s/ Justin Cohen
Name:
Justin Cohen
Title:
Chief Executive Officer
Power of attorney
Each of the undersigned officers and directors of Ategrity Specialty Holdings LLC hereby constitutes and appoints Justin Cohen and Neelam Patel, and each of them any of whom may act without joinder of the other, the individual’s true and lawful attorneys in fact and agents, each with full power of substitution and resubstituting, for the person and in his or her name, place, and stead, in any and all capacities, to sign this registration statement, and any other registration statement relating to the same offering (including any registration statement, or amendment thereto, that is to become effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and any and all amendments thereto (including post effective amendments to the registration statement), and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys in fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys in fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.
| |
Signature
|
|
|
Title
|
|
|
Date
|
|
| |
/s/ Justin Cohen
Justin Cohen
|
|
|
Chief Executive Officer and Director
(Principal Executive Officer)
|
|
|
March 24, 2025
|
|
| |
/s/ Neelam Patel
Neelam Patel
|
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
|
March 24, 2025
|
|
| |
/s/ Stuart J. Zimmer
Stuart J. Zimmer
|
|
|
Director, Chair
|
|
|
March 24, 2025
|
|
| |
/s/ Tom Hulst
Tom Hulst
|
|
|
Director
|
|
|
March 24, 2025
|
|
Exhibit 10.3
ATEGRITY SPECIALTY HOLDINGS LLC
EQUITY INCENTIVE PLAN
Article I
Purpose
Ategrity Specialty Holdings
LLC, a Delaware limited liability company (the “Company”), hereby establishes the Ategrity Specialty Holdings Equity
Incentive Plan (as amended and restated from time to time, the “Plan”), effective as of February 5, 2019, as most
recently amended pursuant to that certain Unanimous Written Consent of the Board of Managers of the Company dated as of December 8,
2024. The purpose of the Plan is to advance the interests of the Company and its Members by providing a means by which the Company and
its Affiliates and Subsidiaries can attract, retain and motivate selected directors, officers, other employees and consultants and provide
such personnel with an opportunity to participate in the increased value of the Company which their effort, initiative and skill have
helped produce.
Article II
Definitions
“Affiliate”
means, with respect to any person or entity, any other person or entity that, directly or indirectly through one or more intermediaries,
controls, is controlled by or is under common control with, such person or entity through the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of a person or entity, whether through ownership of the voting securities,
by contract or otherwise.
“Award”
means any grant of an Option, Restricted Unit, Other Unit-Based Award under the Plan.
“Award Agreement”
means any written agreement, contract or other instrument or document evidencing any Award, which may, but need not (as determined by
the Board), be required to be executed or acknowledged by a Participant as a condition precedent to receiving an Award or the benefits
under an Award.
“Beneficial owner”
or “beneficially own” has the meaning given to such term in Rule 13d-3 under the Exchange Act.
“Board”
means the Board of Managers of the Company.
“Call Notice”
has the meaning set forth in Section 7.01.
“Call Period”
has the meaning assigned to it in Section 7.01.
“Call Price”
has the meaning set forth in Section 7.02.
“Call Right”
has the meaning set forth in Section 7.01.
“Call Units”
has the meaning set forth in Section 7.01.
“Cause”
means, with respect to any Participant, (a) “Cause” as defined in an offer letter or employment agreement applicable
to the Participant (if applicable, the “Employment Agreement”) or (b) in the case of a Participant who does not
have an Employment Agreement that defines “Cause,” the occurrence of any of the following, as reasonably determined by the
Board: (i) the Participant’s commission of an act of misappropriation, dishonesty, fraud, embezzlement or breach of a fiduciary
duty to the Company or any of its Affiliates or Subsidiaries (collectively, the “Company Group”) (including, without
limitation, the unauthorized disclosure of confidential information or trade secrets and the obtaining of personal profit in connection
with a transaction entered into by or on behalf of any member of the Company Group without prior disclosure to and approval by the Board);
(ii) the Participant’s indictment for, conviction of or plea of nolo contendere with respect to, (x) a felony or
(y) any other crime involving moral turpitude; (iii) the Participant reporting to work under the influence of alcohol or illegal
drugs or other conduct which causes any member of the Company Group public disgrace or disrepute or economic harm; (iv) the Participant’s
material breach of any agreement with any member of the Company Group; (v) the Participant’s willful and prolonged absence
from work (other than by reason of Disability); (vi) the Participant’s gross negligence or willful misconduct with respect
to any member of the Company Group or the performance of his or her duties under any agreement with a member of the Company Group; or
(vii) the Participant’s failure to perform his or her material duties as reasonably directed by any authorized member of the
Company Group. In the cases of clauses (iv), (v), (vi) or (vii) above, the Participant shall not be deemed to have been terminated
for Cause, unless (x) written notice has been delivered to him or her setting forth the Company’s (or any of its Affiliates’
or Subsidiaries’) reasons for the termination for Cause, (y) the Participant has not cured (if curable) the breaches or failures
set forth in such notice to the satisfaction of the Company (or any of its Affiliates or Subsidiaries) within 30 days after receipt of
such notice and (z) the Company terminates the Participant’s employment not later than the 60th day after the expiration of
the cure period (if any).
“Change in Control”
means the consummation of any transaction or series of related transactions, pursuant to which one or more Person or group of Persons
(other than a Proposed Transferee and other than an Affiliate of the Company) acquires or becomes the beneficial owner, directly or indirectly,
of (a) equity interests in the Company possessing (i) the power to vote more than 50% of the Units of the Company or (ii) the
voting power sufficient to elect a majority of the members of the Board or the board of directors of any successor to the Company (whether
such transaction is effected by merger, consolidation, recapitalization, sale or transfer of the Company’s equity interests or otherwise),
or (b) all or substantially all of the assets of the Company and its Subsidiaries.
“Code”
means the Internal Revenue Code of 1986, as amended, and applicable rules and regulations thereunder.
“Disability”
means any medically determinable physical or mental impairment resulting in the Participant’s inability to engage in any substantial
gainful activity, where such impairment is likely to result in death or can be expected to last for a continuous period of not less than
12 months, as determined reasonably and in good faith by the Board.
“Eligible Individual”
means any officer, employee, director, independent contractor or consultant to, the Company or a Subsidiary and includes any holders of
Substitute Awards (whether or not employed by the Company or a Subsidiary).
“Encumbrance”
means any lien, security interest, pledge, claim, option, right of first refusal, marital right or other encumbrance with respect to any
Unit issued in respect of any Award.
“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and applicable rules and regulations thereunder.
“Exercise Price”
means the price at which a Unit may be purchased by a Participant pursuant to an Option as set forth in the relevant Award Agreement.
“Fair Market Value”
means (a) if the Units are not listed or traded on the New York Stock Exchange, the NYSE MKT LLC or other principal exchange or the
Nasdaq Stock Market, or reported by OTC Markets Group, or any similar successor organization, the fair market value as determined by the
Board in good faith, and (b) otherwise, the average of the closing prices of all Units (at the end of the regular session, as reported
on the Consolidated Tape) on the New York Stock Exchange, the NYSE MKT LLC (or other principal stock exchange) or the Nasdaq Stock Market,
as applicable, or, if there have been no sales on any such exchange on any day, the average of the highest bid and lowest asked prices
on all such applicable exchanges (at the end of the regular session, as reported on the Consolidated Tape) on such day or, if on any day
the Units are not so listed, the average of the highest bid and lowest asked prices on such day in the domestic over-the-counter market
as reported by OTC Markets Group, or any similar successor organization, in each case averaged over a 21-day period consisting of the
day as of which the Fair Market Value is being determined and the 20 consecutive business days prior to such day.
“Incentive Option”
means an Option granted pursuant to Section 6.01 that is intended to meet the requirements of Section 422 of the Code.
“Involuntary Transfer”
means a transfer of a Participant’s Award or any Unit issued in respect of any Award by operation of law including, without limitation,
as a result of (a) a sale or other disposition by a trustee or debtor in possession appointed or retained in a bankruptcy case, (b) a
sale at any creditors’ or judicial sale, (c) a transfer arising out of a divorce or separation proceeding or (d) by will
or the laws of descent and distribution.
“Member”
shall have the meaning designated in the Operating Agreement.
“Operating Agreement”
means the Amended and Restated Limited Liability Company Agreement of Ategrity Specialty Holdings LLC, dated as of April 1, 2018,
as the same may be amended from time to time.
“Option”
means an option to purchase Units granted to an Eligible Individual under the Plan.
“Other Unit-Based
Award” means any award denominated in or based on Units granted to a Participant, pursuant to Section 6.03.
“Participant”
means an Eligible Individual who receives an Award under the Plan.
“Person”
means a partnership, joint venture, limited partnership, limited liability partnership, limited liability limited partnership, corporation,
limited liability company, professional corporation, professional association, trust, estate, custodian, trustee, executor, administrator,
nominee, representative, unincorporated organization, sole proprietorship, employee benefit plan, tribunal, governmental entity, department,
agency, quasi-governmental entity, any other business, entity or organization, including a government or political subdivision or an agency,
unit or instrumentality thereof, or any natural person (regardless of citizenship or residency).
“Plan”
has the meaning set forth in Article I.
“Prime Rate”
means the rate which the Company’s principal financial institution (as designated by the Company from time to time) announces from
time to time at its principal office as its prime lending rate for domestic commercial loans, the Prime Rate to change when and as such
prime lending rate changes.
“Proposed Transferee”
(a) with respect to any Units issued in respect of an Award held by a Participant, means any person to whom a Participant proposes
to transfer any such Units and (b) with respect to any Awards or Units held by a Participant, means any person to whom such Awards
are transferred pursuant to an Involuntary Transfer.
“Restricted Unit”
means a contractual right to receive a designated number of Units or the Fair Market Value thereof, granted to a Participant pursuant
to Section 6.02.
“Section 409A”
has the meaning assigned to it in Article XVII.
“Section 457A”
has the meaning assigned to it in Article XVII.
“Securities Act”
means the Securities Act of 1933, as amended, and applicable rules and regulations thereunder.
“Subsidiary”
means (a) any company during any period in which it is a “subsidiary corporation” as that term is defined in Section 424(f) of
the Code with respect to the Company, or (b) any other entity of which ownership interests having ordinary voting power to elect
a majority of the board of directors or other persons performing similar functions are directly or indirectly owned by the Company.
“Substitute Award”
means an Award granted pursuant to Article V in assumption of, or as an alternative to or replacement of, an outstanding award
previously granted by a business or entity all or a portion of which is acquired by the Company or any of its Affiliates or Subsidiaries,
or with which the Company or any of its Affiliates or Subsidiaries combines.
“Unit”
means a limited liability company interest of the Company.
“Unvested Award”
means, as of any date, any Award (or any portion thereof) which by its terms has not yet vested and become exercisable as of such date.
“Vested Award”
means, as of any date, any Award (or any portion thereof) which by its terms has vested and become exercisable as of such date.
Article III
Administration
Section 3.01. Board.
The Plan shall be administered by the Board.
Section 3.02. Authority
of the Board. Subject to the provisions of the Plan, the Board shall have the authority, in its discretion and on behalf of the Company:
(a) to
select from among the Eligible Individuals those persons who shall receive Awards, to determine the time or times of receipt, to determine
the types of Awards and the number of Units covered by the Awards, to establish the terms, conditions, performance criteria, restrictions
and other aspects of the Awards and the provisions of the applicable Award Agreement and to modify, amend, cancel or suspend Awards;
(b) to
interpret the Plan;
(c) to
prescribe, amend and rescind any rules and regulations relating to the Plan;
(d) to
determine whether, to what extent and under what circumstances Awards may be settled in cash, Units, other Awards or other property, including,
without limitation, the authority to settle Awards in cash or property upon a Change in Control or other similar corporate transaction;
(e) to
determine whether, to what extent and under what circumstances cash, Units, other Awards, other property and any other amounts payable
with respect to an Award shall or may be deferred either automatically or at the election of the Participant or of the Board;
(f) to
cancel and regrant, accelerate vesting or otherwise adjust the Exercise Price of an Award previously granted under the Plan; and
(g) to
make all other determinations and findings, including factual findings, deemed necessary or advisable for the administration of the Plan.
Section 3.03. Board
Discretion. In exercising its authority, the Board shall have the broadest possible discretion. Unless otherwise expressly provided
in the Plan, all designations, determinations, interpretations and other decisions made in good faith by the Board under or with respect
to the Plan, any Award or Award Agreement shall be final, binding and conclusive on all persons.
Section 3.04. Board
Delegation. To the extent permitted by applicable law, the Board may delegate its authority, or specified items thereof, to one or
more designated individuals or committees of the Board.
Article IV
Units Subject To The Plan
Section 4.01. General
Limitation.
(a) Subject
to Section 4.02 below, the maximum number of Units that may be issued under the Plan is 50,000,000 Units.
(b) To
the extent any Units covered by an Award, other than a Substitute Award, are not issued because the Award is forfeited, canceled, expires
without being exercised or the Units are not delivered because the Award is settled in cash or used to satisfy applicable minimum tax
withholding obligations or otherwise, such Units shall not be deemed to have been issued for purposes of determining the maximum number
of Units available for issuance under the Plan.
(c) If
the Exercise Price of any Option or the Exercise Price of any Other Unit-Based Award granted under the Plan, other than a Substitute Award,
is satisfied by tendering Units to the Company (by either actual delivery or by attestation), only the number of Units issued net of the
Units tendered shall be deemed issued for purposes of determining the maximum number of Units remaining available for issuance under the
Plan.
(d) Any
Units underlying a Substitute Award shall not be deemed to have been issued for purposes of determining the maximum number of Units remaining
available for issuance under the Plan.
Section 4.02. Adjustments.
In the event that any corporate transaction or distribution (including, without limitation, any Unit split, Unit dividend, extraordinary
cash dividend, recapitalization, reorganization, merger, consolidation, split up, spin off, repurchase, combination or exchange of Units
or other securities of the Company, but not including ordinary dividends) affects the Units such that an adjustment is appropriate in
order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the
Board shall, in such manner as it may deem equitable, adjust any or all of (a) the number of Units or other securities of the Company
(or number and kind of other securities or property) with respect to which Awards may be granted under Section 4.01; (b) the
number of Units or other securities of the Company (or number and kind of other securities and property) subject to outstanding Awards;
and (c) the Exercise Price or other terms and conditions of any Award or, if deemed appropriate, the Board may make provision for
a cash payment to the holder of an outstanding Award in full satisfaction of such Award as set forth in Section 4.03.
Section 4.03. Cancellation
of Awards. For the avoidance of doubt, if an adjustment is appropriate under Section 4.02, the Board may, if deemed equitable
by the Board in light of the applicable circumstances, cause any Award granted hereunder to be canceled in consideration of a cash payment
to the holder of such Award equal in value to the product of (a) the number of Units subject to such Award, multiplied by
(b) the Fair Market Value of a Unit as of the date of such cancellation (less any Exercise Price or other applicable exercise, hurdle
or similar price) with respect to such canceled Award; provided, for the avoidance of doubt, if the Award has an Exercise Price
that exceeds the Fair Market Value of the Units underlying the Award, the Award may be canceled for no consideration.
Section 4.04. Other
Provisions. The grant of any Award may also be subject to such other provisions as the Board deems appropriate (whether or not applicable
to any Award granted to any other Participant).
Article V
Eligibility and Participation
Subject to the terms and conditions
of the Plan, the Board shall determine and designate, from time to time, from among the Eligible Individuals those persons who will be
granted one or more Awards under the Plan and thereby become Participants in the Plan. Awards may be granted on conditions specified by
the Board. Awards may be granted as alternatives to or in replacement of Awards outstanding under the Plan or any other plan or arrangement
of the Company or any of its Affiliates or Subsidiaries (including a plan or arrangement of a business or entity, all or a portion of
which is acquired by or combines with the Company or any of its Affiliates or Subsidiaries).
Article VI
Awards
Section 6.01. Options.
(a) General.
The Board is authorized to grant Options under the Plan, which shall be evidenced by an Award Agreement and shall contain terms and conditions
not inconsistent with the following limitations and conditions.
(b) Exercise
Price. The Exercise Price of each Option shall be established by the Board at the time the Option is granted. Unless otherwise determined
by the Board and specified in the Award Agreement, the Exercise Price shall be the Fair Market Value of a Unit on the date of grant of
the Option (which shall not be less than the “fair market value” of a Unit within the meaning of Section 409A).
(c) Vesting.
The vesting schedule for each grant of Options shall be set forth in the applicable Award Agreement, including the treatment of outstanding
Options upon a Participant’s termination of employment or service. An Option shall be exercisable only in accordance with the terms
and conditions and during such periods as may be established by the Board in the Award Agreement or otherwise in accordance with the Plan
and the Award Agreement. The Board may, in its discretion, provide that such an Option may be exercised in whole or in part, in installments,
cumulative or otherwise, for any period of time specified by the Board or based on performance or other criteria established by the Board.
(d) Payment.
No Units shall be delivered pursuant to any exercise of an Option until payment in full of the Exercise Price, or adequate provision
therefor (in the discretion of the Board), is received by the Company. Unless otherwise determined by the Board in its sole discretion,
such payment shall be made by surrendering Units then issuable to the Participant upon exercise of the Option at their Fair Market Value
on the date of exercise, provided that, a Participant shall be entitled to make a cash payment to the Company to purchase any fractional
Unit at the Fair Market Value.
(e) Term
of Options. An Option and all rights and obligations thereunder shall expire on the date to be determined by the Board and set forth
in the applicable Award Agreement, which shall be not later than ten years from the date of grant of such Option.
(f) Incentive
Options. The terms of any Incentive Option granted under this Plan shall comply in all respects with the provisions of Section 422
of the Code. Subject to adjustment under Section 4.02, the maximum number of Units that may be issued under Incentive Options under
the Plan is 100,000, less the number of Restricted Units issued under the Plan.
Section 6.02. Restricted
Units.
(a) General.
The Board is authorized to grant Restricted Units to Participants with the following terms and conditions and with such additional terms
and conditions, in either case not inconsistent with the provisions of the Plan, as the Board will determine.
(b) Terms
of Grant. Restricted Units granted pursuant to the Plan will be subject to such restrictions as the Board may impose, including service,
performance or other criteria, which restrictions may lapse in each case on a specified date or dates, over any period or periods or on
the occurrence of one or more events, as determined by the Board. The Board will set forth the treatment of Restricted Units, as applicable,
upon a Participant’s termination of employment or service with the Company or any of its Affiliates or Subsidiaries in the applicable
Award Agreement.
(c) Vesting.
The vesting schedule for each grant of Restricted Units shall be set forth in the applicable Award Agreement, including the treatment
of outstanding Restricted Units upon a Participant’s termination of employment or service.
(d) Settlement.
Restricted Units may be settled in Units, in cash, or a combination thereof, as determined by the Board and set forth in the applicable
Award Agreement.
(e) Rights. Restricted
Units shall have no voting rights, and shall not receive dividends, but the applicable Award Agreement shall specify the effect, if any,
of dividends paid on Units during the period such Award is outstanding.
Section 6.03. Other
Unit-Based Awards. The Board is authorized to grant unrestricted Units or Other Unit-Based Awards under the Plan to Participants,
alone or in tandem with other Awards, in such amounts and subject to such terms and conditions, including vesting schedules or other criteria
(including performance criteria) as the Board will from time to time in its sole discretion determine.
Section 6.04. Settlement
of Award. Units delivered pursuant to the exercise of an Option or the exercise or vesting and settlement of Other Unit-Based Awards
shall be subject to such conditions (other than vesting conditions), restrictions and contingencies as the Board may establish pursuant
to the Plan and Award Agreement, in addition to the conditions set forth herein.
Section 6.05. Amendment
to Awards. The Board may waive any conditions or rights under any Award theretofore granted, prospectively or retroactively.
Section 6.06. Other
Provisions. The grant of any Award may also be subject to such other provisions as the Board deems appropriate (whether or not applicable
to any Award granted to any other Participant), including the treatment of Awards and Units upon the occurrence of any corporate transaction
or distribution involving the Company, including any merger, reorganization, recapitalization or other similar corporate event.
Article VII
Company Call Right
Section 7.01. Call
Right. If a Participant’s employment, directorship, consulting or other service relationship with the Company and any of its
Affiliates and Subsidiaries terminates for any reason, or an Involuntary Transfer occurs, the Company shall have the right (a “Call
Right”), exercisable during the Call Period (as defined below), to purchase all or a portion (as determined by the Board from
time to time during the Call Period) of any Units that have been issued to a Participant (or his or her Proposed Transferee, if applicable)
in respect of any Award. The “Call Period” shall mean, (a) with respect to Units beneficially owned by the Participant
or a permitted transferee, the period commencing on the date of termination or Involuntary Transfer and expiring one year thereafter,
or (b) with respect to any Award that has not been exercised or settled as of the date of such termination or Involuntary Transfer,
the period commencing on the exercise or settlement of such Award and expiring one year after such exercise or settlement of such Award.
The Company may exercise the Call Right (which may be exercised on more than one occasion during the Call Period) by giving written notice
thereof to the Participant (or his or her Proposed Transferee) prior to the expiration of the Call Period (such notice the “Call
Notice”). The Call Notice shall set forth the number of Units being purchased pursuant to the Call Right (the “Call
Units”) and the Board’s determination of the Call Price of the Call Units in accordance with Section 7.02 below.
Section 7.02. Call
Price. The aggregate purchase price with respect to any Call Units (the “Call Price”) will be determined as follows:
(a) if
a Participant’s employment or other service relationship with the Company and any of its Affiliates and Subsidiaries terminates
for any reason other than a termination by the Company or any of its Affiliates or Subsidiaries for Cause, or if there is an Involuntary
Transfer, then the purchase price per Unit will be the Fair Market Value determined as of the date of the applicable Call Notice; or
(b) if
(i) a Participant’s employment or other service relationship with the Company and any of its Affiliates and Subsidiaries is
terminated by the Company or any of its Affiliates or Subsidiaries for Cause or (ii) a termination of a Participant’s employment
or other service relationship with the Company and any of its Affiliates and Subsidiaries is followed by the Participant’s material
breach of any restrictive covenant provisions applicable to the Participant, then the purchase price per Unit will be the lesser of (x) the
Exercise Price or other purchase price paid by such Participant for such Unit (or, if no such Exercise Price or purchase price was paid,
zero) or (y) the Fair Market Value of such Restricted Unit or other Unit, determined as of the date of the Call Notice.
Section 7.03. Election
and Delivery Procedures.
(a) The
closing of any exercise of the Call Right pursuant to this Article VII shall take place at the offices of the Company, or such
other place as reasonably determined by the Company, not less than 15 nor more than 45 days after the date such Call Right is exercised.
The exact date and time of closing shall be specified by the Company.
(b) At
such closing, the Participant and his or her Proposed Transferees (or, following the Participant’s death, the Participant’s
beneficiary or Beneficiaries) shall deliver certificates for the Call Units to be sold to the Company duly endorsed, or accompanied by
written instruments of transfer, in a form reasonably satisfactory to the Company, duly executed by such transferor, free and clear of
any Encumbrances, and shall consent to the cancellation of such Awards to be surrendered, which Awards shall also be free and clear of
any Encumbrances. The Company shall pay the Call Price for the Call Units in cash in a lump sum or, if (i) the terms of any credit
facility or any arrangement of the Company or any of its Affiliates or Subsidiaries limit or restrict the ability of the Company to make
such payment or (ii) the Board determines that the Company is not financially capable of making such payment, at the election of
the Company, in up to three equal installments, the first of which will be paid on the date of such closing, and the second and third
of which will be paid on the first and second anniversaries of the date of such closing, plus interest at the Prime Rate from the date
of such closing to the applicable date of payment. Any such installment payments shall be subject to compliance with Section 409A,
where applicable.
Article VIII
Change in Control
Section 8.01. Board
Actions on a Change in Control. In the event of a Change in Control, the Board will have full discretion, subject to any applicable
regulatory approvals, to take whatever actions that it deems necessary or appropriate with respect to outstanding Awards, including: (a) to
provide for full or partial accelerated vesting of any Award or portion thereof, either immediately prior to such Change in Control or
on such terms and conditions following the Change in Control as the Board may determine in its sole discretion; (b) to provide for
the assumption of an Award (or portions thereof) or the issuance of Substitute Awards of the surviving or acquiring company (subject to
Section 409A, where applicable); (c) to provide for the cash-out and cancellation of any Vested Award (or portion thereof) immediately
prior to such Change in Control, which cash-out may (subject to Section 409A, where applicable) be subject to any escrow, earn-out
or other contingent or deferred payment arrangement that is contemplated by such Change in Control; (d) to cancel, without consideration,
any Unvested Award and any other Award that is not otherwise exercised on or prior to any Change in Control; provided that, for
the avoidance of doubt, if the Award has an Exercise Price that exceeds the Fair Market Value of the Units underlying the Award, the Award
may be canceled for no consideration; or (e) to take any other actions as the Board deems necessary or advisable in connection with
such Change in Control. The Board may, in connection with a Change of Control, take different actions with respect to different Participants
under the Plan, different Awards under the Plan and different portions of Awards granted under the Plan.
Article IX
Tax Withholding
All
distributions, issuances and payments under the Plan are subject to minimum tax withholding obligations, and the Board may condition the
delivery of Units or other benefits upon satisfaction of all applicable withholding requirements. The Board, in its sole discretion and
subject to such requirements as it may prescribe, may permit such withholding obligations to be satisfied through any combination of the
following: (a) cash payment by the Participant; (b) payroll withholding of the Participant’s salary, wages or other compensation;
(c) surrender of Units which the Participant already owns (either by actual surrender or attestation); or (d) surrender of Units
or other benefits to which the Participant is otherwise entitled (e.g., upon exercise of an Option) under the terms of the Plan.
Notwithstanding the foregoing, unless and until otherwise determined by the Board, the only method permitted for the satisfaction
of all applicable withholding requirements arising upon the exercise of any Option shall be the method described in clause (d).
Article X
Transferability
Section 10.01. Transferability
of Awards. Except as otherwise expressly provided in an Award Agreement or Section 10.04, no Award may be assigned, alienated,
pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution.
An Option (or Other Unit-Based Award subject to exercise) may be exercised during the lifetime of the Participant only by him or her or
by his or her legal representative.
Section 10.02. Transferability
of Units. Except as otherwise expressly provided in an Award Agreement or the Operating Agreement, Units issued in respect of an Award
may not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor’s process, whether
voluntarily, involuntarily or by operation of law.
Section 10.03. Transferability
of Restricted Units. Except as otherwise expressly provided in an Award Agreement or the Operating Agreement, Restricted Units or
other Units issued in connection with any Award may not be anticipated, assigned, attached, garnished, optioned, transferred or made subject
to any creditor’s process, whether voluntarily, involuntarily or by operation of law.
Section 10.04. Permitted
Transfers. Notwithstanding the foregoing, a Participant may transfer an Award or any Units issued with respect to an Award to a Proposed
Transferee with the prior written consent of the Board; provided that (a) the Proposed Transferee agrees to be bound by the
terms of the Plan and the applicable Award Agreement and (b) the provisions of the Plan and the Award Agreement with respect to any
Award or Units so transferred will continue to apply as though the Award or Units were still held by the applicable Participant.
Section 10.05. Operating
Agreement. Unless otherwise determined by the Board in its sole discretion, each Participant who is granted any Restricted Unit or
who is issued any Unit in connection with any other Award shall as a condition to the issuance of such Restricted Unit or Unit, execute
an agreement pursuant to which he or she shall become a party to the Operating Agreement. Unless otherwise determined by the Board in
its sole discretion, each Proposed Transferee (other than the Company) by will, by the laws of descent and distribution or otherwise,
of any Award or any Unit issued in respect of any Award shall, as a condition to the transfer thereof to such permitted transferee, execute
an agreement pursuant to which it shall become a party to the Operating Agreement and any other agreements applicable to the transferor.
Article XI
Limitation on Implied Rights
Section 11.01. Property
Rights. Neither a Participant nor any other Person shall, by reason of participation in the Plan, acquire any right in or title to
any assets, funds or property of the Company or any of its Affiliates or Subsidiaries whatsoever, including, without limitation, any specific
funds, assets or other property which the Company or any of its Affiliates or Subsidiaries, in its or their sole discretion, may set aside
in anticipation of a liability under the Plan. Subject to the terms of the Plan, a Participant shall have only a contractual right to
the Units or amounts, if any, payable under the Plan, unsecured by any assets of the Company or any of its Affiliates or Subsidiaries,
and nothing contained in the Plan shall constitute a representation or guarantee that the assets of the Company or any of its Affiliates
or Subsidiaries shall be sufficient to pay any benefits to any Person.
Section 11.02. Employment
Rights. Nothing in this Plan nor in any Award Agreement shall confer upon any Participant any promise or commitment by the Company
or its Affiliates or Subsidiaries regarding employment, employment positions, work assignments, compensation or any other term or condition
of employment or affiliation.
Section 11.03. No
Implied Rights or Obligations. The Company, in establishing and maintaining the Plan as a voluntary and unilateral undertaking, expressly
disavows the creation of any rights in Participants or others claiming entitlement under the Plan or any obligations on the part of the
Company, any of its Affiliates or Subsidiaries or the Board, except as expressly provided herein. No Award shall be deemed to be salary
or compensation for the purposes of computing benefits under any employee benefit, severance, pension or retirement plan of the Company
or any of its Affiliates or Subsidiaries, unless the Board shall determine otherwise, applicable local law provides otherwise or the terms
of such plan specifically include such compensation.
Section 11.04. No
Trust or Fund Created. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind
or a fiduciary relationship between the Company or any of its Affiliates or Subsidiaries and a Participant or any other Person. To the
extent that any Person acquires a right to receive payments from the Company or any of its Affiliates or Subsidiaries pursuant to an Award,
such right shall be no greater than the right of any unsecured general creditor of the Company.
Section 11.05. Rights
as a Stockholder. No Participant or holder of any Award shall have any rights as a Member with respect to any Units underlying such
Award until the Award has been exercised or settled, and the Participant or holder has been issued Units in accordance with the terms
of the Plan.
Section 11.06. Additional
Conditions of Awards. The Board may specify in an Award Agreement that the Participant’s rights, payments and benefits with
respect to an Award will be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events,
in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include a termination of the Participant’s
employment or service with the Company or any of its Affiliates or Subsidiaries, a violation of material policies, breach of noncompetition,
confidentiality or other restrictive covenants that may apply to the Participant or other conduct by the Participant that is detrimental
to the business or reputation of the Company and/or its Affiliates and/or Subsidiaries.
Section 11.07. No
Fractional Units. No fractional Units will be issued or delivered pursuant to the Plan or any Award, and the Board will determine
whether cash or other securities will be paid or transferred in lieu of any fractional Units, or whether such fractional Units or any
rights thereto will be canceled, terminated or otherwise eliminated.
Section 11.08. Variations
by Jurisdiction. Awards may be granted to Participants in different legal jurisdictions on such terms and conditions as may, in the
judgment of the Board, be necessary or desirable to recognize differences in local law, tax policy or custom. The Board also may impose
conditions on the exercise or vesting of Awards in order to minimize the Company’s obligation with respect to tax equalization for
Participants on assignments outside their home country.
Section 11.09. Data
Protection. By participating in the Plan, the Participant consents to the holding and processing of personal information provided
by the Participant to the Company or its Affiliates or Subsidiaries, or to any trustee or third-party service provider, for all purposes
relating to the operation of the Plan. These include:
(a) administering
and maintaining Participant records;
(b) providing
information to the Company or its Affiliates or Subsidiaries, or any trustees of any employee benefit trust, registrars, brokers or third-party
administrators of the Plan;
(c) providing
information to future purchasers or other transaction counterparties of the Company or its Affiliates or Subsidiaries, or the business
in which the Participant works; and
(d) transferring
information about the Participant to any country or territory that may not provide the same protection for the information as the Participant’s
home country.
Article XII
Government and Stock Exchange Regulations
The Board may refuse to issue
or transfer any Units or other consideration under an Award if, acting in its sole discretion, it determines that the issuance or transfer
of such Units or such other consideration might violate any applicable law or regulation or entitle the Company to recover the same under
Section 16(b) of the Exchange Act, and any payment tendered to the Company by a Participant, other holder or beneficiary in
connection with the exercise of such Award shall be promptly refunded to the relevant Participant, holder or beneficiary. Without limiting
the generality of the foregoing, no Award granted hereunder shall be construed as an offer to sell securities of the Company, and no such
offer shall be outstanding, unless and until the Board in its sole discretion has determined that any such offer, if made, would be in
compliance with all applicable requirements of the U.S. federal and state securities laws and any other laws to which such offer, if made,
would be subject.
Upon the issuance of Units
in connection with the vesting, exercise or settlement of an Award at a time when there is not in effect a registration statement under
the Securities Act relating to such Units and available for delivery a prospectus meeting the requirements of Section 10(a)(3) of
the Securities Act, or if the rules or interpretations of the United States Securities and Exchange Commission so require, such Units
may be issued only if the Company and the holder of such Units are in compliance with all securities law requirements for an exemption
from registration and the holder represents and warrants in writing to the Company that the Units purchased are being acquired for investment
and not with a view to distribution thereof.
The Company is under no duty
to ensure that Units may legally be delivered under the Plan, and shall have no liability to Award recipients in the event such delivery
of Units may not be made.
Article XIII
Amendments, Suspensions or Termination of the Plan
Section 13.01. Amendment
and Termination of the Plan. The Board may at any time suspend or terminate the Plan and may amend it from time to time in such respects
as the Board may deem advisable in order that Awards granted thereunder shall conform to any change in the law, or in any other respect
which the Board may deem to be in the best interests of the Company; provided, however, that no such amendment, alteration,
suspension, discontinuation or termination shall be made without approval by the Members of the Company if such approval is necessary
to comply with any tax or regulatory requirement for which or with which the Board deems it necessary or desirable to qualify or comply.
Section 13.02. Amendment
of Award Agreements. The Board may, to the extent consistent with the terms of any applicable Award Agreement, waive any conditions
or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated
Award Agreement, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance,
cancellation or termination that would materially adversely impair the rights of any Participant or any holder of any Award theretofore
granted will not to that extent be effective without the consent of the affected Participant or holder.
Section 13.03. Corrections.
The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the
extent that it shall deem desirable to carry the Plan into effect.
Article XIV
Termination
The Plan shall continue in
effect until April 1, 2028 unless earlier terminated by the Board pursuant to Article XIII.
Article XV
Governing Law; Waiver of Jury Trial
The validity, construction
and effect of the Plan, the Award Agreements and any rules, regulations or procedures relating thereto shall be governed by, and construed
in accordance with, the laws of the State of New York without regard to the conflicts of laws rules of such state. Participants acknowledge
and agree that any controversy which may arise under or relate to the Plan or an Award Agreement is likely to involve complicated and
difficult issues, and the Company and each Participant will agree to irrevocably waive any and all right to trial by jury in any legal
proceeding arising out of or relating to the Plan or an Award Agreement, or the transactions and matters contemplated hereby or thereby.
Article XVI
Arbitration of Disputes
Any controversy arising out
of or relating to the Plan or an Award Agreement shall be resolved by arbitration conducted pursuant to the arbitration rules of
the American Arbitration Association. The arbitration shall be final and binding on the parties. The arbitration shall be conducted in
New York City.
Article XVII
Section 409A and Section 457A of The Code
The Plan is intended to comply
with the requirements of Section 409A and Section 457A of the Code and the regulations and guidance thereunder (respectively,
“Section 409A” and “Section 457A”), the provisions of the Plan shall be interpreted in
a manner that satisfies such requirements, and the Plan shall be operated accordingly. If any provision of the Plan would otherwise frustrate
or conflict with this intent, the provision will be interpreted and deemed amended so as to avoid this conflict. If an operational failure
occurs with respect to the requirements of Section 409A and Section 457A, any affected Participant shall fully cooperate with
the Company to correct the failure, to the extent possible, in accordance with any correction procedure established by the United States
Internal Revenue Service. No provision of the Plan shall be interpreted to transfer any liability for a failure to comply with Section 409A
or Section 457A from a Participant or any other Person to the Company.
Notwithstanding any provision
of the Plan or any Award Agreement, if at the time of termination of a Participant’s employment or service with the Company he or
she is a “specified employee” (as defined in Section 409A) and any payments upon such termination under the Plan or such
Award Agreement are treated as deferred compensation subject to Section 409A, he or she will not be entitled to such payments until
the earlier of (a) the date that is six months after such termination or (b) any earlier date that does not result in any additional
tax or interest to such Participant under Section 409A. For purposes of Section 409A, a payment or settlement of an Award made
under the Plan shall be designated as a “separate payment” within the meaning of Section 409A.
Exhibit 10.8

Management & Cost Sharing Agreement
This Management & Cost Sharing Agreement (“Agreement”)
is between Ategrity Specialty Insurance Company, a Delaware corporation with offices at 14000 N. Pima Road, Suite 200, Scottsdale,
Arizona 85260, and its affiliates (“Ategrity”), and Zimmer Insurance Services, LLC a Delaware company with offices
at 9 West 57th Street, 33rd Floor New York, New York 10019 (“Zimmer”). This Agreement is effective
as of September 30, 2023 (the “Effective Date”).
This Agreement governs the management
and cost sharing arrangement between Ategrity and Zimmer, which is being entered into for the purpose of reducing Ategrity’s administrative
costs, gaining greater efficiencies, and creating economies of scale in its operations.
“Affiliate” has the
meaning ascribed to the term under has the meaning ascribed to the term under Title 18 §5001(1) of the Delaware Code.
“Fees” means the
proportion of Shared Costs obligated to be paid by Ategrity to Zimmer as may be reasonably determined by the parties under this Agreement.
Notwithstanding the foregoing, in no event shall such fees exceed the Shared Costs.
“Guidelines” means
all policies, procedures, obligations, or processes that apply generally to Ategrity employees in the performance of their responsibilities
or that may be created by Ategrity to govern the specific nature of the expected delivery of the Services.
“Personal Data” means
any information relating to (i) an identified or identifiable natural person and, (ii) an identified or identifiable legal entity
(where such information is protected similarly to personal data or personally identifiable information under applicable law).
“Services” means
the management, administrative, human resources, benefits, accounts payable, accounts receivable, premium audit, underwriting operations,
collections, real estate, legal, infrastructure, accounting, reporting, or staffing/recruiting, services provided by Zimmer.
“Shared Costs” means
all reasonable costs incurred by Zimmer in providing the Services to Ategrity.
| 3.1. | Shared Costs. In consideration of the Services provided by Zimmer, Ategrity agrees to contribute
to the operating costs and expenses of Zimmer in proportion and to the extent to which Ategrity and their respective subsidiaries make
use of such Services. |
| 3.2. | Assigned Resources. From time to time Zimmer employees may be assigned to the role of an employee
or officer of Ategrity (“Assigned Roles”). In such an occurrence, the Assigned Roles will be subject to the oversight
of Ategrity and shall be subject to all Ategrity Guidelines in the activities they perform in addition to the policies and procedures
of Zimmer. Notwithstanding the foregoing, any appointment of a director or officer would be subject to the biographical affidavit submission
requirements under Delaware law. |
| 3.3. | Review & Oversight. Performance by Zimmer of the Services and performance of Zimmer employees
in their Assigned Roles under this Agreement will be subject to the general oversight of Ategrity. Zimmer shall maintain appropriate and
accurate books of account and records relating to Services utilized by Ategrity under this Agreement, and such books of account and records
shall be accessible for inspection by representatives (including the auditors) of Ategrity or the Commissioner at any time. |
| 3.4. | Resource Sharing. In order to facilitate the Services certain assets may be transferred between
Zimmer and Ategrity. Notwithstanding the foregoing the transfer of such assets shall be permitted only upon the payment of the fair market
value for such assets, as solely determined by Ategrity. For avoidance of doubt transfers of assets under this provision that meet the
criteria in Del. Code Title XVIII Section 5005, would still be subject to non-disapproval of the Commissioner |
| 3.5. | Performance Warranty. As part of the performance of the Services, Zimmer may provide to Ategrity
a performance warranty (“Warranty”) as may be reasonably determined by Ategrity from time to time including as included
in the Guidelines. Under such Warranty, Zimmer shall absorb the risks and costs associated with the failure to meet the performance benchmarks
established by Ategrity. If Zimmer objects to a proposed Warranty, it shall provide prompt notice to Ategrity of such objection. In the
event of such an objection the parties will work in good faith to resolve the objection. If such objection was not able to be resolved,
Zimmer would not be required to provide the Services subject to the proposed Warranty. |
Ategrity Specialty Insurance Company
14000
N. Pima Road, Suite 200, Scottsdale, AZ 85260 / 480.237.2417 / ategrity.com
| 4.1. | Fees and Payment. Zimmer shall provide invoices to Ategrity on a quarterly basis setting forth
the Fees for such period. Undisputed Fees are due and payable net 90 days from the invoice date. |
| 5. | CONFIDENTIALITY AND DATA PROTECTION |
| 5.1. | Confidential Information. “Confidential Information” means non-public information
disclosed orally or in writing by a party or its Affiliate (“Discloser”) to the other party or its Affiliate (“Recipient”)
about (without limitation) its business, employees, finances, customers, operations, products, technology, plans, or pricing, that is
designated as confidential or reasonably should be considered confidential given the nature of the information and the circumstances of
its disclosure. |
| 5.2. | Protection of Confidential Information. Recipient will use the same degree of care that it uses
to protect the confidentiality of its own information of a like nature, but in no event less than reasonable care, (a) not to use
Discloser’s Confidential Information for a purpose inconsistent with the activities contemplated under this Agreement, and (b) to
limit access to Discloser’s Confidential Information to those of Recipient’s and its Affiliates’ employees, directors,
contractors, advisors and auditors who need such access for activities contemplated under this Agreement and who are legally or contractually
bound to protect the Confidential Information as provided in this section. Confidential Information excludes information that: (i) is
or becomes generally known to the public without breach of a duty owed to Discloser, (ii) was known to Recipient before its disclosure
hereunder without breach of a duty owed to Discloser, (iii) is received from a third party without breach of a duty owed to Discloser,
or (iv) is independently developed by Recipient without use of Discloser’s Confidential Information. |
| 5.3. | Requests for Confidential Information. If Recipient receives a government or other third-party
request for Discloser’s Confidential Information, Recipient will direct the requestor to, and promptly notify, Discloser if legally
permitted to do so. Recipient will comply with such a third-party request only if so required by law; in such an event, Recipient will
seek to limit the disclosure to that Confidential Information which Recipient is legally required to disclose. |
| 5.4. | Data Privacy. Each party shall at all times protect Personal Data received under this Agreement
in accordance with applicable law. |
| 5.5. | Data Breach. If a Recipient becomes aware of an unauthorized access to or disclosure, loss or alteration
of Discloser’s Confidential Information, Recipient will promptly notify Discloser, seek to mitigate the breach, and preserve forensic
evidence, and provide information to Discloser about the nature and scope of the breach. |
| 6.1. | Term of this Agreement. This Agreement shall run from the Effective Date until terminated in accordance
with the provisions of the Agreement. |
| 6.2. | Termination for Material Breach. If either party is in material breach of this Agreement, the other
party may terminate this Agreement, at the end of a written 30-day notice and cure period if the breach has not been cured. |
| 6.3. | Termination for Convenience. Ategrity may terminate this Agreement at any time upon 90-day notice
to Zimmer. Notwithstanding the foregoing, Ategrity may terminate this Agreement with immediate effect, if required by the Delaware Insurance
Commissioner (“Commissioner”). |
| 6.4. | Termination of Warranty(s). Notwithstanding anything to the contrary, any Warranty provided subject
to Clause 3.5 shall terminate, (i) upon the institution by or against either party of insolvency, receivership or bankruptcy proceedings
or any other proceedings for the settlement of such party’s debts or receivership of such party’s business, (ii) upon
either party making an assignment for the benefit of creditors, (iii) upon either party’s dissolution or ceasing to do business
or (iv) upon the parties ceasing to be Affiliates, unless mutually agreed by the parties or their respective successors in interest. |
|
Ategrity Specialty Insurance Company
14000 N.
Pima Road, Suite 200, Scottsdale, AZ 85260 / 480.237.2417 / ategrity.com |
 |
| 6.5. | Survival of Terms. Any terms that by their nature survive termination of this Agreement for a party
to assert its rights and receive the protections of this Agreement, will survive (including, without limitation, the confidentiality terms
in this Agreement). |
| 7. | LIMITATION OF LIABILITY |
| 7.1. | No Indirect Damages. Neither party or its Affiliates will be liable for any indirect, special,
incidental, or consequential damages or losses arising out of or related to this Agreement (including, without limitation, lost profits,
lost revenue, lost savings, or costs of delay). |
| 7.2. | Conditions. The exclusions and limits in this “Limitation of Liability” section reflect
the parties’ allocation of risk and will apply under any legal theory (including, without limitation, contract, or tort), even where
a party was aware of the possibility of such damages, the damages were foreseeable, and/or any remedies hereunder fail of their essential
purpose. Such exclusions and limits will not limit damages that result from a party’s gross negligence, willful misconduct, or fraud,
or to the extent prohibited by law. |
| 8.1. | Defense of Third-Party Claims. Zimmer will indemnify, defend, and hold harmless Ategrity from any
claim, demand, suit or proceeding that arises as a result of Zimmer’s breach of the Agreement (“Claim”), provided
Ategrity (a) promptly notifies Zimmer of the Claim, (b) gives Zimmer sole control of the defense and settlement of the Claim
(except Zimmer may not settle a Claim unless Ategrity is unconditionally released of all liability), and (c) gives Zimmer all reasonable
assistance at Zimmer’s expense. For purposes of this section, “Ategrity”
includes its affiliates. |
| 9.1. | Governing Law and Arbitration. This Agreement, and any disputes arising out of or related hereto,
will be governed exclusively by the laws of the State of Delaware, U.S.A., without regard to its conflicts of laws rules or the United
Nations Convention on the International Sale of Goods. Any dispute or claim arising out of or relating to this Agreement, including the
scope or applicability of this arbitration clause, will be determined by confidential and binding arbitration in New Castle County, Delaware,
before a single arbitrator. The arbitration will be administered by JAMS pursuant to its Comprehensive Arbitration Rules and Procedures
and the Expedited Procedures in those Rules. Judgment on the arbitrator’s award may be entered in any court having jurisdiction.
The parties will treat all disputes arising under this Agreement, including arbitration proceedings and awards, as Confidential Information
of both parties, except as necessary in connection with a judicial challenge to or enforcement of an award or otherwise required by law
or judicial decision. Notwithstanding the above, either party may seek injunctive relief in a court of competent jurisdiction, and issues
of patent or copyright ownership or infringement may be decided only by a federal court in New Castle County, Delaware and not by arbitration.
The prevailing party in any action arising from or relating to this Agreement shall be entitled to recover its reasonable attorneys’
fees and costs including, without limitation, arbitration, and expert fees. |
| 9.2. | Entire Agreement and Amendment. This Agreement constitutes the entire agreement of the parties
and supersede all prior and contemporaneous discussions and agreements, oral and written, related to this Agreement’s subject matter.
Neither party is relying on any representation not expressly included in this Agreement concerning the subject matter hereof. No representation,
promise or inducement not included in this Agreement is binding. Any amendment or modification of this Agreement requires both parties’
signatures and shall be subject to review and approval by the Commissioner |
| 9.3. | No Assignment. Neither party may assign or transfer this Agreement to a third party without the
expressed written consent of the other party. |
| 9.4. | Anti-Corruption. The parties shall comply with all applicable laws relating to anti-bribery and
anti-corruption. Each party represents that it has not received or been offered any illegal or improper bribe, kickback, payment, gift,
or thing of value from an employee or agent of the other party in connection with this Agreement. |
| 9.5. | Notices. Notices under this Agreement will be written and be effective on (i) the second business
day after mailing, (ii) confirmed delivery by courier service, or (iii), except for notices of breach or an indemnifiable claim (“Legal
Notices”), the day sent by email. |
| 9.6. | Independent Contractors. The parties are independent contractors with respect to each other. |
| 9.7. | Waiver and Enforceability. Any waiver of a right under this Agreement requires the waiving party’s
signature. If any term of this Agreement is invalid or unenforceable, the other terms remain in effect. |
|
Ategrity Specialty Insurance Company
14000 N.
Pima Road, Suite 200, Scottsdale, AZ 85260 / 480.237.2417 / ategrity.com |
 |
| 9.8. | Money Damages Insufficient. A party’s breach of its confidentiality obligations under this
Agreement or violation of the other party’s intellectual property rights could cause the other party irreparable harm. The other
party may seek a court order to stop or prevent any such breach or violation. |
| 9.9. | No Third-Party Beneficiaries. There are no third-party beneficiaries under this Agreement. |
| 9.10. | Regulatory Approval. Notwithstanding anything to the contrary this Agreement is subject to the
approval of the Commissioner and may be subject to cancellation or amendment at the request of the Commissioner. |
| 9.11. | Regulatory Requirements. To the extent that Ategrity is subject to the provisions of 18 Del. Admin
code, Regulation 1801, Section 19.2 the following additional terms shall apply; |
| 9.11.1. | Any settlements will be made in compliance with the requirements set forth in the Accounting Practices
and Procedures Manual of the National Association of Insurance Commissioners. |
| 9.11.2. | Ategrity will not advance funds to Zimmer pursuant to this Agreement except to pay for Services. |
| 9.11.3. | Ategrity will maintain oversight for functions provided by Zimmer and Ategrity will monitor Services annually
for quality assurance. |
| 9.11.4. | All records and data developed or maintained under or related to this Agreement that are otherwise the
property of Ategrity, in whatever form maintained, including, but not limited to financial records, claims and claim files, policyholder
lists, application files, litigation files, premium records, rate books, underwriting manuals, personnel records, financial records or
similar records within the possession, or similar records within the possession, custody or control of Zimmer (“Records and Data”)
of Ategrity are and remain the property of Ategrity, and shall be: (1) subject to control of Ategrity; (2) identifiable; and
(3) segregated from all other persons’ Records and Data or readily capable of segregation at no additional cost to Ategrity. |
| 9.11.5. | All funds and invested assets of Ategrity are the exclusive property of Ategrity, held for the benefit
of Ategrity and are subject to the control of Ategrity. |
| 9.11.6. | If Ategrity is placed in supervision, seizure, conservatorship, or receivership pursuant to 18 Del.C.
Ch. 59: (1) all of the rights of Ategrity under this Agreement extend to the receiver or Delaware Insurance Commissioner to the extent
permitted by Delaware law; (2) all Records and Data of Ategrity shall be identifiable and segregated from all other persons’
records and data or readily capable of segregation at no additional cost to the receiver or the Delaware Insurance Commissioner; (3) a
complete set of Records and Data of Ategrity will immediately be made available to the receiver or the Delaware Insurance Commissioner,
shall be made available in a usable format, and shall be turned over to the receiver or the Delaware Insurance Commissioner immediately
upon the receiver or the Delaware Insurance Commissioner’s request, and the cost to transfer data to the receiver or the Delaware
Insurance Commissioner shall be fair and reasonable; and (4) Zimmer will make available all employees essential to the operations
of Ategrity and the services associated therewith for the immediate continued performance of the essential services ordered or directed
by the receiver or Delaware Insurance Commissioner. |
| 9.11.7. | Zimmer has no automatic right to terminate this Agreement if Ategrity is placed into supervision, seizure,
conservatorship, or receivership pursuant to 18 Del.C. Ch. 59. |
| 9.11.8. | Zimmer will provide the essential services for at least six months after termination of this Agreement,
if Ategrity is placed into supervision, seizure, conservatorship or receivership pursuant to 18 Del.C. Ch. 59, as ordered or directed
by the receiver or the Delaware Insurance Commissioner. Performance of the essential services will continue to be provided without regard
to pre-receivership unpaid fees, so long as Zimmer continues to receive timely payment for post-receivership services rendered, and unless
released by the receiver, the Delaware Insurance Commissioner or supervising court. |
| 9.11.9. | Zimmer will continue to maintain any systems, programs, or other infrastructure notwithstanding supervision,
seizure, conservatorship or receivership pursuant to 18 Del.C. Ch. 59, and will make them available to the receiver or the Delaware Insurance
Commissioner as ordered or directed by the receiver or the Delaware Insurance Commissioner, for so long as Zimmer continues to receive
timely payment for post-receivership services rendered, and unless released by the receiver, the Delaware Insurance Commissioner or supervising
court. |
| 9.11.10. | In furtherance of the cooperation between the receiver and the affected guaranty association or associations
and subject to the receiver’s authority over Ategrity, if Ategrity is placed into supervision, seizure, conservatorship or receivership
pursuant to 18 Del.C. Ch. 59, and portions of Ategrity’s policies or contracts are eligible for coverage by one or more guaranty
associations, Zimmer’s commitments under Section 9.11(1)-(6) of this Agreement will extend to such guaranty association
or associations. |
|
Ategrity Specialty Insurance Company
14000 N.
Pima Road, Suite 200, Scottsdale, AZ 85260 / 480.237.2417 / ategrity.com |
 |
| 9.11.11. | Notwithstanding anything to the contrary, Ategrity and its employees and affiliates (such persons, the “Indemnitees”)
shall be indemnified and held harmless by Zimmer to the fullest extent legally permissible, from and against any and all loss, liability
and expense (including without limitation judgments, fines, amounts paid or to be paid in settlement and reasonable attorney’s fees)
to the extent incurred or suffered by the Indemnitees as a result of Zimmer’s gross negligence, wilful misconduct, or fraud and
for any actions by Zimmer that violate Section 9.11 of this Agreement. |
The signers below are authorized to execute this
Agreement, for Ategrity and Zimmer, respectively.
| Zimmer |
|
|
Ategrity |
|
| |
|
|
|
|
| Signature: |
/s/ Barbara Burger |
|
Signature: |
/s/ Justin Cohen |
| |
|
|
|
|
| Name: |
Barbara Burger |
|
Name: |
Justin Cohen |
| |
|
|
|
|
| Title: |
General Counsel and Authorized Signatory of Investment Manager |
|
Title: |
CEO |
| |
|
|
|
|
| Date: |
9/14/2023 |
|
Date: |
9/18/2023 |
|
Ategrity Specialty Insurance Company
14000 N.
Pima Road, Suite 200, Scottsdale, AZ 85260 / 480.237.2417 / ategrity.com |
 |
Exhibit 10.9
SUB-LEASE AGREEMENT
THIS SUB-LEASE, dated as of September 30,
2022 (“Sublease”), is by and between ATEGRITY SPECIALTY INSURANCE COMPANY, a Delaware insurance company (“Sublessor”)
and ZIMMER FINANCIAL SERVICES GROUP LLC, a Delaware limited liability company (“Sublessee”).
RECITALS
WHEREAS, Sublessor, as tenant, entered into that
certain Lease Agreement, dated as of September 3, 2020 (as amended, the “Master Lease”), with MG-PIMA, LLC, a
Colorado limited liability company, with respect to the approximately 23,490 rentable square feet located in Suite 200 of the Building
located at 14000 North Pima Road, Scottsdale, Arizona 85260 (the “Premises”), as further described on Exhibits A and
B of the Master Lease attached hereto as Exhibit A.
WHEAREAS, the Master Lease was subsequently transferred
by MG-PIMA, LLC to 14000 Piedmont LLC, a Delaware limited liability company (the “Master Lessor”).
NOW, THEREFORE, for good and sufficient consideration,
Sublessor and Sublessee agree:
1. Premises.
Sublessor hereby subleases to Sublessee, and Sublessee hereby subleases from Sublessor, the Premises (hereinafter, the “Subleased
Premises”). Notwithstanding the foregoing, Sublessor shall, at no cost to Sublessor and with no reduction in Rent due hereunder,
have the right to use the areas designated as the “Sublessor Area” in Exhibit B until December 31, 2024 (the “Sublessor
Occupancy Period”). During the Sublessor Occupancy Period, Sublessor shall also have the non-exclusive right to use the hallways,
kitchenettes, breakrooms, conference rooms, lobbies, restrooms and other common areas in the Subleased Premises and shall also have the
right to co-locate Sublessor’s IT equipment (including Sublessor’s wireless access equipment) in the IT room in the Subleased
Premises. Sublessee and Sublessor shall each use commercially reasonable efforts to prevent its employees, agents, contractors, invitees
and licensees from discovering or otherwise coming into contact with confidential information of the other and shall hold and use reasonable
efforts to cause its employees, agents, contractors, invitees and licensees to hold such information confidential if discovered.
2. Term.
The term (the “Term”) of this Sublease shall be for the period commencing on July 1, 2022 and ending on November 30,
2028, unless this Sublease is sooner terminated pursuant to its terms or the Master Lease is sooner terminated pursuant to its terms.
Notwithstanding the foregoing, Sublessor and Sublessee may terminate this Sublease by written agreement at any time.
3. Rent.
a. Sublessee
shall pay to Sublessor as base rent for the Subleased Premises for each month during the Term (“Base Rent”) as follows:
| Period | |
$ per RSF | | |
Monthly Payment | | |
Periodic Payment | |
| 07-1-22 to 11-30-22 | |
$ | 29.50 | | |
$ | 57,746.25 | | |
$ | 288,731.25 | |
| 12-1-22 to 11-30-23 | |
$ | 30.25 | | |
$ | 59,214.38 | | |
$ | 710,572.56 | |
| 12-1-23 to 11-30-24 | |
$ | 31.00 | | |
$ | 60,682.50 | | |
$ | 728,190.00 | |
| 12-1-24 to 11-30-25 | |
$ | 31.75 | | |
$ | 62,150.63 | | |
$ | 745,807.56 | |
| 12-1-25 to 11-30-26 | |
$ | 32.50 | | |
$ | 63,618.75 | | |
$ | 763,425.00 | |
| 12-1-26 to 11-30-27 | |
$ | 33.25 | | |
$ | 65,086.88 | | |
$ | 781,042.56 | |
| 12-1-27 to 11-30-28 | |
$ | 34.00 | | |
$ | 66,555.00 | | |
$ | 798,660.00 | |
Sublessee will be charged applicable rental tax on monthly Base Rent,
which is currently 2.25% for the City of Scottsdale, Arizona. Base Rent shall be paid by Sublessee no later than the first day of each
month.
b. All
monies other than Base Rent required to be paid by Sublessor under the Master Lease, including any amounts payable by Sublessor to Master
Lessor as “Operating Costs” (including any taxes thereon), shall be paid by Sublessee hereunder as and when such amounts are
due under the Master Lease, as incorporated herein. All such amounts shall be deemed additional rent (“Additional Rent”).
Base Rent and Additional Rent hereinafter collectively shall be referred to as “Rent”. Notwithstanding the foregoing, in the
event any cost or expense is incurred under the Master Lease for Sublessee’s sole benefit (including the disproportionate use of
utilities, regardless of whether they are otherwise “Operating Costs” under the Master Lease) or as a result of Sublessee’s
request for certain services (such as after-hours HVAC charges as provided in the Master Lease), Sublessee shall pay the entire cost thereof.
4. Security
Deposit. Promptly following execution hereof by Sublessee, Sublessee shall deposit with Sublessor the sum of Two Hundred Fifty Thousand
and 00/100 Dollars ($250,000.00) (the “Security Deposit”), in cash, as security for the performance by Sublessee of
the terms and conditions of this Sublease. The Security Deposit shall be held, applied and released in accordance with the terms of Section 9
of the Master Lease, which is incorporated in this Sublease. Provided that Sublessee has surrendered possession of the Subleased Premises
and has satisfied its obligations under this Sublease, Sublessor shall return the Security Deposit to Sublessee within sixty (60) days
of the expiration or earlier termination of this Sublease.
5. Repairs.
Sublessor shall deliver the Subleased Premises to Sublessee in “broom clean” condition. The parties acknowledge and agree
that Sublessee is otherwise subleasing the Subleased Premises on an “as is” basis and that Sublessor has made no representations
or warranties with respect to the condition of the Subleased Premises. Except as set forth in this Sublease, Sublessor shall have no obligation
whatsoever to make or pay the cost of any alterations, improvements or repairs to the Subleased Premises, including, without limitation,
any improvement or repair required to comply with any law. Master Lessor shall be solely responsible for performance of any maintenance
or repairs required to be performed by Master Lessor under the terms of the Master Lease.
6. Assignment
and Subletting. Sublessee may not assign this Sublease, sublet the Subleased Premises, transfer any interest of Sublessee therein
or permit any use of the Subleased Premises by another party (collectively, “Transfer”) without prior notice to Sublessor.
The terms of Section 14 of the Master Lease, as incorporated herein, shall apply to any Transfer.
7. Use.
Sublessee may use the Subleased Premises only for the uses identified in Section 10 of the Master Lease. Sublessee shall comply with
all reasonable rules and regulations promulgated from time to time by Master Lessor.
8. Improvements.
No alteration or improvements shall be made to the Subleased Premises except in accordance with the Master Lease and with the prior written
consent of both Master Lessor and Sublessor. Sublessee shall be required to remove all such alterations or improvements prior to the expiration
or earlier termination of this Sublease and to restore the Subleased Premises to the condition existing prior to such alterations or improvements,
unless Master Lessor agrees that such alterations or improvements may remain.
9. Insurance.
Sublessee shall name Sublessor as an additional insured under its liability insurance policy and provide a Certificate of Liability Insurance
to Sublessor.
10. Default.
Sublessee shall be in material default of its obligations under this Sublease if any of the following events occur:
a. Any
failure by Sublessee to pay Rent on the due date which is not cured within five (5) days after receipt of written notice from Sublessor;
provided, however, Sublessor shall not be required to send more than one (1) written notice in any one (1) calendar year and
on the second, and each subsequent, failure by Sublessee to pay Rent on the due date during each calendar year, Sublessee shall be in
default without the requirement for Sublessor to send a written notice;
b. This
Sublease or Sublessee’s interest is transferred whether voluntarily or by operation of law except as permitted in Section 6;
c. This
Sublease or any part of the Subleased Premises is taken by process of law and is not released within thirty (30) days after a levy;
d. Commencement
by Sublessee of a proceeding under any provision of federal or state law relating to insolvency, bankruptcy or reorganization (“Bankruptcy
Proceeding”);
e. Commencement
of a Bankruptcy Proceeding against Sublessee, unless dismissed within sixty (60) days after commencement;
f. The
insolvency of Sublessee or execution by Sublessee of an assignment for the benefit of creditors; the convening by Sublessee of a meeting
of its creditors or any significant class thereof for purposes of effecting a moratorium upon or extension or composition of its debts;
or the failure of Sublessee generally to pay its debts as they mature;
g. The
admission in writing by Sublessee that it is unable to pay its debts as they mature or it is generally not paying its debts as they mature;
h. The
dissolution or failure to maintain Sublessee’s legal existence;
i. Sublessee
fails to perform any of its other obligations under this Sublease and non-performance continues for thirty (30) days after written notice
by Sublessor or, if such performance cannot be reasonably had within such thirty (30) day period, Sublessee does not in good faith commence
performance within such thirty (30) day period and diligently proceed to completion; provided, however, Sublessee’s right to cure
shall not exceed the period provided by applicable law; or
j. Any
event which is expressly defined as or deemed an automatic “Event of Default” under the Master Lease.
11. Remedies.
In the event of any default by Sublessee, Sublessor shall have all remedies provided pursuant to Sections 20.2, 20.3, 20.4, 20.5 and 20.6
of the Master Lease and by applicable law. Sublessor may resort to its remedies cumulatively or in the alternative.
12. Surrender.
Prior to expiration or earlier termination of this Sublease, Sublessee shall remove all of its trade fixtures and shall surrender the
Subleased Premises to Sublessor in good condition, free of hazardous materials caused by Sublessee, reasonable wear and tear, casualty
and condemnation excepted, all in accordance with Section 17 of the Master Lease.
13. Notices.
Unless at least five (5) days’ prior written notice is given in the manner set forth in this paragraph, the address of each
party for all purposes connected with this Sublease shall be that address set forth below its signature at the end of this Sublease. All
notices shall otherwise be provided in accordance with the terms of Section 28 of the Master Lease, as incorporated herein. All notices
given to Master Lessor under the Master Lease shall be considered received only when delivered in accordance with the Master Lease.
14. Assumption
of Obligations. This Sublease is and at all times shall be subject and subordinate to the Master Lease and the rights of Master Lessor
thereunder. Sublessee hereby expressly assumes and agrees: (i) to comply with all provisions of the Master Lease which are incorporated
hereunder and (ii) to perform all the obligations on the part of the “Tenant” to be performed under the terms of the
Master Lease which are incorporated hereunder during the Term of this Sublease. In the event the Master Lease is terminated for any reason
whatsoever, this Sublease shall terminate simultaneously with such termination without any liability of Sublessor to Sublessee. In the
event of a conflict between the provisions of this Sublease and the Master Lease, as between Sublessor and Sublessee, the provisions of
this Sublease shall control. In the event of a conflict between the express provisions of this Sublease and the provisions of the Master
Lease, as incorporated herein, the express provisions of this Sublease shall prevail.
15. Signage.
During the Sublessor Occupancy Period, Sublessor may continue to display signage on the Subleased Premises as permitted under the Master
Lease.
16. Furniture,
Fixtures and Equipment. So long as Sublessee performs all of its obligations under this Sublease, Sublessee shall have the right to
use the office furnishings, fixtures and equipment within the Subleased Premises (the “FF&E”). Sublessor makes
no representations or warranties regarding the condition, use or fitness of the FF&E and Sublessee acknowledges and agrees that it
shall accept the same on an “as-is” basis.
17. Parking.
Sublessor has licensed from Master Lessor directly or through the operator of the parking garage, if applicable, the number of garage
parking spaces set forth below (“Parking Allotment”).
| 122 | spaces total |
| 8 | reserved, covered |
| 82 | unreserved, covered |
| 32 | unreserved, surface |
Sublessor hereby licenses to Sublessee the use of the Parking Allotment
on an in and out basis in the parking structure. Sublessee shall pay to Sublessor the current monthly rate charged for each space Sublessor
licenses in an amount equal to the monthly charge per parking space of Parking Allotment established by Master Lessor from time to time
(“Parking Rate”), which monthly Parking Rate for each parking space initially is $45.00 for each unreserved, covered parking
space and $55.00 for each reserved, covered parking space. There is no charge for uncovered, unreserved parking spaces. Parking charges
shall be subject to adjustment pursuant to Master Lessor's market rate parking charges. Sublessee will be billed monthly and Sublessee
shall pay the parking rents (including any taxes thereon) to Sublessor. Notwithstanding the above, the right granted to Sublessee to use
any parking spaces is a license only and Sublessor’s inability to make spaces available at any time for reasons beyond Sublessor's
reasonable control is not a material breach by Sublessor of its obligations hereunder. If Sublessee fails to pay any portion of the parking
fee in a timely manner, Sublessor, at its election, may cancel Sublessee’s right to use the number of parking spaces for which Sublessee
has failed to pay. All vehicles parked in the parking facilities and the personal property therein shall be at the sole risk of Sublessee
and the users of such spaces and Sublessor shall have no liability for loss or damage thereto for whatever cause.
18. Governing
Law. This Agreement shall be deemed to be a contract entered into pursuant to the laws of Arizona and shall in all respects be governed,
construed, applied and enforced in accordance with the laws of such State (without regard to conflict of law provisions thereof that would
apply the laws of another jurisdiction).
19. Counterparts.
This Sublease may be executed in counterparts, each of which shall constitute the original. Electronic signatures shall be binding as
original signatures.
[Signatures on the following page]
IN WITNESS WHEREOF, the parties have executed this Sublease as of the
day and year first above written.
SUBLESSOR:
Ategrity Specialty Insurance Company |
|
SUBLESSEE:
Zimmer Financial Services Group
LLC
|
By:
Name:
Title: |
/s/ Mike Miller
Mike Miller
Chief Executive Officer |
|
By:
Name:
Title: |
/s/ Barbara Burger
Barbara Burger
General Counsel
|
Address:
Attention: |
14000 North Pima Road
Scottsdale,
AZ 85260
Mike Miller
|
|
Address:
Attention: |
9 West 57th
St, 33rd Floor
New York, NY
10019
Barbara Burger
|
EXHIBIT A
MASTER LEASE
EXHIBIT B
SUBLEASED PREMISES AND SUBLESSOR AREA
Exhibit 10.10
TAX ALLOCATION AGREEMENT
This Tax Allocation Agreement (“Agreement”)
dated and effective as of April 1, 2018 among Sequentis Financial LLC (“Parent”) and its Affiliated Companies (“Affiliates”)
as designated on Attachment A and as amended from time to time.
Recitals
WHEREAS, Sequentis Financial LLC is the common
parent of a controlled Group of Corporations (“Group” as defined below) consisting of itself and the affiliates as detailed
on Attachment A (“Sequentis Group”); and
WHEREAS, it is the intent and desire of the parties
hereto to confirm the method for allocating the consolidated tax liability of the Sequentis Group among its members, for reimbursing Sequentis
Financial LLC for payments of such liabilities, for compensating any Affiliate for the use of its tax attributes and to provide for the
allocation of refunds or subsequent adjustments to tax liabilities due to audits, carrybacks, etc.; and
WHEREAS, Sequentis Financial LLC and its Affiliated
Companies desire to enter into this Tax Allocation Agreement upon the terms and conditions set forth herein.
NOW THEREFORE, the Parties hereby agree as follows:
| 1. | Definitions. For purposes of this Agreement: |
“Code” means the Internal
Revenue Code of 1986, as amended.
“Federal Income Tax or Taxes”
means any income tax that is imposed by subtitle A of the Code, including, without limitation, any such tax that has been or could have
been asserted (by reason of joint and several liability or otherwise) as a result of membership in an affiliated group, together with
any interest and any penalties, additions to tax or additional amounts imposed with respect to such tax in the United States.
“Group” means an affiliated
group of corporations or other entities that is permitted or required to file a Return or Returns on a consolidated, combined, or unitary
basis.
“Method Two Share of Federal Income
Taxes” means, with respect to each Party for any applicable period, an amount equal to the product of (a) the total
positive Federal Income Tax liability for the relevant period of the Sequentis Group times (b) a fraction, the numerator of which
is equal to the Party’s hypothetical Separate Return Federal Income Tax Liability for such period, calculated as set forth below
(taking into account only a positive Federal Income Tax liability), and the denominator of which is equal to the sum of the positive
hypothetical Separate Return Federal Income Tax Liabilities for such period for each corporation in the Sequentis Group, calculated as
set forth below, but in each case considering only those hypothetical Separate Return Federal Income Tax Liabilites that are greater than
zero.
If either (i) the computation of Separate
Return Federal Income Tax Liability of a party hereunder does not result in a positive Federal Income Tax Liability, or (ii) the
Sequentis Group does not have a positive consolidated Federal Income Tax Liability, then the Party’s Method Two Share of Federal
Income Taxes shall be zero.
Each Party’s hypothetical Separate Return
Federal Income Tax Liability shall be computed as if it were a Separate Corporation and filed a separate Return for the applicable period.
The allocation of tax among the Group members and
the calculation of Separate Return Federal Income Tax liability is intended to comply with Treasury Regulation Section 1.1552-1(a)(2).
“Regulations” means the
United States Treasury Regulations promulgated pursuant to the Code.
“Returns” means all reports,
estimates, declarations of estimated tax, information statements and returns relating to, or required to be filed in connection with,
any Federal Income Tax.
“Separate Corporation”
means a corporation that is not a member of a Group.
“Separate Return Federal Income Tax
Liability” means the hypothetical Federal Income Tax liability that a Member would have had for a particular period if it
were a Separate Corporation, computed with the adjustments set forth in the Treasury Regulation Section 1.1552-1(a)(2)(ii).
“Separate Return Year”
means a separate return year or SRY, which is a taxable year for which the member files a separate return or joins in the filing of a
consolidated return with another group.
“Separate Return Limitation Year”
means a separate return limitation year or SRLY and is any SRY of a member or its predecessor, subject to the exceptions in Treasury
Regulation Section 1.1502-1(f)(2)-(3).
“SRLY Net Operating Loss”
means a net operating loss incurred by a member or its predecessor in a SRLY.
“Subsidiary” means a
Party other than Sequentis Financial LLC in which Sequentis Financial LLC owns 80% or more in vote or value.
“Affiliate” means a Party
other than Sequentis Financial LLC, including Subsidiaries.
| 2. | Consolidated Return Election. Effective for the taxable year of the Sequentis Group ending December 31, 2018, and
for each taxable year thereafter, each Subsidiary will join, at any time, Sequentis Financial LLC and each other member of the Sequentis
Group in the filing of a consolidated Federal Income Tax Return for any taxable period for which the Sequentis Group is required or permitted
to file such a Return. Sequentis Financial LLC agrees to file, and as appropriate to cause to be filed such consents, elections and other
documents and to take other action as may be necessary or appropriate to carry out the purposes of this Section 2. Sequentis Financial
LLC as the Parent Corporation of the Sequentis Group has elected to allocate the consolidated Federal Income Tax liability among its members
in accordance with the methods set out in Treasury Regulation Sections 1.1502-33(d)(3) and 1.1552-1(a)(2). |
| 3. | Payment of Share of Federal Income Taxes. |
| (a) | In order to compensate the Parties for the use of net operating losses or tax credits in arriving at the consolidated Federal Income
Tax liability of the Sequentis Group, the Parties agree to determine and allocate the Federal Income Tax liability of the Sequentis Group
for each taxable year among themselves in the following manner: |
Step
1: Each party (including Sequentis Financial LLC) shall pay to Sequentis Financial LLC an amount equal to such Subsidiary’s
Method Two Share of Federal Income Taxes for such taxable year. To the extent any such party (including Sequentis Financial LLC) has unexpired
SRLY Net Operating Loss (taking into account any applicable limitations to utilization of such SRLY Net Operating Loss i.e. Sec 382 limitation),
such loss shall be taken into account, to the extent of the taxable income generated in such year, for the calculation of a Subsidiary’s
Method Two Share of Federal Income Taxes for such taxable year (subject to -21(c)(1) regulations).
Step
2: Each Party (including Sequentis Financial LLC) shall pay to Sequentis Financial LLC an additional amount equal to the excess,
if any, of (i) the Separate Return Federal Income Tax Liability of such Party for such taxable year over (ii) such Party’s
Method Two Share of Federal Income Taxes for such taxable year. To the extent that Sequentis Group has an overall Net Operating Loss for
a taxable year, each party (including Sequentis Financial LLC) shall pay to Sequentis Financial LLC its Separate Return Federal Income
Tax Liability computed taking into account any unexpired SRLY Net Operating Loss of such party (taking into account any applicable limitations
to utilization of such SRLY Net Operating Loss i.e. Sec 382 limitation) to the extent of the taxable income generated in such year (subject
to -21(c)(1) regulations).
Step
3: The total of the amounts to be paid by the Parties (including Sequentis Financial LLC pursuant to Step 2 of this
Section 3(a) (including any amounts allocated as result of a carryback) shall be paid by Sequentis Financial LLC to those other
Parties (including Sequentis Financial LLC) that had a hypothetical negative tax liability for such taxable year (that is, those Parties
whose tax attributes were applied by the Sequentis Financial LLC Group to reduce overall Federal Income Tax liability of the Sequentis
Group for such year). In no event shall a benefit under Step 3 be granted to a Party unless the net operating loss or tax credits
of such party are availed to the Group in reducing the consolidated Federal Income Tax liability of the Sequentis Group.
Step
4: Any attribute remaining unused after application of Step 1 and Step 2 shall be recorded and carried on the
books of the Subsidiary originating the attribute.
Sequentis Financial LLC shall be responsible
for determining the amount of payments due from and to the Parties under Steps 1, 2, and 3 above, applying such methods
and conventions as Sequentis Financial LLC deems to be reasonable for such purposes, and Sequentis Financial LLC’s determination
of such matters shall be binding upon all of the Parties hereto.
All payments required to be made by a
Party under this Section 3(a) with respect to a taxable year shall be made not later than the due date (including extensions)
of the Federal Income Tax Return of the Sequentis Group for such taxable year. Any amounts paid by a Party pursuant to Section 3(b) hereof
in respect of estimated Federal Taxes shall be credited in satisfaction of such Party’s obligation under this Section 3(a).
In the event that the amount of payments made by the Party for estimated Federal Taxes under Section 3(b) hereof with respect
to a taxable year exceeds the amount the Party is required to pay under this Section 3(a) for such taxable year, such excess
shall, at the Party’s election, be applied to estimated tax payments due under Section 3(b) hereof for future periods
or repaid by Parent to the Subsidiary.
| (b) | At the request of Sequentis Financial LLC, and in Sequentis Financial LLC’s sole discretion, each Affiliate shall pay, on or
before the due date of any estimated Federal Income Tax payment due on or after the date of this Agreement, to/settle with Sequentis Financial
LLC the amount determined by Sequentis Financial LLC as such Affiliate’s share of the estimated Federal Income Tax liability of
the Sequentis Group, using such methods and assumptions as Sequentis Financial LLC deems reasonable. All such payments in respect of estimated
Federal Income Taxes by an Affiliate shall be credited in satisfaction of the Affiliate’s obligation under Section 3(a) hereof. |
| (c) | Sequentis Financial LLC shall prepare and file (or cause to be prepared and filed) in a timely manner all Returns and forms required
to be filed in respect of Federal Income Taxes. |
| (d) | Each Affiliate shall provide Parent with documentation sufficient to permit Sequentis Financial LLC to calculate the amounts payable
under Sections 3(a) and 3(b) hereof on or before the due date of each payment. |
| 4. | Subsequent Tax Adjustments. |
In the event of any adjustment to the
Returns for periods ending on or after the date of this Agreement, as filed, or Parent or any other member of the Sequentis Group (by
reason of an amended Return, claim for refund, or an examination or audit by the Internal Revenue Service or other taxing authority),
the obligation of each Affiliate under Section 3(a) for such period shall be recomputed to give effect to any such adjustment
applicable to such Affiliate as if it had been made as part of the original computation of tax liability. Such recomputation and any adjusting
payment required as a result shall be made as soon as practicable following the final administrative or judicial determination of such
adjustment.
| 5. | Treatment of Payments Under Section 3(a) for Federal Income Tax Purposes. |
The following principles will govern
the federal income tax treatment of payments under Section 3(a) hereof:
| (a) | An Affiliate’s Method Two Share of Federal Income Taxes payable under Step 1 of Section 3(a) shall (in accordance
with Section 1.1552-1(b)(2) of the Regulations) (i) decrease the earnings and profits of such Affiliate, and (ii) be
treated as a liability of such Affiliate for such amount. |
| (b) | An Affiliate’s liability under Step 2 of Section 3(a) or right to payment under Step 3 of Section 3(a) will
be regarded for federal income tax purposes as distributions in respect of stock, contributions of capital, or a combination thereof,
as applicable. |
| (a) | This Agreement shall in all respects be governed by, and construed in accordance with, the laws of the Sequentis Financial LLC. Any
provision of the Agreement that is prohibited and unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to
the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. |
| (b) | The principles of the Agreement (including, without limitation, the making of payments as provided herein) shall also apply to determine
and allocate the state income tax liability of the Sequentis Group where such state income tax liability is computed on a consolidated,
combined, or unitary basis. |
| (c) | This Agreement address only the obligations of the Affiliates in respect of Federal Income Taxes and those state income taxes specified
in Section 6(c). The obligations of the Affiliates in respect of any other taxes shall be determined separate from this Agreement
as necessary by and among the Affiliates. |
Each signatory to this Agreement has
signature authority and is empowered on behalf of his or her respective party to execute this Agreement.
| By: | /s/ Mitchell Pressman |
| Name: | Mitchell Pressman |
| Title: | Treasurer |
| |
ATEGRITY SPECIALTY HOLDINGS LLC |
| By: | /s/ Jeffrey H. Marshall |
| Name: | Jeffrey H. Marshall |
| Title: | Chief Financial Officer |
| |
ATEGRITY SPECIALTY INSURANCE COMPANY |
| By: | /s/ Jeffrey H. Marshall |
| Name: | Jeffrey H. Marshall |
| Title: | Chief Financial Officer |
| |
SEQUENTIS REINSURANCE COMPANY LIMITED |
| By: | /s/ Jeffrey H. Marshall |
| Name: | Jeffrey H. Marshall |
| Title: | Chief Financial Officer |
Attachment A - List of Subsidiaries
| · | Ategrity Specialty Insurance Company |
| · | Ategrity Specialty Holdings LLC |
| · | Sequentis Reinsurance Company Limited (Once it becomes
a Corp) |
Exhibit 10.11
Technology Transactions Agreement
This Technology Transactions Agreement (“Agreement”)
is between Ategrity Specialty Insurance Company, a Delaware corporation with offices at 14000 N. Pima Road, Suite 200, Scottsdale,
Arizona 85260 (“ASIC”), and Zimmer Technology Group, LLC a Delaware company with offices at 9 West 57th
Street, 33rd Floor New York, New York 10019 named above (“ZTG”). This Agreement is effective as of January 01,
2023.
This Agreement governs the Sale or
Licensing of Software and/or Services by Seller to Buyer, made subject to the applicable Schedules.
“Affiliate” has
the meaning ascribed to the term under Title 18 §5001(1) of the Delaware Code.
“Buyer” means the
party identified as purchasing or obtaining a license to use the Software or Services under an applicable Technical Sale or Technical
Licensing Schedule.
“Documentation”
means the technical materials, including administrator and user guides, which relate to the Software, describe the functionality of the
Software and instruct Buyer’s personnel in the use of the Software or that may be otherwise specified on the applicable Schedule.
“Fees” means the
amount obligated to be paid by Buyer to Seller as identified on the applicable Schedule.
“Licensing” or “Technical
Licensing” means the non-exclusive, term-based provision of the Software and Services by the Seller to the Buyer as provided
in the applicable Schedule(s).
“Personal Data”
means any information relating to (i) an identified or identifiable natural person and, (ii) an identified or identifiable
legal entity (where such information is protected similarly to personal data or personally identifiable information under applicable
law).
“Schedule” means
an ordering document for the Technical Licensing or Technical Sale of Software and/or Services entered into between Buyer and Seller
under this Agreement, taking a form substantially similar to that of Exhibit A, incorporated hereunder.
“Sale” or “Technical
Sale” means the permanent transfer of ownership in the Software from the Seller to the Buyer as provided in the applicable
Schedule(s).
“Services” means
the Seller-provided professional, implementation, or support services identified on a Schedule or comparable statement of work hereunder.
“Seller” means the
party identified as selling or providing a license to use the Software or Services under an applicable Technical Sale or Technical Licensing
Schedule.
“Software” means
the software and technologies specified in a Schedule hereunder, as may be further described in the Documentation, including in the instance
of a Sale Schedule the underlying source code.
“Supported Environment”
means the configuration and conditions, as stated in the applicable Documentation, required for the proper operation and use of the
Software.
| 3.1. | Provision of Software and Services.
Seller will (a) provide the Software to Buyer pursuant to this Agreement, the Schedule(s) and
the Documentation, and (b) provide Support for the Software to Buyer as specified on
the Schedule(s). |
| 3.2. | Affiliates and Contractors.
Buyer and its Affiliates may enter into Schedules with Seller and its Affiliates. An Affiliate
entering into a Schedule adopts and agrees to be bound by this Agreement. Under a Licensing
Schedule, Buyer may allow its Affiliates and contractors (“Authorized Users”)
to use the Software, provided Buyer is responsible for the Authorized Users’ compliance
with this Agreement. |
| 4. | WARRANTIES AND EXCLUSIVE REMEDY |
| 4.1. | Licensing Warranties. With
respect to Technical Licensing, Seller warrants to Buyer that: (a) the Software will
materially perform the functions described in the Documentation and applicable Schedules,
and (b) the Software shall not infringe the rights of any third party. |
| 4.2. | Sale Warranties. With respect
to Technical Sale, Seller warrants to Buyer that: (a) the Software will materially perform
the functions described in the applicable Schedules based on the provided Documentation,
(b) all Documentation has been provided or made available to Buyer, and (c) as
delivered to the Buyer the Software does not infringe the rights of any third party. |
| 2022-12 Technology Transactions Agreement | 1 | Confidential |
| 4.3. | Services Warranties. With respect
to Services, Seller warrants to Buyer that: (a) the Services will be performed in a
timely, efficient, and professional manner, and (b) all individuals assigned to perform
the Services will possess the requisite skills, training, and background reasonably required
to meet the Services obligations in accordance with the Services Schedule and standard industry
practice. |
| 4.4. | Exclusive Remedy. For any warranty
breach, Buyer’s exclusive remedy and Seller’s sole obligation shall be: (a) Seller’s
cure of the breach within a reasonable period after Buyer’s notice to Seller specifying
the breach, or (b) if Seller does not cure the breach within such period, termination
of this Agreement with immediate effect upon notice to Seller, along with the remedies for
termination for breach described in the “Effect of Termination” section below. |
| 4.5. | Disclaimer. Seller disclaims all
implied warranties, including, without limitation, any implied warranties of merchantability,
fitness for a particular purpose, and satisfactory quality. |
| 5.1. | Fees and Payment. Undisputed
Fees are due and payable net 90 days from the invoice date. Except as provided herein or
in a Schedule, payment obligations are noncancelable and Fees paid are nonrefundable. Buyer
is responsible for payment of all sales, use, VAT, withholding (without reducing the amounts
payable to Seller under invoices) and similar taxes. |
| 6. | CONFIDENTIALITY AND DATA PROTECTION |
| 6.1. | Confidential Information. “Confidential
Information” means non-public information disclosed orally or in writing by a party
or its Affiliate (“Discloser”) to the other party or its Affiliate (“Recipient”)
about (without limitation) its business, finances, buyers, operations, products, technology,
plans, or pricing, that is designated as confidential or reasonably should be considered
confidential given the nature of the information and the circumstances of its disclosure.
Where the Software is provided under a Licensing Schedule, Confidential Information includes
any information uploaded or otherwise provided by the Buyer to the Software (“Buyer
Data”). |
| 6.2. | Protection of Confidential Information.
Recipient will use the same degree of care that it uses to protect the confidentiality
of its own information of a like nature, but in no event less than reasonable care, (a) not
to use Discloser’s Confidential Information for a purpose inconsistent with the activities
contemplated under this Agreement, and (b) to limit access to Discloser’s Confidential
Information to those of Recipient’s and its Affiliates’ employees, directors,
contractors, advisors and auditors who need such access for activities contemplated under
this Agreement and who are legally or contractually bound to protect the Confidential Information
as provided in this section. Confidential Information excludes information that: (i) is
or becomes generally known to the public without breach of a duty owed to Discloser, (ii) was
known to Recipient before its disclosure hereunder without breach of a duty owed to Discloser,
(iii) is received from a third party without breach of a duty owed to Discloser, or
(iv) is independently developed by Recipient without use of Discloser’s Confidential
Information. |
| 6.3. | Requests for Confidential Information.
If Recipient receives a government or other third-party request for Discloser’s
Confidential Information (including but not limited to Buyer Data), Recipient will direct
the requestor to, and promptly so notify, Discloser if legally permitted to do so. Recipient
will comply with such a third-party request only if so required by law; in such event, Recipient
will seek to limit the disclosure to that Confidential Information which Recipient is legally
required to disclose. |
| 6.4. | Data Privacy. Each party shall
at all times protect Personal Data received under this Agreement in accordance with applicable
law. |
| 6.5. | Data Breach. If a Recipient
becomes aware of an unauthorized access to or disclosure, loss or alteration of Discloser’s
Confidential Information, Recipient will promptly notify Discloser, seek to mitigate the
breach and preserve forensic evidence, and provide information to Discloser about the nature
and scope of the breach. |
| 7. | LICENSES AND PROPRIETARY RIGHTS |
| 7.1. | Licenses. Seller grants Buyer
a worldwide right and license to the Software under all applicable intellectual property
laws in accordance with and subject to the relevant Schedule(s) and this Agreement. |
| 7.2. | Ownership. Under a Technical Licensing Schedule, Buyer
solely owns the Buyer Data, including all intellectual property rights therein, and reserves
all rights not expressly granted to Seller and Seller solely owns the Software, including
their underlying applications, interfaces and architecture, and all intellectual property
rights therein, and reserve all rights not expressly granted to Buyer. Under a Technical
Sale Schedule Buyer takes ownership of all intellectual property identified on the Schedule
and Seller shall take all actions reasonably required to ensure such ownership interest is
perfected. |
| 7.3. | Restrictions. Except as otherwise
provided in the Agreement or an applicable Schedule, Buyer under a Technical Licensing Schedule
may not (a) make the Software available to, or use Software for the benefit of, anyone
other than Buyer and Buyer’s Affiliates, (b) sell, resell, license, sublicense,
distribute, rent or lease the Software, or include Software in a service bureau or outsourcing
offering, (c) copy the Software, except Software copies as part of a disaster recovery
plan, (d) make a derivative work based on the Software, (e) use the Software to
store or transmit malware, (f) reverse engineer or decompile the Software (to the extent
such restriction is permitted by law), or (g) access the Software to build a competitive
service or product, or copy any feature, function or graphic for competitive purposes. Seller
may suspend Buyer use of the Software if it believes in good faith that it is necessary to
do so to mitigate an imminent threat to the integrity of the Software or data processed by
it. Seller will work with Buyer to avoid such suspension to the extent practicable, and in
the event of such suspension will work with Buyer to restore usage of the Software as quickly
as possible. |
| 2023-03 Technology Transactions Agreement | 2 | Confidential |
| 8.1. | Term of this Agreement. This
Agreement continues until the 30th day after all Schedules have expired, unless
earlier terminated as provided below, provided that all the terms of this Agreement shall
continue to govern any Schedules still in force. |
| 8.2. | Term of Schedules. Except for
a Technical Sale Schedule, each Schedule shall specify a term. Except as provided in a Schedule,
(a) either party may cancel the Schedule at the end of the term (the “Renewal
Date”) by so notifying the Seller 30 or more days before the Renewal Date, (b) if
no such notice is given, then on the Renewal Date the Schedule will renew for an additional
year, (c) in any such renewal, the Schedule terms will remain unchanged from the prior
term, and (d) the Schedule will continue to renew until canceled in accordance with
this section. |
| 8.3. | Termination for Material Breach.
If either party is in material breach of this Agreement, the other party may terminate
this Agreement, together with all Schedules, at the end of a written 30-day notice and cure
period, if the breach has not been cured. |
| 8.4. | Effect of Termination. If this
Agreement is terminated for Seller’s breach, Seller will refund Fees prepaid by Buyer,
and where governed by a Technical Licensing Schedule such amount shall be prorated for the
remaining term of such Schedule after the termination date. If this Agreement is terminated
for Buyer’s breach, Buyer will pay any unpaid Fees for the term of the applicable Schedules.
Upon request following any termination of this Agreement, each party will destroy or return
all copies of the other party’s Confidential Information that it holds, subject to
its regular backup retention processes. |
| 8.5. | Survival of Terms. Any terms
that by their nature survive termination of this Agreement for a party to assert its rights
and receive the protections of this Agreement, will survive (including, without limitation,
the confidentiality and ownership terms in this Agreement). |
| 9. | LIMITATION OF LIABILITY |
| 9.1. | No Indirect Damages. Neither
party or its Affiliates will be liable for any indirect, special, incidental or consequential
damages or losses arising out of or related to this Agreement (including, without limitation,
lost profits, lost revenue, lost savings, or costs of delay). |
| 9.2. | Liability Limit. With respect
to each Technical Sale or Technical Licensing Schedule, each party’s and its Affiliates’
total, aggregate liability arising out of or related to this Agreement will not exceed the
Fees paid by Buyer within the 12 months before the first incident out of which the liability
arose. |
| 9.3. | Conditions. The exclusions
and limits in this “Limitation of Liability” section reflect the parties’
allocation of risk and will apply under any legal theory (including, without limitation,
contract or tort), even where a party was aware of the possibility of such damages, the damages
were foreseeable, and/or any remedies hereunder fail of their essential purpose. Such exclusions
and limits will not limit damages that result from a party’s gross negligence, willful
misconduct, or fraud, either party’s liability for intellectual property infringement
(including the obligations in Section 10), or to the extent prohibited by law. |
| 10.1. | Defense of Third-Party Claims.
Seller will defend Buyer against any claim, demand, suit or proceeding against Buyer
alleging that use of any Software in accordance with this Agreement infringes or misappropriates
a third party’s intellectual property rights (a “Claim”), and will
indemnify and hold harmless Buyer from and against any damages, attorney fees and costs awarded
against Buyer as a result of, or for amounts paid by Buyer in settlement of, a Claim, provided
Buyer (a) promptly notifies Seller of the Claim, (b) gives Seller sole control
of the defense and settlement of the Claim (except Seller may not settle a Claim unless Buyer
is unconditionally released of all liability), and (c) gives Seller all reasonable assistance
at Seller’s expense. If Buyer’s use of the Software is enjoined, Seller shall
(or if Seller receives information about a potential or actual Claim, Seller may), at no
cost to Buyer (i) modify the Software without breaching Seller’s warranties above,
(ii) obtain a license for Buyer’s continued use of the Software in accordance
with this Agreement, or if options (i) and (ii) are not reasonably available to
Seller, (iii) terminate the applicable Schedules and refund Buyer all Fees prepaid for
the remainder of the term of such Schedules after the termination date. Seller’s obligations
in this section do not apply if a Claim arises from
(1) the use or combination of the Software or any part thereof with software, hardware
or processes not provided by Seller, if the Software or use thereof would not infringe without
such combination, (2) modifications to the Software made by the Buyer, or (3) where
infringement arises from a breach of any warranty against non-infringement by the party seeking
indemnification. For purposes of this section, “Buyer” includes its Affiliates. |
| 2023-03 Technology Transactions Agreement | 3 | Confidential |
| 11.1. | Governing Law and Arbitration.
This Agreement, and any disputes arising out of or related hereto, will be governed exclusively
by the laws of the State of Delaware, U.S.A., without regard to its conflicts of laws rules or
the United Nations Convention on the International Sale of Goods. Any dispute or claim arising
out of or relating to this Agreement, including the scope or applicability of this arbitration
clause, will be determined by confidential and binding arbitration in New Castle County,
Delaware, before a single arbitrator. The arbitration will be administered by JAMS pursuant
to its Comprehensive Arbitration Rules and Procedures and the Expedited Procedures in
those Rules. Judgment on the arbitrator’s award may be entered in any court having
jurisdiction. The parties will treat all disputes arising under this Agreement, including
arbitration proceedings and awards, as Confidential Information of both parties, except as
necessary in connection with a judicial challenge to or enforcement of an award or otherwise
required by law or judicial decision. Notwithstanding the above, either party may seek injunctive
relief in a court of competent jurisdiction, and issues of patent or copyright ownership
or infringement may be decided only by a federal court in New Castle County, Delaware and
not by arbitration. The prevailing party in any action arising from or relating to this Agreement
shall be entitled to recover its reasonable attorneys’ fees and costs including, without
limitation, arbitration and expert fees. |
| 11.2. | Entire Agreement and Amendment.
This Agreement and the Schedules constitute the entire agreement of the parties and supersede
all prior and contemporaneous discussions and agreements, oral and written, related to this
Agreement’s subject matter. Neither party is relying on any representation not expressly
included in this Agreement concerning the subject matter hereof. No representation, promise
or inducement not included in this Agreement or a Schedule is binding. Any amendment or modification
of this Agreement or a Schedule requires both parties’ signatures. In the event of
any inconsistency among the following documents, the order of precedence shall be: (1) Schedules,
(2) this Agreement and (3) the Documentation. |
| 11.3. | No Assignment. Neither party
may assign or transfer this Agreement or a Schedule to a third party, except that this Agreement
with all Schedules may be assigned, without the consent of the other party, as part of a
merger, or sale of substantially all of a party’s assets, business, or stock not involving
a competitor of the other party, or at any time to an Affiliate. |
| 11.4. | Export Compliance. The Software
and Confidential Information may be subject to export laws and regulations of the United
States and other jurisdictions. Each party represents that it is not named on any U.S. government
denied-party list. Neither party will permit its personnel or representatives to access any
Software in a U.S.-embargoed country or in violation of any applicable export law or regulation. |
| 11.5. | Anti-Corruption. The parties
shall comply with all applicable laws relating to anti-bribery and anti-corruption. Each
party represents that it has not received or been offered any illegal or improper bribe,
kickback, payment, gift, or thing of value from an employee or agent of the other party in
connection with this Agreement. |
| 11.6. | Notices. Notices under this
Agreement will be written and be effective on (i) the second business day after mailing,
(ii) confirmed delivery by courier service, or (iii), except for notices of breach or
an indemnifiable claim (“Legal Notices”), the day sent by email. |
| 11.7. | Independent Contractors. The
parties are independent contractors with respect to each other. |
| 11.8. | Waiver and Enforceability.
Any waiver of a right under this Agreement requires the waiving party’s signature.
If any term of this Agreement is invalid or unenforceable, the other terms remain in effect. |
| 11.9. | Money Damages Insufficient.
A party’s breach of its confidentiality obligations under this Agreement or violation
of the other party’s intellectual property rights could cause the other party irreparable
harm. The other party may seek a court order to stop or prevent any such breach or violation. |
| 11.10. | No Third-Party Beneficiaries.
There are no third-party beneficiaries under this Agreement. |
| 11.11. | Regulatory Approval. Notwithstanding
anything to the contrary this Agreement and each Schedule is subject to the approval of the
Delaware Insurance Commissioner (“Commissioner”) and may be subject to cancellation
or amendment at the request of the Commissioner. |
| 11.12. | Regulatory Requirements.
To the extent that ASIC enters any Services Schedule under this Agreement that are agreements
for cost sharing or management services under the provisions of 18 Del. Admin code, Regulation
1801, Section 19.2 the following additional terms shall apply; |
11.12.1. Any
settlements will be made in compliance with the requirements set forth in the Accounting Practices and Procedures Manual of the National
Association of Insurance Commissioners.
11.12.2.
The Buyer will not advance funds to the Seller pursuant to this Agreement except to
pay for Services.
11.12.3.
The Buyer will maintain oversight for functions provided by the Seller and the Buyer
will monitor Services annually for quality assurance.
| 2023-03 Technology Transactions Agreement | 4 | Confidential |
11.12.4.
All records and data developed or maintained under or related to this Agreement that are otherwise
the property of the Buyer, in whatever form maintained, including, but not limited to financial records or similar records within the
possession, custody or control of the Seller (“Records and Data”) of the Buyer are and remain the property of the
Buyer, and shall be: (1) subject to control of the Buyer; (2) identifiable; and (3) segregated from all other persons’
Records and Data or readily capable of segregation at no additional cost to the Buyer.
11.12.5.
All funds and invested assets of the Buyer are the exclusive property of the Buyer, held for
the benefit of the Buyer and are subject to the control of the Buyer.
11.12.6.
If the Buyer is placed in supervision, seizure, conservatorship, or receivership pursuant
to 18 Del.C. Ch. 59: (1) all of the rights of the Buyer under this Agreement extend to the receiver or Delaware Insurance Commissioner
to the extent permitted by Delaware law; (2) all Records and Data of the Buyer shall be identifiable and segregated from all other
persons’ records and data or readily capable of segregation at no additional cost to the receiver or the Delaware Insurance Commissioner;
(3) a complete set of Records and Data of the Buyer will immediately be made available to the receiver or the Delaware Insurance
Commissioner, shall be made available in a usable format, and shall be turned over to the receiver or the Delaware Insurance Commissioner
immediately upon the receiver or the Delaware Insurance Commissioner’s request, and the cost to transfer data to the receiver or
the Delaware Insurance Commissioner shall be fair and reasonable; and (4) the Seller will make available all employees essential
to the operations of the Buyer and the services associated therewith for the immediate continued performance of the essential services
ordered or directed by the receiver or Delaware Insurance Commissioner.
11.12.7.
The Seller has no automatic right to terminate this Agreement if the Buyer is placed into supervision,
seizure, conservatorship, or receivership pursuant to 18 Del.C. Ch. 59.
11.12.8.
The Seller will provide the essential services for at least six months after termination of
this Agreement, if the Buyer is placed into supervision, seizure, conservatorship or receivership pursuant to 18 Del.C. Ch. 59, as ordered
or directed by the receiver or the Delaware Insurance Commissioner. Performance of the essential services will continue to be provided
without regard to pre-receivership unpaid fees, so long as the Seller continues to receive timely payment for post-receivership services
rendered, and unless released by the receiver, the Delaware Insurance Commissioner or supervising court.
11.12.9.
The Seller will continue to maintain any systems, programs, or other infrastructure
notwithstanding supervision, seizure, conservatorship or receivership pursuant to 18 Del.C. Ch. 59, and will make them available to the
receiver or the Delaware Insurance Commissioner as ordered or directed by the receiver or the Delaware Insurance Commissioner, for so
long as the Seller continues to receive timely payment for post-receivership services rendered, and unless released by the receiver,
the Delaware Insurance Commissioner or supervising court.
11.12.10.
In furtherance of the cooperation between the receiver and the affected guaranty association or associations
and subject to the receiver’s authority over the Buyer, if the Buyer is placed into supervision, seizure, conservatorship or receivership
pursuant to 18 Del.C. Ch. 59, and portions of the Buyer’s policies or contracts are eligible for coverage by one or more guaranty
associations, the Seller’s commitments under Section 11.12(1)-(6) of this Agreement will extend to such guaranty association
or associations.
11.12.11.
Notwithstanding anything to the contrary, Buyer and its employees and affiliates (such persons, the “Indemnitees”)
shall be indemnified and held harmless by the Seller to the fullest extent legally permissible, from and against any and all loss, liability
and expense (including without limitation judgments, fines, amounts paid or to be paid in settlement and reasonable attorney’s
fees) to the extent incurred or suffered by the Indemnitees as a result of the Seller’s gross negligence, willful misconduct, or
fraud and for any actions by the Seller that violate Sections 11.12 of this Agreement.
The signers below are authorized to execute this
Agreement, including all exhibits, schedules, and appendices for the Buyer entity first named above and Seller, respectively.
| ZTG |
|
|
ASIC |
|
| |
|
|
|
|
| Signature: |
/s/ Barbara
Burger |
|
Signature: |
/s/ Justin Cohen |
| |
|
|
|
|
| Name: |
Barbara Burger |
|
Name: |
Justin Cohen |
| |
|
|
|
|
| Title: |
Authorized Signatory |
|
Title: |
CEO |
| |
|
|
|
|
| Date: |
5/10/2023 |
|
Date: |
5/10/2023 |
| 2023-03 Technology Transactions Agreement | 5 | Confidential |
Exhibit List
Exhibit A – Sample Technology Transaction Schedule
| 2023-03 Technology Transactions Agreement | 6 | Confidential |
EXHIBIT A

TECHNOLOGY TRANSACTION SCHEDULE
SELLER: [Seller Entity]
BUYER: [Buyer Entity]
TRANSACTION TYPE:
[ ] TECHNOLOGY SALE
[ ] TECHNOLOGY LICENSING
[ ] SERVICES
DESCRIPTION OF TRANSACTION:
[Description of the Transaction]
SCHEDULE TERM:
[Schedule Term or Effective Date]
FEES: [$XXX,XXX.XX]
SPECIAL TERMS:
[Additional terms applicable to this Schedule or modifications
to the Agreement]
Governing Agreement. For avoidance of doubt, this Schedule
is governed by the Technology Transactions Agreement executed by the parties effective as of January 01, 2023.
| [Buyer Entity] |
|
|
[Seller Entity] |
| |
|
|
|
|
| Signature: |
|
|
Signature: |
|
| |
|
|
|
|
| Name: |
|
|
Name: |
|
| |
|
|
|
|
| Title: |
|
|
Title: |
|
| |
|
|
|
|
| Date: |
|
|
Date: |
|
| 2023-03 Technology Transactions Agreement | 7 | Confidential |

TECHNOLOGY
TRANSACTION SCHEDULE
SELLER:
Ategrity Specialty Insurance Company
BUYER:
Zimmer Technology Group, LLC
TRANSACTION
TYPE:
[X]
TECHNOLOGY SALE
[ ] TECHNOLOGY LICENSING
[ ] SERVICES
DESCRIPTION
OF TRANSACTION:
Seller
hereby sells, transfers, assigns, or otherwise provides all rights of interest and ownership in the following technologies to Buyer and
shall make commercially reasonable efforts to ensure that Buyer is granted the same ownership rights to any additional intellectual property
in development at the time of this transaction.
| · | Ategrity
Integration Framework |
| · | ARS
Reporting and Analytics |
EFFECTIVE
DATE OF SCHEDULE: January 01, 2023
FEES:
$13,501,289.59
SPECIAL
TERMS:
Governing
Agreement. For avoidance of doubt, this Schedule is governed by the Technology Transactions Agreement executed by the parties effective
as of January 01, 2023.
Regulatory
Approval. Notwithstanding anything to the contrary this Schedule is subject to the approval of the Delaware Insurance Commissioner
(“Commissioner”) and may be subject to cancellation or amendment at the request of the Commissioner.
Payment
Via Note. Notwithstanding anything to the contrary in the Agreement or this Schedule, Buyer’s payment for Fees under this Schedule
shall be in the form of a note issued by Buyer’s parent company, Zimmer Financial Services Group LLC executed contemporaneously
with this Schedule. If such note is not executed, this Schedule shall be null and void. In addition, Zimmer Financial Services Group
LLC has executed this Schedule as the parental guarantor for Zimmer Technology Group LLC.
Buyer
Assumes All Commercial Responsibility. For avoidance of doubt, as of the effective date of this Schedule, Buyer assumes all commercial
responsibility for the assets under the transaction and that payments made under this Schedule will be due regardless of Buyer’s
ability to make a commercial success of such assets.
| 2023-03 Technology Transactions Agreement | 1 | Confidential |
| Zimmer Technology Group, LLC | |
Ategrity Specialty Insurance Company |
| |
| |
|
|
| Signature: |
/s/ Barbara Burger | |
Signature: |
/s/ Justin Cohen |
| |
| |
|
|
| Name: |
Barbara Burger | |
Name: |
Justin Cohen |
| |
| |
|
|
| Title: |
Authorized Signatory | |
Title: |
CEO |
| |
| |
|
|
| Date: |
5/10/2023 | |
Date: |
5/10/2023 |
Zimmer
Financial Services Group LLC
| Signature: |
/s/ Barbara Burger |
|
|
|
| |
|
|
|
|
| Name: |
Barbara Burger |
|
|
|
| |
|
|
|
|
| Title: |
Authorized Signatory |
|
|
|
| |
|
|
|
|
| Date: |
5/10/2023 |
|
|
|
| 2023-03 Technology Transactions Agreement | 2 | Confidential |

TECHNOLOGY
TRANSACTION SCHEDULE
SELLER:
Zimmer Technology Group, LLC
BUYER:
Ategrity Specialty Insurance Company
TRANSACTION
TYPE:
[ ] TECHNOLOGY SALE
[X]
TECHNOLOGY LICENSING
[ ] SERVICES
DESCRIPTION
OF TRANSACTION:
Seller
hereby grants to Buyer a worldwide right and license under all applicable intellectual property rights to use the Software identified
below for the term of this Schedule in accordance with and subject to the terms of the Agreement.
| · | Ategrity
Integration Framework |
| · | ARS
Reporting and Analytics |
EFFECTIVE
DATE OF SCHEDULE: January 01, 2023 – December 31, 2023
FEES:
$750,000.00
SPECIAL
TERMS:
Governing
Agreement. For avoidance of doubt, this Schedule is governed by the Technology Transactions Agreement executed by the parties effective
as of January 01, 2023.
Regulatory
Approval. Notwithstanding anything to the contrary this Schedule is subject to the approval of the Delaware Insurance Commissioner
(“Commissioner”) and may be subject to cancellation or amendment at the request of the Commissioner.
Payment
Frequency. Notwithstanding anything to the contrary in this Schedule, payment of Fees under this Schedule shall be made in equal
quarterly installments of $187,500.00
| Zimmer Technology Group,
LLC | |
Ategrity Specialty
Insurance Company |
| |
| |
|
|
| Signature: |
/s/
Barbara Burger | |
Signature: |
/s/
Justin Cohen |
| |
| |
|
|
| Name: |
Barbara
Burger | |
Name: |
Justin
Cohen |
| |
| |
|
|
| Title: |
Authorized
Signatory | |
Title: |
CEO |
| |
| |
|
|
| Date: |
5/10/2023 | |
Date: |
5/10/2023 |
| 2023-03 Technology Transactions Agreement | 1 | Confidential |

TECHNOLOGY
TRANSACTION SCHEDULE
SELLER:
Ategrity Specialty Insurance Company
BUYER:
Zimmer Technology Group, LLC
TRANSACTION
TYPE:
[ ] TECHNOLOGY SALE
[ ] TECHNOLOGY LICENSING
[X]
SERVICES
DESCRIPTION
OF TRANSACTION:
Buyer
hereby retains Seller to work with applicable third-party vendor(s) to develop proposals to provide for the required supporting
infrastructure, support services, ongoing maintenance, and continued development of the following technologies or future technologies
developed under this Schedule.
| · | Ategrity
Integration Framework |
| · | ARS
Reporting and Analytics |
In
the event that Buyer chooses to approve any proposals developed at the request of Seller, Buyer shall bear all third-party costs for
such development. Where Buyer has not paid such costs directly to the applicable third-party vendor(s), Buyer shall pay such costs as
fees to Seller in accordance with the terms of the Agreement.
TERM
OF SCHEDULE: January 01, 2023 – December 31, 2023
FEES:
Reimbursement for all internal and external costs incurred by the Seller pursuant to this Schedule.
SPECIAL
TERMS:
Governing
Agreement. For avoidance of doubt, this Schedule is governed by the Technology Transactions Agreement executed by the parties effective
as of January 01, 2023.
Regulatory
Approval. Notwithstanding anything to the contrary this Schedule is subject to the approval of the Delaware Insurance Commissioner
(“Commissioner”) and may be subject to cancellation or amendment at the request of the Commissioner.
Payment
Frequency. Notwithstanding anything to the contrary, settlements for Fees incurred under this Schedule will be made not less frequently
than quarterly.
| Zimmer Technology Group, LLC | |
Ategrity Specialty Insurance Company |
| |
| |
|
|
| Signature: |
/s/ Barbara Burger | |
Signature: |
/s/ Justin Cohen |
| |
| |
|
|
| Name: |
Barbara Burger | |
Name: |
Justin Cohen |
| |
| |
|
|
| Title: |
Authorized Signatory | |
Title: |
CEO |
| |
| |
|
|
| Date: |
5/10/2023 | |
Date: |
5/10/2023 |
| 2023-03 Technology Transactions Agreement | 1 | Confidential |

TECHNOLOGY TRANSACTION SCHEDULE
SELLER: Zimmer Technology Group, LLC
BUYER: Ategrity Specialty Holdings LLC
TRANSACTION TYPE:
x TECHNOLOGY
SALE
¨ TECHNOLOGY LICENSING
¨ SERVICES
DESCRIPTION OF TRANSACTION:
Seller hereby sells, transfers, assigns, or otherwise provides all
rights of interest and ownership in the following technologies to Buyer and shall make commercially reasonable efforts to ensure that
Buyer is granted the same ownership rights to any additional intellectual property in development at the time of this transaction.
| · | Technologies developed subject to the Services Schedule between Zimmer Technology
Group, LLC and Ategrity Specialty Insurance Company executed on or about May 10, 2023 collectively referred to by the parties as
AtegrityOne. |
EFFECTIVE DATE OF SCHEDULE: April 01, 2025
FEES: $3,200,000.00
SPECIAL TERMS:
Governing Agreement. For avoidance of doubt, this Schedule is
governed by the Technology Transactions Agreement executed by the parties or their Affiliates effective as of January 01, 2023.
Existing Sublicensing. For avoidance of doubt to the extent
that the technologies subject to this Technical Sale are subject to an existing Technical Licensing or Services Schedule, seller shall
maintain the right to continue such transaction until such Schedule expires or is terminated in accordance with the Agreement.
Form of Payment. Notwithstanding anything to the contrary,
the fees due under this Schedule may take the form of a payment in kind of equivalent value.
| Zimmer Technology Group, LLC |
Ategrity Specialty Holdings LLC |
| Signature: |
/s/ Mitchell Pressman |
|
Signature: |
/s/ Justin Cohen |
| |
|
|
|
|
| Name: |
Mitchell Pressman |
|
Name: |
Justin Cohen |
| |
|
|
|
|
| Title: |
CFO |
|
Title: |
CEO |
| |
|
|
|
|
| Date: |
3/24/2025 |
|
Date: |
3/24/2025 |
| Technology Transactions Agreement |
1 |
Confidential |
Exhibit 10.12
EXECUTION VERSION
AMENDED AND RESTATED
LIMITED PARTNERSHIP AGREEMENT
of
ZP UTILITY INSURANCE FUND, L.P.
This AMENDED AND RESTATED
LIMITED PARTNERSHIP AGREEMENT (this “Agreement”), made and entered into as of April 1, 2018, by and among ZP
Utility Insurance GP, LLC as general partner (the “General Partner”) and Limited Partners (as defined below), shall
hereafter govern ZP Utility Insurance Fund, L.P. (the “Partnership”). (The General Partner and the Persons who sign
as Limited Partners are sometimes collectively referred to herein as the “Partners”.) Whenever the masculine or feminine
gender is used in this document it shall equally, where the context admits, include the other, as well as include entities.
WHEREAS, the General Partner
wishes to amend and restate the Limited Partnership Agreement of ZP Utility Insurance Fund, L.P. (the “Initial Agreement”)
in its entirety.
NOW, THEREFORE, the parties
hereto hereby agree to continue the Partnership and hereby amend and restate the Initial Agreement, which is replaced and superseded
in its entirety by this Agreement, as follows.
Article I
General Provisions
Section 1.01 Formation.
The Partnership was formed as a limited partnership pursuant to the provisions of the Delaware Revised Uniform Limited Partnership Act,
as amended from time to time (the “Act”). The existence of the Partnership commenced upon the filing with the Secretary
of State of Delaware of a Certificate of Limited Partnership in accordance with the provisions of such law. The General Partner will
make all filings necessary for the maintenance of the Partnership under the Act.
Section 1.02 Partnership
Name. The name of the Partnership is “ZP Utility Insurance Fund, L.P.”
Section 1.03 Purpose.
The purpose of the Partnership is to serve as a fund through which the assets of its Partners will be utilized to invest, hold and trade
in securities and other financial instruments and rights and options relating thereto, and to engage in all activities and transactions
as the General Partner may deem necessary and advisable in connection therewith, including to do such acts as are necessary or advisable
in connection with the maintenance and administration of the Partnership.
Section 1.04 Registered
Office and Agent for Service of Process. The registered office of the Partnership is at 251 Little Falls Drive, Wilmington, New Castle
County, Delaware 19808 and the registered agent for service of process at such office is Corporation Service Company.
Section 1.05 Place
of Business. The principal place of business of the Partnership is at 9 W. 57th Street, 33rd Floor, New York, NY 10019 or at such
other place as the General Partner shall determine from time to time.
Section 1.06 Fiscal
Year and Fiscal Periods. The fiscal year of the Partnership shall end on December 31 of each year, subject to change by the
General Partner from time to time. A new fiscal period (“Fiscal Period”) shall commence on the first day of each fiscal
quarter, on each date of any capital contribution to the Partnership, on each date next following the date of any withdrawal of capital
or retirement from the Partnership and on any other date that the General Partner determines in its sole discretion, and the prior Fiscal
Period shall end on the date immediately preceding such date of commencement of a new Fiscal Period.
Section 1.07 Liability
of Limited Partners. Except as expressly provided in the Act, the Limited Partners shall not be liable for any liabilities, or for
the payment of any debts and obligations, of the Partnership, except for liabilities, debts or obligations of the Partnership relating
to withholding taxes imposed on the Partnership with respect to any particular Limited Partner or Limited Partners, for which a Limited
Partner may be liable pursuant to Section 11.01. “Limited Partner” means each Person admitted as a limited partner
of the Partnership in accordance with this Agreement, including any Persons hereafter admitted as Limited Partners in accordance with
this Agreement and excluding any Persons who cease to be Limited Partners in accordance with this Agreement. “Person”
means a natural Person, partnership, limited liability company, corporation, unincorporated association, joint venture, trust, state
or any other entity or any governmental agency or political subdivision thereof.
Section 1.08 Assignability
of Limited Partnership Interest. The limited partnership interest of a Limited Partner in the Partnership or any beneficial interest
therein may not be assigned, in whole or in part, except with the consent thereto of the General Partner given in its sole and absolute
discretion, other than by operation of law. In no event, however, shall any assignee be admitted as a Partner without obtaining the consent
of the General Partner and executing an instrument, in form and substance satisfactory to the General Partner, accepting and agreeing
to be bound by all terms and conditions of this Agreement. Any attempted assignment not made in accordance with this Section 1.08,
to the fullest extent permitted by law, shall be void.
Article II
Admissions
Section 2.01 Admission
of Partners; Special Limited Partners.
(a) With
the consent of the General Partner, additional Limited Partners may be admitted to the Partnership on any date selected by the General
Partner. Additional general partners may be admitted by the General Partner at any time if they are affiliated with the General Partner
or as of the beginning of any calendar quarter upon 60 days’ written notice to the Limited Partners if they are not affiliated
with the General Partner. In connection with the admission of a Partner to the Partnership, such Partner shall, in advance of such admission
and as a condition thereto, sign a copy of this Agreement, a separate signature page or a supplement hereto pursuant to which he
agrees to be bound by the terms of this Agreement.
(b) The
General Partner, in its sole discretion, may designate one or more Limited Partners as “Special Limited Partners”.
A Special Limited Partner will be eligible to be allocated a portion of the Incentive Allocation (as defined in Section 6.01) in
such amount as the General Partner shall determine. Special Limited Partners are subject to all the same terms and conditions as Limited
Partners except as otherwise specifically provided herein.
Article III
Management of Partnership
Section 3.01 Management
of the Partnership. The Partnership shall be managed by the General Partner, which shall have the discretion of making investments
on behalf of the Partnership and of exercising the powers set forth in Section 3.02. The General Partner may appoint such agents
of the Partnership as it deems necessary who shall hold such offices, exercise such powers and perform such duties as shall be determined
from time to time by the General Partner. The General Partner shall devote so much of its time and efforts to the affairs of the Partnership
as may, in its judgment, be necessary to accomplish the purposes of the Partnership. Nothing herein contained shall prevent the General
Partner, the Management Company (as defined below), their members or any of their affiliates or any other Partner from conducting any
other business, including any business within the securities industry whether or not such business is in competition with the Partnership.
Without limiting the generality of the foregoing, the General Partner, the Management Company, their members or any of their affiliates
may act as investment adviser or investment manager for others, may manage funds or capital for others, may have, make and maintain investments
in their own name or through other entities and may serve as an officer, director, consultant, partner or stockholder of one or more
investment funds, partnerships, securities firms or advisory firms. It is recognized that in effecting transactions, it may not always
be possible or consistent with the investment objectives of the various Persons or entities described above and of the Partnership to
take or liquidate the same investment positions at the same time or at the same prices.
Section 3.02 Powers
of the General Partner. The General Partner shall have the power on behalf of the Partnership:
(a) To
purchase, hold, sell, sell short and otherwise deal in securities of any sort and rights therein, on margin or otherwise;
(b) To
write, purchase, hold, sell, sell short and otherwise deal in put and call options of any sort and in any combination thereof;
(c) To
purchase, hold, sell, sell short and otherwise deal in commodities, commodity contracts, commodity futures, financial futures and options
in respect thereof (but the General Partner will not do so until, to the extent required, it has registered with the Commodity Futures
Trading Commission or filed an exemption therefrom);
(d) To
purchase, hold, sell, sell short and otherwise deal in currencies, forwards, swaps, partnership interests, interests in other investment
companies and any other financial instruments which exist now or are hereafter created;
(e) To
conduct margin accounts with brokers;
(f) To
open, maintain and close bank accounts and draw checks or other orders for the payment of moneys;
(g) To
pledge securities for loans, and, in connection with any such pledge, to effect borrowings from brokers, banks and other financial institutions;
(h) To
invest all or any portion of the Partnership’s assets in ZP Master Utility Fund, Ltd., an exempted company formed under the
laws of the Cayman Islands, or similar investment vehicles;
(i) To
enter into, make and perform any other contracts, agreements or other undertakings it may deem advisable in conducting the business of
the Partnership, including but not limited to contracts, agreements or other undertakings with Persons, firms or corporations with which
the General Partner or any other Partner is affiliated;
(j) To
retain Zimmer Partners, LP, a Delaware limited partnership, or other Persons selected by the General Partner, as the Partnership’s
management company (the “Management Company”) and to cause the Partnership to compensate the Management Company for
certain management and administrative services; provided, however, management, control and conduct of the activities of the Partnership
shall remain the responsibility of the General Partner;
(k) To
organize one or more corporations or other entities formed to hold record title, as nominee for the Partnership (whether alone or together
with other clients of the Management Company), of securities or funds of the Partnership;
(l) To
exercise all rights of the Partnership, with respect to its interests in any Person, including, without limitation, the voting of securities,
participation in arrangements with creditors, the institution and settlement or compromise of suits and administrative proceedings and
other like or similar matters;
(m) To
cause the Partnership to engage in agency, agency cross and principal transactions with affiliates to the extent permitted by applicable
securities laws;
(n) To
engage and authorize other agents to engage personnel, whether part-time or full-time, and attorneys, independent accountants or such
other Persons as the General Partner may deem necessary or advisable;
(o) To
authorize any member or other agent of the General Partner or agent or employee of the Partnership to act for, and on behalf of, the
Partnership in all matters incidental to the foregoing; and
(p) To
act for the Partnership in all other matters.
Section 3.03 Limitation
of Liability; Indemnification.
(a) The
General Partner, and the Person or Persons designated pursuant to Section 9.02, shall not be liable for any loss or cost arising
out of, or in connection with, any act or activity undertaken (or omitted to be undertaken) in fulfillment of any obligation or responsibility
under this Agreement, including any such loss sustained by reason of any investment or the sale or retention of any security or other
asset of the Partnership; provided that any Persons exculpated from liability under this Section 3.03(a) shall not be exculpated
from any liability arising from losses caused by his, her or its gross negligence or willful malfeasance.
(b) The
General Partner, its members, any employee or affiliate of the General Partner and the Person or Persons designated pursuant to Section 9.02
shall be indemnified and held harmless by the Partnership to the fullest extent legally permissible under and by virtue of the laws of
the State of Delaware, as amended from time to time, from and against any and all loss, liability and expense (including without limitation
judgments, fines, amounts paid or to be paid in settlement and reasonable attorneys fees) incurred or suffered by the General Partner,
its members, any employee or affiliate of the General Partner or such other Persons in connection with the good faith performance by
the General Partner, its members, any employee or affiliate of the General Partner or such other Persons of their responsibilities to
the Partnership; provided that any Person entitled to be indemnified under this Section 3.03(b) shall not be indemnified nor
held harmless for any loss, liability or expense resulting from his, her or its gross negligence or willful malfeasance.
(c) Notwithstanding
any of the foregoing to the contrary, the provisions of this Section 3.03 shall not be construed so as to provide for the exculpation
or indemnification of the General Partner, its members, any employee or affiliate of the General Partner or the Person or Persons designated
pursuant to Section 9.02, from any liability (including liability under U.S. securities laws which, under certain circumstances,
impose liability even on Persons that act in good faith), to the extent (but only to the extent) that such liability may not be waived,
modified or limited under applicable law, or to the extent such indemnification would be in violation of applicable law, but shall be
construed so as to effectuate the provisions of this Section 3.03 to the fullest extent permitted by law.
Article IV
Expenses of Partnership, Organizational Expenses,
Overhead Expenses and Fixed Fee
Section 4.01 Expenses
of Partnership Generally. The General Partner is authorized to incur and pay in the name and on behalf of the Partnership all expenses
which it deems necessary or advisable.
Section 4.02 Overhead
Expenses. The Management Company will be responsible for and shall pay, or cause to be paid, all “Office Overhead Expenses”
of the Partnership. “Office Overhead Expenses” shall mean certain overhead expenses of an ordinarily recurring nature
such as rent, supplies, secretarial expenses, printing and stationery, charges for furniture and fixtures, employee insurance, payroll
taxes, compensation of security analysts and other administrative personnel, and other reasonable expenses of the Partnership as determined
by the General Partner in its sole and absolute discretion. The Partnership will be responsible for all of its other expenses including
(i) the fees paid to the Management Company, administrator fees and expenses, accounting and legal expenses and costs related to
errors and omissions insurance and directors and officers insurance for the General Partner and the Management Company; (ii) investment
expenses such as commissions, research expenses, research-related travel expenses, interest on margin accounts and other indebtedness,
borrowing charges on securities sold short, custodial fees, bank service fees and other reasonable expenses related to the purchase,
sale or transmittal of Partnership assets; and (iii) telecommunications and all computer hardware and software (including modifications,
upgrades and servicing) as shall be determined by the General Partner in its sole and absolute discretion. To the extent that expenses
to be borne by the Partnership are paid by the Management Company, the Partnership shall reimburse the Management Company for such expenses.
The Partnership invests substantially all of its assets in the Master Fund, and shall, accordingly, indirectly bear its pro rata share
of any operating and other expenses incurred by the Master Fund. Such expenses, other than the Fixed Fee, shall be charged to the Capital
Accounts of all of the Partners on a pro rata basis. If any of the expenses listed above are incurred for the account of the Partnership
as well as for any other clients of the Management Company, the General Partner, their principal or their affiliates, such expenses shall
be allocated among the Partnership and such other clients in proportion to the size of the investment made by each to which such expense
relates, or in such other manner as the General Partner considers fair and equitable.
Section 4.03 Fixed
Fee. In consideration for the Management Company providing services to the Partnership, the Partnership shall pay the Management
Company a quarterly fixed fee computed at an annual rate of 2.0% (i.e., 0.5% per quarter) of the balance of each Limited Partner’s
Capital Account (the “Fixed Fee”). The Fixed Fee shall be paid quarterly in advance and shall be calculated based
on the balance of each Limited Partner’s Capital Account as of the first day of such quarter; provided, however, that any
such fee shall be reduced by the amount of any fixed fee charged to the Partnership by any investment fund in which the Partnership is
invested and which is payable to the Management Company (or an affiliate of, or a Person or entity designated by, the Management Company).
The Fixed Fee shall be prorated for periods less than a full quarter. In addition, the Management Company may, in effect, waive or reduce
the Fixed Fee to be paid by certain Limited Partners, including, but not limited to, Limited Partners that are employees of the Management
Company (or its affiliates) or relatives of such Persons or other Persons at the Management Company’s discretion. The Capital Account
of the General Partner shall not be subject to the Fixed Fee.
Article V
Capital Accounts and Capital Contributions
Section 5.01 Capital
Accounts. A Partner’s “Capital Account” as of a particular date shall consist of the following:
(a) an
amount equal to his original capital contribution;
(b) the
additions, if any, to such account by reason of capital contributions made on or before such date; and
(c) the
adjustments, if any, to such account in accordance with the provisions of Sections 4.03, 5.03 and 11.01 and Article VI.
Section 5.02 Capital
Contributions. Contributions to the capital of the Partnership shall be made in cash or, in the sole and absolute discretion of the
General Partner, in securities or partly in cash and partly in securities.
Section 5.03 Certain
Adjustments to Capital Accounts. The amount of withdrawals, if any, made by a Partner shall be deducted from such Partner’s
Capital Account as of the date of such withdrawal.
Section 5.04 Additional
Contributions to Capital. A Partner may, with the consent of the General Partner, make additional contributions to the capital of
the Partnership on any date selected by the General Partner.
Article VI
Allocation of Net Profits and Net Losses;
Determination of Net Profits and Net Losses; New Issues
Section 6.01 Allocation
of Net Profits and Net Losses.
(a) Except
as otherwise provided in Section 6.03 any Net Profits or Net Losses (as defined in Section 6.02) during any Fiscal Period shall
be allocated as of the end of such Fiscal Period to the Capital Accounts of all the Partners in the proportions which each Partner’s
Capital Account as of the beginning of such Fiscal Period bore to the sum of the Capital Accounts of all the Partners as of the beginning
of such Fiscal Period.
(b) If
in any fiscal year (“Current Year”) the Net Profits allocated to the Capital Account of a Limited Partner pursuant
to Sections 6.01(a) and 6.03 exceed the Net Losses so allocated to such Limited Partner’s Account, there shall be reallocated
to the General Partner, as of the end of the Current Year, an amount equal to 20% of such excess (the “Incentive Allocation”),
provided that this reallocation shall be subject to a loss carryforward provision (“Loss Carryforward”) such that
the Incentive Allocation for the Current Year may not exceed 20% of the excess of the Net Profits for the Current Year over the Loss
Carryforward applicable to the Current Year, and, for the avoidance of doubt, in determining the amount of the Incentive Allocation,
Net Profits shall be gross up by the amount of any amounts described in Section 11.01.
The Loss Carryforward applicable
to the Current Year shall be the sum of all prior year Net Losses allocated to the Limited Partner and not subsequently offset by prior
year Net Profits. The Loss Carryforward shall be reduced proportionately to reflect any net withdrawals made by such Limited Partner
subsequent to any such prior year Net Losses. In addition, the Incentive Allocation shall be reduced by such Limited Partner’s
share of any incentive allocation charged by any investment fund in which the Partnership is invested and which is allocated to the General
Partner or an affiliate of, or a Person or entity designated by, the General Partner.
The Incentive Allocation
shall be credited as of the end of the fiscal year to the Capital Account of the General Partner or, if so designated by the General
Partner, the Capital Account of any Special Limited Partner, in such proportions as the General Partner shall determine.
The General Partner may,
in its sole and absolute discretion, waive or reduce the Incentive Allocation charged to any Limited Partners, including, but not limited
to, Limited Partners that are employees of the General Partner (or its affiliates) or relatives of such Persons or other Persons at the
General Partner’s discretion.
(c) In
the event of the retirement of a Partner at any time other than the end of a fiscal year, the reallocation provided for in Section 6.01(b) shall
be made with respect to such Partner as though the date of retirement was the last day of a fiscal year and the amount so reallocated
shall be reallocated as of such date in the manner provided in Section 6.01(b).
Section 6.02 Determination
of Net Profits and Net Losses. “Net Profits” or “Net Losses” of the Partnership for a Fiscal Period shall
be determined on the accrual basis of accounting using generally accepted accounting principles applied in the United States as a guideline
and further in accordance with the following:
(a) Net
Profits and Net Losses shall include realized and unrealized profits and losses with respect to all securities positions. In computing
such realized and unrealized profits and losses, profit and loss shall mean, for each position held in a security during any Fiscal Period,
the realized or unrealized appreciation or realized or unrealized depreciation, as the case may be, with respect to such position, determined
by comparing the net proceeds from the closing of such position or the market value of such position at the end of such Fiscal Period
with (i) the cost of such position if established during such Fiscal Period, or (ii) if such position were established during
a prior Fiscal Period, the market value of such position at the end of the last preceding Fiscal Period. Securities contributed to the
Partnership shall be treated as if purchased by the Partnership at market value on the date of contribution and securities distributed
from the Partnership shall be treated as if sold by the Partnership at market value on the date of distribution;
(b) no
value will be assigned to goodwill;
(c) the
value of positions in securities shall be as follows: securities that are listed on national exchanges and are freely transferable shall
be valued at their last sales price on the date of determination on the exchange that constitutes the principal market or, if no sales
occurred on such day, at the “mean” of the “bid” and “ask” price on such exchange at the close of
business on such day and if sold short at the “asked” price at the close of business on such day. Securities traded over
the counter which are freely transferable shall be valued at the last sales price on the date of determination, or, if no sales occurred
on such day, at the “mean” of the “bid” and “ask” price at the close of business on such day and
if sold short at the “asked” price at the close of business on such day; and
(d) all
other assets of the Partnership will be valued in the manner determined by the General Partner to reflect their fair market value.
Section 6.03 New
Issues. In the event that the General Partner invests the Partnership’s assets in securities that are considered to be “new
issues”, as that term is defined in the Consolidated FINRA Rulebook of the Financial Industry Regulatory Authority, Inc.,
as may be amended from time to time (the “Rules”), the General Partner shall be permitted to take all such actions
as it deems are necessary to ensure that new issues are allocated among the Partners in a manner permitted under the Rules. In this regard,
the General Partner is authorized to determine, among other things: (i) the manner in which new issues are purchased, held, transferred
and sold by the Partnership and any adjustments (including interest) with respect thereto; (ii) the Partners who are eligible and
ineligible to participate in new issues; (iii) the method by which profits and losses from new issues are to be allocated among
Partners in a manner that is permitted under the Rules (including whether the Partnership will avail itself of the “de minimis”
exemption or any other exemption); and (iv) the time at which new issues are no longer considered as such under the Rules. The General
Partner shall have the right to vary its policy with respect to the allocation of appreciation and depreciation attributable to new issue
securities as it deems appropriate for the Partnership as a whole, in light of, among other things, existing interpretations of, and
amendments to, the Rules and practical considerations, including, without limitation, administrative burdens and the principles
of fairness and equity.
Article VII
Allocation of Income For Tax Purposes; Tax
Matters
Section 7.01 Ordinary
Deductions and Ordinary Income. For Federal income tax purposes, all items of deduction other than realized capital losses, and all
items of income other than realized capital gains, shall be allocated, as nearly as is practicable, in accordance with the manner in
which such items of deduction or income affected the amounts which were either deducted from or added to the Capital Accounts of the
Partners.
Section 7.02 Capital
Gains and Capital Losses on Contributed Securities. For Federal income tax purposes, capital gains and capital losses (short-term
and long-term, as the case may be) recognized by the Partnership on the disposition of securities contributed by a Partner to the capital
of the Partnership shall be allocated in accordance with the provisions of Section 704(c) of the Internal Revenue Code of 1986,
as amended (the “Code”).
Section 7.03 Other
Capital Gains and Capital Losses. Except as provided in Section 7.02, for Federal income tax purposes, capital gains and capital
losses (short-term and long-term, as the case may be) recognized in any Fiscal Period shall be allocated, as nearly as is practicable,
in accordance with the manner in which the aggregate of the increase or decrease in the value of the securities positions giving rise
to such gains or losses was added to or deducted from the Capital Accounts of the Partners in such Fiscal Period and prior Fiscal Periods.
Section 7.04 Allocation
of Capital Gains and Losses to Retiring Partners. Notwithstanding Section 7.03 above, in the event a Partner withdraws all of
his Capital Account from the Partnership, the General Partner in its sole and absolute discretion may make a special allocation to said
Partner for Federal income tax purposes of the net capital gains or losses, as the case may be, recognized by the Partnership in such
a manner as will reduce the amount of the difference, if any, between such Partner’s Liquidating Share (as defined in Section 10.01)
and his Federal income tax basis in his interest in the Partnership before such allocation.
Section 7.05 Death
of a Partner. If a Partner dies on a day other than the last day of a Fiscal Period, all items of income, gain, loss or deduction
for such Fiscal Period allocable to such Partner pursuant to this Article VII shall be allocated to such Partner for Federal income
tax purposes based on a fraction, the numerator of which shall be the number of days (including the date of death) that the Partner was
alive during such Fiscal Period, and the denominator of which shall be the total number of days in such Fiscal Period. The balance of
such items allocable to such Partner for such Fiscal Period shall be allocated to the deceased Partner’s estate. Each Partner agrees
that his legal representative, when filing any tax returns on his or his estate’s behalf, will treat this allocation as effecting
a termination of the taxable year of the Partnership for Federal income tax purposes in order to determine the deceased Partner’s
and his estate’s respective shares of such items for any applicable reporting period.
Section 7.06 Tax
Matters. In furtherance of the powers of the General Partner described under Section 3.02, the General Partner shall have the power
on behalf of the Partnership to make all elections not otherwise expressly provided for in this Agreement required or permitted to be
made by the Partnership under the Code and any state, local or non-U.S. tax laws (including, but not limited to, making an election under
Section 475(f) of the Code or Section 6226 of Subchapter C of Chapter 63 of the Code (§§6221 through 6241 of
the Code), as enacted by the Bipartisan Budget Act of 2015, Pub. L. No. 114-74, as hereafter amended (the “BBA”).
The General Partner, or a delegate appointed by the General Partner, shall act (x) as the “tax matters partner,” within
the meaning of Section 6231(a)(7) of the Code, and, (y) for any taxable year commencing after 2017, taking into account
any extensions of the effective date set forth in Section 1101(g)(1) of the BBA, as applicable, or in any other BBA guidance,
as the “partnership representative” within the meaning of Section 6223 of the Code (such taxable year, the “BBA
Effective Period”, and the status referred to under (x) or (y), as applicable, the “Tax Matters Partner”),
or, in each case, under any similar state or local law. The Tax Matters Partner shall have any powers necessary to perform fully in such
capacity, and shall be permitted to take any and all actions, to the extent permitted by law, in consultation with the General Partner
if the General Partner is not the Tax Matters Partner. The Tax Matters Partner shall be reimbursed by the Partnership for all costs and
expenses incurred by it, and indemnified by the Partnership with respect to any action brought against it, in its capacity as the Tax
Matters Partner. The Limited Partners agree that any and all actions taken by the Tax Matters Partner shall be binding on the Partnership
and all of the Limited Partners, and the Limited Partners shall reasonably cooperate with the Partnership and the General Partner, and
undertake any action reasonably requested by the Partnership or the General Partner, in connection with any elections made by the Tax
Matters Partner or as determined to be reasonably necessary by the Tax Matters Partner under any BBA provision. Each Limited Partner
shall reasonably cooperate with the General Partner in connection with any tax audit of the Partnership, or any existing or former Investment
and agrees to not independently act with respect to tax audits or tax litigation affecting the Partnership, unless the prior written
consent of the General Partner has been obtained.
Article VIII
Withdrawals from Capital Accounts and Retirements
Section 8.01 Permissible
Withdrawals. A Partner may withdraw all or any part of his Capital Account in the manner and to the extent provided in Section 8.02.
Section 8.02 Withdrawal
Procedure.
(a) Upon
written notice, which notice must be received by the Investment Manager at least 45 days prior to the withdrawal date, a Limited Partner
may withdraw all or a portion of its Capital Account at the end of each calendar quarter:
(i) to
the extent required to pay insurance claims, but only to the extent other funds of the applicable Limited Partner are not available for
such purpose; provided that a liquidity buffer of an amount as may be mutually agreed between the Investment Manager and the applicable
Limited Partner shall not be considered as funds otherwise available for such purpose;
(ii) to
the extent required to pay for reasonable operating expenses as may be determined
by the Board of Directors of the applicable Limited Partner but only to the extent other funds of such Limited Partner are not available
for such purpose; or
(iii) in
the event (x) a Limited Partner receives a notification from A.M. Best that such withdrawal is required to maintain such Limited
Partner’s financial strength rating of at least A-, or (y) a Limited Partner is required to diversify its assets pursuant
to any law, order or regulation proposed or promulgated by any Governmental Authority.
(b) Written
notice of withdrawal must set forth (i) such Limited Partner’s intention to make such withdrawal and (ii) the amount
thereof or the basis on which the amount thereof is to be determined. The General Partner, in its sole discretion, may waive or modify
any terms related to withdrawals for any Limited Partner, including, but not limited to, Limited Partners that are employees of the General
Partner (or its affiliates) or relatives of such Persons or other Persons at the General Partner’s discretion.
(c) The
General Partner may withdraw all or a portion of its Capital Account at any time. Notwithstanding the foregoing, the General Partner
shall at all times maintain its Capital Account in an amount equal to at least the lesser of 1% of the aggregate Capital Accounts of
the Partnership and $500,000. A Partner withdrawing his entire Capital Account pursuant to this Section 8.02 shall be deemed to
have retired as of the date of such withdrawal.
Section 8.03 Payment
on Retirement. Retirement of a Partner, whether by (a) withdrawal of such Partner’s entire Capital Account, or (b) action
of the General Partner under Section 8.04, shall be subject to the provisions of Article X.
Section 8.04 Mandatory
Retirement of a Limited Partner. The General Partner, in its sole and absolute discretion, may require any Limited Partner to retire
from the Partnership at any time on not less than 20 days’ notice, such retirement to be effective on the date specified in such
notice. If the General Partner, in its sole and absolute discretion, deems it to be in the best interests of the Partnership to do so
because the continued participation of any Limited Partner in the Partnership might cause the Partnership to violate any law, rule or
regulation or expose the Partnership to litigation, arbitration, administrative proceedings or any similar action or proceeding, the
General Partner may require such Limited Partner to retire from the Partnership at any time on not less than 5 days’ notice, such
retirement to be effective on the date specified in such notice. A Limited Partner who is so required to retire pursuant to this Section 8.04
shall be entitled to receive the value of his Liquidating Share (as defined in Section 10.01) computed as of the date on which such
Limited Partner’s retirement shall become effective.
Section 8.05 Death,
Bankruptcy, or Incapacity of a Limited Partner. In the event the beneficial interest of a Limited Partner passes to his estate or
another Person by reason of his death, bankruptcy or incapacity, the General Partner may, in its discretion and with the consent of the
estate or the Person or Persons to whom such interest passed, admit the estate or such Person as a Limited Partner to the Partnership
as a successor to the deceased, bankrupt or incapacitated Limited Partner. Except as otherwise provided in the preceding sentence, the
deceased, bankrupt or incapacitated Limited Partner shall be deemed to have elected to withdraw all of his Capital Account as of the
last day of the calendar year in which the General Partner has been informed of the death, bankruptcy or incapacity of such Limited Partner.
Article IX
Term and Dissolution of Partnership
Section 9.01 Term
of Partnership. The term of the Partnership commenced upon the filing of the Certificate of Limited Partnership in the office of
the Secretary of State of the State of Delaware and shall continue until dissolved pursuant to Section 9.02. The legal existence
of the Partnership as a separate legal entity shall continue until the cancellation of the Certificate of Limited Partnership.
Section 9.02 Dissolution
of Partnership. The Partnership may be dissolved at any time by the General Partner, and thereupon the affairs of the Partnership
shall be promptly wound up by the General Partner. The retirement, dissolution or bankruptcy of the General Partner shall dissolve the
Partnership, unless at such time there is another general partner who agrees to continue the business of the Partnership. If there is
no remaining general partner who agrees to continue the business of the Partnership, the affairs of the Partnership shall be promptly
wound up. In the event of the dissolution of the Partnership, (a) the General Partner, or (b) if the General Partner is unavailable,
the Person (or Persons) previously designated by the General Partner or (c) if the General Partner has made no such designation,
the Person (or Persons) designated by Limited Partners owning a majority in interest of the Capital Accounts of all the Limited Partners,
shall wind up the affairs of the Partnership. Such Person shall take all steps necessary or appropriate to wind up the affairs of the
Partnership as promptly as practicable thereafter. Such Person is hereinafter referred to as the “Liquidator.” Neither the
admission of Partners nor the retirement of a Limited Partner shall dissolve the Partnership.
Section 9.03 Procedure
on Winding Up.
(a) Upon
the winding up of the Partnership, a full account of the assets and liabilities of the Partnership shall be taken and the assets of the
Partnership shall be liquidated to the extent determined by the General Partner (or the Liquidator) and, as promptly as practicable,
the cash proceeds thereof shall be applied in the following order of priority:
(i) to
the payment of all debts, taxes, obligations and liabilities of the Partnership including the expenses of liquidation; provided that
the General Partner (or the Liquidator) may establish reserves for contingent liabilities of the Partnership in an amount (including
estimated expenses, if any, in connection therewith) determined by the General Partner (or the Liquidator) and upon the satisfaction
of such contingent liabilities the amounts, if any, remaining in such reserves shall be distributed as provided in subparagraphs (i) and
(ii) of this Section 9.03(a); and
(ii) to
the payment to Partners of their remaining Capital Accounts in proportion to the amounts thereof.
(b) Distributions
to a Partner pursuant to Section 9.03(a)(ii) may be made in installments and shall be made in cash or, in the discretion of
the General Partner (or the Liquidator), in securities selected by the General Partner (or the Liquidator), or partly in cash and partly
in securities selected by the General Partner (or the Liquidator).
(c) Upon
the winding up of the Partnership, the name of the Partnership and its goodwill shall not be appraised, sold or otherwise liquidated
but shall remain the exclusive property of the General Partner.
(d) Within
90 days after the completion of the winding up of the Partnership, the General Partner (or the Liquidator) shall cause to be prepared
and forwarded to each Partner a final statement and report of the Partnership.
Article X
Payments to and by a Person
Who Has Ceased to be a Partner
Section 10.01 Payments
on Retirement, Death, Bankruptcy or Incapacity of any Partner. Within 30 days after (a) the date of retirement of a Partner
hereunder or (b) in the discretion of the General Partner, the last day of the fiscal year during which a Partner died or became
bankrupt or incapacitated, there shall be paid or distributed to such Partner or to the legal representative of such Partner an amount
in cash or, as determined by the General Partner, in securities selected by the General Partner or in cash and securities selected by
the General Partner, equal in value to not less than 90% of the estimated amount of the Liquidating Share (as hereinafter defined) of
such Partner. Promptly after the General Partner has determined the Capital Accounts of the Partners as of such date (which in the General
Partner’s discretion may be after the Partnership’s independent public accountants have completed their examination thereof
required by Section 11.03), the Partnership shall pay to such Partner or his representative, in cash and/or securities selected
by the General Partner, the amount of the excess, if any, of the Liquidating Share of such Partner over the amount previously paid, or
such Partner or representative shall return and pay to the Partnership in cash the amount of the excess, if any, of the amount so paid
over such Liquidating Share, in each case together with interest thereon, to the extent permitted by applicable law, from the applicable
date referred to in clauses (a) and (b) above to the date of the payment at an annual rate equal to the Federal Funds rate,
less 75 basis points. The term “Liquidating Share”, when used with respect to any retiring, deceased, bankrupt, or
incapacitated Partner, shall mean the Capital Account of such Partner on the date in question.
Section 10.02 Reserve
for Liabilities. The right of any retired, deceased, bankrupt, or incapacitated Partner (or their legal representative) to have distributed
the Liquidating Share of such Partner shall in all instances be subject to retention by the Partnership of a reserve, in such amount
as shall be determined by the General Partner, in its sole and absolute discretion, for Partnership liabilities and for other contingencies.
Upon determination by the General Partner that such reserve (or portion thereof) is no longer required there shall be distributed to
such Partner his proportionate share of the reserve which is no longer required together with interest thereon at an annual rate equal
to the Federal Funds rate, less 75 basis points.
Article XI
Miscellaneous Provisions
Section 11.01 Withholding
Taxes. Any taxes, fees or other charges (including under the BBA) the Partnership is required to withhold or pay under applicable
law with respect to any Partner shall be paid by the Partnership to the appropriate governmental authorities and shall be deducted from
the Capital Account of such Partner as of the last day of the Fiscal Period or fiscal year with respect to which such amount is required
to be withheld or paid, and any amount in excess of the Capital Account of such Partner shall be treated as a loan payable in full on
demand by the General Partner. The foregoing provision shall apply, mutatis mutandis, to any taxes, fees or other charges (including
under the BBA) that are borne economically by the Partnership but which are not required to be withheld or paid by the Partnership.
Section 11.02 Maintaining
Books of Account. Proper and complete books of account shall be kept at all times and shall be open to inspection by any Partner
or their accredited representative at reasonable times during office hours.
Section 11.03 Audit
of Books. The books of account and records of the Partnership shall be audited as of the end of each fiscal year by independent certified
public accountants designated from time to time by the General Partner.
Section 11.04 Reports
to Partners. The Partnership shall furnish to the Partners unaudited reports of the performance of the Partnership promptly after
the end of each fiscal quarter and the financial statements of the Partnership audited by the Partnership’s independent certified
public accountants promptly after the end of each fiscal year. In addition, as promptly as practicable after the end of each fiscal year,
the Partnership shall send to each Partner a report indicating the amounts representing such Partner’s respective share of net
long-term capital gain or loss, net short-term capital gain or loss and operating profit or loss for purposes of reporting such amounts
for Federal income tax purposes.
Section 11.05 Amendment
of Agreement. This Agreement may be amended by the General Partner in any manner that does not adversely affect any Limited Partner.
This Agreement may also be amended by the General Partner with the consent of the Limited Partners (which may be in the form of a negative
consent) owning a majority in interest of the Capital Accounts owned by the Limited Partners at the time of the amendment, provided that
such amendment does not discriminate among the Limited Partners. The Partnership may obtain the consent of a majority in interest of
the Capital Accounts of all the Limited Partners by providing each Limited Partner with notice of a proposed amendment to the Partnership
Agreement and specifying that if a Limited Partner does not respond within the relevant time frame as set forth in the notice, such Limited
Partner will be deemed to have consented to the proposed amendment.
Section 11.06 Non-Voting
Interests of BHC Limited Partners.
(a) The
portion of any interests held for their own account by any Limited Partner that is, or is a company that controls, is controlled by,
or is under common control with, a bank holding company (as defined in Section 2(a) of the Bank Holding Company Act of 1956,
as amended (the “BHCA”)) that is subject to the provisions of Regulation Y issued by the Board of Governors of the
Federal Reserve System, (unless such Limited Partner has requested, and the General Partner agrees, that the Limited Partner not be treated
as a BHC Limited Partner) (a “BHC Limited Partner”) whose interests in the Partnership are determined, at any time,
to be in excess of 4.99% (or such greater or lesser percentage as may be permitted or required under Section 4(c)(6) of the
BHCA) of the total outstanding aggregate voting interests of all Limited Partners, excluding any other interests in the Partnership that
are non-voting interests in the Partnership, the holder of which is not entitled to vote, grant consent or withhold consent with respect
to any Partnership matter, except as otherwise expressly provided in this Agreement or in another agreement between the General Partner
and such Limited Partner pursuant to this Section 11.06, shall be deemed to be “Non-Voting Interests” to the
extent of such excess above 4.99% (whether or not subsequently transferred, in whole or in part, to any other Person); provided, that
such Non-Voting Interests shall be permitted to vote (i) on any proposal to dissolve or continue the business of the Partnership,
and (ii) on matters with respect to which voting rights are not considered to be "voting securities" under 12 C.F.R. 8
225.2(q)(2), including such matters which may "significantly and adversely" affect a BHC Limited Partner (such as amendments
to this Agreement or modifications of the terms of its interest). To the extent permitted by the BHCA, and except as otherwise provided
in this Section 11.05 and Section 11.06, Non-Voting Interests shall not be counted as interests in the Partnership held by
any Limited Partner for purposes of determining whether any vote or consent required by this Agreement has been approved or given by
the requisite percentage of the Limited Partners.
(b) A
BHC Limited Partner shall be permitted to vote on the selection of any successor general partner only to the extent of its voting interests
in the Partnership, and each BHC Limited Partner irrevocably waives its right to vote its Non-Voting Interest on the selection of a successor
general partner under the Act, which waiver shall be binding upon such BHC Limited Partner or any Person that succeeds to its interests
in the Partnership.
(c) Notwithstanding
the foregoing, any BHC Limited Partner may elect to no longer be treated as a BHC Limited Partner
for purposes of this Agreement by delivering written notice of such election to the General Partner. Any such election made by a
BHC Limited Partner may be rescinded at any time by providing written notice thereof to the General Partner.
(d) Except
as provided in this Section 11.06, an interest held by a Limited Partner as a Non-Voting Interest shall be identical in all regards
to all other interests in the Partnership held by Limited Partners.
Section 11.07 Non-Voting
Interests of Registered Fund Limited Partners.
An
interest in the Partnership owned by a Limited Partner that is an investment fund registered as
an investment company under the Investment Company Act of 1940, as amended (the “Company Act”) (a “Registered
Fund Limited Partner”), or by an affiliate (as such term is defined under the Company Act) of a Registered Fund Limited Partner,
or by a Person controlling, controlled by or under common control with a Registered Fund Limited Partner, shall be a Non-Voting Interest;
provided, however, that such Non-Voting Interest shall be permitted to vote on matters with respect to which voting rights are not considered
to be "voting securities" as defined under Section 2(a)(42) of the Company Act.
(a) Except
as provided in this Section 11.07, an interest held by a Registered Fund Limited Partner as a Non-Voting Interest shall be identical
in all regards to all other interests in the Partnership held by Limited Partners.
Section 11.08 Notices.
All notices provided for under this Agreement shall be in writing and shall be deemed to have been duly given as indicated if sent to
the Partner’s address as set forth in the schedule in the files of the Partnership as of the date of such notice:
(i) if
delivered in Person or by courier, on the date it is delivered;
(ii) if
sent by certified or registered mail (airmail, if overseas) or the equivalent (return receipt requested), on the date delivered or delivery
is attempted;
(iii) if
sent by first-class mail, on the date of postmark; and
(iv) if
sent by facsimile, on generation of confirmation.
Notice by any Limited Partner
to the Partnership shall be deemed effective upon receipt by the Partnership.
A Partner may change his
or its address for purposes of this Agreement upon 5 days’ prior written notice to the General Partner.
Section 11.09 Binding
Effect of Agreement. This Agreement shall be binding on the successors, assigns and the legal representatives of each of the Partners.
Section 11.10 Counterparts.
This Agreement may be executed in more than one counterpart with the same effect as if the Partners executing the several counterparts
had all executed one document.
Section 11.11 Entire
Agreement. This Agreement, each subscription agreement and, with reference to a Limited Partner that has entered into another agreement
with the General Partner, such other Agreement, supersede any and all existing agreements, oral or written, between or among the Partnership,
the General Partner and the Limited Partners, with respect to the Partnership.
Section 11.12 Choice
of Law. The parties expressly agree that this Agreement and all of its terms and provisions shall be governed by and construed under
the laws of the State of Delaware applicable to contracts made and to be entirely performed in such state and, without limitation thereof,
that the Act as now adopted or as may be hereafter amended shall govern all partnership aspects of this Agreement.
Section 11.13 Severability.
If any provision of this Agreement is invalid or unenforceable under any applicable law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed modified to conform with such applicable law. Any provision hereof which
may be held invalid or unenforceable under any applicable law shall not affect the validity or enforceability of any other provisions
hereof, and to this extent the provisions hereof shall be severable.
Section 11.14 Forum.
To the fullest extent permitted by law, in the event of any legal action or proceeding arising out of the terms and conditions of this
Agreement, the parties hereto irrevocably (i) consent and submit to the exclusive jurisdiction of the Supreme Court, State of New
York, New York County and of the U.S. District Court for the Southern District of New York, (ii) waive any defense based on doctrines
of venue or forum non conveniens, or similar rules or doctrines, and (iii) agree that all claims in respect of such a legal
action or proceeding must be heard and determined exclusively in the Supreme Court, State of New York, New York County or the U.S. District
Court for the Southern District of New York. Process in any such legal action or proceeding may be served on any party anywhere in the
world, whether within or without the jurisdiction of any such court.
Section 11.15 Successors
and Assigns. This Agreement shall inure to the benefit of each Partner and the executors, administrators, estates, heirs, legal successors
and representatives of such Partner.
Section 11.16 No
Waiver. The failure of a party to insist upon strict adherence to any term or provision of this Agreement on any occasion shall not
be considered a waiver thereof or deprive that party of the right thereafter to insist upon strict adherence to that term or provision
or any other term or provision of this Agreement.
Section 11.17 No
Third-Party Rights. Except for the provisions of Sections 3.03, the provisions of this Agreement are not intended to be for the benefit
of any creditor or other Person (other than the Partners in their capacities as such) to which any debts, liabilities or obligations
are owed by (or who otherwise have a claim against or dealings with) the Partnership or any Partner, and, to the fullest extent permitted
by law, no such creditor or other Person shall obtain any rights under any of such provisions (whether as a third-party beneficiary or
otherwise) or shall by reason of any such provisions have a right to make any claim in respect to any debt, liability or obligation (or
otherwise) including any debt, liability or obligation against the Partnership or any Partner.
IN WITNESS WHEREOF, the undersigned
has hereunto signed this Agreement on the date set forth below.
| |
General Partner |
| |
|
| |
ZP Utility INSURANCE GP, LLC |
| |
|
| |
By: |
/s/ Stuart J. Zimmer |
| |
|
Name: |
Stuart J. Zimmer |
| |
|
Title: |
Managing Member |
| |
|
| |
LIMITED PARTNERS |
| |
|
| |
By: ZP Utility Insurance GP, LLC, as attorney-in-fact on behalf of the Limited Partners |
| |
|
| |
By: |
/s/ Stuart J. Zimmer |
| |
|
Name: |
Stuart J. Zimmer |
| |
|
Title: Managing Member |
Exhibit 10.13
AMENDED
AND RESTATED Investment Management Agreement
(Zimmer Partners, LP)
This amended and restated
investment management agreement (this “Agreement”) is made and entered into effective as of October 01, 2024
(the “Effective Date”), by and between Zimmer Partners, LP, a Delaware limited partnership (the “Manager”),
and Ategrity Specialty Insurance Limited, a Bermuda company (the “Client”).
RECITALS
WHEREAS, the Client and the
Manager entered into an investment management agreement, dated January 1, 2024 (the “Investment Management Agreement”);
and
WHEREAS, the Client and the
Manager desire to amend the Investment Management Agreement as set forth herein.
NOW, THEREFORE, in consideration
of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Client and the Manager hereby agree to amend and restate the Investment Management Agreement, which
is replaced and superseded in its entirety by this Agreement, as follows:
AGREEMENT
1. The
Account. The cash, securities and other assets placed by Client in the account to be managed under this Agreement (the “Account”)
are set forth below.
| Trust
Bank |
Trust
Account Name: |
Custodian
Account Number: |
| Computer
Share |
Sequentis
Reinsurance Company Limited (For the benefit of Ategrity Specialty Insurance Company) |
*9500 |
Assets may be added by the Client to the Account
at any time. Client will provide notification to the Manager of any such additions. The Account will include these assets and any changes
in them resulting from transactions directed by Manager, withdrawals and additions made by Client, or dividends, interest, stock splits
and other earnings, gains or losses on the assets.
2. Appointment
of Manager. The Client hereby appoints the Manager as the investment manager with respect to the Account and all assets in
the Account. The Manager has the full and exclusive authority and discretion to effect investment transactions through the Account, for
the account and risk of the Client, in accordance with the provisions of this Agreement. Notwithstanding the foregoing, except at the
Client’s instruction, the Manager does not have the power and is not authorized to withdraw any cash, securities or other assets
from the Account (other than, for the avoidance of doubt, to effect investment transactions through and for the Account or otherwise
at the instruction of the Client). As agent and attorney-in-fact for the Client, the Manager is authorized to exercise all voting and
other rights and privileges associated with the ownership of any Account positions in accordance with the Manager’s proxy voting
policies and procedures. Subject to the investment guidelines set out in Schedule B attached hereto (the “Investment
Guidelines”), the Manager’s investment strategy with respect to the Account is within the discretion of the Manager.
Client may change these Investment Guidelines at any time, but Manager will be bound by the changes only after it has received and agreed
to them in writing. In the event that the Account ceases to conform to the Investment Guidelines as a result of market values, maturities,
amortization rates, credit ratings, or other characteristics of the securities within the portfolio, Manager will not be required to
take immediate action to bring the portfolio back into compliance with the Investment Guidelines, but will (a) inform Client of
the non-compliance within 30 days; (b) offer Client the opportunity to consult on the non-conformance and (c) use its discretion
to return the portfolio to conformity over time with a minimum disruption to the portfolio.
3. Withdrawals.
Upon five (5) business days’ prior written notice to the Manager, the Client may withdraw all or a portion of the
Account (each a “Withdrawal Date”):
(i) to
the extent required by the Client or its affiliates to pay insurance claims;
(ii) to
the extent required by the Client or its affiliates to pay for reasonable operating expenses as may be determined by the Board
of Directors of the Client; or
(iii) in
the event the Client or any of its affiliates (x) receives a notification from A.M. Best that such withdrawal is required to
maintain the financial strength rating of at least A- of the Client or its affiliate, as applicable, or (y) is required to diversify
its assets pursuant to any law, order or regulation proposed or promulgated by any Governmental Authority.
The Manager shall use its commercially
reasonable efforts to dispose of positions, and to pay withdrawal proceeds, as soon as reasonably practicable following any Withdrawal
Date in respect of which a withdrawal request is made.
4. Brokers
and Other Agents. The Manager’s authority includes the discretion to select brokers, dealers and other intermediaries
or agents (“Brokers”) for the execution of Account transactions and to negotiate commission rates and other transaction
terms. The Client understands that in the selecting, and negotiating transaction terms with, Brokers, the Manager may take into account
considerations other than the cost of the services, including, but not limited to, the quality of research or other services and products
made available to the Manager (even if such research or other services and products are not for the exclusive benefit of the Account).
5. Soft
Dollars. Subject to the Manager’s obligation to obtain best execution, the Manager is authorized to pay, or authorize the payment
and reimbursement of, brokerage commissions which may be in excess of the lowest rates available and which are paid to Brokers who execute
transactions for the Account and who supply or pay for the cost of research and execution services in accordance with the provisions
of Section 28(e) of the Securities Exchange Act of 1934, as amended (the “Safe Harbor”), as interpreted
by the Securities and Exchange Commission (“SEC”). The Manager shall not knowingly use any “soft dollars”
generated by the Account for purposes outside of the Safe Harbor without the consent of the Client in each instance.
6. Fees
and Expenses. The Manager is entitled to fees, and the Account will bear expenses, in accordance with Schedule A attached
hereto.
7. Other
Activities of the Manager. This Agreement does not restrict in any way the ability of the Manager and its affiliates to engage
in any other business or investment activities. It is understood that the Manager and its affiliates effect investment transactions for
their own account and for the accounts of other clients. The Manager may give advice or take action with respect to such other entities
or accounts that differs from the advice given with respect to the Account. To the extent a particular investment is suitable for
both the Account and the other clients, such investments will be allocated between the Account and the other clients in a manner which
the Investment Manager determines is fair and equitable under the circumstances to all clients, including the Account. Situations
may occur where the Account could be disadvantaged because of the investment activities conducted by the Manager for other clients due,
among other things, to the limited availability of an opportunity or the market impact of orders for multiple accounts. From the standpoint
of the Account, simultaneous identical portfolio transactions for the Account and the other clients may tend to decrease the prices received,
and increase the prices required to be paid, by the Account for its portfolio sales and purchases. Where less than the maximum
desired number of shares of a particular security, loans or other products to be purchased is available at a favorable price, the shares,
loans or other products purchased will be allocated among the Account and the other clients in an equitable manner as determined by the
Manager.
8. Confidentiality.
The Client acknowledges that the investment methods employed by the Manager are proprietary and that investment recommendations and
positions provided hereunder by the Manager are for the exclusive use of the Client. The Client agrees not to disclose or make use of
in any manner any of the Manager’s investments to any third party without the Manager’s prior written consent. The Client
agrees to treat all such communication related to the Account as confidential. In addition, the Client represents and warrants to the
Manager that neither it nor any third party will analyze the Manager’s investments transacted on behalf of the Client in a manner
which would allow the Client or any third party directly or indirectly to attempt to reverse engineer, reverse compile, decompile, disassemble
or derive the composition of the Manager’s investment system. The provisions of this Section 8 will survive the termination
of this Agreement.
9. Term
and Termination. This Agreement will continue in effect for a period commencing on the date first written above and ending
on December 31, 2027 (the
“Initial Term”), subject to automatic renewal for additional successive three year periods, and may be terminated by any
party hereto, without penalty, upon sixty (60) days’ prior written notice to the end of the Initial Term or the end of any automatic
renewal term. Termination will not affect the settlement of any transactions pending at the termination date.
10. Representations
and Warranties. The Client represents and warrants to the Manager and agrees with the Manager as follows:
(a) The
Client has the requisite legal capacity and authority to execute, deliver and perform its obligations under this Agreement. This Agreement
has been duly authorized, executed and delivered by the Client and is the legal, valid and binding agreement of the Client, enforceable
against the Client in accordance with its terms. The Client’s execution of this Agreement and the performance of its obligations
hereunder do not conflict with or violate any provisions of the governing documents (if any) of the Client or any obligations by which
the Client is bound, whether arising by contract, operation of law or otherwise.
(b) The
custody of all Account assets will be maintained with a “qualified custodian” (as that term is defined in the U.S. Investment
Advisers Act of 1940) selected pursuant to Section 1 (the “Custodian”). The Client further hereby represents
and warrants that the Custodian sends account statements to the Client (or the Client’s independent representative, if so designated
by the Client) at least monthly identifying all assets, including the amount of funds and each security, and all transactions, including
all Management Fees paid to the Manager, in the Account for the relevant period. The Client will cause the Custodian to simultaneously
deliver a copy of each such account statement to the Manager. The Client will be solely responsible for paying all fees and charges of
the Custodian. The Client understands and agrees that (i) neither the Manager nor any “related person” (as that term
is defined in the U.S. Investment Advisers Act of 1940) of the Manager will serve as the Custodian for the Account, (ii) the Manager
will not be liable for any act or omission of the Custodian, and (iii) the Manager will be entitled to rely on any information provided
by the Custodian or any other agent of the Client. The Client will promptly notify the Manager if any of the representations and warranties
in this Section 10(b) becomes inaccurate in any respect.
(c) The
Client has received and reviewed a copy of Parts 2A and 2B of the Manager’s Form ADV and Privacy Notice prior to the date
of this Agreement.
(d) The
Client is the owner of all cash, securities and other assets in the Account and there are no restrictions on the pledge, hypothecation,
transfer, sale or public distribution of such cash, securities or other assets.
(e) The
investment program contemplated by this Agreement is prudent in light of the Client’s overall investment portfolio and the Client
is experienced in the engagement of investment advisers and is aware of the risks associated with such engagements, including the risk
that the Account could suffer substantial diminution in value.
(f) The
assets in the Account do not contravene applicable anti-money laundering laws and regulations, are not derived from illegal or illegitimate
activities and neither the Client nor any of its investors (if applicable) are a prohibited entity or person listed on the web site of
the U.S. Treasury Department’s Office of Foreign Assets Control and do not have any affiliation of any kind with such an entity
or person. The Client will provide to the Manager all such information and documents that are required pursuant to any anti-money laundering
or “Know Your Client” requirements applicable to the Manager.
(g) The
assets of the Account do not, and will not, constitute “plan assets” for purposes of the U.S. Employee Retirement Income
Security Act of 1974, as amended, or Section 4975 of the U.S. Internal Revenue Code of 1986, as amended.
(h) The
representations and warranties in this Section 10 will continue during the term of this Agreement, and if any time any event
occurs that makes or tends to make any of the foregoing incomplete or inaccurate, the Client will promptly notify the Manager of the
occurrence of such event in writing.
11. Risk
Acknowledgement. The Manager does not guarantee the future performance of the Account or any specific level of investment
performance, the success of any investment decision or strategy that the Manager may use, or the success of the Manager’s overall
management of the Account. The Client understands that investment decisions made for the Account by the Manager are subject to various
market, economic, political and business risks, and that those investment decisions may not always be profitable. The Manager cannot
and does not imply or guarantee that the Client will make a profit and it is agreed that the Manager will not be held responsible for
losses with respect to the Account.
12. Standard
of Liability; Indemnification.
(a) The
Manager or any of its principal, partners, employees and affiliates (such persons, the “Manager Indemnitees”) shall
not be liable for any loss or cost arising out of, or in connection with, any act or activity undertaken (or omitted to be undertaken)
in good faith in fulfillment of any obligation or responsibility under this Agreement, including any such loss sustained by reason of
any investment or the sale or retention of any security or other asset of the Account; provided that any Manager Indemnitees exculpated
from liability under this Section 12 shall not be exculpated from any liability arising from losses caused by his, her or
its gross negligence or willful malfeasance.
(b) The
Manager Indemnitees shall be indemnified and held harmless by the Client to the fullest extent legally permissible, from and against
any and all loss, liability and expense (including without limitation judgments, fines, amounts paid or to be paid in settlement and
reasonable attorneys fees) incurred or suffered by the Indemnitees in connection with the good faith performance by the Indemnitees of
their responsibilities under this Agreement; provided that any Indemnitee entitled to be indemnified under this Section 12(b) shall
not be indemnified nor held harmless for any loss, liability or expense resulting from his, her or its reckless disregard of its obligations
and duties pursuant to this Agreement, gross negligence, or willful malfeasance.
(c) The
Client and its principal, partners, employees and affiliates (such persons, the “Client Indemnitees”) shall be indemnified
and held harmless by the Manager from and against any and all loss, liability and expense (including without limitation judgments, fines,
amounts paid or to be paid in settlement and reasonable attorneys’ fees) incurred or suffered by the Client Indemnitees as a direct
result of the Manager’s gross negligence or willful malfeasance, or for Manager’s reckless disregard of its obligations and
duties pursuant to this Agreement.
(d) Notwithstanding
any of the foregoing to the contrary, the provisions of this Section 12 shall not be construed so as to provide for the exculpation
or indemnification of the Indemnitees, from any liability (including liability under U.S. securities laws which, under certain circumstances,
impose liability even on persons that act in good faith), to the extent (but only to the extent) that such liability may not be waived,
modified or limited under applicable law, or to the extent such indemnification would be in violation of applicable law, but shall be
construed so as to effectuate the provisions of this Section 12 to the fullest extent permitted by law.
(e) Manager
will not be responsible for the Client’s own compliance with the insurance investment laws of the Client’s state of domicile
or for the Client’s compliance with applicable tax laws.
(f) The
provisions of this Section 12 will survive the termination of this Agreement.
13. Further
Information. The Client will furnish to the Manager all information, authorizations and documentation as the Manager may from
time to time require to enable the Manager to carry out its obligations under this Agreement or as required by applicable law.
14. Change
in Control. The Manager will notify the Client in writing within 30 days after any change in control of the ownership of the
Manager.
15. Successors.
This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and permitted assigns.
16. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder will be in writing and will be deemed
to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if
sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by electronic transmission if sent during
normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient; or (d) on
the 3rd day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must
be sent to the respective parties at the following addresses:
| If
to the Client |
Ategrity Specialty
Insurance Limited |
| |
9 West 57th Street,
33rd Floor |
| |
New York, New York 10019 |
| |
Attn: Eric Crespolini |
| |
E-mail: legal@ategrity.com |
| |
|
| If to the
Manager: |
Zimmer Partners, LP |
| |
9 West 57th Street,
33rd Floor |
| |
New York, New York 10019 |
| |
Attn: Barbara Burger |
| |
E-mail: legal@zimmerpartners.com |
17. Entire
Agreement. This Agreement contains the entire understanding and agreement of the Manager and the Client concerning the subject
matter of this Agreement.
18. Waiver
of Breach. The waiver by any party of a breach of any provision of this Agreement will not operate or be construed as a waiver
of any subsequent breach by any party. The failure of a party to insist upon strict adherence to any provision of the Agreement will
not constitute a waiver or thereafter deprive such party of the right to insist upon strict adherence.
19. Not
for Benefit of Third Parties. The provisions of this Agreement are intended only for the regulation of relations between the
Manager and the Client. This Agreement is not intended for the benefit of third parties, and no rights are granted to third parties under
this Agreement.
20. Amendment
and Assignment. This Agreement may not be amended except in writing signed by both the Manager and the Client. This Agreement
may not be assigned by either party hereto without the prior written consent of the other party.
21. Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together
will constitute one and the same instrument. Signatures on this Agreement may be communicated via email of PDF copies and will be binding
upon the parties so transmitting their signatures.
22. Governing
Law. This Agreement is, and the rights of the parties hereto are, governed by and will be construed in accordance with the
laws of the State of New York, without regard to the conflict of laws rule thereof that would result in the application of the laws
of a different jurisdiction.
23. Severability.
If any provision of this Agreement is or becomes inconsistent with any law or rule of any governmental or regulatory
body having jurisdiction over the subject matter of this Agreement, that provision will be deemed to be rescinded or modified in accordance
with any such law or rule and, in all other respects, this Agreement will remain in full force and effect.
24. Headings.
Headings to sections in this Agreement are for convenience only and will not affect the construction, meaning or interpretation
of this Agreement.
[Signature Page Follows]
The Parties have executed
this Agreement as of the Effective Date.
| |
MANAGER |
| |
|
| |
Zimmer
Partners, LP, |
| |
a Delaware limited
partnership |
| |
|
| |
By: Zimmer Partners
GP, LLC, its general partner |
| |
|
| |
By: |
/s/ Mitchell Pressman |
| |
Name: |
Mitchell Pressman |
| |
Title: |
Chief Financial Officer |
| |
|
| |
CLIENT |
| |
|
| |
Ategrity
Specialty Insurance Limited, |
| |
a Bermuda company |
| |
|
| |
By: |
/s/ Justin Cohen |
| |
Name: |
Justin Cohen |
| |
Title: |
Chief Executive Officer |
Signature Page – Investment Management Agreement
Schedule
A
Schedule
B
Exhibit 10.14
AMENDED
AND RESTATED Investment Management Agreement
(Zimmer Partners, LP)
This amended and restated
investment management agreement (this “Agreement”) is made and entered into effective as of October 1, 2024 (the
“Effective Date”), by and between Zimmer Partners, LP, a Delaware limited partnership (the “Manager”),
and Ategrity Specialty Holdings LLC, a Delaware limited liability company (the “Client”).
RECITALS
WHEREAS, the Client and the
Manager entered into an investment management agreement, dated October 1, 2021 (the “Investment Management Agreement”);
and
WHEREAS, the Client and the
Manager desire to amend the Investment Management Agreement as set forth herein.
NOW, THEREFORE, in consideration
of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Client and the Manager hereby agree to amend and restate the Investment Management Agreement, which
is replaced and superseded in its entirety by this Agreement, as follows:
AGREEMENT
1. The
Account. The cash, securities and other assets placed by Client in an account established in the Client’s name at Barclays
Capital Inc. (the “Account”) will be managed by the Manager under this Agreement. Assets may be added by Client to
the Account at any time. Client will provide notification to the Manager of any such additions. The Account will include these assets
and any changes in them resulting from transactions directed by Manager, withdrawals and additions made by Client, or dividends, interest,
stock splits and other earnings, gains or losses on the assets.
2. Appointment
of Manager. The Client hereby appoints the Manager as the investment manager with respect to the Account and all assets in the Account.
The Manager has the full and exclusive authority and discretion to effect investment transactions through the Account, for the account
and risk of the Client in accordance with the provisions of this Agreement. Notwithstanding the foregoing, the Manager does not have
the power and is not authorized to withdraw any cash, securities or other assets from the Account (other than, for the avoidance of doubt,
to effect investment transactions through and for the Account or otherwise at the instruction of the Client). As agent and attorney-in-fact
for the Client, the Manager is authorized to exercise all voting and other rights and privileges associated with the ownership of any
Account positions in accordance with the Manager’s proxy voting policies and procedures. Subject to the investment guidelines set
out in Schedule B attached hereto (the “Investment Guidelines”), the Manager’s investment strategy with
respect to the Account is within the discretion of the Manager. Client may change these Investment Guidelines at any time, but Manager
will be bound by the changes only after it has received and agreed to them in writing. In the event that the Account ceases to conform
to the Investment Guidelines as a result of market values, maturities, amortization rates, credit ratings, or other characteristics of
the securities within the portfolio, Manager will not be required to take immediate action to bring the portfolio back into compliance
with the Investment Guidelines, but will (a) inform Client of the non-compliance within 30 days; (b) offer Client the opportunity
to consult on the non-conformance and (c) use its discretion to return the portfolio to conformity over time with a minimum disruption
to the portfolio.
3. Withdrawals.
Upon five (5) business days’ prior written notice to the Manager, the Client may withdraw all or a portion of the Account
(each a “Withdrawal Date”):
(i) to
the extent required by the Client or its affiliates to pay insurance claims;
(ii) to
the extent required by the Client or its affiliates to pay for reasonable operating
expenses as may be determined by the Board of Directors of the Client; or
(iii) in
the event the Client or any of its affiliates (x) receives a notification from A.M. Best that such withdrawal is required to
maintain the financial strength rating of at least A- of the Client or its affiliate, as applicable, or (y) is required to diversify
its assets pursuant to any law, order or regulation proposed or promulgated by any Governmental Authority.
The Manager shall use its commercially reasonable
efforts to dispose of positions, and to pay withdrawal proceeds, as soon as reasonably practicable following any Withdrawal Date in respect
of which a withdrawal request is made.
4. Brokers
and Other Agents. The Manager’s authority includes the discretion to select brokers, dealers and other intermediaries or agents
(“Brokers”) for the execution of Account transactions and to negotiate commission rates and other transaction terms.
The Client understands that in the selecting, and negotiating transaction terms with, Brokers, the Manager may take into account considerations
other than the cost of the services, including, but not limited to, the quality of research or other services and products made available
to the Manager (even if such research or other services and products are not for the exclusive benefit of the Account).
5. Soft
Dollars. Subject to the Manager’s obligation to obtain best execution, the Manager is authorized to pay, or authorize the payment
and reimbursement of, brokerage commissions which may be in excess of the lowest rates available and which are paid to Brokers who execute
transactions for the Account and who supply or pay for the cost of research and execution services in accordance with the provisions
of Section 28(e) of the Securities Exchange Act of 1934, as amended (the “Safe Harbor”), as interpreted
by the Securities and Exchange Commission (“SEC”). The Manager shall not knowingly use any “soft dollars”
generated by the Account for purposes outside of the Safe Harbor without the consent of the Client in each instance.
6. Fees
and Expenses. The Manager is entitled to fees, and the Account will bear expenses, in accordance with Schedule A attached
hereto.
7. Other
Activities of the Manager. This Agreement does not restrict in any way the ability of the Manager and its affiliates to engage in
any other business or investment activities. It is understood that the Manager and its affiliates effect investment transactions for
their own account and for the accounts of other clients. The Manager may give advice or take action with respect to such other entities
or accounts that differs from the advice given with respect to the Account. To the extent a particular investment is suitable for
both the Account and the other clients, such investments will be allocated between the Account and the other clients in a manner which
the Investment Manager determines is fair and equitable under the circumstances to all clients, including the Account. Situations
may occur where the Account could be disadvantaged because of the investment activities conducted by the Manager for other clients due,
among other things, to the limited availability of an opportunity or the market impact of orders for multiple accounts. From the standpoint
of the Account, simultaneous identical portfolio transactions for the Account and the other clients may tend to decrease the prices received,
and increase the prices required to be paid, by the Account for its portfolio sales and purchases. Where less than the maximum
desired number of shares of a particular security, loans or other products to be purchased is available at a favorable price, the shares,
loans or other products purchased will be allocated among the Account and the other clients in an equitable manner as determined by the
Manager.
8. Confidentiality.
The Client acknowledges that the investment methods employed by the Manager are proprietary and that investment recommendations and
positions provided hereunder by the Manager are for the exclusive use of the Client. The Client agrees not to disclose or make use of
in any manner any of the Manager’s investments to any third party without the Manager’s prior written consent. The Client
agrees to treat all such communication related to the Account as confidential. In addition, the Client represents and warrants to the
Manager that neither it nor any third party will analyze the Manager’s investments transacted on behalf of the Client in a manner
which would allow the Client or any third party directly or indirectly to attempt to reverse engineer, reverse compile, decompile, disassemble
or derive the composition of the Manager’s investment system. The provisions of this Section 8 will survive the termination
of this Agreement.
9. Term
and Termination. This Agreement will continue in effect for a period commencing on the date first written above and ending on December 31,
2027 (the “Initial Term”), subject to automatic renewal for additional successive three year periods, and may be terminated
by any party hereto, without penalty, upon sixty (60) days’ prior written notice to the end of the Initial Term or the end of any
automatic renewal term. Termination will not affect the settlement of any transactions pending at the termination date.
10. Representations
and Warranties. The Client represents and warrants to the Manager and agrees with the Manager as follows:
(a) The
Client has the requisite legal capacity and authority to execute, deliver and perform its obligations under this Agreement. This Agreement
has been duly authorized, executed and delivered by the Client and is the legal, valid and binding agreement of the Client, enforceable
against the Client in accordance with its terms. The Client’s execution of this Agreement and the performance of its obligations
hereunder do not conflict with or violate any provisions of the governing documents (if any) of the Client or any obligations by which
the Client is bound, whether arising by contract, operation of law or otherwise.
(b) The
custody of all Account assets will be maintained with a “qualified custodian” (as that term is defined in the U.S. Investment
Advisers Act of 1940) selected pursuant to Section 1 (the “Custodian”). The Client further hereby represents
and warrants that the Custodian sends account statements to the Client (or the Client’s independent representative, if so designated
by the Client) at least monthly identifying all assets, including the amount of funds and each security, and all transactions, including
all Management Fees paid to the Manager, in the Account for the relevant period. The Client will cause the Custodian to simultaneously
deliver a copy of each such account statement to the Manager. The Client will be solely responsible for paying all fees and charges of
the Custodian. The Client understands and agrees that (i) neither the Manager nor any “related person” (as that term
is defined in the U.S. Investment Advisers Act of 1940) of the Manager will serve as the Custodian for the Account, (ii) the Manager
will not be liable for any act or omission of the Custodian, and (iii) the Manager will be entitled to rely on any information provided
by the Custodian or any other agent of the Client. The Client will promptly notify the Manager if any of the representations and warranties
in this Section 10(b) becomes inaccurate in any respect.
(c) The
Client has received and reviewed a copy of Parts 2A and 2B of the Manager’s Form ADV and Privacy Notice prior to the date
of this Agreement.
(d) The
Client is the owner of all cash, securities and other assets in the Account and there are no restrictions on the pledge, hypothecation,
transfer, sale or public distribution of such cash, securities or other assets.
(e) The
investment program contemplated by this Agreement is prudent in light of the Client’s overall investment portfolio and the Client
is experienced in the engagement of investment advisers and is aware of the risks associated with such engagements, including the risk
that the Account could suffer substantial diminution in value.
(f) The
assets in the Account do not contravene applicable anti-money laundering laws and regulations, are not derived from illegal or illegitimate
activities and neither the Client nor any of its investors (if applicable) are a prohibited entity or person listed on the web site of
the U.S. Treasury Department’s Office of Foreign Assets Control and do not have any affiliation of any kind with such an entity
or person. The Client will provide to the Manager all such information and documents that are required pursuant to any anti-money laundering
or “Know Your Client” requirements applicable to the Manager.
(g) The
assets of the Account do not, and will not, constitute “plan assets” for purposes of the U.S. Employee Retirement Income
Security Act of 1974, as amended, or Section 4975 of the U.S. Internal Revenue Code of 1986, as amended.
(h) The
representations and warranties in this Section 10 will continue during the term of this Agreement, and if any time any event
occurs that makes or tends to make any of the foregoing incomplete or inaccurate, the Client will promptly notify the Manager of the
occurrence of such event in writing.
11. Risk
Acknowledgement. The Manager does not guarantee the future performance of the Account or any specific level of investment performance,
the success of any investment decision or strategy that the Manager may use, or the success of the Manager’s overall management
of the Account. The Client understands that investment decisions made for the Account by the Manager are subject to various market, economic,
political and business risks, and that those investment decisions may not always be profitable. The Manager cannot and does not imply
or guarantee that the Client will make a profit and it is agreed that the Manager will not be held responsible for losses with respect
to the Account.
12. Standard
of Liability; Indemnification.
(a) The
Manager or any of its principal, partners, employees and affiliates (such persons, the “Manager Indemnitees”) shall
not be liable for any loss or cost arising out of, or in connection with, any act or activity undertaken (or omitted to be undertaken)
in good faith in fulfillment of any obligation or responsibility under this Agreement, including any such loss sustained by reason of
any investment or the sale or retention of any security or other asset of the Account; provided, that any Manager Indemnitees
exculpated from liability under this Section 12 shall not be exculpated from any liability arising from losses caused by
his, her or its gross negligence or willful malfeasance.
(b) The
Manager Indemnitees shall be indemnified and held harmless by the Client to the fullest extent legally permissible, from and against
any and all loss, liability and expense (including without limitation judgments, fines, amounts paid or to be paid in settlement and
reasonable attorneys fees) incurred or suffered by the Indemnitees in connection with the good faith performance by the Indemnitees of
their responsibilities under this Agreement; provided, that any Indemnitee entitled to be indemnified under this Section 12(b) shall
not be indemnified nor held harmless for any loss, liability or expense resulting from his, her or its reckless disregard of its obligations
and duties pursuant to this Agreement, gross negligence or willful malfeasance.
(c) The
Client and its principal, partners, employees and affiliates (such persons, the “Client Indemnitees”) shall be indemnified
and held harmless by the Manager from and against any and all loss, liability and expense (including without limitation judgments, fines,
amounts paid or to be paid in settlement and reasonable attorneys’ fees) incurred or suffered by the Client Indemnitees as a direct
result of the Manager’s gross negligence or willful malfeasance, or for Manager’s reckless disregard of its obligations and
duties pursuant to this Agreement.
(d) Notwithstanding
any of the foregoing to the contrary, the provisions of this Section 12 shall not be construed so as to provide for the exculpation
or indemnification of the Indemnitees, from any liability (including liability under U.S. securities laws which, under certain circumstances,
impose liability even on persons that act in good faith), to the extent (but only to the extent) that such liability may not be waived,
modified or limited under applicable law, or to the extent such indemnification would be in violation of applicable law, but shall be
construed so as to effectuate the provisions of this Section 12 to the fullest extent permitted by law.
(e) Manager
will not be responsible for the Client’s own compliance with the insurance investment laws of the Client’s state of domicile
or for the Client’s compliance with applicable tax laws.
(f) The
provisions of this Section 12 will survive the termination of this Agreement.
13. Further
Information. The Client will furnish to the Manager all information, authorizations and documentation as the Manager may from time
to time require to enable the Manager to carry out its obligations under this Agreement or as required by applicable law.
14. Change
in Control. The Manager will notify the Client in writing within 30 days after any change in control of the ownership of the Manager.
15. Successors.
This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and permitted assigns.
16. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder will be in writing and will be deemed
to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if
sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by electronic transmission if sent during
normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient; or (d) on
the 3rd day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must
be sent to the respective parties at the following addresses:
| If
to the Client: |
Ategrity Specialty
Holdings LLC |
| |
9 West 57th Street,
33rd Floor |
| |
New York, New York 10019 |
| |
Attn: Eric Crespolini |
| |
E-mail: legal@ategrity.com |
| |
|
| If to the
Manager: |
Zimmer Partners, LP |
| |
9 West 57th Street,
33rd Floor |
| |
New York, New York 10019 |
| |
Attn: Barbara Burger |
| |
E-mail: legal@zimmerpartners.com |
17. Entire
Agreement. This Agreement contains the entire understanding and agreement of the Manager and the Client concerning the subject matter
of this Agreement.
18. Waiver
of Breach. The waiver by any party of a breach of any provision of this Agreement will not operate or be construed as a waiver of
any subsequent breach by any party. The failure of a party to insist upon strict adherence to any provision of the Agreement will not
constitute a waiver or thereafter deprive such party of the right to insist upon strict adherence.
19. Not
for Benefit of Third Parties. The provisions of this Agreement are intended only for the regulation of relations between the Manager
and the Client. This Agreement is not intended for the benefit of third parties, and no rights are granted to third parties under this
Agreement.
20. Amendment
and Assignment. This Agreement may not be amended except in writing signed by both the Manager and the Client. This Agreement may
not be assigned by either party hereto without the prior written consent of the other party.
21. Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together will
constitute one and the same instrument. Signatures on this Agreement may be communicated via email of PDF copies and will be binding
upon the parties so transmitting their signatures.
22. Governing
Law. This Agreement is, and the rights of the parties hereto are, governed by and will be construed in accordance with the laws of
the State of New York, without regard to the conflict of laws rule thereof that would result in the application of the laws of a
different jurisdiction.
23. Severability.
If any provision of this Agreement is or becomes inconsistent with any law or rule of any governmental or regulatory body having
jurisdiction over the subject matter of this Agreement, that provision will be deemed to be rescinded or modified in accordance with
any such law or rule and, in all other respects, this Agreement will remain in full force and effect.
24. Headings.
Headings to sections in this Agreement are for convenience only and will not affect the construction, meaning or interpretation of
this Agreement.
[Signature Page Follows]
The Parties have executed
this Agreement as of the Effective Date.
| |
MANAGER |
| |
|
| |
Zimmer
Partners, LP, |
| |
a Delaware limited
partnership |
| |
|
| |
By: Zimmer Partners
GP, LLC, its general partner |
| |
|
| |
By: |
/s/ Mitchell Pressman |
| |
Name: |
Mitchell Pressman |
| |
Title: |
Chief Financial Officer |
| |
|
|
| |
CLIENT |
| |
|
| |
Ategrity
Specialty Holdings LLC, |
| |
a Delaware limited
liability company |
| |
|
| |
By: |
/s/ Justin Cohen |
| |
Name: |
Justin Cohen |
| |
Title: |
Chief Executive Officer |
Signature Page – A&R Investment Management Agreement
Schedule
A
Schedule
B
Exhibit 10.15
Investment
Management Agreement
(Zimmer Partners, LP)
This investment management
agreement (this “Agreement”) is made and entered into effective as of December 1, 2024 (the “Effective
Date”), by and between Zimmer Partners, LP, a Delaware limited partnership (the “Manager”), and Ategrity
Specialty Insurance Limited (fka Sequentis Reinsurance Company Limited), a Bermuda company (the “Client”).
RECITALS
WHEREAS, the Client desires
to appoint the Manager as the investment manager regarding certain assets of the Client; and
WHEREAS, the Manager is willing
to accept the duties and the responsibilities of an investment manager regarding such assets.
NOW, THEREFORE, in consideration
of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Client and the Manager agree as follows:
AGREEMENT
1. The
Account. The cash, securities and other assets placed by Client in an account established in the Client’s name at Barclays
Capital Inc. (the “Account”) will be managed by the Manager under this Agreement. Assets may be added by Client to
the Account at any time. Client will provide notification to the Manager of any such additions. The Account will include these assets
and any changes in them resulting from transactions directed by Manager, withdrawals and additions made by Client, or dividends, interest,
stock splits and other earnings, gains or losses on the assets.
2. Appointment
of Manager. The Client hereby appoints the Manager as the investment manager with respect to the Account and all assets in
the Account. The Manager has the full and exclusive authority and discretion to effect investment transactions through the Account, for
the account and risk of the Client in accordance with the provisions of this Agreement. Notwithstanding the foregoing, the Manager does
not have the power and is not authorized to withdraw any cash, securities or other assets from the Account (other than, for the avoidance
of doubt, to effect investment transactions through and for the Account or otherwise at the instruction of the Client). As agent and
attorney-in-fact for the Client, the Manager is authorized to exercise all voting and other rights and privileges associated with the
ownership of any Account positions in accordance with the Manager’s proxy voting policies and procedures. Subject to the investment
guidelines set out in Schedule B attached hereto (the “Investment Guidelines”), the Manager’s investment
strategy with respect to the Account is within the discretion of the Manager. Client may change these Investment Guidelines at any time,
but Manager will be bound by the changes only after it has received and agreed to them in writing. In the event that the Account ceases
to conform to the Investment Guidelines as a result of market values, maturities, amortization rates, credit ratings, or other characteristics
of the securities within the portfolio, Manager will not be required to take immediate action to bring the portfolio back into compliance
with the Investment Guidelines, but will (a) inform Client of the non-compliance within 30 days; (b) offer Client the opportunity
to consult on the non-conformance and (c) use its discretion to return the portfolio to conformity over time with a minimum disruption
to the portfolio.
3. Withdrawals.
Upon five (5) business days’ prior written notice to the Manager, the Client may withdraw all or a portion of the
Account (each a “Withdrawal Date”):
(i) to
the extent required by the Client or its affiliates to pay insurance claims;
(ii) to
the extent required by the Client or its affiliates to pay for reasonable operating expenses as may be determined by the Board
of Directors of the Client; or
(iii) in
the event the Client or any of its affiliates (x) receives a notification from A.M. Best that such withdrawal is required to
maintain the financial strength rating of at least A- of the Client or its affiliate, as applicable, or (y) is required to diversify
its assets pursuant to any law, order or regulation proposed or promulgated by any Governmental Authority.
The Manager shall use its commercially reasonable
efforts to dispose of positions, and to pay withdrawal proceeds, as soon as reasonably practicable following any Withdrawal Date in respect
of which a withdrawal request is made.
4. Brokers
and Other Agents. The Manager’s authority includes the discretion to select brokers, dealers and other intermediaries
or agents (“Brokers”) for the execution of Account transactions and to negotiate commission rates and other transaction
terms. The Client understands that in the selecting, and negotiating transaction terms with, Brokers, the Manager may take into account
considerations other than the cost of the services, including, but not limited to, the quality of research or other services and products
made available to the Manager (even if such research or other services and products are not for the exclusive benefit of the Account).
5. Soft
Dollars. Subject to the Manager’s obligation to obtain best execution, the Manager is authorized to pay, or authorize the payment
and reimbursement of, brokerage commissions which may be in excess of the lowest rates available and which are paid to Brokers who execute
transactions for the Account and who supply or pay for the cost of research and execution services in accordance with the provisions
of Section 28(e) of the Securities Exchange Act of 1934, as amended (the “Safe Harbor”), as interpreted
by the Securities and Exchange Commission (“SEC”). The Manager shall not knowingly use any “soft dollars”
generated by the Account for purposes outside of the Safe Harbor without the consent of the Client in each instance.
6. Fees
and Expenses. The Manager is entitled to fees, and the Account will bear expenses, in accordance with Schedule A attached
hereto.
7. Other
Activities of the Manager. This Agreement does not restrict in any way the ability of the Manager and its affiliates to engage
in any other business or investment activities. It is understood that the Manager and its affiliates effect investment transactions for
their own account and for the accounts of other clients. The Manager may give advice or take action with respect to such other entities
or accounts that differs from the advice given with respect to the Account. To the extent a particular investment is suitable for
both the Account and the other clients, such investments will be allocated between the Account and the other clients in a manner which
the Investment Manager determines is fair and equitable under the circumstances to all clients, including the Account. Situations
may occur where the Account could be disadvantaged because of the investment activities conducted by the Manager for other clients due,
among other things, to the limited availability of an opportunity or the market impact of orders for multiple accounts. From the standpoint
of the Account, simultaneous identical portfolio transactions for the Account and the other clients may tend to decrease the prices received,
and increase the prices required to be paid, by the Account for its portfolio sales and purchases. Where less than the maximum
desired number of shares of a particular security, loans or other products to be purchased is available at a favorable price, the shares,
loans or other products purchased will be allocated among the Account and the other clients in an equitable manner as determined by the
Manager.
8. Confidentiality.
The Client acknowledges that the investment methods employed by the Manager are proprietary and that investment recommendations and
positions provided hereunder by the Manager are for the exclusive use of the Client. The Client agrees not to disclose or make use of
in any manner any of the Manager’s investments to any third party without the Manager’s prior written consent. The Client
agrees to treat all such communication related to the Account as confidential. In addition, the Client represents and warrants to the
Manager that neither it nor any third party will analyze the Manager’s investments transacted on behalf of the Client in a manner
which would allow the Client or any third party directly or indirectly to attempt to reverse engineer, reverse compile, decompile, disassemble
or derive the composition of the Manager’s investment system. The provisions of this Section 8 will survive the termination
of this Agreement.
9. Term
and Termination. This Agreement will continue in effect for a period commencing on the date first written above and ending
on December 31, 2027 (the “Initial Term”), subject to automatic renewal for additional successive three year periods,
and may be terminated by any party hereto, without penalty, upon sixty (60) days’ prior written notice to the end of the Initial
Term or the end of any automatic renewal term. Termination will not affect the settlement of any transactions pending at the termination
date.
10. Representations
and Warranties. The Client represents and warrants to the Manager and agrees with the Manager as follows:
(a) The
Client has the requisite legal capacity and authority to execute, deliver and perform its obligations under this Agreement. This Agreement
has been duly authorized, executed and delivered by the Client and is the legal, valid and binding agreement of the Client, enforceable
against the Client in accordance with its terms. The Client’s execution of this Agreement and the performance of its obligations
hereunder do not conflict with or violate any provisions of the governing documents (if any) of the Client or any obligations by which
the Client is bound, whether arising by contract, operation of law or otherwise.
(b) The
custody of all Account assets will be maintained with a “qualified custodian” (as that term is defined in the U.S. Investment
Advisers Act of 1940) selected pursuant to Section 1 (the “Custodian”). The Client further hereby represents
and warrants that the Custodian sends account statements to the Client (or the Client’s independent representative, if so designated
by the Client) at least monthly identifying all assets, including the amount of funds and each security, and all transactions, including
all Management Fees paid to the Manager, in the Account for the relevant period. The Client will cause the Custodian to simultaneously
deliver a copy of each such account statement to the Manager. The Client will be solely responsible for paying all fees and charges of
the Custodian. The Client understands and agrees that (i) neither the Manager nor any “related person” (as that term
is defined in the U.S. Investment Advisers Act of 1940) of the Manager will serve as the Custodian for the Account, (ii) the Manager
will not be liable for any act or omission of the Custodian, and (iii) the Manager will be entitled to rely on any information provided
by the Custodian or any other agent of the Client. The Client will promptly notify the Manager if any of the representations and warranties
in this Section 10(b) becomes inaccurate in any respect.
(c) The
Client has received and reviewed a copy of Parts 2A and 2B of the Manager’s Form ADV and Privacy Notice prior to the date
of this Agreement.
(d) The
Client is the owner of all cash, securities and other assets in the Account and there are no restrictions on the pledge, hypothecation,
transfer, sale or public distribution of such cash, securities or other assets.
(e) The
investment program contemplated by this Agreement is prudent in light of the Client’s overall investment portfolio and the Client
is experienced in the engagement of investment advisers and is aware of the risks associated with such engagements, including the risk
that the Account could suffer substantial diminution in value.
(f) The assets in the Account do not contravene applicable anti-money laundering laws and regulations, are
not derived from illegal or illegitimate activities and neither the Client nor any of its investors (if applicable) are a prohibited
entity or person listed on the web site of the U.S. Treasury Department’s Office of Foreign Assets Control and do not have any
affiliation of any kind with such an entity or person. The Client will provide to the Manager all such information and documents
that are required pursuant to any anti-money laundering or “Know Your Client” requirements applicable to the
Manager.
(g) The
assets of the Account do not, and will not, constitute “plan assets” for purposes of the U.S. Employee Retirement Income
Security Act of 1974, as amended, or Section 4975 of the U.S. Internal Revenue Code of 1986, as amended.
(h) The
representations and warranties in this Section 10 will continue during the term of this Agreement, and if any time any event
occurs that makes or tends to make any of the foregoing incomplete or inaccurate, the Client will promptly notify the Manager of the
occurrence of such event in writing.
11. Risk
Acknowledgement. The Manager does not guarantee the future performance of the Account or any specific level of investment
performance, the success of any investment decision or strategy that the Manager may use, or the success of the Manager’s overall
management of the Account. The Client understands that investment decisions made for the Account by the Manager are subject to various
market, economic, political and business risks, and that those investment decisions may not always be profitable. The Manager cannot
and does not imply or guarantee that the Client will make a profit and it is agreed that the Manager will not be held responsible for
losses with respect to the Account.
12. Standard
of Liability; Indemnification.
(a) The
Manager or any of its principal, partners, employees and affiliates (such persons, the “Manager Indemnitees”) shall
not be liable for any loss or cost arising out of, or in connection with, any act or activity undertaken (or omitted to be undertaken)
in good faith in fulfillment of any obligation or responsibility under this Agreement, including any such loss sustained by reason of
any investment or the sale or retention of any security or other asset of the Account; provided, that any Manager Indemnitees exculpated
from liability under this Section 12 shall not be exculpated from any liability arising from losses caused by his, her or
its gross negligence or willful malfeasance.
(b) The
Manager Indemnitees shall be indemnified and held harmless by the Client to the fullest extent legally permissible, from and against
any and all loss, liability and expense (including without limitation judgments, fines, amounts paid or to be paid in settlement and
reasonable attorneys fees) incurred or suffered by the Indemnitees in connection with the good faith performance by the Indemnitees of
their responsibilities under this Agreement; provided that any Indemnitee entitled to be indemnified under this Section 12(b) shall
not be indemnified nor held harmless for any loss, liability or expense resulting from his, her or its reckless disregard of its obligations
and duties pursuant to this Agreement, gross negligence or willful malfeasance.
(c) The
Client and its principal, partners, employees and affiliates (such persons, the “Client Indemnitees”) shall be indemnified
and held harmless by the Manager from and against any and all loss, liability and expense (including without limitation judgments, fines,
amounts paid or to be paid in settlement and reasonable attorneys’ fees) incurred or suffered by the Client Indemnitees as a direct
result of the Manager’s gross negligence or willful malfeasance, or for Manager’s reckless disregard of its obligations and
duties pursuant to this Agreement.
(d) Notwithstanding
any of the foregoing to the contrary, the provisions of this Section 12 shall not be construed so as to provide for the exculpation
or indemnification of the Indemnitees, from any liability (including liability under U.S. securities laws which, under certain circumstances,
impose liability even on persons that act in good faith), to the extent (but only to the extent) that such liability may not be waived,
modified or limited under applicable law, or to the extent such indemnification would be in violation of applicable law, but shall be
construed so as to effectuate the provisions of this Section 12 to the fullest extent permitted by law.
(e) Manager
will not be responsible for the Client’s own compliance with the insurance investment laws of the Client’s state of domicile
or for the Client’s compliance with applicable tax laws.
(f) The
provisions of this Section 12 will survive the termination of this Agreement.
13. Further
Information. The Client will furnish to the Manager all information, authorizations and documentation as the Manager may from
time to time require to enable the Manager to carry out its obligations under this Agreement or as required by applicable law.
14. Change
in Control. The Manager will notify the Client in writing within 30 days after any change in control of the ownership of the
Manager.
15. Successors.
This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and permitted assigns.
16. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder will be in writing and will be deemed
to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if
sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by electronic transmission if sent during
normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient; or (d) on
the 3rd day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must
be sent to the respective parties at the following addresses:
| If
to the Client |
Ategrity
Specialty Insurance Limited |
| |
Clarendon House |
| |
2 Church Street |
| |
Hamilton HM 11 |
| |
Bermuda |
| |
|
| If to the
Manager: |
Zimmer Partners, LP |
| |
9 West 57th Street,
33rd Floor |
| |
New York, New York 10019 |
| |
Attn: General Counsel |
| |
E-mail: legal@zimmerpartners.com |
17. Entire
Agreement. This Agreement contains the entire understanding and agreement of the Manager and the Client concerning the subject
matter of this Agreement.
18. Waiver
of Breach. The waiver by any party of a breach of any provision of this Agreement will not operate or be construed as a waiver
of any subsequent breach by any party. The failure of a party to insist upon strict adherence to any provision of the Agreement will
not constitute a waiver or thereafter deprive such party of the right to insist upon strict adherence.
19. Not
for Benefit of Third Parties. The provisions of this Agreement are intended only for the regulation of relations between the
Manager and the Client. This Agreement is not intended for the benefit of third parties, and no rights are granted to third parties under
this Agreement.
20. Amendment
and Assignment. This Agreement may not be amended except in writing signed by both the Manager and the Client. This Agreement
may not be assigned by either party hereto without the prior written consent of the other party.
21. Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together
will constitute one and the same instrument. Signatures on this Agreement may be communicated via email of PDF copies and will be binding
upon the parties so transmitting their signatures.
22. Governing
Law. This Agreement is, and the rights of the parties hereto are, governed by and will be construed in accordance with the
laws of the State of New York, without regard to the conflict of laws rule thereof that would result in the application of the laws
of a different jurisdiction.
23. Severability.
If any provision of this Agreement is or becomes inconsistent with any law or rule of any governmental or regulatory
body having jurisdiction over the subject matter of this Agreement, that provision will be deemed to be rescinded or modified in accordance
with any such law or rule and, in all other respects, this Agreement will remain in full force and effect.
24. Headings.
Headings to sections in this Agreement are for convenience only and will not affect the construction, meaning or interpretation
of this Agreement.
[Signature Page Follows]
The Parties have executed
this Agreement as of the Effective Date.
| |
MANAGER |
| |
|
| |
Zimmer
Partners, LP, |
| |
a Delaware limited
partnership |
| |
|
| |
By: Zimmer Partners
GP, LLC, its general partner |
| |
|
| |
By: |
/s/ Mitchell Pressman |
| |
Name: |
Mitchell Pressman |
| |
Title: |
Chief Financial Officer |
| |
|
|
| |
CLIENT |
| |
|
| |
Ategrity
Specialty Insurance Limited |
| |
a Bermuda company |
| |
|
| |
By: |
/s/ Justin Cohen |
| |
Name: |
Justin Cohen |
| |
Title: |
Chief Executive Officer |
Signature Page – Investment Management Agreement
Schedule
A
Schedule
B
Exhibit 10.16
PROMISSORY NOTE
ON THIS 1ST DAY OF JANUARY, 2023, Zimmer Financial Services Group
LLC, a Delaware Limited Liability Corporation having its principal office at 9 West 57th Street, 33rd Floor,
New York, New York 10019, hereinafter known as the “Borrower”, promises to pay Ategrity Specialty Insurance Company,,
an Arizona corporation, having its principal office at 14000 N. Pima Road, Suite 200, Scottsdale, Arizona 85260, hereinafter known
as the “Lender”, the principal sum of thirteen million five hundred one thousand two hundred eighty nine dollars and
fifty nine cents ($13,501,289.59), with interest accruing on the unpaid balance at a rate of seven point four two percent (7.42%) per
annum.
PAYMENTS: Borrower shall pay interest on the outstanding principal
balance accrued through the last day of every quarter beginning on the 31st day of March, 2023 on or promptly after such date
FINAL DUE DATE: The full balance on this Note, including any accrued
interest and late fees, is due and payable on the 31st day of December, 2029.
INTEREST DUE IN THE EVENT OF DEFAULT: In the event that the Borrower
fails to pay the note in full on the final due date or has failed to make one or more interest payments by the applicable due date, unpaid
principal shall accrue interest at the rate of seven point four two percent (7.42%) per annum OR the maximum rate allowed by law, whichever
is less, until the Borrower is no longer in default.
ALLOCATION OF PAYMENTS: Payments shall be first be applied to any
late fees due, then to interest due and then any remainder to principal.
PREPAYMENT: Borrower may pre-pay this Note without penalty.
NON-WAIVER: No failure or delay by Lender in exercising Lender’s
rights under this Note shall be considered a waiver of such rights.
SEVERABILITY: In the event that any provision herein is determined
to be void or unenforceable for any reason, such determination shall not affect the validity or enforceability of any other provision,
all of which shall remain in full force and effect.
ALL REMEDIES AVAILABLE: Nothing in this Note should be interpreted
as limiting Lender’s rights in the event of non-payment by Borrower, including all rights to see redress, including seeking specific
performance with a court of competent jurisdiction.
REGULATORY APPROVAL: Notwithstanding anything to the contrary this
Note is subject to the approval of the Delaware Insurance Commissioner (“Commissioner”) and may be subject to cancellation
or amendment at the request of the Commissioner.
INTEGRATION: There are no verbal or other agreements which modify
or affect the terms of this Note. This Note may not be modified or amended except by written agreement signed by Borrower and Lender.
NOTICE: Any notices required or permitted to be given hereunder shall
be given in writing and shall be delivered (a) in person, (b) by certified mail, postage prepaid, return receipt requested,
(c) by facsimile, or (d) by a commercial overnight courier that guarantees next day delivery and provides a receipt, and such
notices shall be made to the parties at the addresses listed below.
EXECUTION: The Borrower executes this Note as a principal and not
as a surety. If there is more than one Borrower, each Borrower shall be jointly and severally liable under this Note.
SIGNATURE AREA
Zimmer Financial Services Group LLC
| By: |
/s/ Barbara Burger |
|
| Name: |
Barbara Burger |
|
| Title: |
General Counsel, Zimmer Financial Services Group
LLC |
|
Notice Information:
Zimmer Partners, LP
Attn: Barbara Burger
9 West 57th Street, 33rd
Floor
New York, New York 10019
[***]
Ategrity Specialty Insurance Company
| By: |
/s/ Justin Cohen |
|
| Name: |
Justin Cohen |
|
| Title: |
Chief Executive Officer, Ategrity Specialty Insurance
Company |
|
Notice Information:
Ategrity Specialty Insurance Company
Attn: General Counsel
14000 N. Pima Road, Suite 200
Scottsdale, Arizona 85260
Exhibit 10.17
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(“Agreement”), dated as of March 21, 2025 between Ategrity Specialty Holdings LLC, a Delaware limited liability
company (the “Company”), and Chris Schenk (the “Executive”) replaces
and supersedes all other employment agreements between the Executive and the Company, including the Executive’s previous employment
agreements dated August 11, 2021 and August 11, 2023.
The parties hereto agree as
follows:
Article 1
DEFINITIONS
Section 1.01 Definitions.
For purposes of this Agreement, the following terms have the meanings set forth below:
“Accounting Firm”
has the meaning set forth in Section 12.10(b).
“Affiliate”
means any Person, directly or indirectly, through one or more intermediaries, Controlling, Controlled by, or under common Control with
the Company. For purposes hereof, (a) “Control” means the ownership, directly or indirectly, of (i) in the
case of a corporation, Voting Securities (as defined below) representing 50% or more of the total voting power or value of all the then
outstanding Voting Securities of such corporation or (ii) in the case of a partnership, limited liability company, association or
other business entity (“Business Entity”), 50% or more of the partnership or other similar ownership interest of such
Business Entity; and (b) “Voting Security” means any security of a corporation which carries the right to vote
generally in the election of directors. For purposes of the definition of “Control,” (x) a Person will be deemed to have
a 50% or more ownership interest in a Business Entity if such Person is allocated 50% or more of Business Entity gains or losses or controls
the managing director or member or general partner of such Business Entity; and (y) “Controlling” and “Controlled”
have meanings correlative thereto.
“Base Salary”
has the meaning set forth in Section 4.01.
“Board”
means the Board of Managers of the Company.
“Cause”
means (a) theft or embezzlement by the Executive with respect to the Company or its Affiliates; (b) willful misconduct or gross
negligence in the performance of the Executive’s duties; (c) the commission by the Executive of any felony or any crime involving
moral turpitude; (d) willful or prolonged absence from work by the Executive (other than by reason of disability due to physical
or mental illness) or failure, neglect or refusal by the Executive to perform his duties and responsibilities without the same being corrected
within ten (10) days after being given written notice thereof; (e) continued and habitual use of alcohol by the Executive to
an extent which impairs the Executive’s performance of his duties; (f) the Executive’s use of illegal drugs; or (g) a
material breach by the Executive of this Agreement. Cause shall not exist with respect to items (b), (d), (e) or (f) unless
and until Executive has been given written notice specifying in detail the circumstances giving rise to the alleged cause.
“Code”
has the meaning set forth in Section 12.09.
“Commencement Date”
means April 1, 2025.
“Confidential Information”
means information of any Person, including without limitation Zimmer Partners, LP or its affiliates, that is not generally known to the
public and that was or is used, developed or obtained by the Company or its Affiliates in connection with their business. It shall not
include information (a) required to be disclosed by court or administrative order, (b) lawfully obtainable from other sources
or which is in the public domain through no fault of the Executive; or (c) the disclosure of which is consented to in writing by
the Company.
“Date of Termination”
has the meaning set forth in Section 5.06.
“Employment Period”
has the meaning set forth in Section 2.01.
“Intellectual Property”
has the meaning set forth in Section 7.01.
“Notice of Termination”
has the meaning set forth in Section 5.05.
“Nonsolicitation
Period” has the meaning set forth in Section 9.02.
“Permanent Disability”
means those circumstances where the Executive is unable to continue to perform the usual customary duties of his assigned job or as otherwise
assigned in accordance with the provisions of this Agreement for a period of six (6) months in any twelve (12) month period because
of physical, mental or emotional incapacity resulting from injury, sickness or disease. Any questions as to the existence of a Permanent
Disability shall be determined by a qualified, independent physician selected by the Company and approved by the Executive (which approval
shall not be unreasonably withheld). The determination of any such physician shall be final and conclusive for all purposes of this Agreement.
“Person”
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, an estate, a trust,
a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof.
“Reimbursable Expenses”
has the meaning set forth in Section 4.04.
“Severance Amount”
has the meaning set forth in Section 5.03.
“Target Amount”
has the meaning set forth in Section 4.02.
Article 2
EMPLOYMENT
Section 2.01 Employment.
The Company shall continue to employ the Executive, and the Executive shall accept continued employment with the Company, for the period
beginning on the Commencement Date and ending as provided in Section 5.01 (the “Employment Period”).
Article 3
POSITION AND DUTIES
Section 3.01 Position
and Duties. During the Employment Period, the Executive shall serve as President and Chief Underwriting Officer of the Company. The
Executive shall have such responsibilities, powers and duties as may from time to time be prescribed by the Board; provided that
such responsibilities and duties are substantially consistent with those customarily assigned to individuals serving in comparable positions
at comparable companies or are reasonably required by the conduct of the business of the Company. During the Employment Period, the Executive
shall devote substantially all of his working time and efforts to the business and affairs of the Company. The Executive may serve as
a director, trustee or officer of not-for-profit corporations and entities, including without limitation charitable organizations, and
may serve as a director, trustee or officer of other corporations and entities or engage in other outside activities to the extent that
such activities do not conflict with the business of the Company and its Affiliates with the prior written approval of the Board.
Article 4
BASE SALARY AND BENEFITS
Section 4.01 Base
Salary. During the Employment Period, the Executive’s base salary will be $550,000 per annum, which shall be paid in
accordance with the customary payroll practices of the Company and shall be pro-rated for partial years of employment. Such annual base
salary shall be reviewed (and may be adjusted) from time to time by the Board (such annual base salary, as it may be adjusted from time
to time, the “Base Salary”). The Base Salary will be payable bi-weekly.
Section 4.02 Bonuses.
In addition to the Base Salary, the Executive shall be eligible to participate in an annual bonus plan on terms set forth from time to
time by the Board. The Executive’s target annual bonus for the 2025 fiscal year will be one hundred percent (100%) of the Base
Salary (such target, as may be increased by the Board from time to time, the “Target Amount”). The Executive’s
annual bonus shall be determined by the Board based upon (a) the Executive’s achievement of individual performance objectives
communicated to the Executive, and (b) the Company’s results. Any annual bonus payable to the Executive shall be paid no later
than the date on which annual bonuses are paid to other Company executives, and in no event later than March 15 of the year following
the calendar year to which the annual bonus relates.
Section 4.03 Benefits.
In addition to the Base Salary, and any bonuses payable to the Executive pursuant to this Agreement, the Executive shall be entitled to,
subject to commercial availability on reasonable terms, benefits under any plan or arrangement available generally for the senior executive
officers of the Company, as set forth from time to time in the applicable plan documents and as may be amended by the Company from time
to time.
Section 4.04 Expenses.
The Company shall reimburse the Executive for all reasonable expenses incurred by him in the course of performing his duties under this
Agreement which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and
other business expenses (“Reimbursable Expenses”), subject to the Company’s requirements with respect to reporting
and documentation of expenses.
Section 4.05 Indemnification;
D&O Insurance. The Company shall defend and indemnify the Executive for any claims brought against him arising out of or relating
to, directly or indirectly, his employment with the Company and its formation to the fullest extent permitted by law, in accordance with
the Company by-laws, including following any termination of Executive with respect to his conduct or other circumstances occurring prior
to such termination. The Company shall ensure the Executive is covered by the Company’s directors’ and officers’ liability
insurance policy (or policies) during the Employment Period and thereafter to the extent such policy (or policies) are maintained and
cover other Company directors and officers.
Article 5
TERM AND TERMINATION
Section 5.01 Term.
The Employment Period will terminate on December 31, 2026; provided, however, that (a) the Employment Period shall terminate
prior to such date upon the Executive’s death or Permanent Disability, and (b) the Employment Period may be terminated by the
Company or the Executive for any reason prior to such date. In addition, this Agreement will be automatically extended on the same terms
and conditions for successive one-year periods following the original term until either the Company or the Executive, at least sixty (60)
days prior to the expiration of the original term or any extended term, shall give written notice of its or his intention not to renew
the Agreement (“Notice of Non-Renewal”).
Section 5.02 Payments
Upon Termination. If the Employment Period shall terminate for any reason, then the Executive (or the Executive’s estate, in
the event of his death) shall be entitled to receive his Base Salary, accrued and unpaid vacation (if applicable at the time of termination
of employment), employee benefits earned through the date of termination of employment and reimbursement of all Reimbursable Expenses
incurred by the Executive prior to such date of termination submitted with reasonable documentation in a timely manner in accordance with
the Company’s policies (the amounts in this Section 5.02 collectively, the “Accrued Obligations”).
Section 5.03 Termination
without Cause. Except as otherwise provided in Sections 9.01 and 12.09, if the Employment Period shall be terminated by the Company
pursuant to Section 5.01 without Cause (such terminations are collectively referred to as “Termination without Cause”),
in addition to the Accrued Obligations, the Executive shall be paid (except as provided in Section 5.04 below) an amount equal to
the sum of (a) twelve months of the Base Salary (the “Severance Amount”); (b) any awarded but unpaid annual
bonus with respect to a calendar year prior to the year of termination; and (c) the Executive's target annual bonus with respect
to the calendar year of termination, prorated for the number of months served by the Executive in the relevant calendar year; provided,
however, that the Executive’s entitlement to the amounts set forth in this Section 5.03 shall be subject to the Executive’s
continued compliance with the provisions of Sections 6.01, 7.01, 8.01, 9.01 and 9.02 and the Executive’s execution and non-revocation
of a general release of claims in customary form and reasonably satisfactory to the Company, on or before the date that is fifty (50)
days following the Date of Termination, provided that if such 50-day period spans two taxable years, payment will be made in the second
taxable year, in accordance with Section 409A of the Code. Subject to Section 12.09 below, such amount will be paid in a number
of equal monthly installments equal to the number of months of Base Salary due, the first of which to be paid on the date that is two
(2) months following the Date of Termination. For purposes of this Agreement, a Notice of Non-Renewal given by the Company pursuant
to Section 5.01 shall not constitute a Termination without Cause.
Section 5.04 Benefits.
Except as otherwise required by mandatory provisions of law, all of the Executive’s rights to fringe and other benefits under this
Agreement or otherwise, if any, will cease upon the termination of the Employment Period.
Section 5.05 Notice
of Termination and Opportunity to Cure. Any termination by the Company for Permanent Disability or Cause or without Cause or by the
Executive shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a “Notice
of Termination” shall mean a notice which shall indicate the date the termination is to take effect (consistent with the terms
of this Agreement), the specific termination provision in this Agreement relied upon and, for a termination for Permanent Disability or
for Cause, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment under
the provision indicated. Upon the delivery of the Notice of Termination for Cause or Permanent Disability, Executive shall have a period
of thirty (30) days from and after the receipt by the Executive of a Notice of Termination to cure the circumstances giving rise to the
termination; provided such facts and circumstances giving rise to the termination are capable of being cured and do not relate to malfeasance
or fraudulent acts of the Executive.
Section 5.06 Date
of Termination. “Date of Termination” shall mean (a) if the Employment Period is terminated as a result of
a Permanent Disability, five (5) days after a Notice of Termination is given, (b) if the Employment Period is terminated by
the Executive, the date specified in the Notice of Termination consistent with the terms hereof which shall be no sooner than sixty (60)
days following delivery of such notice (which notice period may be waived by the Company), (c) if the Employment Period terminates
due to expiration of the term of this Agreement (including pursuant to a Notice of Non-Renewal), the date the term expires, and (d) if
the Employment Period is terminated for any other reason (including for Cause), the date designated by the Company in the Notice of Termination,
subject to Section 5.05.
Article 6
CONFIDENTIAL INFORMATION
Section 6.01 Nondisclosure
and Nonuse of Confidential Information. The Executive will not disclose or use at any time during or after the Employment Period any
Confidential Information, whether or not such information is developed by him, except to the extent that such disclosure or use is directly
related to and required by the Executive’s performance of duties. Under all circumstances and at all times, the Executive will take
all appropriate steps to safeguard Confidential Information in his possession and to protect it against disclosure, misuse, espionage,
loss and theft.
Section 6.02 Protected
Disclosures. Nothing in this Agreement or any other agreement between the Executive and the Company or any of its subsidiaries in
effect as of the date the Executive receives this Agreement (together, the “Subject Documents”) shall prevent the Executive
from (a) communicating directly with, cooperating with, or providing information to, or receiving financial awards from, any federal,
state or local government agency, including without limitation the U.S. Securities and Exchange Commission, the U.S. Commodity Futures
Trading Commission, the U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations
Board, without notifying or seeking permission from the Company, provided, however, to the fullest extent provided by law, the Executive
acknowledges and agrees that the Executive is waiving any right to recover monetary damages and other relief in connection therewith (but
not the right to recover a whistleblower award, which the Executive retains), (b) exercising any rights the Executive may have under
Section 7 of the U.S. National Labor Relations Act, such as the right to engage in concerted activity, including collective action
or discussion concerning wages or working conditions, or (c) discussing or disclosing information about unlawful acts in the workplace,
such as harassment or discrimination based on a protected characteristic or any other conduct that the Executive has reason to believe
is unlawful. In addition, the Executive acknowledges receipt of the following notice of immunity rights under the U.S. Defend Trade Secrets
Act, which states: “(1) An individual shall not be held criminally or civilly liable under any federal or state trade secret
law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state, or local government official,
either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation
of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal;
and (2) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose
a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files
any document containing the trade secret under seal, and (B) does not disclose a trade secret, except pursuant to court order.”
Article 7
INTELLECTUAL PROPERTY
Section 7.01 Ownership
of Intellectual Property. In the event that the Executive as part of his activities on behalf of the Company or its Affiliates generates,
authors or contributes to any invention, design, new development, device, product, method of process (whether or not patentable or reduced
to practice or comprising Confidential Information), any copyrightable work (whether or not comprising Confidential Information) or any
other form of Confidential Information relating directly or indirectly to the business of the Company or its Affiliates as now or hereinafter
conducted (collectively, “Intellectual Property”), the Executive acknowledges that such Intellectual Property is the
sole and exclusive property of the Company and its Affiliates and hereby assigns all right title and interest in and to such Intellectual
Property to the Company and its Affiliates. Any copyrightable work prepared in whole or in part by the Executive during the Employment
Period will be deemed “a work made for hire” under Section 201(b) of the United States Copyright Act of 1976, as
amended, and the Company and its Affiliates will own all of the rights comprised in the copyright therein. The Executive will promptly
and fully disclose all Intellectual Property and will cooperate with the Company and its Affiliates to protect the interests of the Company
and its Affiliates in and rights to such Intellectual Property (including providing reasonable assistance in securing patent protection
and copyright registrations and executing all documents as reasonably requested by the Company or its Affiliates, whether such requests
occur prior to or after termination of Executive’s employment hereunder).
Article 8
DELIVERY OF MATERIALS UPON TERMINATION OF EMPLOYMENT
Section 8.01 Delivery
of Materials upon Termination of Employment. As requested by the Company, from time to time and upon the termination of the Executive’s
employment with the Company for any reason, the Executive will promptly deliver to the Company all property of the Company and its Affiliates
in the Executive’s possession or within his control, including, without limitation, all copies and embodiments, in whatever form
or medium, of all Confidential Information or Intellectual Property (including written records, notes, photographs, manuals, notebooks,
documentation, program listings, flow charts, magnetic media, disks, diskettes, tapes and all other materials containing any Confidential
Information or Intellectual Property), irrespective of the location or form of such property and, if requested by the Company, will provide
the Company with written confirmation that all such property has been delivered to the Company.
Article 9
NONCOMPETITION AND NONSOLICITATION
Section 9.01 Noncompetition.
The Executive acknowledges that during his employment with the Company, he will become familiar with Confidential Information concerning
the Company, its subsidiaries and their respective predecessors, and that his services will be of special, unique and extraordinary value
to the Company. The Executive hereby agrees that any time during the Employment Period and for a period of twelve (12) months after the
termination of the Executive’s employment for any reason, he will not directly or indirectly own, manage, control, participate in,
consult with, render services for or in any manner engage in any activity competing with the business of the Company or its Affiliates
(which, for reference, as of the date hereof is initially and primarily focused on the excess and surplus lines insurance markets) or
its subsidiaries as such business exists as of the Date of Termination, within any geographical area in which the Company or its subsidiaries
engage in such business. It shall not be considered a violation of this Section 9.01 for the Executive to be a passive owner of not
more than 2% of the outstanding stock of any class of a corporation which is publicly traded, so long as the Executive has no active participation
in the management or operation of such corporation. The preceding notwithstanding, in the event of a termination by the Company Without
Cause, the Company shall have the right, in its sole discretion, to reduce the twelve month noncompetition period. In the event of such
reduction, the Severance Amount due the Executive under Section 5.03(a) shall be correspondingly reduced to match the actual
period of noncompetition period (but shall in no event equal less than three (3) months of Base Salary).
Section 9.02 Nonsolicitation.
The Executive acknowledges that during his employment with the Company, he will become familiar with Confidential Information concerning
the Company, its Affiliates and their respective predecessors, and that his services will be of special, unique and extraordinary value
to the Company. The Executive hereby agrees that (a) during the Employment Period and for a period of eighteen (18) months after
the date of termination of employment (the “Nonsolicitation Period”) the Executive will not, directly or indirectly,
(i) induce or attempt to induce any employee of the Company or its Affiliates to leave the employ of the Company or its Affiliates
or (ii) on his own behalf or on behalf of any other Person, hire any employee of the Company
or its Affiliates, and (b) during the Nonsolicitation Period, the Executive will not induce or attempt to induce any customer,
supplier, client, insured, reinsured, reinsurer, broker, agent, licensee or other business relation of the Company or its Affiliates to
cease doing business with the Company or its Affiliates.
Section 9.03 Enforcement.
If a court of competent jurisdiction holds that any provision of the restrictive covenants contained in Section 9.01 or 9.02 (including
duration or scope) are unreasonable under circumstances then existing, the parties agree that the maximum duration and scope reasonable
under such circumstances will be substituted for the stated duration or scope and that the court will be permitted to revise the restrictions
contained in this Article 9 to cover the maximum scope and duration permitted by law.
Article 10
EQUITABLE RELIEF
Section 10.01 Equitable
Relief. The Executive acknowledges that (a) the covenants contained herein are reasonable, (b) the Executive’s services
are unique, and (c) a breach or threatened breach by him of any of his covenants and agreements with the Company and its Affiliates
contained in Sections 6.01, 7.01, 8.01, 9.01 or 9.02 could cause irreparable harm to the Company or its Affiliates for which they
would have no adequate remedy at law. Accordingly, and in addition to any remedies which the Company and its Affiliates may have at law,
in the event of an actual or threatened breach by the Executive of his covenants and agreements contained in Sections 6.01, 7.01,
8.01, 9.01 or 9.02, the Company and its Affiliates shall have the absolute right to apply to any court of competent jurisdiction for such
injunctive or other equitable relief as such court may deem necessary or appropriate in the circumstances.
Article 11
EXECUTIVE REPRESENTATIONS
Section 11.01 Executive
Representations. The Executive hereby represents and warrants to the Company that (a) the execution, delivery and performance
of this Agreement by the Executive does not and will not conflict with, breach, violate or cause a default under any contract, agreement,
instrument, order, judgment or decree to which the Executive is a party or by which he is bound, (b) the Executive is not a party
to or bound by any employment agreement, noncompetition agreement or confidentiality agreement with any other Person that affects his
right or ability to perform the duties contemplated by this Agreement, (c) the Executive did not, while working for any employer
other than the Company: solicit his fellow employees to leave their employment and work with him at the Company; or solicit clients, or
potential clients, of such employer, for the Company; or take any type of information that is proprietary information of such employer,
and (d) upon the execution and delivery of this Agreement by the Company, this Agreement will be the valid and binding obligation
of the Executive, enforceable in accordance with its terms.
Article 12
MISCELLANEOUS
Section 12.01 Remedies.
The Company will have all rights and remedies set forth in this Agreement, all rights and remedies which the Company has been granted
at any time under any other agreement or contract and all of the rights which the Company has under any law. The Company will be entitled
to enforce such rights specifically, without posting a bond or other security, to recover damages by reason of any breach of any provision
of this Agreement and to exercise all other rights granted by law. There are currently no disciplinary or grievance procedures in place,
there is no collective agreement in place, and there is no probationary period.
Section 12.02 Consent
to Amendments. The provisions of this Agreement may be amended or waived only by a written agreement executed and delivered by the
Company and the Executive. No other course of dealing between the parties to this Agreement or any delay in exercising any rights hereunder
will operate as a waiver of any rights of any such parties.
Section 12.03 Successors
and Assigns. All covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto will bind and inure
to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not; provided that the Executive
may not assign his rights or delegate his obligations under this Agreement without the written consent of the Company.
Section 12.04 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.
Section 12.05 Counterparts.
This Agreement may be executed simultaneously in two counterparts, any one of which need not contain the signatures of more than one party,
but all of which counterparts taken together will constitute one and the same agreement.
Section 12.06 Descriptive
Headings. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement.
Section 12.07 Notices.
All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement will be in
writing and shall be delivered personally by hand, by electronic transmission (with a copy following by hand or by overnight courier),
by registered or certified mail, postage prepaid, return receipt requested, or by overnight courier service (charges prepaid). Communications
delivered personally by hand shall be deemed received on the date when delivered personally to the recipient; communications sent by electronic
means shall be deemed received one (1) business day after the sending thereof; communications sent by registered or certified mail
shall be deemed received four (4) business days after the sending thereof; and communications delivered by overnight courier shall
be deemed received one (1) business day after the date when sent to the recipient. Such notices, demands and other communications
will be sent to the Executive and to the Company at the addresses set forth below.
| If to the Executive: |
| |
Chris Schenk |
| |
[***] |
| |
|
| If to the Company: |
Ategrity Specialty Holdings LLC |
| |
9 West 57th Street, 33rd Floor |
| |
New York, NY 10019 |
| |
Attn: Justin Cohen |
| |
|
| With a copy to: |
Zimmer Financial Services
Group LLC |
| |
9 West 57th Street, 33rd Floor |
| |
New York, NY 10019 |
| |
Attn: Jelena Napolitano |
| |
|
| And: |
Latham & Watkins LLP |
| |
1271 Avenue of the Americas |
| |
New York, NY 10020 |
| |
Attn: Gary Boss |
or to such other address or to the attention of
such other person as the recipient party has specified by prior written notice to the sending party.
Section 12.08 Withholding.
The Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.
Section 12.09 Section 409A.
It is intended that this Agreement will comply with Section 409A and Section 457A of the Internal Revenue Code of 1986, as amended
(the “Code”) (and any regulations and guidelines issued thereunder), to the extent the Agreement is subject thereto,
and the Agreement shall be interpreted on a basis consistent with such intent. If an amendment of the Agreement is necessary in order
for it to comply with Section 409A or Section 457A, the parties hereto will negotiate in good faith to amend the Agreement in
a manner that preserves the original intent of the parties to the extent reasonably possible. No action or failure to act, pursuant to
this Section 12.09 shall subject the Company to any claim, liability, or expense, and the Company shall not have any obligation to
indemnify or otherwise protect the Executive from the obligation to pay any taxes, interest or penalties pursuant to Section 409A
and Section 457A of the Code.
Notwithstanding any provision
to the contrary in this Agreement, if the Executive is deemed on the date of his “separation from service” (within the meaning
of Treasury Regulation Section 1.409A-1(h)) to be a “specified employee” within the meaning of that term under Section 409A(a)(2)(B) of
the Code, then with regard to any payment that is required to be delayed pursuant to Section 409A(a)(2)(B) of the Code (after
taking into account the applicable provisions of Treasury Regulation Section 1.409A-1(b)(9)(iii)), the portion, if any, of such payment
so required to be delayed shall not be made prior to the earlier of (i) the expiration of the six (6)-month period measured from
the date of his “separation from service” or (ii) the date of his death (the “Delay Period”). Upon
the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section (whether they would have otherwise
been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum,
and any remaining payments due under this Agreement shall be paid in accordance with the normal payment dates specified for them herein.
Whenever payments under this Agreement are to be made in installments, each such installment shall be deemed to be a separate payment
for purposes of Section 409A of the Code. In no case will compliance with this Section by the Company constitute a breach of
the Company’s obligations under this Agreement. Notwithstanding any provision of this Agreement to the contrary, for purposes of
any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment that
are considered deferred compensation under Section 409A, references to Executive’s “termination of employment”
(and corollary terms) with the Company shall be construed to refer to Executive’s “separation from service” (within
the meaning of Treas. Reg. Section 1.409A-1(h)) with the Company.
With respect to any reimbursement
or in-kind benefit arrangements of the Company and its subsidiaries that constitute deferred compensation for purposes of Section 409A,
except as otherwise permitted by Section 409A, the following conditions shall be applicable: (i) the amount eligible for reimbursement,
or in-kind benefits provided, under any such arrangement in one calendar year may not affect the amount eligible for reimbursement, or
in-kind benefits to be provided, under such arrangement in any other calendar year (except that the health and dental plans may impose
a limit on the amount that may be reimbursed or paid), (ii) any reimbursement must be made on or before the last day of the calendar
year following the calendar year in which the expense was incurred, and (iii) the right to reimbursement or in-kind benefits is not
subject to liquidation or exchange for another benefit.
Section 12.10 Excess
Parachute Payments.
(a) Notwithstanding
any other provision of this Agreement, in the event that the amount of payments or other benefits payable to the Executive under this
Agreement (including, without limitation, the acceleration of any payment or the accelerated vesting of any payment or other benefit),
together with any payments, awards or benefits payable under any other plan, program, arrangement or agreement maintained by the Company
or one of its Affiliates, would constitute an “excess parachute payment” (within the meaning of Section 280G of the Code),
the payments under Section 5.03 of this Agreement shall be reduced (by the minimum possible amounts) until no amount payable to the
Executive under this Agreement constitutes an “excess parachute payment” (within the meaning of Section 280G of the Code);
provided, however, that no such reduction shall be made if the net after-tax payment (after taking into account federal,
state, local or other income, employment and excise taxes) to which the Executive would otherwise be entitled without such reduction would
be greater than the net after-tax payment (after taking into account federal, state, local or other income, employment and excise taxes)
to the Executive resulting from the receipt of such payments with such reduction.
(b) All
determinations required to be made under this Section 12.10, including whether a payment would result in an “excess parachute
payment” and the assumptions to be utilized in arriving at such determinations, shall be made by an accounting firm designated by
the Company (the “Accounting Firm”) which shall provide detailed supporting calculations both to the Company and the
Executive as requested by the Company or the Executive. All fees and expenses of the Accounting Firm shall be borne solely by the Company
and shall be paid by the Company. Absent manifest error, all determinations made by the Accounting Firm under this Section 12.10
shall be final and binding upon the Company and the Executive.
Section 12.11 No
Third Party Beneficiary. This Agreement will not confer any rights or remedies upon any person other than the Company and its Affiliates,
the Executive and their respective heirs, executors, successors and assigns.
Section 12.12 Entire
Agreement. Effective as of the Commencement Date, this Agreement (including the documents referred to herein) shall constitute the
entire agreement among the parties and shall supersede any prior understandings, agreements or representations by or among the parties,
written or oral, that may have related in any way to the subject matter hereof.
Section 12.13 Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of
strict construction will be applied against any party. Any reference to any federal, state, local or foreign statute or law will be deemed
also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The use of the word “including”
in this Agreement means including without limitation and is intended by the parties to be by way of example rather than limitation.
Section 12.14 Survival.
Sections 5.02, 5.03, 6.01, 7.01, 8.01 and Articles 9, 10, 11 and 12 will survive and continue in full force in accordance with
their terms notwithstanding any termination of the Employment Period.
Section 12.15 GOVERNING
LAW. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY AND INTERPRETATION OF THIS AGREEMENT WILL BE GOVERNED BY THE LAWS OF THE
STATE OF ARIZONA, WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS.
Section 12.16 Jurisdiction.
The parties agree to the nonexclusive jurisdiction of the federal and state courts situated in Maricopa County, Arizona, for the resolution
of any dispute arising under this Agreement or under any share-based award agreements between the Company and the Executive.
Section 12.17 Arbitration.
Any dispute, controversy or claim arising out of or related to this Agreement or any breach of this Agreement shall
be submitted to and decided by binding arbitration. Arbitration shall be administered exclusively by Judicial Arbitration and Mediation
Services and shall be conducted consistent with the rules, regulations, and requirements thereof as well as any requirements imposed by
state law. Any arbitral award determination shall be final and binding upon the parties.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the date and year first above written.
| | ATEGRITY SPECIALTY HOLDINGS LLC |
| | | |
| By: | /s/ Justin Cohen |
| | | Printed Name: Justin Cohen |
| | | Title: Chief Executive Officer |
| | | |
| | /s/ Chris Schenk |
| | Name: Chris Schenk |
[Signature
Page to Schenk Employment Agreement]
Exhibit 10.18
EMPLOYMENT AGREEMENT
This EMPLOYMENT AGREEMENT (“Agreement”),
dated as of August 13, 2024, is entered into by and between Ategrity Specialty Holdings LLC, a Delaware limited liability company
(the “Company”) and Neelam Patel (the “Executive”).
The parties hereto agree
as follows:
Article 1
DEFINITIONS
Section 1.01 Definitions.
For purposes of this Agreement, the following terms have the meanings set forth below:
“Accounting Firm”
has the meaning set forth in Section 12.10(b).
“Affiliate”
means any Person, directly or indirectly, through one or more intermediaries, Controlling, Controlled by, or under common Control with
the Company. For purposes hereof, (a) “Control” means the ownership, directly or indirectly, of (i) in the
case of a corporation, Voting Securities (as defined below) representing 50% or more of the total voting power or value of all the then
outstanding Voting Securities of such corporation or (ii) in the case of a partnership, limited liability company, association or
other business entity (“Business Entity”), 50% or more of the partnership or other similar ownership interest of such
Business Entity; and (b) “Voting Security” means any security of a corporation which carries the right to vote
generally in the election of directors. For purposes of the definition of “Control,” (x) a Person will be deemed to
have a 50% or more ownership interest in a Business Entity if such Person is allocated 50% or more of Business Entity gains or losses
or controls the managing director or member or general partner of such Business Entity; and (y) “Controlling”
and “Controlled” have meanings correlative thereto.
“Base Salary”
has the meaning set forth in Section 4.01.
“Board”
means the Board of Managers of the Company.
“Cause”
means (a) theft, embezzlement, dishonesty, fraud or breach of fiduciary duty by the Executive with respect to the Company or its
Affiliates; (b) willful misconduct or gross negligence in the performance of the Executive’s duties; (c) the commission
by the Executive of any felony or any crime involving moral turpitude; (d) violation of any applicable local, state or federal law
or regulation affecting the Company in any material respect, as determined by the Company and the Board; (e) willful or prolonged
absence from work by the Executive (other than by reason of disability due to physical or mental illness) or failure, neglect or refusal
by the Executive to perform her duties and responsibilities without the same being corrected within ten (10) days after being given
written notice thereof; (f) continued and habitual use of alcohol by the Executive to an extent which impairs the Executive’s
performance of her duties; (g) the Executive’s use of illegal drugs; or (h) a material breach by the Executive of this
Agreement or the Company’s code of conduct or other similar written policy. Cause shall not exist with respect to items (b),
(e), (f) or (g) unless and until Executive has been given written notice specifying in detail the circumstances giving rise
to the alleged cause.
“Code”
has the meaning set forth in Section 12.09.
“Commencement Date”
means September 3, 2024, or such earlier or later date as the parties may otherwise agree in writing.
“Confidential Information”
means information of the Company or its affiliates, whether in graphic, written, electronic or oral form, including without limitation
information relating to the Company’s business, strategies, designs, products, services and technologies and any derivatives, improvements
and enhancements relating to any of the foregoing, or to the Company’s suppliers, customers or business partners. Confidential
Information may be identified at the time of disclosure as confidential or proprietary or information which by its context would reasonably
be deemed to be confidential or proprietary. “Confidential Information” may also include, without limitation, business and
financial information, including without limitation, purchasing, procurement, manufacturing, customer lists, information relating to
investors, employees, business and contractual relationships, business forecasts, sales and merchandising, business and marketing plans,
product plans, and business strategies, including without limitation information the Company provides regarding third parties, such as,
but not limited to, suppliers, customers, employees, investors, or vendors; and any other information, to the extent such information
contains, reflects or is based upon any of the foregoing Confidential Information. “Confidential Information” may also include
information of a third party that is disclosed to the Executive by the Company or such third party at the Company’s direction.
“Date of Termination”
has the meaning set forth in Section 5.06.
“Employment Period”
has the meaning set forth in Section 2.01.
“Intellectual Property”
has the meaning set forth in Section 7.01.
“Notice of Termination”
has the meaning set forth in Section 5.05.
“Nonsolicitation
Period” has the meaning set forth in Section 9.02.
“Permanent Disability”
means those circumstances where the Executive is unable to continue to perform the usual customary duties of her assigned job or as otherwise
assigned in accordance with the provisions of this Agreement for a period of six (6) months in any twelve (12) month period because
of physical, mental or emotional incapacity resulting from injury, sickness or disease. Any questions as to the existence of a Permanent
Disability shall be determined by a qualified, independent physician selected by the Company and approved by the Executive (which approval
shall not be unreasonably withheld). The determination of any such physician shall be final and conclusive for all purposes of this Agreement.
“Person”
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, an estate, a trust,
a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof.
“Reimbursable Expenses”
has the meaning set forth in Section 4.04.
“Severance Amount”
has the meaning set forth in Section 5.02.
“Target Amount”
has the meaning set forth in Section 4.02.
Article 2
EMPLOYMENT
Section 2.01 Employment.
The Company shall employ the Executive, and the Executive shall accept employment with the Company, for the period beginning on the Commencement
Date and ending as provided in Section 5.01 (the “Employment Period”).
Article 3
POSITION AND DUTIES
Section 3.01 Position
and Duties. During the Employment Period, the Executive shall serve as Chief Financial Officer of the Company. The Executive shall
have such responsibilities, powers and duties as may from time to time be prescribed by the Board; provided that such responsibilities
and duties are substantially consistent with those customarily assigned to individuals serving in comparable positions at comparable
companies or are reasonably required by the conduct of the business of the Company. During the Employment Period, the Executive shall
devote substantially all of her working time and efforts to the business and affairs of the Company. The Executive may serve as a director,
trustee or officer of not-for-profit corporations and entities, including without limitation charitable organizations, and may serve
as a director, trustee or officer of other corporations and entities or engage in other outside activities to the extent that such activities
do not conflict with the business of the Company and its Affiliates with the prior written approval of the Board. During the Employment
Term, Executive shall perform her responsibilities and duties remotely at a location of her discretion in the Tri-State Area; provided,
however, that Executive shall work from the Company’s offices in New York, New York from time to time as requested by the Chief
Executive Officer.
Article 4
BASE SALARY AND BENEFITS
Section 4.01 Base
Salary. During the Employment Period, the Executive’s base salary will be $400,000 per annum (the “Base Salary”).
The Base Salary will be payable bi-weekly.
Section 4.02 Bonuses.
In addition to the Base Salary, the Executive shall be eligible to participate in an annual bonus plan on terms set forth from time to
time by the Board. The Executive’s target annual bonus will be $500,000 per annum (“Target Amount”).
The Executive’s annual bonus shall be based upon the Executive’s individual contribution and the Company’s results.
Any annual bonus payable to the Executive shall be paid no later than the date on which annual bonuses are paid to other Company executives,
and in no event later than March 15 of the year following the calendar year to which the annual bonus relates. The Executive will
also be entitled to a one-time signing bonus of $75,000 (the Signing Bonus) payable within 10 days following the Commencement
Date; provided however, if the Executive voluntarily resigns within 180 days of the Commencement Date, the Executive will be required
to reimburse the Company the full amount of the Signing Bonus.
Section 4.03 Benefits.
In addition to the Base Salary, and any bonuses payable to the Executive pursuant to this Agreement, the Executive shall be entitled
to the following benefits during the Employment Period:
(a) subject
to commercial availability on reasonable terms, benefits under any plan or arrangement available generally for the senior executive officers
of the Company, as set forth from time to time in the applicable plan documents and as may be amended by the Company from time to time;
(b) 20
vacation days (excluding public holidays) with respect to each calendar year during the term of the Employment Period;
(c) The
Company will recommend to the Board that the Executive be granted (at such time as options are granted to employees of the Company generally)
an award of unit options with respect to 1,000,000 units in the Company under the Ategrity Specialty Holdings LLC Equity Incentive Plan
(“Plan”), with an exercise price of $1.00 and a 10-year term (the “Option”). The Option exercise price
will not be less than the fair market value of Company units on the date of grant, will vest annually over five (5) years from the
date of grant, subject to the Executive remaining employed on each applicable vesting date, and will be subject to the terms of the Plan
and the applicable option award agreement.
Section 4.04 Expenses.
The Company shall reimburse the Executive for all reasonable expenses incurred by her in the course of performing her duties under this
Agreement which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and
other business expenses (“Reimbursable Expenses”), subject to the Company’s requirements with respect to reporting
and documentation of expenses.
Section 4.05 Indemnification;
D&O Insurance. The Company shall defend and indemnify the Executive for any claims brought against her arising out of or relating
to, directly or indirectly, her employment with the Company to the fullest extent permitted by law, in accordance with the Company by-laws,
including following any termination of Executive with respect to her conduct or other circumstances occurring prior to such termination.
The Company shall ensure the Executive is covered by the Company’s directors’ and officers’ liability insurance policy
(or policies) during the Employment Period and thereafter to the extent such policy (or policies) is maintained and covers other Company
directors and officers.
Article 5
TERM AND TERMINATION
Section 5.01 Term.
The Employment Period will terminate on the second (2nd) anniversary of the Commencement Date; provided, however, that (a) the
Employment Period shall terminate prior to such date upon the Executive’s death or Permanent Disability, and (b) the Employment
Period may be terminated by the Company or the Executive for any reason prior to such date. In addition, this Agreement will be automatically
extended on the same terms and conditions for successive one-year periods following the original term until either the Company or the
Executive, at least sixty (60) days prior to the expiration of the original term or any extended term, shall give written notice of its
or her intention not to renew the Agreement.
Section 5.02 Termination
without Cause; Termination Due to Death. Except as otherwise provided in Section 12.09, if the Employment Period shall be terminated
by the Company pursuant to Section 5.01 without Cause (such terminations are collectively referred to as “Termination
without Cause”), the Executive shall be paid solely (except as provided in Section 5.04 below) an amount equal to the
sum of (a) six months of the Base Salary (the “Severance Amount”); (b) any awarded but unpaid annual bonus
with respect to a calendar year prior to the year of termination; (c) the Executive's target annual bonus with respect to the calendar
year of termination, prorated for the number of months served by the Executive in the relevant calendar year and (d) six (6) months
of subsidized COBRA coverage, such that the premiums paid for such coverage do not exceed the active employee premiums paid by Executive
immediately prior to termination of employment; provided, however, that the Executive’s entitlement to the amounts set forth
in this Section 5.02 shall be subject to the Executive’s continued compliance with the provisions of Sections 6.01, 7.01,
8.01, 9.01 and 9.02 and the Executive’s execution and non-revocation of a general release of claims in customary form and reasonably
satisfactory to the Company, on or before the date that is thirty (30) days following the Date of Termination, provided that if such
30-day period spans two taxable years, payment will be made in the second taxable year, in accordance with Section 409A of the Code.
Subject to Section 12.09 below, such amount will be paid in a number of equal monthly installments equal to the number of months
of Base Salary due, the first of which to be paid on the date that is two (2) months following the Date of Termination. In addition,
promptly following a Termination without Cause, the Executive shall also be reimbursed for all Reimbursable Expenses incurred by the
Executive prior to such Termination without Cause submitted with reasonable documentation in a timely manner in accordance with the Company’s
policies. In the event of Executive’s death prior to the expiration of the Employment Period, Executive’s estate shall be
entitled the amounts set forth in subsections (b) and (c) above: provided, however, such payments shall be conditioned
upon the execution and non-revocation of a general release by Executive’s estate of claims in customary form and reasonably satisfactory
to the Company.
Section 5.03 Termination
with Cause. If the Employment Period shall terminate due to the Executive’s Permanent Disability or for any other reason other
than as set forth in Section 5.02 above (a “Termination with Cause”), the Executive shall be entitled to receive
solely her Base Salary and accrued and unpaid vacation and employee benefits earned through the date of termination of employment and
reimbursement of all Reimbursable Expenses incurred by the Executive prior to such Termination with Cause submitted with reasonable documentation
in a timely manner in accordance with the Company’s policies.
Section 5.04 Benefits.
Except as otherwise required by mandatory provisions of law, all of the Executive’s rights to fringe and other benefits under this
Agreement or otherwise, if any, will cease upon the termination of the Employment Period.
Section 5.05 Notice
of Termination and Opportunity to Cure. Any termination by the Company for Permanent Disability or Cause or without Cause or by the
Executive shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a “Notice
of Termination” shall mean a notice which shall indicate the date the termination is to take effect (consistent with the terms
of this Agreement), the specific termination provision in this Agreement relied upon and, for a termination for Permanent Disability
or for Cause, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment
under the provision indicated. Upon the delivery of the Notice of Termination for Cause or Permanent Disability, Executive shall have
a period of thirty (30) days from and after the receipt by the Executive of a Notice of Termination to cure the circumstances giving
rise to the termination; provided such facts and circumstances giving rise to the termination are capable of being cured and do not relate
to malfeasance or fraudulent acts of the Executive.
Section 5.06 Date
of Termination. “Date of Termination” shall mean (a) if the Employment Period is terminated as a result of
a Permanent Disability, five (5) days after a Notice of Termination is given, (b) if the Employment Period is terminated by
the Executive, the date specified in the Notice of Termination consistent with the terms hereof which shall be no sooner than sixty (60)
days following delivery of such notice (which notice period may be waived by the Company, in which case the Date of Termination will
be such earlier date as the Company may determine), (c) if the Employment Period terminates due to expiration of the term of this
Agreement, the date the term expires, and (d) if the Employment Period is terminated for any other reason (including for Cause),
the date designated by the Company in the Notice of Termination, subject to Section 5.05.
Article 6
CONFIDENTIAL INFORMATION
Section 6.01 Nondisclosure
and Nonuse of Confidential Information. The Executive acknowledges the confidential and secret character of Confidential Information,
and agrees that the Confidential Information is the sole, exclusive and valuable property of the Company. Accordingly, the Executive
will not use at any time during or after the Employment Period any Confidential Information, whether or not such information is developed
by her, except to the extent that such disclosure or use is directly related to and required by the Executive’s performance of
duties and will not disclose all or any part of the Confidential Information in any form to any third party, either during or after the
Employment Period, without the prior written consent of the Company on a case-by-case basis. Under all circumstances and at all times,
the Executive will take all appropriate steps to safeguard Confidential Information in her possession and to protect it against disclosure,
misuse, espionage, loss and theft. The Executive understands that the Executive’s obligations of nondisclosure with respect to
Confidential Information shall not apply to information that the Executive can establish by competent proof (x) was actually in
the public domain at the time of disclosure or enters the public domain following disclosure other than as a result of a breach of this
Agreement, (y) is already in the Executive’s possession without breach of any obligations of confidentiality at the time of
disclosure by the Company as shown by the Executive’s files and records immediately prior to the time of disclosure, or (z) is
obtained by the Executive from a third party not under confidentiality obligations and without a breach of any obligations of confidentiality.
If the Executive becomes compelled by law, regulation (including without limitation the rules of any applicable securities exchange),
court order, or other governmental authority to disclose the Confidential Information, the Executive shall, to the extent possible and
permissible under applicable law, first give the Company prompt notice. The Executive agrees to cooperate reasonably with the Company
in any proceeding to obtain a protective order or other remedy. If such protective order or other remedy is not obtained, the Executive
shall only disclose that portion of such Confidential Information required to be disclosed, in the opinion of the Executive’s legal
counsel. The Executive shall request that confidential treatment be accorded such Confidential Information, where available. Compulsory
disclosures made pursuant to this section shall not relieve the Executive of her obligations of confidentiality and non-use with respect
to non-compulsory disclosures. The Executive understands that nothing herein is intended to or shall prevent the Executive from (i) communicating
directly with, cooperating with, or providing information to, or receiving financial awards from, any federal, state or local government
agency, including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the
U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations Board, without notifying
or seeking permission from the Company, (ii) exercising any rights the Executive may have under Section 7 of the U.S. National
Labor Relations Act, such as the right to engage in concerted activity, including collective action or discussion concerning wages or
working conditions, or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination
based on a protected characteristic or any other conduct that the Executive has reason to believe is unlawful. The Executive shall promptly
notify the Board or Chief Executive Officer if the Executives learn of any possible unauthorized use or disclosure of Confidential Information
and shall cooperate fully with the Company to enforce its rights in such information.
Section 6.02 Defend
Trade Secrets Act Notice of Immunity Rights. The Executive acknowledges that the Company has provided the Executive notice of the
Executive’s immunity rights under the Defend Trade Secrets Act, which states: “(1) An individual shall not be held criminally
or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in
confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely
for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed
in a lawsuit or other proceeding, if such filing is made under seal; and (2) an individual who files a lawsuit for retaliation by
an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade
secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal, and
(B) does not disclose a trade secret, except pursuant to court order.”
Section 6.03 Property
of the Company. The Executive acknowledges and agrees that all notes, memoranda, reports, drawings, blueprints, manuals, materials,
data, emails and other papers and records of every kind, or other tangible or intangible materials which shall come into the Executive’s
possession in the course of the Executive’s employment with the Company, relating to any Confidential Information, shall be the
sole and exclusive property of the Company and the Executive hereby assigns any rights or interests the Executive may obtain in any of
the foregoing to the Company. The Executive further agrees that any property situated on the Company’s data systems or on the Company’s
premises and owned by the Company, including without limitation electronic storage media, filing cabinets or other work areas, is subject
to inspection by the Company at any time with or without notice.
Article 7
INTELLECTUAL PROPERTY
Section 7.01 Ownership
of Intellectual Property. In the event that the Executive as part of her activities on behalf of the Company or its Affiliates generates,
authors or contributes to any invention, design, new development, device, product, method of process (whether or not patentable or reduced
to practice or comprising Confidential Information), any copyrightable work (whether or not comprising Confidential Information) or any
other form of Confidential Information relating directly or indirectly to the business of the Company or its Affiliates as now or hereinafter
conducted (collectively, “Intellectual Property”), the Executive acknowledges that such Intellectual Property is the
sole and exclusive property of the Company and its Affiliates and hereby assigns all right title and interest in and to such Intellectual
Property to the Company and its Affiliates. Any copyrightable work prepared in whole or in part by the Executive during the Employment
Period will be deemed “a work made for hire” under Section 201(b) of the United States Copyright Act of 1976, as
amended, and the Company and its Affiliates will own all of the rights comprised in the copyright therein. The Executive will promptly
and fully disclose all Intellectual Property and will cooperate with the Company and its Affiliates to protect the interests of the Company
and its Affiliates in and rights to such Intellectual Property (including providing reasonable assistance in securing patent protection
and copyright registrations and executing all documents as reasonably requested by the Company or its Affiliates, whether such requests
occur prior to or after termination of Executive’s employment hereunder).
Article 8
DELIVERY OF MATERIALS UPON TERMINATION OF EMPLOYMENT
Section 8.01 Delivery
of Materials upon Termination of Employment. As requested by the Company, from time to time and upon the termination of the Executive’s
employment with the Company for any reason, the Executive will promptly deliver to the Company all property of the Company and its Affiliates
in the Executive’s possession or within her control, including, without limitation, all copies and embodiments, in whatever form
or medium, of all Confidential Information or Intellectual Property (including written records, notes, photographs, manuals, notebooks,
documentation, program listings, flow charts, magnetic media, disks, diskettes, tapes and all other materials containing any Confidential
Information or Intellectual Property), irrespective of the location or form of such property and, if requested by the Company, will provide
the Company with written confirmation that all such property has been delivered to the Company.
Article 9
NONCOMPETITION
AND NONSOLICITATION
Section 9.01 Noncompetition.
The Executive acknowledges that during her employment with the Company, she will become familiar with Confidential Information concerning
the Company, its subsidiaries and their respective predecessors, and that her services will be of special, unique and extraordinary value
to the Company. The Executive hereby agrees that any time during the Employment Period and for a period of six (6) months after
the termination of the Executive’s employment for any reason (including as a result of Executive’s resignation), she will
not directly or indirectly own, manage, control, participate in, consult with, render services for or in any manner engage in any activity
competing with the business of the Company or its Affiliates (which, for reference, as of the date hereof is initially and primarily
focused on the excess and surplus lines insurance markets) or its subsidiaries as such business exists as of the Date of Termination,
within any geographical area in which the Company or its subsidiaries engage in such business. It shall not be considered a violation
of this Section 9.01 for the Executive to be a passive owner of not more than 2% of the outstanding stock of any class of a corporation
which is publicly traded, so long as the Executive has no active participation in the management or operation of such corporation. The
preceding withstanding, in the event of a termination by the Company Without Cause or as a result of Executive’s resignation, the
Company shall have the right, in its sole discretion, to reduce the six-month noncompetition period. In the event of such reduction,
the Severance Amount due the Executive under Section 5.02 (a) shall be correspondingly reduced to match the actual period of
noncompetition period (but shall no event equal less than three (3) months of Base Salary and three (3) months of subsidized
COBRA coverage in the event of a termination by the Company Without Cause). In the event of Executive’s resignation, the Company
shall have the right, in its sole discretion, to reduce the six-month noncompetition period to zero.
Section 9.02 Nonsolicitation.
The Executive acknowledges that during her employment with the Company, she will become familiar with Confidential Information concerning
the Company, its Affiliates and their respective predecessors, and that her services will be of special, unique and extraordinary value
to the Company. The Executive hereby agrees that (a) during the Employment Period and for a period of twenty four (24) months after
the date of termination of employment (the “Nonsolicitation Period”) the Executive will not, directly or indirectly,
(i) induce or attempt to induce any employee of the Company or its Affiliates to leave the employ of the Company or its Affiliates
or (ii) on her own behalf or on behalf of any other Person, hire any employee of the Company
or its Affiliates, and (b) during the Nonsolicitation Period, the Executive will not induce or attempt to induce any customer,
supplier, client, insured, reinsured, reinsurer, broker, agent, licensee or other business relation of the Company or its Affiliates
to cease doing business with the Company or its Affiliates.
Section 9.03 Enforcement.
If a court of competent jurisdiction holds that any provision of the restrictive covenants contained in Section 9.01 or 9.02 (including
duration or scope) are unreasonable under circumstances then existing, the parties agree that the maximum duration and scope reasonable
under such circumstances will be substituted for the stated duration or scope and that the court will be permitted to revise the restrictions
contained in this Article 9 to cover the maximum scope and duration permitted by law.
Article 10
EQUITABLE RELIEF
Section 10.01 Equitable
Relief. The Executive acknowledges that (a) the covenants contained herein are reasonable, (b) the Executive’s services
are unique, and (c) a breach or threatened breach by her of any of her covenants and agreements with the Company and its Affiliates
contained in Sections 6.01, 7.01, 8.01, 9.01 or 9.02 could cause irreparable harm to the Company or its Affiliates for which they
would have no adequate remedy at law. Accordingly, and in addition to any remedies which the Company and its Affiliates may have at law,
in the event of an actual or threatened breach by the Executive of her covenants and agreements contained in Sections 6.01, 7.01,
8.01, 9.01 or 9.02, the Company and its Affiliates shall have the absolute right to apply to any court of competent jurisdiction for
such injunctive or other equitable relief as such court may deem necessary or appropriate in the circumstances.
Article 11
EXECUTIVE REPRESENTATIONS
Section 11.01 Executive
Representations. The Executive hereby represents and warrants to the Company that (a) the execution, delivery and performance
of this Agreement by the Executive does not and will not conflict with, breach, violate or cause a default under any contract, agreement,
instrument, order, judgment or decree to which the Executive is a party or by which she is bound, (b) the Executive is not a party
to or bound by any employment agreement, noncompetition agreement or confidentiality agreement with any other Person that affects her
right or ability to perform the duties contemplated by this Agreement, (c) the Executive did not, while working for any employer
other than the Company: solicit her fellow employees to leave their employment and work with her at the Company; or solicit clients,
or potential clients, of such employer, for the Company; or take any type of information that is proprietary information of such employer,
and (d) upon the execution and delivery of this Agreement by the Company, this Agreement will be the valid and binding obligation
of the Executive, enforceable in accordance with its terms.
Article 12
MISCELLANEOUS
Section 12.01 Remedies.
The Company will have all rights and remedies set forth in this Agreement, all rights and remedies which the Company has been granted
at any time under any other agreement or contract and all of the rights which the Company has under any law. The Company will be entitled
to enforce such rights specifically, without posting a bond or other security, to recover damages by reason of any breach of any provision
of this Agreement and to exercise all other rights granted by law. There are currently no disciplinary or grievance procedures in place,
there is no collective agreement in place, and there is no probationary period.
Section 12.02 Consent
to Amendments. The provisions of this Agreement may be amended or waived only by a written agreement executed and delivered by the
Company and the Executive. No other course of dealing between the parties to this Agreement or any delay in exercising any rights hereunder
will operate as a waiver of any rights of any such parties.
Section 12.03 Successors
and Assigns. All covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto will bind and
inure to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not; provided that
the Executive may not assign her rights or delegate her obligations under this Agreement without the written consent of the Company.
Section 12.04 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.
Section 12.05 Counterparts.
This Agreement may be executed simultaneously in two counterparts, any one of which need not contain the signatures of more than one
party, but all of which counterparts taken together will constitute one and the same agreement.
Section 12.06 Descriptive
Headings. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement.
Section 12.07 Notices.
All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement will be
in writing and shall be delivered personally by hand, by electronic transmission (with a copy following by hand or by overnight courier),
by registered or certified mail, postage prepaid, return receipt requested, or by overnight courier service (charges prepaid). Communications
delivered personally by hand shall be deemed received on the date when delivered personally to the recipient; communications sent by
electronic means shall be deemed received one (1) business day after the sending thereof; communications sent by registered or certified
mail shall be deemed received four (4) business days after the sending thereof; and communications delivered by overnight courier
shall be deemed received one (1) business day after the date when sent to the recipient. Such notices, demands and other communications
will be sent to the Executive and to the Company at the addresses set forth below.
| |
If to the Executive: |
|
| |
Neelam Patel |
| |
[***] |
| |
|
| |
If to the Company: |
Ategrity Specialty
Holdings LLC |
| |
9 West 57th Street,
33rd Floor |
| |
New York, NY 10019 |
| |
Attn: Justin Cohen |
| |
|
| |
With a copy to: |
Zimmer Financial Services Group
LLC |
| |
9 West 57th St.,
33rd Floor |
| |
New York, NY 10019 |
| |
Attn: Barbara Burger |
| And: | Latham & Watkins LLP |
| | | 1271 Avenue of the Americas |
| | | New York, NY 10020 |
| | | Attn: Gary Boss |
or to such other address or to the attention
of such other person as the recipient party has specified by prior written notice to the sending party.
Section 12.08 Withholding.
The Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.
Section 12.09 Section 409A.
It is intended that this Agreement will comply with Section 409A and Section 457A of the Internal Revenue Code of 1986, as
amended (the “Code”) (and any regulations and guidelines issued thereunder), to the extent the Agreement is subject
thereto, and the Agreement shall be interpreted on a basis consistent with such intent. If an amendment of the Agreement is necessary
in order for it to comply with Section 409A or Section 457A, the parties hereto will negotiate in good faith to amend the Agreement
in a manner that preserves the original intent of the parties to the extent reasonably possible. No action or failure to act, pursuant
to this Section 12.09 shall subject the Company to any claim, liability, or expense, and the Company shall not have any obligation
to indemnify or otherwise protect the Executive from the obligation to pay any taxes, interest or penalties pursuant to Section 409A
and Section 457A of the Code.
Notwithstanding any provision
to the contrary in this Agreement, if the Executive is deemed on the date of her “separation from service” (within the meaning
of Treasury Regulation Section 1.409A-1(h)) to be a “specified employee” within the meaning of that term under Section 409A(a)(2)(B) of
the Code, then with regard to any payment that is required to be delayed pursuant to Section 409A(a)(2)(B) of the Code (after
taking into account the applicable provisions of Treasury Regulation Section 1.409A-1(b)(9)(iii)), the portion, if any, of such
payment so required to be delayed shall not be made prior to the earlier of (i) the expiration of the six (6)-month period measured
from the date of her “separation from service” or (ii) the date of her death (the “Delay Period”).
Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this Section (whether they would have otherwise
been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump
sum, and any remaining payments due under this Agreement shall be paid in accordance with the normal payment dates specified for them
herein. Whenever payments under this Agreement are to be made in installments, each such installment shall be deemed to be a separate
payment for purposes of Section 409A of the Code. In no case will compliance with this Section by the Company constitute a
breach of the Company’s obligations under this Agreement. Notwithstanding any provision of this Agreement to the contrary, for
purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment
that are considered deferred compensation under Section 409A, references to Executive’s “termination of employment”
(and corollary terms) with the Company shall be construed to refer to Executive’s “separation from service” (within
the meaning of Treas. Reg. Section 1.409A-1(h)) with the Company.
With respect to any reimbursement
or in-kind benefit arrangements of the Company and its subsidiaries that constitute deferred compensation for purposes of Section 409A,
except as otherwise permitted by Section 409A, the following conditions shall be applicable: (i) the amount eligible for reimbursement,
or in-kind benefits provided, under any such arrangement in one calendar year may not affect the amount eligible for reimbursement, or
in-kind benefits to be provided, under such arrangement in any other calendar year (except that the health and dental plans may impose
a limit on the amount that may be reimbursed or paid), (ii) any reimbursement must be made on or before the last day of the calendar
year following the calendar year in which the expense was incurred, and (iii) the right to reimbursement or in-kind benefits is
not subject to liquidation or exchange for another benefit.
Section 12.10 Excess
Parachute Payments.
(a) Notwithstanding
any other provision of this Agreement, in the event that the amount of payments or other benefits payable to the Executive under this
Agreement (including, without limitation, the acceleration of any payment or the accelerated vesting of any payment or other benefit),
together with any payments, awards or benefits payable under any other plan, program, arrangement or agreement maintained by the Company
or one of its Affiliates, would constitute an “excess parachute payment” (within the meaning of Section 280G of the
Code), the payments under Section 5.02 of this Agreement shall be reduced (by the minimum possible amounts) until no amount payable
to the Executive under this Agreement constitutes an “excess parachute payment” (within the meaning of Section 280G
of the Code); provided, however, that no such reduction shall be made if the net after-tax payment (after taking
into account federal, state, local or other income, employment and excise taxes) to which the Executive would otherwise be entitled without
such reduction would be greater than the net after-tax payment (after taking into account federal, state, local or other income, employment
and excise taxes) to the Executive resulting from the receipt of such payments with such reduction.
(b) All
determinations required to be made under this Section 12.10, including whether a payment would result in an “excess parachute
payment” and the assumptions to be utilized in arriving at such determinations, shall be made by an accounting, financial services
or other professional services firm or other Person designated by the Company (the “Accounting Firm”) which shall
provide supporting calculations both to the Company and the Executive as requested by the Company or the Executive. All fees and expenses
of the Accounting Firm shall be borne solely by the Company and shall be paid by the Company. Absent manifest error, all determinations
made by the Accounting Firm under this Section 12.10 shall be final and binding upon the Company and the Executive.
Section 12.11 No
Third-Party Beneficiary. This Agreement will not confer any rights or remedies upon any person other than the Company and its Affiliates,
the Executive and their respective heirs, executors, successors and assigns.
Section 12.12 Entire
Agreement. This Agreement (including the documents referred to herein) constitutes the entire agreement among the parties and supersedes
any prior understandings, agreements or representations by or among the parties, written or oral, that may have related in any way to
the subject matter hereof.
Section 12.13 Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of
strict construction will be applied against any party. Any reference to any federal, state, local or foreign statute or law will be deemed
also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The use of the word “including”
in this Agreement means including without limitation and is intended by the parties to be by way of example rather than limitation.
Section 12.14 Survival.
Sections 5.02, 6.01, 7.01, 8.01 and Articles 9, 10, 11 and 12 will survive and continue in full force in accordance with their
terms notwithstanding any termination of the Employment Period.
Section 12.15 GOVERNING
LAW. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY AND INTERPRETATION OF THIS AGREEMENT WILL BE GOVERNED BY THE LAWS OF THE
STATE OF ARIZONA, WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS.
Section 12.16 Jurisdiction.
The parties agree to the nonexclusive jurisdiction of the federal and state courts situated in New York, New York, for the resolution
of any dispute excluded from mandatory arbitration under Section 12.17.
Section 12.17 Arbitration.
Except as excluded herein below, any controversy, dispute or claim arising out of or relating to this Agreement, or breach thereof, or
the Executive’s employment with or termination of employment from the Company (each, a “Covered Claim”) shall
be resolved by final and binding arbitration administered by JAMS. The arbitration shall be conducted by a single, neutral arbitrator,
pursuant to JAMS’s Employment Arbitration Rules & Procedures, available at https://www.jamsadr.com/rules-employment-arbitration/English,
as in effect at the time of the initiation of arbitration, which the Company will provide to the Executive upon reasonable request, in
New York, New York. Notwithstanding anything in this Agreement to the contrary, the arbitration provisions of this Agreement shall be
governed by and enforceable pursuant to the Federal Arbitration Act, and, in all other respects, the arbitrator shall apply the substantive
laws of Arizona or applicable Federal law, with the same statutes of limitation and available remedies that would apply if the claims
were brought in a court of law of competent jurisdiction. The costs unique to arbitration, including the arbitration administrative fees,
arbitrator compensation and expenses, and any costs of any witnesses call by the arbitrator, that would not be incurred in a court proceeding
shall be borne by the Company. Unless otherwise ordered by the arbitrator under applicable law, the Company and the Executive shall each
bear its, their, his, or her own expenses, such as expert witness fees, filing fees, and attorneys’ fees and costs. Nothing herein
shall prevent the Company or the Executive from seeking a statutory award of reasonable attorneys’ fees and costs under applicable
law. THE COMPANY AND THE EXECUTIVE RECOGNIZE THAT, BY AGREEING TO ARBITRATE THEIR DISPUTES, EACH WAIVE ITS, THEIR, HIS, OR HER RIGHT
TO A TRIAL BY JURY OF ANY COVERED CLAIM. THE COMPANY AND THE EXECUTIVE WAIVE ITS, THEIR, HIS, OR HER RIGHT TO BRING ANY COVERED CLAIM
AS PART OF OR IN CONNECTION WITH A CLASS OR COLLECTIVE ACTION. Notwithstanding the foregoing, this Section shall not preclude
either party from seeking a temporary restraining order or a preliminary injunction from a court of competent jurisdiction if such relief
is not available in a timely fashion through arbitration. Further, this arbitration agreement shall not apply to: (a) claims for
unemployment and workers’ compensation benefits; (b) sexual harassment and sexual assault disputes arising under federal,
state, local, or tribal law, unless the Executive elects to arbitrate such disputes; (c) claims arising under the National Labor
Relations Act or which are brought before the National Labor Relations Board; (d) claims brought before the Equal Employment Opportunity
Commission or similar state or local agency, if the Executive is required to exhaust the Executive’s administrative remedies; provided,
that any appeal from an award or denial of an award by any such agency or any further action upon receipt of a right-to-sue letter shall
be arbitrated pursuant to the terms of this Agreement; and (e) any other claim, which by law cannot be subject to mandatory arbitration.
IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the date and year first above written.
| | ATEGRITY SPECIALTY HOLDINGS
LLC |
| | | |
| By: | /s/ Justin Cohen |
| | | Printed
Name: Justin Cohen |
| | | Title:
Chief Executive Officer |
| | | |
| | /s/
Neelam Patel |
| | Name: Neelam Patel |
| [Signature
Page to Patel Employment Agreement] |
Exhibit 21.1
Subsidiaries of Ategrity Specialty Holdings LLC*
| Name |
State
or Other Jurisdiction of Incorporation or Organization |
| |
|
| Ategrity Specialty
Insurance Company |
Delaware |
| |
|
| Ategrity Specialty
Insurance Limited |
Bermuda |
| |
|
| Ategrity Specialty
Holdings Limited |
Bermuda |
* Ategrity
Specialty Holdings LLC will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings prior to the consummation
of this offering.
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We consent to the reference to our firm under the caption “Experts”
and to the use of our report dated March 4, 2025, in the Registration Statement (Form S-1) and the related Prospectus of Ategrity
Specialty Holdings LLC for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Tysons, Virginia
March 24, 2025
Exhibit 99.1
Consent of Director Nominee
In connection with the filing
by Ategrity Specialty Holdings LLC, which will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings
prior to the consummation of this offering (the “Company”), of its Registration Statement (the “Registration Statement”)
on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I
hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company
in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an
exhibit to such Registration Statement and any amendments and supplements thereto.
| |
/s/
William Mercer |
| |
William
Mercer |
Exhibit 99.2
Consent of Director Nominee
In connection with the filing
by Ategrity Specialty Holdings LLC, which will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings
prior to the consummation of this offering (the “Company”), of its Registration Statement (the “Registration Statement”)
on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I
hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company
in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an
exhibit to such Registration Statement and any amendments and supplements thereto.
| |
/s/
Robert C. Merton |
| |
Robert
C. Merton |
Exhibit 99.3
Consent of Director Nominee
In connection with the filing
by Ategrity Specialty Holdings LLC, which will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings
prior to the consummation of this offering (the “Company”), of its Registration Statement (the “Registration Statement”)
on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I
hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company
in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an
exhibit to such Registration Statement and any amendments and supplements thereto.
| |
/s/
Mitchell Pressman |
| |
Mitchell
Pressman |
Exhibit 99.4
Consent of Director Nominee
In connection with the filing
by Ategrity Specialty Holdings LLC, which will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings
prior to the consummation of this offering (the “Company”), of its Registration Statement (the “Registration Statement”)
on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I
hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company
in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an
exhibit to such Registration Statement and any amendments and supplements thereto.
| |
/s/
John (Jack) L. Sennott, Jr. |
| |
John
(Jack) L. Sennott, Jr. |